data_2fjl_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2fjl _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.5 m . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.845 0.355 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.411 ' CD1' ' HA ' ' A' ' 26' ' ' SER . 41.7 mt -84.34 -33.98 9.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.197 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.416 ' HE3' ' CD1' ' A' ' 139' ' ' TRP . 2.9 mmtt -134.38 139.36 45.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.02 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -149.79 125.54 10.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.803 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -169.99 178.62 42.76 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.476 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 23.1 mm -94.02 90.02 2.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.882 0.372 . . . . 0.0 111.034 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -92.04 139.67 30.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.929 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -79.86 164.84 23.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.97 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.3 tt -171.86 134.38 0.78 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.932 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.417 ' HG3' ' CZ3' ' A' ' 17' ' ' TRP . 14.6 mt-10 -65.31 90.54 0.1 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.962 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.72 138.36 96.86 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.679 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.56 -8.66 22.91 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.447 2.098 . . . . 0.0 112.552 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.4 t -67.43 -42.4 87.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.992 0.425 . . . . 0.0 110.998 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -132.1 4.54 4.1 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.555 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 8.5 t-160 52.66 59.49 4.45 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.915 0.388 . . . . 0.0 111.147 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -158.68 159.59 35.48 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.884 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.417 ' CZ3' ' HG3' ' A' ' 10' ' ' GLU . 46.4 m95 -57.6 129.86 43.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.923 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -134.67 124.64 17.0 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.836 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.13 88.54 0.82 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.377 2.052 . . . . 0.0 112.318 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -111.75 151.89 28.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.839 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -60.05 155.74 16.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.898 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.405 ' HB3' ' CH2' ' A' ' 139' ' ' TRP . 0.1 OUTLIER -154.14 138.29 16.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.775 -179.892 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.3 t -127.77 153.86 37.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.37 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -133.5 119.37 19.46 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.923 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.0 p -103.26 157.51 16.96 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.94 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.411 ' HA ' ' CD1' ' A' ' 2' ' ' ILE . 4.1 t -39.94 -32.45 0.16 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.246 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 58.6 m -152.09 48.27 0.77 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.657 0.265 . . . . 0.0 111.467 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.1 mtmm -175.5 156.54 1.97 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.989 0.423 . . . . 0.0 111.252 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.7 mt -124.34 123.7 66.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.707 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -115.5 154.0 30.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.025 0.44 . . . . 0.0 111.255 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 21.6 p90 -158.99 148.9 19.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.713 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 84.2 p . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.033 -179.912 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.38 0 N-CA-C 112.42 -0.272 . . . . 0.0 112.42 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 11.4 p -144.23 151.82 15.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.78 0.324 . . . . 0.0 111.115 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -156.04 170.89 21.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.891 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -100.59 118.56 37.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.976 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.659 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 12.6 p -83.31 -27.6 0.42 Allowed Pre-proline 0 CA--C 1.535 0.403 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.659 ' CD ' ' N ' ' A' ' 95' ' ' VAL . 95.2 Cg_endo -85.51 49.77 2.51 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.153 1.902 . . . . 0.0 112.539 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -179.43 38.13 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.977 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 31.1 p -137.31 173.94 11.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.961 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 50.0 tp60 -137.84 113.5 9.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.703 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 14.6 mm -79.13 159.68 4.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.035 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -151.68 92.5 1.76 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.969 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 50.1 mt -58.24 138.54 19.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.022 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -127.31 107.95 21.35 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.715 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -77.69 22.85 0.58 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.783 2.322 . . . . 0.0 112.631 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -173.38 64.86 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.961 0.41 . . . . 0.0 110.483 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -56.79 -95.84 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.721 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.85 156.04 0.6 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.855 0.36 . . . . 0.0 111.045 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 66.2 m-80 58.43 57.4 3.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.113 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 59.06 58.49 3.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.088 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -152.59 90.14 1.46 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.723 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.43 ' CD1' ' CZ ' ' A' ' 112' ' ' PHE . 0.3 OUTLIER -81.41 -27.97 34.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.184 -179.84 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.43 ' CZ ' ' CD1' ' A' ' 111' ' ' LEU . 36.3 m-85 -101.31 95.59 6.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.001 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 21.4 t -153.6 120.9 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.039 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.441 ' CZ ' ' HB ' ' A' ' 128' ' ' VAL . 42.1 p90 -105.3 122.17 45.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.805 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 22.9 t -92.95 131.44 37.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.12 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.432 HD11 HG21 ' A' ' 116' ' ' ILE . 16.6 mt -97.62 160.72 2.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.828 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 99.2 p -173.29 128.66 0.45 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.094 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.38 127.56 32.66 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.721 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -84.37 48.15 2.38 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.733 2.289 . . . . 0.0 112.708 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.8 m 177.8 39.25 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.935 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.485 ' CG1' ' N ' ' A' ' 122' ' ' ALA . 2.5 p -131.72 -49.61 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.086 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.485 ' N ' ' CG1' ' A' ' 121' ' ' VAL . . . 165.3 40.16 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.195 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 7.0 mm100 51.19 32.16 7.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.148 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 23.0 m95 -69.75 171.59 8.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.895 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 75.3 p -158.23 110.75 2.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.912 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 5.3 tp -100.02 162.01 13.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.881 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -140.26 130.93 25.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.936 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.441 ' HB ' ' CZ ' ' A' ' 114' ' ' PHE . 39.1 t -144.32 147.02 19.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.922 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -139.64 133.88 31.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.244 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -102.85 135.0 45.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.851 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.76 -47.93 59.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.321 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -87.61 117.4 26.39 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.897 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.428 ' HG2' ' CE2' ' A' ' 112' ' ' PHE . 1.3 mt-30 -47.92 -27.96 2.44 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.342 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.66 -42.54 51.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.523 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -64.54 -34.04 77.31 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.055 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 8.9 tt -66.83 -52.24 46.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.543 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -67.03 -36.9 83.12 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.313 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -69.72 -31.53 69.58 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.483 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' TRP . . . . . 0.416 ' CD1' ' HE3' ' A' ' 3' ' ' LYS . 0.4 OUTLIER -67.68 -44.8 76.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.489 179.592 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 23.8 t -61.48 -45.21 99.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.723 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 8.3 ttmt -60.94 -36.22 78.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.633 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.99 -50.03 65.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.347 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 69.0 mt -52.79 -36.88 24.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.246 0.546 . . . . 0.0 109.641 178.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 28.6 mtp85 -78.69 -27.65 45.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.509 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -73.44 -38.38 65.52 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.645 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 13.4 m -79.27 -30.51 14.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.272 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -76.25 -34.16 59.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.396 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -76.12 -11.0 59.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.894 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 15.3 t -119.07 15.52 13.26 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.198 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.204 -0.903 . . . . 0.0 111.092 179.973 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 8.4 t . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.871 0.367 . . . . 0.0 111.24 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 31.0 mt -83.53 -34.6 10.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.082 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.7 tptt -148.75 115.72 6.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.03 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -137.08 137.53 39.42 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.81 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -170.03 -167.92 31.18 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.532 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 23.9 mm -94.27 96.31 5.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.799 0.333 . . . . 0.0 111.056 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.444 ' HG ' ' CZ3' ' A' ' 139' ' ' TRP . 1.3 mm? -101.6 154.28 19.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.847 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.44 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 3.0 m-85 -109.92 131.22 55.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.918 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.432 ' CD1' ' CZ ' ' A' ' 22' ' ' PHE . 3.6 mp -125.09 -2.09 7.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.632 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.447 ' HB3' ' CD2' ' A' ' 17' ' ' TRP . 2.9 pt-20 46.5 -169.8 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.951 0.405 . . . . 0.0 111.449 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -150.5 146.27 19.55 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.531 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -75.04 -17.37 19.5 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.434 2.09 . . . . 0.0 112.577 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.4 t -73.85 -41.73 53.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.935 0.397 . . . . 0.0 111.155 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -106.32 -23.18 12.61 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.906 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 64.88 33.24 10.17 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.917 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -126.0 143.86 50.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.852 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.447 ' CD2' ' HB3' ' A' ' 10' ' ' GLU . 40.0 m95 -90.04 124.81 35.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.042 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.421 ' CE1' ' HA ' ' A' ' 10' ' ' GLU . 1.7 p90 -127.81 147.6 63.56 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.63 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -67.99 124.72 12.14 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.491 2.127 . . . . 0.0 112.452 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -125.55 165.29 18.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.664 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -98.99 110.01 22.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.884 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.433 ' CD2' ' HB3' ' A' ' 31' ' ' TYR . 7.5 m-85 -123.1 132.01 53.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.842 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 29.8 t -121.13 134.39 64.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.92 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 24.6 tp -110.4 107.37 17.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.146 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 17.3 p -100.86 144.2 30.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.788 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.6 p -51.91 -21.47 3.01 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.827 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.412 ' O ' ' CG ' ' A' ' 28' ' ' LYS . 12.6 p -101.19 -27.58 13.14 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.412 ' CG ' ' O ' ' A' ' 27' ' ' SER . 4.5 mtmp? -162.2 -175.45 4.59 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.912 0.387 . . . . 0.0 111.341 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 3.1 mt -128.82 117.31 44.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.677 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -89.28 138.87 31.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.157 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.433 ' HB3' ' CD2' ' A' ' 22' ' ' PHE . 5.4 p90 -162.04 102.7 1.13 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.829 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 34.9 p . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.745 -179.995 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 CA-C-O 120.441 -0.088 . . . . 0.0 112.942 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.0 p -163.74 141.58 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.758 0.313 . . . . 0.0 111.298 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -151.95 153.47 34.16 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.917 0.389 . . . . 0.0 111.05 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -71.99 133.87 45.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.956 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.487 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 13.6 t -75.04 -47.71 4.6 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.707 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 95' ' ' VAL . 73.7 Cg_endo -75.67 58.78 5.42 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.156 1.904 . . . . 0.0 112.495 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -176.21 36.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.974 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 27.3 p -139.12 162.43 34.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.924 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.15 108.74 6.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.859 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 15.1 mm -79.84 160.51 4.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.168 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -161.21 92.26 0.9 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.99 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 45.5 mt -59.47 141.26 16.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.073 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -134.79 106.64 10.66 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.731 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -69.8 50.91 0.86 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.576 2.184 . . . . 0.0 112.409 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 173.36 53.09 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.991 0.424 . . . . 0.0 110.26 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -44.47 -87.43 0.01 OUTLIER Glycine 0 C--N 1.332 0.312 0 CA-C-N 115.986 -0.552 . . . . 0.0 113.127 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.1 mttt 178.96 169.02 0.93 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.997 0.427 . . . . 0.0 111.101 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 60.95 -82.75 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.21 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -150.55 31.85 0.65 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.908 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 1.2 mmt85 -118.0 110.5 17.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.878 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -85.62 -32.07 22.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.954 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.427 ' CE2' ' HG3' ' A' ' 133' ' ' GLN . 5.2 m-85 -105.89 87.52 2.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.87 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 22.0 t -132.21 143.66 39.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.104 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.425 ' CE2' ' HB ' ' A' ' 128' ' ' VAL . 19.0 p90 -125.57 133.65 52.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.928 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -105.18 141.35 36.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.831 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 12.5 mt -105.26 157.91 5.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.97 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 55.8 p -150.13 -166.84 2.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.839 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 28.0 mtp -135.9 155.57 77.76 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.934 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -63.7 73.11 0.16 Allowed 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.692 2.261 . . . . 0.0 112.359 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 59.26 109.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.947 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.0 t -145.56 -66.63 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.058 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.405 ' O ' ' HG2' ' A' ' 123' ' ' GLN . . . -176.01 73.06 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.032 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.405 ' HG2' ' O ' ' A' ' 122' ' ' ALA . 0.0 OUTLIER 40.63 36.87 0.41 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.781 -179.917 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 22.6 m95 -91.89 126.25 36.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.872 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.9 t -165.65 120.37 1.24 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.903 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.88 166.66 10.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.877 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -115.08 142.26 46.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.936 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.425 ' HB ' ' CE2' ' A' ' 114' ' ' PHE . 17.1 t -148.56 154.01 10.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.022 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -159.84 135.08 8.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.252 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -104.71 132.25 51.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.962 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -54.49 -36.75 64.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.069 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.77 111.98 23.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.804 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.427 ' HG3' ' CE2' ' A' ' 112' ' ' PHE . 5.2 tt0 -48.31 -28.64 3.25 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.521 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.95 -40.88 53.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.279 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.53 -33.33 73.93 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.054 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.2 tt -66.68 -48.52 69.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.41 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -69.26 -38.1 78.27 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.291 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -69.88 -28.76 65.9 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.282 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' TRP . . . . . 0.444 ' CZ3' ' HG ' ' A' ' 7' ' ' LEU . 1.3 m95 -69.64 -46.93 65.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.599 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 25.4 t -63.44 -40.11 87.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.033 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 5.5 ttpp -65.59 -36.6 84.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.797 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.42 -50.35 59.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.464 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 54.7 mt -54.53 -35.85 33.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.311 0.577 . . . . 0.0 109.498 178.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 14.4 mtp-105 -76.97 -29.4 55.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.385 179.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -75.87 -32.18 59.61 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-O 120.825 0.345 . . . . 0.0 110.621 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 59.1 t -78.82 -32.18 15.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.142 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.93 -39.68 66.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.845 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -72.47 -16.65 61.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.881 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 11.9 t -111.62 16.81 20.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.896 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.14 -179.963 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.829 0.347 . . . . 0.0 111.2 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.405 HD13 HG22 ' A' ' 2' ' ' ILE . 30.1 mt -85.29 -33.18 7.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.246 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.5 tttp -160.0 141.52 12.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.944 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.419 ' HB3' ' CZ ' ' A' ' 21' ' ' TYR . 5.7 m120 -139.53 132.81 29.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.81 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -169.97 175.53 44.01 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.51 -0.853 . . . . 0.0 112.623 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 22.5 mm -93.1 75.83 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.775 0.321 . . . . 0.0 111.099 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.444 ' CD2' ' CZ2' ' A' ' 139' ' ' TRP . 4.0 mm? -79.05 131.5 36.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.734 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -81.58 155.25 25.78 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.164 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.1 mp -141.46 164.85 29.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.716 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.435 ' HG2' ' CE3' ' A' ' 17' ' ' TRP . 1.4 mm-40 -111.76 111.78 23.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.908 0.385 . . . . 0.0 111.1 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.22 113.04 50.07 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.339 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.58 -17.08 8.94 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.562 2.175 . . . . 0.0 113.137 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.6 t -63.99 -39.66 86.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.018 0.437 . . . . 0.0 110.947 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 16.4 m-80 -128.19 -6.74 5.4 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.597 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 53.84 63.24 2.26 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.88 0.371 . . . . 0.0 111.036 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -148.36 160.86 42.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.892 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.435 ' CE3' ' HG2' ' A' ' 10' ' ' GLU . 70.7 m95 -81.01 136.97 36.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.929 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -137.22 129.29 16.8 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.726 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.1 138.95 31.76 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.487 2.125 . . . . 0.0 112.246 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -155.39 130.04 9.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.911 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.419 ' CZ ' ' HB3' ' A' ' 4' ' ' ASN . 25.4 t80 -74.2 90.63 2.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.907 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -76.84 143.73 39.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.927 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 22.6 t -121.54 102.75 12.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.926 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.4 tt -91.22 112.12 23.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.989 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -106.64 152.04 24.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.826 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 7.7 t -70.11 58.57 0.16 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.714 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 178.38 -28.64 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.875 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.7 mtpt -172.89 168.82 4.92 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.831 0.348 . . . . 0.0 110.864 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 15.3 mt -107.99 128.51 63.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.012 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -121.69 118.51 29.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.868 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.41 ' CZ ' ' HA3' ' A' ' 91' ' ' GLY . 37.7 p90 -123.43 146.86 47.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.944 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.7 m . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.934 179.97 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.41 ' HA3' ' CZ ' ' A' ' 31' ' ' TYR . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 11.4 p -111.44 155.1 12.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.757 0.313 . . . . 0.0 111.127 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -154.29 112.33 3.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.918 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.51 127.14 30.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.091 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.499 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 38.8 t -74.24 -48.4 5.77 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.577 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 95' ' ' VAL . 64.3 Cg_endo -74.16 57.82 4.11 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.19 1.926 . . . . 0.0 112.349 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 171.94 40.55 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.655 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -159.81 99.66 1.41 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.893 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -79.58 136.94 36.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.764 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 6.2 mm -87.26 162.58 2.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.054 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -149.85 83.74 1.4 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.0 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 69.0 mt -58.68 152.82 3.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.078 0.466 . . . . 0.0 111.215 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.94 114.99 4.01 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.213 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -78.42 42.47 1.24 Allowed 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.358 2.038 . . . . 0.0 112.688 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 175.16 62.32 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.045 0.45 . . . . 0.0 110.424 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -53.47 -93.54 0.01 OUTLIER Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.757 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.9 pttt -177.8 170.09 1.97 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.845 0.355 . . . . 0.0 110.949 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 64.07 -79.78 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.859 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -159.51 31.98 0.19 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.957 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 25.1 mmm180 -119.82 92.39 3.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.878 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.8 mp -68.3 -30.75 69.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.854 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -105.66 92.84 4.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.985 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 24.1 t -137.24 143.16 35.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.048 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.42 ' CD1' ' HG ' ' A' ' 136' ' ' LEU . 39.8 p90 -128.9 131.1 47.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.891 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.2 m -102.38 128.33 49.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.833 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 1.6 mt -100.12 159.99 3.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.987 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 60.9 p -153.76 149.95 27.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.945 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 39.7 mtp -96.12 108.48 41.53 Favored Pre-proline 0 CA--C 1.531 0.234 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.106 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -74.97 54.77 3.72 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.72 2.28 . . . . 0.0 112.394 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.9 p 171.39 41.84 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.72 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 45.2 t -150.5 -68.35 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.995 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -177.62 -154.36 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.316 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -85.62 45.62 1.22 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.7 0.286 . . . . 0.0 111.169 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 11.8 m0 -73.95 139.56 44.96 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.784 0.326 . . . . 0.0 110.744 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -140.58 110.25 6.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.097 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.45 112.37 24.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.913 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -84.51 118.75 24.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.98 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.419 ' HB ' ' CE2' ' A' ' 114' ' ' PHE . 21.7 t -141.95 151.79 18.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.925 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.407 ' HA ' ' CE1' ' A' ' 114' ' ' PHE . . . -160.32 148.58 16.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.269 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -114.2 150.41 34.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.909 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.12 -58.82 6.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.864 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.76 113.64 11.14 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.751 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -48.74 -27.56 3.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.567 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 25.8 mp0 -73.84 -40.54 63.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.482 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -67.37 -31.77 72.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.173 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.42 ' HG ' ' CD1' ' A' ' 114' ' ' PHE . 7.5 tt -68.12 -49.44 61.14 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.521 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.78 -40.31 84.0 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.307 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -67.32 -29.21 68.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.322 179.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' TRP . . . . . 0.444 ' CZ2' ' CD2' ' A' ' 7' ' ' LEU . 0.8 OUTLIER -67.82 -49.09 64.16 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.471 179.611 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 33.5 t -60.28 -40.97 85.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.034 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -67.25 -38.37 85.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.907 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 6.4 mptt -66.59 -49.86 64.95 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.524 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 41.6 mt -55.21 -37.14 42.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.369 0.605 . . . . 0.0 109.532 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 24.3 mtp180 -79.85 -25.74 40.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.212 -0.903 . . . . 0.0 110.673 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -76.04 -38.71 56.88 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-O 120.909 0.385 . . . . 0.0 110.75 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.404 HG12 ' N ' ' A' ' 147' ' ' ALA . 7.2 p -80.85 -28.57 11.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.236 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.404 ' N ' HG12 ' A' ' 146' ' ' VAL . . . -79.29 -33.89 42.94 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.291 179.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -74.2 -13.78 60.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.883 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 9.2 t -105.4 -20.5 13.47 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.101 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.216 -0.897 . . . . 0.0 111.141 179.922 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 6.7 m . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.844 0.354 . . . . 0.0 111.184 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.401 ' CD1' ' HA ' ' A' ' 26' ' ' SER . 38.3 mt -76.53 -34.78 24.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.148 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.8 tptp -142.01 91.94 2.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.871 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -125.06 131.91 53.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.919 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -169.88 -165.18 26.83 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.525 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 25.1 mm -97.21 80.45 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.743 0.306 . . . . 0.0 111.1 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.448 ' CD2' ' CZ2' ' A' ' 139' ' ' TRP . 0.8 OUTLIER -87.58 158.62 18.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.779 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -102.16 163.68 12.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.026 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -177.78 129.16 0.14 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.785 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.429 ' HG2' ' CZ3' ' A' ' 17' ' ' TRP . 0.0 OUTLIER -95.16 166.29 11.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.974 0.416 . . . . 0.0 111.024 -179.814 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.42 150.12 53.8 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.709 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -73.63 -17.96 22.84 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.597 2.198 . . . . 0.0 112.506 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.1 t -77.77 -38.62 25.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.985 0.421 . . . . 0.0 110.975 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -101.81 -23.88 14.13 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.835 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 63.87 33.27 12.72 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.822 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -144.76 156.1 43.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.048 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.429 ' CZ3' ' HG2' ' A' ' 10' ' ' GLU . 30.8 m95 -77.24 139.57 39.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.869 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -132.4 138.72 32.81 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.838 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.42 130.26 14.81 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.464 2.11 . . . . 0.0 112.3 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -144.75 -178.34 5.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.864 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -119.96 139.39 52.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.934 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.49 ' CZ ' ' CD1' ' A' ' 31' ' ' TYR . 1.5 m-85 -132.44 148.28 52.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.873 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.7 t -140.0 92.06 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.03 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.84 115.09 8.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.094 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -99.44 157.28 16.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.023 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.401 ' HA ' ' CD1' ' A' ' 2' ' ' ILE . 0.3 OUTLIER -42.83 -34.37 0.93 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.229 -179.47 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.5 p -144.14 46.66 1.43 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.732 0.301 . . . . 0.0 111.622 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 177.12 167.68 0.57 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.834 0.35 . . . . 0.0 111.358 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.472 HD12 HG22 ' A' ' 29' ' ' ILE . 3.0 mt -132.2 100.32 4.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.539 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -73.43 132.17 42.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.172 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.49 ' CD1' ' CZ ' ' A' ' 22' ' ' PHE . 69.4 t80 -143.31 123.37 13.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.783 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.5 t . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.885 179.971 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.419 0 N-CA-C 112.567 -0.213 . . . . 0.0 112.567 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.2 m -84.87 139.47 17.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.733 0.301 . . . . 0.0 111.091 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.1 mt -130.98 134.56 46.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.895 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -69.39 126.8 30.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.871 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.649 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 13.3 p -81.95 -27.73 0.44 Allowed Pre-proline 0 CA--C 1.534 0.347 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.649 ' CD ' ' N ' ' A' ' 95' ' ' VAL . 88.8 Cg_endo -85.97 47.64 1.89 Allowed 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.146 1.898 . . . . 0.0 112.665 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 178.69 39.37 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.865 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 1.9 m -119.48 173.51 6.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.958 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.01 102.59 2.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.769 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 14.7 mm -79.2 158.19 4.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.078 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -155.56 93.17 1.46 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.037 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 54.3 mt -59.25 143.87 13.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.144 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.404 ' C ' ' H ' ' A' ' 105' ' ' GLU . 4.6 mtt180 -133.28 114.15 13.53 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.525 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -74.78 29.87 0.35 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.587 2.191 . . . . 0.0 112.651 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.404 ' H ' ' C ' ' A' ' 103' ' ' ARG . 1.9 tt0 -177.62 74.22 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.734 0.302 . . . . 0.0 110.413 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -42.28 -84.67 0.01 OUTLIER Glycine 0 C--N 1.332 0.344 0 CA-C-N 116.077 -0.51 . . . . 0.0 113.19 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -175.11 -80.5 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.832 0.349 . . . . 0.0 111.236 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -96.8 109.71 22.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.215 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 32.8 m120 48.04 38.78 10.11 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.235 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 7.9 mmp_? -140.11 112.66 7.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.936 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.86 -33.51 12.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.822 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -108.21 107.12 17.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.861 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 22.0 t -151.18 132.3 4.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.128 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.421 ' CZ ' HG12 ' A' ' 128' ' ' VAL . 31.3 p90 -115.54 122.51 45.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.895 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 58.1 m -89.32 128.38 35.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.983 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.405 HD11 HG21 ' A' ' 116' ' ' ILE . 14.1 mt -100.97 158.5 4.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.996 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 54.6 p -151.38 -170.52 3.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.968 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 32.7 mtp -146.82 105.02 3.92 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.073 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -78.16 59.17 6.91 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.506 2.137 . . . . 0.0 112.376 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -177.2 -45.6 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.877 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 43.1 t -65.63 -66.69 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.999 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 179.88 -154.76 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.296 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -84.63 47.63 1.4 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.772 0.32 . . . . 0.0 111.04 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 23.6 m95 -79.94 128.7 33.78 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.804 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.14 114.95 14.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.944 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.3 tp -112.5 112.62 24.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.022 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -82.2 126.46 32.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.858 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.421 HG12 ' CZ ' ' A' ' 114' ' ' PHE . 21.2 t -136.44 154.43 32.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.077 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -161.21 127.37 3.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.144 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -92.55 142.46 27.37 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.978 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -56.0 -37.66 69.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.896 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -97.55 114.02 25.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.797 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -48.5 -27.42 2.69 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.539 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -73.67 -42.12 61.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.357 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.19 -30.21 68.36 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.117 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.402 ' HG ' ' CD1' ' A' ' 114' ' ' PHE . 9.8 tt -68.44 -45.89 71.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.418 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 80.3 mm-40 -68.05 -42.7 80.1 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.309 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -66.87 -30.44 70.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.325 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' TRP . . . . . 0.448 ' CZ2' ' CD2' ' A' ' 7' ' ' LEU . 1.0 OUTLIER -66.38 -46.74 75.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.512 179.563 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 40.6 t -61.45 -44.62 98.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.941 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 7.2 ttmm -63.46 -35.9 81.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.936 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.7 -52.0 49.69 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.476 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 74.0 mt -53.64 -34.92 25.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.28 0.562 . . . . 0.0 109.646 178.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 3.1 mtt180 -78.4 -28.39 46.91 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.584 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -74.91 -39.56 61.37 Favored 'General case' 0 CA--C 1.523 -0.088 0 CA-C-O 120.898 0.38 . . . . 0.0 110.78 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 8.9 m -78.74 -26.71 13.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.258 179.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -77.43 -35.01 54.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.819 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -78.53 -9.58 59.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.136 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 15.2 t -113.5 -30.14 6.95 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.777 0.323 . . . . 0.0 111.144 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.251 -0.88 . . . . 0.0 111.088 -179.989 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.4 p . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.749 0.309 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 33.9 mt -74.93 -30.9 24.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.145 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.9 mttp -147.51 116.79 6.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.964 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -135.37 124.81 24.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.896 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -163.31 -156.07 8.46 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.498 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.405 HD11 ' CD2' ' A' ' 21' ' ' TYR . 26.5 mm -105.53 99.61 8.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.814 0.34 . . . . 0.0 111.184 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.433 HD21 ' CE2' ' A' ' 139' ' ' TRP . 3.2 mm? -102.92 139.88 37.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.834 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -80.68 140.83 35.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.035 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.412 HD13 ' CZ ' ' A' ' 22' ' ' PHE . 5.9 tt -152.49 102.57 2.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.797 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.409 ' HB3' ' CD2' ' A' ' 17' ' ' TRP . 0.6 OUTLIER -70.67 153.26 43.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.878 -179.806 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -113.25 150.71 43.46 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.913 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.07 -17.98 24.34 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.619 2.213 . . . . 0.0 112.549 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -72.4 -48.41 47.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.168 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -100.73 -19.39 16.05 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.936 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 59.9 42.51 16.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.973 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -146.4 146.62 30.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.874 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.417 ' CE2' ' HG3' ' A' ' 110' ' ' ARG . 58.7 m95 -72.72 150.5 42.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.873 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -144.33 139.91 16.22 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.851 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -73.83 87.94 1.1 Allowed 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.583 2.189 . . . . 0.0 112.41 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -104.27 162.64 13.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.874 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.405 ' CD2' HD11 ' A' ' 6' ' ' ILE . 0.8 OUTLIER -93.3 137.64 32.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.845 -179.963 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.501 ' CZ ' ' CE1' ' A' ' 31' ' ' TYR . 44.0 m-85 -138.66 156.56 47.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.938 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 25.3 t -141.17 150.28 20.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.874 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 21.0 tp -133.02 118.37 18.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.237 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 15.0 p -109.76 149.12 30.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.695 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -56.79 -18.72 13.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.863 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.2 m -99.09 -24.7 14.8 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 111.624 0.231 . . . . 0.0 111.624 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.01 -173.92 0.73 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.727 0.298 . . . . 0.0 110.799 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 7.7 mt -110.83 162.28 8.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.705 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -133.59 138.25 45.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.075 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.501 ' CE1' ' CZ ' ' A' ' 22' ' ' PHE . 10.9 t80 -121.25 139.15 53.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.87 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.943 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.226 0 N-CA-C 112.406 -0.278 . . . . 0.0 112.406 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 11.8 p -169.49 131.04 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.77 0.319 . . . . 0.0 111.297 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.9 tp -113.88 -173.74 2.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.542 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -123.71 140.01 53.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.94 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.466 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 22.7 t -86.05 -45.89 0.59 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.982 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' A' ' 95' ' ' VAL . 88.0 Cg_endo -80.36 54.7 5.34 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.258 1.972 . . . . 0.0 112.525 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 176.03 39.57 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.797 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 8.4 m -141.05 -178.88 5.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.979 0.419 . . . . 0.0 111.198 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -160.38 105.5 1.48 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.525 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 14.7 mm -74.47 160.59 5.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.224 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -160.6 92.78 0.98 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.866 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 15.0 mt -57.07 136.4 20.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.017 0.437 . . . . 0.0 111.31 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.87 123.86 26.74 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.197 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -82.71 19.2 1.34 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.465 2.11 . . . . 0.0 112.926 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -169.0 70.95 0.08 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.797 0.332 . . . . 0.0 110.674 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -56.59 -95.13 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.682 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -168.33 165.85 12.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.851 0.357 . . . . 0.0 110.992 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 63.63 -80.4 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.114 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -158.29 31.23 0.24 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.911 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.417 ' HG3' ' CE2' ' A' ' 17' ' ' TRP . 11.7 mmt180 -119.62 85.67 2.42 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.853 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -69.19 -32.22 71.37 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.084 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -97.73 87.71 4.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.017 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 21.4 t -139.94 144.66 27.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.939 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.42 ' CE2' ' HB ' ' A' ' 128' ' ' VAL . 48.9 p90 -118.22 125.51 50.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.895 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.2 t -98.62 133.03 43.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.985 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 14.6 mt -101.67 159.69 4.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.828 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.7 t -151.97 -179.67 7.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.81 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 10.2 mtt -135.38 135.44 22.44 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.833 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -59.4 -66.01 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.479 2.119 . . . . 0.0 112.697 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.65 104.65 11.91 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.327 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.486 ' CG1' ' N ' ' A' ' 122' ' ' ALA . 2.0 p -178.81 -47.99 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.787 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.486 ' N ' ' CG1' ' A' ' 121' ' ' VAL . . . 169.26 -167.41 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.769 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 9.7 mm100 -98.16 36.31 1.6 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.807 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 22.9 m95 -63.94 -177.7 0.27 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.983 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 89.3 p -178.16 103.02 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.758 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 10.0 tp -92.53 104.7 16.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.143 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -85.97 131.85 34.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.822 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.42 ' HB ' ' CE2' ' A' ' 114' ' ' PHE . 22.0 t -152.5 147.53 14.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.06 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -148.27 143.92 27.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.261 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -104.83 135.77 45.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.031 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -54.29 -34.61 61.28 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.995 0.426 . . . . 0.0 110.898 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 5.9 t -95.94 114.89 26.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.669 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -48.96 -26.16 2.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.725 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -75.63 -42.9 50.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.591 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -67.86 -32.0 72.21 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.239 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 7.4 tt -68.99 -46.93 66.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.516 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -68.86 -41.08 78.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.39 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.55 -28.93 68.2 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.357 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' TRP . . . . . 0.433 ' CE2' HD21 ' A' ' 7' ' ' LEU . 1.1 m95 -69.05 -47.51 65.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.608 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 33.2 t -61.53 -40.39 86.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.904 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.94 -38.26 90.36 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.841 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.92 -52.13 52.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.366 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 73.9 mt -53.85 -34.37 25.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.23 0.538 . . . . 0.0 109.644 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -81.23 -27.91 35.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.482 179.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -70.93 -39.95 72.36 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-O 120.906 0.384 . . . . 0.0 110.413 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.403 ' HB ' ' CG1' ' A' ' 95' ' ' VAL . 61.8 t -78.48 -33.55 17.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.859 179.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.34 -34.33 65.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.479 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.88 -11.72 60.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.858 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 10.6 t -120.98 17.07 11.72 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.083 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.282 -0.866 . . . . 0.0 111.082 -179.982 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 25.7 m . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.808 0.337 . . . . 0.0 111.271 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 30.2 mt -85.59 -33.01 7.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.064 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.43 ' HE3' ' CD1' ' A' ' 139' ' ' TRP . 21.2 tttp -158.63 116.41 2.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.007 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -131.72 127.73 37.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.966 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -166.29 -155.54 8.91 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.549 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.408 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 3.4 mp -115.42 100.96 11.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.815 0.341 . . . . 0.0 111.114 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -96.18 140.2 31.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.77 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -76.93 145.35 38.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.127 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -158.06 122.23 4.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.69 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.433 ' HB2' ' CE3' ' A' ' 17' ' ' TRP . 0.7 OUTLIER -74.18 120.9 20.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.11 -179.8 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.47 138.47 59.21 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.028 179.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -67.98 -12.0 33.84 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.192 1.928 . . . . 0.0 112.564 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.4 t -77.76 -36.31 22.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.886 0.374 . . . . 0.0 110.919 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -111.92 -24.39 9.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.044 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 2.4 m170 66.63 34.53 5.8 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.901 0.381 . . . . 0.0 110.654 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.402 ' N ' ' CG ' ' A' ' 10' ' ' GLU . 48.8 mt-10 -138.15 144.54 40.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.859 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.433 ' CE3' ' HB2' ' A' ' 10' ' ' GLU . 49.7 m95 -52.87 146.27 11.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.128 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -150.04 130.65 7.02 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.883 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.94 97.14 1.09 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.436 2.091 . . . . 0.0 112.364 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 15.5 m80 -115.96 149.21 39.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.856 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -65.35 164.44 13.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.946 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.498 ' CD2' ' CD1' ' A' ' 31' ' ' TYR . 0.2 OUTLIER -177.28 119.99 0.11 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.672 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.4 t -104.76 142.16 18.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.101 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 23.1 tp -118.83 103.08 9.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.902 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -101.8 152.2 21.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.865 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.18 -16.69 21.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.643 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.0 p -99.54 -23.34 15.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.575 0.226 . . . . 0.0 111.513 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 178.41 -174.72 0.17 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.897 0.379 . . . . 0.0 110.953 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 6.0 mt -119.62 123.9 71.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.812 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -95.42 160.41 14.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.942 0.401 . . . . 0.0 111.01 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.498 ' CD1' ' CD2' ' A' ' 22' ' ' PHE . 45.8 t80 -151.88 123.35 7.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.765 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.1 t . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.863 -179.993 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.565 -0.214 . . . . 0.0 112.565 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 21.5 t -127.72 136.0 61.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.755 0.312 . . . . 0.0 111.107 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -130.86 120.88 24.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.02 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -57.98 148.58 25.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.928 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.467 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 17.3 t -78.68 -47.94 1.79 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.823 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 95' ' ' VAL . 71.6 Cg_endo -77.49 58.28 6.27 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.225 1.95 . . . . 0.0 112.505 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -179.63 38.68 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.901 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 67.4 m -139.13 178.13 7.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.011 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.4 tm0? -158.71 102.49 1.69 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.72 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 8.3 mm -76.57 160.75 4.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.326 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -153.0 89.47 1.38 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.803 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.437 HG23 HD13 ' A' ' 102' ' ' ILE . 73.9 mt -62.47 145.73 13.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.101 0.477 . . . . 0.0 111.553 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -134.81 125.85 17.57 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.879 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -82.55 25.55 0.67 Allowed 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.431 2.087 . . . . 0.0 113.22 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -178.23 74.34 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.722 0.296 . . . . 0.0 111.013 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -59.13 -96.67 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.578 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.67 173.74 1.59 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.795 0.331 . . . . 0.0 110.938 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 68.36 -68.39 0.17 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.12 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -175.46 36.67 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.903 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -129.98 88.44 2.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.796 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 86.2 mt -59.31 -37.58 78.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.825 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -99.12 119.34 37.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.844 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 9.4 p -155.05 162.18 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.134 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.428 ' CZ ' ' HB ' ' A' ' 128' ' ' VAL . 10.2 p90 -148.66 114.29 5.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.922 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 12.4 m -92.64 140.01 29.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.939 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 13.0 mt -104.95 157.48 5.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.977 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 5.5 t -162.01 138.31 7.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.781 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 29.0 mtp -102.39 96.92 7.85 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.062 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.26 59.06 4.51 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.491 2.127 . . . . 0.0 112.368 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 92.2 p -177.85 37.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.809 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.419 ' CG2' ' N ' ' A' ' 122' ' ' ALA . 0.4 OUTLIER -161.15 -82.33 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.727 -179.854 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.419 ' N ' ' CG2' ' A' ' 121' ' ' VAL . . . -140.59 -168.89 2.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.921 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -93.55 47.45 1.24 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.77 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . 0.407 ' CD1' ' HB1' ' A' ' 122' ' ' ALA . 29.5 m95 -85.28 148.56 26.0 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.853 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 92.1 p -144.34 103.67 4.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.79 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.59 100.55 13.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.059 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -77.37 124.03 27.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.856 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.428 ' HB ' ' CZ ' ' A' ' 114' ' ' PHE . 15.7 t -137.1 152.74 28.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.1 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -157.31 127.11 6.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.234 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -93.12 137.35 32.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.924 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -52.5 -35.78 53.76 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.964 0.412 . . . . 0.0 111.106 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.8 t -96.95 115.41 27.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.742 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.22 -27.46 2.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.566 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.42 -45.44 38.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.44 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -63.92 -32.29 73.77 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.197 179.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.419 ' HG ' ' CD1' ' A' ' 114' ' ' PHE . 7.6 tt -67.45 -51.85 46.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.557 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -67.6 -35.52 79.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.375 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -70.8 -30.66 67.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.419 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' TRP . . . . . 0.43 ' CD1' ' HE3' ' A' ' 3' ' ' LYS . 0.8 OUTLIER -68.72 -45.58 71.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.67 179.749 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 44.6 t -63.49 -42.19 95.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.886 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 11.6 mttm -63.87 -35.62 81.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.809 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.04 -50.41 62.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.603 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 68.6 mt -54.44 -35.57 31.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.328 0.585 . . . . 0.0 109.5 178.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 47.3 mtp180 -78.01 -28.68 49.21 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.447 179.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -76.03 -32.67 59.46 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.864 0.364 . . . . 0.0 110.53 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 90.2 t -80.0 -31.47 13.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.294 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.1 -35.21 66.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.828 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -75.32 -11.08 59.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.144 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 8.9 t -114.27 -34.69 5.23 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.774 0.321 . . . . 0.0 111.097 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.225 -0.893 . . . . 0.0 111.155 -179.928 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.859 0.361 . . . . 0.0 111.12 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 29.6 mt -76.48 -34.2 24.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.047 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.56 169.31 24.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.911 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -166.58 125.4 1.46 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.81 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -159.65 -170.59 24.41 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.583 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 28.4 mm -94.81 92.44 3.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.791 0.329 . . . . 0.0 111.142 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -96.58 129.58 43.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.847 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -79.9 146.32 32.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.917 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -147.59 133.69 19.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.766 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.466 ' CG ' ' CD2' ' A' ' 17' ' ' TRP . 3.2 mt-10 -80.36 118.05 21.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.134 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.72 134.32 50.76 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.352 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -68.8 -10.52 29.34 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.306 2.004 . . . . 0.0 112.654 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.2 t -66.56 -39.22 83.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.924 0.392 . . . . 0.0 110.937 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -138.02 9.34 2.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.463 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 49.79 49.46 20.11 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.92 0.391 . . . . 0.0 111.136 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.55 149.62 49.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.876 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.466 ' CD2' ' CG ' ' A' ' 10' ' ' GLU . 43.2 m95 -72.97 143.57 47.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.911 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -129.92 119.04 18.79 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.79 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -68.82 82.65 0.56 Allowed 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.398 2.065 . . . . 0.0 112.353 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 4.4 m80 -114.23 168.36 9.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.882 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -73.85 172.05 12.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.901 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -167.03 141.42 3.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.877 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 38.8 t -134.68 153.39 34.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.868 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.8 tp -133.41 109.49 9.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.117 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 16.9 p -95.46 157.8 15.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.581 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.4 m -63.73 -13.86 47.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.915 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.0 m -111.43 -7.14 14.38 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 173.55 -174.84 0.06 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.925 0.393 . . . . 0.0 111.29 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 5.8 mt -113.59 136.78 48.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.399 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -113.92 138.36 50.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.861 0.362 . . . . 0.0 111.066 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 54.1 p90 -157.55 158.47 35.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.879 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.893 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.375 0 N-CA-C 112.506 -0.237 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 11.8 p -132.85 137.76 53.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.757 0.313 . . . . 0.0 111.085 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -139.63 129.16 24.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.14 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -60.38 119.7 8.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.82 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.566 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 8.7 p -83.13 -34.18 0.6 Allowed Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.566 ' CD ' ' N ' ' A' ' 95' ' ' VAL . 3.1 Cg_exo -75.24 54.48 3.77 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.262 1.975 . . . . 0.0 112.597 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 168.78 42.56 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.018 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 1.7 m -125.3 162.94 23.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.943 0.401 . . . . 0.0 111.215 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.04 101.18 3.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.542 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 14.2 mm -71.03 160.12 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.403 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -156.08 90.25 1.19 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.898 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.3 mt -56.43 149.28 3.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.33 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 15.6 mtp180 -142.97 113.75 5.83 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.554 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -67.5 0.33 4.22 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.549 2.166 . . . . 0.0 113.034 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -141.27 59.15 1.52 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.988 0.423 . . . . 0.0 110.536 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -43.06 -85.49 0.01 OUTLIER Glycine 0 C--N 1.331 0.251 0 CA-C-N 115.769 -0.65 . . . . 0.0 113.249 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 23.9 ttmt -176.69 160.47 1.95 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.947 0.403 . . . . 0.0 111.358 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 60.53 -84.3 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.128 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -146.41 31.2 1.0 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.951 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.411 ' HG3' ' CE2' ' A' ' 17' ' ' TRP . 13.9 mmt180 -114.57 100.36 8.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.777 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.2 mt -85.08 5.41 29.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.469 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -139.98 78.6 1.67 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.822 0.344 . . . . 0.0 110.972 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 36.2 t -129.13 135.61 61.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.933 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.421 ' CZ ' ' HB ' ' A' ' 128' ' ' VAL . 42.0 p90 -114.48 122.57 47.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.017 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 10.9 t -97.7 136.06 38.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.885 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 10.9 mt -96.31 157.94 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.974 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 1.5 m -150.04 166.85 28.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.951 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 13.7 mtp -139.53 100.43 7.56 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.903 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -79.94 54.69 5.32 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.568 2.179 . . . . 0.0 112.627 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 178.94 49.49 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.98 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.402 ' CG2' ' N ' ' A' ' 122' ' ' ALA . 0.3 OUTLIER -161.85 -82.11 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.92 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.402 ' N ' ' CG2' ' A' ' 121' ' ' VAL . . . -157.08 -165.47 1.84 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.184 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -84.64 56.93 4.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.945 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 39.9 m95 -104.21 148.87 25.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.926 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 14.1 m -153.3 123.66 7.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.808 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 14.4 tp -102.83 155.85 18.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.99 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -131.95 134.41 45.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.836 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.421 ' HB ' ' CZ ' ' A' ' 114' ' ' PHE . 23.7 t -152.38 159.15 3.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.092 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -158.57 117.65 3.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.161 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -81.37 134.98 35.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.842 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -54.47 -34.39 61.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.885 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.94 113.4 24.94 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.744 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -48.04 -27.94 2.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.475 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 -76.65 -44.29 34.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.292 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -65.66 -31.88 73.14 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.011 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 7.2 tt -67.77 -50.78 55.25 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.314 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -66.39 -37.17 84.64 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.262 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -70.43 -31.5 68.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.403 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -67.65 -43.03 81.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.58 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 26.7 t -65.22 -44.2 95.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.848 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 7.3 ttmm -63.84 -33.77 76.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.884 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 17.0 mmtt -67.93 -49.46 61.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.525 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 30.7 mt -54.35 -38.15 39.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.352 0.596 . . . . 0.0 109.517 178.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 66.2 mtt180 -77.95 -27.69 49.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.479 179.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -75.16 -33.23 61.47 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.861 0.362 . . . . 0.0 110.705 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 9.9 p -79.63 -34.3 15.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.065 0.459 . . . . 0.0 110.19 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -71.48 -34.43 70.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.563 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -75.1 -10.7 59.71 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.931 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 10.9 t -126.26 21.34 7.34 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.103 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.166 -0.921 . . . . 0.0 111.19 179.985 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 8.0 t . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 120.885 0.374 . . . . 0.0 111.159 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 39.4 mt -79.79 -34.48 15.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.121 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.7 tttp -140.1 153.82 46.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.01 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -160.97 124.39 3.34 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.924 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -160.4 -178.0 34.01 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.542 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.421 ' N ' ' CD1' ' A' ' 6' ' ' ILE . 3.2 mp -89.52 92.01 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.909 0.385 . . . . 0.0 110.985 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -95.6 135.38 37.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.732 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -76.76 158.36 30.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.95 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.4 tp -161.78 128.19 3.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.808 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.424 ' HG3' ' CZ3' ' A' ' 17' ' ' TRP . 3.4 mt-10 -71.11 111.57 6.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.99 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.92 127.54 66.77 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.53 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -56.69 -16.81 20.56 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.504 2.136 . . . . 0.0 112.899 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 37.8 t -69.36 -41.67 80.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.858 0.361 . . . . 0.0 111.352 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -117.75 -10.18 10.57 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.649 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 62.86 30.84 16.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.789 0.328 . . . . 0.0 110.815 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.64 160.4 39.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.801 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.438 ' NE1' ' HG3' ' A' ' 110' ' ' ARG . 45.0 m95 -56.7 138.04 53.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.051 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -126.07 125.31 24.73 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.686 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.64 112.06 2.95 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.439 2.092 . . . . 0.0 112.228 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 22.0 m80 -148.64 141.79 24.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.871 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -59.38 154.6 16.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.719 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.427 ' CE2' ' CD1' ' A' ' 31' ' ' TYR . 0.1 OUTLIER -147.35 138.86 23.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.976 -179.827 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.8 t -131.41 150.8 34.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.113 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 25.7 tp -134.37 118.99 18.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.952 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 62.6 p -97.95 157.58 16.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.983 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 29.4 t -48.97 -38.08 22.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.85 -0.613 . . . . 0.0 112.057 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.3 m -129.59 39.06 3.78 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.6 tttt 175.01 170.03 0.28 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.007 0.432 . . . . 0.0 111.378 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 3.5 mt -128.87 153.23 38.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.716 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.404 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 0.6 OUTLIER -129.93 146.28 51.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.904 0.383 . . . . 0.0 111.112 -179.889 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.427 ' CD1' ' CE2' ' A' ' 22' ' ' PHE . 39.7 t80 -146.35 143.48 29.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.84 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.963 -179.926 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 11.3 p -151.43 136.33 10.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.877 0.37 . . . . 0.0 111.033 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.92 -176.44 3.48 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.891 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -119.59 141.36 49.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.91 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.465 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 21.8 t -80.87 -46.87 1.19 Allowed Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.778 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 95' ' ' VAL . 84.6 Cg_endo -81.83 50.31 3.44 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.367 2.045 . . . . 0.0 112.497 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -179.55 37.85 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.959 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 14.4 p -134.34 -177.45 4.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.963 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.4 100.79 0.83 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.697 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 16.9 mm -76.82 160.58 4.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.02 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -159.02 91.75 1.05 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.901 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 27.7 mt -58.07 157.47 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.242 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -151.41 112.32 3.01 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.366 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.09 49.25 2.75 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.429 2.086 . . . . 0.0 112.523 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 167.35 61.98 0.0 OUTLIER 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.001 0.429 . . . . 0.0 110.223 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -55.04 -94.97 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.676 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 174.1 163.18 0.19 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.823 0.344 . . . . 0.0 111.014 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 57.07 54.6 6.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.975 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 9.0 m120 62.76 51.98 2.89 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.215 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.438 ' HG3' ' NE1' ' A' ' 17' ' ' TRP . 23.9 mmt180 -147.53 97.38 2.83 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.718 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.01 -32.47 57.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.978 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -102.87 104.21 14.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.939 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 20.4 t -152.0 134.04 5.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.16 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -118.96 131.3 56.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.744 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 15.0 t -100.18 132.86 45.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.965 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 2.4 mp -104.29 159.82 5.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.942 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 70.5 p -155.74 179.99 8.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.905 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' MET . . . . . 0.413 ' CB ' ' CG1' ' A' ' 121' ' ' VAL . 7.3 mtm -143.33 93.26 6.47 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.782 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.93 -2.29 12.51 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.584 2.189 . . . . 0.0 112.794 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 48.6 m -108.9 33.88 4.0 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.718 0.294 . . . . 0.0 111.142 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.413 ' CG1' ' CB ' ' A' ' 118' ' ' MET . 0.4 OUTLIER -160.31 -82.45 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.94 179.907 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.406 ' N ' ' CG2' ' A' ' 121' ' ' VAL . . . -143.98 -166.06 2.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.838 0.351 . . . . 0.0 111.049 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -86.21 55.32 3.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.971 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 89.4 m95 -85.93 142.24 28.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.786 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.16 119.94 5.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.006 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -129.28 124.7 35.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.88 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -86.9 142.89 27.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.949 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 14.0 t -151.32 141.9 15.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.081 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -140.93 131.49 25.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.129 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -93.22 138.58 31.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.92 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -55.5 -39.62 70.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.0 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.73 113.13 25.31 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.905 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -48.05 -28.41 2.81 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.547 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -76.8 -44.29 33.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.328 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -65.65 -32.29 73.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.996 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.2 tt -67.38 -51.22 54.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.394 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 73.4 mm-40 -67.68 -35.25 78.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.192 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -71.5 -30.18 65.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.205 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' TRP . . . . . 0.407 ' CH2' ' HB3' ' A' ' 22' ' ' PHE . 0.5 OUTLIER -67.41 -47.07 71.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.348 179.54 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 23.3 t -61.76 -45.52 98.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.797 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 1.1 ttpt -62.97 -36.94 85.18 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.742 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 17.9 tppt? -65.66 -56.26 13.08 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.294 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 71.0 mt -50.97 -31.76 10.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.107 0.48 . . . . 0.0 109.706 178.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 30.5 mtt180 -78.69 -30.15 45.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.493 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -77.23 -35.94 55.04 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-O 120.761 0.315 . . . . 0.0 110.777 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.405 ' CG2' ' CG1' ' A' ' 95' ' ' VAL . 5.6 m -79.44 -28.45 13.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.306 179.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -74.37 -36.97 63.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.684 179.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -72.34 -13.07 61.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.042 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 11.5 p -106.53 -38.96 6.01 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.107 0.479 . . . . 0.0 110.48 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.271 -0.871 . . . . 0.0 111.291 -179.924 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 24.1 m . . . . . 0 N--CA 1.487 1.409 0 CA-C-O 120.776 0.322 . . . . 0.0 111.179 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.9 mt -88.5 -34.09 6.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.933 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.56 142.1 43.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.768 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -154.58 121.27 5.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.968 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -170.04 -176.32 39.59 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.421 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.2 mp -103.26 89.17 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.866 0.365 . . . . 0.0 111.026 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.408 HD23 ' CE2' ' A' ' 139' ' ' TRP . 3.4 mm? -82.06 142.46 32.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.651 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -77.74 144.67 37.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.29 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.6 mp -152.89 115.55 4.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.611 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.416 ' HB3' ' CE3' ' A' ' 17' ' ' TRP . 2.0 pp20? -72.6 140.73 48.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.257 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.42 148.33 36.98 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.531 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.39 -5.46 17.17 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.434 2.089 . . . . 0.0 112.705 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 25.2 t -65.75 -40.83 88.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.984 0.421 . . . . 0.0 110.724 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -139.12 9.34 2.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.407 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 49.03 59.07 4.71 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.878 0.371 . . . . 0.0 111.266 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -149.1 139.33 22.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.808 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.416 ' CE3' ' HB3' ' A' ' 10' ' ' GLU . 75.5 m95 -57.72 143.03 43.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.895 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -135.73 137.17 24.97 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.84 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.75 90.51 1.22 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.491 2.127 . . . . 0.0 112.399 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 12.7 m170 -112.3 138.72 48.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.008 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -60.19 159.5 9.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.782 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.483 ' CD2' ' CD1' ' A' ' 31' ' ' TYR . 0.1 OUTLIER -170.95 128.69 0.75 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.789 179.901 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 19.1 t -122.22 153.66 26.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.09 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.9 tp -128.58 118.99 23.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.986 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.8 p -99.54 154.43 18.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.846 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.4 m -54.43 -25.53 25.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.832 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.8 p -136.24 35.56 2.77 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.4 mttt 170.9 177.13 0.06 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.973 0.415 . . . . 0.0 111.12 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.8 mt -140.16 131.71 31.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.707 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -110.35 144.32 39.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.938 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.483 ' CD1' ' CD2' ' A' ' 22' ' ' PHE . 35.1 t80 -139.5 130.21 25.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.871 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.777 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.397 0 N-CA-C 112.741 -0.144 . . . . 0.0 112.741 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 10.6 p -158.13 130.84 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.775 0.322 . . . . 0.0 110.903 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -148.48 150.53 33.59 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.103 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -81.96 128.05 33.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.711 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.573 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 8.3 p -71.44 -32.87 2.4 Favored Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' A' ' 95' ' ' VAL . 6.3 Cg_exo -73.9 56.36 3.57 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.202 1.934 . . . . 0.0 112.418 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 170.09 63.48 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.963 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 64.9 m -146.46 168.11 21.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.125 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -154.0 99.47 2.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.606 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 11.2 mm -76.34 159.18 5.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.235 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -154.45 88.21 1.21 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.904 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.408 ' CG2' ' N ' ' A' ' 103' ' ' ARG . 7.6 mt -58.27 156.32 2.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.158 0.504 . . . . 0.0 111.365 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.408 ' N ' ' CG2' ' A' ' 102' ' ' ILE . 33.2 mtt180 -145.81 125.56 6.91 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.082 179.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -82.98 30.06 0.54 Allowed 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.41 2.073 . . . . 0.0 112.914 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -177.75 69.73 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.88 0.371 . . . . 0.0 110.642 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -55.11 -94.21 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.732 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -174.88 169.68 3.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.861 0.362 . . . . 0.0 110.913 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 61.66 -82.69 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.031 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -153.92 31.71 0.45 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.943 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 6.1 mmt85 -117.51 90.2 3.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.834 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.9 mp -62.91 -30.86 71.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.826 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.42 ' CD1' ' HG2' ' A' ' 133' ' ' GLN . 75.2 m-85 -109.82 105.24 14.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.035 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 39.4 t -144.76 138.87 22.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.967 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.417 ' CE2' ' HB ' ' A' ' 128' ' ' VAL . 39.9 p90 -122.88 133.47 54.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.928 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.59 129.49 50.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.933 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 1.7 mt -97.84 159.56 3.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.014 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 52.3 p -156.72 175.22 14.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.964 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' MET . . . . . 0.42 ' CB ' ' CG1' ' A' ' 121' ' ' VAL . 2.2 mtm -137.95 91.56 13.23 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.815 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.45 -2.04 12.19 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.624 2.216 . . . . 0.0 112.816 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.4 m -108.94 31.44 5.68 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.692 0.282 . . . . 0.0 111.261 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.42 ' CG1' ' CB ' ' A' ' 118' ' ' MET . 0.4 OUTLIER -158.41 -82.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.885 179.864 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.41 ' N ' ' CG2' ' A' ' 121' ' ' VAL . . . -146.07 -164.93 2.08 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.079 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -85.05 57.18 4.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.827 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 36.9 m95 -102.47 117.27 34.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.793 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -142.39 138.85 31.43 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.882 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.6 170.08 13.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.901 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -123.87 129.54 51.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.955 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.417 ' HB ' ' CE2' ' A' ' 114' ' ' PHE . 18.7 t -140.94 159.54 23.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.928 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -159.94 148.89 17.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.909 0.385 . . . . 0.0 111.221 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -112.59 135.5 53.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.938 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.47 -35.35 52.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.954 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.04 112.77 24.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.826 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.42 ' HG2' ' CD1' ' A' ' 112' ' ' PHE . 3.1 mt-30 -48.56 -27.8 3.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.725 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -77.12 -43.87 32.51 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.34 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -65.82 -31.25 72.1 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.137 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 7.7 tt -69.84 -50.44 42.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.474 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 36.2 mm-40 -67.87 -36.61 80.57 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.237 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -71.0 -28.51 64.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.407 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' TRP . . . . . 0.408 ' CE2' HD23 ' A' ' 7' ' ' LEU . 0.8 OUTLIER -69.75 -46.32 66.14 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.52 179.667 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 30.5 t -63.45 -42.29 95.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.741 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.45 -36.79 84.9 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.819 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.77 -56.0 14.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.312 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.438 HD13 HG22 ' A' ' 143' ' ' ILE . 65.9 mt -51.6 -31.8 13.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.167 0.508 . . . . 0.0 109.844 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 58.2 mtt180 -80.88 -28.63 35.89 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.535 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.59 -39.52 67.27 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.839 0.352 . . . . 0.0 110.675 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 9.0 m -78.48 -32.72 16.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.072 179.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.42 -34.26 65.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.416 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -73.05 -13.28 61.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.791 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 8.9 t -122.96 19.24 10.09 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.152 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.257 -0.878 . . . . 0.0 111.112 179.92 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 61.7 m . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.765 0.317 . . . . 0.0 111.262 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.436 ' CD1' ' HA ' ' A' ' 26' ' ' SER . 12.3 mt -77.2 -35.55 22.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.887 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -157.92 150.44 22.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.873 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 36.1 p-10 -157.91 137.8 12.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.887 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -170.06 179.06 42.56 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.493 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.7 mp -93.31 79.24 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.933 0.397 . . . . 0.0 111.105 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.458 ' CD2' ' CZ2' ' A' ' 139' ' ' TRP . 2.0 mm? -77.26 163.62 26.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.808 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -100.51 142.51 31.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.04 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -148.64 105.62 3.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.768 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.59 120.74 11.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.126 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.07 129.14 68.46 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.49 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -68.74 -9.82 27.29 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.395 2.063 . . . . 0.0 112.687 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.9 t -64.22 -40.19 88.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.069 0.462 . . . . 0.0 110.602 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 54.6 p30 -142.22 12.81 1.99 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.355 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 50.27 79.35 0.09 Allowed 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 120.666 0.27 . . . . 0.0 111.071 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -162.96 133.34 4.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.922 0.391 . . . . 0.0 111.028 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 29.5 m95 -67.9 137.3 55.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.863 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -137.32 132.27 17.82 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.879 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.22 127.18 24.77 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.414 2.076 . . . . 0.0 112.241 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -135.51 122.17 20.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.869 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -80.24 85.27 5.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.924 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.423 ' CE2' ' HB3' ' A' ' 31' ' ' TYR . 4.0 m-85 -79.42 157.45 27.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.873 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.6 t -143.03 104.38 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.399 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 20.0 tp -86.51 117.36 25.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.717 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -99.7 157.97 16.1 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.301 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.436 ' HA ' ' CD1' ' A' ' 2' ' ' ILE . 7.0 t -44.55 -33.43 1.75 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.835 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.6 m -144.07 46.33 1.44 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.798 0.332 . . . . 0.0 111.403 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.3 mttt 179.27 167.91 1.03 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.939 0.399 . . . . 0.0 111.174 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.1 mt -139.51 106.15 2.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.825 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -97.03 139.61 32.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.989 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.423 ' HB3' ' CE2' ' A' ' 22' ' ' PHE . 13.2 p90 -140.33 112.95 8.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.827 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.5 m . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.837 -179.95 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.421 ' HA3' ' CZ ' ' A' ' 31' ' ' TYR . . . . . . . . 0 N--CA 1.45 -0.399 0 N-CA-C 112.61 -0.196 . . . . 0.0 112.61 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.5 p -95.77 133.52 36.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.765 0.317 . . . . 0.0 111.033 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.7 tp -132.56 152.41 51.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.056 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.454 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 2.3 p30 -89.56 126.88 35.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.752 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.568 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 7.6 p -72.42 -33.33 2.23 Favored Pre-proline 0 CA--C 1.534 0.365 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' A' ' 95' ' ' VAL . 6.4 Cg_exo -74.28 55.23 3.5 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.334 2.022 . . . . 0.0 112.546 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 170.02 66.44 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.999 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 31.1 p -142.87 161.39 38.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.121 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.59 105.97 3.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.636 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.7 mm -78.02 163.33 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.322 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -159.89 87.63 0.81 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.822 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 84.1 mt -56.72 155.16 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.127 0.489 . . . . 0.0 111.292 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.2 mtt85 -148.61 118.19 4.09 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.174 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -81.53 33.85 0.54 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.43 2.086 . . . . 0.0 112.784 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 178.87 69.35 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.894 0.378 . . . . 0.0 110.42 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -61.51 -98.79 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.735 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.54 170.27 21.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.866 0.365 . . . . 0.0 110.976 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 60.85 -83.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.114 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -161.35 31.22 0.14 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.824 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -118.25 94.26 4.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.771 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.9 -34.69 73.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.934 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.411 ' CE2' ' HG3' ' A' ' 133' ' ' GLN . 12.1 m-85 -86.56 81.76 8.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.893 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 23.6 t -134.06 120.45 35.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.153 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.424 ' CD1' ' HG ' ' A' ' 136' ' ' LEU . 38.7 p90 -106.79 120.45 42.05 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.687 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 31.4 t -92.64 131.39 37.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.227 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 6.3 mm -92.99 162.84 2.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.684 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 2.3 m -150.0 -179.55 7.25 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.027 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 31.1 mtp -155.67 96.59 2.38 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.87 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -67.3 -27.01 41.14 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.443 2.095 . . . . 0.0 112.297 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.2 p -94.65 43.57 1.1 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.793 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 44.2 t -154.61 -68.51 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.984 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 179.57 -155.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.225 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 -83.88 49.96 1.73 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.803 0.335 . . . . 0.0 110.977 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 12.4 m0 -83.73 122.88 29.24 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.876 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -142.29 96.11 2.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.671 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -98.58 161.6 13.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.03 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -117.04 142.32 47.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.03 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.401 ' HB ' ' CE2' ' A' ' 114' ' ' PHE . 15.6 t -148.38 141.58 18.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.939 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -146.43 134.33 21.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.307 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -99.81 138.52 36.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.912 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -52.88 -34.67 55.78 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.036 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 9.2 t -102.1 115.94 31.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.844 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.411 ' HG3' ' CE2' ' A' ' 112' ' ' PHE . 0.3 OUTLIER -48.47 -28.0 3.03 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.386 179.424 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -73.31 -39.89 64.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.206 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.32 -32.79 72.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.027 179.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.424 ' HG ' ' CD1' ' A' ' 114' ' ' PHE . 6.2 tt -66.35 -46.4 76.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.48 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 12.8 mm-40 -70.11 -39.2 75.65 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.293 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -68.68 -31.2 70.14 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.325 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' TRP . . . . . 0.458 ' CZ2' ' CD2' ' A' ' 7' ' ' LEU . 1.1 m95 -68.77 -46.72 68.01 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.656 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -60.88 -40.43 85.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.753 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 15.7 mtmt -68.18 -37.38 80.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.742 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 10.5 mttt -67.61 -51.82 45.67 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.295 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 85.8 mt -54.22 -35.13 28.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.308 0.575 . . . . 0.0 109.579 178.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 34.1 mtt180 -79.17 -27.45 42.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.595 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -77.35 -34.04 55.23 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.867 0.365 . . . . 0.0 110.767 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 9.6 p -81.97 -29.46 9.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.372 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -81.0 -34.77 32.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.493 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -79.27 -11.15 59.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.965 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 15.2 t -107.38 -21.5 12.91 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.078 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.215 -0.897 . . . . 0.0 111.14 179.945 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 78.0 p . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 120.845 0.355 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.409 ' CD1' ' HA ' ' A' ' 26' ' ' SER . 19.6 mt -78.27 -34.94 19.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.145 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.31 140.57 4.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.049 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 33.1 p-10 -146.47 141.91 27.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.819 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -163.4 -171.14 29.26 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.467 -0.873 . . . . 0.0 112.611 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.432 HD11 ' CE2' ' A' ' 21' ' ' TYR . 20.8 mm -98.24 80.1 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.777 0.322 . . . . 0.0 111.031 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.456 ' CD2' ' CZ2' ' A' ' 139' ' ' TRP . 1.7 mm? -88.59 134.72 33.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.663 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -73.11 165.56 24.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.242 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -160.01 114.44 2.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.669 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.429 ' HG2' ' CZ3' ' A' ' 17' ' ' TRP . 3.6 pt-20 -73.43 90.49 1.7 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.17 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -60.73 113.33 7.38 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.62 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.66 -18.68 16.27 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.66 2.24 . . . . 0.0 112.916 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.4 t -68.44 -41.11 83.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.897 0.38 . . . . 0.0 111.269 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 -113.92 -13.34 12.56 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.231 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 68.4 m80 61.99 50.91 3.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.862 0.363 . . . . 0.0 110.854 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -152.94 151.7 30.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.792 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.429 ' CZ3' ' HG2' ' A' ' 10' ' ' GLU . 67.1 m95 -80.42 125.1 29.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.931 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -119.85 142.33 32.96 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.813 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -68.6 101.03 0.72 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.46 2.106 . . . . 0.0 112.176 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 35.2 m170 -119.16 138.05 53.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.847 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.432 ' CE2' HD11 ' A' ' 6' ' ' ILE . 0.5 OUTLIER -82.67 140.0 33.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.865 179.995 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.487 ' CZ ' ' CD2' ' A' ' 31' ' ' TYR . 0.2 OUTLIER -133.55 124.78 27.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.914 179.854 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.5 t -111.89 103.31 15.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.829 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.9 tp -82.69 109.37 16.8 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.018 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 43.2 p -99.1 155.94 17.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.794 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.409 ' HA ' ' CD1' ' A' ' 2' ' ' ILE . 1.5 m -65.0 -12.13 46.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.898 -179.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.8 m -121.22 2.78 10.37 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 173.28 -170.91 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.97 0.414 . . . . 0.0 111.316 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.4 mt -136.74 119.91 21.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.838 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -103.03 153.08 20.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.029 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.487 ' CD2' ' CZ ' ' A' ' 22' ' ' PHE . 25.3 p90 -167.17 148.25 5.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.953 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.931 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.417 ' HA3' ' CE1' ' A' ' 31' ' ' TYR . . . . . . . . 0 N--CA 1.45 -0.414 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.6 m -97.87 156.8 3.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.87 0.367 . . . . 0.0 111.062 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 9.9 tp -151.05 129.77 12.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.027 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.39 138.93 49.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.816 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.442 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 18.7 t -79.66 -47.87 1.46 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.752 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.442 ' HD2' ' N ' ' A' ' 95' ' ' VAL . 94.3 Cg_endo -79.07 55.33 5.56 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.232 1.955 . . . . 0.0 112.499 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 175.53 39.53 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.034 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -156.82 104.15 2.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.943 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -89.76 131.32 35.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.765 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 11.5 mm -82.28 160.93 3.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.147 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -154.93 93.95 1.6 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.959 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 46.3 mt -58.48 151.25 4.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.089 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.41 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 10.3 mtt180 -140.72 114.26 7.21 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.617 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 103' ' ' ARG . 5.9 Cg_exo -74.11 11.54 1.18 Allowed 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.681 2.254 . . . . 0.0 112.942 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.74 65.39 0.6 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.925 0.393 . . . . 0.0 110.423 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -48.87 -90.24 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.935 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -171.74 171.61 5.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.89 0.376 . . . . 0.0 111.127 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 60.69 -83.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.233 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -155.07 32.13 0.39 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.069 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 15.1 mtt-85 -122.05 109.97 15.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.806 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -96.51 23.48 6.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.124 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -143.99 68.65 1.27 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.921 0.391 . . . . 0.0 110.764 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 39.5 t -130.02 140.96 47.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.047 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.456 ' CE2' ' CG2' ' A' ' 128' ' ' VAL . 25.1 p90 -117.64 132.71 56.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.589 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.4 m -110.58 137.23 48.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.093 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 2.9 mp -99.89 159.08 3.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.85 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 20.1 m -147.87 159.65 43.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.901 0.382 . . . . 0.0 110.953 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 12.9 mtp -113.05 155.33 44.43 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.889 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.96 74.35 0.33 Allowed 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.541 2.161 . . . . 0.0 112.228 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 13.3 p 58.87 107.65 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.985 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.5 t -140.4 -66.66 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.101 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -169.39 44.77 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.162 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 61.27 37.5 17.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.983 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 24.1 m95 -90.2 115.01 27.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.871 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -129.29 118.12 21.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.887 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -84.65 151.15 24.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.917 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -138.33 117.95 13.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.81 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.456 ' CG2' ' CE2' ' A' ' 114' ' ' PHE . 2.3 m -144.94 154.42 14.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.201 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -148.74 122.33 9.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.146 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -90.13 130.96 36.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.991 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.07 -35.94 65.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.922 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.1 m -90.9 111.21 22.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.828 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.84 -28.45 3.74 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.525 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.93 -40.36 60.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.383 179.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -68.06 -33.1 73.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.223 179.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.2 tt -67.53 -47.91 68.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.449 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -68.21 -40.9 82.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.297 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -66.62 -30.35 70.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.216 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' TRP . . . . . 0.456 ' CZ2' ' CD2' ' A' ' 7' ' ' LEU . 1.0 OUTLIER -66.31 -50.21 64.43 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.535 179.64 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 38.4 t -61.63 -38.17 79.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.051 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -68.29 -38.83 82.06 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.047 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 3.3 mttt -67.11 -52.76 37.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.302 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 74.1 mt -54.71 -33.79 28.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.43 -28.44 46.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.547 179.093 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -75.26 -39.51 59.72 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.857 0.36 . . . . 0.0 110.579 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.408 ' CG1' ' CG1' ' A' ' 95' ' ' VAL . 7.8 p -77.54 -27.81 15.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.147 179.181 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.404 ' N ' HG11 ' A' ' 146' ' ' VAL . . . -74.5 -39.04 62.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.621 179.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -72.53 -16.84 61.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.918 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 11.8 t -112.79 18.53 18.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.794 179.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.225 -0.893 . . . . 0.0 111.113 179.945 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 120.862 0.363 . . . . 0.0 111.273 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.424 ' CD1' ' HA ' ' A' ' 26' ' ' SER . 39.2 mt -74.19 -37.61 46.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.032 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.442 ' HE2' ' CD1' ' A' ' 139' ' ' TRP . 0.1 OUTLIER -156.12 145.09 20.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.965 -179.828 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -161.92 135.02 6.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.834 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -161.59 -163.86 15.35 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.501 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 25.2 mm -99.66 73.49 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.938 0.399 . . . . 0.0 111.083 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.455 ' CD2' ' CZ2' ' A' ' 139' ' ' TRP . 0.9 OUTLIER -79.75 150.11 30.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.734 179.957 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -87.49 138.4 31.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.977 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.429 ' HG ' ' CE1' ' A' ' 22' ' ' PHE . 4.4 mm? -126.74 175.03 8.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.845 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.426 ' HG3' ' CZ3' ' A' ' 17' ' ' TRP . 18.0 mt-10 -118.33 107.85 14.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.095 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.27 146.63 62.73 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.492 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.23 -17.33 19.14 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.486 2.124 . . . . 0.0 112.735 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.3 t -69.12 -43.76 81.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.0 0.428 . . . . 0.0 111.187 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -112.42 -18.47 12.45 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.192 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 20.6 m170 62.16 29.25 17.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.809 0.338 . . . . 0.0 110.862 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -130.76 176.17 8.43 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.699 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.426 ' CZ3' ' HG3' ' A' ' 10' ' ' GLU . 21.7 m95 -61.79 137.92 58.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.693 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -139.45 141.69 29.56 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.858 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.72 126.41 10.13 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.542 2.161 . . . . 0.0 112.252 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -152.45 167.81 27.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.93 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -108.29 115.23 29.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.974 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.429 ' CE1' ' HG ' ' A' ' 9' ' ' LEU . 2.2 m-85 -108.54 141.46 40.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.922 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 25.8 t -126.63 148.8 31.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.174 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -128.04 110.84 12.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.873 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.1 p -98.76 155.37 17.39 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.006 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.424 ' HA ' ' CD1' ' A' ' 2' ' ' ILE . 56.4 p -60.58 -16.41 37.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.079 -179.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -133.94 24.27 3.92 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 171.67 -176.36 0.05 OUTLIER 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 121.077 0.465 . . . . 0.0 111.684 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.5 mt -144.79 127.03 9.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.639 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -104.07 142.02 35.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.859 0.361 . . . . 0.0 111.037 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.428 ' HB2' ' CZ ' ' A' ' 22' ' ' PHE . 3.6 p90 -156.66 100.97 1.96 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.942 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.7 t . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.986 179.889 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.273 0 N-CA-C 112.528 -0.229 . . . . 0.0 112.528 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.2 p -107.45 152.83 8.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.803 0.335 . . . . 0.0 111.158 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.4 tt -139.96 129.58 24.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.943 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.93 141.65 54.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.829 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.646 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 11.7 p -81.98 -29.08 0.48 Allowed Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.646 ' CD ' ' N ' ' A' ' 95' ' ' VAL . 98.6 Cg_endo -86.18 47.15 1.74 Allowed 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.149 1.899 . . . . 0.0 112.642 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -177.95 37.85 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.006 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 1.3 m -131.67 120.13 22.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.966 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.15 109.09 20.92 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.736 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 14.2 mm -75.35 157.66 5.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.079 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -153.87 87.6 1.22 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.987 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 52.9 mt -58.58 146.22 8.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.193 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.83 104.82 5.77 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.618 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -73.65 52.95 2.61 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.36 2.04 . . . . 0.0 112.424 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 168.0 56.65 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.408 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.429 ' O ' ' HG3' ' A' ' 107' ' ' LYS . . . -65.85 -102.6 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.768 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.429 ' HG3' ' O ' ' A' ' 106' ' ' GLY . 0.0 OUTLIER -154.35 -177.0 6.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.993 0.425 . . . . 0.0 111.191 -179.795 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.419 ' HB2' ' NE1' ' A' ' 17' ' ' TRP . 1.3 m-80 47.9 41.65 14.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.611 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 61.84 31.3 18.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.337 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 -118.31 106.3 12.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.517 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.3 mt -96.54 30.28 2.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.108 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.416 ' CZ ' ' HG2' ' A' ' 133' ' ' GLN . 39.4 m-85 -145.82 61.72 1.26 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.528 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 38.7 t -125.32 126.37 70.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.009 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.435 ' CZ ' ' HB ' ' A' ' 128' ' ' VAL . 35.8 p90 -103.63 131.53 50.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.578 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 13.0 t -105.45 127.08 52.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.105 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 12.8 mt -94.97 158.16 2.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.499 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 2.5 m -154.62 132.17 11.31 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.803 0.335 . . . . 0.0 111.146 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 77.1 mtp -92.17 115.56 64.9 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.85 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -79.68 53.67 4.84 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.485 2.124 . . . . 0.0 112.519 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 30.5 t 177.59 39.95 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.634 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 45.6 t -145.66 -69.96 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.088 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -179.26 -155.13 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.416 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -83.78 49.27 1.58 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.738 0.304 . . . . 0.0 111.07 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 12.4 m95 -74.47 169.87 16.85 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.73 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -169.17 98.61 0.36 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.955 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.6 tp -83.97 95.73 8.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.075 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.5 130.56 35.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.96 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.435 ' HB ' ' CZ ' ' A' ' 114' ' ' PHE . 21.7 t -152.25 159.03 4.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.147 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -164.81 131.05 2.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.241 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -97.55 141.52 30.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.981 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -55.66 -34.36 64.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.952 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.0 m -94.23 114.49 26.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.816 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.416 ' HG2' ' CZ ' ' A' ' 112' ' ' PHE . 1.1 mp0 -49.67 -27.16 4.37 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.431 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -74.77 -45.45 43.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.424 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -64.6 -31.38 72.58 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.202 179.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.4 tp -68.05 -50.07 57.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.445 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -68.17 -36.94 80.42 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.332 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -69.19 -34.4 74.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.163 179.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' TRP . . . . . 0.455 ' CZ2' ' CD2' ' A' ' 7' ' ' LEU . 1.3 m95 -63.8 -47.67 79.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.564 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 33.4 t -62.83 -44.5 99.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.801 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.1 -33.03 72.71 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.701 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.06 -50.89 36.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.378 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.409 HD13 HG23 ' A' ' 143' ' ' ILE . 66.8 mt -53.83 -31.27 20.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.178 0.513 . . . . 0.0 109.617 178.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 50.4 mtp85 -80.23 -32.37 38.44 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.159 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -77.97 -31.34 50.75 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.755 0.312 . . . . 0.0 110.895 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.443 HG12 ' N ' ' A' ' 147' ' ' ALA . 9.8 p -83.63 -29.24 7.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.01 0.433 . . . . 0.0 110.296 179.217 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.443 ' N ' HG12 ' A' ' 146' ' ' VAL . . . -75.3 -34.62 61.3 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.587 179.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -74.55 -11.5 60.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.952 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 10.5 t -117.23 13.05 14.57 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.285 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.2 -0.905 . . . . 0.0 111.204 -179.968 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.488 1.438 0 CA-C-O 120.822 0.344 . . . . 0.0 111.146 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 15.6 mt -88.87 -32.88 5.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.051 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.403 ' HE3' ' CD1' ' A' ' 139' ' ' TRP . 3.2 tptp -125.94 135.08 51.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.775 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 17.9 p-10 -154.52 121.8 5.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.006 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -170.02 -145.68 4.8 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.485 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.409 ' N ' ' CD1' ' A' ' 6' ' ' ILE . 3.2 mp -127.97 88.44 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.824 0.345 . . . . 0.0 110.953 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.4 ' CD2' ' CZ2' ' A' ' 139' ' ' TRP . 4.4 mm? -87.78 144.24 26.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.84 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -76.33 165.84 24.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.019 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -171.12 101.33 0.21 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.822 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.428 ' HB3' ' CE3' ' A' ' 17' ' ' TRP . 0.3 OUTLIER -78.55 164.22 24.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.064 -179.875 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -126.42 132.1 24.19 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.714 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.98 -15.59 28.23 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.536 2.157 . . . . 0.0 112.917 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.1 t -68.78 -42.85 83.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.98 0.419 . . . . 0.0 111.438 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -115.41 -15.84 11.48 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.412 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 2.2 m80 62.79 42.7 7.73 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.931 0.396 . . . . 0.0 110.802 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.73 134.81 37.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.818 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.428 ' CE3' ' HB3' ' A' ' 10' ' ' GLU . 85.5 m95 -65.59 135.05 54.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.915 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.414 ' HB3' ' CD2' ' A' ' 20' ' ' HIS . 11.5 m-85 -120.31 104.59 43.04 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.939 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -67.05 107.84 1.41 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.48 2.12 . . . . 0.0 112.317 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.414 ' CD2' ' HB3' ' A' ' 18' ' ' TYR . 95.1 m-70 -132.25 158.08 42.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.869 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -59.85 151.38 25.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.925 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.477 ' CZ ' ' CD1' ' A' ' 31' ' ' TYR . 0.3 OUTLIER -154.9 142.9 20.13 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.806 -179.939 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.3 t -139.29 145.82 26.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.158 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 27.2 tp -125.94 115.88 20.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.792 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 35.0 p -90.58 158.29 17.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.932 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.5 t -52.75 -24.0 7.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.693 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.0 m -143.33 35.5 1.33 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.552 0.215 . . . . 0.0 111.435 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.2 tttt 177.73 179.21 0.3 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.891 0.377 . . . . 0.0 111.305 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.456 HD13 HG22 ' A' ' 29' ' ' ILE . 1.6 mt -141.25 130.27 24.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.715 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -124.52 133.59 53.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.078 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.477 ' CD1' ' CZ ' ' A' ' 22' ' ' PHE . 33.5 p90 -156.43 153.58 29.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.911 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 84.0 p . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.848 -179.958 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.4 0 N-CA-C 112.499 -0.241 . . . . 0.0 112.499 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 11.5 p -129.06 142.65 43.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.863 0.364 . . . . 0.0 111.07 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.3 tp -147.31 145.05 29.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.931 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.0 133.11 34.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.827 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.485 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 19.8 t -82.46 -45.34 0.95 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.605 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.485 ' CD ' ' N ' ' A' ' 95' ' ' VAL . 11.6 Cg_exo -71.29 55.14 1.9 Allowed 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.632 2.221 . . . . 0.0 112.457 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 168.83 40.47 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.878 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -157.37 98.25 1.69 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.989 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -80.27 129.79 34.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.693 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 10.7 mm -84.34 157.63 3.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.151 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -145.84 88.41 1.82 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.869 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 86.3 mt -57.79 143.4 12.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.091 0.472 . . . . 0.0 111.349 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 9.0 mtt-85 -132.45 125.64 19.79 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.069 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -82.42 24.36 0.73 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.386 2.058 . . . . 0.0 112.956 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -176.77 74.83 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.948 0.404 . . . . 0.0 110.538 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -54.45 -93.77 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.68 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.79 172.01 1.02 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.877 0.37 . . . . 0.0 111.07 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 61.8 m-80 61.8 -82.04 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.149 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -152.96 42.9 0.62 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.95 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.424 ' HG3' ' CD1' ' A' ' 17' ' ' TRP . 0.6 OUTLIER -135.48 108.64 7.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.92 179.911 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.5 mt -78.28 -33.75 49.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.823 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.421 ' CE2' ' HG3' ' A' ' 133' ' ' GLN . 41.1 m-85 -108.7 115.24 29.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.975 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 21.1 t -153.22 140.23 12.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.029 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.427 ' CE2' ' HB ' ' A' ' 128' ' ' VAL . 25.3 p90 -119.93 115.31 23.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.828 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.4 p -93.44 125.94 38.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.992 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 3.1 mp -92.01 159.99 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.918 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 22.1 p -158.43 158.96 35.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.955 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 32.3 mtp -110.14 155.65 41.43 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.724 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -65.54 -30.9 51.68 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.528 2.152 . . . . 0.0 112.385 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 78.9 p -178.78 129.69 0.11 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.101 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.417 ' CG2' ' N ' ' A' ' 122' ' ' ALA . 0.2 OUTLIER -167.18 -80.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.817 179.799 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.417 ' N ' ' CG2' ' A' ' 121' ' ' VAL . . . -155.53 37.33 0.37 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.172 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 61.1 44.22 10.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.857 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 27.2 m95 -90.45 132.62 35.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.061 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 59.9 m -128.33 139.23 52.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.837 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.72 143.32 46.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.944 0.402 . . . . 0.0 111.111 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -130.56 119.13 22.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.52 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.427 ' HB ' ' CE2' ' A' ' 114' ' ' PHE . 21.9 t -141.32 159.61 22.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.172 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -159.66 141.16 12.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.222 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -105.97 145.75 30.92 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.834 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -58.13 -60.94 2.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.045 0.45 . . . . 0.0 110.875 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.8 t -70.7 115.7 10.16 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.72 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.421 ' HG3' ' CE2' ' A' ' 112' ' ' PHE . 0.1 OUTLIER -48.71 -26.45 2.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.664 179.59 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -76.03 -43.37 44.31 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.474 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.79 -32.49 74.06 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.292 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 8.1 tt -68.57 -50.07 54.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.465 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 57.9 mm-40 -68.17 -36.53 79.77 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.355 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -70.44 -29.77 66.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.446 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' TRP . . . . . 0.403 ' CD1' ' HE3' ' A' ' 3' ' ' LYS . 0.6 OUTLIER -69.28 -46.18 67.86 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.034 0.445 . . . . 0.0 110.621 179.629 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 21.9 t -63.31 -40.99 91.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.878 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 2.3 mtpp -64.18 -37.42 87.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.781 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.8 -54.3 28.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.374 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 70.9 mt -52.72 -32.99 17.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.194 0.521 . . . . 0.0 109.691 178.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 25.0 mtp85 -80.01 -29.3 39.39 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.388 179.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -74.49 -37.4 63.17 Favored 'General case' 0 N--CA 1.457 -0.106 0 CA-C-O 120.922 0.391 . . . . 0.0 110.64 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 11.7 m -80.73 -28.32 11.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.228 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -78.98 -34.35 44.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.754 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -78.47 -10.01 59.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.958 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 12.4 t -110.84 -29.83 7.8 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.882 0.373 . . . . 0.0 111.066 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.198 -0.906 . . . . 0.0 111.111 179.948 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.816 0.341 . . . . 0.0 111.138 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 30.5 mt -77.95 -36.13 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.138 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.42 ' HG2' ' CD1' ' A' ' 139' ' ' TRP . 0.2 OUTLIER -138.09 102.57 4.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.005 -179.906 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -131.22 124.62 30.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.77 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -166.35 -147.22 5.13 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.55 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 25.2 mm -107.98 86.07 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.735 0.302 . . . . 0.0 111.168 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.436 ' HG ' ' CZ3' ' A' ' 139' ' ' TRP . 0.4 OUTLIER -88.0 163.96 16.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.833 179.891 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -110.61 150.41 29.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.104 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -161.29 129.52 4.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.772 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.434 ' HB3' ' CD2' ' A' ' 17' ' ' TRP . 0.2 OUTLIER -86.69 121.51 29.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.127 -179.772 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.91 146.77 37.39 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.601 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.0 -4.52 15.53 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.487 2.125 . . . . 0.0 113.388 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -67.97 -45.52 83.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.032 0.444 . . . . 0.0 110.818 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -128.6 -2.06 5.46 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.175 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 14.6 m170 57.62 74.83 0.4 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.964 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.95 135.47 1.77 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.976 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.434 ' CD2' ' HB3' ' A' ' 10' ' ' GLU . 27.9 m95 -63.92 134.37 54.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.895 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -135.98 148.62 65.65 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.922 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.77 124.58 10.31 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.594 2.196 . . . . 0.0 112.356 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -141.09 111.45 6.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.897 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -54.28 111.38 0.77 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.124 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.51 ' CZ ' ' CD2' ' A' ' 31' ' ' TYR . 2.8 m-30 -109.27 155.77 20.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.829 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 24.5 t -142.0 92.52 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.122 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.7 tp -76.03 117.91 18.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.926 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 17.1 p -97.88 154.71 17.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.984 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 51.7 p -52.53 -24.66 8.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.997 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -140.79 37.49 1.8 Allowed 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.99 -0.284 . . . . 0.0 111.726 -179.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 172.45 171.94 0.11 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.926 0.393 . . . . 0.0 111.383 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.44 HD11 HG21 ' A' ' 29' ' ' ILE . 2.6 mt -134.56 116.64 22.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.55 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -96.13 141.41 29.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.316 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.51 ' CD2' ' CZ ' ' A' ' 22' ' ' PHE . 4.4 m-85 -119.33 124.29 46.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.726 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 12.3 m . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.824 179.983 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 N-CA-C 112.611 -0.196 . . . . 0.0 112.611 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 11.1 p -158.66 133.83 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.834 0.35 . . . . 0.0 111.026 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -146.31 153.49 40.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.892 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -83.82 137.31 33.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.903 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.638 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 13.0 p -83.33 -27.99 0.42 Allowed Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.638 ' CD ' ' N ' ' A' ' 95' ' ' VAL . 89.8 Cg_endo -84.52 49.87 2.82 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.079 1.852 . . . . 0.0 112.593 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 178.33 38.96 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.968 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -156.69 97.44 1.72 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.953 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -78.95 136.36 37.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.84 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 8.1 mm -87.52 161.21 2.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.168 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -149.83 96.39 2.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.96 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 70.3 mt -61.03 149.85 7.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.079 0.466 . . . . 0.0 111.255 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 72.3 mtp180 -138.99 123.14 11.28 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.292 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -73.84 11.9 1.04 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.569 2.179 . . . . 0.0 113.004 -179.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -160.37 67.82 0.35 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.103 0.478 . . . . 0.0 110.591 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.401 ' HA3' ' CG2' ' A' ' 113' ' ' VAL . . . -46.95 -88.67 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.224 0 CA-C-N 115.925 -0.579 . . . . 0.0 113.134 -179.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -174.99 162.59 3.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.849 0.357 . . . . 0.0 111.224 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 59.01 -84.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.157 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 44.7 m-20 -148.28 31.58 0.83 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.977 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -115.33 94.66 4.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.805 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.1 mt -67.65 -28.83 68.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.102 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -109.09 100.26 9.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.944 0.402 . . . . 0.0 111.094 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.401 ' CG2' ' HA3' ' A' ' 106' ' ' GLY . 42.8 t -146.47 127.27 6.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.69 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.429 ' CE2' ' HB ' ' A' ' 128' ' ' VAL . 29.6 p90 -108.65 124.31 50.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.064 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 28.0 t -94.48 129.46 41.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.672 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 11.0 mt -93.87 160.01 2.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.092 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.411 ' HB2' ' CZ3' ' A' ' 124' ' ' TRP . 0.3 OUTLIER -158.61 158.14 33.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.563 179.874 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' MET . . . . . 0.444 ' HB2' ' CD1' ' A' ' 124' ' ' TRP . 13.4 mtp -98.02 152.72 38.19 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.748 0.309 . . . . 0.0 111.236 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -80.59 77.95 3.86 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.661 2.241 . . . . 0.0 112.6 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.404 ' O ' ' CG2' ' A' ' 121' ' ' VAL . 0.9 OUTLIER 69.68 107.63 0.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.922 179.95 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.433 ' HB ' ' CD1' ' A' ' 124' ' ' TRP . 3.4 t -164.45 -76.61 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.318 0.58 . . . . 0.0 110.815 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.402 ' N ' ' CG1' ' A' ' 121' ' ' VAL . . . -146.65 -149.67 0.3 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.267 -0.878 . . . . 0.0 110.671 -179.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -89.36 29.94 1.05 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.747 0.308 . . . . 0.0 111.607 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . 0.444 ' CD1' ' HB2' ' A' ' 118' ' ' MET . 1.7 p-90 -46.38 168.51 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.299 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.405 ' CB ' ' O ' ' A' ' 124' ' ' TRP . 0.9 OUTLIER 163.89 103.12 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.805 179.512 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 8.0 tp -116.39 157.37 25.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.99 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -142.86 139.27 30.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.896 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.429 ' HB ' ' CE2' ' A' ' 114' ' ' PHE . 22.4 t -151.74 153.5 9.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.131 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -155.99 136.98 13.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.197 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -105.01 139.74 39.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.985 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -53.89 -35.85 62.05 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.903 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.5 m -93.32 111.53 23.21 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.811 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -48.35 -28.49 3.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.54 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.88 -43.34 58.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.216 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -67.12 -31.37 71.79 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.194 179.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.4 tt -67.82 -46.92 70.49 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.503 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -69.0 -40.43 78.73 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.377 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.0 -29.1 68.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.286 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' TRP . . . . . 0.436 ' CZ3' ' HG ' ' A' ' 7' ' ' LEU . 1.1 m95 -68.52 -48.29 64.73 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.694 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 33.9 t -63.55 -39.86 86.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.678 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 31.2 tttt -63.79 -36.75 84.93 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.744 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -67.26 -52.32 42.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.273 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.444 HG23 HD11 ' A' ' 143' ' ' ILE . 69.5 mt -52.77 -33.45 18.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.16 0.505 . . . . 0.0 109.76 178.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -79.59 -28.11 41.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.628 179.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.47 -38.29 55.59 Favored 'General case' 0 CA--C 1.523 -0.096 0 CA-C-O 120.856 0.36 . . . . 0.0 110.861 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 16.2 m -79.67 -29.28 13.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.299 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -77.83 -34.83 51.75 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.544 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -74.13 -13.78 60.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.987 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 10.8 t -107.51 -22.11 12.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.106 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.158 -0.925 . . . . 0.0 111.091 -179.996 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.859 0.361 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.6 mt -71.77 -32.94 46.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.953 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.413 ' HD2' ' CD1' ' A' ' 139' ' ' TRP . 3.4 mttm -157.86 123.77 4.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.89 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -143.99 135.04 25.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.909 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -170.02 -135.47 1.91 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.434 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.414 ' N ' ' CD1' ' A' ' 6' ' ' ILE . 3.2 mp -127.15 83.64 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.963 0.411 . . . . 0.0 110.981 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.457 ' CD2' ' CZ2' ' A' ' 139' ' ' TRP . 1.8 mm? -80.85 145.12 31.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.911 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -90.92 119.08 30.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.98 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.86 144.22 51.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.95 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.423 ' HG2' ' CZ3' ' A' ' 17' ' ' TRP . 0.0 OUTLIER -87.5 122.81 31.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.895 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -93.14 126.68 50.03 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.67 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.37 -15.4 24.16 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.505 2.137 . . . . 0.0 112.869 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.0 t -68.76 -42.82 83.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.887 0.375 . . . . 0.0 111.275 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -115.82 -15.82 11.25 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.484 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 63.21 50.81 2.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.918 0.39 . . . . 0.0 110.907 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -157.31 157.25 33.82 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.89 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.423 ' CZ3' ' HG2' ' A' ' 10' ' ' GLU . 40.5 m95 -72.56 139.06 47.28 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.725 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -138.86 121.77 10.72 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.961 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.38 92.86 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.426 2.084 . . . . 0.0 112.256 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 43.9 m-70 -117.27 150.27 39.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.921 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -77.65 147.65 35.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.927 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.49 ' CE2' ' CD1' ' A' ' 31' ' ' TYR . 0.2 OUTLIER -154.57 133.81 12.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.765 -179.876 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.7 t -117.13 138.32 48.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.105 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 34.3 tp -118.69 104.08 10.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.879 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.59 149.28 23.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.763 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.04 -14.62 50.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.626 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.2 t -105.89 -14.17 15.29 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.4 mttt -179.81 -173.32 0.24 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.916 0.388 . . . . 0.0 111.138 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 3.2 mt -129.72 130.13 66.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.436 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -106.82 142.85 35.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.016 0.436 . . . . 0.0 111.357 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.49 ' CD1' ' CE2' ' A' ' 22' ' ' PHE . 25.3 t80 -136.49 122.05 19.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.805 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.4 p . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.986 -179.941 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.279 0 N-CA-C 112.44 -0.264 . . . . 0.0 112.44 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 11.3 p -93.14 147.18 5.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.776 0.322 . . . . 0.0 111.082 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.2 mp -142.26 133.21 25.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.948 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -70.55 127.42 32.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.906 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.492 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 4.5 t -69.12 -45.96 29.68 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.347 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.492 ' CD ' ' N ' ' A' ' 95' ' ' VAL . 6.4 Cg_exo -73.87 56.37 3.56 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.766 2.311 . . . . 0.0 112.409 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 175.22 38.94 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.021 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 34.2 m -148.6 108.67 4.08 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.902 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -91.45 126.25 36.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.816 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 6.4 mm -90.04 161.37 2.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.106 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -152.52 88.66 1.36 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.857 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 76.4 mt -57.02 152.54 2.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.283 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 18.1 mtt180 -143.7 118.08 6.09 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.241 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -81.02 37.44 0.68 Allowed 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.351 2.034 . . . . 0.0 112.756 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -178.42 63.58 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.939 0.4 . . . . 0.0 110.525 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -56.37 -95.9 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.73 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.59 165.36 0.82 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.83 0.348 . . . . 0.0 111.126 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 31.6 m-20 56.12 47.14 20.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.073 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 24.6 m-20 63.17 58.26 1.46 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.088 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 6.8 mmt85 -152.25 88.73 1.39 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.782 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 69.4 mt -67.78 -33.01 73.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.02 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.404 ' CZ ' ' HG3' ' A' ' 133' ' ' GLN . 19.0 m-85 -91.62 96.83 10.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.966 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 22.0 t -152.74 127.56 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.03 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.415 ' CZ ' ' HB ' ' A' ' 128' ' ' VAL . 43.4 p90 -114.64 138.55 50.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.785 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 20.3 m -107.63 128.38 54.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.074 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 20.0 mt -99.09 159.59 3.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.928 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 81.1 p -152.54 158.81 43.06 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.866 0.365 . . . . 0.0 110.939 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 43.7 mtp -130.63 93.96 30.49 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.828 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.39 61.89 2.1 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.475 2.117 . . . . 0.0 112.306 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.7 m -165.16 -44.88 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.979 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.478 ' CG1' ' N ' ' A' ' 122' ' ' ALA . 2.5 p -75.57 -47.72 32.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.93 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.478 ' N ' ' CG1' ' A' ' 121' ' ' VAL . . . 174.64 -163.32 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.742 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 24.1 mm-40 -93.6 44.92 1.14 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.886 0.374 . . . . 0.0 110.751 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 13.7 m95 -98.39 130.17 45.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.901 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 8.6 t -120.47 133.99 55.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.941 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 12.2 tp -98.58 152.68 19.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.922 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -125.72 128.16 47.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.775 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.415 ' HB ' ' CZ ' ' A' ' 114' ' ' PHE . 16.9 t -150.15 141.1 16.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.16 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -143.57 121.86 12.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.167 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -82.39 142.2 32.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.883 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -54.07 -44.15 70.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.082 0.468 . . . . 0.0 110.95 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.1 p -92.63 120.4 33.02 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.718 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.404 ' HG3' ' CZ ' ' A' ' 112' ' ' PHE . 0.6 OUTLIER -49.86 -24.13 2.29 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.654 179.553 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -73.99 -48.15 32.28 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.626 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -62.76 -33.11 74.48 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.319 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 8.8 tt -66.92 -49.3 65.96 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.634 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -69.67 -36.44 76.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.416 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -70.98 -29.26 65.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.378 179.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' TRP . . . . . 0.457 ' CZ2' ' CD2' ' A' ' 7' ' ' LEU . 1.5 m95 -70.49 -46.05 64.46 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.742 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 26.2 t -64.55 -38.66 83.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.864 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.69 -38.04 88.13 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.835 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.0 -49.18 68.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.364 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 30.5 mt -54.1 -38.52 38.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.275 0.56 . . . . 0.0 109.573 178.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 14.7 mtt180 -77.95 -27.8 49.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.395 179.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -73.34 -35.65 66.06 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.584 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 46.6 t -78.01 -34.02 18.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.034 179.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.71 -38.47 73.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.506 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -64.86 -20.34 66.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.611 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 5.1 p -101.12 -33.48 10.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.118 0.485 . . . . 0.0 110.499 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.195 -0.907 . . . . 0.0 111.283 -179.953 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.5 m . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.845 0.355 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.411 ' CD1' ' HA ' ' A' ' 26' ' ' SER . 41.7 mt -84.34 -33.98 9.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.197 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.416 ' HE3' ' CD1' ' A' ' 139' ' ' TRP . 2.9 mmtt -134.38 139.36 45.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.02 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -149.79 125.54 10.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.803 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -169.99 178.62 42.76 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.476 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 23.1 mm -94.02 90.02 2.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.882 0.372 . . . . 0.0 111.034 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -92.04 139.67 30.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.929 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -79.86 164.84 23.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.97 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.3 tt -171.86 134.38 0.78 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.932 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.417 ' HG3' ' CZ3' ' A' ' 17' ' ' TRP . 14.6 mt-10 -65.31 90.54 0.1 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.962 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.72 138.36 96.86 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.679 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.56 -8.66 22.91 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.447 2.098 . . . . 0.0 112.552 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.4 t -67.43 -42.4 87.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.992 0.425 . . . . 0.0 110.998 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -132.1 4.54 4.1 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.555 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 8.5 t-160 52.66 59.49 4.45 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.915 0.388 . . . . 0.0 111.147 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -158.68 159.59 35.48 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.884 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.417 ' CZ3' ' HG3' ' A' ' 10' ' ' GLU . 46.4 m95 -57.6 129.86 43.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.923 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -134.67 124.64 17.0 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.836 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.13 88.54 0.82 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.377 2.052 . . . . 0.0 112.318 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -111.75 151.89 28.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.839 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -60.05 155.74 16.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.898 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.405 ' HB3' ' CH2' ' A' ' 139' ' ' TRP . 0.1 OUTLIER -154.14 138.29 16.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.775 -179.892 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.3 t -127.77 153.86 37.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.37 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -133.5 119.37 19.46 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.923 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.0 p -103.26 157.51 16.96 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.94 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.411 ' HA ' ' CD1' ' A' ' 2' ' ' ILE . 4.1 t -39.94 -32.45 0.16 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.246 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 58.6 m -152.09 48.27 0.77 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.657 0.265 . . . . 0.0 111.467 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.1 mtmm -175.5 156.54 1.97 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.989 0.423 . . . . 0.0 111.252 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.7 mt -124.34 123.7 66.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.707 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -115.5 154.0 30.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.025 0.44 . . . . 0.0 111.255 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 21.6 p90 -158.99 148.9 19.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.713 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 84.2 p -150.69 176.45 11.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.033 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.41 -16.45 25.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.172 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 68.49 96.77 0.06 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.866 0.365 . . . . 0.0 110.882 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.08 -174.76 1.02 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.938 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.9 p -98.2 39.92 1.21 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.888 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.0 t -102.9 118.11 36.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.937 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -161.28 80.51 0.6 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.914 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 59.27 31.97 21.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.825 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -86.76 59.07 4.6 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.487 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -133.29 42.62 3.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.889 0.376 . . . . 0.0 110.886 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -139.03 40.58 2.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.969 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -154.12 85.8 1.16 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.907 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -103.25 135.32 45.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.921 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.19 101.91 9.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.838 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -144.54 159.12 52.41 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.939 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.96 63.16 1.91 Allowed 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.512 2.142 . . . . 0.0 112.325 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 63.54 137.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.994 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -84.05 163.39 19.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.834 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -144.0 125.16 14.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.142 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.8 m -101.48 146.09 28.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.991 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.81 -168.37 33.62 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.53 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.8 m -98.68 32.67 2.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.735 0.302 . . . . 0.0 110.889 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.3 t -151.08 121.84 7.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.906 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -161.88 179.52 7.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.851 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.1 mp -124.6 166.03 16.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.945 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -176.07 90.24 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.824 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.3 m -99.77 -178.3 3.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.93 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.411 ' O ' ' CB ' ' A' ' 60' ' ' LEU . 2.5 p -150.09 166.98 28.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.758 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.411 ' CB ' ' O ' ' A' ' 59' ' ' SER . 0.2 OUTLIER 80.67 -10.58 1.23 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.573 -179.889 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.67 -28.32 21.89 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.935 0.397 . . . . 0.0 110.419 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.2 t -70.17 -36.51 68.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.733 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.53 -15.6 63.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.934 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -89.73 21.58 3.46 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.261 0.553 . . . . 0.0 110.561 179.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -151.43 26.47 0.68 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.493 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -114.74 -75.01 0.62 Allowed Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.377 -0.828 . . . . 0.0 112.181 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -62.61 84.22 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.656 2.237 . . . . 0.0 112.26 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 59.56 80.49 0.27 Allowed Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.962 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -80.26 7.7 4.56 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 123.163 2.575 . . . . 0.0 112.794 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -96.5 30.18 2.66 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.794 0.33 . . . . 0.0 111.279 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 17.4 mt -104.75 -12.33 9.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.697 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 14.2 mt -90.15 20.69 4.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.138 0.494 . . . . 0.0 111.471 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -150.31 66.86 7.99 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.449 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -68.69 59.56 1.15 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.858 2.372 . . . . 0.0 112.356 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -107.31 -41.79 5.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.013 0.435 . . . . 0.0 110.884 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 13.0 mtt85 -156.78 139.4 15.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.764 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -124.16 131.76 53.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.921 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 62.52 38.29 12.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.891 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.94 -178.25 4.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.858 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.91 72.33 0.24 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.873 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -93.43 116.34 28.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.998 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 59.46 40.02 21.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.864 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.407 ' N ' ' CD ' ' A' ' 84' ' ' PRO . 0.3 OUTLIER -76.43 -55.28 1.7 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.926 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.407 ' CD ' ' N ' ' A' ' 83' ' ' SER . 85.9 Cg_endo -83.02 50.94 3.51 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 123.148 2.565 . . . . 0.0 112.402 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.6 mt -164.57 -44.04 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.895 0.378 . . . . 0.0 110.908 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -111.92 40.45 2.53 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.594 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -165.77 -44.81 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.937 0.398 . . . . 0.0 110.873 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 8.8 mp 56.12 89.17 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.925 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.79 132.65 47.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.044 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -95.52 -36.4 11.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.771 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -138.7 147.75 19.45 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.42 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 11.4 p -144.23 151.82 15.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.78 0.324 . . . . 0.0 111.115 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -156.04 170.89 21.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.891 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -100.59 118.56 37.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.976 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.659 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 12.6 p -83.31 -27.6 0.42 Allowed Pre-proline 0 CA--C 1.535 0.403 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.659 ' CD ' ' N ' ' A' ' 95' ' ' VAL . 95.2 Cg_endo -85.51 49.77 2.51 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.153 1.902 . . . . 0.0 112.539 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -179.43 38.13 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.977 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 31.1 p -137.31 173.94 11.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.961 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 50.0 tp60 -137.84 113.5 9.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.703 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 14.6 mm -79.13 159.68 4.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.035 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -151.68 92.5 1.76 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.969 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 50.1 mt -58.24 138.54 19.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.022 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -127.31 107.95 21.35 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.715 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -77.69 22.85 0.58 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.783 2.322 . . . . 0.0 112.631 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -173.38 64.86 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.961 0.41 . . . . 0.0 110.483 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -56.79 -95.84 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.721 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.85 156.04 0.6 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.855 0.36 . . . . 0.0 111.045 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 66.2 m-80 58.43 57.4 3.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.113 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 59.06 58.49 3.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.088 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -152.59 90.14 1.46 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.723 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.43 ' CD1' ' CZ ' ' A' ' 112' ' ' PHE . 0.3 OUTLIER -81.41 -27.97 34.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.184 -179.84 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.43 ' CZ ' ' CD1' ' A' ' 111' ' ' LEU . 36.3 m-85 -101.31 95.59 6.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.001 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 21.4 t -153.6 120.9 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.039 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.441 ' CZ ' ' HB ' ' A' ' 128' ' ' VAL . 42.1 p90 -105.3 122.17 45.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.805 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 22.9 t -92.95 131.44 37.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.12 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.432 HD11 HG21 ' A' ' 116' ' ' ILE . 16.6 mt -97.62 160.72 2.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.828 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 99.2 p -173.29 128.66 0.45 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.094 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.38 127.56 32.66 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.721 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -84.37 48.15 2.38 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.733 2.289 . . . . 0.0 112.708 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.8 m 177.8 39.25 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.935 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.485 ' CG1' ' N ' ' A' ' 122' ' ' ALA . 2.5 p -131.72 -49.61 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.086 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.485 ' N ' ' CG1' ' A' ' 121' ' ' VAL . . . 165.3 40.16 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.195 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 7.0 mm100 51.19 32.16 7.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.148 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 23.0 m95 -69.75 171.59 8.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.895 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 75.3 p -158.23 110.75 2.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.912 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 5.3 tp -100.02 162.01 13.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.881 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -140.26 130.93 25.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.936 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.441 ' HB ' ' CZ ' ' A' ' 114' ' ' PHE . 39.1 t -144.32 147.02 19.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.922 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -139.64 133.88 31.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.244 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -102.85 135.0 45.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.851 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.76 -47.93 59.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.321 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -87.61 117.4 26.39 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.897 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.428 ' HG2' ' CE2' ' A' ' 112' ' ' PHE . 1.3 mt-30 -47.92 -27.96 2.44 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.342 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.66 -42.54 51.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.523 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -64.54 -34.04 77.31 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.055 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 8.9 tt -66.83 -52.24 46.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.543 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -67.03 -36.9 83.12 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.313 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -69.72 -31.53 69.58 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.483 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' TRP . . . . . 0.416 ' CD1' ' HE3' ' A' ' 3' ' ' LYS . 0.4 OUTLIER -67.68 -44.8 76.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.489 179.592 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 23.8 t -61.48 -45.21 99.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.723 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 8.3 ttmt -60.94 -36.22 78.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.633 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.99 -50.03 65.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.347 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 69.0 mt -52.79 -36.88 24.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.246 0.546 . . . . 0.0 109.641 178.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 28.6 mtp85 -78.69 -27.65 45.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.509 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -73.44 -38.38 65.52 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.645 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 13.4 m -79.27 -30.51 14.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.272 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -76.25 -34.16 59.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.396 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -76.12 -11.0 59.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.894 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 15.3 t -119.07 15.52 13.26 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.198 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.204 -0.903 . . . . 0.0 111.092 179.973 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 8.4 t . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.871 0.367 . . . . 0.0 111.24 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 31.0 mt -83.53 -34.6 10.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.082 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.7 tptt -148.75 115.72 6.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.03 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -137.08 137.53 39.42 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.81 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -170.03 -167.92 31.18 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.532 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 23.9 mm -94.27 96.31 5.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.799 0.333 . . . . 0.0 111.056 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.444 ' HG ' ' CZ3' ' A' ' 139' ' ' TRP . 1.3 mm? -101.6 154.28 19.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.847 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.44 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 3.0 m-85 -109.92 131.22 55.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.918 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.432 ' CD1' ' CZ ' ' A' ' 22' ' ' PHE . 3.6 mp -125.09 -2.09 7.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.632 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.447 ' HB3' ' CD2' ' A' ' 17' ' ' TRP . 2.9 pt-20 46.5 -169.8 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.951 0.405 . . . . 0.0 111.449 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -150.5 146.27 19.55 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.531 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -75.04 -17.37 19.5 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.434 2.09 . . . . 0.0 112.577 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.4 t -73.85 -41.73 53.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.935 0.397 . . . . 0.0 111.155 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -106.32 -23.18 12.61 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.906 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 64.88 33.24 10.17 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.917 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -126.0 143.86 50.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.852 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.447 ' CD2' ' HB3' ' A' ' 10' ' ' GLU . 40.0 m95 -90.04 124.81 35.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.042 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.421 ' CE1' ' HA ' ' A' ' 10' ' ' GLU . 1.7 p90 -127.81 147.6 63.56 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.63 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -67.99 124.72 12.14 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.491 2.127 . . . . 0.0 112.452 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -125.55 165.29 18.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.664 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -98.99 110.01 22.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.884 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.433 ' CD2' ' HB3' ' A' ' 31' ' ' TYR . 7.5 m-85 -123.1 132.01 53.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.842 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 29.8 t -121.13 134.39 64.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.92 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 24.6 tp -110.4 107.37 17.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.146 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 17.3 p -100.86 144.2 30.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.788 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.6 p -51.91 -21.47 3.01 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.827 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.412 ' O ' ' CG ' ' A' ' 28' ' ' LYS . 12.6 p -101.19 -27.58 13.14 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.412 ' CG ' ' O ' ' A' ' 27' ' ' SER . 4.5 mtmp? -162.2 -175.45 4.59 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.912 0.387 . . . . 0.0 111.341 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 3.1 mt -128.82 117.31 44.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.677 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -89.28 138.87 31.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.157 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.433 ' HB3' ' CD2' ' A' ' 22' ' ' PHE . 5.4 p90 -162.04 102.7 1.13 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.829 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 34.9 p 178.29 85.4 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.745 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 62.71 177.93 0.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.891 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -77.11 167.03 22.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.895 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -73.91 146.45 44.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.994 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.3 m -163.69 37.45 0.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.914 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.9 m 60.65 171.43 0.09 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.903 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.7 t70 60.44 40.55 17.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.874 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -128.88 31.82 4.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.914 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 68.55 29.51 72.92 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.585 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -107.67 31.43 5.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.842 0.353 . . . . 0.0 110.825 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -104.21 37.09 2.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.902 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -146.35 83.79 1.62 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.919 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -86.55 149.63 24.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.937 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.82 84.46 1.29 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.821 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -141.37 100.45 6.28 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.903 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -68.33 111.54 2.54 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.403 2.069 . . . . 0.0 112.297 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.65 51.4 0.79 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.0 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 61.34 177.45 0.11 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.967 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -128.72 -175.9 3.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.104 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.4 m -148.76 -72.48 0.19 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.875 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -91.57 161.72 27.49 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.491 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.1 p -109.79 139.65 44.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.861 0.362 . . . . 0.0 110.94 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.6 t -158.23 159.55 36.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.964 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.22 128.6 37.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.936 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.7 tp -97.78 145.15 26.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.91 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 7.3 m170 -105.49 107.61 18.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.84 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.7 t -64.27 118.39 8.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.835 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.71 109.5 21.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.879 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.6 mp -147.45 -45.85 0.17 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.944 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -57.3 -30.6 64.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.997 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.7 t -63.59 -29.72 48.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.158 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.8 tt -87.48 -13.49 42.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.29 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -88.41 24.47 1.91 Allowed 'General case' 0 C--O 1.231 0.118 0 CA-C-O 121.27 0.557 . . . . 0.0 110.465 179.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 177.04 33.5 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.669 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.42 ' N ' ' CD ' ' A' ' 67' ' ' PRO . . . -166.84 50.22 0.25 Allowed Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.692 -0.686 . . . . 0.0 112.361 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.42 ' CD ' ' N ' ' A' ' 66' ' ' GLY . 43.6 Cg_endo -67.66 135.94 37.5 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.537 2.158 . . . . 0.0 112.018 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 62.91 105.69 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.595 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.2 11.04 1.89 Allowed 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.848 2.366 . . . . 0.0 113.07 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -95.21 29.92 2.34 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.802 0.334 . . . . 0.0 111.422 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.403 HD12 HG23 ' A' ' 71' ' ' ILE . 21.1 mt -101.97 -11.78 8.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.631 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 15.6 mt -88.77 20.2 3.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.2 0.524 . . . . 0.0 111.414 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 76.8 mt-10 -156.24 83.73 3.34 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.231 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -68.87 57.24 1.08 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.85 2.367 . . . . 0.0 112.654 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.21 -76.89 0.45 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.865 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.6 mtt85 -115.15 137.61 51.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.934 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -160.63 80.32 0.65 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.854 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 60.08 79.03 0.25 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.843 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.2 mp -101.43 -170.14 1.79 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.926 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 33.5 p30 -82.65 61.15 5.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.917 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -67.74 122.53 18.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.824 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 23.9 p30 -97.22 38.43 1.25 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.126 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.453 ' CB ' ' HD2' ' A' ' 84' ' ' PRO . 0.3 OUTLIER -54.67 173.97 0.21 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.168 179.455 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.453 ' HD2' ' CB ' ' A' ' 83' ' ' SER . 52.2 Cg_endo -69.88 55.85 1.37 Allowed 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.154 1.903 . . . . 0.0 112.457 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.1 mt 51.12 23.49 1.59 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.535 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 43.38 42.93 5.86 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 121.012 -0.614 . . . . 0.0 113.049 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -99.49 -38.07 8.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.751 0.31 . . . . 0.0 111.231 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.68 -73.03 0.7 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.996 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.22 115.62 20.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.999 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.402 ' HB3' ' CZ ' ' A' ' 31' ' ' TYR . 1.7 tpt180 -120.76 -37.46 2.99 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.238 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 103.4 -23.19 33.81 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.942 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.0 p -163.74 141.58 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.758 0.313 . . . . 0.0 111.298 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -151.95 153.47 34.16 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.917 0.389 . . . . 0.0 111.05 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -71.99 133.87 45.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.956 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.487 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 13.6 t -75.04 -47.71 4.6 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.707 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 95' ' ' VAL . 73.7 Cg_endo -75.67 58.78 5.42 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.156 1.904 . . . . 0.0 112.495 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -176.21 36.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.974 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 27.3 p -139.12 162.43 34.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.924 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.15 108.74 6.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.859 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 15.1 mm -79.84 160.51 4.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.168 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -161.21 92.26 0.9 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.99 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 45.5 mt -59.47 141.26 16.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.073 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -134.79 106.64 10.66 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.731 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -69.8 50.91 0.86 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.576 2.184 . . . . 0.0 112.409 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 173.36 53.09 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.991 0.424 . . . . 0.0 110.26 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -44.47 -87.43 0.01 OUTLIER Glycine 0 C--N 1.332 0.312 0 CA-C-N 115.986 -0.552 . . . . 0.0 113.127 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.1 mttt 178.96 169.02 0.93 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.997 0.427 . . . . 0.0 111.101 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 60.95 -82.75 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.21 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -150.55 31.85 0.65 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.908 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 1.2 mmt85 -118.0 110.5 17.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.878 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -85.62 -32.07 22.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.954 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.427 ' CE2' ' HG3' ' A' ' 133' ' ' GLN . 5.2 m-85 -105.89 87.52 2.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.87 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 22.0 t -132.21 143.66 39.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.104 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.425 ' CE2' ' HB ' ' A' ' 128' ' ' VAL . 19.0 p90 -125.57 133.65 52.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.928 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -105.18 141.35 36.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.831 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 12.5 mt -105.26 157.91 5.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.97 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 55.8 p -150.13 -166.84 2.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.839 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 28.0 mtp -135.9 155.57 77.76 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.934 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -63.7 73.11 0.16 Allowed 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.692 2.261 . . . . 0.0 112.359 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 59.26 109.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.947 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.0 t -145.56 -66.63 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.058 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.405 ' O ' ' HG2' ' A' ' 123' ' ' GLN . . . -176.01 73.06 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.032 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.405 ' HG2' ' O ' ' A' ' 122' ' ' ALA . 0.0 OUTLIER 40.63 36.87 0.41 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.781 -179.917 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 22.6 m95 -91.89 126.25 36.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.872 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.9 t -165.65 120.37 1.24 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.903 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.88 166.66 10.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.877 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -115.08 142.26 46.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.936 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.425 ' HB ' ' CE2' ' A' ' 114' ' ' PHE . 17.1 t -148.56 154.01 10.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.022 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -159.84 135.08 8.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.252 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -104.71 132.25 51.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.962 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -54.49 -36.75 64.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.069 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.77 111.98 23.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.804 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.427 ' HG3' ' CE2' ' A' ' 112' ' ' PHE . 5.2 tt0 -48.31 -28.64 3.25 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.521 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.95 -40.88 53.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.279 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.53 -33.33 73.93 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.054 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.2 tt -66.68 -48.52 69.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.41 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -69.26 -38.1 78.27 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.291 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -69.88 -28.76 65.9 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.282 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' TRP . . . . . 0.444 ' CZ3' ' HG ' ' A' ' 7' ' ' LEU . 1.3 m95 -69.64 -46.93 65.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.599 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 25.4 t -63.44 -40.11 87.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.033 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 5.5 ttpp -65.59 -36.6 84.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.797 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.42 -50.35 59.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.464 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 54.7 mt -54.53 -35.85 33.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.311 0.577 . . . . 0.0 109.498 178.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 14.4 mtp-105 -76.97 -29.4 55.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.385 179.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -75.87 -32.18 59.61 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-O 120.825 0.345 . . . . 0.0 110.621 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 59.1 t -78.82 -32.18 15.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.142 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.93 -39.68 66.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.845 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -72.47 -16.65 61.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.881 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 11.9 t -111.62 16.81 20.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.896 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.14 -179.963 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.829 0.347 . . . . 0.0 111.2 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.405 HD13 HG22 ' A' ' 2' ' ' ILE . 30.1 mt -85.29 -33.18 7.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.246 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.5 tttp -160.0 141.52 12.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.944 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.419 ' HB3' ' CZ ' ' A' ' 21' ' ' TYR . 5.7 m120 -139.53 132.81 29.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.81 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -169.97 175.53 44.01 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.51 -0.853 . . . . 0.0 112.623 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 22.5 mm -93.1 75.83 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.775 0.321 . . . . 0.0 111.099 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.444 ' CD2' ' CZ2' ' A' ' 139' ' ' TRP . 4.0 mm? -79.05 131.5 36.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.734 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -81.58 155.25 25.78 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.164 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.1 mp -141.46 164.85 29.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.716 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.435 ' HG2' ' CE3' ' A' ' 17' ' ' TRP . 1.4 mm-40 -111.76 111.78 23.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.908 0.385 . . . . 0.0 111.1 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.22 113.04 50.07 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.339 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.58 -17.08 8.94 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.562 2.175 . . . . 0.0 113.137 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.6 t -63.99 -39.66 86.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.018 0.437 . . . . 0.0 110.947 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 16.4 m-80 -128.19 -6.74 5.4 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.597 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 53.84 63.24 2.26 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.88 0.371 . . . . 0.0 111.036 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -148.36 160.86 42.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.892 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.435 ' CE3' ' HG2' ' A' ' 10' ' ' GLU . 70.7 m95 -81.01 136.97 36.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.929 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -137.22 129.29 16.8 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.726 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.1 138.95 31.76 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.487 2.125 . . . . 0.0 112.246 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -155.39 130.04 9.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.911 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.419 ' CZ ' ' HB3' ' A' ' 4' ' ' ASN . 25.4 t80 -74.2 90.63 2.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.907 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -76.84 143.73 39.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.927 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 22.6 t -121.54 102.75 12.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.926 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.4 tt -91.22 112.12 23.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.989 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -106.64 152.04 24.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.826 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 7.7 t -70.11 58.57 0.16 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.714 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 178.38 -28.64 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.875 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.7 mtpt -172.89 168.82 4.92 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.831 0.348 . . . . 0.0 110.864 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 15.3 mt -107.99 128.51 63.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.012 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -121.69 118.51 29.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.868 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.41 ' CZ ' ' HA3' ' A' ' 91' ' ' GLY . 37.7 p90 -123.43 146.86 47.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.944 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.7 m -163.34 151.84 13.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.934 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -59.2 114.2 2.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.81 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -150.49 130.75 13.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.987 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.14 179.13 0.1 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.919 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 74.9 m -91.69 51.37 1.85 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.849 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 7.2 m -87.46 -169.48 2.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.959 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 60.93 86.1 0.11 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.901 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -143.89 37.79 1.31 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.954 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 116.21 -25.8 9.09 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.51 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 62.1 31.68 17.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.869 0.366 . . . . 0.0 110.898 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -101.26 35.49 2.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.952 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -146.25 123.51 11.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.906 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -138.67 172.4 12.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.879 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -164.01 130.18 3.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.809 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -59.86 141.65 89.24 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.954 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -74.12 157.14 46.74 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.56 2.173 . . . . 0.0 112.382 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.57 67.87 3.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.751 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -107.32 79.38 1.3 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.925 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -127.06 143.78 51.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.174 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.3 m -135.99 168.58 19.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.951 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 150.13 107.81 0.41 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.409 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -92.98 -31.51 14.87 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.779 0.323 . . . . 0.0 110.876 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.3 t -133.63 111.54 10.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.881 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.76 172.48 12.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.881 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.65 -74.7 0.3 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.895 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 54.0 m80 -134.57 -52.31 0.81 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.868 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 53.3 p -86.95 -169.83 2.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.922 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.9 p -157.82 135.72 10.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.913 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.1 tp -144.18 -47.62 0.27 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.95 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -65.58 -30.58 71.33 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.772 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 27.6 t -70.69 -38.43 73.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.001 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.7 mp -68.28 -18.04 64.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.062 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -91.94 22.53 4.21 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.137 0.494 . . . . 0.0 110.805 179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -155.64 27.74 0.38 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.865 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -97.91 -56.16 1.09 Allowed Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.423 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -51.68 139.56 48.08 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.634 2.223 . . . . 0.0 112.286 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 59.72 69.23 1.3 Allowed Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.865 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -85.98 15.54 2.18 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.738 2.292 . . . . 0.0 112.846 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.49 29.87 3.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.859 0.361 . . . . 0.0 111.264 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.463 HG21 HD13 ' A' ' 71' ' ' ILE . 24.9 mt -101.7 -5.2 9.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.651 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 14.4 mt -91.69 22.06 4.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.059 0.457 . . . . 0.0 111.578 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -136.06 69.07 63.81 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.793 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -68.6 60.44 1.15 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.917 2.411 . . . . 0.0 112.191 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -55.2 -28.83 55.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.213 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.7 mtt85 -138.16 135.06 35.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.945 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -172.82 87.84 0.07 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.87 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 61.62 78.97 0.27 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.927 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 69.9 mt -134.51 115.38 13.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.906 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 59.73 31.74 21.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.804 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -69.5 142.38 53.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.968 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -73.07 -49.16 30.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.982 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.473 ' CB ' ' HD2' ' A' ' 84' ' ' PRO . 0.3 OUTLIER 55.49 178.4 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.208 -179.798 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.473 ' HD2' ' CB ' ' A' ' 83' ' ' SER . 68.0 Cg_endo -75.54 44.48 1.25 Allowed 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 122.022 1.815 . . . . 0.0 112.883 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.1 mp 43.57 54.22 5.5 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 113.3 -41.02 2.32 Favored Glycine 0 C--N 1.33 0.223 0 C-N-CA 120.559 -0.829 . . . . 0.0 113.054 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.43 ' CA ' ' HG2' ' A' ' 84' ' ' PRO . 16.3 t70 75.52 96.29 0.07 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.945 0.402 . . . . 0.0 110.992 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.2 mt -122.73 57.13 1.12 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.743 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.49 77.56 0.07 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.058 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -167.73 80.84 0.19 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.894 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.41 ' HA3' ' CZ ' ' A' ' 31' ' ' TYR . . . -104.38 140.43 14.96 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.52 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 11.4 p -111.44 155.1 12.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.757 0.313 . . . . 0.0 111.127 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -154.29 112.33 3.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.918 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.51 127.14 30.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.091 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.499 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 38.8 t -74.24 -48.4 5.77 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.577 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 95' ' ' VAL . 64.3 Cg_endo -74.16 57.82 4.11 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.19 1.926 . . . . 0.0 112.349 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 171.94 40.55 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.655 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -159.81 99.66 1.41 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.893 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -79.58 136.94 36.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.764 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 6.2 mm -87.26 162.58 2.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.054 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -149.85 83.74 1.4 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.0 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 69.0 mt -58.68 152.82 3.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.078 0.466 . . . . 0.0 111.215 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.94 114.99 4.01 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.213 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -78.42 42.47 1.24 Allowed 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.358 2.038 . . . . 0.0 112.688 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 175.16 62.32 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.045 0.45 . . . . 0.0 110.424 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -53.47 -93.54 0.01 OUTLIER Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.757 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.9 pttt -177.8 170.09 1.97 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.845 0.355 . . . . 0.0 110.949 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 64.07 -79.78 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.859 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -159.51 31.98 0.19 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.957 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 25.1 mmm180 -119.82 92.39 3.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.878 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.8 mp -68.3 -30.75 69.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.854 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -105.66 92.84 4.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.985 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 24.1 t -137.24 143.16 35.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.048 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.42 ' CD1' ' HG ' ' A' ' 136' ' ' LEU . 39.8 p90 -128.9 131.1 47.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.891 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.2 m -102.38 128.33 49.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.833 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 1.6 mt -100.12 159.99 3.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.987 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 60.9 p -153.76 149.95 27.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.945 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 39.7 mtp -96.12 108.48 41.53 Favored Pre-proline 0 CA--C 1.531 0.234 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.106 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -74.97 54.77 3.72 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.72 2.28 . . . . 0.0 112.394 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.9 p 171.39 41.84 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.72 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 45.2 t -150.5 -68.35 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.995 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -177.62 -154.36 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.316 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -85.62 45.62 1.22 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.7 0.286 . . . . 0.0 111.169 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 11.8 m0 -73.95 139.56 44.96 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.784 0.326 . . . . 0.0 110.744 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -140.58 110.25 6.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.097 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.45 112.37 24.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.913 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -84.51 118.75 24.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.98 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.419 ' HB ' ' CE2' ' A' ' 114' ' ' PHE . 21.7 t -141.95 151.79 18.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.925 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.407 ' HA ' ' CE1' ' A' ' 114' ' ' PHE . . . -160.32 148.58 16.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.269 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -114.2 150.41 34.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.909 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.12 -58.82 6.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.864 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.76 113.64 11.14 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.751 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -48.74 -27.56 3.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.567 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 25.8 mp0 -73.84 -40.54 63.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.482 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -67.37 -31.77 72.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.173 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.42 ' HG ' ' CD1' ' A' ' 114' ' ' PHE . 7.5 tt -68.12 -49.44 61.14 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.521 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.78 -40.31 84.0 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.307 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -67.32 -29.21 68.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.322 179.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' TRP . . . . . 0.444 ' CZ2' ' CD2' ' A' ' 7' ' ' LEU . 0.8 OUTLIER -67.82 -49.09 64.16 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.471 179.611 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 33.5 t -60.28 -40.97 85.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.034 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -67.25 -38.37 85.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.907 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 6.4 mptt -66.59 -49.86 64.95 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.524 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 41.6 mt -55.21 -37.14 42.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.369 0.605 . . . . 0.0 109.532 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 24.3 mtp180 -79.85 -25.74 40.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.212 -0.903 . . . . 0.0 110.673 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -76.04 -38.71 56.88 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-O 120.909 0.385 . . . . 0.0 110.75 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.404 HG12 ' N ' ' A' ' 147' ' ' ALA . 7.2 p -80.85 -28.57 11.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.236 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.404 ' N ' HG12 ' A' ' 146' ' ' VAL . . . -79.29 -33.89 42.94 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.291 179.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -74.2 -13.78 60.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.883 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 9.2 t -105.4 -20.5 13.47 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.101 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.216 -0.897 . . . . 0.0 111.141 179.922 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 6.7 m . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.844 0.354 . . . . 0.0 111.184 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.401 ' CD1' ' HA ' ' A' ' 26' ' ' SER . 38.3 mt -76.53 -34.78 24.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.148 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.8 tptp -142.01 91.94 2.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.871 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -125.06 131.91 53.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.919 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -169.88 -165.18 26.83 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.525 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 25.1 mm -97.21 80.45 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.743 0.306 . . . . 0.0 111.1 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.448 ' CD2' ' CZ2' ' A' ' 139' ' ' TRP . 0.8 OUTLIER -87.58 158.62 18.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.779 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -102.16 163.68 12.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.026 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -177.78 129.16 0.14 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.785 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.429 ' HG2' ' CZ3' ' A' ' 17' ' ' TRP . 0.0 OUTLIER -95.16 166.29 11.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.974 0.416 . . . . 0.0 111.024 -179.814 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.42 150.12 53.8 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.709 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -73.63 -17.96 22.84 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.597 2.198 . . . . 0.0 112.506 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.1 t -77.77 -38.62 25.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.985 0.421 . . . . 0.0 110.975 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -101.81 -23.88 14.13 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.835 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 63.87 33.27 12.72 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.822 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -144.76 156.1 43.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.048 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.429 ' CZ3' ' HG2' ' A' ' 10' ' ' GLU . 30.8 m95 -77.24 139.57 39.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.869 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -132.4 138.72 32.81 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.838 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.42 130.26 14.81 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.464 2.11 . . . . 0.0 112.3 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -144.75 -178.34 5.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.864 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.422 ' CD1' ' HG2' ' A' ' 34' ' ' GLU . 34.1 t80 -119.96 139.39 52.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.934 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.49 ' CZ ' ' CD1' ' A' ' 31' ' ' TYR . 1.5 m-85 -132.44 148.28 52.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.873 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.7 t -140.0 92.06 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.03 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.84 115.09 8.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.094 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -99.44 157.28 16.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.023 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.401 ' HA ' ' CD1' ' A' ' 2' ' ' ILE . 0.3 OUTLIER -42.83 -34.37 0.93 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.229 -179.47 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.5 p -144.14 46.66 1.43 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.732 0.301 . . . . 0.0 111.622 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 177.12 167.68 0.57 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.834 0.35 . . . . 0.0 111.358 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.472 HG22 HD12 ' A' ' 29' ' ' ILE . 3.0 mt -132.2 100.32 4.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.539 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -73.43 132.17 42.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.172 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.49 ' CD1' ' CZ ' ' A' ' 22' ' ' PHE . 69.4 t80 -143.31 123.37 13.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.783 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.5 t -166.88 -79.02 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.885 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -162.06 179.4 8.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.918 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.422 ' HG2' ' CD1' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -80.83 146.56 30.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.918 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.05 143.99 28.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.817 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 95.2 p -148.99 38.11 0.81 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.944 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.1 m -128.2 173.76 9.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.879 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -122.26 97.17 5.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.977 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -144.73 48.93 1.31 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.877 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.37 44.75 2.43 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.485 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 31.6 p-10 -134.37 35.87 3.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.797 0.332 . . . . 0.0 110.826 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 45.14 35.22 1.59 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.433 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.6 t70 60.1 171.27 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.952 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -86.42 112.78 21.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.885 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -143.18 125.49 15.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.868 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -70.72 111.55 10.06 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.889 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.93 168.38 23.25 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.398 2.065 . . . . 0.0 112.261 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.06 152.25 22.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.853 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -118.99 168.02 11.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.886 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -111.96 90.99 3.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.137 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.6 p -86.78 160.59 18.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.92 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -101.37 -132.37 7.72 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.474 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.2 t -100.02 160.41 14.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.747 0.308 . . . . 0.0 110.858 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.3 t 43.1 72.21 0.19 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.487 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -160.12 170.38 21.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.853 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.98 138.33 52.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.845 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 20.7 p-80 -164.84 160.03 19.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.87 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.6 t -163.54 128.66 2.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.895 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 72.2 m -152.28 122.62 7.23 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.874 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -147.55 -46.92 0.17 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.906 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -59.53 -31.31 69.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.738 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.3 t -62.14 -34.41 63.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.859 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.0 mp -63.92 -18.89 64.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.958 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -90.27 21.97 3.56 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 121.188 0.518 . . . . 0.0 110.735 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.1 mm-40 -152.03 26.3 0.63 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.736 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -101.87 -71.66 0.92 Allowed Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.483 -0.78 . . . . 0.0 112.206 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -46.06 113.21 0.55 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 123.03 2.487 . . . . 0.0 112.109 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.0 t30 63.35 90.91 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.778 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -82.23 9.53 3.94 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.769 2.313 . . . . 0.0 113.019 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -96.85 29.96 2.85 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.863 0.363 . . . . 0.0 111.223 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 27.7 mt -99.59 -6.63 9.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.692 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 17.4 mt -92.0 21.31 5.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.114 0.483 . . . . 0.0 111.595 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -139.14 67.93 40.5 Favored Pre-proline 0 C--N 1.317 -0.821 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.575 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -68.18 60.22 1.0 Allowed 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 123.017 2.478 . . . . 0.0 112.279 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -93.45 20.17 7.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.209 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.1 mmt85 -147.16 170.76 16.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.891 0.376 . . . . 0.0 110.742 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 61.48 112.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.869 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 60.56 91.83 0.05 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.905 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.4 mp -124.05 -177.71 3.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.898 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.9 t70 60.33 38.21 19.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.8 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -87.55 55.11 3.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.903 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 -98.19 28.85 3.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.975 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.406 ' CB ' ' CD ' ' A' ' 84' ' ' PRO . 0.3 OUTLIER -74.04 -58.94 1.89 Allowed Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.96 -179.921 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.406 ' CD ' ' CB ' ' A' ' 83' ' ' SER . 74.0 Cg_endo -76.62 -44.4 0.23 Allowed 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.919 2.413 . . . . 0.0 112.47 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.4 tp 68.89 -66.79 0.23 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.042 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -100.77 155.69 19.3 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.591 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.45 -70.87 0.76 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.925 0.393 . . . . 0.0 110.963 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -145.93 -56.32 0.29 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.836 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -133.14 31.93 3.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.971 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -133.65 77.82 1.74 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.924 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -89.24 75.48 1.89 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.567 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.2 m -84.87 139.47 17.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.733 0.301 . . . . 0.0 111.091 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.1 mt -130.98 134.56 46.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.895 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -69.39 126.8 30.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.871 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.649 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 13.3 p -81.95 -27.73 0.44 Allowed Pre-proline 0 CA--C 1.534 0.347 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.649 ' CD ' ' N ' ' A' ' 95' ' ' VAL . 88.8 Cg_endo -85.97 47.64 1.89 Allowed 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.146 1.898 . . . . 0.0 112.665 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 178.69 39.37 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.865 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 1.9 m -119.48 173.51 6.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.958 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.01 102.59 2.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.769 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 14.7 mm -79.2 158.19 4.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.078 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -155.56 93.17 1.46 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.037 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 54.3 mt -59.25 143.87 13.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.144 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.404 ' C ' ' H ' ' A' ' 105' ' ' GLU . 4.6 mtt180 -133.28 114.15 13.53 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.525 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -74.78 29.87 0.35 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.587 2.191 . . . . 0.0 112.651 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.404 ' H ' ' C ' ' A' ' 103' ' ' ARG . 1.9 tt0 -177.62 74.22 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.734 0.302 . . . . 0.0 110.413 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -42.28 -84.67 0.01 OUTLIER Glycine 0 C--N 1.332 0.344 0 CA-C-N 116.077 -0.51 . . . . 0.0 113.19 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -175.11 -80.5 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.832 0.349 . . . . 0.0 111.236 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -96.8 109.71 22.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.215 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 32.8 m120 48.04 38.78 10.11 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.235 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 7.9 mmp_? -140.11 112.66 7.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.936 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.86 -33.51 12.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.822 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -108.21 107.12 17.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.861 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 22.0 t -151.18 132.3 4.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.128 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.421 ' CZ ' HG12 ' A' ' 128' ' ' VAL . 31.3 p90 -115.54 122.51 45.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.895 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 58.1 m -89.32 128.38 35.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.983 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.405 HD11 HG21 ' A' ' 116' ' ' ILE . 14.1 mt -100.97 158.5 4.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.996 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 54.6 p -151.38 -170.52 3.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.968 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 32.7 mtp -146.82 105.02 3.92 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.073 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -78.16 59.17 6.91 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.506 2.137 . . . . 0.0 112.376 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -177.2 -45.6 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.877 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 43.1 t -65.63 -66.69 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.999 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 179.88 -154.76 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.296 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -84.63 47.63 1.4 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.772 0.32 . . . . 0.0 111.04 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 23.6 m95 -79.94 128.7 33.78 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.804 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.14 114.95 14.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.944 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.3 tp -112.5 112.62 24.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.022 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -82.2 126.46 32.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.858 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.421 HG12 ' CZ ' ' A' ' 114' ' ' PHE . 21.2 t -136.44 154.43 32.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.077 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -161.21 127.37 3.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.144 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -92.55 142.46 27.37 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.978 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -56.0 -37.66 69.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.896 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -97.55 114.02 25.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.797 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -48.5 -27.42 2.69 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.539 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -73.67 -42.12 61.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.357 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.19 -30.21 68.36 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.117 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.402 ' HG ' ' CD1' ' A' ' 114' ' ' PHE . 9.8 tt -68.44 -45.89 71.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.418 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 80.3 mm-40 -68.05 -42.7 80.1 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.309 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -66.87 -30.44 70.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.325 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' TRP . . . . . 0.448 ' CZ2' ' CD2' ' A' ' 7' ' ' LEU . 1.0 OUTLIER -66.38 -46.74 75.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.512 179.563 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 40.6 t -61.45 -44.62 98.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.941 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 7.2 ttmm -63.46 -35.9 81.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.936 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.7 -52.0 49.69 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.476 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 74.0 mt -53.64 -34.92 25.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.28 0.562 . . . . 0.0 109.646 178.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 3.1 mtt180 -78.4 -28.39 46.91 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.584 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -74.91 -39.56 61.37 Favored 'General case' 0 CA--C 1.523 -0.088 0 CA-C-O 120.898 0.38 . . . . 0.0 110.78 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 8.9 m -78.74 -26.71 13.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.258 179.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -77.43 -35.01 54.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.819 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -78.53 -9.58 59.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.136 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 15.2 t -113.5 -30.14 6.95 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.777 0.323 . . . . 0.0 111.144 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.251 -0.88 . . . . 0.0 111.088 -179.989 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.4 p . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.749 0.309 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 33.9 mt -74.93 -30.9 24.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.145 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.9 mttp -147.51 116.79 6.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.964 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -135.37 124.81 24.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.896 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -163.31 -156.07 8.46 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.498 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.405 HD11 ' CD2' ' A' ' 21' ' ' TYR . 26.5 mm -105.53 99.61 8.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.814 0.34 . . . . 0.0 111.184 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.433 HD21 ' CE2' ' A' ' 139' ' ' TRP . 3.2 mm? -102.92 139.88 37.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.834 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -80.68 140.83 35.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.035 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.412 HD13 ' CZ ' ' A' ' 22' ' ' PHE . 5.9 tt -152.49 102.57 2.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.797 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.409 ' HB3' ' CD2' ' A' ' 17' ' ' TRP . 0.6 OUTLIER -70.67 153.26 43.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.878 -179.806 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -113.25 150.71 43.46 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.913 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.07 -17.98 24.34 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.619 2.213 . . . . 0.0 112.549 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -72.4 -48.41 47.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.168 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -100.73 -19.39 16.05 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.936 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 59.9 42.51 16.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.973 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -146.4 146.62 30.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.874 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.417 ' CE2' ' HG3' ' A' ' 110' ' ' ARG . 58.7 m95 -72.72 150.5 42.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.873 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -144.33 139.91 16.22 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.851 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -73.83 87.94 1.1 Allowed 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.583 2.189 . . . . 0.0 112.41 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -104.27 162.64 13.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.874 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.405 ' CD2' HD11 ' A' ' 6' ' ' ILE . 0.8 OUTLIER -93.3 137.64 32.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.845 -179.963 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.501 ' CZ ' ' CE1' ' A' ' 31' ' ' TYR . 44.0 m-85 -138.66 156.56 47.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.938 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 25.3 t -141.17 150.28 20.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.874 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 21.0 tp -133.02 118.37 18.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.237 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 15.0 p -109.76 149.12 30.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.695 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -56.79 -18.72 13.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.863 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.2 m -99.09 -24.7 14.8 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 111.624 0.231 . . . . 0.0 111.624 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.01 -173.92 0.73 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.727 0.298 . . . . 0.0 110.799 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 7.7 mt -110.83 162.28 8.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.705 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -133.59 138.25 45.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.075 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.501 ' CE1' ' CZ ' ' A' ' 22' ' ' PHE . 10.9 t80 -121.25 139.15 53.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.87 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.39 161.33 41.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.943 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -126.46 152.98 45.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.882 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -92.04 179.63 5.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.887 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.3 t -129.12 -170.07 2.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.822 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 56.5 p -83.55 144.11 29.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.888 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -153.3 156.35 38.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.847 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -90.19 -38.42 13.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.895 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 57.94 31.72 20.97 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.878 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -132.02 34.12 2.59 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.499 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -163.82 31.69 0.08 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.814 0.34 . . . . 0.0 110.875 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -107.04 34.67 3.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.012 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.1 t70 61.04 -175.3 0.12 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.922 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -88.17 -174.7 4.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.928 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -71.0 105.54 3.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.897 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 58.92 84.41 0.2 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.946 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.33 161.26 46.23 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.606 2.204 . . . . 0.0 112.363 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -88.05 167.33 13.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.874 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.95 136.31 39.11 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.825 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -109.35 -176.09 2.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.025 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.7 m -160.35 -45.4 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.951 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 166.3 137.31 2.19 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.485 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -105.21 31.71 4.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.823 0.344 . . . . 0.0 110.829 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 10.4 t -79.79 -177.79 6.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.916 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -141.14 158.41 43.95 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.848 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.7 tp 69.26 -66.28 0.26 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.991 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 30.4 t60 -127.59 158.77 36.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.83 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 63.8 m -129.64 158.85 38.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.814 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 7.9 t -152.8 178.5 9.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.943 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.6 mp 65.21 9.69 5.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.48 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -109.26 -30.81 7.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.071 0.462 . . . . 0.0 109.894 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.9 t -80.12 -26.03 11.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.524 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -84.1 -12.48 54.98 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.245 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -91.41 26.17 2.35 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 121.063 0.459 . . . . 0.0 110.709 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -168.97 31.23 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.963 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -120.89 -72.95 0.32 Allowed Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.199 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -43.73 133.69 7.68 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.024 2.483 . . . . 0.0 112.295 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 64.12 103.37 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.718 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -77.16 8.89 3.01 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.809 2.339 . . . . 0.0 113.044 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -95.34 29.59 2.48 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.833 0.349 . . . . 0.0 111.437 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 22.2 mt -103.13 -3.31 9.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.689 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 12.7 mt -91.85 22.41 4.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.092 0.472 . . . . 0.0 111.607 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -134.01 69.87 74.61 Favored Pre-proline 0 C--N 1.318 -0.78 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.829 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -69.14 59.47 1.32 Allowed 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.939 2.426 . . . . 0.0 112.366 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -68.82 -43.5 75.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.969 0.414 . . . . 0.0 110.576 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 5.2 mtt180 -143.24 122.44 12.96 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.94 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -111.47 30.44 6.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.858 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -139.74 31.34 2.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.399 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.1 tt -112.95 144.13 43.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.933 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 14.2 t0 57.17 40.35 28.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.98 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -141.27 116.74 10.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.991 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 57.49 83.31 0.11 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.067 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.458 ' N ' ' CD ' ' A' ' 84' ' ' PRO . 0.1 OUTLIER -84.18 -52.18 0.56 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.042 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.458 ' CD ' ' N ' ' A' ' 83' ' ' SER . 50.2 Cg_exo -52.31 -31.4 46.74 Favored 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.857 2.372 . . . . 0.0 112.271 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.4 tt -116.29 78.67 1.22 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.886 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -138.68 -81.75 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.547 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -83.7 -36.54 23.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.785 0.326 . . . . 0.0 110.892 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 72.5 mt 60.22 97.99 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.853 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -95.14 148.66 22.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.809 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.4 tpm_? -173.43 -66.65 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.999 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -127.78 173.11 18.85 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.406 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 11.8 p -169.49 131.04 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.77 0.319 . . . . 0.0 111.297 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.9 tp -113.88 -173.74 2.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.542 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -123.71 140.01 53.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.94 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.466 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 22.7 t -86.05 -45.89 0.59 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.982 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' A' ' 95' ' ' VAL . 88.0 Cg_endo -80.36 54.7 5.34 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.258 1.972 . . . . 0.0 112.525 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 176.03 39.57 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.797 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 8.4 m -141.05 -178.88 5.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.979 0.419 . . . . 0.0 111.198 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -160.38 105.5 1.48 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.525 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 14.7 mm -74.47 160.59 5.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.224 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -160.6 92.78 0.98 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.866 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 15.0 mt -57.07 136.4 20.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.017 0.437 . . . . 0.0 111.31 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.87 123.86 26.74 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.197 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -82.71 19.2 1.34 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.465 2.11 . . . . 0.0 112.926 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -169.0 70.95 0.08 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.797 0.332 . . . . 0.0 110.674 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -56.59 -95.13 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.682 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -168.33 165.85 12.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.851 0.357 . . . . 0.0 110.992 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 63.63 -80.4 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.114 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -158.29 31.23 0.24 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.911 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.417 ' HG3' ' CE2' ' A' ' 17' ' ' TRP . 11.7 mmt180 -119.62 85.67 2.42 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.853 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -69.19 -32.22 71.37 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.084 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -97.73 87.71 4.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.017 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 21.4 t -139.94 144.66 27.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.939 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.42 ' CE2' ' HB ' ' A' ' 128' ' ' VAL . 48.9 p90 -118.22 125.51 50.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.895 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.2 t -98.62 133.03 43.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.985 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 14.6 mt -101.67 159.69 4.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.828 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.7 t -151.97 -179.67 7.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.81 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 10.2 mtt -135.38 135.44 22.44 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.833 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -59.4 -66.01 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.479 2.119 . . . . 0.0 112.697 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.65 104.65 11.91 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.327 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.486 ' CG1' ' N ' ' A' ' 122' ' ' ALA . 2.0 p -178.81 -47.99 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.787 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.486 ' N ' ' CG1' ' A' ' 121' ' ' VAL . . . 169.26 -167.41 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.769 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 9.7 mm100 -98.16 36.31 1.6 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.807 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 22.9 m95 -63.94 -177.7 0.27 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.983 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 89.3 p -178.16 103.02 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.758 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 10.0 tp -92.53 104.7 16.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.143 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -85.97 131.85 34.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.822 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.42 ' HB ' ' CE2' ' A' ' 114' ' ' PHE . 22.0 t -152.5 147.53 14.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.06 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -148.27 143.92 27.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.261 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -104.83 135.77 45.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.031 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -54.29 -34.61 61.28 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.995 0.426 . . . . 0.0 110.898 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 5.9 t -95.94 114.89 26.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.669 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -48.96 -26.16 2.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.725 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -75.63 -42.9 50.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.591 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -67.86 -32.0 72.21 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.239 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 7.4 tt -68.99 -46.93 66.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.516 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -68.86 -41.08 78.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.39 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.55 -28.93 68.2 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.357 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' TRP . . . . . 0.433 ' CE2' HD21 ' A' ' 7' ' ' LEU . 1.1 m95 -69.05 -47.51 65.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.608 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 33.2 t -61.53 -40.39 86.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.904 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.94 -38.26 90.36 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.841 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.92 -52.13 52.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.366 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 73.9 mt -53.85 -34.37 25.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.23 0.538 . . . . 0.0 109.644 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -81.23 -27.91 35.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.482 179.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -70.93 -39.95 72.36 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-O 120.906 0.384 . . . . 0.0 110.413 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.403 ' HB ' ' CG1' ' A' ' 95' ' ' VAL . 61.8 t -78.48 -33.55 17.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.859 179.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.34 -34.33 65.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.479 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.88 -11.72 60.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.858 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 10.6 t -120.98 17.07 11.72 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.083 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.282 -0.866 . . . . 0.0 111.082 -179.982 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 25.7 m . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.808 0.337 . . . . 0.0 111.271 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 30.2 mt -85.59 -33.01 7.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.064 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.43 ' HE3' ' CD1' ' A' ' 139' ' ' TRP . 21.2 tttp -158.63 116.41 2.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.007 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -131.72 127.73 37.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.966 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -166.29 -155.54 8.91 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.549 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.408 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 3.4 mp -115.42 100.96 11.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.815 0.341 . . . . 0.0 111.114 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -96.18 140.2 31.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.77 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -76.93 145.35 38.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.127 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -158.06 122.23 4.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.69 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.433 ' HB2' ' CE3' ' A' ' 17' ' ' TRP . 0.7 OUTLIER -74.18 120.9 20.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.11 -179.8 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.47 138.47 59.21 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.028 179.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -67.98 -12.0 33.84 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.192 1.928 . . . . 0.0 112.564 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.4 t -77.76 -36.31 22.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.886 0.374 . . . . 0.0 110.919 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -111.92 -24.39 9.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.044 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 2.4 m170 66.63 34.53 5.8 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.901 0.381 . . . . 0.0 110.654 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.402 ' N ' ' CG ' ' A' ' 10' ' ' GLU . 48.8 mt-10 -138.15 144.54 40.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.859 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.433 ' CE3' ' HB2' ' A' ' 10' ' ' GLU . 49.7 m95 -52.87 146.27 11.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.128 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -150.04 130.65 7.02 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.883 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.94 97.14 1.09 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.436 2.091 . . . . 0.0 112.364 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 15.5 m80 -115.96 149.21 39.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.856 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -65.35 164.44 13.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.946 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.498 ' CD2' ' CD1' ' A' ' 31' ' ' TYR . 0.2 OUTLIER -177.28 119.99 0.11 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.672 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.4 t -104.76 142.16 18.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.101 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 23.1 tp -118.83 103.08 9.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.902 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -101.8 152.2 21.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.865 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.18 -16.69 21.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.643 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.0 p -99.54 -23.34 15.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.575 0.226 . . . . 0.0 111.513 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 178.41 -174.72 0.17 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.897 0.379 . . . . 0.0 110.953 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 6.0 mt -119.62 123.9 71.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.812 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -95.42 160.41 14.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.942 0.401 . . . . 0.0 111.01 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.498 ' CD1' ' CD2' ' A' ' 22' ' ' PHE . 45.8 t80 -151.88 123.35 7.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.765 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.1 t -158.34 147.99 19.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.863 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.37 159.64 17.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.995 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -156.06 -177.66 6.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.929 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.1 t 45.12 -166.41 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.323 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.8 t 61.92 80.18 0.23 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.015 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 50.5 p -133.99 157.61 45.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.874 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.89 -35.8 37.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.891 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 58.9 31.5 21.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.922 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -134.39 34.65 2.33 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.495 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -159.02 42.84 0.24 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.85 0.357 . . . . 0.0 110.842 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -134.75 44.41 2.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.961 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -144.49 -169.74 3.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.83 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -140.77 126.1 18.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.983 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -151.79 32.05 0.56 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.873 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -68.16 152.4 96.51 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.839 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.89 88.19 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.639 2.226 . . . . 0.0 112.31 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.8 tttt -95.13 90.44 5.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.877 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -71.6 122.57 20.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.812 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -165.96 34.33 0.05 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.115 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.1 m 62.26 150.62 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.954 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 163.3 -111.59 0.48 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.516 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.1 m -156.29 26.92 0.35 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.753 0.311 . . . . 0.0 111.089 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.4 -176.67 3.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.958 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -152.63 159.79 43.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.797 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -159.03 109.83 2.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.968 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 4.3 m170 -89.77 119.11 29.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.801 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 96.0 p -74.56 120.46 20.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.938 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.6 -172.42 2.39 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.352 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.2 tp -58.82 -41.41 86.77 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.129 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -53.14 -25.35 13.08 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.972 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.8 t -68.44 -44.68 83.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.157 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.3 mp -69.62 -11.23 60.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.304 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -93.48 26.29 3.07 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-O 121.122 0.487 . . . . 0.0 110.727 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -169.39 30.76 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.149 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -113.01 -64.42 0.46 Allowed Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.394 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -50.9 146.51 21.23 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.604 2.203 . . . . 0.0 112.213 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.5 m120 60.9 91.66 0.07 OUTLIER Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.941 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -84.89 18.89 1.48 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.764 2.309 . . . . 0.0 113.005 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.35 28.74 3.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.967 0.413 . . . . 0.0 111.186 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 13.3 mt -111.65 -5.24 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.881 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.7 mp -92.26 19.85 6.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.122 0.487 . . . . 0.0 111.831 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.448 ' N ' ' HD3' ' A' ' 74' ' ' PRO . 17.5 mt-10 -140.86 63.5 19.51 Favored Pre-proline 0 C--N 1.316 -0.861 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.983 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.448 ' HD3' ' N ' ' A' ' 73' ' ' GLU . 7.8 Cg_exo -72.53 61.13 3.51 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.768 2.312 . . . . 0.0 112.052 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -92.41 -34.31 14.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.079 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 11.0 mmt-85 -79.28 172.23 14.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.886 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 62.89 35.34 13.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.956 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -178.86 44.58 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.911 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.1 mp -85.68 133.4 34.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.973 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 58.65 32.35 22.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.981 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -140.97 67.23 1.35 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.904 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -96.25 20.81 9.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.194 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.451 ' CB ' ' HD3' ' A' ' 84' ' ' PRO . 0.1 OUTLIER -85.04 -54.73 0.44 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 120.936 0.398 . . . . 0.0 110.868 179.883 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.451 ' HD3' ' CB ' ' A' ' 83' ' ' SER . 76.6 Cg_endo -88.2 41.39 0.63 Allowed 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 123.322 2.681 . . . . 0.0 112.601 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -166.39 -42.03 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.925 0.393 . . . . 0.0 111.109 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -94.38 33.56 5.22 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.576 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 43.57 31.45 0.44 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.785 0.326 . . . . 0.0 111.464 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -111.66 61.39 0.62 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.911 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.59 38.24 1.55 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.888 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.06 82.46 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.813 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.9 138.26 21.19 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.565 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 21.5 t -127.72 136.0 61.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.755 0.312 . . . . 0.0 111.107 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -130.86 120.88 24.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.02 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -57.98 148.58 25.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.928 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.467 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 17.3 t -78.68 -47.94 1.79 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.823 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 95' ' ' VAL . 71.6 Cg_endo -77.49 58.28 6.27 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.225 1.95 . . . . 0.0 112.505 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -179.63 38.68 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.901 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 67.4 m -139.13 178.13 7.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.011 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.4 tm0? -158.71 102.49 1.69 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.72 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 8.3 mm -76.57 160.75 4.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.326 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -153.0 89.47 1.38 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.803 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.437 HG23 HD13 ' A' ' 102' ' ' ILE . 73.9 mt -62.47 145.73 13.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.101 0.477 . . . . 0.0 111.553 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -134.81 125.85 17.57 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.879 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -82.55 25.55 0.67 Allowed 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.431 2.087 . . . . 0.0 113.22 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -178.23 74.34 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.722 0.296 . . . . 0.0 111.013 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -59.13 -96.67 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.578 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.67 173.74 1.59 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.795 0.331 . . . . 0.0 110.938 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 68.36 -68.39 0.17 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.12 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -175.46 36.67 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.903 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -129.98 88.44 2.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.796 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 86.2 mt -59.31 -37.58 78.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.825 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -99.12 119.34 37.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.844 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 9.4 p -155.05 162.18 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.134 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.428 ' CZ ' ' HB ' ' A' ' 128' ' ' VAL . 10.2 p90 -148.66 114.29 5.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.922 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 12.4 m -92.64 140.01 29.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.939 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 13.0 mt -104.95 157.48 5.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.977 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 5.5 t -162.01 138.31 7.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.781 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 29.0 mtp -102.39 96.92 7.85 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.062 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.26 59.06 4.51 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.491 2.127 . . . . 0.0 112.368 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 92.2 p -177.85 37.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.809 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.419 ' CG2' ' N ' ' A' ' 122' ' ' ALA . 0.4 OUTLIER -161.15 -82.33 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.727 -179.854 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.419 ' N ' ' CG2' ' A' ' 121' ' ' VAL . . . -140.59 -168.89 2.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.921 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -93.55 47.45 1.24 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.77 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . 0.407 ' CD1' ' HB1' ' A' ' 122' ' ' ALA . 29.5 m95 -85.28 148.56 26.0 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.853 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 92.1 p -144.34 103.67 4.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.79 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.59 100.55 13.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.059 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -77.37 124.03 27.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.856 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.428 ' HB ' ' CZ ' ' A' ' 114' ' ' PHE . 15.7 t -137.1 152.74 28.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.1 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -157.31 127.11 6.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.234 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -93.12 137.35 32.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.924 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -52.5 -35.78 53.76 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.964 0.412 . . . . 0.0 111.106 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.8 t -96.95 115.41 27.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.742 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.22 -27.46 2.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.566 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.42 -45.44 38.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.44 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -63.92 -32.29 73.77 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.197 179.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.419 ' HG ' ' CD1' ' A' ' 114' ' ' PHE . 7.6 tt -67.45 -51.85 46.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.557 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -67.6 -35.52 79.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.375 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -70.8 -30.66 67.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.419 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' TRP . . . . . 0.43 ' CD1' ' HE3' ' A' ' 3' ' ' LYS . 0.8 OUTLIER -68.72 -45.58 71.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.67 179.749 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 44.6 t -63.49 -42.19 95.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.886 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 11.6 mttm -63.87 -35.62 81.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.809 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.04 -50.41 62.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.603 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 68.6 mt -54.44 -35.57 31.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.328 0.585 . . . . 0.0 109.5 178.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 47.3 mtp180 -78.01 -28.68 49.21 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.447 179.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -76.03 -32.67 59.46 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.864 0.364 . . . . 0.0 110.53 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 90.2 t -80.0 -31.47 13.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.294 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.1 -35.21 66.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.828 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -75.32 -11.08 59.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.144 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 8.9 t -114.27 -34.69 5.23 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.774 0.321 . . . . 0.0 111.097 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.225 -0.893 . . . . 0.0 111.155 -179.928 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.859 0.361 . . . . 0.0 111.12 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 29.6 mt -76.48 -34.2 24.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.047 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.56 169.31 24.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.911 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -166.58 125.4 1.46 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.81 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -159.65 -170.59 24.41 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.583 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 28.4 mm -94.81 92.44 3.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.791 0.329 . . . . 0.0 111.142 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -96.58 129.58 43.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.847 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -79.9 146.32 32.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.917 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -147.59 133.69 19.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.766 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.466 ' CG ' ' CD2' ' A' ' 17' ' ' TRP . 3.2 mt-10 -80.36 118.05 21.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.134 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.72 134.32 50.76 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.352 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -68.8 -10.52 29.34 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.306 2.004 . . . . 0.0 112.654 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.2 t -66.56 -39.22 83.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.924 0.392 . . . . 0.0 110.937 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -138.02 9.34 2.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.463 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 49.79 49.46 20.11 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.92 0.391 . . . . 0.0 111.136 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.55 149.62 49.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.876 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.466 ' CD2' ' CG ' ' A' ' 10' ' ' GLU . 43.2 m95 -72.97 143.57 47.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.911 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -129.92 119.04 18.79 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.79 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -68.82 82.65 0.56 Allowed 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.398 2.065 . . . . 0.0 112.353 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 4.4 m80 -114.23 168.36 9.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.882 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -73.85 172.05 12.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.901 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -167.03 141.42 3.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.877 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 38.8 t -134.68 153.39 34.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.868 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.8 tp -133.41 109.49 9.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.117 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 16.9 p -95.46 157.8 15.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.581 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.4 m -63.73 -13.86 47.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.915 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.0 m -111.43 -7.14 14.38 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 173.55 -174.84 0.06 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.925 0.393 . . . . 0.0 111.29 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 5.8 mt -113.59 136.78 48.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.399 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -113.92 138.36 50.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.861 0.362 . . . . 0.0 111.066 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 54.1 p90 -157.55 158.47 35.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.879 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.0 -70.13 0.82 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.893 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 62.01 32.09 17.78 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.826 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -71.52 113.68 8.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.874 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -71.19 -68.12 0.46 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.894 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.4 m 61.01 82.17 0.17 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.893 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.5 m -124.27 100.25 6.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.85 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -141.79 87.34 2.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.888 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 60.23 32.05 20.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.893 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -138.18 43.68 1.17 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.546 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -98.22 31.62 2.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.801 0.334 . . . . 0.0 110.907 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -107.76 36.76 2.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.952 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -122.99 48.52 1.79 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.914 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -133.91 -175.31 3.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.862 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 64.05 133.12 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.882 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -133.59 129.06 20.32 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.922 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.33 162.39 4.45 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.443 2.095 . . . . 0.0 112.319 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -96.98 165.62 12.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.899 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 59.97 109.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.899 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.66 -32.53 73.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.141 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.7 m -123.71 95.61 4.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.909 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -169.13 88.02 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.549 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.5 p 58.41 32.95 22.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.891 0.377 . . . . 0.0 110.958 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -98.34 158.83 15.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.963 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -64.36 -171.82 0.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.998 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 13.1 tp -151.15 140.73 21.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.883 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -105.52 38.29 2.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.063 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.8 t -81.44 64.18 6.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.92 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 7.4 m -162.95 109.9 1.21 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.918 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.4 tt -99.53 -35.43 9.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.892 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -67.45 -28.94 68.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.914 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 32.8 t -71.24 -33.04 49.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.052 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -87.71 -4.44 58.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.364 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -91.27 25.24 2.6 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-O 121.224 0.535 . . . . 0.0 110.551 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -176.1 31.32 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.977 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.456 ' N ' ' CD ' ' A' ' 67' ' ' PRO . . . -149.59 48.17 0.6 Allowed Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.437 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' ' 66' ' ' GLY . 89.6 Cg_endo -77.3 97.8 1.17 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.595 2.197 . . . . 0.0 112.293 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 61.07 98.54 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.698 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -82.55 12.94 2.72 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.653 2.235 . . . . 0.0 113.059 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -96.79 30.27 2.72 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.818 0.342 . . . . 0.0 111.164 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.424 HD12 HG22 ' A' ' 71' ' ' ILE . 15.7 mt -105.3 -12.95 9.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.703 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 11.6 mt -89.4 18.21 5.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.326 0.584 . . . . 0.0 111.545 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -145.78 75.15 13.31 Favored Pre-proline 0 C--N 1.316 -0.883 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.315 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -68.46 59.45 1.07 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.844 2.363 . . . . 0.0 112.41 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -88.95 -34.59 16.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.836 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -129.06 143.98 51.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.948 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -139.87 31.2 2.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.899 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 5.2 m170 -161.86 31.41 0.12 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.527 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.0 tp -90.0 175.93 6.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.931 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.07 85.88 1.33 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.971 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.91 160.7 15.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.869 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -98.11 34.62 1.9 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.967 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.451 ' CB ' ' HD2' ' A' ' 84' ' ' PRO . 0.3 OUTLIER -52.85 173.3 0.18 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.222 179.434 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.451 ' HD2' ' CB ' ' A' ' 83' ' ' SER . 41.8 Cg_endo -67.71 62.18 0.87 Allowed 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.086 1.857 . . . . 0.0 112.341 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.7 mp -87.18 -31.37 20.4 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.934 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -72.06 68.79 1.08 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.523 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -175.25 89.5 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.794 0.33 . . . . 0.0 110.832 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 6.5 mt -144.59 -55.86 0.34 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.985 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 61.06 92.64 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.857 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -113.99 -33.25 5.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.036 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -64.67 123.16 26.38 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.506 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 11.8 p -132.85 137.76 53.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.757 0.313 . . . . 0.0 111.085 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -139.63 129.16 24.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.14 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -60.38 119.7 8.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.82 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.566 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 8.7 p -83.13 -34.18 0.6 Allowed Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.566 ' CD ' ' N ' ' A' ' 95' ' ' VAL . 3.1 Cg_exo -75.24 54.48 3.77 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.262 1.975 . . . . 0.0 112.597 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 168.78 42.56 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.018 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 1.7 m -125.3 162.94 23.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.943 0.401 . . . . 0.0 111.215 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.04 101.18 3.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.542 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 14.2 mm -71.03 160.12 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.403 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -156.08 90.25 1.19 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.898 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.3 mt -56.43 149.28 3.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.33 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 15.6 mtp180 -142.97 113.75 5.83 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.554 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -67.5 0.33 4.22 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.549 2.166 . . . . 0.0 113.034 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -141.27 59.15 1.52 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.988 0.423 . . . . 0.0 110.536 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -43.06 -85.49 0.01 OUTLIER Glycine 0 C--N 1.331 0.251 0 CA-C-N 115.769 -0.65 . . . . 0.0 113.249 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 23.9 ttmt -176.69 160.47 1.95 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.947 0.403 . . . . 0.0 111.358 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 60.53 -84.3 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.128 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -146.41 31.2 1.0 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.951 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.411 ' HG3' ' CE2' ' A' ' 17' ' ' TRP . 13.9 mmt180 -114.57 100.36 8.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.777 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.2 mt -85.08 5.41 29.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.469 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -139.98 78.6 1.67 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.822 0.344 . . . . 0.0 110.972 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 36.2 t -129.13 135.61 61.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.933 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.421 ' CZ ' ' HB ' ' A' ' 128' ' ' VAL . 42.0 p90 -114.48 122.57 47.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.017 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 10.9 t -97.7 136.06 38.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.885 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 10.9 mt -96.31 157.94 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.974 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 1.5 m -150.04 166.85 28.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.951 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 13.7 mtp -139.53 100.43 7.56 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.903 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -79.94 54.69 5.32 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.568 2.179 . . . . 0.0 112.627 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 178.94 49.49 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.98 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.402 ' CG2' ' N ' ' A' ' 122' ' ' ALA . 0.3 OUTLIER -161.85 -82.11 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.92 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.402 ' N ' ' CG2' ' A' ' 121' ' ' VAL . . . -157.08 -165.47 1.84 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.184 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -84.64 56.93 4.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.945 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 39.9 m95 -104.21 148.87 25.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.926 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 14.1 m -153.3 123.66 7.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.808 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 14.4 tp -102.83 155.85 18.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.99 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -131.95 134.41 45.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.836 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.421 ' HB ' ' CZ ' ' A' ' 114' ' ' PHE . 23.7 t -152.38 159.15 3.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.092 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -158.57 117.65 3.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.161 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -81.37 134.98 35.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.842 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -54.47 -34.39 61.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.885 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.94 113.4 24.94 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.744 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -48.04 -27.94 2.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.475 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 -76.65 -44.29 34.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.292 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -65.66 -31.88 73.14 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.011 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 7.2 tt -67.77 -50.78 55.25 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.314 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -66.39 -37.17 84.64 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.262 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -70.43 -31.5 68.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.403 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -67.65 -43.03 81.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.58 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 26.7 t -65.22 -44.2 95.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.848 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 7.3 ttmm -63.84 -33.77 76.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.884 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 17.0 mmtt -67.93 -49.46 61.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.525 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 30.7 mt -54.35 -38.15 39.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.352 0.596 . . . . 0.0 109.517 178.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 66.2 mtt180 -77.95 -27.69 49.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.479 179.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -75.16 -33.23 61.47 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.861 0.362 . . . . 0.0 110.705 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 9.9 p -79.63 -34.3 15.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.065 0.459 . . . . 0.0 110.19 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -71.48 -34.43 70.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.563 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -75.1 -10.7 59.71 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.931 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 10.9 t -126.26 21.34 7.34 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.103 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.166 -0.921 . . . . 0.0 111.19 179.985 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 8.0 t . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 120.885 0.374 . . . . 0.0 111.159 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 39.4 mt -79.79 -34.48 15.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.121 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.7 tttp -140.1 153.82 46.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.01 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -160.97 124.39 3.34 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.924 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -160.4 -178.0 34.01 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.542 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.421 ' N ' ' CD1' ' A' ' 6' ' ' ILE . 3.2 mp -89.52 92.01 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.909 0.385 . . . . 0.0 110.985 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -95.6 135.38 37.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.732 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -76.76 158.36 30.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.95 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.4 tp -161.78 128.19 3.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.808 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.424 ' HG3' ' CZ3' ' A' ' 17' ' ' TRP . 3.4 mt-10 -71.11 111.57 6.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.99 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.92 127.54 66.77 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.53 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -56.69 -16.81 20.56 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.504 2.136 . . . . 0.0 112.899 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 37.8 t -69.36 -41.67 80.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.858 0.361 . . . . 0.0 111.352 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -117.75 -10.18 10.57 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.649 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 62.86 30.84 16.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.789 0.328 . . . . 0.0 110.815 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.64 160.4 39.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.801 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.438 ' NE1' ' HG3' ' A' ' 110' ' ' ARG . 45.0 m95 -56.7 138.04 53.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.051 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -126.07 125.31 24.73 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.686 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.64 112.06 2.95 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.439 2.092 . . . . 0.0 112.228 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 22.0 m80 -148.64 141.79 24.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.871 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -59.38 154.6 16.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.719 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.427 ' CE2' ' CD1' ' A' ' 31' ' ' TYR . 0.1 OUTLIER -147.35 138.86 23.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.976 -179.827 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.8 t -131.41 150.8 34.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.113 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 25.7 tp -134.37 118.99 18.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.952 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 62.6 p -97.95 157.58 16.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.983 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 29.4 t -48.97 -38.08 22.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.85 -0.613 . . . . 0.0 112.057 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.3 m -129.59 39.06 3.78 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.6 tttt 175.01 170.03 0.28 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.007 0.432 . . . . 0.0 111.378 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 3.5 mt -128.87 153.23 38.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.716 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.404 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 0.6 OUTLIER -129.93 146.28 51.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.904 0.383 . . . . 0.0 111.112 -179.889 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.427 ' CD1' ' CE2' ' A' ' 22' ' ' PHE . 39.7 t80 -146.35 143.48 29.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.84 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.4 m -124.23 174.13 7.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.963 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -146.97 178.98 7.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.864 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.93 155.48 21.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.939 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.58 132.11 47.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.896 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.4 m -162.74 33.45 0.1 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.928 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.0 m 60.69 62.25 1.53 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.886 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.11 115.94 18.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.869 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -148.46 60.92 1.09 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.731 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 179.58 -32.48 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.748 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -94.58 31.69 1.73 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.79 0.329 . . . . 0.0 111.099 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -101.95 33.14 3.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.845 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.5 t70 61.7 82.59 0.17 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.95 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -86.35 177.48 7.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.934 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -121.21 135.81 55.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.902 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 58.33 78.68 0.35 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.009 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.4 87.89 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.559 2.172 . . . . 0.0 112.298 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.78 -169.33 2.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.008 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 47.2 mm-40 -100.57 119.75 39.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.807 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -112.15 102.43 10.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.064 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.3 p -89.14 88.96 7.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.979 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 66.93 141.84 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.45 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.68 125.33 35.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.803 0.335 . . . . 0.0 110.857 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.3 t -99.81 37.1 1.67 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.897 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -80.29 150.29 30.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.881 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 60.2 84.09 0.13 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.812 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -132.58 165.05 25.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.926 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 66.6 m -104.31 162.61 13.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.93 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.3 m -58.93 132.36 53.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.955 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.63 -61.92 1.38 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.09 0.471 . . . . 0.0 110.973 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -59.89 -34.05 72.65 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.885 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.8 t -71.84 -27.67 28.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.085 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.5 mp -79.21 -12.87 59.97 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.27 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -85.96 23.79 1.41 Allowed 'General case' 0 CA--C 1.528 0.123 0 CA-C-O 121.259 0.552 . . . . 0.0 110.311 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 172.56 35.34 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.438 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 163.67 66.5 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.222 -179.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -66.62 138.86 51.05 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.576 2.184 . . . . 0.0 112.301 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.427 ' N ' ' HD3' ' A' ' 69' ' ' PRO . 2.4 m120 61.9 51.77 2.02 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.92 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.427 ' HD3' ' N ' ' A' ' 68' ' ' ASN . 86.3 Cg_endo -80.81 1.77 9.05 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.645 2.23 . . . . 0.0 112.781 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -96.24 30.09 2.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.797 0.332 . . . . 0.0 111.347 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 14.9 mt -106.04 -7.88 10.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.764 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 15.8 mt -89.5 19.69 4.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.107 0.479 . . . . 0.0 111.45 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -144.07 90.41 6.82 Favored Pre-proline 0 C--N 1.319 -0.748 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.358 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -67.27 59.34 0.67 Allowed 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.936 2.424 . . . . 0.0 112.471 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -122.36 -40.75 2.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.843 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -68.39 -171.98 0.3 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.874 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 63.57 31.55 14.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.917 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -177.05 75.5 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.854 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.6 mp -131.36 153.38 49.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.919 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.0 t70 59.84 31.07 20.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.094 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -70.71 -174.04 0.85 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.705 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 -94.4 38.48 1.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.34 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.423 ' CB ' ' HD2' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -61.15 171.79 1.09 Allowed Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.07 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.423 ' HD2' ' CB ' ' A' ' 83' ' ' SER . 39.2 Cg_endo -67.1 61.8 0.64 Allowed 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.087 1.858 . . . . 0.0 112.059 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -116.31 -38.1 3.63 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.098 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 57.97 97.21 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.523 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -117.6 -77.53 0.57 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.868 0.365 . . . . 0.0 110.876 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.1 mp 60.48 35.11 20.35 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.849 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 8.7 tt -96.65 111.91 23.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.899 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.81 -48.71 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.847 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -139.52 142.62 12.93 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.51 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 11.3 p -151.43 136.33 10.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.877 0.37 . . . . 0.0 111.033 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.92 -176.44 3.48 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.891 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -119.59 141.36 49.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.91 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.465 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 21.8 t -80.87 -46.87 1.19 Allowed Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.778 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 95' ' ' VAL . 84.6 Cg_endo -81.83 50.31 3.44 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.367 2.045 . . . . 0.0 112.497 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -179.55 37.85 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.959 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 14.4 p -134.34 -177.45 4.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.963 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.4 100.79 0.83 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.697 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 16.9 mm -76.82 160.58 4.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.02 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -159.02 91.75 1.05 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.901 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 27.7 mt -58.07 157.47 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.242 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -151.41 112.32 3.01 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.366 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.09 49.25 2.75 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.429 2.086 . . . . 0.0 112.523 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 167.35 61.98 0.0 OUTLIER 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.001 0.429 . . . . 0.0 110.223 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -55.04 -94.97 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.676 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 174.1 163.18 0.19 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.823 0.344 . . . . 0.0 111.014 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 57.07 54.6 6.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.975 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 9.0 m120 62.76 51.98 2.89 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.215 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.438 ' HG3' ' NE1' ' A' ' 17' ' ' TRP . 23.9 mmt180 -147.53 97.38 2.83 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.718 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.01 -32.47 57.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.978 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -102.87 104.21 14.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.939 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 20.4 t -152.0 134.04 5.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.16 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -118.96 131.3 56.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.744 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 15.0 t -100.18 132.86 45.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.965 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 2.4 mp -104.29 159.82 5.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.942 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 70.5 p -155.74 179.99 8.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.905 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' MET . . . . . 0.413 ' CB ' ' CG1' ' A' ' 121' ' ' VAL . 7.3 mtm -143.33 93.26 6.47 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.782 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.93 -2.29 12.51 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.584 2.189 . . . . 0.0 112.794 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 48.6 m -108.9 33.88 4.0 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.718 0.294 . . . . 0.0 111.142 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.413 ' CG1' ' CB ' ' A' ' 118' ' ' MET . 0.4 OUTLIER -160.31 -82.45 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.94 179.907 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.406 ' N ' ' CG2' ' A' ' 121' ' ' VAL . . . -143.98 -166.06 2.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.838 0.351 . . . . 0.0 111.049 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -86.21 55.32 3.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.971 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 89.4 m95 -85.93 142.24 28.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.786 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.16 119.94 5.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.006 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -129.28 124.7 35.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.88 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -86.9 142.89 27.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.949 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 14.0 t -151.32 141.9 15.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.081 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -140.93 131.49 25.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.129 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -93.22 138.58 31.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.92 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -55.5 -39.62 70.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.0 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.73 113.13 25.31 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.905 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -48.05 -28.41 2.81 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.547 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -76.8 -44.29 33.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.328 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -65.65 -32.29 73.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.996 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.2 tt -67.38 -51.22 54.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.394 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 73.4 mm-40 -67.68 -35.25 78.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.192 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -71.5 -30.18 65.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.205 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' TRP . . . . . 0.407 ' CH2' ' HB3' ' A' ' 22' ' ' PHE . 0.5 OUTLIER -67.41 -47.07 71.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.348 179.54 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 23.3 t -61.76 -45.52 98.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.797 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 1.1 ttpt -62.97 -36.94 85.18 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.742 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 17.9 tppt? -65.66 -56.26 13.08 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.294 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 71.0 mt -50.97 -31.76 10.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.107 0.48 . . . . 0.0 109.706 178.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 30.5 mtt180 -78.69 -30.15 45.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.493 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -77.23 -35.94 55.04 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-O 120.761 0.315 . . . . 0.0 110.777 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.405 ' CG2' ' CG1' ' A' ' 95' ' ' VAL . 5.6 m -79.44 -28.45 13.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.306 179.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -74.37 -36.97 63.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.684 179.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -72.34 -13.07 61.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.042 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 11.5 p -106.53 -38.96 6.01 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.107 0.479 . . . . 0.0 110.48 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.271 -0.871 . . . . 0.0 111.291 -179.924 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 24.1 m . . . . . 0 N--CA 1.487 1.409 0 CA-C-O 120.776 0.322 . . . . 0.0 111.179 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.9 mt -88.5 -34.09 6.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.933 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.56 142.1 43.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.768 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -154.58 121.27 5.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.968 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -170.04 -176.32 39.59 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.421 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.2 mp -103.26 89.17 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.866 0.365 . . . . 0.0 111.026 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.408 HD23 ' CE2' ' A' ' 139' ' ' TRP . 3.4 mm? -82.06 142.46 32.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.651 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -77.74 144.67 37.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.29 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.6 mp -152.89 115.55 4.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.611 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.416 ' HB3' ' CE3' ' A' ' 17' ' ' TRP . 2.0 pp20? -72.6 140.73 48.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.257 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.42 148.33 36.98 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.531 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.39 -5.46 17.17 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.434 2.089 . . . . 0.0 112.705 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 25.2 t -65.75 -40.83 88.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.984 0.421 . . . . 0.0 110.724 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -139.12 9.34 2.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.407 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 49.03 59.07 4.71 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.878 0.371 . . . . 0.0 111.266 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -149.1 139.33 22.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.808 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.416 ' CE3' ' HB3' ' A' ' 10' ' ' GLU . 75.5 m95 -57.72 143.03 43.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.895 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -135.73 137.17 24.97 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.84 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.75 90.51 1.22 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.491 2.127 . . . . 0.0 112.399 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 12.7 m170 -112.3 138.72 48.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.008 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -60.19 159.5 9.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.782 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.483 ' CD2' ' CD1' ' A' ' 31' ' ' TYR . 0.1 OUTLIER -170.95 128.69 0.75 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.789 179.901 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 19.1 t -122.22 153.66 26.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.09 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.9 tp -128.58 118.99 23.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.986 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.8 p -99.54 154.43 18.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.846 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.4 m -54.43 -25.53 25.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.832 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.8 p -136.24 35.56 2.77 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.4 mttt 170.9 177.13 0.06 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.973 0.415 . . . . 0.0 111.12 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.8 mt -140.16 131.71 31.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.707 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -110.35 144.32 39.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.938 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.483 ' CD1' ' CD2' ' A' ' 22' ' ' PHE . 35.1 t80 -139.5 130.21 25.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.871 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -135.8 178.89 6.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.777 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -140.32 -45.95 0.42 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.002 0.43 . . . . 0.0 111.031 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -144.56 108.19 4.66 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.939 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.73 176.08 7.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.826 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -148.42 144.64 27.58 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.899 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.24 108.13 3.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.962 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -147.27 76.23 1.4 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.909 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -141.15 33.01 1.72 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.993 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -94.66 99.66 2.47 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.443 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -170.47 71.36 0.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.847 0.356 . . . . 0.0 110.886 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -140.12 44.81 1.89 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.953 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.3 t0 61.34 154.6 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.919 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -88.42 114.01 24.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.921 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.74 177.05 5.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.854 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -88.09 114.21 58.32 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.888 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -51.71 160.34 2.82 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.417 2.078 . . . . 0.0 112.342 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -87.07 65.88 9.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.883 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -92.69 169.55 10.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.843 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -154.79 139.81 17.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.146 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -164.91 34.05 0.06 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.895 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -165.48 -169.26 28.86 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.442 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.4 m -125.28 31.91 5.48 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.832 0.349 . . . . 0.0 110.822 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.2 t -131.52 84.06 2.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.793 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -173.1 155.94 3.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.902 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 62.71 147.82 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.841 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 64.7 m80 -156.3 102.98 2.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.872 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 60.55 160.81 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.892 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.5 m -93.41 123.35 36.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.919 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -163.91 -44.07 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.842 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -68.18 -35.7 78.45 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.847 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.5 t -70.3 -30.52 43.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.101 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -76.96 -13.6 59.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.237 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -91.1 24.83 2.69 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 121.223 0.535 . . . . 0.0 110.73 179.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -163.4 29.76 0.09 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.668 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -123.36 -73.69 0.27 Allowed Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.178 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -56.52 83.89 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.832 2.355 . . . . 0.0 112.289 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 55.35 93.26 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.927 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.77 -0.05 10.11 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.646 2.231 . . . . 0.0 112.979 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -96.77 29.87 2.86 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.815 0.341 . . . . 0.0 111.352 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 6.8 mt -117.5 -8.53 11.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.817 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 7.0 mt -88.34 20.63 3.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.032 0.444 . . . . 0.0 111.6 -179.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.458 ' N ' ' HD3' ' A' ' 74' ' ' PRO . 8.7 pt-20 -145.18 63.69 10.19 Favored Pre-proline 0 C--N 1.317 -0.812 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.753 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.458 ' HD3' ' N ' ' A' ' 73' ' ' GLU . 1.9 Cg_endo -85.32 39.32 0.7 Allowed 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 123.235 2.623 . . . . 0.0 112.498 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -97.21 -34.28 11.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.834 0.35 . . . . 0.0 110.903 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.84 167.03 22.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.946 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -174.68 127.54 0.31 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.764 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 5.1 t60 64.43 31.79 12.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.691 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.3 tp -85.76 -168.56 2.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.983 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -78.87 74.51 5.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.893 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -76.96 142.18 40.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.896 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -98.28 32.16 2.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.025 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.419 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 0.4 OUTLIER -71.12 -58.93 3.68 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.113 179.907 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.419 ' HD2' ' N ' ' A' ' 83' ' ' SER . 67.4 Cg_endo -75.37 -23.89 12.77 Favored 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 122.916 2.411 . . . . 0.0 112.426 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.38 33.38 2.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.97 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -78.88 148.61 31.98 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.516 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -62.32 -22.52 66.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.723 0.296 . . . . 0.0 111.104 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 12.5 mt -96.42 37.96 1.23 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.029 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.0 mt -154.47 109.8 3.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.739 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 7.5 tpt180 -113.89 -33.67 5.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.227 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -83.28 125.45 7.02 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.741 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 10.6 p -158.13 130.84 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.775 0.322 . . . . 0.0 110.903 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -148.48 150.53 33.59 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.103 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -81.96 128.05 33.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.711 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.573 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 8.3 p -71.44 -32.87 2.4 Favored Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' A' ' 95' ' ' VAL . 6.3 Cg_exo -73.9 56.36 3.57 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.202 1.934 . . . . 0.0 112.418 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 170.09 63.48 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.963 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 64.9 m -146.46 168.11 21.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.125 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -154.0 99.47 2.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.606 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 11.2 mm -76.34 159.18 5.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.235 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -154.45 88.21 1.21 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.904 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.408 ' CG2' ' N ' ' A' ' 103' ' ' ARG . 7.6 mt -58.27 156.32 2.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.158 0.504 . . . . 0.0 111.365 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.408 ' N ' ' CG2' ' A' ' 102' ' ' ILE . 33.2 mtt180 -145.81 125.56 6.91 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.082 179.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -82.98 30.06 0.54 Allowed 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.41 2.073 . . . . 0.0 112.914 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -177.75 69.73 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.88 0.371 . . . . 0.0 110.642 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -55.11 -94.21 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.732 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -174.88 169.68 3.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.861 0.362 . . . . 0.0 110.913 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 61.66 -82.69 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.031 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -153.92 31.71 0.45 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.943 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 6.1 mmt85 -117.51 90.2 3.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.834 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.9 mp -62.91 -30.86 71.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.826 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.42 ' CD1' ' HG2' ' A' ' 133' ' ' GLN . 75.2 m-85 -109.82 105.24 14.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.035 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 39.4 t -144.76 138.87 22.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.967 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.417 ' CE2' ' HB ' ' A' ' 128' ' ' VAL . 39.9 p90 -122.88 133.47 54.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.928 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.59 129.49 50.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.933 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 1.7 mt -97.84 159.56 3.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.014 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 52.3 p -156.72 175.22 14.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.964 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' MET . . . . . 0.42 ' CB ' ' CG1' ' A' ' 121' ' ' VAL . 2.2 mtm -137.95 91.56 13.23 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.815 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.45 -2.04 12.19 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.624 2.216 . . . . 0.0 112.816 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.4 m -108.94 31.44 5.68 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.692 0.282 . . . . 0.0 111.261 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.42 ' CG1' ' CB ' ' A' ' 118' ' ' MET . 0.4 OUTLIER -158.41 -82.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.885 179.864 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.41 ' N ' ' CG2' ' A' ' 121' ' ' VAL . . . -146.07 -164.93 2.08 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.079 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -85.05 57.18 4.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.827 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 36.9 m95 -102.47 117.27 34.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.793 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -142.39 138.85 31.43 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.882 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.6 170.08 13.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.901 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -123.87 129.54 51.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.955 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.417 ' HB ' ' CE2' ' A' ' 114' ' ' PHE . 18.7 t -140.94 159.54 23.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.928 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -159.94 148.89 17.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.909 0.385 . . . . 0.0 111.221 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -112.59 135.5 53.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.938 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.47 -35.35 52.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.954 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.04 112.77 24.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.826 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.42 ' HG2' ' CD1' ' A' ' 112' ' ' PHE . 3.1 mt-30 -48.56 -27.8 3.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.725 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -77.12 -43.87 32.51 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.34 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -65.82 -31.25 72.1 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.137 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 7.7 tt -69.84 -50.44 42.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.474 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 36.2 mm-40 -67.87 -36.61 80.57 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.237 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -71.0 -28.51 64.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.407 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' TRP . . . . . 0.408 ' CE2' HD23 ' A' ' 7' ' ' LEU . 0.8 OUTLIER -69.75 -46.32 66.14 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.52 179.667 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 30.5 t -63.45 -42.29 95.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.741 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.45 -36.79 84.9 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.819 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.77 -56.0 14.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.312 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.438 HD13 HG22 ' A' ' 143' ' ' ILE . 65.9 mt -51.6 -31.8 13.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.167 0.508 . . . . 0.0 109.844 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 58.2 mtt180 -80.88 -28.63 35.89 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.535 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.59 -39.52 67.27 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.839 0.352 . . . . 0.0 110.675 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 9.0 m -78.48 -32.72 16.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.072 179.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.42 -34.26 65.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.416 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -73.05 -13.28 61.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.791 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 8.9 t -122.96 19.24 10.09 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.152 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.257 -0.878 . . . . 0.0 111.112 179.92 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 61.7 m . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.765 0.317 . . . . 0.0 111.262 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.436 ' CD1' ' HA ' ' A' ' 26' ' ' SER . 12.3 mt -77.2 -35.55 22.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.887 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -157.92 150.44 22.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.873 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 36.1 p-10 -157.91 137.8 12.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.887 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -170.06 179.06 42.56 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.493 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.7 mp -93.31 79.24 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.933 0.397 . . . . 0.0 111.105 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.458 ' CD2' ' CZ2' ' A' ' 139' ' ' TRP . 2.0 mm? -77.26 163.62 26.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.808 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -100.51 142.51 31.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.04 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -148.64 105.62 3.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.768 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.59 120.74 11.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.126 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.07 129.14 68.46 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.49 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -68.74 -9.82 27.29 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.395 2.063 . . . . 0.0 112.687 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.9 t -64.22 -40.19 88.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.069 0.462 . . . . 0.0 110.602 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 54.6 p30 -142.22 12.81 1.99 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.355 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 50.27 79.35 0.09 Allowed 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 120.666 0.27 . . . . 0.0 111.071 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -162.96 133.34 4.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.922 0.391 . . . . 0.0 111.028 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 29.5 m95 -67.9 137.3 55.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.863 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -137.32 132.27 17.82 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.879 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.22 127.18 24.77 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.414 2.076 . . . . 0.0 112.241 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -135.51 122.17 20.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.869 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -80.24 85.27 5.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.924 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.423 ' CE2' ' HB3' ' A' ' 31' ' ' TYR . 4.0 m-85 -79.42 157.45 27.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.873 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.6 t -143.03 104.38 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.399 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 20.0 tp -86.51 117.36 25.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.717 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -99.7 157.97 16.1 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.301 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.436 ' HA ' ' CD1' ' A' ' 2' ' ' ILE . 7.0 t -44.55 -33.43 1.75 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.835 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.6 m -144.07 46.33 1.44 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.798 0.332 . . . . 0.0 111.403 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.3 mttt 179.27 167.91 1.03 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.939 0.399 . . . . 0.0 111.174 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.1 mt -139.51 106.15 2.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.825 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -97.03 139.61 32.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.989 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.423 ' HB3' ' CE2' ' A' ' 22' ' ' PHE . 13.2 p90 -140.33 112.95 8.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.827 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.5 m -124.07 151.28 44.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.837 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -96.26 130.28 43.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.88 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -67.79 167.3 13.68 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.84 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.7 t -127.26 -171.19 2.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.94 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -168.54 117.07 0.7 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.894 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 8.6 m -118.26 90.27 3.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.913 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.2 t0 59.6 61.5 1.96 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.903 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -144.47 55.67 1.28 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.905 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 106.2 31.76 3.97 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.505 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -164.17 49.93 0.13 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.925 0.393 . . . . 0.0 110.903 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -98.04 31.67 2.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.982 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -95.19 151.57 19.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.928 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.72 89.69 8.09 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.872 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 60.5 -170.42 0.15 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.91 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -116.14 84.25 13.62 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.967 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.58 157.04 10.3 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.543 2.162 . . . . 0.0 112.337 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.83 149.3 22.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.897 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -128.72 170.6 13.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.89 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -160.58 -173.89 4.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.07 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.85 31.64 4.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.934 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 137.91 -86.5 0.22 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.525 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 91.5 p -152.82 157.93 41.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.726 0.298 . . . . 0.0 110.868 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -106.88 -175.68 2.86 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.931 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.11 -174.62 4.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.872 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.44 -31.02 14.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.02 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -102.09 31.54 3.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.921 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 54.2 p -127.08 24.57 6.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.111 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 62.86 125.75 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.963 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -151.52 -46.27 0.11 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.017 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -68.06 -30.74 70.02 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.897 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.5 t -73.66 -30.58 29.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.092 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -78.22 -13.62 59.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.289 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -93.01 26.18 2.92 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.115 0.483 . . . . 0.0 110.75 179.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -167.8 30.02 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.147 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -109.5 -60.29 0.52 Allowed Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.411 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_exo -53.01 91.92 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.635 2.223 . . . . 0.0 112.391 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 58.51 81.06 0.26 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.957 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -88.94 17.83 1.57 Allowed 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.871 2.381 . . . . 0.0 112.853 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.52 29.66 3.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.837 0.351 . . . . 0.0 111.186 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 7.8 mt -116.65 -11.3 11.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.926 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 7.9 mt -88.86 21.24 3.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.022 0.439 . . . . 0.0 111.768 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.481 ' N ' ' HD3' ' A' ' 74' ' ' PRO . 19.8 mt-10 -144.55 61.9 9.12 Favored Pre-proline 0 C--N 1.318 -0.799 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.809 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.481 ' HD3' ' N ' ' A' ' 73' ' ' GLU . 5.8 Cg_exo -74.49 59.35 4.76 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.718 2.279 . . . . 0.0 112.049 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -93.13 -49.79 5.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.106 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -91.07 179.64 5.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.07 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 62.11 111.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.878 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 12.0 t60 61.69 83.11 0.16 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.874 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.2 mp -104.67 -170.45 1.76 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.843 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.3 94.04 5.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.974 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -143.19 156.61 44.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.907 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -97.22 25.49 5.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.026 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.41 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 0.9 OUTLIER -73.86 -59.96 1.69 Allowed Pre-proline 0 C--N 1.331 -0.211 0 CA-C-O 120.915 0.388 . . . . 0.0 111.014 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.41 ' HD2' ' N ' ' A' ' 83' ' ' SER . 64.7 Cg_endo -74.54 -22.37 15.97 Favored 'Trans proline' 0 N--CA 1.465 -0.179 0 C-N-CA 122.902 2.401 . . . . 0.0 112.501 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.6 mp 63.48 -80.6 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.965 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -171.59 91.91 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.598 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -136.01 75.85 1.57 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.954 0.407 . . . . 0.0 110.947 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.25 -49.08 59.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.865 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -129.61 165.63 21.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.858 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 59.77 50.27 7.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.846 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.421 ' HA3' ' CZ ' ' A' ' 31' ' ' TYR . . . -70.85 113.86 4.99 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.61 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.5 p -95.77 133.52 36.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.765 0.317 . . . . 0.0 111.033 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.7 tp -132.56 152.41 51.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.056 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.454 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 2.3 p30 -89.56 126.88 35.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.752 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.568 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 7.6 p -72.42 -33.33 2.23 Favored Pre-proline 0 CA--C 1.534 0.365 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' A' ' 95' ' ' VAL . 6.4 Cg_exo -74.28 55.23 3.5 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.334 2.022 . . . . 0.0 112.546 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 170.02 66.44 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.999 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 31.1 p -142.87 161.39 38.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.121 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.59 105.97 3.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.636 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.7 mm -78.02 163.33 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.322 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -159.89 87.63 0.81 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.822 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 84.1 mt -56.72 155.16 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.127 0.489 . . . . 0.0 111.292 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.2 mtt85 -148.61 118.19 4.09 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.174 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -81.53 33.85 0.54 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.43 2.086 . . . . 0.0 112.784 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 178.87 69.35 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.894 0.378 . . . . 0.0 110.42 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -61.51 -98.79 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.735 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.54 170.27 21.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.866 0.365 . . . . 0.0 110.976 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 60.85 -83.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.114 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -161.35 31.22 0.14 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.824 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -118.25 94.26 4.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.771 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.9 -34.69 73.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.934 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.411 ' CE2' ' HG3' ' A' ' 133' ' ' GLN . 12.1 m-85 -86.56 81.76 8.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.893 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 23.6 t -134.06 120.45 35.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.153 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.424 ' CD1' ' HG ' ' A' ' 136' ' ' LEU . 38.7 p90 -106.79 120.45 42.05 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.687 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 31.4 t -92.64 131.39 37.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.227 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 6.3 mm -92.99 162.84 2.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.684 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 2.3 m -150.0 -179.55 7.25 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.027 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 31.1 mtp -155.67 96.59 2.38 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.87 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -67.3 -27.01 41.14 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.443 2.095 . . . . 0.0 112.297 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.2 p -94.65 43.57 1.1 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.793 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 44.2 t -154.61 -68.51 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.984 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 179.57 -155.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.225 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 -83.88 49.96 1.73 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.803 0.335 . . . . 0.0 110.977 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 12.4 m0 -83.73 122.88 29.24 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.876 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -142.29 96.11 2.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.671 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -98.58 161.6 13.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.03 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -117.04 142.32 47.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.03 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.401 ' HB ' ' CE2' ' A' ' 114' ' ' PHE . 15.6 t -148.38 141.58 18.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.939 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -146.43 134.33 21.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.307 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -99.81 138.52 36.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.912 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -52.88 -34.67 55.78 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.036 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 9.2 t -102.1 115.94 31.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.844 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.411 ' HG3' ' CE2' ' A' ' 112' ' ' PHE . 0.3 OUTLIER -48.47 -28.0 3.03 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.386 179.424 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -73.31 -39.89 64.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.206 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.32 -32.79 72.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.027 179.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.424 ' HG ' ' CD1' ' A' ' 114' ' ' PHE . 6.2 tt -66.35 -46.4 76.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.48 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 12.8 mm-40 -70.11 -39.2 75.65 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.293 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -68.68 -31.2 70.14 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.325 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' TRP . . . . . 0.458 ' CZ2' ' CD2' ' A' ' 7' ' ' LEU . 1.1 m95 -68.77 -46.72 68.01 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.656 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -60.88 -40.43 85.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.753 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 15.7 mtmt -68.18 -37.38 80.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.742 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 10.5 mttt -67.61 -51.82 45.67 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.295 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 85.8 mt -54.22 -35.13 28.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.308 0.575 . . . . 0.0 109.579 178.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 34.1 mtt180 -79.17 -27.45 42.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.595 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -77.35 -34.04 55.23 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.867 0.365 . . . . 0.0 110.767 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 9.6 p -81.97 -29.46 9.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.372 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -81.0 -34.77 32.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.493 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -79.27 -11.15 59.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.965 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 15.2 t -107.38 -21.5 12.91 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.078 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.215 -0.897 . . . . 0.0 111.14 179.945 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 78.0 p . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 120.845 0.355 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.409 ' CD1' ' HA ' ' A' ' 26' ' ' SER . 19.6 mt -78.27 -34.94 19.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.145 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.31 140.57 4.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.049 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 33.1 p-10 -146.47 141.91 27.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.819 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -163.4 -171.14 29.26 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.467 -0.873 . . . . 0.0 112.611 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.432 HD11 ' CE2' ' A' ' 21' ' ' TYR . 20.8 mm -98.24 80.1 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.777 0.322 . . . . 0.0 111.031 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.456 ' CD2' ' CZ2' ' A' ' 139' ' ' TRP . 1.7 mm? -88.59 134.72 33.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.663 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -73.11 165.56 24.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.242 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -160.01 114.44 2.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.669 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.429 ' HG2' ' CZ3' ' A' ' 17' ' ' TRP . 3.6 pt-20 -73.43 90.49 1.7 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.17 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -60.73 113.33 7.38 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.62 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.66 -18.68 16.27 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.66 2.24 . . . . 0.0 112.916 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.4 t -68.44 -41.11 83.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.897 0.38 . . . . 0.0 111.269 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 -113.92 -13.34 12.56 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.231 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 68.4 m80 61.99 50.91 3.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.862 0.363 . . . . 0.0 110.854 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -152.94 151.7 30.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.792 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.429 ' CZ3' ' HG2' ' A' ' 10' ' ' GLU . 67.1 m95 -80.42 125.1 29.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.931 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -119.85 142.33 32.96 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.813 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -68.6 101.03 0.72 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.46 2.106 . . . . 0.0 112.176 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 35.2 m170 -119.16 138.05 53.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.847 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.432 ' CE2' HD11 ' A' ' 6' ' ' ILE . 0.5 OUTLIER -82.67 140.0 33.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.865 179.995 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.487 ' CZ ' ' CD2' ' A' ' 31' ' ' TYR . 0.2 OUTLIER -133.55 124.78 27.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.914 179.854 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.5 t -111.89 103.31 15.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.829 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.9 tp -82.69 109.37 16.8 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.018 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 43.2 p -99.1 155.94 17.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.794 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.409 ' HA ' ' CD1' ' A' ' 2' ' ' ILE . 1.5 m -65.0 -12.13 46.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.898 -179.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.8 m -121.22 2.78 10.37 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 173.28 -170.91 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.97 0.414 . . . . 0.0 111.316 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.4 mt -136.74 119.91 21.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.838 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -103.03 153.08 20.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.029 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.487 ' CD2' ' CZ ' ' A' ' 22' ' ' PHE . 25.3 p90 -167.17 148.25 5.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.953 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.45 -175.85 3.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.931 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -68.47 129.05 38.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.928 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -167.14 170.4 11.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.776 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.7 t -98.74 174.89 6.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.865 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 40.1 p -91.25 109.08 20.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.958 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.2 p -106.46 128.83 54.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.823 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -110.86 -30.63 7.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.029 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 7.2 mm100 -135.02 53.81 1.97 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.852 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -94.78 38.53 3.1 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.565 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 59.88 31.66 20.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.839 0.352 . . . . 0.0 110.868 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -114.5 41.53 2.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.06 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -111.55 -179.64 3.77 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.018 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -82.49 100.39 10.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.932 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -72.28 160.24 32.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.863 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -78.66 137.42 58.71 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.832 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.99 166.46 1.51 Allowed 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.35 2.033 . . . . 0.0 112.328 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.71 137.0 33.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.924 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -106.16 31.84 4.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.977 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -101.66 147.41 26.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.042 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.6 m -138.2 -48.87 0.55 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.919 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 138.98 -34.88 2.04 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.517 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.6 m 60.59 99.4 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.837 0.351 . . . . 0.0 110.928 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 10.1 t -165.68 73.58 0.19 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.925 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -174.51 -174.5 0.85 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.943 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.2 mt -145.33 -48.26 0.23 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.877 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -104.81 157.44 17.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.939 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.7 m -143.85 129.36 19.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.008 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 69.7 m -105.92 121.32 43.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.82 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.96 -44.29 15.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.915 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.8 -38.33 79.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.708 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 40.9 t -68.44 -29.61 44.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.607 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 11.0 mt -81.78 -3.75 54.64 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.074 179.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -87.29 25.9 1.31 Allowed 'General case' 0 C--O 1.231 0.108 0 CA-C-O 121.198 0.523 . . . . 0.0 110.476 179.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -178.36 32.04 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.927 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.414 ' N ' ' CD ' ' A' ' 67' ' ' PRO . . . -163.32 50.32 0.31 Allowed Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.458 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 66' ' ' GLY . 73.1 Cg_endo -75.77 -173.46 1.66 Allowed 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.646 2.231 . . . . 0.0 112.501 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -66.25 112.74 9.93 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.832 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -77.34 0.38 9.81 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.426 2.084 . . . . 0.0 112.988 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.22 29.72 3.07 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.796 0.331 . . . . 0.0 111.242 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.414 HG23 HD11 ' A' ' 71' ' ' ILE . 7.3 mt -117.39 -12.31 11.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.843 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.9 mt -88.03 17.62 4.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.194 0.521 . . . . 0.0 111.813 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.457 ' N ' ' HD3' ' A' ' 74' ' ' PRO . 4.4 mm-40 -142.3 63.18 14.66 Favored Pre-proline 0 C--N 1.315 -0.931 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.623 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.457 ' HD3' ' N ' ' A' ' 73' ' ' GLU . 5.7 Cg_exo -78.17 53.73 4.62 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.997 2.465 . . . . 0.0 112.293 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -108.96 -34.23 6.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.906 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.9 mmt85 -138.64 -172.27 3.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.802 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 63.36 110.77 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.822 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 61.9 91.73 0.06 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.924 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.9 mp -129.91 -178.83 4.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.857 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.83 59.56 4.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.711 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.28 175.45 7.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.025 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 58.67 20.54 7.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.266 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.476 ' CB ' ' HD2' ' A' ' 84' ' ' PRO . 0.3 OUTLIER -62.09 175.44 0.57 Allowed Pre-proline 0 C--N 1.329 -0.295 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.116 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.476 ' HD2' ' CB ' ' A' ' 83' ' ' SER . 41.0 Cg_endo -67.74 61.71 0.87 Allowed 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 121.974 1.782 . . . . 0.0 112.249 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.47 30.55 4.9 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.952 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -75.63 -74.59 0.9 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.488 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -138.46 75.04 1.5 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.902 0.382 . . . . 0.0 110.86 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.2 mp -145.07 38.63 1.18 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.846 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.17 121.68 34.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.824 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -177.31 -39.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.875 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.417 ' HA3' ' CE1' ' A' ' 31' ' ' TYR . . . -119.62 100.24 0.79 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.498 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.6 m -97.87 156.8 3.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.87 0.367 . . . . 0.0 111.062 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 9.9 tp -151.05 129.77 12.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.027 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.39 138.93 49.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.816 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.442 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 18.7 t -79.66 -47.87 1.46 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.752 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.442 ' HD2' ' N ' ' A' ' 95' ' ' VAL . 94.3 Cg_endo -79.07 55.33 5.56 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.232 1.955 . . . . 0.0 112.499 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 175.53 39.53 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.034 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -156.82 104.15 2.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.943 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -89.76 131.32 35.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.765 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 11.5 mm -82.28 160.93 3.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.147 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -154.93 93.95 1.6 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.959 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 46.3 mt -58.48 151.25 4.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.089 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.41 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 10.3 mtt180 -140.72 114.26 7.21 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.617 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 103' ' ' ARG . 5.9 Cg_exo -74.11 11.54 1.18 Allowed 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.681 2.254 . . . . 0.0 112.942 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.74 65.39 0.6 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.925 0.393 . . . . 0.0 110.423 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -48.87 -90.24 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.935 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -171.74 171.61 5.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.89 0.376 . . . . 0.0 111.127 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 60.69 -83.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.233 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -155.07 32.13 0.39 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.069 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 15.1 mtt-85 -122.05 109.97 15.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.806 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -96.51 23.48 6.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.124 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -143.99 68.65 1.27 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.921 0.391 . . . . 0.0 110.764 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 39.5 t -130.02 140.96 47.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.047 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.456 ' CE2' ' CG2' ' A' ' 128' ' ' VAL . 25.1 p90 -117.64 132.71 56.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.589 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.4 m -110.58 137.23 48.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.093 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 2.9 mp -99.89 159.08 3.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.85 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 20.1 m -147.87 159.65 43.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.901 0.382 . . . . 0.0 110.953 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 12.9 mtp -113.05 155.33 44.43 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.889 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.96 74.35 0.33 Allowed 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.541 2.161 . . . . 0.0 112.228 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 13.3 p 58.87 107.65 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.985 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.5 t -140.4 -66.66 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.101 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -169.39 44.77 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.162 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 61.27 37.5 17.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.983 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 24.1 m95 -90.2 115.01 27.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.871 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -129.29 118.12 21.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.887 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -84.65 151.15 24.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.917 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -138.33 117.95 13.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.81 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.456 ' CG2' ' CE2' ' A' ' 114' ' ' PHE . 2.3 m -144.94 154.42 14.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.201 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -148.74 122.33 9.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.146 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -90.13 130.96 36.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.991 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.07 -35.94 65.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.922 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.1 m -90.9 111.21 22.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.828 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.84 -28.45 3.74 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.525 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.93 -40.36 60.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.383 179.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -68.06 -33.1 73.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.223 179.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.2 tt -67.53 -47.91 68.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.449 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -68.21 -40.9 82.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.297 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -66.62 -30.35 70.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.216 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' TRP . . . . . 0.456 ' CZ2' ' CD2' ' A' ' 7' ' ' LEU . 1.0 OUTLIER -66.31 -50.21 64.43 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.535 179.64 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 38.4 t -61.63 -38.17 79.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.051 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -68.29 -38.83 82.06 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.047 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 3.3 mttt -67.11 -52.76 37.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.302 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 74.1 mt -54.71 -33.79 28.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.43 -28.44 46.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.547 179.093 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -75.26 -39.51 59.72 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.857 0.36 . . . . 0.0 110.579 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.408 ' CG1' ' CG1' ' A' ' 95' ' ' VAL . 7.8 p -77.54 -27.81 15.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.147 179.181 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.404 ' N ' HG11 ' A' ' 146' ' ' VAL . . . -74.5 -39.04 62.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.621 179.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -72.53 -16.84 61.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.918 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 11.8 t -112.79 18.53 18.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.794 179.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.225 -0.893 . . . . 0.0 111.113 179.945 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 120.862 0.363 . . . . 0.0 111.273 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.424 ' CD1' ' HA ' ' A' ' 26' ' ' SER . 39.2 mt -74.19 -37.61 46.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.032 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.442 ' HE2' ' CD1' ' A' ' 139' ' ' TRP . 0.1 OUTLIER -156.12 145.09 20.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.965 -179.828 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -161.92 135.02 6.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.834 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -161.59 -163.86 15.35 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.501 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 25.2 mm -99.66 73.49 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.938 0.399 . . . . 0.0 111.083 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.455 ' CD2' ' CZ2' ' A' ' 139' ' ' TRP . 0.9 OUTLIER -79.75 150.11 30.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.734 179.957 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -87.49 138.4 31.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.977 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.429 ' HG ' ' CE1' ' A' ' 22' ' ' PHE . 4.4 mm? -126.74 175.03 8.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.845 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.426 ' HG3' ' CZ3' ' A' ' 17' ' ' TRP . 18.0 mt-10 -118.33 107.85 14.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.095 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.27 146.63 62.73 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.492 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.23 -17.33 19.14 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.486 2.124 . . . . 0.0 112.735 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.3 t -69.12 -43.76 81.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.0 0.428 . . . . 0.0 111.187 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -112.42 -18.47 12.45 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.192 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 20.6 m170 62.16 29.25 17.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.809 0.338 . . . . 0.0 110.862 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -130.76 176.17 8.43 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.699 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.426 ' CZ3' ' HG3' ' A' ' 10' ' ' GLU . 21.7 m95 -61.79 137.92 58.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.693 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -139.45 141.69 29.56 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.858 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.72 126.41 10.13 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.542 2.161 . . . . 0.0 112.252 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -152.45 167.81 27.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.93 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -108.29 115.23 29.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.974 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.429 ' CE1' ' HG ' ' A' ' 9' ' ' LEU . 2.2 m-85 -108.54 141.46 40.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.922 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 25.8 t -126.63 148.8 31.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.174 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -128.04 110.84 12.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.873 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.1 p -98.76 155.37 17.39 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.006 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.424 ' HA ' ' CD1' ' A' ' 2' ' ' ILE . 56.4 p -60.58 -16.41 37.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.079 -179.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -133.94 24.27 3.92 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 171.67 -176.36 0.05 OUTLIER 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 121.077 0.465 . . . . 0.0 111.684 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.5 mt -144.79 127.03 9.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.639 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -104.07 142.02 35.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.859 0.361 . . . . 0.0 111.037 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.428 ' HB2' ' CZ ' ' A' ' 22' ' ' PHE . 3.6 p90 -156.66 100.97 1.96 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.942 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.7 t -169.68 158.61 7.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.986 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -76.58 157.81 31.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -167.42 154.8 8.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.88 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.0 t -126.16 -171.67 2.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.883 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.3 m -146.3 95.36 2.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.867 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.8 p -145.57 115.94 7.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.889 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -128.54 86.44 2.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.885 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 60.3 mm-40 -143.48 37.36 1.35 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.925 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -141.15 61.23 0.55 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.536 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 16.1 m-20 -102.02 36.01 2.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.861 0.362 . . . . 0.0 110.878 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -133.19 33.63 3.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.012 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 59.68 92.92 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.903 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -125.97 155.92 40.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.946 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -128.47 -175.52 3.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.883 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -114.17 87.62 13.57 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.955 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -52.11 174.63 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.6 2.2 . . . . 0.0 112.285 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.56 102.18 14.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.89 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -113.74 143.07 45.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.867 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 59.7 36.97 22.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.158 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.3 p -62.51 166.68 4.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.918 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -72.42 115.64 5.45 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.471 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 44.7 m -73.94 169.82 16.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.83 0.348 . . . . 0.0 110.891 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.75 31.77 4.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.914 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -153.15 141.26 20.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.917 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 18.3 mt -81.64 128.63 34.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.886 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 57.2 m-70 -141.65 175.18 9.9 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.963 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 60.98 169.13 0.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.831 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -127.18 170.26 12.59 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.905 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 77.31 -2.75 2.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.48 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -96.1 -28.11 14.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.012 0.434 . . . . 0.0 110.106 179.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.8 t -74.26 -29.8 25.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.819 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -80.08 -9.24 59.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.165 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -93.44 25.97 3.2 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.049 0.452 . . . . 0.0 110.605 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -165.54 29.84 0.05 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.187 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -108.16 -62.19 0.55 Allowed Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.672 -0.694 . . . . 0.0 112.143 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.95 140.66 58.42 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.572 2.181 . . . . 0.0 112.112 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.5 m120 60.09 100.19 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.716 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.94 -4.19 14.97 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.56 2.174 . . . . 0.0 112.988 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.64 28.98 2.43 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.853 0.359 . . . . 0.0 111.385 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.451 HD13 HG21 ' A' ' 71' ' ' ILE . 6.7 mt -117.36 -13.24 10.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.764 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.8 mp -88.21 18.74 4.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.126 0.489 . . . . 0.0 111.704 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 -143.44 75.12 16.87 Favored Pre-proline 0 C--N 1.316 -0.867 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.414 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -68.04 59.33 0.92 Allowed 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.971 2.447 . . . . 0.0 112.352 -179.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -95.37 -36.0 11.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.812 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 26.6 mmt-85 -105.02 176.06 5.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.893 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 59.61 103.7 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.869 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 61.02 86.36 0.1 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.813 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.1 mp -103.6 150.48 23.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.917 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 60.89 41.44 14.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.933 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -128.95 32.16 4.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.923 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -103.98 -27.19 12.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.005 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.435 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 0.3 OUTLIER -56.23 -59.42 11.96 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.15 -179.915 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' A' ' 83' ' ' SER . 60.3 Cg_endo -74.01 -26.11 13.35 Favored 'Trans proline' 0 N--CA 1.465 -0.152 0 C-N-CA 122.846 2.364 . . . . 0.0 112.413 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 14.8 tp 73.65 6.37 4.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.518 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 57.57 108.35 0.01 OUTLIER Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.753 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.54 -34.99 72.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.901 0.382 . . . . 0.0 110.727 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 63.97 98.94 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.255 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 16.2 tp 51.65 38.31 22.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.313 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.6 mmt85 -140.89 95.86 2.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.94 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 173.87 -146.25 8.66 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.528 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.2 p -107.45 152.83 8.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.803 0.335 . . . . 0.0 111.158 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.4 tt -139.96 129.58 24.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.943 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.93 141.65 54.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.829 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.646 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 11.7 p -81.98 -29.08 0.48 Allowed Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.646 ' CD ' ' N ' ' A' ' 95' ' ' VAL . 98.6 Cg_endo -86.18 47.15 1.74 Allowed 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.149 1.899 . . . . 0.0 112.642 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -177.95 37.85 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.006 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 1.3 m -131.67 120.13 22.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.966 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.15 109.09 20.92 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.736 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 14.2 mm -75.35 157.66 5.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.079 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -153.87 87.6 1.22 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.987 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 52.9 mt -58.58 146.22 8.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.193 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.83 104.82 5.77 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.618 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -73.65 52.95 2.61 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.36 2.04 . . . . 0.0 112.424 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 168.0 56.65 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.408 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.429 ' O ' ' HG3' ' A' ' 107' ' ' LYS . . . -65.85 -102.6 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.768 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.429 ' HG3' ' O ' ' A' ' 106' ' ' GLY . 0.0 OUTLIER -154.35 -177.0 6.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.993 0.425 . . . . 0.0 111.191 -179.795 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.419 ' HB2' ' NE1' ' A' ' 17' ' ' TRP . 1.3 m-80 47.9 41.65 14.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.611 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 61.84 31.3 18.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.337 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 -118.31 106.3 12.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.517 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.3 mt -96.54 30.28 2.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.108 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.416 ' CZ ' ' HG2' ' A' ' 133' ' ' GLN . 39.4 m-85 -145.82 61.72 1.26 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.528 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 38.7 t -125.32 126.37 70.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.009 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.435 ' CZ ' ' HB ' ' A' ' 128' ' ' VAL . 35.8 p90 -103.63 131.53 50.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.578 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 13.0 t -105.45 127.08 52.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.105 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 12.8 mt -94.97 158.16 2.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.499 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 2.5 m -154.62 132.17 11.31 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.803 0.335 . . . . 0.0 111.146 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 77.1 mtp -92.17 115.56 64.9 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.85 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -79.68 53.67 4.84 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.485 2.124 . . . . 0.0 112.519 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 30.5 t 177.59 39.95 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.634 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 45.6 t -145.66 -69.96 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.088 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -179.26 -155.13 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.416 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -83.78 49.27 1.58 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.738 0.304 . . . . 0.0 111.07 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 12.4 m95 -74.47 169.87 16.85 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.73 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -169.17 98.61 0.36 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.955 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.6 tp -83.97 95.73 8.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.075 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.5 130.56 35.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.96 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.435 ' HB ' ' CZ ' ' A' ' 114' ' ' PHE . 21.7 t -152.25 159.03 4.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.147 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -164.81 131.05 2.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.241 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -97.55 141.52 30.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.981 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -55.66 -34.36 64.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.952 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.0 m -94.23 114.49 26.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.816 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.416 ' HG2' ' CZ ' ' A' ' 112' ' ' PHE . 1.1 mp0 -49.67 -27.16 4.37 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.431 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -74.77 -45.45 43.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.424 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -64.6 -31.38 72.58 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.202 179.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.4 tp -68.05 -50.07 57.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.445 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -68.17 -36.94 80.42 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.332 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -69.19 -34.4 74.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.163 179.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' TRP . . . . . 0.455 ' CZ2' ' CD2' ' A' ' 7' ' ' LEU . 1.3 m95 -63.8 -47.67 79.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.564 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 33.4 t -62.83 -44.5 99.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.801 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.1 -33.03 72.71 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.701 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.06 -50.89 36.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.378 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.409 HD13 HG23 ' A' ' 143' ' ' ILE . 66.8 mt -53.83 -31.27 20.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.178 0.513 . . . . 0.0 109.617 178.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 50.4 mtp85 -80.23 -32.37 38.44 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.159 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -77.97 -31.34 50.75 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.755 0.312 . . . . 0.0 110.895 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.443 HG12 ' N ' ' A' ' 147' ' ' ALA . 9.8 p -83.63 -29.24 7.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.01 0.433 . . . . 0.0 110.296 179.217 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.443 ' N ' HG12 ' A' ' 146' ' ' VAL . . . -75.3 -34.62 61.3 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.587 179.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -74.55 -11.5 60.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.952 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 10.5 t -117.23 13.05 14.57 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.285 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.2 -0.905 . . . . 0.0 111.204 -179.968 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.488 1.438 0 CA-C-O 120.822 0.344 . . . . 0.0 111.146 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 15.6 mt -88.87 -32.88 5.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.051 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.403 ' HE3' ' CD1' ' A' ' 139' ' ' TRP . 3.2 tptp -125.94 135.08 51.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.775 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 17.9 p-10 -154.52 121.8 5.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.006 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -170.02 -145.68 4.8 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.485 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.409 ' N ' ' CD1' ' A' ' 6' ' ' ILE . 3.2 mp -127.97 88.44 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.824 0.345 . . . . 0.0 110.953 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.4 ' CD2' ' CZ2' ' A' ' 139' ' ' TRP . 4.4 mm? -87.78 144.24 26.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.84 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -76.33 165.84 24.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.019 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -171.12 101.33 0.21 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.822 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.428 ' HB3' ' CE3' ' A' ' 17' ' ' TRP . 0.3 OUTLIER -78.55 164.22 24.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.064 -179.875 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -126.42 132.1 24.19 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.714 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.98 -15.59 28.23 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.536 2.157 . . . . 0.0 112.917 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.1 t -68.78 -42.85 83.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.98 0.419 . . . . 0.0 111.438 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -115.41 -15.84 11.48 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.412 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 2.2 m80 62.79 42.7 7.73 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.931 0.396 . . . . 0.0 110.802 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.73 134.81 37.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.818 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.428 ' CE3' ' HB3' ' A' ' 10' ' ' GLU . 85.5 m95 -65.59 135.05 54.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.915 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.414 ' HB3' ' CD2' ' A' ' 20' ' ' HIS . 11.5 m-85 -120.31 104.59 43.04 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.939 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -67.05 107.84 1.41 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.48 2.12 . . . . 0.0 112.317 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.414 ' CD2' ' HB3' ' A' ' 18' ' ' TYR . 95.1 m-70 -132.25 158.08 42.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.869 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -59.85 151.38 25.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.925 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.477 ' CZ ' ' CD1' ' A' ' 31' ' ' TYR . 0.3 OUTLIER -154.9 142.9 20.13 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.806 -179.939 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.3 t -139.29 145.82 26.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.158 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 27.2 tp -125.94 115.88 20.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.792 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 35.0 p -90.58 158.29 17.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.932 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.5 t -52.75 -24.0 7.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.693 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.0 m -143.33 35.5 1.33 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.552 0.215 . . . . 0.0 111.435 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.2 tttt 177.73 179.21 0.3 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.891 0.377 . . . . 0.0 111.305 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.456 HD13 HG22 ' A' ' 29' ' ' ILE . 1.6 mt -141.25 130.27 24.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.715 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -124.52 133.59 53.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.078 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.477 ' CD1' ' CZ ' ' A' ' 22' ' ' PHE . 33.5 p90 -156.43 153.58 29.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.911 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 84.0 p -156.13 -171.04 3.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.848 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -142.22 33.49 1.51 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.811 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.48 94.66 4.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.824 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.54 -173.76 4.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.953 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.7 t 60.3 38.44 19.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.956 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -111.44 37.81 2.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.934 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -125.2 97.6 5.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.934 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 60.04 32.57 21.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.902 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -77.15 82.41 1.13 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.542 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.9 t30 59.56 50.3 7.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.85 0.357 . . . . 0.0 111.01 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -98.61 34.27 2.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.89 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.8 t0 61.69 88.08 0.09 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.838 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -87.74 122.97 32.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.947 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -173.68 178.76 2.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.848 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -156.8 84.1 3.1 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.893 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.54 145.57 52.98 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.628 2.218 . . . . 0.0 112.315 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.86 163.87 11.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.984 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -61.27 175.62 0.54 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.97 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -151.64 112.22 4.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.151 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 28.5 t 62.97 -79.9 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.939 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 148.04 129.47 1.88 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.469 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -147.23 152.11 37.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.847 0.356 . . . . 0.0 110.937 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.3 t -144.82 175.1 10.44 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.924 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -122.61 141.31 51.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.813 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.14 -58.47 3.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.958 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 8.2 t-160 -153.5 -47.43 0.09 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.854 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 60.1 m -128.04 153.5 46.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.922 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.9 m -65.5 118.15 9.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.925 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -149.85 -46.36 0.13 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.898 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.23 -31.61 69.22 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.902 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.4 t -73.71 -31.1 30.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.165 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 15.8 mt -84.85 -4.38 59.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.3 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -90.02 24.96 2.27 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 121.233 0.54 . . . . 0.0 110.424 179.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.29 33.01 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.746 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.418 ' N ' ' CD ' ' A' ' 67' ' ' PRO . . . -165.9 50.43 0.27 Allowed Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.31 -179.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.418 ' CD ' ' N ' ' A' ' 66' ' ' GLY . 39.5 Cg_endo -66.54 128.32 18.94 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.528 2.152 . . . . 0.0 112.102 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.5 t30 63.2 117.44 0.02 OUTLIER Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.573 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.4 ' O ' HG13 ' A' ' 71' ' ' ILE . 47.1 Cg_endo -90.83 -136.74 0.02 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.876 2.384 . . . . 0.0 111.699 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 58.59 27.63 15.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.901 0.381 . . . . 0.0 110.999 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.4 HG13 ' O ' ' A' ' 69' ' ' PRO . 7.0 mt -115.8 -16.58 8.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.647 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 72.8 mt -86.23 18.92 2.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.095 0.474 . . . . 0.0 111.592 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -149.09 82.39 7.09 Favored Pre-proline 0 C--N 1.316 -0.873 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.159 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_exo -66.57 59.3 0.52 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.94 2.427 . . . . 0.0 112.556 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -96.79 47.32 1.05 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.7 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 11.1 mtm-85 63.28 128.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.761 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -123.26 118.23 27.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.936 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 58.66 83.95 0.11 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.892 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.07 -163.47 1.34 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.768 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -86.18 52.53 2.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.846 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -101.92 122.0 43.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.778 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -95.43 19.31 11.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.369 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.407 ' CB ' ' HD3' ' A' ' 84' ' ' PRO . 0.3 OUTLIER -80.9 -55.1 0.7 Allowed Pre-proline 0 C--N 1.331 -0.219 0 CA-C-O 120.895 0.378 . . . . 0.0 110.839 179.906 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.407 ' HD3' ' CB ' ' A' ' 83' ' ' SER . 95.8 Cg_endo -84.53 48.91 2.55 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 123.141 2.561 . . . . 0.0 112.483 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -128.67 30.4 5.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.958 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 156.02 -146.28 13.78 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.587 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.7 t0 61.38 18.8 9.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.716 0.294 . . . . 0.0 111.132 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 48.33 84.11 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.883 0.373 . . . . 0.0 111.301 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.0 117.57 15.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.806 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.97 82.43 0.17 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.692 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -67.67 131.18 28.83 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.499 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 11.5 p -129.06 142.65 43.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.863 0.364 . . . . 0.0 111.07 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.3 tp -147.31 145.05 29.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.931 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.0 133.11 34.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.827 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.485 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 19.8 t -82.46 -45.34 0.95 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.605 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.485 ' CD ' ' N ' ' A' ' 95' ' ' VAL . 11.6 Cg_exo -71.29 55.14 1.9 Allowed 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.632 2.221 . . . . 0.0 112.457 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 168.83 40.47 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.878 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -157.37 98.25 1.69 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.989 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -80.27 129.79 34.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.693 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 10.7 mm -84.34 157.63 3.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.151 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -145.84 88.41 1.82 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.869 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 86.3 mt -57.79 143.4 12.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.091 0.472 . . . . 0.0 111.349 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 9.0 mtt-85 -132.45 125.64 19.79 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.069 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -82.42 24.36 0.73 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.386 2.058 . . . . 0.0 112.956 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -176.77 74.83 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.948 0.404 . . . . 0.0 110.538 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -54.45 -93.77 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.68 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.79 172.01 1.02 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.877 0.37 . . . . 0.0 111.07 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 61.8 m-80 61.8 -82.04 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.149 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -152.96 42.9 0.62 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.95 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.424 ' HG3' ' CD1' ' A' ' 17' ' ' TRP . 0.6 OUTLIER -135.48 108.64 7.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.92 179.911 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.5 mt -78.28 -33.75 49.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.823 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.421 ' CE2' ' HG3' ' A' ' 133' ' ' GLN . 41.1 m-85 -108.7 115.24 29.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.975 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 21.1 t -153.22 140.23 12.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.029 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.427 ' CE2' ' HB ' ' A' ' 128' ' ' VAL . 25.3 p90 -119.93 115.31 23.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.828 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.4 p -93.44 125.94 38.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.992 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 3.1 mp -92.01 159.99 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.918 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 22.1 p -158.43 158.96 35.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.955 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 32.3 mtp -110.14 155.65 41.43 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.724 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -65.54 -30.9 51.68 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.528 2.152 . . . . 0.0 112.385 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 78.9 p -178.78 129.69 0.11 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.101 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.417 ' CG2' ' N ' ' A' ' 122' ' ' ALA . 0.2 OUTLIER -167.18 -80.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.817 179.799 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.417 ' N ' ' CG2' ' A' ' 121' ' ' VAL . . . -155.53 37.33 0.37 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.172 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 61.1 44.22 10.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.857 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 27.2 m95 -90.45 132.62 35.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.061 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 59.9 m -128.33 139.23 52.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.837 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.72 143.32 46.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.944 0.402 . . . . 0.0 111.111 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -130.56 119.13 22.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.52 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.427 ' HB ' ' CE2' ' A' ' 114' ' ' PHE . 21.9 t -141.32 159.61 22.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.172 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -159.66 141.16 12.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.222 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -105.97 145.75 30.92 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.834 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -58.13 -60.94 2.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.045 0.45 . . . . 0.0 110.875 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.8 t -70.7 115.7 10.16 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.72 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.421 ' HG3' ' CE2' ' A' ' 112' ' ' PHE . 0.1 OUTLIER -48.71 -26.45 2.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.664 179.59 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -76.03 -43.37 44.31 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.474 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.79 -32.49 74.06 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.292 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 8.1 tt -68.57 -50.07 54.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.465 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 57.9 mm-40 -68.17 -36.53 79.77 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.355 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -70.44 -29.77 66.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.446 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' TRP . . . . . 0.403 ' CD1' ' HE3' ' A' ' 3' ' ' LYS . 0.6 OUTLIER -69.28 -46.18 67.86 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.034 0.445 . . . . 0.0 110.621 179.629 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 21.9 t -63.31 -40.99 91.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.878 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 2.3 mtpp -64.18 -37.42 87.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.781 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.8 -54.3 28.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.374 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 70.9 mt -52.72 -32.99 17.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.194 0.521 . . . . 0.0 109.691 178.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 25.0 mtp85 -80.01 -29.3 39.39 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.388 179.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -74.49 -37.4 63.17 Favored 'General case' 0 N--CA 1.457 -0.106 0 CA-C-O 120.922 0.391 . . . . 0.0 110.64 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 11.7 m -80.73 -28.32 11.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.228 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -78.98 -34.35 44.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.754 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -78.47 -10.01 59.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.958 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 12.4 t -110.84 -29.83 7.8 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.882 0.373 . . . . 0.0 111.066 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.198 -0.906 . . . . 0.0 111.111 179.948 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.816 0.341 . . . . 0.0 111.138 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 30.5 mt -77.95 -36.13 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.138 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.42 ' HG2' ' CD1' ' A' ' 139' ' ' TRP . 0.2 OUTLIER -138.09 102.57 4.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.005 -179.906 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -131.22 124.62 30.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.77 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -166.35 -147.22 5.13 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.55 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 25.2 mm -107.98 86.07 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.735 0.302 . . . . 0.0 111.168 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.436 ' HG ' ' CZ3' ' A' ' 139' ' ' TRP . 0.4 OUTLIER -88.0 163.96 16.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.833 179.891 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -110.61 150.41 29.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.104 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -161.29 129.52 4.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.772 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.434 ' HB3' ' CD2' ' A' ' 17' ' ' TRP . 0.2 OUTLIER -86.69 121.51 29.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.127 -179.772 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.91 146.77 37.39 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.601 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.0 -4.52 15.53 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.487 2.125 . . . . 0.0 113.388 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -67.97 -45.52 83.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.032 0.444 . . . . 0.0 110.818 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -128.6 -2.06 5.46 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.175 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 14.6 m170 57.62 74.83 0.4 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.964 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.95 135.47 1.77 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.976 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.434 ' CD2' ' HB3' ' A' ' 10' ' ' GLU . 27.9 m95 -63.92 134.37 54.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.895 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -135.98 148.62 65.65 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.922 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.77 124.58 10.31 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.594 2.196 . . . . 0.0 112.356 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -141.09 111.45 6.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.897 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -54.28 111.38 0.77 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.124 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.51 ' CZ ' ' CD2' ' A' ' 31' ' ' TYR . 2.8 m-30 -109.27 155.77 20.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.829 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 24.5 t -142.0 92.52 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.122 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.7 tp -76.03 117.91 18.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.926 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 17.1 p -97.88 154.71 17.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.984 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 51.7 p -52.53 -24.66 8.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.997 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -140.79 37.49 1.8 Allowed 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.99 -0.284 . . . . 0.0 111.726 -179.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 172.45 171.94 0.11 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.926 0.393 . . . . 0.0 111.383 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.44 HD11 HG21 ' A' ' 29' ' ' ILE . 2.6 mt -134.56 116.64 22.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.55 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -96.13 141.41 29.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.316 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.51 ' CD2' ' CZ ' ' A' ' 22' ' ' PHE . 4.4 m-85 -119.33 124.29 46.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.726 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 12.3 m -131.8 -176.79 4.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.824 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 67.91 115.59 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.121 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -100.81 159.39 15.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.684 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.47 175.15 10.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.974 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.6 t 61.57 114.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.977 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.9 m 60.88 -169.54 0.16 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.887 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -179.12 -37.82 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.786 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 63.45 62.8 0.93 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.837 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -98.79 89.64 0.94 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.35 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.66 38.77 15.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.883 0.373 . . . . 0.0 110.803 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -135.41 36.17 2.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.844 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -59.63 151.03 25.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.983 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -87.37 123.31 32.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.974 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -62.61 141.33 58.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.695 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -110.68 99.14 40.48 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.085 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -68.49 62.64 1.16 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.667 2.245 . . . . 0.0 112.132 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.37 -171.28 0.92 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.87 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -142.27 119.82 11.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.832 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.51 -69.86 0.71 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.116 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 61.49 90.38 0.07 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.033 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -77.21 155.84 44.56 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.453 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.0 t -99.77 114.56 27.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.791 0.329 . . . . 0.0 110.916 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 8.6 t -115.36 146.46 41.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.914 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -73.25 156.91 38.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.903 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 54.9 mt -64.8 -56.93 10.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.959 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -89.52 116.7 27.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.85 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.6 m -84.63 150.23 25.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.956 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -155.88 123.07 5.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.884 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.6 mt -171.09 -41.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.921 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.66 -31.16 72.25 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.828 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 26.2 t -70.26 -37.7 72.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.073 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.6 tp -72.84 -12.64 61.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.272 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -91.23 25.2 2.6 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.195 0.521 . . . . 0.0 110.687 179.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -164.36 29.91 0.07 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.831 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -120.45 -74.19 0.38 Allowed Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.061 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -49.83 140.36 30.64 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.825 2.35 . . . . 0.0 111.989 179.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 21.5 m120 60.83 110.99 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.688 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -84.32 27.64 0.6 Allowed 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.641 2.228 . . . . 0.0 113.101 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.07 29.34 3.91 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.932 0.396 . . . . 0.0 110.978 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 44.1 mt -93.49 -4.26 10.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.62 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 98.4 mt -93.41 20.02 7.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.165 0.507 . . . . 0.0 111.558 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -139.57 68.33 37.91 Favored Pre-proline 0 C--N 1.315 -0.911 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.621 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -68.53 59.97 1.11 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.984 2.456 . . . . 0.0 112.278 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -85.95 -30.35 22.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.015 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 34.8 mtt85 -120.21 127.56 52.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.959 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -160.27 133.85 6.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.817 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 60.71 31.66 20.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.757 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.88 -168.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.959 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -72.35 68.67 0.78 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.811 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.24 -175.78 4.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.717 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 77.17 -53.6 0.55 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.286 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.493 ' CB ' ' HD2' ' A' ' 84' ' ' PRO . 0.8 OUTLIER 59.12 -179.97 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 -179.663 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.493 ' HD2' ' CB ' ' A' ' 83' ' ' SER . 59.5 Cg_endo -73.99 55.74 3.47 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 121.802 1.668 . . . . 0.0 112.435 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.2 tp -104.75 28.53 7.0 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 120.858 0.361 . . . . 0.0 111.008 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.26 -162.61 10.96 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.479 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -117.12 -37.18 3.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.749 0.309 . . . . 0.0 110.92 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 5.6 mp -73.19 -77.85 0.1 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.961 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.37 118.69 11.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.854 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.97 -34.02 6.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.903 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -156.06 168.28 33.46 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.611 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 11.1 p -158.66 133.83 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.834 0.35 . . . . 0.0 111.026 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -146.31 153.49 40.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.892 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -83.82 137.31 33.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.903 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.638 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 13.0 p -83.33 -27.99 0.42 Allowed Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.638 ' CD ' ' N ' ' A' ' 95' ' ' VAL . 89.8 Cg_endo -84.52 49.87 2.82 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.079 1.852 . . . . 0.0 112.593 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 178.33 38.96 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.968 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -156.69 97.44 1.72 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.953 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -78.95 136.36 37.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.84 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 8.1 mm -87.52 161.21 2.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.168 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -149.83 96.39 2.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.96 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 70.3 mt -61.03 149.85 7.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.079 0.466 . . . . 0.0 111.255 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 72.3 mtp180 -138.99 123.14 11.28 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.292 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -73.84 11.9 1.04 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.569 2.179 . . . . 0.0 113.004 -179.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -160.37 67.82 0.35 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.103 0.478 . . . . 0.0 110.591 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.401 ' HA3' ' CG2' ' A' ' 113' ' ' VAL . . . -46.95 -88.67 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.224 0 CA-C-N 115.925 -0.579 . . . . 0.0 113.134 -179.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -174.99 162.59 3.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.849 0.357 . . . . 0.0 111.224 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 59.01 -84.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.157 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 44.7 m-20 -148.28 31.58 0.83 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.977 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -115.33 94.66 4.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.805 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.1 mt -67.65 -28.83 68.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.102 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -109.09 100.26 9.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.944 0.402 . . . . 0.0 111.094 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.401 ' CG2' ' HA3' ' A' ' 106' ' ' GLY . 42.8 t -146.47 127.27 6.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.69 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.429 ' CE2' ' HB ' ' A' ' 128' ' ' VAL . 29.6 p90 -108.65 124.31 50.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.064 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 28.0 t -94.48 129.46 41.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.672 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 11.0 mt -93.87 160.01 2.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.092 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.411 ' HB2' ' CZ3' ' A' ' 124' ' ' TRP . 0.3 OUTLIER -158.61 158.14 33.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.563 179.874 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' MET . . . . . 0.444 ' HB2' ' CD1' ' A' ' 124' ' ' TRP . 13.4 mtp -98.02 152.72 38.19 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.748 0.309 . . . . 0.0 111.236 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -80.59 77.95 3.86 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.661 2.241 . . . . 0.0 112.6 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.404 ' O ' ' CG2' ' A' ' 121' ' ' VAL . 0.9 OUTLIER 69.68 107.63 0.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.922 179.95 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.433 ' HB ' ' CD1' ' A' ' 124' ' ' TRP . 3.4 t -164.45 -76.61 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.318 0.58 . . . . 0.0 110.815 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.402 ' N ' ' CG1' ' A' ' 121' ' ' VAL . . . -146.65 -149.67 0.3 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.267 -0.878 . . . . 0.0 110.671 -179.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -89.36 29.94 1.05 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.747 0.308 . . . . 0.0 111.607 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . 0.444 ' CD1' ' HB2' ' A' ' 118' ' ' MET . 1.7 p-90 -46.38 168.51 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.299 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.405 ' CB ' ' O ' ' A' ' 124' ' ' TRP . 0.9 OUTLIER 163.89 103.12 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.805 179.512 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 8.0 tp -116.39 157.37 25.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.99 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -142.86 139.27 30.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.896 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.429 ' HB ' ' CE2' ' A' ' 114' ' ' PHE . 22.4 t -151.74 153.5 9.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.131 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -155.99 136.98 13.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.197 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -105.01 139.74 39.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.985 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -53.89 -35.85 62.05 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.903 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.5 m -93.32 111.53 23.21 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.811 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -48.35 -28.49 3.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.54 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.88 -43.34 58.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.216 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -67.12 -31.37 71.79 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.194 179.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.4 tt -67.82 -46.92 70.49 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.503 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -69.0 -40.43 78.73 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.377 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.0 -29.1 68.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.286 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' TRP . . . . . 0.436 ' CZ3' ' HG ' ' A' ' 7' ' ' LEU . 1.1 m95 -68.52 -48.29 64.73 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.694 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 33.9 t -63.55 -39.86 86.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.678 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 31.2 tttt -63.79 -36.75 84.93 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.744 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -67.26 -52.32 42.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.273 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.444 HG23 HD11 ' A' ' 143' ' ' ILE . 69.5 mt -52.77 -33.45 18.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.16 0.505 . . . . 0.0 109.76 178.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -79.59 -28.11 41.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.628 179.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.47 -38.29 55.59 Favored 'General case' 0 CA--C 1.523 -0.096 0 CA-C-O 120.856 0.36 . . . . 0.0 110.861 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 16.2 m -79.67 -29.28 13.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.299 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -77.83 -34.83 51.75 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.544 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -74.13 -13.78 60.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.987 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 10.8 t -107.51 -22.11 12.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.106 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.158 -0.925 . . . . 0.0 111.091 -179.996 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.859 0.361 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.6 mt -71.77 -32.94 46.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.953 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.413 ' HD2' ' CD1' ' A' ' 139' ' ' TRP . 3.4 mttm -157.86 123.77 4.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.89 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -143.99 135.04 25.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.909 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -170.02 -135.47 1.91 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.434 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.414 ' N ' ' CD1' ' A' ' 6' ' ' ILE . 3.2 mp -127.15 83.64 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.963 0.411 . . . . 0.0 110.981 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.457 ' CD2' ' CZ2' ' A' ' 139' ' ' TRP . 1.8 mm? -80.85 145.12 31.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.911 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -90.92 119.08 30.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.98 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.86 144.22 51.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.95 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.423 ' HG2' ' CZ3' ' A' ' 17' ' ' TRP . 0.0 OUTLIER -87.5 122.81 31.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.895 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -93.14 126.68 50.03 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.67 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.37 -15.4 24.16 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.505 2.137 . . . . 0.0 112.869 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.0 t -68.76 -42.82 83.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.887 0.375 . . . . 0.0 111.275 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -115.82 -15.82 11.25 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.484 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 63.21 50.81 2.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.918 0.39 . . . . 0.0 110.907 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -157.31 157.25 33.82 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.89 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.423 ' CZ3' ' HG2' ' A' ' 10' ' ' GLU . 40.5 m95 -72.56 139.06 47.28 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.725 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -138.86 121.77 10.72 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.961 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.38 92.86 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.426 2.084 . . . . 0.0 112.256 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 43.9 m-70 -117.27 150.27 39.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.921 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -77.65 147.65 35.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.927 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.49 ' CE2' ' CD1' ' A' ' 31' ' ' TYR . 0.2 OUTLIER -154.57 133.81 12.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.765 -179.876 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.7 t -117.13 138.32 48.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.105 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 34.3 tp -118.69 104.08 10.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.879 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.59 149.28 23.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.763 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.04 -14.62 50.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.626 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.2 t -105.89 -14.17 15.29 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.4 mttt -179.81 -173.32 0.24 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.916 0.388 . . . . 0.0 111.138 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 3.2 mt -129.72 130.13 66.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.436 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -106.82 142.85 35.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.016 0.436 . . . . 0.0 111.357 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.49 ' CD1' ' CE2' ' A' ' 22' ' ' PHE . 25.3 t80 -136.49 122.05 19.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.805 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.4 p -171.63 -177.83 2.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.986 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -110.33 142.68 41.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.899 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -107.12 145.34 32.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.908 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.44 175.6 0.43 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.92 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 59.91 103.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.901 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.2 t 61.5 115.75 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.931 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 176.97 -33.17 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.816 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 63.63 30.09 14.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.782 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -125.71 -33.75 0.68 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.533 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -100.33 34.94 2.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.86 0.362 . . . . 0.0 111.016 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -137.84 37.95 2.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.957 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -89.66 94.38 9.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.848 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -86.8 147.84 25.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.998 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -85.77 171.71 11.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.875 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -99.89 97.52 6.05 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.97 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -68.18 144.39 62.75 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.426 2.084 . . . . 0.0 112.306 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.9 mttt -69.31 132.22 46.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.924 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 57.7 mm-40 -73.36 154.34 40.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.907 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -126.76 143.39 51.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.094 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.3 m -95.07 74.91 3.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.877 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -69.04 161.69 51.88 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.463 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 63.8 m -83.83 63.19 7.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.915 0.388 . . . . 0.0 110.86 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -104.45 165.05 11.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.825 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -150.56 165.03 34.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.937 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.3 mt -60.3 -177.82 0.07 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.824 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 62.39 149.84 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.823 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 32.5 t -127.87 166.08 18.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.874 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.35 165.06 25.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.912 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.5 tt -59.53 -40.72 88.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.819 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -68.02 -31.47 71.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.552 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 26.0 t -69.48 -43.85 80.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.825 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.4 mt -59.68 -33.48 71.62 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.128 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -92.15 21.56 5.01 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.49 0.662 . . . . 0.0 109.821 178.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.421 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 0.5 OUTLIER -155.0 28.62 0.41 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.856 -1.066 . . . . 0.0 109.133 179.718 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -113.62 -74.89 0.66 Allowed Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.156 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -54.1 -178.82 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.766 2.311 . . . . 0.0 112.163 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -56.38 108.86 1.34 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.099 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -88.91 20.94 1.03 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.756 2.304 . . . . 0.0 112.779 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.22 29.98 3.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.836 0.351 . . . . 0.0 111.284 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 26.6 mt -100.44 -9.91 8.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.637 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 20.6 mt -90.8 20.47 4.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.122 0.487 . . . . 0.0 111.603 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -145.2 70.7 14.47 Favored Pre-proline 0 C--N 1.319 -0.757 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.543 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -67.77 59.69 0.84 Allowed 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.012 2.475 . . . . 0.0 112.417 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -75.31 -78.39 0.11 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.875 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -93.57 137.87 32.41 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.889 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -150.88 100.84 2.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.937 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 24.8 m170 60.92 43.65 11.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.95 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.0 mp -87.09 -177.4 6.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.823 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -69.79 69.27 0.29 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.902 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -66.13 101.89 0.76 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.939 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 -131.74 24.59 4.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.089 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.4 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 0.4 OUTLIER -76.25 -57.1 1.44 Allowed Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.998 179.939 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.4 ' HD2' ' N ' ' A' ' 83' ' ' SER . 77.6 Cg_endo -79.22 57.46 6.48 Favored 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 122.98 2.453 . . . . 0.0 112.341 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 17.5 mt -142.53 34.58 1.45 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.872 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -111.82 97.56 0.94 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.503 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -144.7 -47.3 0.24 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.91 0.386 . . . . 0.0 110.979 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 58.46 81.81 0.15 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.878 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -132.64 54.83 1.92 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.971 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -96.21 93.62 7.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.954 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.87 106.89 2.34 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.44 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 11.3 p -93.14 147.18 5.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.776 0.322 . . . . 0.0 111.082 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.2 mp -142.26 133.21 25.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.948 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -70.55 127.42 32.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.906 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.492 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 4.5 t -69.12 -45.96 29.68 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.347 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.492 ' CD ' ' N ' ' A' ' 95' ' ' VAL . 6.4 Cg_exo -73.87 56.37 3.56 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.766 2.311 . . . . 0.0 112.409 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 175.22 38.94 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.021 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 34.2 m -148.6 108.67 4.08 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.902 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -91.45 126.25 36.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.816 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 6.4 mm -90.04 161.37 2.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.106 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -152.52 88.66 1.36 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.857 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 76.4 mt -57.02 152.54 2.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.283 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 18.1 mtt180 -143.7 118.08 6.09 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.241 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -81.02 37.44 0.68 Allowed 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.351 2.034 . . . . 0.0 112.756 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -178.42 63.58 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.939 0.4 . . . . 0.0 110.525 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -56.37 -95.9 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.73 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.59 165.36 0.82 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.83 0.348 . . . . 0.0 111.126 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 31.6 m-20 56.12 47.14 20.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.073 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 24.6 m-20 63.17 58.26 1.46 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.088 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 6.8 mmt85 -152.25 88.73 1.39 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.782 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 69.4 mt -67.78 -33.01 73.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.02 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.404 ' CZ ' ' HG3' ' A' ' 133' ' ' GLN . 19.0 m-85 -91.62 96.83 10.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.966 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 22.0 t -152.74 127.56 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.03 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.415 ' CZ ' ' HB ' ' A' ' 128' ' ' VAL . 43.4 p90 -114.64 138.55 50.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.785 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 20.3 m -107.63 128.38 54.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.074 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 20.0 mt -99.09 159.59 3.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.928 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 81.1 p -152.54 158.81 43.06 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.866 0.365 . . . . 0.0 110.939 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 43.7 mtp -130.63 93.96 30.49 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.828 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.39 61.89 2.1 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.475 2.117 . . . . 0.0 112.306 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.7 m -165.16 -44.88 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.979 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.478 ' CG1' ' N ' ' A' ' 122' ' ' ALA . 2.5 p -75.57 -47.72 32.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.93 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.478 ' N ' ' CG1' ' A' ' 121' ' ' VAL . . . 174.64 -163.32 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.742 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 24.1 mm-40 -93.6 44.92 1.14 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.886 0.374 . . . . 0.0 110.751 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 13.7 m95 -98.39 130.17 45.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.901 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 8.6 t -120.47 133.99 55.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.941 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 12.2 tp -98.58 152.68 19.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.922 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -125.72 128.16 47.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.775 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.415 ' HB ' ' CZ ' ' A' ' 114' ' ' PHE . 16.9 t -150.15 141.1 16.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.16 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -143.57 121.86 12.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.167 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -82.39 142.2 32.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.883 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -54.07 -44.15 70.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.082 0.468 . . . . 0.0 110.95 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.1 p -92.63 120.4 33.02 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.718 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.404 ' HG3' ' CZ ' ' A' ' 112' ' ' PHE . 0.6 OUTLIER -49.86 -24.13 2.29 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.654 179.553 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -73.99 -48.15 32.28 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.626 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -62.76 -33.11 74.48 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.319 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 8.8 tt -66.92 -49.3 65.96 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.634 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -69.67 -36.44 76.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.416 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -70.98 -29.26 65.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.378 179.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' TRP . . . . . 0.457 ' CZ2' ' CD2' ' A' ' 7' ' ' LEU . 1.5 m95 -70.49 -46.05 64.46 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.742 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 26.2 t -64.55 -38.66 83.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.864 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.69 -38.04 88.13 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.835 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.0 -49.18 68.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.364 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 30.5 mt -54.1 -38.52 38.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.275 0.56 . . . . 0.0 109.573 178.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 14.7 mtt180 -77.95 -27.8 49.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.395 179.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -73.34 -35.65 66.06 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.584 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 46.6 t -78.01 -34.02 18.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.034 179.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.71 -38.47 73.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.506 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -64.86 -20.34 66.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.611 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 5.1 p -101.12 -33.48 10.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.118 0.485 . . . . 0.0 110.499 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.195 -0.907 . . . . 0.0 111.283 -179.953 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.5 m . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.845 0.355 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.41 ' CD1' ' HA ' ' A' ' 26' ' ' SER . 41.7 mt -84.34 -33.98 9.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.197 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.412 ' HB2' ' HB3' ' A' ' 24' ' ' LEU . 2.9 mmtt -134.38 139.36 45.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.02 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.759 ' OD1' HG22 ' A' ' 23' ' ' VAL . 7.0 m-80 -149.79 125.54 10.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.803 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -169.99 178.62 42.76 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.476 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.601 HD13 ' HD1' ' A' ' 21' ' ' TYR . 23.1 mm -94.02 90.02 2.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.882 0.372 . . . . 0.0 111.034 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.875 HD12 HG12 ' A' ' 128' ' ' VAL . 3.4 mm? -92.04 139.67 30.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.929 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -79.86 164.84 23.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.97 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.3 tt -171.86 134.38 0.78 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.932 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.441 ' HG3' ' CZ3' ' A' ' 17' ' ' TRP . 14.6 mt-10 -65.31 90.54 0.1 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.962 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.72 138.36 96.86 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.679 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.56 -8.66 22.91 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.447 2.098 . . . . 0.0 112.552 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.4 t -67.43 -42.4 87.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.992 0.425 . . . . 0.0 110.998 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -132.1 4.54 4.1 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.555 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 8.5 t-160 52.66 59.49 4.45 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.915 0.388 . . . . 0.0 111.147 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -158.68 159.59 35.48 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.884 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.441 ' CZ3' ' HG3' ' A' ' 10' ' ' GLU . 46.4 m95 -57.6 129.86 43.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.923 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -134.67 124.64 17.0 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.836 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.13 88.54 0.82 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.377 2.052 . . . . 0.0 112.318 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -111.75 151.89 28.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.839 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.601 ' HD1' HD13 ' A' ' 6' ' ' ILE . 5.1 t80 -60.05 155.74 16.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.898 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.406 ' HB3' ' CH2' ' A' ' 139' ' ' TRP . 0.1 OUTLIER -154.14 138.29 16.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.775 -179.892 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.759 HG22 ' OD1' ' A' ' 4' ' ' ASN . 6.3 t -127.77 153.86 37.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.37 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.533 HD13 ' N ' ' A' ' 25' ' ' THR . 0.8 OUTLIER -133.5 119.37 19.46 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.923 -179.939 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.533 ' N ' HD13 ' A' ' 24' ' ' LEU . 11.0 p -103.26 157.51 16.96 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.94 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.41 ' HA ' ' CD1' ' A' ' 2' ' ' ILE . 4.1 t -39.94 -32.45 0.16 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.246 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 58.6 m -152.09 48.27 0.77 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.657 0.265 . . . . 0.0 111.467 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.1 mtmm -175.5 156.54 1.97 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.989 0.423 . . . . 0.0 111.252 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.7 mt -124.34 123.7 66.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.707 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -115.5 154.0 30.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.025 0.44 . . . . 0.0 111.255 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 21.6 p90 -158.99 148.9 19.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.713 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 84.2 p . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.033 -179.912 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.38 0 N-CA-C 112.42 -0.272 . . . . 0.0 112.42 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 11.4 p -144.23 151.82 15.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.78 0.324 . . . . 0.0 111.115 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.521 HD23 ' N ' ' A' ' 94' ' ' ASP . 0.6 OUTLIER -156.04 170.89 21.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.891 -179.991 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.521 ' N ' HD23 ' A' ' 93' ' ' LEU . 64.0 m-20 -100.59 118.56 37.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.976 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.694 HG23 HG23 ' A' ' 143' ' ' ILE . 12.6 p -83.31 -27.6 0.42 Allowed Pre-proline 0 CA--C 1.535 0.403 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.659 ' CD ' ' N ' ' A' ' 95' ' ' VAL . 95.2 Cg_endo -85.51 49.77 2.51 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.153 1.902 . . . . 0.0 112.539 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -179.43 38.13 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.977 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 31.1 p -137.31 173.94 11.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.961 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 50.0 tp60 -137.84 113.5 9.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.703 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.914 HD13 HG23 ' A' ' 116' ' ' ILE . 14.6 mm -79.13 159.68 4.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.035 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.476 ' N ' HG22 ' A' ' 100' ' ' ILE . . . -151.68 92.5 1.76 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.969 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 50.1 mt -58.24 138.54 19.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.022 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -127.31 107.95 21.35 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.715 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -77.69 22.85 0.58 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.783 2.322 . . . . 0.0 112.631 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -173.38 64.86 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.961 0.41 . . . . 0.0 110.483 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -56.79 -95.84 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.721 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.85 156.04 0.6 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.855 0.36 . . . . 0.0 111.045 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 66.2 m-80 58.43 57.4 3.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.113 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 59.06 58.49 3.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.088 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -152.59 90.14 1.46 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.723 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.456 HD12 ' CZ ' ' A' ' 112' ' ' PHE . 0.3 OUTLIER -81.41 -27.97 34.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.184 -179.84 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.738 ' HB3' HD13 ' A' ' 136' ' ' LEU . 36.3 m-85 -101.31 95.59 6.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.001 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.492 HG22 ' HB2' ' A' ' 129' ' ' ALA . 21.4 t -153.6 120.9 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.039 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.451 ' CZ ' ' HB ' ' A' ' 128' ' ' VAL . 42.1 p90 -105.3 122.17 45.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.805 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 22.9 t -92.95 131.44 37.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.12 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.914 HG23 HD13 ' A' ' 100' ' ' ILE . 16.6 mt -97.62 160.72 2.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.828 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.463 ' N ' HG22 ' A' ' 116' ' ' ILE . 99.2 p -173.29 128.66 0.45 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.094 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.38 127.56 32.66 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.721 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -84.37 48.15 2.38 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.733 2.289 . . . . 0.0 112.708 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.8 m 177.8 39.25 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.935 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.587 ' O ' ' HB2' ' A' ' 122' ' ' ALA . 2.5 p -131.72 -49.61 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.086 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.587 ' HB2' ' O ' ' A' ' 121' ' ' VAL . . . 165.3 40.16 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.195 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 7.0 mm100 51.19 32.16 7.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.148 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' TRP . . . . . 0.43 ' CD1' ' HB3' ' A' ' 122' ' ' ALA . 23.0 m95 -69.75 171.59 8.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.895 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 75.3 p -158.23 110.75 2.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.912 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 5.3 tp -100.02 162.01 13.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.881 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -140.26 130.93 25.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.936 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.875 HG12 HD12 ' A' ' 7' ' ' LEU . 39.1 t -144.32 147.02 19.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.922 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.492 ' HB2' HG22 ' A' ' 113' ' ' VAL . . . -139.64 133.88 31.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.244 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.554 ' H ' HD12 ' A' ' 136' ' ' LEU . . . -102.85 135.0 45.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.851 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.76 -47.93 59.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.321 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -87.61 117.4 26.39 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.897 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.452 ' HG2' ' CE2' ' A' ' 112' ' ' PHE . 1.3 mt-30 -47.92 -27.96 2.44 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.342 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.66 -42.54 51.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.523 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -64.54 -34.04 77.31 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.055 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.738 HD13 ' HB3' ' A' ' 112' ' ' PHE . 8.9 tt -66.83 -52.24 46.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.543 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -67.03 -36.9 83.12 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.313 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -69.72 -31.53 69.58 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.483 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' TRP . . . . . 0.409 ' CZ2' HD23 ' A' ' 7' ' ' LEU . 0.4 OUTLIER -67.68 -44.8 76.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.489 179.592 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.649 HG13 HG21 ' A' ' 100' ' ' ILE . 23.8 t -61.48 -45.21 99.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.723 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 8.3 ttmt -60.94 -36.22 78.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.633 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.514 ' O ' HG22 ' A' ' 146' ' ' VAL . 0.0 OUTLIER -65.99 -50.03 65.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.347 179.787 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.728 HG21 HD11 ' A' ' 100' ' ' ILE . 69.0 mt -52.79 -36.88 24.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.246 0.546 . . . . 0.0 109.641 178.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 28.6 mtp85 -78.69 -27.65 45.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.509 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.503 ' O ' HG22 ' A' ' 149' ' ' THR . 1.9 tt0 -73.44 -38.38 65.52 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.645 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.514 HG22 ' O ' ' A' ' 142' ' ' LYS . 13.4 m -79.27 -30.51 14.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.272 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -76.25 -34.16 59.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.396 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -76.12 -11.0 59.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.894 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.503 HG22 ' O ' ' A' ' 145' ' ' GLU . 15.3 t -119.07 15.52 13.26 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.198 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.431 ' HB3' ' HB3' ' A' ' 96' ' ' PRO . . . . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.204 -0.903 . . . . 0.0 111.092 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 8.4 t . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.871 0.367 . . . . 0.0 111.24 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.832 HD11 ' HB3' ' A' ' 26' ' ' SER . 31.0 mt -83.53 -34.6 10.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.082 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.7 tptt -148.75 115.72 6.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.03 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.9 ' HB3' HG13 ' A' ' 23' ' ' VAL . 14.5 p-10 -137.08 137.53 39.42 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.81 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -170.03 -167.92 31.18 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.532 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 23.9 mm -94.27 96.31 5.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.799 0.333 . . . . 0.0 111.056 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.62 HD12 HG12 ' A' ' 128' ' ' VAL . 1.3 mm? -101.6 154.28 19.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.847 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.44 ' CD1' ' N ' ' A' ' 8' ' ' TYR . 3.0 m-85 -109.92 131.22 55.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.918 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.75 HD13 ' CZ ' ' A' ' 22' ' ' PHE . 3.6 mp -125.09 -2.09 7.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.632 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.455 ' HB3' ' CD2' ' A' ' 17' ' ' TRP . 2.9 pt-20 46.5 -169.8 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.951 0.405 . . . . 0.0 111.449 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -150.5 146.27 19.55 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.531 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -75.04 -17.37 19.5 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.434 2.09 . . . . 0.0 112.577 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.4 t -73.85 -41.73 53.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.935 0.397 . . . . 0.0 111.155 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -106.32 -23.18 12.61 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.906 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 64.88 33.24 10.17 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.917 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -126.0 143.86 50.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.852 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.455 ' CD2' ' HB3' ' A' ' 10' ' ' GLU . 40.0 m95 -90.04 124.81 35.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.042 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.434 ' CE1' ' HA ' ' A' ' 10' ' ' GLU . 1.7 p90 -127.81 147.6 63.56 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.63 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -67.99 124.72 12.14 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.491 2.127 . . . . 0.0 112.452 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -125.55 165.29 18.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.664 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -98.99 110.01 22.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.884 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.75 ' CZ ' HD13 ' A' ' 9' ' ' LEU . 7.5 m-85 -123.1 132.01 53.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.842 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.9 HG13 ' HB3' ' A' ' 4' ' ' ASN . 29.8 t -121.13 134.39 64.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.92 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.628 HD12 HG12 ' A' ' 29' ' ' ILE . 24.6 tp -110.4 107.37 17.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.146 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 17.3 p -100.86 144.2 30.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.788 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.832 ' HB3' HD11 ' A' ' 2' ' ' ILE . 12.6 p -51.91 -21.47 3.01 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.827 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.412 ' O ' ' CG ' ' A' ' 28' ' ' LYS . 12.6 p -101.19 -27.58 13.14 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.745 ' HA ' HG23 ' A' ' 95' ' ' VAL . 4.5 mtmp? -162.2 -175.45 4.59 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.912 0.387 . . . . 0.0 111.341 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.628 HG12 HD12 ' A' ' 24' ' ' LEU . 3.1 mt -128.82 117.31 44.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.677 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.415 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 7.4 m-85 -89.28 138.87 31.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.157 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.457 ' HB3' ' CD2' ' A' ' 22' ' ' PHE . 5.4 p90 -162.04 102.7 1.13 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.829 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 34.9 p . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.745 -179.995 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 CA-C-O 120.441 -0.088 . . . . 0.0 112.942 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.716 HG22 ' HD2' ' A' ' 28' ' ' LYS . 15.0 p -163.74 141.58 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.758 0.313 . . . . 0.0 111.298 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -151.95 153.47 34.16 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.917 0.389 . . . . 0.0 111.05 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -71.99 133.87 45.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.956 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.745 HG23 ' HA ' ' A' ' 28' ' ' LYS . 13.6 t -75.04 -47.71 4.6 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.707 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.507 ' HD2' ' N ' ' A' ' 95' ' ' VAL . 73.7 Cg_endo -75.67 58.78 5.42 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.156 1.904 . . . . 0.0 112.495 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -176.21 36.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.974 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 27.3 p -139.12 162.43 34.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.924 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.15 108.74 6.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.859 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 1.037 HD13 HG23 ' A' ' 116' ' ' ILE . 15.1 mm -79.84 160.51 4.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.168 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.469 ' N ' HG22 ' A' ' 100' ' ' ILE . . . -161.21 92.26 0.9 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.99 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 45.5 mt -59.47 141.26 16.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.073 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -134.79 106.64 10.66 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.731 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.402 ' HA ' ' O ' ' A' ' 111' ' ' LEU . 13.0 Cg_exo -69.8 50.91 0.86 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.576 2.184 . . . . 0.0 112.409 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 173.36 53.09 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.991 0.424 . . . . 0.0 110.26 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.401 ' HA3' HG21 ' A' ' 113' ' ' VAL . . . -44.47 -87.43 0.01 OUTLIER Glycine 0 C--N 1.332 0.312 0 CA-C-N 115.986 -0.552 . . . . 0.0 113.127 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.1 mttt 178.96 169.02 0.93 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.997 0.427 . . . . 0.0 111.101 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 60.95 -82.75 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.21 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -150.55 31.85 0.65 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.908 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 1.2 mmt85 -118.0 110.5 17.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.878 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.447 ' H ' HD23 ' A' ' 111' ' ' LEU . 0.3 OUTLIER -85.62 -32.07 22.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.954 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.439 ' CE2' ' HG3' ' A' ' 133' ' ' GLN . 5.2 m-85 -105.89 87.52 2.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.87 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.723 HG13 ' HB2' ' A' ' 129' ' ' ALA . 22.0 t -132.21 143.66 39.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.104 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.435 ' CE2' ' HB ' ' A' ' 128' ' ' VAL . 19.0 p90 -125.57 133.65 52.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.928 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -105.18 141.35 36.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.831 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 1.037 HG23 HD13 ' A' ' 100' ' ' ILE . 12.5 mt -105.26 157.91 5.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.97 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.424 ' N ' HG22 ' A' ' 116' ' ' ILE . 55.8 p -150.13 -166.84 2.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.839 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 28.0 mtp -135.9 155.57 77.76 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.934 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -63.7 73.11 0.16 Allowed 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.692 2.261 . . . . 0.0 112.359 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 59.26 109.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.947 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.0 t -145.56 -66.63 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.058 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.706 ' HB3' ' NE1' ' A' ' 124' ' ' TRP . . . -176.01 73.06 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.032 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.402 ' HG2' ' O ' ' A' ' 122' ' ' ALA . 0.0 OUTLIER 40.63 36.87 0.41 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.781 -179.917 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 124' ' ' TRP . . . . . 0.706 ' NE1' ' HB3' ' A' ' 122' ' ' ALA . 22.6 m95 -91.89 126.25 36.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.872 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.9 t -165.65 120.37 1.24 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.903 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.493 ' H ' HD23 ' A' ' 126' ' ' LEU . 0.5 OUTLIER -101.88 166.66 10.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.877 179.943 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -115.08 142.26 46.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.936 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.62 HG12 HD12 ' A' ' 7' ' ' LEU . 17.1 t -148.56 154.01 10.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.022 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.723 ' HB2' HG13 ' A' ' 113' ' ' VAL . . . -159.84 135.08 8.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.252 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -104.71 132.25 51.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.962 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -54.49 -36.75 64.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.069 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.77 111.98 23.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.804 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.439 ' HG3' ' CE2' ' A' ' 112' ' ' PHE . 5.2 tt0 -48.31 -28.64 3.25 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.521 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.95 -40.88 53.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.279 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.53 -33.33 73.93 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.054 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.542 ' O ' HG23 ' A' ' 140' ' ' VAL . 5.2 tt -66.68 -48.52 69.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.41 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -69.26 -38.1 78.27 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.291 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -69.88 -28.76 65.9 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.282 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' TRP . . . . . 0.615 ' CZ2' HD23 ' A' ' 7' ' ' LEU . 1.3 m95 -69.64 -46.93 65.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.599 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 136' ' ' LEU . 25.4 t -63.44 -40.11 87.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.033 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 5.5 ttpp -65.59 -36.6 84.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.797 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.428 ' O ' HG23 ' A' ' 146' ' ' VAL . 0.1 OUTLIER -67.42 -50.35 59.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.464 179.849 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.491 HG21 HD11 ' A' ' 100' ' ' ILE . 54.7 mt -54.53 -35.85 33.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.311 0.577 . . . . 0.0 109.498 178.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 14.4 mtp-105 -76.97 -29.4 55.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.385 179.05 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.697 ' O ' HG22 ' A' ' 149' ' ' THR . 3.9 tt0 -75.87 -32.18 59.61 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-O 120.825 0.345 . . . . 0.0 110.621 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.738 ' HB ' HG11 ' A' ' 95' ' ' VAL . 59.1 t -78.82 -32.18 15.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.142 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.93 -39.68 66.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.845 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -72.47 -16.65 61.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.881 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.697 HG22 ' O ' ' A' ' 145' ' ' GLU . 11.9 t -111.62 16.81 20.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.896 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.14 -179.963 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.613 ' N ' HG22 ' A' ' 25' ' ' THR . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.829 0.347 . . . . 0.0 111.2 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.699 HD11 ' HA ' ' A' ' 26' ' ' SER . 30.1 mt -85.29 -33.18 7.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.246 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.5 tttp -160.0 141.52 12.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.944 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.771 ' OD1' HG13 ' A' ' 23' ' ' VAL . 6.4 m-80 -139.53 132.81 29.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.81 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -169.97 175.53 44.01 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.51 -0.853 . . . . 0.0 112.623 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.508 HD13 ' HA ' ' A' ' 21' ' ' TYR . 22.5 mm -93.1 75.83 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.775 0.321 . . . . 0.0 111.099 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.788 HD12 HG12 ' A' ' 128' ' ' VAL . 4.0 mm? -79.05 131.5 36.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.734 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.692 ' O ' HD12 ' A' ' 9' ' ' LEU . 50.6 m-85 -81.58 155.25 25.78 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.164 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.692 HD12 ' O ' ' A' ' 8' ' ' TYR . 2.1 mp -141.46 164.85 29.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.716 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.454 ' HG2' ' CE3' ' A' ' 17' ' ' TRP . 1.4 mm-40 -111.76 111.78 23.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.908 0.385 . . . . 0.0 111.1 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.22 113.04 50.07 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.339 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.58 -17.08 8.94 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.562 2.175 . . . . 0.0 113.137 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.6 t -63.99 -39.66 86.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.018 0.437 . . . . 0.0 110.947 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 16.4 m-80 -128.19 -6.74 5.4 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.597 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 53.84 63.24 2.26 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.88 0.371 . . . . 0.0 111.036 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -148.36 160.86 42.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.892 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.454 ' CE3' ' HG2' ' A' ' 10' ' ' GLU . 70.7 m95 -81.01 136.97 36.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.929 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -137.22 129.29 16.8 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.726 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.1 138.95 31.76 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.487 2.125 . . . . 0.0 112.246 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -155.39 130.04 9.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.911 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.508 ' HA ' HD13 ' A' ' 6' ' ' ILE . 25.4 t80 -74.2 90.63 2.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.907 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.413 ' CD2' ' HB3' ' A' ' 31' ' ' TYR . 5.5 m-85 -76.84 143.73 39.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.927 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.771 HG13 ' OD1' ' A' ' 4' ' ' ASN . 22.6 t -121.54 102.75 12.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.926 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.546 HD23 ' HB ' ' A' ' 2' ' ' ILE . 1.4 tt -91.22 112.12 23.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.989 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.613 HG22 ' N ' ' A' ' 1' ' ' SER . 0.6 OUTLIER -106.64 152.04 24.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.826 179.885 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.699 ' HA ' HD11 ' A' ' 2' ' ' ILE . 7.7 t -70.11 58.57 0.16 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.714 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 178.38 -28.64 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.875 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.609 ' HE3' HG21 ' A' ' 92' ' ' VAL . 9.7 mtpt -172.89 168.82 4.92 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.831 0.348 . . . . 0.0 110.864 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 15.3 mt -107.99 128.51 63.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.012 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -121.69 118.51 29.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.868 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.413 ' HB3' ' CD2' ' A' ' 22' ' ' PHE . 37.7 p90 -123.43 146.86 47.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.944 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.7 m . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.934 179.97 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.412 ' HA3' ' CZ ' ' A' ' 31' ' ' TYR . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.609 HG21 ' HE3' ' A' ' 28' ' ' LYS . 11.4 p -111.44 155.1 12.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.757 0.313 . . . . 0.0 111.127 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.426 ' N ' HG22 ' A' ' 92' ' ' VAL . 0.5 OUTLIER -154.29 112.33 3.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.918 -180.0 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.51 127.14 30.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.091 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.902 HG11 HG13 ' A' ' 146' ' ' VAL . 38.8 t -74.24 -48.4 5.77 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.577 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.659 ' HB3' ' HB3' ' A' ' 150' ' ' ALA . 64.3 Cg_endo -74.16 57.82 4.11 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.19 1.926 . . . . 0.0 112.349 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.494 ' HB2' ' O ' ' A' ' 96' ' ' PRO . . . 171.94 40.55 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.655 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -159.81 99.66 1.41 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.893 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -79.58 136.94 36.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.764 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.723 HD11 HG21 ' A' ' 143' ' ' ILE . 6.2 mm -87.26 162.58 2.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.054 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.562 ' HB3' ' O ' ' A' ' 115' ' ' SER . . . -149.85 83.74 1.4 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.0 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.577 HG12 HG21 ' A' ' 140' ' ' VAL . 69.0 mt -58.68 152.82 3.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.078 0.466 . . . . 0.0 111.215 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.419 ' N ' HG22 ' A' ' 102' ' ' ILE . 0.0 OUTLIER -147.94 114.99 4.01 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.213 179.644 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -78.42 42.47 1.24 Allowed 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.358 2.038 . . . . 0.0 112.688 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 175.16 62.32 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.045 0.45 . . . . 0.0 110.424 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -53.47 -93.54 0.01 OUTLIER Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.757 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.9 pttt -177.8 170.09 1.97 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.845 0.355 . . . . 0.0 110.949 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 64.07 -79.78 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.859 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -159.51 31.98 0.19 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.957 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 25.1 mmm180 -119.82 92.39 3.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.878 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.432 ' H ' HD12 ' A' ' 111' ' ' LEU . 3.8 mp -68.3 -30.75 69.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.854 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.487 ' HB3' HD13 ' A' ' 136' ' ' LEU . 40.2 m-85 -105.66 92.84 4.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.985 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.41 HG13 ' HB2' ' A' ' 129' ' ' ALA . 24.1 t -137.24 143.16 35.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.048 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.428 ' CE2' ' HB ' ' A' ' 128' ' ' VAL . 39.8 p90 -128.9 131.1 47.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.891 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.562 ' O ' ' HB3' ' A' ' 101' ' ' ALA . 1.2 m -102.38 128.33 49.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.833 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.691 HG23 HD13 ' A' ' 100' ' ' ILE . 1.6 mt -100.12 159.99 3.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.987 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.472 ' N ' HG22 ' A' ' 116' ' ' ILE . 60.9 p -153.76 149.95 27.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.945 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 39.7 mtp -96.12 108.48 41.53 Favored Pre-proline 0 CA--C 1.531 0.234 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.106 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -74.97 54.77 3.72 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.72 2.28 . . . . 0.0 112.394 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.9 p 171.39 41.84 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.72 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 45.2 t -150.5 -68.35 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.995 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -177.62 -154.36 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.316 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -85.62 45.62 1.22 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.7 0.286 . . . . 0.0 111.169 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 11.8 m0 -73.95 139.56 44.96 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.784 0.326 . . . . 0.0 110.744 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -140.58 110.25 6.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.097 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.45 112.37 24.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.913 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -84.51 118.75 24.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.98 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.788 HG12 HD12 ' A' ' 7' ' ' LEU . 21.7 t -141.95 151.79 18.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.925 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.542 ' O ' HD13 ' A' ' 7' ' ' LEU . . . -160.32 148.58 16.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.269 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -114.2 150.41 34.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.909 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.12 -58.82 6.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.864 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.76 113.64 11.14 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.751 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -48.74 -27.56 3.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.567 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 25.8 mp0 -73.84 -40.54 63.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.482 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -67.37 -31.77 72.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.173 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.489 ' O ' HG23 ' A' ' 140' ' ' VAL . 7.5 tt -68.12 -49.44 61.14 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.521 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.78 -40.31 84.0 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.307 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -67.32 -29.21 68.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.322 179.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' TRP . . . . . 0.502 ' CZ2' HD23 ' A' ' 7' ' ' LEU . 0.8 OUTLIER -67.82 -49.09 64.16 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.471 179.611 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.68 HG13 ' CB ' ' A' ' 100' ' ' ILE . 33.5 t -60.28 -40.97 85.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.034 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -67.25 -38.37 85.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.907 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.486 ' O ' HG12 ' A' ' 146' ' ' VAL . 6.4 mptt -66.59 -49.86 64.95 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.524 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.723 HG21 HD11 ' A' ' 100' ' ' ILE . 41.6 mt -55.21 -37.14 42.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.369 0.605 . . . . 0.0 109.532 178.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 24.3 mtp180 -79.85 -25.74 40.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.212 -0.903 . . . . 0.0 110.673 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -76.04 -38.71 56.88 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-O 120.909 0.385 . . . . 0.0 110.75 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.902 HG13 HG11 ' A' ' 95' ' ' VAL . 7.2 p -80.85 -28.57 11.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.236 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.47 ' HB2' HG12 ' A' ' 95' ' ' VAL . . . -79.29 -33.89 42.94 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.291 179.198 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -74.2 -13.78 60.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.883 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.45 HG22 ' HA ' ' A' ' 146' ' ' VAL . 9.2 t -105.4 -20.5 13.47 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.101 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.659 ' HB3' ' HB3' ' A' ' 96' ' ' PRO . . . . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.216 -0.897 . . . . 0.0 111.141 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.49 ' HB3' HG13 ' A' ' 23' ' ' VAL . 6.7 m . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.844 0.354 . . . . 0.0 111.184 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.4 HD12 HG11 ' A' ' 146' ' ' VAL . 38.3 mt -76.53 -34.78 24.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.148 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.8 tptp -142.01 91.94 2.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.871 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.678 ' HB3' HG13 ' A' ' 23' ' ' VAL . 24.5 p-10 -125.06 131.91 53.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.919 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -169.88 -165.18 26.83 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.525 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.657 HD13 ' HD1' ' A' ' 21' ' ' TYR . 25.1 mm -97.21 80.45 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.743 0.306 . . . . 0.0 111.1 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.697 HD23 ' CZ2' ' A' ' 139' ' ' TRP . 0.8 OUTLIER -87.58 158.62 18.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.779 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.476 ' C ' HD23 ' A' ' 9' ' ' LEU . 36.1 m-85 -102.16 163.68 12.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.026 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.75 HD21 ' HB2' ' A' ' 20' ' ' HIS . 0.6 OUTLIER -177.78 129.16 0.14 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.785 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.443 ' HG2' ' CZ3' ' A' ' 17' ' ' TRP . 0.0 OUTLIER -95.16 166.29 11.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.974 0.416 . . . . 0.0 111.024 -179.814 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.42 150.12 53.8 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.709 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -73.63 -17.96 22.84 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.597 2.198 . . . . 0.0 112.506 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.1 t -77.77 -38.62 25.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.985 0.421 . . . . 0.0 110.975 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -101.81 -23.88 14.13 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.835 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 63.87 33.27 12.72 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.822 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -144.76 156.1 43.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.048 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.443 ' CZ3' ' HG2' ' A' ' 10' ' ' GLU . 30.8 m95 -77.24 139.57 39.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.869 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -132.4 138.72 32.81 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.838 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.42 130.26 14.81 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.464 2.11 . . . . 0.0 112.3 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.75 ' HB2' HD21 ' A' ' 9' ' ' LEU . 9.7 m-70 -144.75 -178.34 5.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.864 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.657 ' HD1' HD13 ' A' ' 6' ' ' ILE . 34.1 t80 -119.96 139.39 52.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.934 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.49 ' CZ ' ' CD1' ' A' ' 31' ' ' TYR . 1.5 m-85 -132.44 148.28 52.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.873 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.678 HG13 ' HB3' ' A' ' 4' ' ' ASN . 21.7 t -140.0 92.06 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.03 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.64 HD11 HG21 ' A' ' 146' ' ' VAL . 0.2 OUTLIER -69.84 115.09 8.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.094 -179.857 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -99.44 157.28 16.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.023 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -42.83 -34.37 0.93 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.229 -179.47 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.432 ' HA ' HG11 ' A' ' 95' ' ' VAL . 5.5 p -144.14 46.66 1.43 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.732 0.301 . . . . 0.0 111.622 -179.499 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 177.12 167.68 0.57 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.834 0.35 . . . . 0.0 111.358 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.639 HG23 HD22 ' A' ' 24' ' ' LEU . 3.0 mt -132.2 100.32 4.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.539 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -73.43 132.17 42.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.172 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.49 ' CD1' ' CZ ' ' A' ' 22' ' ' PHE . 69.4 t80 -143.31 123.37 13.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.783 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.5 t . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.885 179.971 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.419 0 N-CA-C 112.567 -0.213 . . . . 0.0 112.567 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.41 HG22 ' H ' ' A' ' 92' ' ' VAL . 5.2 m -84.87 139.47 17.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.733 0.301 . . . . 0.0 111.091 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.1 mt -130.98 134.56 46.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.895 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -69.39 126.8 30.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.871 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.946 HG21 HG23 ' A' ' 146' ' ' VAL . 13.3 p -81.95 -27.73 0.44 Allowed Pre-proline 0 CA--C 1.534 0.347 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.649 ' CD ' ' N ' ' A' ' 95' ' ' VAL . 88.8 Cg_endo -85.97 47.64 1.89 Allowed 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.146 1.898 . . . . 0.0 112.665 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 178.69 39.37 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.865 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 1.9 m -119.48 173.51 6.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.958 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.01 102.59 2.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.769 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 1.031 HD13 HG23 ' A' ' 116' ' ' ILE . 14.7 mm -79.2 158.19 4.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.078 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.422 ' N ' HG22 ' A' ' 100' ' ' ILE . . . -155.56 93.17 1.46 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.037 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 54.3 mt -59.25 143.87 13.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.144 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.413 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 4.6 mtt180 -133.28 114.15 13.53 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.525 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 103' ' ' ARG . 3.0 Cg_exo -74.78 29.87 0.35 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.587 2.191 . . . . 0.0 112.651 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -177.62 74.22 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.734 0.302 . . . . 0.0 110.413 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -42.28 -84.67 0.01 OUTLIER Glycine 0 C--N 1.332 0.344 0 CA-C-N 116.077 -0.51 . . . . 0.0 113.19 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -175.11 -80.5 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.832 0.349 . . . . 0.0 111.236 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -96.8 109.71 22.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.215 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 32.8 m120 48.04 38.78 10.11 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.235 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 7.9 mmp_? -140.11 112.66 7.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.936 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.86 -33.51 12.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.822 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.667 ' HB3' HD13 ' A' ' 136' ' ' LEU . 3.4 m-85 -108.21 107.12 17.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.861 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.445 HG13 ' HB2' ' A' ' 129' ' ' ALA . 22.0 t -151.18 132.3 4.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.128 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.418 ' CE2' ' HB ' ' A' ' 128' ' ' VAL . 31.3 p90 -115.54 122.51 45.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.895 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 58.1 m -89.32 128.38 35.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.983 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 1.031 HG23 HD13 ' A' ' 100' ' ' ILE . 14.1 mt -100.97 158.5 4.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.996 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.422 ' N ' HG22 ' A' ' 116' ' ' ILE . 54.6 p -151.38 -170.52 3.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.968 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' MET . . . . . 0.481 ' SD ' HG21 ' A' ' 121' ' ' VAL . 32.7 mtp -146.82 105.02 3.92 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.073 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -78.16 59.17 6.91 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.506 2.137 . . . . 0.0 112.376 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -177.2 -45.6 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.877 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.481 HG21 ' SD ' ' A' ' 118' ' ' MET . 43.1 t -65.63 -66.69 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.999 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.439 ' HB3' ' HD1' ' A' ' 124' ' ' TRP . . . 179.88 -154.76 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.296 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -84.63 47.63 1.4 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.772 0.32 . . . . 0.0 111.04 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' TRP . . . . . 0.439 ' HD1' ' HB3' ' A' ' 122' ' ' ALA . 23.6 m95 -79.94 128.7 33.78 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.804 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.14 114.95 14.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.944 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.3 tp -112.5 112.62 24.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.022 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -82.2 126.46 32.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.858 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.47 HG12 HD12 ' A' ' 7' ' ' LEU . 21.2 t -136.44 154.43 32.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.077 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.445 ' HB2' HG13 ' A' ' 113' ' ' VAL . . . -161.21 127.37 3.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.144 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.494 ' H ' HD12 ' A' ' 136' ' ' LEU . . . -92.55 142.46 27.37 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.978 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -56.0 -37.66 69.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.896 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -97.55 114.02 25.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.797 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -48.5 -27.42 2.69 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.539 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -73.67 -42.12 61.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.357 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.19 -30.21 68.36 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.117 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.667 HD13 ' HB3' ' A' ' 112' ' ' PHE . 9.8 tt -68.44 -45.89 71.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.418 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 19.7 mm100 -68.05 -42.7 80.1 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.309 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -66.87 -30.44 70.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.325 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' TRP . . . . . 0.697 ' CZ2' HD23 ' A' ' 7' ' ' LEU . 1.0 OUTLIER -66.38 -46.74 75.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.512 179.563 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.677 HG13 HG21 ' A' ' 100' ' ' ILE . 40.6 t -61.45 -44.62 98.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.941 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 7.2 ttmm -63.46 -35.9 81.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.936 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.623 ' O ' HG22 ' A' ' 146' ' ' VAL . 0.0 OUTLIER -66.7 -52.0 49.69 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.476 179.792 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.578 HG21 HD11 ' A' ' 100' ' ' ILE . 74.0 mt -53.64 -34.92 25.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.28 0.562 . . . . 0.0 109.646 178.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 3.1 mtt180 -78.4 -28.39 46.91 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.584 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -74.91 -39.56 61.37 Favored 'General case' 0 CA--C 1.523 -0.088 0 CA-C-O 120.898 0.38 . . . . 0.0 110.78 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.946 HG23 HG21 ' A' ' 95' ' ' VAL . 8.9 m -78.74 -26.71 13.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.258 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -77.43 -35.01 54.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.819 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -78.53 -9.58 59.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.136 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.52 HG22 ' HA ' ' A' ' 146' ' ' VAL . 15.2 t -113.5 -30.14 6.95 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.777 0.323 . . . . 0.0 111.144 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.251 -0.88 . . . . 0.0 111.088 -179.989 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.4 p . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.749 0.309 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.891 HD11 ' HB3' ' A' ' 26' ' ' SER . 33.9 mt -74.93 -30.9 24.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.145 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.9 mttp -147.51 116.79 6.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.964 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.731 ' HB3' HG13 ' A' ' 23' ' ' VAL . 4.2 p-10 -135.37 124.81 24.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.896 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -163.31 -156.07 8.46 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.498 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 26.5 mm -105.53 99.61 8.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.814 0.34 . . . . 0.0 111.184 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.941 HD12 HG12 ' A' ' 128' ' ' VAL . 3.2 mm? -102.92 139.88 37.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.834 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -80.68 140.83 35.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.035 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.495 HD12 HG22 ' A' ' 128' ' ' VAL . 5.9 tt -152.49 102.57 2.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.797 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.409 ' HB3' ' CD2' ' A' ' 17' ' ' TRP . 0.6 OUTLIER -70.67 153.26 43.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.878 -179.806 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -113.25 150.71 43.46 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.913 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.07 -17.98 24.34 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.619 2.213 . . . . 0.0 112.549 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -72.4 -48.41 47.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.168 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -100.73 -19.39 16.05 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.936 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 59.9 42.51 16.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.973 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -146.4 146.62 30.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.874 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.429 ' CE2' ' HG3' ' A' ' 110' ' ' ARG . 58.7 m95 -72.72 150.5 42.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.873 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -144.33 139.91 16.22 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.851 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -73.83 87.94 1.1 Allowed 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.583 2.189 . . . . 0.0 112.41 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -104.27 162.64 13.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.874 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -93.3 137.64 32.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.845 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.501 ' CZ ' ' CE1' ' A' ' 31' ' ' TYR . 44.0 m-85 -138.66 156.56 47.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.938 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.731 HG13 ' HB3' ' A' ' 4' ' ' ASN . 25.3 t -141.17 150.28 20.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.874 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.453 HD12 HG12 ' A' ' 29' ' ' ILE . 21.0 tp -133.02 118.37 18.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.237 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 15.0 p -109.76 149.12 30.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.695 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.891 ' HB3' HD11 ' A' ' 2' ' ' ILE . 0.2 OUTLIER -56.79 -18.72 13.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.863 -179.671 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.2 m -99.09 -24.7 14.8 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 111.624 0.231 . . . . 0.0 111.624 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.546 ' HA ' HG23 ' A' ' 95' ' ' VAL . 0.0 OUTLIER -175.01 -173.92 0.73 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.727 0.298 . . . . 0.0 110.799 -179.647 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.699 ' O ' HG23 ' A' ' 92' ' ' VAL . 7.7 mt -110.83 162.28 8.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.705 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.454 ' N ' HG22 ' A' ' 29' ' ' ILE . 0.7 OUTLIER -133.59 138.25 45.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.075 -179.895 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.501 ' CE1' ' CZ ' ' A' ' 22' ' ' PHE . 10.9 t80 -121.25 139.15 53.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.87 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.943 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.226 0 N-CA-C 112.406 -0.278 . . . . 0.0 112.406 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.699 HG23 ' O ' ' A' ' 29' ' ' ILE . 11.8 p -169.49 131.04 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.77 0.319 . . . . 0.0 111.297 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.663 ' HB3' HD12 ' A' ' 29' ' ' ILE . 2.9 tp -113.88 -173.74 2.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.542 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -123.71 140.01 53.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.94 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.844 HG11 ' HB ' ' A' ' 146' ' ' VAL . 22.7 t -86.05 -45.89 0.59 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.982 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' A' ' 95' ' ' VAL . 88.0 Cg_endo -80.36 54.7 5.34 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.258 1.972 . . . . 0.0 112.525 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.433 ' HB2' ' O ' ' A' ' 96' ' ' PRO . . . 176.03 39.57 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.797 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 8.4 m -141.05 -178.88 5.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.979 0.419 . . . . 0.0 111.198 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -160.38 105.5 1.48 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.525 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 1.004 HD13 HG23 ' A' ' 116' ' ' ILE . 14.7 mm -74.47 160.59 5.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.224 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.47 ' N ' HG22 ' A' ' 100' ' ' ILE . . . -160.6 92.78 0.98 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.866 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 15.0 mt -57.07 136.4 20.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.017 0.437 . . . . 0.0 111.31 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.87 123.86 26.74 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.197 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -82.71 19.2 1.34 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.465 2.11 . . . . 0.0 112.926 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -169.0 70.95 0.08 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.797 0.332 . . . . 0.0 110.674 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -56.59 -95.13 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.682 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -168.33 165.85 12.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.851 0.357 . . . . 0.0 110.992 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 63.63 -80.4 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.114 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -158.29 31.23 0.24 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.911 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.429 ' HG3' ' CE2' ' A' ' 17' ' ' TRP . 11.7 mmt180 -119.62 85.67 2.42 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.853 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -69.19 -32.22 71.37 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.084 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -97.73 87.71 4.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.017 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.725 HG13 ' HB2' ' A' ' 129' ' ' ALA . 21.4 t -139.94 144.66 27.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.939 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.43 ' CE2' ' HB ' ' A' ' 128' ' ' VAL . 48.9 p90 -118.22 125.51 50.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.895 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.2 t -98.62 133.03 43.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.985 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 1.004 HG23 HD13 ' A' ' 100' ' ' ILE . 14.6 mt -101.67 159.69 4.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.828 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.452 ' N ' HG22 ' A' ' 116' ' ' ILE . 19.7 t -151.97 -179.67 7.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.81 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 10.2 mtt -135.38 135.44 22.44 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.833 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -59.4 -66.01 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.479 2.119 . . . . 0.0 112.697 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.65 104.65 11.91 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.327 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.541 ' O ' ' HB2' ' A' ' 122' ' ' ALA . 2.0 p -178.81 -47.99 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.787 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.541 ' HB2' ' O ' ' A' ' 121' ' ' VAL . . . 169.26 -167.41 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.769 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 9.7 mm100 -98.16 36.31 1.6 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.807 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' TRP . . . . . 0.424 ' CD1' ' HB3' ' A' ' 122' ' ' ALA . 22.9 m95 -63.94 -177.7 0.27 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.983 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 89.3 p -178.16 103.02 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.758 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.47 HD22 HD22 ' A' ' 93' ' ' LEU . 10.0 tp -92.53 104.7 16.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.143 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -85.97 131.85 34.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.822 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.941 HG12 HD12 ' A' ' 7' ' ' LEU . 22.0 t -152.5 147.53 14.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.06 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.725 ' HB2' HG13 ' A' ' 113' ' ' VAL . . . -148.27 143.92 27.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.261 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -104.83 135.77 45.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.031 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -54.29 -34.61 61.28 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.995 0.426 . . . . 0.0 110.898 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 5.9 t -95.94 114.89 26.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.669 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -48.96 -26.16 2.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.725 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -75.63 -42.9 50.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.591 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -67.86 -32.0 72.21 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.239 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.577 ' O ' HG23 ' A' ' 140' ' ' VAL . 7.4 tt -68.99 -46.93 66.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.516 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -68.86 -41.08 78.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.39 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.55 -28.93 68.2 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.357 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' TRP . . . . . 0.474 ' CZ2' HD23 ' A' ' 7' ' ' LEU . 1.1 m95 -69.05 -47.51 65.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.608 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.684 HG13 HG21 ' A' ' 100' ' ' ILE . 33.2 t -61.53 -40.39 86.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.904 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.94 -38.26 90.36 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.841 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.92 -52.13 52.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.366 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.992 HG21 HD11 ' A' ' 100' ' ' ILE . 73.9 mt -53.85 -34.37 25.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.23 0.538 . . . . 0.0 109.644 178.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -81.23 -27.91 35.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.482 179.127 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.607 ' O ' HG22 ' A' ' 149' ' ' THR . 1.5 tm-20 -70.93 -39.95 72.36 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-O 120.906 0.384 . . . . 0.0 110.413 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.844 ' HB ' HG11 ' A' ' 95' ' ' VAL . 61.8 t -78.48 -33.55 17.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.859 179.187 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.34 -34.33 65.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.479 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.88 -11.72 60.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.858 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.607 HG22 ' O ' ' A' ' 145' ' ' GLU . 10.6 t -120.98 17.07 11.72 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.083 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.282 -0.866 . . . . 0.0 111.082 -179.982 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 25.7 m . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.808 0.337 . . . . 0.0 111.271 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.577 HG22 ' HE2' ' A' ' 142' ' ' LYS . 30.2 mt -85.59 -33.01 7.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.064 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.445 ' HE3' ' CD1' ' A' ' 139' ' ' TRP . 21.2 tttp -158.63 116.41 2.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.007 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.841 ' HB3' HG13 ' A' ' 23' ' ' VAL . 8.2 p30 -131.72 127.73 37.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.966 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -166.29 -155.54 8.91 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.549 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.643 ' N ' HD12 ' A' ' 6' ' ' ILE . 3.4 mp -115.42 100.96 11.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.815 0.341 . . . . 0.0 111.114 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.658 HD12 HG12 ' A' ' 128' ' ' VAL . 3.5 mm? -96.18 140.2 31.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.77 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -76.93 145.35 38.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.127 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.495 HD11 ' OH ' ' A' ' 31' ' ' TYR . 0.2 OUTLIER -158.06 122.23 4.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.69 179.891 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.453 ' HB2' ' CE3' ' A' ' 17' ' ' TRP . 0.7 OUTLIER -74.18 120.9 20.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.11 -179.8 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.47 138.47 59.21 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.028 179.34 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -67.98 -12.0 33.84 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.192 1.928 . . . . 0.0 112.564 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.4 t -77.76 -36.31 22.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.886 0.374 . . . . 0.0 110.919 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -111.92 -24.39 9.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.044 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 2.4 m170 66.63 34.53 5.8 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.901 0.381 . . . . 0.0 110.654 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.411 ' N ' ' HG3' ' A' ' 10' ' ' GLU . 48.8 mt-10 -138.15 144.54 40.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.859 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.453 ' CE3' ' HB2' ' A' ' 10' ' ' GLU . 49.7 m95 -52.87 146.27 11.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.128 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -150.04 130.65 7.02 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.883 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.94 97.14 1.09 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.436 2.091 . . . . 0.0 112.364 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 15.5 m80 -115.96 149.21 39.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.856 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -65.35 164.44 13.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.946 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.498 ' CD2' ' CD1' ' A' ' 31' ' ' TYR . 0.2 OUTLIER -177.28 119.99 0.11 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.672 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.841 HG13 ' HB3' ' A' ' 4' ' ' ASN . 16.4 t -104.76 142.16 18.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.101 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.649 HD12 HG12 ' A' ' 29' ' ' ILE . 23.1 tp -118.83 103.08 9.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.902 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -101.8 152.2 21.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.865 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.513 ' CB ' HD11 ' A' ' 2' ' ' ILE . 0.4 OUTLIER -59.18 -16.69 21.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.643 -179.768 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.0 p -99.54 -23.34 15.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.575 0.226 . . . . 0.0 111.513 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.602 ' HA ' HG23 ' A' ' 95' ' ' VAL . 0.1 OUTLIER 178.41 -174.72 0.17 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.897 0.379 . . . . 0.0 110.953 -179.722 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.649 HG12 HD12 ' A' ' 24' ' ' LEU . 6.0 mt -119.62 123.9 71.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.812 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.625 ' HD1' HG22 ' A' ' 92' ' ' VAL . 40.7 m-85 -95.42 160.41 14.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.942 0.401 . . . . 0.0 111.01 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.498 ' CD1' ' CD2' ' A' ' 22' ' ' PHE . 45.8 t80 -151.88 123.35 7.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.765 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.1 t . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.863 -179.993 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.565 -0.214 . . . . 0.0 112.565 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.625 HG22 ' HD1' ' A' ' 30' ' ' TYR . 21.5 t -127.72 136.0 61.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.755 0.312 . . . . 0.0 111.107 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.637 HD21 ' CE ' ' A' ' 118' ' ' MET . 0.7 OUTLIER -130.86 120.88 24.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.02 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -57.98 148.58 25.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.928 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.826 HG11 ' HB ' ' A' ' 146' ' ' VAL . 17.3 t -78.68 -47.94 1.79 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.823 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' A' ' 95' ' ' VAL . 71.6 Cg_endo -77.49 58.28 6.27 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.225 1.95 . . . . 0.0 112.505 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -179.63 38.68 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.901 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' CYS . . . . . 0.436 ' SG ' HD22 ' A' ' 93' ' ' LEU . 67.4 m -139.13 178.13 7.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.011 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.4 tm0? -158.71 102.49 1.69 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.72 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.966 HD13 HG23 ' A' ' 116' ' ' ILE . 8.3 mm -76.57 160.75 4.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.326 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.435 ' N ' HG22 ' A' ' 100' ' ' ILE . . . -153.0 89.47 1.38 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.803 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 73.9 mt -62.47 145.73 13.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.101 0.477 . . . . 0.0 111.553 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.402 ' HB2' ' CG1' ' A' ' 113' ' ' VAL . 0.2 OUTLIER -134.81 125.85 17.57 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.879 179.305 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -82.55 25.55 0.67 Allowed 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.431 2.087 . . . . 0.0 113.22 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -178.23 74.34 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.722 0.296 . . . . 0.0 111.013 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -59.13 -96.67 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.578 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.67 173.74 1.59 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.795 0.331 . . . . 0.0 110.938 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 68.36 -68.39 0.17 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.12 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -175.46 36.67 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.903 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -129.98 88.44 2.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.796 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 86.2 mt -59.31 -37.58 78.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.825 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -99.12 119.34 37.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.844 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 1.014 HG23 ' HB2' ' A' ' 129' ' ' ALA . 9.4 p -155.05 162.18 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.134 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.432 ' CZ ' ' HB ' ' A' ' 128' ' ' VAL . 10.2 p90 -148.66 114.29 5.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.922 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 12.4 m -92.64 140.01 29.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.939 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.966 HG23 HD13 ' A' ' 100' ' ' ILE . 13.0 mt -104.95 157.48 5.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.977 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.412 ' N ' HG22 ' A' ' 116' ' ' ILE . 5.5 t -162.01 138.31 7.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.781 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' MET . . . . . 0.637 ' CE ' HD21 ' A' ' 93' ' ' LEU . 29.0 mtp -102.39 96.92 7.85 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.062 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.26 59.06 4.51 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.491 2.127 . . . . 0.0 112.368 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 92.2 p -177.85 37.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.809 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.671 HG13 ' H ' ' A' ' 122' ' ' ALA . 0.4 OUTLIER -161.15 -82.33 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.727 -179.854 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.671 ' H ' HG13 ' A' ' 121' ' ' VAL . . . -140.59 -168.89 2.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.921 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -93.55 47.45 1.24 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.77 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' TRP . . . . . 0.458 ' CD1' ' HB3' ' A' ' 122' ' ' ALA . 29.5 m95 -85.28 148.56 26.0 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.853 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 92.1 p -144.34 103.67 4.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.79 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.503 HD23 ' CG2' ' A' ' 128' ' ' VAL . 0.3 OUTLIER -89.59 100.55 13.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.059 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -77.37 124.03 27.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.856 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.658 HG12 HD12 ' A' ' 7' ' ' LEU . 15.7 t -137.1 152.74 28.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.1 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 1.014 ' HB2' HG23 ' A' ' 113' ' ' VAL . . . -157.31 127.11 6.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.234 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.579 ' HB2' HD11 ' A' ' 7' ' ' LEU . . . -93.12 137.35 32.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.924 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -52.5 -35.78 53.76 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.964 0.412 . . . . 0.0 111.106 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.8 t -96.95 115.41 27.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.742 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.22 -27.46 2.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.566 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.42 -45.44 38.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.44 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -63.92 -32.29 73.77 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.197 179.283 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.454 ' C ' HD23 ' A' ' 136' ' ' LEU . 7.6 tt -67.45 -51.85 46.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.557 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -67.6 -35.52 79.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.375 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -70.8 -30.66 67.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.419 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' TRP . . . . . 0.445 ' CD1' ' HE3' ' A' ' 3' ' ' LYS . 0.8 OUTLIER -68.72 -45.58 71.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.67 179.749 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.547 HG22 HG21 ' A' ' 100' ' ' ILE . 44.6 t -63.49 -42.19 95.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.886 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 11.6 mttm -63.87 -35.62 81.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.809 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.577 ' HE2' HG22 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -67.04 -50.41 62.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.603 179.669 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 68.6 mt -54.44 -35.57 31.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.328 0.585 . . . . 0.0 109.5 178.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 47.3 mtp180 -78.01 -28.68 49.21 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.447 179.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.418 ' O ' HG22 ' A' ' 149' ' ' THR . 12.2 tt0 -76.03 -32.67 59.46 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.864 0.364 . . . . 0.0 110.53 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.826 ' HB ' HG11 ' A' ' 95' ' ' VAL . 90.2 t -80.0 -31.47 13.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.294 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.1 -35.21 66.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.828 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -75.32 -11.08 59.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.144 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.462 HG22 ' HA ' ' A' ' 146' ' ' VAL . 8.9 t -114.27 -34.69 5.23 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.774 0.321 . . . . 0.0 111.097 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.225 -0.893 . . . . 0.0 111.155 -179.928 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.859 0.361 . . . . 0.0 111.12 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.745 HD11 ' HA ' ' A' ' 26' ' ' SER . 29.6 mt -76.48 -34.2 24.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.047 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.56 169.31 24.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.911 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.44 ' HB3' HG13 ' A' ' 23' ' ' VAL . 5.6 p-10 -166.58 125.4 1.46 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.81 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -159.65 -170.59 24.41 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.583 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 28.4 mm -94.81 92.44 3.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.791 0.329 . . . . 0.0 111.142 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.58 HD12 HG12 ' A' ' 128' ' ' VAL . 4.3 mm? -96.58 129.58 43.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.847 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -79.9 146.32 32.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.917 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -147.59 133.69 19.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.766 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.466 ' CG ' ' CD2' ' A' ' 17' ' ' TRP . 3.2 mt-10 -80.36 118.05 21.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.134 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.72 134.32 50.76 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.352 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -68.8 -10.52 29.34 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.306 2.004 . . . . 0.0 112.654 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.2 t -66.56 -39.22 83.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.924 0.392 . . . . 0.0 110.937 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -138.02 9.34 2.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.463 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 49.79 49.46 20.11 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.92 0.391 . . . . 0.0 111.136 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.55 149.62 49.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.876 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.466 ' CD2' ' CG ' ' A' ' 10' ' ' GLU . 43.2 m95 -72.97 143.57 47.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.911 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -129.92 119.04 18.79 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.79 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -68.82 82.65 0.56 Allowed 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.398 2.065 . . . . 0.0 112.353 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 4.4 m80 -114.23 168.36 9.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.882 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -73.85 172.05 12.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.901 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -167.03 141.42 3.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.877 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.44 HG13 ' HB3' ' A' ' 4' ' ' ASN . 38.8 t -134.68 153.39 34.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.868 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.686 HD12 HG12 ' A' ' 29' ' ' ILE . 5.8 tp -133.41 109.49 9.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.117 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 16.9 p -95.46 157.8 15.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.581 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.745 ' HA ' HD11 ' A' ' 2' ' ' ILE . 3.4 m -63.73 -13.86 47.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.915 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.0 m -111.43 -7.14 14.38 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 173.55 -174.84 0.06 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.925 0.393 . . . . 0.0 111.29 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.686 HG12 HD12 ' A' ' 24' ' ' LEU . 5.8 mt -113.59 136.78 48.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.399 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.411 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 39.4 m-85 -113.92 138.36 50.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.861 0.362 . . . . 0.0 111.066 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 54.1 p90 -157.55 158.47 35.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.879 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.893 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.375 0 N-CA-C 112.506 -0.237 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 11.8 p -132.85 137.76 53.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.757 0.313 . . . . 0.0 111.085 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -139.63 129.16 24.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.14 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -60.38 119.7 8.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.82 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.698 HG12 ' HD3' ' A' ' 96' ' ' PRO . 8.7 p -83.13 -34.18 0.6 Allowed Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.698 ' HD3' HG12 ' A' ' 95' ' ' VAL . 3.1 Cg_exo -75.24 54.48 3.77 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.262 1.975 . . . . 0.0 112.597 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.558 ' HB2' ' O ' ' A' ' 96' ' ' PRO . . . 168.78 42.56 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.018 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 1.7 m -125.3 162.94 23.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.943 0.401 . . . . 0.0 111.215 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.04 101.18 3.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.542 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.867 HD13 HG23 ' A' ' 116' ' ' ILE . 14.2 mm -71.03 160.12 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.403 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.468 ' N ' HG22 ' A' ' 100' ' ' ILE . . . -156.08 90.25 1.19 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.898 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.3 mt -56.43 149.28 3.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.33 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 15.6 mtp180 -142.97 113.75 5.83 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.554 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -67.5 0.33 4.22 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.549 2.166 . . . . 0.0 113.034 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -141.27 59.15 1.52 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.988 0.423 . . . . 0.0 110.536 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -43.06 -85.49 0.01 OUTLIER Glycine 0 C--N 1.331 0.251 0 CA-C-N 115.769 -0.65 . . . . 0.0 113.249 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 23.9 ttmt -176.69 160.47 1.95 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.947 0.403 . . . . 0.0 111.358 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 60.53 -84.3 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.128 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -146.41 31.2 1.0 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.951 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.428 ' HG3' ' CE2' ' A' ' 17' ' ' TRP . 13.9 mmt180 -114.57 100.36 8.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.777 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.2 mt -85.08 5.41 29.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.469 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -139.98 78.6 1.67 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.822 0.344 . . . . 0.0 110.972 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.49 HG13 ' HB2' ' A' ' 129' ' ' ALA . 36.2 t -129.13 135.61 61.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.933 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.428 ' CZ ' ' HB ' ' A' ' 128' ' ' VAL . 42.0 p90 -114.48 122.57 47.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.017 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 10.9 t -97.7 136.06 38.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.885 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.867 HG23 HD13 ' A' ' 100' ' ' ILE . 10.9 mt -96.31 157.94 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.974 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.416 ' N ' HG22 ' A' ' 116' ' ' ILE . 1.5 m -150.04 166.85 28.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.951 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 13.7 mtp -139.53 100.43 7.56 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.903 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -79.94 54.69 5.32 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.568 2.179 . . . . 0.0 112.627 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 178.94 49.49 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.98 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.647 HG22 ' N ' ' A' ' 122' ' ' ALA . 0.3 OUTLIER -161.85 -82.11 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.92 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.647 ' N ' HG22 ' A' ' 121' ' ' VAL . . . -157.08 -165.47 1.84 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.184 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -84.64 56.93 4.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.945 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 39.9 m95 -104.21 148.87 25.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.926 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 14.1 m -153.3 123.66 7.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.808 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.657 HD23 HD12 ' A' ' 116' ' ' ILE . 14.4 tp -102.83 155.85 18.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.99 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -131.95 134.41 45.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.836 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.58 HG12 HD12 ' A' ' 7' ' ' LEU . 23.7 t -152.38 159.15 3.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.092 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.49 ' HB2' HG13 ' A' ' 113' ' ' VAL . . . -158.57 117.65 3.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.161 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.581 ' HB3' ' HB2' ' A' ' 136' ' ' LEU . . . -81.37 134.98 35.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.842 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -54.47 -34.39 61.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.885 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.94 113.4 24.94 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.744 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -48.04 -27.94 2.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.475 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 -76.65 -44.29 34.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.292 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -65.66 -31.88 73.14 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.011 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.581 ' HB2' ' HB3' ' A' ' 130' ' ' ALA . 7.2 tt -67.77 -50.78 55.25 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.314 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -66.39 -37.17 84.64 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.262 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -70.43 -31.5 68.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.403 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' TRP . . . . . 0.444 ' CE2' HD21 ' A' ' 7' ' ' LEU . 0.7 OUTLIER -67.65 -43.03 81.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.58 179.821 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.686 HG13 ' CB ' ' A' ' 100' ' ' ILE . 26.7 t -65.22 -44.2 95.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.848 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 7.3 ttmm -63.84 -33.77 76.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.884 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.671 ' HD2' HG22 ' A' ' 2' ' ' ILE . 17.0 mmtt -67.93 -49.46 61.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.525 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.753 HD13 HD11 ' A' ' 100' ' ' ILE . 30.7 mt -54.35 -38.15 39.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.352 0.596 . . . . 0.0 109.517 178.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 66.2 mtt180 -77.95 -27.69 49.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.479 179.105 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.651 ' O ' HG22 ' A' ' 149' ' ' THR . 2.1 tp10 -75.16 -33.23 61.47 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.861 0.362 . . . . 0.0 110.705 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.645 HG11 HG21 ' A' ' 95' ' ' VAL . 9.9 p -79.63 -34.3 15.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.065 0.459 . . . . 0.0 110.19 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -71.48 -34.43 70.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.563 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -75.1 -10.7 59.71 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.931 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.651 HG22 ' O ' ' A' ' 145' ' ' GLU . 10.9 t -126.26 21.34 7.34 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.103 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.166 -0.921 . . . . 0.0 111.19 179.985 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 8.0 t . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 120.885 0.374 . . . . 0.0 111.159 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.424 HD11 ' HA ' ' A' ' 26' ' ' SER . 39.4 mt -79.79 -34.48 15.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.121 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.7 tttp -140.1 153.82 46.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.01 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -160.97 124.39 3.34 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.924 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -160.4 -178.0 34.01 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.542 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.637 ' N ' HD12 ' A' ' 6' ' ' ILE . 3.2 mp -89.52 92.01 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.909 0.385 . . . . 0.0 110.985 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 1.078 HD12 HG12 ' A' ' 128' ' ' VAL . 3.2 mm? -95.6 135.38 37.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.732 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -76.76 158.36 30.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.95 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.437 HD12 ' O ' ' A' ' 127' ' ' ASP . 1.4 tp -161.78 128.19 3.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.808 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.436 ' HG3' ' CE3' ' A' ' 17' ' ' TRP . 3.4 mt-10 -71.11 111.57 6.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.99 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.92 127.54 66.77 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.53 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -56.69 -16.81 20.56 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.504 2.136 . . . . 0.0 112.899 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 37.8 t -69.36 -41.67 80.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.858 0.361 . . . . 0.0 111.352 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -117.75 -10.18 10.57 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.649 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 62.86 30.84 16.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.789 0.328 . . . . 0.0 110.815 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.64 160.4 39.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.801 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.463 ' NE1' ' HG3' ' A' ' 110' ' ' ARG . 45.0 m95 -56.7 138.04 53.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.051 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -126.07 125.31 24.73 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.686 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.64 112.06 2.95 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.439 2.092 . . . . 0.0 112.228 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 22.0 m80 -148.64 141.79 24.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.871 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -59.38 154.6 16.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.719 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.427 ' CE2' ' CD1' ' A' ' 31' ' ' TYR . 0.1 OUTLIER -147.35 138.86 23.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.976 -179.827 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.8 t -131.41 150.8 34.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.113 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 25.7 tp -134.37 118.99 18.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.952 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.431 ' HG1' ' C ' ' A' ' 28' ' ' LYS . 62.6 p -97.95 157.58 16.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.983 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.424 ' HA ' HD11 ' A' ' 2' ' ' ILE . 29.4 t -48.97 -38.08 22.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.85 -0.613 . . . . 0.0 112.057 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.3 m -129.59 39.06 3.78 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.555 ' N ' HG23 ' A' ' 95' ' ' VAL . 2.6 tttt 175.01 170.03 0.28 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.007 0.432 . . . . 0.0 111.378 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.667 HD12 ' HB3' ' A' ' 93' ' ' LEU . 3.5 mt -128.87 153.23 38.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.716 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.404 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 0.6 OUTLIER -129.93 146.28 51.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.904 0.383 . . . . 0.0 111.112 -179.889 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.427 ' CD1' ' CE2' ' A' ' 22' ' ' PHE . 39.7 t80 -146.35 143.48 29.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.84 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.963 -179.926 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 29' ' ' ILE . 11.3 p -151.43 136.33 10.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.877 0.37 . . . . 0.0 111.033 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.667 ' HB3' HD12 ' A' ' 29' ' ' ILE . 0.3 OUTLIER -123.92 -176.44 3.48 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.891 -179.966 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -119.59 141.36 49.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.91 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.724 ' CG1' HG23 ' A' ' 146' ' ' VAL . 21.8 t -80.87 -46.87 1.19 Allowed Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.778 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 95' ' ' VAL . 84.6 Cg_endo -81.83 50.31 3.44 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.367 2.045 . . . . 0.0 112.497 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -179.55 37.85 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.959 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 14.4 p -134.34 -177.45 4.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.963 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.4 100.79 0.83 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.697 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 1.089 HD13 HG23 ' A' ' 116' ' ' ILE . 16.9 mm -76.82 160.58 4.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.02 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.468 ' N ' HG22 ' A' ' 100' ' ' ILE . . . -159.02 91.75 1.05 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.901 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.63 HG12 HG21 ' A' ' 140' ' ' VAL . 27.7 mt -58.07 157.47 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.242 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.498 ' N ' HG22 ' A' ' 102' ' ' ILE . 95.3 mtt180 -151.41 112.32 3.01 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.366 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.09 49.25 2.75 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.429 2.086 . . . . 0.0 112.523 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 167.35 61.98 0.0 OUTLIER 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.001 0.429 . . . . 0.0 110.223 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -55.04 -94.97 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.676 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.406 ' HD2' ' CZ2' ' A' ' 17' ' ' TRP . 0.0 OUTLIER 174.1 163.18 0.19 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.823 0.344 . . . . 0.0 111.014 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 57.07 54.6 6.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.975 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 9.0 m120 62.76 51.98 2.89 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.215 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.463 ' HG3' ' NE1' ' A' ' 17' ' ' TRP . 23.9 mmt180 -147.53 97.38 2.83 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.718 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.01 -32.47 57.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.978 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.614 ' HB3' HD13 ' A' ' 136' ' ' LEU . 6.5 m-85 -102.87 104.21 14.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.939 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.533 HG13 ' HB2' ' A' ' 129' ' ' ALA . 20.4 t -152.0 134.04 5.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.16 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -118.96 131.3 56.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.744 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 15.0 t -100.18 132.86 45.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.965 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 1.089 HG23 HD13 ' A' ' 100' ' ' ILE . 2.4 mp -104.29 159.82 5.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.942 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.477 ' N ' HG22 ' A' ' 116' ' ' ILE . 70.5 p -155.74 179.99 8.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.905 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' MET . . . . . 0.696 ' HE3' HG11 ' A' ' 121' ' ' VAL . 7.3 mtm -143.33 93.26 6.47 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.782 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.93 -2.29 12.51 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.584 2.189 . . . . 0.0 112.794 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 48.6 m -108.9 33.88 4.0 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.718 0.294 . . . . 0.0 111.142 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.696 HG11 ' HE3' ' A' ' 118' ' ' MET . 0.4 OUTLIER -160.31 -82.45 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.94 179.907 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.653 ' H ' HG13 ' A' ' 121' ' ' VAL . . . -143.98 -166.06 2.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.838 0.351 . . . . 0.0 111.049 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -86.21 55.32 3.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.971 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' TRP . . . . . 0.499 ' CD1' ' HB3' ' A' ' 122' ' ' ALA . 89.4 m95 -85.93 142.24 28.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.786 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.16 119.94 5.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.006 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.608 HD23 ' N ' ' A' ' 126' ' ' LEU . 1.2 pt? -129.28 124.7 35.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.88 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.437 ' O ' HD12 ' A' ' 9' ' ' LEU . 1.1 m-20 -86.9 142.89 27.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.949 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 1.078 HG12 HD12 ' A' ' 7' ' ' LEU . 14.0 t -151.32 141.9 15.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.081 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.533 ' HB2' HG13 ' A' ' 113' ' ' VAL . . . -140.93 131.49 25.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.129 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.602 ' HB3' ' HB2' ' A' ' 136' ' ' LEU . . . -93.22 138.58 31.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.92 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -55.5 -39.62 70.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.0 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.73 113.13 25.31 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.905 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -48.05 -28.41 2.81 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.547 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -76.8 -44.29 33.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.328 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -65.65 -32.29 73.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.996 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.614 HD13 ' HB3' ' A' ' 112' ' ' PHE . 6.2 tt -67.38 -51.22 54.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.394 179.408 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 73.4 mm-40 -67.68 -35.25 78.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.192 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -71.5 -30.18 65.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.205 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' TRP . . . . . 0.406 ' CH2' ' HB3' ' A' ' 22' ' ' PHE . 0.5 OUTLIER -67.41 -47.07 71.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.348 179.54 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.729 HG13 HG21 ' A' ' 100' ' ' ILE . 23.3 t -61.76 -45.52 98.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.797 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 1.1 ttpt -62.97 -36.94 85.18 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.742 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.601 ' O ' HG22 ' A' ' 146' ' ' VAL . 17.9 tppt? -65.66 -56.26 13.08 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.294 179.543 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.653 HG21 HD11 ' A' ' 100' ' ' ILE . 71.0 mt -50.97 -31.76 10.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.107 0.48 . . . . 0.0 109.706 178.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.439 ' HD2' HG12 ' A' ' 140' ' ' VAL . 30.5 mtt180 -78.69 -30.15 45.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.493 179.316 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.827 ' O ' HG23 ' A' ' 149' ' ' THR . 5.2 tt0 -77.23 -35.94 55.04 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-O 120.761 0.315 . . . . 0.0 110.777 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.724 HG23 ' CG1' ' A' ' 95' ' ' VAL . 5.6 m -79.44 -28.45 13.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.306 179.227 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.479 ' HA ' HG12 ' A' ' 95' ' ' VAL . . . -74.37 -36.97 63.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.684 179.369 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -72.34 -13.07 61.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.042 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.827 HG23 ' O ' ' A' ' 145' ' ' GLU . 11.5 p -106.53 -38.96 6.01 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.107 0.479 . . . . 0.0 110.48 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.271 -0.871 . . . . 0.0 111.291 -179.924 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 24.1 m . . . . . 0 N--CA 1.487 1.409 0 CA-C-O 120.776 0.322 . . . . 0.0 111.179 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.512 HD11 ' CB ' ' A' ' 26' ' ' SER . 19.9 mt -88.5 -34.09 6.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.933 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.42 ' HG2' ' NE1' ' A' ' 139' ' ' TRP . 0.0 OUTLIER -136.56 142.1 43.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.768 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -154.58 121.27 5.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.968 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -170.04 -176.32 39.59 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.421 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.539 ' N ' HD12 ' A' ' 6' ' ' ILE . 4.2 mp -103.26 89.17 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.866 0.365 . . . . 0.0 111.026 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.534 HD11 ' HB2' ' A' ' 130' ' ' ALA . 3.4 mm? -82.06 142.46 32.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.651 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -77.74 144.67 37.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.29 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.465 HD21 HG22 ' A' ' 128' ' ' VAL . 2.6 mp -152.89 115.55 4.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.611 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.411 ' HB3' ' CE3' ' A' ' 17' ' ' TRP . 2.0 pp20? -72.6 140.73 48.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.257 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.42 148.33 36.98 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.531 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.39 -5.46 17.17 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.434 2.089 . . . . 0.0 112.705 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 25.2 t -65.75 -40.83 88.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.984 0.421 . . . . 0.0 110.724 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -139.12 9.34 2.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.407 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 49.03 59.07 4.71 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.878 0.371 . . . . 0.0 111.266 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -149.1 139.33 22.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.808 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.411 ' CE3' ' HB3' ' A' ' 10' ' ' GLU . 75.5 m95 -57.72 143.03 43.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.895 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -135.73 137.17 24.97 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.84 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.75 90.51 1.22 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.491 2.127 . . . . 0.0 112.399 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 12.7 m170 -112.3 138.72 48.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.008 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -60.19 159.5 9.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.782 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.483 ' CD2' ' CD1' ' A' ' 31' ' ' TYR . 0.1 OUTLIER -170.95 128.69 0.75 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.789 179.901 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 19.1 t -122.22 153.66 26.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.09 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.9 tp -128.58 118.99 23.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.986 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.8 p -99.54 154.43 18.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.846 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.512 ' CB ' HD11 ' A' ' 2' ' ' ILE . 1.4 m -54.43 -25.53 25.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.832 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.8 p -136.24 35.56 2.77 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.4 mttt 170.9 177.13 0.06 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.973 0.415 . . . . 0.0 111.12 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.8 mt -140.16 131.71 31.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.707 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -110.35 144.32 39.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.938 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.483 ' CD1' ' CD2' ' A' ' 22' ' ' PHE . 35.1 t80 -139.5 130.21 25.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.871 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.777 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.413 ' HA3' ' HB3' ' A' ' 31' ' ' TYR . . . . . . . . 0 N--CA 1.45 -0.397 0 N-CA-C 112.741 -0.144 . . . . 0.0 112.741 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 10.6 p -158.13 130.84 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.775 0.322 . . . . 0.0 110.903 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.692 HD23 ' H ' ' A' ' 94' ' ' ASP . 0.6 OUTLIER -148.48 150.53 33.59 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.103 -179.788 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.692 ' H ' HD23 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -81.96 128.05 33.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.711 179.802 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.655 HG12 ' HD3' ' A' ' 96' ' ' PRO . 8.3 p -71.44 -32.87 2.4 Favored Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.655 ' HD3' HG12 ' A' ' 95' ' ' VAL . 6.3 Cg_exo -73.9 56.36 3.57 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.202 1.934 . . . . 0.0 112.418 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.534 ' HB2' ' O ' ' A' ' 96' ' ' PRO . . . 170.09 63.48 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.963 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 64.9 m -146.46 168.11 21.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.125 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -154.0 99.47 2.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.606 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.916 HD13 HG23 ' A' ' 116' ' ' ILE . 11.2 mm -76.34 159.18 5.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.235 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.431 ' N ' HG22 ' A' ' 100' ' ' ILE . . . -154.45 88.21 1.21 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.904 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.559 ' CG1' HG21 ' A' ' 140' ' ' VAL . 7.6 mt -58.27 156.32 2.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.158 0.504 . . . . 0.0 111.365 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.483 ' N ' HG22 ' A' ' 102' ' ' ILE . 33.2 mtt180 -145.81 125.56 6.91 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.082 179.529 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -82.98 30.06 0.54 Allowed 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.41 2.073 . . . . 0.0 112.914 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -177.75 69.73 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.88 0.371 . . . . 0.0 110.642 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -55.11 -94.21 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.732 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -174.88 169.68 3.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.861 0.362 . . . . 0.0 110.913 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 61.66 -82.69 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.031 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -153.92 31.71 0.45 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.943 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.4 ' HB3' ' CG2' ' A' ' 113' ' ' VAL . 6.1 mmt85 -117.51 90.2 3.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.834 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.571 ' H ' HD12 ' A' ' 111' ' ' LEU . 2.9 mp -62.91 -30.86 71.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.826 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.768 ' HB3' HD13 ' A' ' 136' ' ' LEU . 75.2 m-85 -109.82 105.24 14.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.035 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.425 HG13 ' HB2' ' A' ' 129' ' ' ALA . 39.4 t -144.76 138.87 22.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.967 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.425 ' CE2' ' HB ' ' A' ' 128' ' ' VAL . 39.9 p90 -122.88 133.47 54.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.928 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.59 129.49 50.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.933 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.916 HG23 HD13 ' A' ' 100' ' ' ILE . 1.7 mt -97.84 159.56 3.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.014 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.471 ' N ' HG22 ' A' ' 116' ' ' ILE . 52.3 p -156.72 175.22 14.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.964 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' MET . . . . . 0.565 ' CE ' HG11 ' A' ' 121' ' ' VAL . 2.2 mtm -137.95 91.56 13.23 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.815 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.45 -2.04 12.19 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.624 2.216 . . . . 0.0 112.816 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.4 m -108.94 31.44 5.68 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.692 0.282 . . . . 0.0 111.261 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.655 HG13 ' H ' ' A' ' 122' ' ' ALA . 0.4 OUTLIER -158.41 -82.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.885 179.864 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.655 ' H ' HG13 ' A' ' 121' ' ' VAL . . . -146.07 -164.93 2.08 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.079 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -85.05 57.18 4.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.827 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' TRP . . . . . 0.639 ' NE1' ' HB3' ' A' ' 122' ' ' ALA . 36.9 m95 -102.47 117.27 34.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.793 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -142.39 138.85 31.43 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.882 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.45 HD11 HD13 ' A' ' 116' ' ' ILE . 0.5 OUTLIER -127.6 170.08 13.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.901 -179.937 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -123.87 129.54 51.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.955 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.48 HG12 ' N ' ' A' ' 129' ' ' ALA . 18.7 t -140.94 159.54 23.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.928 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.48 ' N ' HG12 ' A' ' 128' ' ' VAL . . . -159.94 148.89 17.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.909 0.385 . . . . 0.0 111.221 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.534 ' HB2' HD11 ' A' ' 7' ' ' LEU . . . -112.59 135.5 53.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.938 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.47 -35.35 52.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.954 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.04 112.77 24.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.826 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.435 ' HG2' ' CD1' ' A' ' 112' ' ' PHE . 15.8 mt-30 -48.56 -27.8 3.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.725 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -77.12 -43.87 32.51 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.34 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -65.82 -31.25 72.1 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.137 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.768 HD13 ' HB3' ' A' ' 112' ' ' PHE . 7.7 tt -69.84 -50.44 42.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.474 179.529 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -67.87 -36.61 80.57 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.237 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -71.0 -28.51 64.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.407 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' TRP . . . . . 0.42 ' NE1' ' HG2' ' A' ' 3' ' ' LYS . 0.8 OUTLIER -69.75 -46.32 66.14 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.52 179.667 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.701 HG13 HG21 ' A' ' 100' ' ' ILE . 30.5 t -63.45 -42.29 95.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.741 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.45 -36.79 84.9 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.819 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.45 ' O ' HG22 ' A' ' 146' ' ' VAL . 0.0 OUTLIER -65.77 -56.0 14.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.312 179.521 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.786 HG21 HD11 ' A' ' 100' ' ' ILE . 65.9 mt -51.6 -31.8 13.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.167 0.508 . . . . 0.0 109.844 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 58.2 mtt180 -80.88 -28.63 35.89 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.535 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.626 ' O ' HG22 ' A' ' 149' ' ' THR . 0.6 OUTLIER -72.59 -39.52 67.27 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.839 0.352 . . . . 0.0 110.675 179.671 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.597 ' CG2' HG21 ' A' ' 95' ' ' VAL . 9.0 m -78.48 -32.72 16.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.072 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.42 -34.26 65.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.416 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -73.05 -13.28 61.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.791 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.626 HG22 ' O ' ' A' ' 145' ' ' GLU . 8.9 t -122.96 19.24 10.09 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.152 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.257 -0.878 . . . . 0.0 111.112 179.92 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 61.7 m . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.765 0.317 . . . . 0.0 111.262 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.833 HD11 ' HA ' ' A' ' 26' ' ' SER . 12.3 mt -77.2 -35.55 22.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.887 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -157.92 150.44 22.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.873 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.435 ' HB3' HG13 ' A' ' 23' ' ' VAL . 36.1 p-10 -157.91 137.8 12.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.887 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -170.06 179.06 42.56 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.493 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.57 ' N ' HD12 ' A' ' 6' ' ' ILE . 3.7 mp -93.31 79.24 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.933 0.397 . . . . 0.0 111.105 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.59 HD23 ' CZ2' ' A' ' 139' ' ' TRP . 2.0 mm? -77.26 163.62 26.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.808 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -100.51 142.51 31.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.04 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -148.64 105.62 3.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.768 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.59 120.74 11.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.126 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.07 129.14 68.46 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.49 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -68.74 -9.82 27.29 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.395 2.063 . . . . 0.0 112.687 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.9 t -64.22 -40.19 88.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.069 0.462 . . . . 0.0 110.602 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 54.6 p30 -142.22 12.81 1.99 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.355 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 50.27 79.35 0.09 Allowed 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 120.666 0.27 . . . . 0.0 111.071 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -162.96 133.34 4.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.922 0.391 . . . . 0.0 111.028 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 29.5 m95 -67.9 137.3 55.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.863 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -137.32 132.27 17.82 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.879 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.22 127.18 24.77 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.414 2.076 . . . . 0.0 112.241 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -135.51 122.17 20.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.869 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -80.24 85.27 5.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.924 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.441 ' CE2' ' HB3' ' A' ' 31' ' ' TYR . 4.0 m-85 -79.42 157.45 27.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.873 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.435 HG13 ' HB3' ' A' ' 4' ' ' ASN . 21.6 t -143.03 104.38 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.399 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.425 HD21 HG11 ' A' ' 146' ' ' VAL . 20.0 tp -86.51 117.36 25.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.717 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -99.7 157.97 16.1 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.301 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.833 ' HA ' HD11 ' A' ' 2' ' ' ILE . 7.0 t -44.55 -33.43 1.75 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.835 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.456 ' HA ' HG11 ' A' ' 95' ' ' VAL . 3.6 m -144.07 46.33 1.44 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.798 0.332 . . . . 0.0 111.403 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.3 mttt 179.27 167.91 1.03 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.939 0.399 . . . . 0.0 111.174 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.1 mt -139.51 106.15 2.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.825 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -97.03 139.61 32.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.989 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.441 ' HB3' ' CE2' ' A' ' 22' ' ' PHE . 13.2 p90 -140.33 112.95 8.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.827 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.5 m . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.837 -179.95 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.428 ' HA3' ' CZ ' ' A' ' 31' ' ' TYR . . . . . . . . 0 N--CA 1.45 -0.399 0 N-CA-C 112.61 -0.196 . . . . 0.0 112.61 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.5 p -95.77 133.52 36.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.765 0.317 . . . . 0.0 111.033 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.7 tp -132.56 152.41 51.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.056 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.475 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 2.3 p30 -89.56 126.88 35.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.752 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.772 HG21 HG13 ' A' ' 146' ' ' VAL . 7.6 p -72.42 -33.33 2.23 Favored Pre-proline 0 CA--C 1.534 0.365 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.649 ' HD3' HG12 ' A' ' 95' ' ' VAL . 6.4 Cg_exo -74.28 55.23 3.5 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.334 2.022 . . . . 0.0 112.546 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.531 ' HB2' ' O ' ' A' ' 96' ' ' PRO . . . 170.02 66.44 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.999 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 31.1 p -142.87 161.39 38.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.121 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.408 ' HB2' ' HD3' ' A' ' 119' ' ' PRO . 0.0 OUTLIER -148.59 105.97 3.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.636 179.878 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 1.031 HG21 HG23 ' A' ' 140' ' ' VAL . 4.7 mm -78.02 163.33 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.322 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.433 ' H ' HG22 ' A' ' 100' ' ' ILE . . . -159.89 87.63 0.81 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.822 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.464 HG22 ' N ' ' A' ' 103' ' ' ARG . 84.1 mt -56.72 155.16 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.127 0.489 . . . . 0.0 111.292 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.464 ' N ' HG22 ' A' ' 102' ' ' ILE . 7.2 mtt85 -148.61 118.19 4.09 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.174 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -81.53 33.85 0.54 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.43 2.086 . . . . 0.0 112.784 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 178.87 69.35 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.894 0.378 . . . . 0.0 110.42 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -61.51 -98.79 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.735 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.54 170.27 21.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.866 0.365 . . . . 0.0 110.976 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 60.85 -83.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.114 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -161.35 31.22 0.14 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.824 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.552 ' O ' HG23 ' A' ' 113' ' ' VAL . 2.6 mmp_? -118.25 94.26 4.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.771 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.514 ' H ' HD12 ' A' ' 111' ' ' LEU . 0.9 OUTLIER -69.9 -34.69 73.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.934 -179.93 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.494 ' HB3' HD13 ' A' ' 136' ' ' LEU . 12.1 m-85 -86.56 81.76 8.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.893 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 110' ' ' ARG . 23.6 t -134.06 120.45 35.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.153 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.427 ' CD1' ' HG ' ' A' ' 136' ' ' LEU . 38.7 p90 -106.79 120.45 42.05 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.687 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 31.4 t -92.64 131.39 37.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.227 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.813 HD12 HD12 ' A' ' 100' ' ' ILE . 6.3 mm -92.99 162.84 2.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.684 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.435 ' N ' HG22 ' A' ' 116' ' ' ILE . 2.3 m -150.0 -179.55 7.25 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.027 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 31.1 mtp -155.67 96.59 2.38 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.87 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.408 ' HD3' ' HB2' ' A' ' 99' ' ' GLN . 40.1 Cg_endo -67.3 -27.01 41.14 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.443 2.095 . . . . 0.0 112.297 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.2 p -94.65 43.57 1.1 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.793 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 44.2 t -154.61 -68.51 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.984 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.465 ' HB3' ' CD1' ' A' ' 124' ' ' TRP . . . 179.57 -155.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.225 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 -83.88 49.96 1.73 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.803 0.335 . . . . 0.0 110.977 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' TRP . . . . . 0.465 ' CD1' ' HB3' ' A' ' 122' ' ' ALA . 12.4 m0 -83.73 122.88 29.24 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.876 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -142.29 96.11 2.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.671 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.484 ' H ' HD23 ' A' ' 126' ' ' LEU . 0.6 OUTLIER -98.58 161.6 13.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.03 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -117.04 142.32 47.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.03 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.542 HG12 HD12 ' A' ' 7' ' ' LEU . 15.6 t -148.38 141.58 18.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.939 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -146.43 134.33 21.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.307 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.409 ' HB2' HD11 ' A' ' 7' ' ' LEU . . . -99.81 138.52 36.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.912 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -52.88 -34.67 55.78 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.036 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 9.2 t -102.1 115.94 31.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.844 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.433 ' HG3' ' CE2' ' A' ' 112' ' ' PHE . 0.0 OUTLIER -48.47 -28.0 3.03 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.386 179.424 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -73.31 -39.89 64.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.206 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.32 -32.79 72.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.027 179.299 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.494 HD13 ' HB3' ' A' ' 112' ' ' PHE . 6.2 tt -66.35 -46.4 76.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.48 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLN . . . . . 0.45 ' O ' HG12 ' A' ' 140' ' ' VAL . 14.8 mm100 -70.11 -39.2 75.65 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.293 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -68.68 -31.2 70.14 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.325 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' TRP . . . . . 0.59 ' CZ2' HD23 ' A' ' 7' ' ' LEU . 1.1 m95 -68.77 -46.72 68.01 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.656 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 1.031 HG23 HG21 ' A' ' 100' ' ' ILE . 0.3 OUTLIER -60.88 -40.43 85.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.753 179.888 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 15.7 mtmt -68.18 -37.38 80.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.742 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 10.5 mttt -67.61 -51.82 45.67 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.295 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.551 HG21 HD11 ' A' ' 100' ' ' ILE . 85.8 mt -54.22 -35.13 28.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.308 0.575 . . . . 0.0 109.579 178.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 34.1 mtt180 -79.17 -27.45 42.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.595 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.522 ' O ' HG22 ' A' ' 149' ' ' THR . 1.2 tm-20 -77.35 -34.04 55.23 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.867 0.365 . . . . 0.0 110.767 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.772 HG13 HG21 ' A' ' 95' ' ' VAL . 9.6 p -81.97 -29.46 9.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.372 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -81.0 -34.77 32.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.493 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -79.27 -11.15 59.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.965 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.532 HG22 ' HA ' ' A' ' 146' ' ' VAL . 15.2 t -107.38 -21.5 12.91 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.078 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.215 -0.897 . . . . 0.0 111.14 179.945 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 78.0 p . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 120.845 0.355 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.766 HD11 ' HA ' ' A' ' 26' ' ' SER . 19.6 mt -78.27 -34.94 19.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.145 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.31 140.57 4.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.049 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 33.1 p-10 -146.47 141.91 27.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.819 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -163.4 -171.14 29.26 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.467 -0.873 . . . . 0.0 112.611 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.8 mm -98.24 80.1 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.777 0.322 . . . . 0.0 111.031 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.754 HD23 ' CZ2' ' A' ' 139' ' ' TRP . 1.7 mm? -88.59 134.72 33.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.663 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.455 ' O ' HG12 ' A' ' 128' ' ' VAL . 28.1 m-85 -73.11 165.56 24.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.242 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -160.01 114.44 2.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.669 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.43 ' HG2' ' CZ3' ' A' ' 17' ' ' TRP . 3.6 pt-20 -73.43 90.49 1.7 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.17 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -60.73 113.33 7.38 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.62 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.66 -18.68 16.27 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.66 2.24 . . . . 0.0 112.916 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.4 t -68.44 -41.11 83.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.897 0.38 . . . . 0.0 111.269 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 -113.92 -13.34 12.56 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.231 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 68.4 m80 61.99 50.91 3.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.862 0.363 . . . . 0.0 110.854 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -152.94 151.7 30.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.792 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.43 ' CZ3' ' HG2' ' A' ' 10' ' ' GLU . 67.1 m95 -80.42 125.1 29.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.931 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -119.85 142.33 32.96 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.813 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -68.6 101.03 0.72 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.46 2.106 . . . . 0.0 112.176 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 35.2 m170 -119.16 138.05 53.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.847 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -82.67 140.0 33.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.865 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.487 ' CZ ' ' CD2' ' A' ' 31' ' ' TYR . 0.2 OUTLIER -133.55 124.78 27.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.914 179.854 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.5 t -111.89 103.31 15.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.829 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.9 tp -82.69 109.37 16.8 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.018 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.512 ' HG1' ' C ' ' A' ' 28' ' ' LYS . 43.2 p -99.1 155.94 17.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.794 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.766 ' HA ' HD11 ' A' ' 2' ' ' ILE . 1.5 m -65.0 -12.13 46.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.898 -179.571 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.8 m -121.22 2.78 10.37 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.559 ' HA ' HG23 ' A' ' 95' ' ' VAL . 0.5 OUTLIER 173.28 -170.91 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.97 0.414 . . . . 0.0 111.316 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.4 mt -136.74 119.91 21.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.838 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -103.03 153.08 20.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.029 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.487 ' CD2' ' CZ ' ' A' ' 22' ' ' PHE . 25.3 p90 -167.17 148.25 5.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.953 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.931 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.43 ' HA3' ' CE1' ' A' ' 31' ' ' TYR . . . . . . . . 0 N--CA 1.45 -0.414 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.6 m -97.87 156.8 3.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.87 0.367 . . . . 0.0 111.062 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.414 ' HA ' HD12 ' A' ' 93' ' ' LEU . 9.9 tp -151.05 129.77 12.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.027 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.39 138.93 49.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.816 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.819 ' CG1' HG13 ' A' ' 146' ' ' VAL . 18.7 t -79.66 -47.87 1.46 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.752 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.469 ' HD3' ' HB ' ' A' ' 95' ' ' VAL . 94.3 Cg_endo -79.07 55.33 5.56 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.232 1.955 . . . . 0.0 112.499 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.449 ' HB2' ' O ' ' A' ' 96' ' ' PRO . . . 175.53 39.53 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.034 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -156.82 104.15 2.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.943 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -89.76 131.32 35.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.765 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.939 HD11 HG21 ' A' ' 143' ' ' ILE . 11.5 mm -82.28 160.93 3.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.147 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.451 ' N ' HG22 ' A' ' 100' ' ' ILE . . . -154.93 93.95 1.6 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.959 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 46.3 mt -58.48 151.25 4.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.089 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.43 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 10.3 mtt180 -140.72 114.26 7.21 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.617 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 103' ' ' ARG . 5.9 Cg_exo -74.11 11.54 1.18 Allowed 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.681 2.254 . . . . 0.0 112.942 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.74 65.39 0.6 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.925 0.393 . . . . 0.0 110.423 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -48.87 -90.24 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.935 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -171.74 171.61 5.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.89 0.376 . . . . 0.0 111.127 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 60.69 -83.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.233 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -155.07 32.13 0.39 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.069 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 15.1 mtt-85 -122.05 109.97 15.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.806 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.501 ' H ' HD23 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -96.51 23.48 6.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.124 -179.88 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -143.99 68.65 1.27 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.921 0.391 . . . . 0.0 110.764 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.937 HG22 ' HB2' ' A' ' 129' ' ' ALA . 39.5 t -130.02 140.96 47.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.047 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.592 ' CZ ' HG23 ' A' ' 128' ' ' VAL . 25.1 p90 -117.64 132.71 56.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.589 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.4 m -110.58 137.23 48.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.093 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.829 HG23 HD13 ' A' ' 100' ' ' ILE . 2.9 mp -99.89 159.08 3.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.85 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.449 ' N ' HG22 ' A' ' 116' ' ' ILE . 20.1 m -147.87 159.65 43.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.901 0.382 . . . . 0.0 110.953 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 12.9 mtp -113.05 155.33 44.43 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.889 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.96 74.35 0.33 Allowed 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.541 2.161 . . . . 0.0 112.228 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 13.3 p 58.87 107.65 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.985 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.5 t -140.4 -66.66 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.101 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.602 ' HB3' ' NE1' ' A' ' 124' ' ' TRP . . . -169.39 44.77 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.162 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 61.27 37.5 17.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.983 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' TRP . . . . . 0.602 ' NE1' ' HB3' ' A' ' 122' ' ' ALA . 24.1 m95 -90.2 115.01 27.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.871 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -129.29 118.12 21.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.887 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -84.65 151.15 24.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.917 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -138.33 117.95 13.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.81 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.661 ' HB ' HD12 ' A' ' 7' ' ' LEU . 2.3 m -144.94 154.42 14.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.201 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.937 ' HB2' HG22 ' A' ' 113' ' ' VAL . . . -148.74 122.33 9.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.146 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -90.13 130.96 36.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.991 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.07 -35.94 65.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.922 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.1 m -90.9 111.21 22.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.828 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.84 -28.45 3.74 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.525 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.93 -40.36 60.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.383 179.491 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -68.06 -33.1 73.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.223 179.285 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.459 ' O ' HG23 ' A' ' 140' ' ' VAL . 5.2 tt -67.53 -47.91 68.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.449 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -68.21 -40.9 82.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.297 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -66.62 -30.35 70.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.216 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' TRP . . . . . 0.754 ' CZ2' HD23 ' A' ' 7' ' ' LEU . 1.0 OUTLIER -66.31 -50.21 64.43 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.535 179.64 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.601 HG12 ' HD2' ' A' ' 144' ' ' ARG . 38.4 t -61.63 -38.17 79.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.051 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -68.29 -38.83 82.06 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.047 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 3.3 mttt -67.11 -52.76 37.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.302 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.939 HG21 HD11 ' A' ' 100' ' ' ILE . 74.1 mt -54.71 -33.79 28.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.601 ' HD2' HG12 ' A' ' 140' ' ' VAL . 0.1 OUTLIER -78.43 -28.44 46.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.547 179.093 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.619 ' O ' HG22 ' A' ' 149' ' ' THR . 47.4 tt0 -75.26 -39.51 59.72 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.857 0.36 . . . . 0.0 110.579 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.819 HG13 ' CG1' ' A' ' 95' ' ' VAL . 7.8 p -77.54 -27.81 15.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.147 179.181 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -74.5 -39.04 62.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.621 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -72.53 -16.84 61.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.918 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.619 HG22 ' O ' ' A' ' 145' ' ' GLU . 11.8 t -112.79 18.53 18.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.794 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.225 -0.893 . . . . 0.0 111.113 179.945 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 120.862 0.363 . . . . 0.0 111.273 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.758 HD11 ' HA ' ' A' ' 26' ' ' SER . 39.2 mt -74.19 -37.61 46.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.032 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.519 ' HB3' ' HZ2' ' A' ' 3' ' ' LYS . 0.1 OUTLIER -156.12 145.09 20.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.965 -179.828 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.578 ' HB3' HG13 ' A' ' 23' ' ' VAL . 2.6 p-10 -161.92 135.02 6.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.834 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -161.59 -163.86 15.35 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.501 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.691 HD13 ' HD1' ' A' ' 21' ' ' TYR . 25.2 mm -99.66 73.49 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.938 0.399 . . . . 0.0 111.083 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.832 HD12 HG12 ' A' ' 128' ' ' VAL . 0.9 OUTLIER -79.75 150.11 30.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.734 179.957 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.659 ' C ' HD22 ' A' ' 9' ' ' LEU . 23.1 m-85 -87.49 138.4 31.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.977 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.659 HD22 ' C ' ' A' ' 8' ' ' TYR . 4.4 mm? -126.74 175.03 8.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.845 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.447 ' HG3' ' CZ3' ' A' ' 17' ' ' TRP . 18.0 mt-10 -118.33 107.85 14.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.095 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.27 146.63 62.73 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.492 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.23 -17.33 19.14 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.486 2.124 . . . . 0.0 112.735 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.3 t -69.12 -43.76 81.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.0 0.428 . . . . 0.0 111.187 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -112.42 -18.47 12.45 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.192 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 24.8 m-70 62.16 29.25 17.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.809 0.338 . . . . 0.0 110.862 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -130.76 176.17 8.43 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.699 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.579 ' HH2' HG11 ' A' ' 113' ' ' VAL . 21.7 m95 -61.79 137.92 58.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.693 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -139.45 141.69 29.56 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.858 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.72 126.41 10.13 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.542 2.161 . . . . 0.0 112.252 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -152.45 167.81 27.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.93 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.691 ' HD1' HD13 ' A' ' 6' ' ' ILE . 7.2 t80 -108.29 115.23 29.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.974 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.446 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 2.2 m-85 -108.54 141.46 40.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.922 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.578 HG13 ' HB3' ' A' ' 4' ' ' ASN . 25.8 t -126.63 148.8 31.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.174 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.646 HD22 HG23 ' A' ' 29' ' ' ILE . 1.5 tm? -128.04 110.84 12.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.873 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.1 p -98.76 155.37 17.39 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.006 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.758 ' HA ' HD11 ' A' ' 2' ' ' ILE . 56.4 p -60.58 -16.41 37.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.079 -179.416 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -133.94 24.27 3.92 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.422 ' CD ' HG21 ' A' ' 92' ' ' VAL . 0.3 OUTLIER 171.67 -176.36 0.05 OUTLIER 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 121.077 0.465 . . . . 0.0 111.684 179.604 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.646 HG23 HD22 ' A' ' 24' ' ' LEU . 1.5 mt -144.79 127.03 9.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.639 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -104.07 142.02 35.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.859 0.361 . . . . 0.0 111.037 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.446 ' HB2' ' CZ ' ' A' ' 22' ' ' PHE . 3.6 p90 -156.66 100.97 1.96 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.942 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.7 t . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.986 179.889 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.273 0 N-CA-C 112.528 -0.229 . . . . 0.0 112.528 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.422 HG21 ' CD ' ' A' ' 28' ' ' LYS . 12.2 p -107.45 152.83 8.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.803 0.335 . . . . 0.0 111.158 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.499 HD23 ' N ' ' A' ' 94' ' ' ASP . 1.4 tt -139.96 129.58 24.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.943 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.499 ' N ' HD23 ' A' ' 93' ' ' LEU . 0.6 OUTLIER -68.93 141.65 54.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.829 179.94 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.723 ' CG2' HG13 ' A' ' 146' ' ' VAL . 11.7 p -81.98 -29.08 0.48 Allowed Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.646 ' CD ' ' N ' ' A' ' 95' ' ' VAL . 98.6 Cg_endo -86.18 47.15 1.74 Allowed 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.149 1.899 . . . . 0.0 112.642 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -177.95 37.85 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.006 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 1.3 m -131.67 120.13 22.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.966 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.15 109.09 20.92 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.736 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.987 HD11 HG21 ' A' ' 143' ' ' ILE . 14.2 mm -75.35 157.66 5.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.079 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.414 ' N ' HG22 ' A' ' 100' ' ' ILE . . . -153.87 87.6 1.22 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.987 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 52.9 mt -58.58 146.22 8.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.193 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.83 104.82 5.77 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.618 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -73.65 52.95 2.61 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.36 2.04 . . . . 0.0 112.424 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.425 ' HG3' HD22 ' A' ' 111' ' ' LEU . 2.6 mt-10 168.0 56.65 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.408 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.418 ' O ' ' HG3' ' A' ' 107' ' ' LYS . . . -65.85 -102.6 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.768 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.418 ' HG3' ' O ' ' A' ' 106' ' ' GLY . 0.0 OUTLIER -154.35 -177.0 6.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.993 0.425 . . . . 0.0 111.191 -179.795 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.447 ' HB2' ' NE1' ' A' ' 17' ' ' TRP . 0.8 OUTLIER 47.9 41.65 14.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.611 179.524 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 61.84 31.3 18.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.337 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 -118.31 106.3 12.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.517 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.425 HD22 ' HG3' ' A' ' 105' ' ' GLU . 3.3 mt -96.54 30.28 2.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.108 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.511 ' O ' HD13 ' A' ' 136' ' ' LEU . 39.4 m-85 -145.82 61.72 1.26 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.528 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.7 HG22 ' HB2' ' A' ' 129' ' ' ALA . 38.7 t -125.32 126.37 70.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.009 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.444 ' CZ ' ' HB ' ' A' ' 128' ' ' VAL . 35.8 p90 -103.63 131.53 50.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.578 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 13.0 t -105.45 127.08 52.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.105 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.956 HG23 HD13 ' A' ' 100' ' ' ILE . 12.8 mt -94.97 158.16 2.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.499 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 2.5 m -154.62 132.17 11.31 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.803 0.335 . . . . 0.0 111.146 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' MET . . . . . 0.44 ' SD ' HD21 ' A' ' 93' ' ' LEU . 77.1 mtp -92.17 115.56 64.9 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.85 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -79.68 53.67 4.84 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.485 2.124 . . . . 0.0 112.519 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 30.5 t 177.59 39.95 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.634 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 45.6 t -145.66 -69.96 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.088 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -179.26 -155.13 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.416 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -83.78 49.27 1.58 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.738 0.304 . . . . 0.0 111.07 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 12.4 m95 -74.47 169.87 16.85 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.73 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -169.17 98.61 0.36 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.955 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.649 HD23 HD12 ' A' ' 116' ' ' ILE . 1.6 tp -83.97 95.73 8.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.075 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.5 130.56 35.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.96 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.832 HG12 HD12 ' A' ' 7' ' ' LEU . 21.7 t -152.25 159.03 4.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.147 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.7 ' HB2' HG22 ' A' ' 113' ' ' VAL . . . -164.81 131.05 2.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.241 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -97.55 141.52 30.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.981 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -55.66 -34.36 64.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.952 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.0 m -94.23 114.49 26.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.816 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.436 ' HG2' ' CZ ' ' A' ' 112' ' ' PHE . 1.1 mp0 -49.67 -27.16 4.37 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.431 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -74.77 -45.45 43.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.424 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -64.6 -31.38 72.58 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.202 179.359 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.525 ' O ' HG23 ' A' ' 140' ' ' VAL . 1.4 tp -68.05 -50.07 57.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.445 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLN . . . . . 0.506 ' OE1' HD23 ' A' ' 136' ' ' LEU . 4.1 mp0 -68.17 -36.94 80.42 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.332 179.588 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -69.19 -34.4 74.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.163 179.189 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' TRP . . . . . 0.697 ' CZ2' HD23 ' A' ' 7' ' ' LEU . 1.3 m95 -63.8 -47.67 79.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.564 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.85 HG13 HG21 ' A' ' 100' ' ' ILE . 33.4 t -62.83 -44.5 99.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.801 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.1 -33.03 72.71 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.701 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.502 ' O ' HG12 ' A' ' 146' ' ' VAL . 0.2 OUTLIER -70.06 -50.89 36.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.378 179.72 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.987 HG21 HD11 ' A' ' 100' ' ' ILE . 66.8 mt -53.83 -31.27 20.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.178 0.513 . . . . 0.0 109.617 178.738 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 50.4 mtp85 -80.23 -32.37 38.44 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.159 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.427 ' O ' HG22 ' A' ' 149' ' ' THR . 4.9 pt-20 -77.97 -31.34 50.75 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.755 0.312 . . . . 0.0 110.895 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.723 HG13 ' CG2' ' A' ' 95' ' ' VAL . 9.8 p -83.63 -29.24 7.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.01 0.433 . . . . 0.0 110.296 179.217 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -75.3 -34.62 61.3 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.587 179.178 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -74.55 -11.5 60.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.952 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.443 HG22 ' HA ' ' A' ' 146' ' ' VAL . 10.5 t -117.23 13.05 14.57 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.285 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.2 -0.905 . . . . 0.0 111.204 -179.968 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.488 1.438 0 CA-C-O 120.822 0.344 . . . . 0.0 111.146 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.449 HD11 ' CB ' ' A' ' 26' ' ' SER . 15.6 mt -88.87 -32.88 5.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.051 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.599 ' O ' HG13 ' A' ' 23' ' ' VAL . 3.2 tptp -125.94 135.08 51.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.775 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 17.9 p-10 -154.52 121.8 5.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.006 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.503 ' C ' HD12 ' A' ' 6' ' ' ILE . . . -170.02 -145.68 4.8 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.485 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.653 ' N ' HD12 ' A' ' 6' ' ' ILE . 3.2 mp -127.97 88.44 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.824 0.345 . . . . 0.0 110.953 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.589 HD11 ' HB2' ' A' ' 130' ' ' ALA . 4.4 mm? -87.78 144.24 26.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.84 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -76.33 165.84 24.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.019 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -171.12 101.33 0.21 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.822 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.431 ' HG2' ' CZ3' ' A' ' 17' ' ' TRP . 0.3 OUTLIER -78.55 164.22 24.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.064 -179.875 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.4 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 2.2 t0 -126.42 132.1 24.19 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.714 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 11' ' ' ASP . 31.5 Cg_exo -58.98 -15.59 28.23 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.536 2.157 . . . . 0.0 112.917 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.1 t -68.78 -42.85 83.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.98 0.419 . . . . 0.0 111.438 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -115.41 -15.84 11.48 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.412 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 2.2 m80 62.79 42.7 7.73 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.931 0.396 . . . . 0.0 110.802 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.73 134.81 37.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.818 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.441 ' CD1' ' HG3' ' A' ' 110' ' ' ARG . 85.5 m95 -65.59 135.05 54.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.915 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.433 ' HB3' ' CD2' ' A' ' 20' ' ' HIS . 11.5 m-85 -120.31 104.59 43.04 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.939 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 18' ' ' TYR . 38.5 Cg_endo -67.05 107.84 1.41 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.48 2.12 . . . . 0.0 112.317 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.433 ' CD2' ' HB3' ' A' ' 18' ' ' TYR . 95.1 m-70 -132.25 158.08 42.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.869 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -59.85 151.38 25.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.925 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.477 ' CZ ' ' CD1' ' A' ' 31' ' ' TYR . 0.3 OUTLIER -154.9 142.9 20.13 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.806 -179.939 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.599 HG13 ' O ' ' A' ' 3' ' ' LYS . 14.3 t -139.29 145.82 26.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.158 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.495 HD12 HG12 ' A' ' 29' ' ' ILE . 27.2 tp -125.94 115.88 20.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.792 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 35.0 p -90.58 158.29 17.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.932 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.449 ' CB ' HD11 ' A' ' 2' ' ' ILE . 4.5 t -52.75 -24.0 7.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.693 -179.571 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.0 m -143.33 35.5 1.33 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.552 0.215 . . . . 0.0 111.435 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.528 ' CA ' HG23 ' A' ' 95' ' ' VAL . 1.2 tttt 177.73 179.21 0.3 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.891 0.377 . . . . 0.0 111.305 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.562 HD12 HD23 ' A' ' 93' ' ' LEU . 1.6 mt -141.25 130.27 24.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.715 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -124.52 133.59 53.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.078 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.477 ' CD1' ' CZ ' ' A' ' 22' ' ' PHE . 33.5 p90 -156.43 153.58 29.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.911 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 84.0 p . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.848 -179.958 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.4 0 N-CA-C 112.499 -0.241 . . . . 0.0 112.499 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 11.5 p -129.06 142.65 43.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.863 0.364 . . . . 0.0 111.07 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.562 HD23 HD12 ' A' ' 29' ' ' ILE . 3.3 tp -147.31 145.05 29.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.931 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.0 133.11 34.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.827 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.777 HG11 HG23 ' A' ' 146' ' ' VAL . 19.8 t -82.46 -45.34 0.95 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.605 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.553 ' O ' ' HB2' ' A' ' 97' ' ' ALA . 11.6 Cg_exo -71.29 55.14 1.9 Allowed 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.632 2.221 . . . . 0.0 112.457 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.553 ' HB2' ' O ' ' A' ' 96' ' ' PRO . . . 168.83 40.47 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.878 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -157.37 98.25 1.69 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.989 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -80.27 129.79 34.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.693 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.713 HD13 HG23 ' A' ' 116' ' ' ILE . 10.7 mm -84.34 157.63 3.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.151 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.424 ' N ' HG22 ' A' ' 100' ' ' ILE . . . -145.84 88.41 1.82 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.869 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.462 HD13 ' OE1' ' A' ' 137' ' ' GLN . 86.3 mt -57.79 143.4 12.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.091 0.472 . . . . 0.0 111.349 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 9.0 mtt-85 -132.45 125.64 19.79 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.069 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -82.42 24.36 0.73 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.386 2.058 . . . . 0.0 112.956 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -176.77 74.83 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.948 0.404 . . . . 0.0 110.538 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -54.45 -93.77 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.68 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.79 172.01 1.02 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.877 0.37 . . . . 0.0 111.07 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 61.8 m-80 61.8 -82.04 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.149 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -152.96 42.9 0.62 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.95 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.441 ' HG3' ' CD1' ' A' ' 17' ' ' TRP . 0.6 OUTLIER -135.48 108.64 7.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.92 179.911 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.5 mt -78.28 -33.75 49.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.823 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.756 ' HB3' HD13 ' A' ' 136' ' ' LEU . 41.1 m-85 -108.7 115.24 29.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.975 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.552 HG13 ' HB2' ' A' ' 129' ' ' ALA . 21.1 t -153.22 140.23 12.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.029 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.436 ' CE2' ' HB ' ' A' ' 128' ' ' VAL . 25.3 p90 -119.93 115.31 23.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.828 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.4 p -93.44 125.94 38.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.992 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.713 HG23 HD13 ' A' ' 100' ' ' ILE . 3.1 mp -92.01 159.99 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.918 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.49 ' N ' HG22 ' A' ' 116' ' ' ILE . 22.1 p -158.43 158.96 35.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.955 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' MET . . . . . 0.453 ' SD ' HG11 ' A' ' 121' ' ' VAL . 32.3 mtp -110.14 155.65 41.43 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.724 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -65.54 -30.9 51.68 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.528 2.152 . . . . 0.0 112.385 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 78.9 p -178.78 129.69 0.11 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.101 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.656 HG22 ' N ' ' A' ' 122' ' ' ALA . 0.2 OUTLIER -167.18 -80.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.817 179.799 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.656 ' N ' HG22 ' A' ' 121' ' ' VAL . . . -155.53 37.33 0.37 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.172 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 61.1 44.22 10.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.857 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' TRP . . . . . 0.541 ' CD1' ' HB3' ' A' ' 122' ' ' ALA . 27.2 m95 -90.45 132.62 35.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.061 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 59.9 m -128.33 139.23 52.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.837 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.639 HD13 ' H ' ' A' ' 127' ' ' ASP . 0.2 OUTLIER -118.72 143.32 46.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.944 0.402 . . . . 0.0 111.111 -179.92 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.639 ' H ' HD13 ' A' ' 126' ' ' LEU . 62.2 m-20 -130.56 119.13 22.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.52 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.611 HG23 HD12 ' A' ' 126' ' ' LEU . 21.9 t -141.32 159.61 22.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.172 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.552 ' HB2' HG13 ' A' ' 113' ' ' VAL . . . -159.66 141.16 12.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.222 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.589 ' HB2' HD11 ' A' ' 7' ' ' LEU . . . -105.97 145.75 30.92 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.834 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -58.13 -60.94 2.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.045 0.45 . . . . 0.0 110.875 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.8 t -70.7 115.7 10.16 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.72 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.443 ' HG3' ' CE2' ' A' ' 112' ' ' PHE . 0.1 OUTLIER -48.71 -26.45 2.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.664 179.59 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -76.03 -43.37 44.31 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.474 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.79 -32.49 74.06 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.292 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.756 HD13 ' HB3' ' A' ' 112' ' ' PHE . 8.1 tt -68.57 -50.07 54.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.465 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLN . . . . . 0.462 ' OE1' HD13 ' A' ' 102' ' ' ILE . 8.5 mm100 -68.17 -36.53 79.77 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.355 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -70.44 -29.77 66.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.446 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' TRP . . . . . 0.418 ' CE2' HD21 ' A' ' 7' ' ' LEU . 0.6 OUTLIER -69.28 -46.18 67.86 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.034 0.445 . . . . 0.0 110.621 179.629 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.547 HG13 HG21 ' A' ' 100' ' ' ILE . 21.9 t -63.31 -40.99 91.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.878 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 2.3 mtpp -64.18 -37.42 87.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.781 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.576 ' O ' HG22 ' A' ' 146' ' ' VAL . 0.0 OUTLIER -65.8 -54.3 28.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.374 179.706 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.621 HG21 HD11 ' A' ' 100' ' ' ILE . 70.9 mt -52.72 -32.99 17.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.194 0.521 . . . . 0.0 109.691 178.788 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 25.0 mtp85 -80.01 -29.3 39.39 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.388 179.25 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.45 ' O ' HG22 ' A' ' 149' ' ' THR . 1.2 tt0 -74.49 -37.4 63.17 Favored 'General case' 0 N--CA 1.457 -0.106 0 CA-C-O 120.922 0.391 . . . . 0.0 110.64 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.777 HG23 HG11 ' A' ' 95' ' ' VAL . 11.7 m -80.73 -28.32 11.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.228 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -78.98 -34.35 44.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.754 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -78.47 -10.01 59.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.958 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.517 HG22 ' HA ' ' A' ' 146' ' ' VAL . 12.4 t -110.84 -29.83 7.8 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.882 0.373 . . . . 0.0 111.066 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.198 -0.906 . . . . 0.0 111.111 179.948 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.816 0.341 . . . . 0.0 111.138 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.486 HD11 ' CB ' ' A' ' 26' ' ' SER . 30.5 mt -77.95 -36.13 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.138 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.436 ' HG2' ' CD1' ' A' ' 139' ' ' TRP . 0.2 OUTLIER -138.09 102.57 4.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.005 -179.906 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.845 ' HB3' HG13 ' A' ' 23' ' ' VAL . 6.9 p30 -131.22 124.62 30.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.77 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -166.35 -147.22 5.13 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.55 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 25.2 mm -107.98 86.07 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.735 0.302 . . . . 0.0 111.168 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.75 HD12 HG12 ' A' ' 128' ' ' VAL . 0.4 OUTLIER -88.0 163.96 16.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.833 179.891 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.707 ' C ' HD23 ' A' ' 9' ' ' LEU . 23.0 m-85 -110.61 150.41 29.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.104 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.797 HD21 ' HB2' ' A' ' 20' ' ' HIS . 0.2 OUTLIER -161.29 129.52 4.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.772 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.435 ' HB3' ' CD2' ' A' ' 17' ' ' TRP . 0.2 OUTLIER -86.69 121.51 29.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.127 -179.772 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.529 ' HB3' HG22 ' A' ' 13' ' ' VAL . 0.3 OUTLIER -88.91 146.77 37.39 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.601 179.622 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.0 -4.52 15.53 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.487 2.125 . . . . 0.0 113.388 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.529 HG22 ' HB3' ' A' ' 11' ' ' ASP . 0.2 OUTLIER -67.97 -45.52 83.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.032 0.444 . . . . 0.0 110.818 179.972 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -128.6 -2.06 5.46 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.175 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 57.62 74.83 0.4 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.964 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.95 135.47 1.77 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.976 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.435 ' CD2' ' HB3' ' A' ' 10' ' ' GLU . 27.9 m95 -63.92 134.37 54.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.895 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -135.98 148.62 65.65 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.922 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.77 124.58 10.31 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.594 2.196 . . . . 0.0 112.356 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.797 ' HB2' HD21 ' A' ' 9' ' ' LEU . 0.1 OUTLIER -141.09 111.45 6.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.897 179.877 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -54.28 111.38 0.77 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.124 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.51 ' CZ ' ' CD2' ' A' ' 31' ' ' TYR . 2.8 m-30 -109.27 155.77 20.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.829 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.845 HG13 ' HB3' ' A' ' 4' ' ' ASN . 24.5 t -142.0 92.52 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.122 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.7 tp -76.03 117.91 18.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.926 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 17.1 p -97.88 154.71 17.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.984 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.486 ' CB ' HD11 ' A' ' 2' ' ' ILE . 51.7 p -52.53 -24.66 8.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.997 -179.567 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -140.79 37.49 1.8 Allowed 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.99 -0.284 . . . . 0.0 111.726 -179.523 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 172.45 171.94 0.11 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.926 0.393 . . . . 0.0 111.383 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.6 mt -134.56 116.64 22.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.55 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -96.13 141.41 29.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.316 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.51 ' CD2' ' CZ ' ' A' ' 22' ' ' PHE . 4.4 m-85 -119.33 124.29 46.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.726 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 12.3 m . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.824 179.983 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 N-CA-C 112.611 -0.196 . . . . 0.0 112.611 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 11.1 p -158.66 133.83 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.834 0.35 . . . . 0.0 111.026 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.451 HD23 ' O ' ' A' ' 94' ' ' ASP . 0.6 OUTLIER -146.31 153.49 40.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.892 -179.901 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.451 ' O ' HD23 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -83.82 137.31 33.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.903 -179.961 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.676 HG21 ' CG2' ' A' ' 146' ' ' VAL . 13.0 p -83.33 -27.99 0.42 Allowed Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.638 ' CD ' ' N ' ' A' ' 95' ' ' VAL . 89.8 Cg_endo -84.52 49.87 2.82 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.079 1.852 . . . . 0.0 112.593 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.406 ' HB2' ' O ' ' A' ' 96' ' ' PRO . . . 178.33 38.96 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.968 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -156.69 97.44 1.72 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.953 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -78.95 136.36 37.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.84 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.813 HD11 HG21 ' A' ' 143' ' ' ILE . 8.1 mm -87.52 161.21 2.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.168 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.445 ' N ' HG22 ' A' ' 100' ' ' ILE . . . -149.83 96.39 2.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.96 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 70.3 mt -61.03 149.85 7.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.079 0.466 . . . . 0.0 111.255 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.407 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 72.3 mtp180 -138.99 123.14 11.28 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.292 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 103' ' ' ARG . 6.3 Cg_exo -73.84 11.9 1.04 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.569 2.179 . . . . 0.0 113.004 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -160.37 67.82 0.35 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.103 0.478 . . . . 0.0 110.591 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.414 ' HA3' ' CG2' ' A' ' 113' ' ' VAL . . . -46.95 -88.67 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.224 0 CA-C-N 115.925 -0.579 . . . . 0.0 113.134 -179.624 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -174.99 162.59 3.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.849 0.357 . . . . 0.0 111.224 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 59.01 -84.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.157 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 44.7 m-20 -148.28 31.58 0.83 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.977 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.402 ' HB3' ' CG2' ' A' ' 113' ' ' VAL . 33.7 mmt180 -115.33 94.66 4.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.805 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.1 mt -67.65 -28.83 68.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.102 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -109.09 100.26 9.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.944 0.402 . . . . 0.0 111.094 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.423 HG11 ' CH2' ' A' ' 17' ' ' TRP . 42.8 t -146.47 127.27 6.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.69 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.439 ' CE2' ' HB ' ' A' ' 128' ' ' VAL . 29.6 p90 -108.65 124.31 50.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.064 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 28.0 t -94.48 129.46 41.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.672 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.791 HG23 HD13 ' A' ' 100' ' ' ILE . 11.0 mt -93.87 160.01 2.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.092 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.449 ' N ' HG22 ' A' ' 116' ' ' ILE . 0.3 OUTLIER -158.61 158.14 33.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.563 179.874 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 118' ' ' MET . . . . . 0.44 ' HB2' ' CD1' ' A' ' 124' ' ' TRP . 13.4 mtp -98.02 152.72 38.19 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.748 0.309 . . . . 0.0 111.236 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -80.59 77.95 3.86 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.661 2.241 . . . . 0.0 112.6 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.686 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.9 OUTLIER 69.68 107.63 0.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.922 179.95 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.686 HG23 ' O ' ' A' ' 120' ' ' SER . 3.4 t -164.45 -76.61 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.318 0.58 . . . . 0.0 110.815 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.634 ' N ' HG12 ' A' ' 121' ' ' VAL . . . -146.65 -149.67 0.3 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.267 -0.878 . . . . 0.0 110.671 -179.138 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -89.36 29.94 1.05 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.747 0.308 . . . . 0.0 111.607 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' TRP . . . . . 0.449 ' CD1' ' HB ' ' A' ' 121' ' ' VAL . 1.7 p-90 -46.38 168.51 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.299 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.405 ' CB ' ' O ' ' A' ' 124' ' ' TRP . 0.9 OUTLIER 163.89 103.12 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.805 179.512 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.459 ' HA ' HD12 ' A' ' 126' ' ' LEU . 8.0 tp -116.39 157.37 25.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.99 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -142.86 139.27 30.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.896 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.75 HG12 HD12 ' A' ' 7' ' ' LEU . 22.4 t -151.74 153.5 9.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.131 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.5 ' O ' HD13 ' A' ' 7' ' ' LEU . . . -155.99 136.98 13.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.197 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -105.01 139.74 39.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.985 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -53.89 -35.85 62.05 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.903 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.5 m -93.32 111.53 23.21 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.811 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -48.35 -28.49 3.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.54 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.88 -43.34 58.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.216 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -67.12 -31.37 71.79 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.194 179.383 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.517 ' O ' HG23 ' A' ' 140' ' ' VAL . 6.4 tt -67.82 -46.92 70.49 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.503 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -69.0 -40.43 78.73 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.377 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.0 -29.1 68.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.286 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' TRP . . . . . 0.62 ' CZ2' HD23 ' A' ' 7' ' ' LEU . 1.1 m95 -68.52 -48.29 64.73 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.694 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.615 HG12 ' HD2' ' A' ' 144' ' ' ARG . 33.9 t -63.55 -39.86 86.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.678 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 31.2 tttt -63.79 -36.75 84.93 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.744 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.515 ' O ' HG22 ' A' ' 146' ' ' VAL . 1.2 mptp? -67.26 -52.32 42.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.273 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.813 HG21 HD11 ' A' ' 100' ' ' ILE . 69.5 mt -52.77 -33.45 18.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.16 0.505 . . . . 0.0 109.76 178.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.615 ' HD2' HG12 ' A' ' 140' ' ' VAL . 0.4 OUTLIER -79.59 -28.11 41.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.628 179.273 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.47 -38.29 55.59 Favored 'General case' 0 CA--C 1.523 -0.096 0 CA-C-O 120.856 0.36 . . . . 0.0 110.861 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.676 ' CG2' HG21 ' A' ' 95' ' ' VAL . 16.2 m -79.67 -29.28 13.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.299 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -77.83 -34.83 51.75 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.544 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -74.13 -13.78 60.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.987 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.445 HG22 ' HA ' ' A' ' 146' ' ' VAL . 10.8 t -107.51 -22.11 12.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.106 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.446 ' HB3' ' HB3' ' A' ' 96' ' ' PRO . . . . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.158 -0.925 . . . . 0.0 111.091 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.464 ' N ' HG22 ' A' ' 25' ' ' THR . 4.0 m . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.859 0.361 . . . . 0.0 111.164 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.906 HD11 ' HB3' ' A' ' 26' ' ' SER . 28.6 mt -71.77 -32.94 46.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.953 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.429 ' HD2' ' CD1' ' A' ' 139' ' ' TRP . 3.4 mttm -157.86 123.77 4.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.89 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.917 ' HB3' HG13 ' A' ' 23' ' ' VAL . 11.1 p-10 -143.99 135.04 25.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.909 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.553 ' C ' HD12 ' A' ' 6' ' ' ILE . . . -170.02 -135.47 1.91 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.434 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.642 ' N ' HD12 ' A' ' 6' ' ' ILE . 3.2 mp -127.15 83.64 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.963 0.411 . . . . 0.0 110.981 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.926 HD12 HG12 ' A' ' 128' ' ' VAL . 1.8 mm? -80.85 145.12 31.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.911 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -90.92 119.08 30.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.98 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.68 HD11 ' OH ' ' A' ' 31' ' ' TYR . 0.5 OUTLIER -126.86 144.22 51.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.95 179.903 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.434 ' HG2' ' CZ3' ' A' ' 17' ' ' TRP . 0.0 OUTLIER -87.5 122.81 31.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.895 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.406 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 1.2 t0 -93.14 126.68 50.03 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.67 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 11' ' ' ASP . 32.2 Cg_exo -58.37 -15.4 24.16 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.505 2.137 . . . . 0.0 112.869 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.0 t -68.76 -42.82 83.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.887 0.375 . . . . 0.0 111.275 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -115.82 -15.82 11.25 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.484 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 63.21 50.81 2.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.918 0.39 . . . . 0.0 110.907 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -157.31 157.25 33.82 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.89 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.434 ' CZ3' ' HG2' ' A' ' 10' ' ' GLU . 40.5 m95 -72.56 139.06 47.28 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.725 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -138.86 121.77 10.72 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.961 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.38 92.86 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.426 2.084 . . . . 0.0 112.256 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.549 ' HB2' HD21 ' A' ' 9' ' ' LEU . 43.9 m-70 -117.27 150.27 39.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.921 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -77.65 147.65 35.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.927 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.49 ' CE2' ' CD1' ' A' ' 31' ' ' TYR . 0.2 OUTLIER -154.57 133.81 12.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.765 -179.876 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.917 HG13 ' HB3' ' A' ' 4' ' ' ASN . 21.7 t -117.13 138.32 48.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.105 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 34.3 tp -118.69 104.08 10.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.879 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.464 HG22 ' N ' ' A' ' 1' ' ' SER . 0.6 OUTLIER -100.59 149.28 23.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.763 179.97 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.906 ' HB3' HD11 ' A' ' 2' ' ' ILE . 0.4 OUTLIER -63.04 -14.62 50.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.626 -179.94 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.2 t -105.89 -14.17 15.29 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.47 ' HA ' HG23 ' A' ' 95' ' ' VAL . 9.4 mttt -179.81 -173.32 0.24 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.916 0.388 . . . . 0.0 111.138 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.449 HG22 ' HE1' ' A' ' 22' ' ' PHE . 3.2 mt -129.72 130.13 66.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.436 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -106.82 142.85 35.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.016 0.436 . . . . 0.0 111.357 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.68 ' OH ' HD11 ' A' ' 9' ' ' LEU . 25.3 t80 -136.49 122.05 19.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.805 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.4 p . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.986 -179.941 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.279 0 N-CA-C 112.44 -0.264 . . . . 0.0 112.44 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.419 HG21 ' HD3' ' A' ' 28' ' ' LYS . 11.3 p -93.14 147.18 5.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.776 0.322 . . . . 0.0 111.082 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.2 mp -142.26 133.21 25.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.948 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.435 ' HA ' ' HG3' ' A' ' 28' ' ' LYS . 1.4 t0 -70.55 127.42 32.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.906 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.737 HG11 ' HB ' ' A' ' 146' ' ' VAL . 4.5 t -69.12 -45.96 29.68 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.347 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.492 ' CD ' ' N ' ' A' ' 95' ' ' VAL . 6.4 Cg_exo -73.87 56.37 3.56 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.766 2.311 . . . . 0.0 112.409 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.457 ' HB2' ' O ' ' A' ' 96' ' ' PRO . . . 175.22 38.94 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.021 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 34.2 m -148.6 108.67 4.08 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.902 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -91.45 126.25 36.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.816 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.937 HD13 HG23 ' A' ' 116' ' ' ILE . 6.4 mm -90.04 161.37 2.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.106 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.414 ' N ' HG22 ' A' ' 100' ' ' ILE . . . -152.52 88.66 1.36 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.857 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.402 HG22 ' N ' ' A' ' 103' ' ' ARG . 76.4 mt -57.02 152.54 2.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.283 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.402 ' N ' HG22 ' A' ' 102' ' ' ILE . 18.1 mtt180 -143.7 118.08 6.09 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.241 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -81.02 37.44 0.68 Allowed 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.351 2.034 . . . . 0.0 112.756 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -178.42 63.58 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.939 0.4 . . . . 0.0 110.525 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -56.37 -95.9 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.73 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.59 165.36 0.82 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.83 0.348 . . . . 0.0 111.126 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.2 m120 56.12 47.14 20.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.073 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 24.6 m-20 63.17 58.26 1.46 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.088 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 6.8 mmt85 -152.25 88.73 1.39 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.782 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 69.4 mt -67.78 -33.01 73.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.02 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.682 ' HB3' HD13 ' A' ' 136' ' ' LEU . 19.0 m-85 -91.62 96.83 10.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.966 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 22.0 t -152.74 127.56 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.03 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.423 ' CZ ' ' HB ' ' A' ' 128' ' ' VAL . 43.4 p90 -114.64 138.55 50.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.785 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 20.3 m -107.63 128.38 54.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.074 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.937 HG23 HD13 ' A' ' 100' ' ' ILE . 20.0 mt -99.09 159.59 3.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.928 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.466 ' N ' HG22 ' A' ' 116' ' ' ILE . 81.1 p -152.54 158.81 43.06 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.866 0.365 . . . . 0.0 110.939 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 43.7 mtp -130.63 93.96 30.49 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.828 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.39 61.89 2.1 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.475 2.117 . . . . 0.0 112.306 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.7 m -165.16 -44.88 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.979 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.478 ' CG1' ' N ' ' A' ' 122' ' ' ALA . 2.5 p -75.57 -47.72 32.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.93 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.642 ' HB3' ' CD1' ' A' ' 124' ' ' TRP . . . 174.64 -163.32 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.742 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 24.1 mm-40 -93.6 44.92 1.14 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.886 0.374 . . . . 0.0 110.751 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' TRP . . . . . 0.642 ' CD1' ' HB3' ' A' ' 122' ' ' ALA . 13.7 m95 -98.39 130.17 45.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.901 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 8.6 t -120.47 133.99 55.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.941 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.551 HD23 HD12 ' A' ' 116' ' ' ILE . 12.2 tp -98.58 152.68 19.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.922 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -125.72 128.16 47.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.775 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.926 HG12 HD12 ' A' ' 7' ' ' LEU . 16.9 t -150.15 141.1 16.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.16 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.453 ' HB1' ' O ' ' A' ' 112' ' ' PHE . . . -143.57 121.86 12.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.167 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.441 ' HB2' HD11 ' A' ' 7' ' ' LEU . . . -82.39 142.2 32.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.883 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -54.07 -44.15 70.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.082 0.468 . . . . 0.0 110.95 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.1 p -92.63 120.4 33.02 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.718 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.401 ' HG3' ' CZ ' ' A' ' 112' ' ' PHE . 0.6 OUTLIER -49.86 -24.13 2.29 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.654 179.553 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -73.99 -48.15 32.28 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.626 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -62.76 -33.11 74.48 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.319 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.682 HD13 ' HB3' ' A' ' 112' ' ' PHE . 8.8 tt -66.92 -49.3 65.96 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.634 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.67 -36.44 76.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.416 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -70.98 -29.26 65.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.378 179.456 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' TRP . . . . . 0.541 ' CZ2' HD23 ' A' ' 7' ' ' LEU . 1.5 m95 -70.49 -46.05 64.46 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.742 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.616 HG13 HG21 ' A' ' 100' ' ' ILE . 26.2 t -64.55 -38.66 83.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.864 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.69 -38.04 88.13 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.835 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.419 ' O ' HG23 ' A' ' 146' ' ' VAL . 0.1 OUTLIER -66.0 -49.18 68.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.364 179.71 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.837 HG21 HD11 ' A' ' 100' ' ' ILE . 30.5 mt -54.1 -38.52 38.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.275 0.56 . . . . 0.0 109.573 178.823 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 14.7 mtt180 -77.95 -27.8 49.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.395 179.033 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.833 ' O ' HG23 ' A' ' 149' ' ' THR . 6.2 tt0 -73.34 -35.65 66.06 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.584 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.737 ' HB ' HG11 ' A' ' 95' ' ' VAL . 46.6 t -78.01 -34.02 18.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.034 179.147 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.71 -38.47 73.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.506 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -64.86 -20.34 66.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.611 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.833 HG23 ' O ' ' A' ' 145' ' ' GLU . 5.1 p -101.12 -33.48 10.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.118 0.485 . . . . 0.0 110.499 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.195 -0.907 . . . . 0.0 111.283 -179.953 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.5 m . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.845 0.355 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.41 ' CD1' ' HA ' ' A' ' 26' ' ' SER . 41.7 mt -84.34 -33.98 9.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.197 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.412 ' HB2' ' HB3' ' A' ' 24' ' ' LEU . 2.9 mmtt -134.38 139.36 45.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.02 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.759 ' OD1' HG22 ' A' ' 23' ' ' VAL . 7.0 m-80 -149.79 125.54 10.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.803 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -169.99 178.62 42.76 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.476 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.601 HD13 ' HD1' ' A' ' 21' ' ' TYR . 23.1 mm -94.02 90.02 2.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.882 0.372 . . . . 0.0 111.034 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.875 HD12 HG12 ' A' ' 128' ' ' VAL . 3.4 mm? -92.04 139.67 30.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.929 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -79.86 164.84 23.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.97 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.3 tt -171.86 134.38 0.78 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.932 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.441 ' HG3' ' CZ3' ' A' ' 17' ' ' TRP . 14.6 mt-10 -65.31 90.54 0.1 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.962 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.72 138.36 96.86 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.679 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.56 -8.66 22.91 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.447 2.098 . . . . 0.0 112.552 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.4 t -67.43 -42.4 87.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.992 0.425 . . . . 0.0 110.998 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -132.1 4.54 4.1 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.555 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 8.5 t-160 52.66 59.49 4.45 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.915 0.388 . . . . 0.0 111.147 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -158.68 159.59 35.48 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.884 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.441 ' CZ3' ' HG3' ' A' ' 10' ' ' GLU . 46.4 m95 -57.6 129.86 43.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.923 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -134.67 124.64 17.0 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.836 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.13 88.54 0.82 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.377 2.052 . . . . 0.0 112.318 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -111.75 151.89 28.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.839 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.601 ' HD1' HD13 ' A' ' 6' ' ' ILE . 5.1 t80 -60.05 155.74 16.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.898 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.406 ' HB3' ' CH2' ' A' ' 139' ' ' TRP . 0.1 OUTLIER -154.14 138.29 16.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.775 -179.892 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.759 HG22 ' OD1' ' A' ' 4' ' ' ASN . 6.3 t -127.77 153.86 37.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.37 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.533 HD13 ' N ' ' A' ' 25' ' ' THR . 0.8 OUTLIER -133.5 119.37 19.46 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.923 -179.939 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.533 ' N ' HD13 ' A' ' 24' ' ' LEU . 11.0 p -103.26 157.51 16.96 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.94 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.41 ' HA ' ' CD1' ' A' ' 2' ' ' ILE . 4.1 t -39.94 -32.45 0.16 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.246 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 58.6 m -152.09 48.27 0.77 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.657 0.265 . . . . 0.0 111.467 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.1 mtmm -175.5 156.54 1.97 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.989 0.423 . . . . 0.0 111.252 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.7 mt -124.34 123.7 66.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.707 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.546 ' HE2' HD13 ' A' ' 89' ' ' LEU . 41.6 m-85 -115.5 154.0 30.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.025 0.44 . . . . 0.0 111.255 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 21.6 p90 -158.99 148.9 19.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.713 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 84.2 p -150.69 176.45 11.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.033 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.41 -16.45 25.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.172 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 68.49 96.77 0.06 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.866 0.365 . . . . 0.0 110.882 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.47 HG22 ' H ' ' A' ' 36' ' ' SER . 0.2 OUTLIER -71.08 -174.76 1.02 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.938 -179.962 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.47 ' H ' HG22 ' A' ' 35' ' ' THR . 2.9 p -98.2 39.92 1.21 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.888 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.0 t -102.9 118.11 36.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.937 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -161.28 80.51 0.6 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.914 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 59.27 31.97 21.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.825 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -86.76 59.07 4.6 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.487 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -133.29 42.62 3.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.889 0.376 . . . . 0.0 110.886 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -139.03 40.58 2.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.969 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -154.12 85.8 1.16 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.907 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -103.25 135.32 45.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.921 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.19 101.91 9.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.838 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -144.54 159.12 52.41 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.939 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.96 63.16 1.91 Allowed 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.512 2.142 . . . . 0.0 112.325 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 63.54 137.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.994 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -84.05 163.39 19.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.834 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -144.0 125.16 14.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.142 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.8 m -101.48 146.09 28.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.991 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.81 -168.37 33.62 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.53 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.8 m -98.68 32.67 2.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.735 0.302 . . . . 0.0 110.889 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.3 t -151.08 121.84 7.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.906 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.462 ' O ' HD12 ' A' ' 56' ' ' LEU . 0.7 OUTLIER -161.88 179.52 7.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.851 179.968 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.462 HD12 ' O ' ' A' ' 55' ' ' GLU . 10.1 mp -124.6 166.03 16.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.945 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -176.07 90.24 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.824 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.3 m -99.77 -178.3 3.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.93 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.411 ' O ' ' CB ' ' A' ' 60' ' ' LEU . 2.5 p -150.09 166.98 28.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.758 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.411 ' CB ' ' O ' ' A' ' 59' ' ' SER . 0.2 OUTLIER 80.67 -10.58 1.23 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.573 -179.889 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.67 -28.32 21.89 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.935 0.397 . . . . 0.0 110.419 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.2 t -70.17 -36.51 68.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.733 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.53 -15.6 63.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.934 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -89.73 21.58 3.46 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.261 0.553 . . . . 0.0 110.561 179.098 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -151.43 26.47 0.68 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.493 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -114.74 -75.01 0.62 Allowed Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.377 -0.828 . . . . 0.0 112.181 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -62.61 84.22 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.656 2.237 . . . . 0.0 112.26 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 59.56 80.49 0.27 Allowed Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.962 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -80.26 7.7 4.56 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 123.163 2.575 . . . . 0.0 112.794 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -96.5 30.18 2.66 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.794 0.33 . . . . 0.0 111.279 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.472 ' O ' HG22 ' A' ' 71' ' ' ILE . 17.4 mt -104.75 -12.33 9.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.697 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.441 HD23 ' HA ' ' A' ' 72' ' ' LEU . 14.2 mt -90.15 20.69 4.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.138 0.494 . . . . 0.0 111.471 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -150.31 66.86 7.99 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.449 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -68.69 59.56 1.15 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.858 2.372 . . . . 0.0 112.356 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -107.31 -41.79 5.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.013 0.435 . . . . 0.0 110.884 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.818 ' HD3' HD22 ' A' ' 79' ' ' LEU . 13.0 mtt85 -156.78 139.4 15.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.764 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.666 ' O ' HD12 ' A' ' 79' ' ' LEU . 13.6 pt-20 -124.16 131.76 53.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.921 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 62.52 38.29 12.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.891 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.818 HD22 ' HD3' ' A' ' 76' ' ' ARG . 0.5 OUTLIER -126.94 -178.25 4.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.858 179.996 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.91 72.33 0.24 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.873 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -93.43 116.34 28.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.998 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 59.46 40.02 21.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.864 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.407 ' N ' ' CD ' ' A' ' 84' ' ' PRO . 0.3 OUTLIER -76.43 -55.28 1.7 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.926 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.407 ' CD ' ' N ' ' A' ' 83' ' ' SER . 85.9 Cg_endo -83.02 50.94 3.51 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 123.148 2.565 . . . . 0.0 112.402 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 85' ' ' LEU . 5.6 mt -164.57 -44.04 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.895 0.378 . . . . 0.0 110.908 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -111.92 40.45 2.53 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.594 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -165.77 -44.81 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.937 0.398 . . . . 0.0 110.873 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 8.8 mp 56.12 89.17 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.925 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.584 ' H ' HD23 ' A' ' 89' ' ' LEU . 0.6 OUTLIER -67.79 132.65 47.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.044 -179.959 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -95.52 -36.4 11.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.771 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -138.7 147.75 19.45 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.42 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 11.4 p -144.23 151.82 15.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.78 0.324 . . . . 0.0 111.115 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.521 HD23 ' N ' ' A' ' 94' ' ' ASP . 0.6 OUTLIER -156.04 170.89 21.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.891 -179.991 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.521 ' N ' HD23 ' A' ' 93' ' ' LEU . 64.0 m-20 -100.59 118.56 37.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.976 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.694 HG23 HG23 ' A' ' 143' ' ' ILE . 12.6 p -83.31 -27.6 0.42 Allowed Pre-proline 0 CA--C 1.535 0.403 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.659 ' CD ' ' N ' ' A' ' 95' ' ' VAL . 95.2 Cg_endo -85.51 49.77 2.51 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.153 1.902 . . . . 0.0 112.539 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -179.43 38.13 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.977 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 31.1 p -137.31 173.94 11.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.961 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 50.0 tp60 -137.84 113.5 9.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.703 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.914 HD13 HG23 ' A' ' 116' ' ' ILE . 14.6 mm -79.13 159.68 4.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.035 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.476 ' N ' HG22 ' A' ' 100' ' ' ILE . . . -151.68 92.5 1.76 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.969 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 50.1 mt -58.24 138.54 19.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.022 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -127.31 107.95 21.35 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.715 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -77.69 22.85 0.58 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.783 2.322 . . . . 0.0 112.631 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -173.38 64.86 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.961 0.41 . . . . 0.0 110.483 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -56.79 -95.84 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.721 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.85 156.04 0.6 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.855 0.36 . . . . 0.0 111.045 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 66.2 m-80 58.43 57.4 3.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.113 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 59.06 58.49 3.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.088 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -152.59 90.14 1.46 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.723 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.456 HD12 ' CZ ' ' A' ' 112' ' ' PHE . 0.3 OUTLIER -81.41 -27.97 34.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.184 -179.84 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.738 ' HB3' HD13 ' A' ' 136' ' ' LEU . 36.3 m-85 -101.31 95.59 6.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.001 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.492 HG22 ' HB2' ' A' ' 129' ' ' ALA . 21.4 t -153.6 120.9 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.039 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.451 ' CZ ' ' HB ' ' A' ' 128' ' ' VAL . 42.1 p90 -105.3 122.17 45.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.805 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 22.9 t -92.95 131.44 37.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.12 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.914 HG23 HD13 ' A' ' 100' ' ' ILE . 16.6 mt -97.62 160.72 2.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.828 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.463 ' N ' HG22 ' A' ' 116' ' ' ILE . 99.2 p -173.29 128.66 0.45 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.094 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.38 127.56 32.66 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.721 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -84.37 48.15 2.38 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.733 2.289 . . . . 0.0 112.708 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.8 m 177.8 39.25 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.935 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.587 ' O ' ' HB2' ' A' ' 122' ' ' ALA . 2.5 p -131.72 -49.61 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.086 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.587 ' HB2' ' O ' ' A' ' 121' ' ' VAL . . . 165.3 40.16 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.195 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 7.0 mm100 51.19 32.16 7.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.148 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' TRP . . . . . 0.43 ' CD1' ' HB3' ' A' ' 122' ' ' ALA . 23.0 m95 -69.75 171.59 8.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.895 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 75.3 p -158.23 110.75 2.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.912 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 5.3 tp -100.02 162.01 13.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.881 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -140.26 130.93 25.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.936 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.875 HG12 HD12 ' A' ' 7' ' ' LEU . 39.1 t -144.32 147.02 19.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.922 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.492 ' HB2' HG22 ' A' ' 113' ' ' VAL . . . -139.64 133.88 31.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.244 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.554 ' H ' HD12 ' A' ' 136' ' ' LEU . . . -102.85 135.0 45.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.851 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.76 -47.93 59.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.321 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -87.61 117.4 26.39 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.897 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.452 ' HG2' ' CE2' ' A' ' 112' ' ' PHE . 1.3 mt-30 -47.92 -27.96 2.44 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.342 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.66 -42.54 51.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.523 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -64.54 -34.04 77.31 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.055 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.738 HD13 ' HB3' ' A' ' 112' ' ' PHE . 8.9 tt -66.83 -52.24 46.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.543 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -67.03 -36.9 83.12 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.313 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -69.72 -31.53 69.58 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.483 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' TRP . . . . . 0.409 ' CZ2' HD23 ' A' ' 7' ' ' LEU . 0.4 OUTLIER -67.68 -44.8 76.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.489 179.592 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.649 HG13 HG21 ' A' ' 100' ' ' ILE . 23.8 t -61.48 -45.21 99.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.723 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 8.3 ttmt -60.94 -36.22 78.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.633 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.514 ' O ' HG22 ' A' ' 146' ' ' VAL . 0.0 OUTLIER -65.99 -50.03 65.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.347 179.787 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.728 HG21 HD11 ' A' ' 100' ' ' ILE . 69.0 mt -52.79 -36.88 24.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.246 0.546 . . . . 0.0 109.641 178.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 28.6 mtp85 -78.69 -27.65 45.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.509 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.503 ' O ' HG22 ' A' ' 149' ' ' THR . 1.9 tt0 -73.44 -38.38 65.52 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.645 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.514 HG22 ' O ' ' A' ' 142' ' ' LYS . 13.4 m -79.27 -30.51 14.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.272 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -76.25 -34.16 59.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.396 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -76.12 -11.0 59.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.894 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.503 HG22 ' O ' ' A' ' 145' ' ' GLU . 15.3 t -119.07 15.52 13.26 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.198 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.431 ' HB3' ' HB3' ' A' ' 96' ' ' PRO . . . . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.204 -0.903 . . . . 0.0 111.092 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 8.4 t . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.871 0.367 . . . . 0.0 111.24 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.832 HD11 ' HB3' ' A' ' 26' ' ' SER . 31.0 mt -83.53 -34.6 10.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.082 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.7 tptt -148.75 115.72 6.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.03 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.9 ' HB3' HG13 ' A' ' 23' ' ' VAL . 14.5 p-10 -137.08 137.53 39.42 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.81 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -170.03 -167.92 31.18 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.532 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 23.9 mm -94.27 96.31 5.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.799 0.333 . . . . 0.0 111.056 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.62 HD12 HG12 ' A' ' 128' ' ' VAL . 1.3 mm? -101.6 154.28 19.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.847 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.44 ' CD1' ' N ' ' A' ' 8' ' ' TYR . 3.0 m-85 -109.92 131.22 55.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.918 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.75 HD13 ' CZ ' ' A' ' 22' ' ' PHE . 3.6 mp -125.09 -2.09 7.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.632 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.455 ' HB3' ' CD2' ' A' ' 17' ' ' TRP . 2.9 pt-20 46.5 -169.8 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.951 0.405 . . . . 0.0 111.449 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -150.5 146.27 19.55 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.531 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -75.04 -17.37 19.5 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.434 2.09 . . . . 0.0 112.577 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.4 t -73.85 -41.73 53.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.935 0.397 . . . . 0.0 111.155 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -106.32 -23.18 12.61 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.906 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 64.88 33.24 10.17 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.917 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -126.0 143.86 50.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.852 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.455 ' CD2' ' HB3' ' A' ' 10' ' ' GLU . 40.0 m95 -90.04 124.81 35.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.042 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.434 ' CE1' ' HA ' ' A' ' 10' ' ' GLU . 1.7 p90 -127.81 147.6 63.56 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.63 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -67.99 124.72 12.14 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.491 2.127 . . . . 0.0 112.452 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -125.55 165.29 18.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.664 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -98.99 110.01 22.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.884 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.75 ' CZ ' HD13 ' A' ' 9' ' ' LEU . 7.5 m-85 -123.1 132.01 53.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.842 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.9 HG13 ' HB3' ' A' ' 4' ' ' ASN . 29.8 t -121.13 134.39 64.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.92 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.628 HD12 HG12 ' A' ' 29' ' ' ILE . 24.6 tp -110.4 107.37 17.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.146 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 17.3 p -100.86 144.2 30.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.788 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.832 ' HB3' HD11 ' A' ' 2' ' ' ILE . 12.6 p -51.91 -21.47 3.01 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.827 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.412 ' O ' ' CG ' ' A' ' 28' ' ' LYS . 12.6 p -101.19 -27.58 13.14 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.745 ' HA ' HG23 ' A' ' 95' ' ' VAL . 4.5 mtmp? -162.2 -175.45 4.59 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.912 0.387 . . . . 0.0 111.341 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.628 HG12 HD12 ' A' ' 24' ' ' LEU . 3.1 mt -128.82 117.31 44.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.677 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.415 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 7.4 m-85 -89.28 138.87 31.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.157 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.457 ' HB3' ' CD2' ' A' ' 22' ' ' PHE . 5.4 p90 -162.04 102.7 1.13 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.829 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 34.9 p 178.29 85.4 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.745 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 62.71 177.93 0.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.891 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -77.11 167.03 22.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.895 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -73.91 146.45 44.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.994 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.3 m -163.69 37.45 0.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.914 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.9 m 60.65 171.43 0.09 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.903 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.7 t70 60.44 40.55 17.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.874 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -128.88 31.82 4.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.914 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 68.55 29.51 72.92 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.585 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -107.67 31.43 5.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.842 0.353 . . . . 0.0 110.825 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -104.21 37.09 2.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.902 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -146.35 83.79 1.62 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.919 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -86.55 149.63 24.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.937 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.82 84.46 1.29 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.821 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -141.37 100.45 6.28 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.903 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -68.33 111.54 2.54 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.403 2.069 . . . . 0.0 112.297 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.65 51.4 0.79 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.0 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 61.34 177.45 0.11 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.967 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -128.72 -175.9 3.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.104 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.4 m -148.76 -72.48 0.19 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.875 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -91.57 161.72 27.49 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.491 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.1 p -109.79 139.65 44.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.861 0.362 . . . . 0.0 110.94 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.6 t -158.23 159.55 36.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.964 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.22 128.6 37.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.936 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.7 tp -97.78 145.15 26.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.91 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 7.3 m170 -105.49 107.61 18.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.84 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.7 t -64.27 118.39 8.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.835 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.71 109.5 21.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.879 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.6 mp -147.45 -45.85 0.17 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.944 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -57.3 -30.6 64.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.997 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.7 t -63.59 -29.72 48.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.158 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.803 ' O ' HD23 ' A' ' 63' ' ' LEU . 3.8 tt -87.48 -13.49 42.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.29 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -88.41 24.47 1.91 Allowed 'General case' 0 C--O 1.231 0.118 0 CA-C-O 121.27 0.557 . . . . 0.0 110.465 179.201 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 177.04 33.5 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.669 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.42 ' N ' ' CD ' ' A' ' 67' ' ' PRO . . . -166.84 50.22 0.25 Allowed Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.692 -0.686 . . . . 0.0 112.361 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.42 ' CD ' ' N ' ' A' ' 66' ' ' GLY . 43.6 Cg_endo -67.66 135.94 37.5 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.537 2.158 . . . . 0.0 112.018 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 62.91 105.69 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.595 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.2 11.04 1.89 Allowed 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.848 2.366 . . . . 0.0 113.07 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -95.21 29.92 2.34 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.802 0.334 . . . . 0.0 111.422 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.485 ' O ' HG22 ' A' ' 71' ' ' ILE . 21.1 mt -101.97 -11.78 8.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.631 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 15.6 mt -88.77 20.2 3.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.2 0.524 . . . . 0.0 111.414 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 76.8 mt-10 -156.24 83.73 3.34 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.231 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -68.87 57.24 1.08 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.85 2.367 . . . . 0.0 112.654 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.21 -76.89 0.45 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.865 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.6 mtt85 -115.15 137.61 51.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.934 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -160.63 80.32 0.65 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.854 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 60.08 79.03 0.25 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.843 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.2 mp -101.43 -170.14 1.79 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.926 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 33.5 p30 -82.65 61.15 5.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.917 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -67.74 122.53 18.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.824 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 23.9 p30 -97.22 38.43 1.25 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.126 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.468 ' CB ' ' HD2' ' A' ' 84' ' ' PRO . 0.3 OUTLIER -54.67 173.97 0.21 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.168 179.455 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.468 ' HD2' ' CB ' ' A' ' 83' ' ' SER . 52.2 Cg_endo -69.88 55.85 1.37 Allowed 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.154 1.903 . . . . 0.0 112.457 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.1 mt 51.12 23.49 1.59 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.535 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 43.38 42.93 5.86 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 121.012 -0.614 . . . . 0.0 113.049 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -99.49 -38.07 8.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.751 0.31 . . . . 0.0 111.231 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.68 -73.03 0.7 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.996 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.22 115.62 20.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.999 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.415 ' HB3' ' CZ ' ' A' ' 31' ' ' TYR . 1.7 tpt180 -120.76 -37.46 2.99 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.238 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 103.4 -23.19 33.81 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.942 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.716 HG22 ' HD2' ' A' ' 28' ' ' LYS . 15.0 p -163.74 141.58 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.758 0.313 . . . . 0.0 111.298 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -151.95 153.47 34.16 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.917 0.389 . . . . 0.0 111.05 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -71.99 133.87 45.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.956 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.745 HG23 ' HA ' ' A' ' 28' ' ' LYS . 13.6 t -75.04 -47.71 4.6 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.707 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.507 ' HD2' ' N ' ' A' ' 95' ' ' VAL . 73.7 Cg_endo -75.67 58.78 5.42 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.156 1.904 . . . . 0.0 112.495 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -176.21 36.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.974 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 27.3 p -139.12 162.43 34.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.924 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.15 108.74 6.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.859 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 1.037 HD13 HG23 ' A' ' 116' ' ' ILE . 15.1 mm -79.84 160.51 4.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.168 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.469 ' N ' HG22 ' A' ' 100' ' ' ILE . . . -161.21 92.26 0.9 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.99 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 45.5 mt -59.47 141.26 16.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.073 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -134.79 106.64 10.66 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.731 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.402 ' HA ' ' O ' ' A' ' 111' ' ' LEU . 13.0 Cg_exo -69.8 50.91 0.86 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.576 2.184 . . . . 0.0 112.409 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 173.36 53.09 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.991 0.424 . . . . 0.0 110.26 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.401 ' HA3' HG21 ' A' ' 113' ' ' VAL . . . -44.47 -87.43 0.01 OUTLIER Glycine 0 C--N 1.332 0.312 0 CA-C-N 115.986 -0.552 . . . . 0.0 113.127 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.1 mttt 178.96 169.02 0.93 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.997 0.427 . . . . 0.0 111.101 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 60.95 -82.75 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.21 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -150.55 31.85 0.65 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.908 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 1.2 mmt85 -118.0 110.5 17.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.878 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.447 ' H ' HD23 ' A' ' 111' ' ' LEU . 0.3 OUTLIER -85.62 -32.07 22.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.954 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.439 ' CE2' ' HG3' ' A' ' 133' ' ' GLN . 5.2 m-85 -105.89 87.52 2.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.87 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.723 HG13 ' HB2' ' A' ' 129' ' ' ALA . 22.0 t -132.21 143.66 39.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.104 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.435 ' CE2' ' HB ' ' A' ' 128' ' ' VAL . 19.0 p90 -125.57 133.65 52.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.928 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -105.18 141.35 36.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.831 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 1.037 HG23 HD13 ' A' ' 100' ' ' ILE . 12.5 mt -105.26 157.91 5.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.97 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.424 ' N ' HG22 ' A' ' 116' ' ' ILE . 55.8 p -150.13 -166.84 2.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.839 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 28.0 mtp -135.9 155.57 77.76 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.934 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -63.7 73.11 0.16 Allowed 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.692 2.261 . . . . 0.0 112.359 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 59.26 109.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.947 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.0 t -145.56 -66.63 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.058 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.706 ' HB3' ' NE1' ' A' ' 124' ' ' TRP . . . -176.01 73.06 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.032 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.402 ' HG2' ' O ' ' A' ' 122' ' ' ALA . 0.0 OUTLIER 40.63 36.87 0.41 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.781 -179.917 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 124' ' ' TRP . . . . . 0.706 ' NE1' ' HB3' ' A' ' 122' ' ' ALA . 22.6 m95 -91.89 126.25 36.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.872 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.9 t -165.65 120.37 1.24 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.903 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.493 ' H ' HD23 ' A' ' 126' ' ' LEU . 0.5 OUTLIER -101.88 166.66 10.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.877 179.943 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -115.08 142.26 46.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.936 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.62 HG12 HD12 ' A' ' 7' ' ' LEU . 17.1 t -148.56 154.01 10.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.022 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.723 ' HB2' HG13 ' A' ' 113' ' ' VAL . . . -159.84 135.08 8.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.252 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -104.71 132.25 51.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.962 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -54.49 -36.75 64.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.069 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.77 111.98 23.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.804 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.439 ' HG3' ' CE2' ' A' ' 112' ' ' PHE . 5.2 tt0 -48.31 -28.64 3.25 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.521 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.95 -40.88 53.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.279 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.53 -33.33 73.93 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.054 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.542 ' O ' HG23 ' A' ' 140' ' ' VAL . 5.2 tt -66.68 -48.52 69.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.41 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -69.26 -38.1 78.27 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.291 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -69.88 -28.76 65.9 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.282 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' TRP . . . . . 0.615 ' CZ2' HD23 ' A' ' 7' ' ' LEU . 1.3 m95 -69.64 -46.93 65.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.599 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 136' ' ' LEU . 25.4 t -63.44 -40.11 87.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.033 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 5.5 ttpp -65.59 -36.6 84.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.797 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.428 ' O ' HG23 ' A' ' 146' ' ' VAL . 0.1 OUTLIER -67.42 -50.35 59.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.464 179.849 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.491 HG21 HD11 ' A' ' 100' ' ' ILE . 54.7 mt -54.53 -35.85 33.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.311 0.577 . . . . 0.0 109.498 178.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 14.4 mtp-105 -76.97 -29.4 55.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.385 179.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.697 ' O ' HG22 ' A' ' 149' ' ' THR . 3.9 tt0 -75.87 -32.18 59.61 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-O 120.825 0.345 . . . . 0.0 110.621 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.738 ' HB ' HG11 ' A' ' 95' ' ' VAL . 59.1 t -78.82 -32.18 15.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.142 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.93 -39.68 66.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.845 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -72.47 -16.65 61.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.881 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.697 HG22 ' O ' ' A' ' 145' ' ' GLU . 11.9 t -111.62 16.81 20.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.896 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.14 -179.963 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.613 ' N ' HG22 ' A' ' 25' ' ' THR . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.829 0.347 . . . . 0.0 111.2 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.699 HD11 ' HA ' ' A' ' 26' ' ' SER . 30.1 mt -85.29 -33.18 7.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.246 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.5 tttp -160.0 141.52 12.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.944 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.771 ' OD1' HG13 ' A' ' 23' ' ' VAL . 6.4 m-80 -139.53 132.81 29.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.81 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -169.97 175.53 44.01 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.51 -0.853 . . . . 0.0 112.623 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.508 HD13 ' HA ' ' A' ' 21' ' ' TYR . 22.5 mm -93.1 75.83 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.775 0.321 . . . . 0.0 111.099 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.788 HD12 HG12 ' A' ' 128' ' ' VAL . 4.0 mm? -79.05 131.5 36.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.734 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.692 ' O ' HD12 ' A' ' 9' ' ' LEU . 50.6 m-85 -81.58 155.25 25.78 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.164 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.692 HD12 ' O ' ' A' ' 8' ' ' TYR . 2.1 mp -141.46 164.85 29.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.716 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.454 ' HG2' ' CE3' ' A' ' 17' ' ' TRP . 1.4 mm-40 -111.76 111.78 23.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.908 0.385 . . . . 0.0 111.1 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.22 113.04 50.07 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.339 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.58 -17.08 8.94 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.562 2.175 . . . . 0.0 113.137 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.6 t -63.99 -39.66 86.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.018 0.437 . . . . 0.0 110.947 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 16.4 m-80 -128.19 -6.74 5.4 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.597 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 53.84 63.24 2.26 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.88 0.371 . . . . 0.0 111.036 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -148.36 160.86 42.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.892 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.454 ' CE3' ' HG2' ' A' ' 10' ' ' GLU . 70.7 m95 -81.01 136.97 36.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.929 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -137.22 129.29 16.8 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.726 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.1 138.95 31.76 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.487 2.125 . . . . 0.0 112.246 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -155.39 130.04 9.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.911 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.508 ' HA ' HD13 ' A' ' 6' ' ' ILE . 25.4 t80 -74.2 90.63 2.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.907 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.413 ' CD2' ' HB3' ' A' ' 31' ' ' TYR . 5.5 m-85 -76.84 143.73 39.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.927 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.771 HG13 ' OD1' ' A' ' 4' ' ' ASN . 22.6 t -121.54 102.75 12.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.926 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.546 HD23 ' HB ' ' A' ' 2' ' ' ILE . 1.4 tt -91.22 112.12 23.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.989 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.613 HG22 ' N ' ' A' ' 1' ' ' SER . 0.6 OUTLIER -106.64 152.04 24.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.826 179.885 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.699 ' HA ' HD11 ' A' ' 2' ' ' ILE . 7.7 t -70.11 58.57 0.16 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.714 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 178.38 -28.64 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.875 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.609 ' HE3' HG21 ' A' ' 92' ' ' VAL . 9.7 mtpt -172.89 168.82 4.92 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.831 0.348 . . . . 0.0 110.864 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 15.3 mt -107.99 128.51 63.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.012 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -121.69 118.51 29.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.868 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.413 ' HB3' ' CD2' ' A' ' 22' ' ' PHE . 37.7 p90 -123.43 146.86 47.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.944 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.7 m -163.34 151.84 13.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.934 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -59.2 114.2 2.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.81 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -150.49 130.75 13.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.987 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.496 HG22 ' H ' ' A' ' 36' ' ' SER . 0.2 OUTLIER -59.14 179.13 0.1 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.919 179.974 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.496 ' H ' HG22 ' A' ' 35' ' ' THR . 74.9 m -91.69 51.37 1.85 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.849 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 7.2 m -87.46 -169.48 2.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.959 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 60.93 86.1 0.11 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.901 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -143.89 37.79 1.31 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.954 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 116.21 -25.8 9.09 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.51 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 62.1 31.68 17.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.869 0.366 . . . . 0.0 110.898 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -101.26 35.49 2.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.952 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -146.25 123.51 11.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.906 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -138.67 172.4 12.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.879 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -164.01 130.18 3.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.809 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -59.86 141.65 89.24 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.954 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -74.12 157.14 46.74 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.56 2.173 . . . . 0.0 112.382 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.57 67.87 3.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.751 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -107.32 79.38 1.3 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.925 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -127.06 143.78 51.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.174 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.3 m -135.99 168.58 19.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.951 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 150.13 107.81 0.41 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.409 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -92.98 -31.51 14.87 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.779 0.323 . . . . 0.0 110.876 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.3 t -133.63 111.54 10.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.881 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.76 172.48 12.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.881 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.65 -74.7 0.3 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.895 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 54.0 m80 -134.57 -52.31 0.81 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.868 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 53.3 p -86.95 -169.83 2.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.922 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.9 p -157.82 135.72 10.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.913 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.1 tp -144.18 -47.62 0.27 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.95 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -65.58 -30.58 71.33 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.772 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 27.6 t -70.69 -38.43 73.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.001 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.7 mp -68.28 -18.04 64.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.062 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -91.94 22.53 4.21 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.137 0.494 . . . . 0.0 110.805 179.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -155.64 27.74 0.38 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.865 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -97.91 -56.16 1.09 Allowed Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.423 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -51.68 139.56 48.08 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.634 2.223 . . . . 0.0 112.286 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 59.72 69.23 1.3 Allowed Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.865 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -85.98 15.54 2.18 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.738 2.292 . . . . 0.0 112.846 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.49 29.87 3.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.859 0.361 . . . . 0.0 111.264 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.571 ' O ' HG22 ' A' ' 71' ' ' ILE . 24.9 mt -101.7 -5.2 9.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.651 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 14.4 mt -91.69 22.06 4.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.059 0.457 . . . . 0.0 111.578 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -136.06 69.07 63.81 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.793 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -68.6 60.44 1.15 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.917 2.411 . . . . 0.0 112.191 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -55.2 -28.83 55.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.213 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.7 mtt85 -138.16 135.06 35.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.945 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -172.82 87.84 0.07 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.87 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 61.62 78.97 0.27 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.927 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 69.9 mt -134.51 115.38 13.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.906 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 59.73 31.74 21.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.804 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -69.5 142.38 53.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.968 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -73.07 -49.16 30.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.982 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.49 ' CB ' ' HD2' ' A' ' 84' ' ' PRO . 0.3 OUTLIER 55.49 178.4 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.208 -179.798 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.49 ' HD2' ' CB ' ' A' ' 83' ' ' SER . 68.0 Cg_endo -75.54 44.48 1.25 Allowed 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 122.022 1.815 . . . . 0.0 112.883 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.1 mp 43.57 54.22 5.5 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 113.3 -41.02 2.32 Favored Glycine 0 C--N 1.33 0.223 0 C-N-CA 120.559 -0.829 . . . . 0.0 113.054 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.45 ' CA ' ' HG2' ' A' ' 84' ' ' PRO . 16.3 t70 75.52 96.29 0.07 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.945 0.402 . . . . 0.0 110.992 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.2 mt -122.73 57.13 1.12 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.743 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.575 ' H ' HD23 ' A' ' 89' ' ' LEU . 0.5 OUTLIER -65.49 77.56 0.07 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.058 -179.838 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -167.73 80.84 0.19 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.894 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.412 ' HA3' ' CZ ' ' A' ' 31' ' ' TYR . . . -104.38 140.43 14.96 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.52 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.609 HG21 ' HE3' ' A' ' 28' ' ' LYS . 11.4 p -111.44 155.1 12.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.757 0.313 . . . . 0.0 111.127 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.426 ' N ' HG22 ' A' ' 92' ' ' VAL . 0.5 OUTLIER -154.29 112.33 3.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.918 -180.0 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.51 127.14 30.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.091 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.902 HG11 HG13 ' A' ' 146' ' ' VAL . 38.8 t -74.24 -48.4 5.77 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.577 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.659 ' HB3' ' HB3' ' A' ' 150' ' ' ALA . 64.3 Cg_endo -74.16 57.82 4.11 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.19 1.926 . . . . 0.0 112.349 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.494 ' HB2' ' O ' ' A' ' 96' ' ' PRO . . . 171.94 40.55 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.655 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -159.81 99.66 1.41 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.893 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -79.58 136.94 36.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.764 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.723 HD11 HG21 ' A' ' 143' ' ' ILE . 6.2 mm -87.26 162.58 2.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.054 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.562 ' HB3' ' O ' ' A' ' 115' ' ' SER . . . -149.85 83.74 1.4 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.0 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.577 HG12 HG21 ' A' ' 140' ' ' VAL . 69.0 mt -58.68 152.82 3.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.078 0.466 . . . . 0.0 111.215 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.419 ' N ' HG22 ' A' ' 102' ' ' ILE . 0.0 OUTLIER -147.94 114.99 4.01 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.213 179.644 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -78.42 42.47 1.24 Allowed 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.358 2.038 . . . . 0.0 112.688 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 175.16 62.32 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.045 0.45 . . . . 0.0 110.424 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -53.47 -93.54 0.01 OUTLIER Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.757 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.9 pttt -177.8 170.09 1.97 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.845 0.355 . . . . 0.0 110.949 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 64.07 -79.78 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.859 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -159.51 31.98 0.19 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.957 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 25.1 mmm180 -119.82 92.39 3.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.878 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.432 ' H ' HD12 ' A' ' 111' ' ' LEU . 3.8 mp -68.3 -30.75 69.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.854 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.487 ' HB3' HD13 ' A' ' 136' ' ' LEU . 40.2 m-85 -105.66 92.84 4.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.985 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.41 HG13 ' HB2' ' A' ' 129' ' ' ALA . 24.1 t -137.24 143.16 35.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.048 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.428 ' CE2' ' HB ' ' A' ' 128' ' ' VAL . 39.8 p90 -128.9 131.1 47.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.891 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.562 ' O ' ' HB3' ' A' ' 101' ' ' ALA . 1.2 m -102.38 128.33 49.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.833 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.691 HG23 HD13 ' A' ' 100' ' ' ILE . 1.6 mt -100.12 159.99 3.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.987 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.472 ' N ' HG22 ' A' ' 116' ' ' ILE . 60.9 p -153.76 149.95 27.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.945 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 39.7 mtp -96.12 108.48 41.53 Favored Pre-proline 0 CA--C 1.531 0.234 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.106 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -74.97 54.77 3.72 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.72 2.28 . . . . 0.0 112.394 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.9 p 171.39 41.84 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.72 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 45.2 t -150.5 -68.35 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.995 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -177.62 -154.36 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.316 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -85.62 45.62 1.22 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.7 0.286 . . . . 0.0 111.169 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 11.8 m0 -73.95 139.56 44.96 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.784 0.326 . . . . 0.0 110.744 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -140.58 110.25 6.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.097 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.45 112.37 24.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.913 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -84.51 118.75 24.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.98 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.788 HG12 HD12 ' A' ' 7' ' ' LEU . 21.7 t -141.95 151.79 18.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.925 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.542 ' O ' HD13 ' A' ' 7' ' ' LEU . . . -160.32 148.58 16.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.269 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -114.2 150.41 34.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.909 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.12 -58.82 6.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.864 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.76 113.64 11.14 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.751 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -48.74 -27.56 3.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.567 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 25.8 mp0 -73.84 -40.54 63.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.482 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -67.37 -31.77 72.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.173 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.489 ' O ' HG23 ' A' ' 140' ' ' VAL . 7.5 tt -68.12 -49.44 61.14 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.521 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.78 -40.31 84.0 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.307 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -67.32 -29.21 68.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.322 179.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' TRP . . . . . 0.502 ' CZ2' HD23 ' A' ' 7' ' ' LEU . 0.8 OUTLIER -67.82 -49.09 64.16 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.471 179.611 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.68 HG13 ' CB ' ' A' ' 100' ' ' ILE . 33.5 t -60.28 -40.97 85.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.034 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -67.25 -38.37 85.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.907 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.486 ' O ' HG12 ' A' ' 146' ' ' VAL . 6.4 mptt -66.59 -49.86 64.95 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.524 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.723 HG21 HD11 ' A' ' 100' ' ' ILE . 41.6 mt -55.21 -37.14 42.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.369 0.605 . . . . 0.0 109.532 178.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 24.3 mtp180 -79.85 -25.74 40.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.212 -0.903 . . . . 0.0 110.673 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -76.04 -38.71 56.88 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-O 120.909 0.385 . . . . 0.0 110.75 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.902 HG13 HG11 ' A' ' 95' ' ' VAL . 7.2 p -80.85 -28.57 11.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.236 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.47 ' HB2' HG12 ' A' ' 95' ' ' VAL . . . -79.29 -33.89 42.94 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.291 179.198 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -74.2 -13.78 60.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.883 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.45 HG22 ' HA ' ' A' ' 146' ' ' VAL . 9.2 t -105.4 -20.5 13.47 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.101 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.659 ' HB3' ' HB3' ' A' ' 96' ' ' PRO . . . . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.216 -0.897 . . . . 0.0 111.141 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.49 ' HB3' HG13 ' A' ' 23' ' ' VAL . 6.7 m . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.844 0.354 . . . . 0.0 111.184 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.4 HD12 HG11 ' A' ' 146' ' ' VAL . 38.3 mt -76.53 -34.78 24.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.148 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.8 tptp -142.01 91.94 2.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.871 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.678 ' HB3' HG13 ' A' ' 23' ' ' VAL . 24.5 p-10 -125.06 131.91 53.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.919 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -169.88 -165.18 26.83 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.525 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.657 HD13 ' HD1' ' A' ' 21' ' ' TYR . 25.1 mm -97.21 80.45 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.743 0.306 . . . . 0.0 111.1 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.697 HD23 ' CZ2' ' A' ' 139' ' ' TRP . 0.8 OUTLIER -87.58 158.62 18.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.779 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.476 ' C ' HD23 ' A' ' 9' ' ' LEU . 36.1 m-85 -102.16 163.68 12.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.026 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.75 HD21 ' HB2' ' A' ' 20' ' ' HIS . 0.6 OUTLIER -177.78 129.16 0.14 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.785 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.443 ' HG2' ' CZ3' ' A' ' 17' ' ' TRP . 0.0 OUTLIER -95.16 166.29 11.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.974 0.416 . . . . 0.0 111.024 -179.814 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.42 150.12 53.8 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.709 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -73.63 -17.96 22.84 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.597 2.198 . . . . 0.0 112.506 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.1 t -77.77 -38.62 25.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.985 0.421 . . . . 0.0 110.975 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -101.81 -23.88 14.13 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.835 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 63.87 33.27 12.72 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.822 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -144.76 156.1 43.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.048 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.443 ' CZ3' ' HG2' ' A' ' 10' ' ' GLU . 30.8 m95 -77.24 139.57 39.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.869 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -132.4 138.72 32.81 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.838 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.42 130.26 14.81 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.464 2.11 . . . . 0.0 112.3 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.75 ' HB2' HD21 ' A' ' 9' ' ' LEU . 9.7 m-70 -144.75 -178.34 5.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.864 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.657 ' HD1' HD13 ' A' ' 6' ' ' ILE . 34.1 t80 -119.96 139.39 52.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.934 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.49 ' CZ ' ' CD1' ' A' ' 31' ' ' TYR . 1.5 m-85 -132.44 148.28 52.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.873 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.678 HG13 ' HB3' ' A' ' 4' ' ' ASN . 21.7 t -140.0 92.06 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.03 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.64 HD11 HG21 ' A' ' 146' ' ' VAL . 0.2 OUTLIER -69.84 115.09 8.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.094 -179.857 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -99.44 157.28 16.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.023 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -42.83 -34.37 0.93 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.229 -179.47 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.432 ' HA ' HG11 ' A' ' 95' ' ' VAL . 5.5 p -144.14 46.66 1.43 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.732 0.301 . . . . 0.0 111.622 -179.499 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 177.12 167.68 0.57 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.834 0.35 . . . . 0.0 111.358 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.639 HG23 HD22 ' A' ' 24' ' ' LEU . 3.0 mt -132.2 100.32 4.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.539 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -73.43 132.17 42.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.172 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.49 ' CD1' ' CZ ' ' A' ' 22' ' ' PHE . 69.4 t80 -143.31 123.37 13.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.783 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.5 t -166.88 -79.02 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.885 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -162.06 179.4 8.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.918 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.431 ' HG2' ' CD1' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -80.83 146.56 30.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.918 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.05 143.99 28.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.817 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 95.2 p -148.99 38.11 0.81 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.944 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.1 m -128.2 173.76 9.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.879 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -122.26 97.17 5.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.977 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -144.73 48.93 1.31 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.877 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.37 44.75 2.43 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.485 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 31.6 p-10 -134.37 35.87 3.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.797 0.332 . . . . 0.0 110.826 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 45.14 35.22 1.59 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.433 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.6 t70 60.1 171.27 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.952 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -86.42 112.78 21.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.885 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -143.18 125.49 15.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.868 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -70.72 111.55 10.06 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.889 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.93 168.38 23.25 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.398 2.065 . . . . 0.0 112.261 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.06 152.25 22.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.853 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -118.99 168.02 11.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.886 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -111.96 90.99 3.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.137 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.6 p -86.78 160.59 18.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.92 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -101.37 -132.37 7.72 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.474 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.2 t -100.02 160.41 14.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.747 0.308 . . . . 0.0 110.858 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.3 t 43.1 72.21 0.19 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.487 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -160.12 170.38 21.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.853 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.98 138.33 52.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.845 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 20.7 p-80 -164.84 160.03 19.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.87 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.6 t -163.54 128.66 2.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.895 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 72.2 m -152.28 122.62 7.23 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.874 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -147.55 -46.92 0.17 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.906 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -59.53 -31.31 69.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.738 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.3 t -62.14 -34.41 63.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.859 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.0 mp -63.92 -18.89 64.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.958 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -90.27 21.97 3.56 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 121.188 0.518 . . . . 0.0 110.735 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.1 mm-40 -152.03 26.3 0.63 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.736 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.401 ' H ' ' HD2' ' A' ' 67' ' ' PRO . . . -101.87 -71.66 0.92 Allowed Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.483 -0.78 . . . . 0.0 112.206 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.401 ' HD2' ' H ' ' A' ' 66' ' ' GLY . 3.2 Cg_endo -46.06 113.21 0.55 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 123.03 2.487 . . . . 0.0 112.109 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.0 t30 63.35 90.91 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.778 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -82.23 9.53 3.94 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.769 2.313 . . . . 0.0 113.019 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -96.85 29.96 2.85 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.863 0.363 . . . . 0.0 111.223 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.549 ' O ' HG22 ' A' ' 71' ' ' ILE . 27.7 mt -99.59 -6.63 9.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.692 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 17.4 mt -92.0 21.31 5.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.114 0.483 . . . . 0.0 111.595 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -139.14 67.93 40.5 Favored Pre-proline 0 C--N 1.317 -0.821 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.575 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -68.18 60.22 1.0 Allowed 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 123.017 2.478 . . . . 0.0 112.279 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -93.45 20.17 7.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.209 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.1 mmt85 -147.16 170.76 16.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.891 0.376 . . . . 0.0 110.742 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 61.48 112.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.869 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 60.56 91.83 0.05 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.905 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.4 mp -124.05 -177.71 3.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.898 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.9 t70 60.33 38.21 19.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.8 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -87.55 55.11 3.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.903 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 -98.19 28.85 3.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.975 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.415 ' CB ' ' HD3' ' A' ' 84' ' ' PRO . 0.3 OUTLIER -74.04 -58.94 1.89 Allowed Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.96 -179.921 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.415 ' HD3' ' CB ' ' A' ' 83' ' ' SER . 74.0 Cg_endo -76.62 -44.4 0.23 Allowed 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.919 2.413 . . . . 0.0 112.47 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.4 tp 68.89 -66.79 0.23 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.042 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -100.77 155.69 19.3 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.591 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.45 -70.87 0.76 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.925 0.393 . . . . 0.0 110.963 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -145.93 -56.32 0.29 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.836 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -133.14 31.93 3.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.971 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.537 ' CD ' HG13 ' A' ' 92' ' ' VAL . 6.0 tmm_? -133.65 77.82 1.74 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.924 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -89.24 75.48 1.89 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.567 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.537 HG13 ' CD ' ' A' ' 90' ' ' ARG . 5.2 m -84.87 139.47 17.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.733 0.301 . . . . 0.0 111.091 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.1 mt -130.98 134.56 46.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.895 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -69.39 126.8 30.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.871 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.946 HG21 HG23 ' A' ' 146' ' ' VAL . 13.3 p -81.95 -27.73 0.44 Allowed Pre-proline 0 CA--C 1.534 0.347 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.649 ' CD ' ' N ' ' A' ' 95' ' ' VAL . 88.8 Cg_endo -85.97 47.64 1.89 Allowed 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.146 1.898 . . . . 0.0 112.665 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 178.69 39.37 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.865 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 1.9 m -119.48 173.51 6.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.958 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.01 102.59 2.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.769 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 1.031 HD13 HG23 ' A' ' 116' ' ' ILE . 14.7 mm -79.2 158.19 4.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.078 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.422 ' N ' HG22 ' A' ' 100' ' ' ILE . . . -155.56 93.17 1.46 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.037 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 54.3 mt -59.25 143.87 13.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.144 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.413 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 4.6 mtt180 -133.28 114.15 13.53 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.525 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 103' ' ' ARG . 3.0 Cg_exo -74.78 29.87 0.35 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.587 2.191 . . . . 0.0 112.651 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -177.62 74.22 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.734 0.302 . . . . 0.0 110.413 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -42.28 -84.67 0.01 OUTLIER Glycine 0 C--N 1.332 0.344 0 CA-C-N 116.077 -0.51 . . . . 0.0 113.19 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -175.11 -80.5 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.832 0.349 . . . . 0.0 111.236 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -96.8 109.71 22.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.215 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 32.8 m120 48.04 38.78 10.11 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.235 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 7.9 mmp_? -140.11 112.66 7.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.936 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.86 -33.51 12.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.822 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.667 ' HB3' HD13 ' A' ' 136' ' ' LEU . 3.4 m-85 -108.21 107.12 17.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.861 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.445 HG13 ' HB2' ' A' ' 129' ' ' ALA . 22.0 t -151.18 132.3 4.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.128 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.418 ' CE2' ' HB ' ' A' ' 128' ' ' VAL . 31.3 p90 -115.54 122.51 45.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.895 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 58.1 m -89.32 128.38 35.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.983 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 1.031 HG23 HD13 ' A' ' 100' ' ' ILE . 14.1 mt -100.97 158.5 4.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.996 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.422 ' N ' HG22 ' A' ' 116' ' ' ILE . 54.6 p -151.38 -170.52 3.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.968 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' MET . . . . . 0.481 ' SD ' HG21 ' A' ' 121' ' ' VAL . 32.7 mtp -146.82 105.02 3.92 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.073 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -78.16 59.17 6.91 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.506 2.137 . . . . 0.0 112.376 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -177.2 -45.6 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.877 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.481 HG21 ' SD ' ' A' ' 118' ' ' MET . 43.1 t -65.63 -66.69 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.999 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.439 ' HB3' ' HD1' ' A' ' 124' ' ' TRP . . . 179.88 -154.76 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.296 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -84.63 47.63 1.4 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.772 0.32 . . . . 0.0 111.04 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' TRP . . . . . 0.439 ' HD1' ' HB3' ' A' ' 122' ' ' ALA . 23.6 m95 -79.94 128.7 33.78 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.804 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.14 114.95 14.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.944 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.3 tp -112.5 112.62 24.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.022 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -82.2 126.46 32.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.858 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.47 HG12 HD12 ' A' ' 7' ' ' LEU . 21.2 t -136.44 154.43 32.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.077 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.445 ' HB2' HG13 ' A' ' 113' ' ' VAL . . . -161.21 127.37 3.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.144 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.494 ' H ' HD12 ' A' ' 136' ' ' LEU . . . -92.55 142.46 27.37 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.978 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -56.0 -37.66 69.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.896 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -97.55 114.02 25.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.797 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -48.5 -27.42 2.69 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.539 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -73.67 -42.12 61.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.357 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.19 -30.21 68.36 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.117 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.667 HD13 ' HB3' ' A' ' 112' ' ' PHE . 9.8 tt -68.44 -45.89 71.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.418 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 19.7 mm100 -68.05 -42.7 80.1 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.309 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -66.87 -30.44 70.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.325 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' TRP . . . . . 0.697 ' CZ2' HD23 ' A' ' 7' ' ' LEU . 1.0 OUTLIER -66.38 -46.74 75.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.512 179.563 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.677 HG13 HG21 ' A' ' 100' ' ' ILE . 40.6 t -61.45 -44.62 98.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.941 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 7.2 ttmm -63.46 -35.9 81.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.936 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.623 ' O ' HG22 ' A' ' 146' ' ' VAL . 0.0 OUTLIER -66.7 -52.0 49.69 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.476 179.792 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.578 HG21 HD11 ' A' ' 100' ' ' ILE . 74.0 mt -53.64 -34.92 25.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.28 0.562 . . . . 0.0 109.646 178.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 3.1 mtt180 -78.4 -28.39 46.91 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.584 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -74.91 -39.56 61.37 Favored 'General case' 0 CA--C 1.523 -0.088 0 CA-C-O 120.898 0.38 . . . . 0.0 110.78 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.946 HG23 HG21 ' A' ' 95' ' ' VAL . 8.9 m -78.74 -26.71 13.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.258 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -77.43 -35.01 54.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.819 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -78.53 -9.58 59.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.136 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.52 HG22 ' HA ' ' A' ' 146' ' ' VAL . 15.2 t -113.5 -30.14 6.95 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.777 0.323 . . . . 0.0 111.144 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.251 -0.88 . . . . 0.0 111.088 -179.989 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.4 p . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.749 0.309 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.891 HD11 ' HB3' ' A' ' 26' ' ' SER . 33.9 mt -74.93 -30.9 24.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.145 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.9 mttp -147.51 116.79 6.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.964 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.731 ' HB3' HG13 ' A' ' 23' ' ' VAL . 4.2 p-10 -135.37 124.81 24.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.896 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -163.31 -156.07 8.46 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.498 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 26.5 mm -105.53 99.61 8.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.814 0.34 . . . . 0.0 111.184 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.941 HD12 HG12 ' A' ' 128' ' ' VAL . 3.2 mm? -102.92 139.88 37.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.834 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -80.68 140.83 35.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.035 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.495 HD12 HG22 ' A' ' 128' ' ' VAL . 5.9 tt -152.49 102.57 2.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.797 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.409 ' HB3' ' CD2' ' A' ' 17' ' ' TRP . 0.6 OUTLIER -70.67 153.26 43.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.878 -179.806 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -113.25 150.71 43.46 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.913 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.07 -17.98 24.34 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.619 2.213 . . . . 0.0 112.549 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -72.4 -48.41 47.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.168 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -100.73 -19.39 16.05 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.936 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 59.9 42.51 16.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.973 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -146.4 146.62 30.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.874 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.429 ' CE2' ' HG3' ' A' ' 110' ' ' ARG . 58.7 m95 -72.72 150.5 42.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.873 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -144.33 139.91 16.22 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.851 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -73.83 87.94 1.1 Allowed 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.583 2.189 . . . . 0.0 112.41 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -104.27 162.64 13.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.874 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -93.3 137.64 32.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.845 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.501 ' CZ ' ' CE1' ' A' ' 31' ' ' TYR . 44.0 m-85 -138.66 156.56 47.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.938 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.731 HG13 ' HB3' ' A' ' 4' ' ' ASN . 25.3 t -141.17 150.28 20.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.874 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.453 HD12 HG12 ' A' ' 29' ' ' ILE . 21.0 tp -133.02 118.37 18.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.237 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 15.0 p -109.76 149.12 30.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.695 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.891 ' HB3' HD11 ' A' ' 2' ' ' ILE . 0.2 OUTLIER -56.79 -18.72 13.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.863 -179.671 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.2 m -99.09 -24.7 14.8 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 111.624 0.231 . . . . 0.0 111.624 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.546 ' HA ' HG23 ' A' ' 95' ' ' VAL . 0.0 OUTLIER -175.01 -173.92 0.73 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.727 0.298 . . . . 0.0 110.799 -179.647 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.699 ' O ' HG23 ' A' ' 92' ' ' VAL . 7.7 mt -110.83 162.28 8.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.705 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.454 ' N ' HG22 ' A' ' 29' ' ' ILE . 0.7 OUTLIER -133.59 138.25 45.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.075 -179.895 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.501 ' CE1' ' CZ ' ' A' ' 22' ' ' PHE . 10.9 t80 -121.25 139.15 53.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.87 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.39 161.33 41.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.943 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -126.46 152.98 45.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.882 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -92.04 179.63 5.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.887 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.3 t -129.12 -170.07 2.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.822 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 56.5 p -83.55 144.11 29.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.888 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -153.3 156.35 38.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.847 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -90.19 -38.42 13.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.895 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 57.94 31.72 20.97 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.878 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -132.02 34.12 2.59 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.499 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -163.82 31.69 0.08 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.814 0.34 . . . . 0.0 110.875 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -107.04 34.67 3.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.012 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.1 t70 61.04 -175.3 0.12 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.922 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -88.17 -174.7 4.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.928 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -71.0 105.54 3.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.897 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 58.92 84.41 0.2 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.946 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.33 161.26 46.23 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.606 2.204 . . . . 0.0 112.363 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -88.05 167.33 13.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.874 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.95 136.31 39.11 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.825 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -109.35 -176.09 2.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.025 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.7 m -160.35 -45.4 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.951 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 166.3 137.31 2.19 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.485 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -105.21 31.71 4.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.823 0.344 . . . . 0.0 110.829 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.492 HG21 ' HA ' ' A' ' 58' ' ' SER . 10.4 t -79.79 -177.79 6.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.916 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -141.14 158.41 43.95 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.848 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.7 tp 69.26 -66.28 0.26 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.991 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 30.4 t60 -127.59 158.77 36.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.83 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.492 ' HA ' HG21 ' A' ' 54' ' ' THR . 63.8 m -129.64 158.85 38.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.814 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 7.9 t -152.8 178.5 9.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.943 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.6 mp 65.21 9.69 5.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.48 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -109.26 -30.81 7.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.071 0.462 . . . . 0.0 109.894 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.9 t -80.12 -26.03 11.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.524 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -84.1 -12.48 54.98 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.245 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -91.41 26.17 2.35 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 121.063 0.459 . . . . 0.0 110.709 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -168.97 31.23 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.963 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -120.89 -72.95 0.32 Allowed Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.199 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -43.73 133.69 7.68 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.024 2.483 . . . . 0.0 112.295 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 64.12 103.37 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.718 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -77.16 8.89 3.01 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.809 2.339 . . . . 0.0 113.044 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -95.34 29.59 2.48 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.833 0.349 . . . . 0.0 111.437 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.591 ' O ' HG22 ' A' ' 71' ' ' ILE . 22.2 mt -103.13 -3.31 9.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.689 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 72' ' ' LEU . 12.7 mt -91.85 22.41 4.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.092 0.472 . . . . 0.0 111.607 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -134.01 69.87 74.61 Favored Pre-proline 0 C--N 1.318 -0.78 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.829 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -69.14 59.47 1.32 Allowed 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.939 2.426 . . . . 0.0 112.366 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -68.82 -43.5 75.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.969 0.414 . . . . 0.0 110.576 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 5.2 mtt180 -143.24 122.44 12.96 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.94 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -111.47 30.44 6.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.858 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -139.74 31.34 2.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.399 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.617 HD23 ' HB2' ' A' ' 80' ' ' ASP . 6.1 tt -112.95 144.13 43.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.933 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.617 ' HB2' HD23 ' A' ' 79' ' ' LEU . 14.2 t0 57.17 40.35 28.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.98 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -141.27 116.74 10.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.991 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 57.49 83.31 0.11 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.067 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.458 ' N ' ' CD ' ' A' ' 84' ' ' PRO . 0.1 OUTLIER -84.18 -52.18 0.56 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.042 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.458 ' CD ' ' N ' ' A' ' 83' ' ' SER . 50.2 Cg_exo -52.31 -31.4 46.74 Favored 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.857 2.372 . . . . 0.0 112.271 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.64 ' O ' HD23 ' A' ' 85' ' ' LEU . 7.4 tt -116.29 78.67 1.22 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.886 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -138.68 -81.75 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.547 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -83.7 -36.54 23.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.785 0.326 . . . . 0.0 110.892 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 72.5 mt 60.22 97.99 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.853 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -95.14 148.66 22.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.809 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.4 tpm_? -173.43 -66.65 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.999 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -127.78 173.11 18.85 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.406 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.699 HG23 ' O ' ' A' ' 29' ' ' ILE . 11.8 p -169.49 131.04 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.77 0.319 . . . . 0.0 111.297 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.663 ' HB3' HD12 ' A' ' 29' ' ' ILE . 2.9 tp -113.88 -173.74 2.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.542 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -123.71 140.01 53.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.94 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.844 HG11 ' HB ' ' A' ' 146' ' ' VAL . 22.7 t -86.05 -45.89 0.59 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.982 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' A' ' 95' ' ' VAL . 88.0 Cg_endo -80.36 54.7 5.34 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.258 1.972 . . . . 0.0 112.525 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.433 ' HB2' ' O ' ' A' ' 96' ' ' PRO . . . 176.03 39.57 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.797 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 8.4 m -141.05 -178.88 5.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.979 0.419 . . . . 0.0 111.198 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -160.38 105.5 1.48 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.525 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 1.004 HD13 HG23 ' A' ' 116' ' ' ILE . 14.7 mm -74.47 160.59 5.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.224 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.47 ' N ' HG22 ' A' ' 100' ' ' ILE . . . -160.6 92.78 0.98 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.866 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 15.0 mt -57.07 136.4 20.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.017 0.437 . . . . 0.0 111.31 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.87 123.86 26.74 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.197 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -82.71 19.2 1.34 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.465 2.11 . . . . 0.0 112.926 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -169.0 70.95 0.08 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.797 0.332 . . . . 0.0 110.674 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -56.59 -95.13 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.682 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -168.33 165.85 12.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.851 0.357 . . . . 0.0 110.992 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 63.63 -80.4 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.114 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -158.29 31.23 0.24 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.911 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.429 ' HG3' ' CE2' ' A' ' 17' ' ' TRP . 11.7 mmt180 -119.62 85.67 2.42 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.853 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -69.19 -32.22 71.37 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.084 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -97.73 87.71 4.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.017 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.725 HG13 ' HB2' ' A' ' 129' ' ' ALA . 21.4 t -139.94 144.66 27.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.939 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.43 ' CE2' ' HB ' ' A' ' 128' ' ' VAL . 48.9 p90 -118.22 125.51 50.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.895 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.2 t -98.62 133.03 43.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.985 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 1.004 HG23 HD13 ' A' ' 100' ' ' ILE . 14.6 mt -101.67 159.69 4.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.828 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.452 ' N ' HG22 ' A' ' 116' ' ' ILE . 19.7 t -151.97 -179.67 7.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.81 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 10.2 mtt -135.38 135.44 22.44 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.833 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -59.4 -66.01 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.479 2.119 . . . . 0.0 112.697 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.65 104.65 11.91 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.327 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.541 ' O ' ' HB2' ' A' ' 122' ' ' ALA . 2.0 p -178.81 -47.99 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.787 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.541 ' HB2' ' O ' ' A' ' 121' ' ' VAL . . . 169.26 -167.41 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.769 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 9.7 mm100 -98.16 36.31 1.6 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.807 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' TRP . . . . . 0.424 ' CD1' ' HB3' ' A' ' 122' ' ' ALA . 22.9 m95 -63.94 -177.7 0.27 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.983 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 89.3 p -178.16 103.02 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.758 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.47 HD22 HD22 ' A' ' 93' ' ' LEU . 10.0 tp -92.53 104.7 16.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.143 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -85.97 131.85 34.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.822 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.941 HG12 HD12 ' A' ' 7' ' ' LEU . 22.0 t -152.5 147.53 14.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.06 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.725 ' HB2' HG13 ' A' ' 113' ' ' VAL . . . -148.27 143.92 27.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.261 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -104.83 135.77 45.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.031 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -54.29 -34.61 61.28 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.995 0.426 . . . . 0.0 110.898 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 5.9 t -95.94 114.89 26.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.669 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -48.96 -26.16 2.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.725 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -75.63 -42.9 50.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.591 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -67.86 -32.0 72.21 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.239 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.577 ' O ' HG23 ' A' ' 140' ' ' VAL . 7.4 tt -68.99 -46.93 66.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.516 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -68.86 -41.08 78.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.39 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.55 -28.93 68.2 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.357 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' TRP . . . . . 0.474 ' CZ2' HD23 ' A' ' 7' ' ' LEU . 1.1 m95 -69.05 -47.51 65.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.608 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.684 HG13 HG21 ' A' ' 100' ' ' ILE . 33.2 t -61.53 -40.39 86.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.904 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.94 -38.26 90.36 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.841 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.92 -52.13 52.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.366 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.992 HG21 HD11 ' A' ' 100' ' ' ILE . 73.9 mt -53.85 -34.37 25.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.23 0.538 . . . . 0.0 109.644 178.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -81.23 -27.91 35.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.482 179.127 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.607 ' O ' HG22 ' A' ' 149' ' ' THR . 1.5 tm-20 -70.93 -39.95 72.36 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-O 120.906 0.384 . . . . 0.0 110.413 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.844 ' HB ' HG11 ' A' ' 95' ' ' VAL . 61.8 t -78.48 -33.55 17.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.859 179.187 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.34 -34.33 65.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.479 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.88 -11.72 60.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.858 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.607 HG22 ' O ' ' A' ' 145' ' ' GLU . 10.6 t -120.98 17.07 11.72 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.083 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.282 -0.866 . . . . 0.0 111.082 -179.982 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 25.7 m . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.808 0.337 . . . . 0.0 111.271 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.577 HG22 ' HE2' ' A' ' 142' ' ' LYS . 30.2 mt -85.59 -33.01 7.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.064 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.445 ' HE3' ' CD1' ' A' ' 139' ' ' TRP . 21.2 tttp -158.63 116.41 2.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.007 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.841 ' HB3' HG13 ' A' ' 23' ' ' VAL . 8.2 p30 -131.72 127.73 37.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.966 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -166.29 -155.54 8.91 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.549 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.643 ' N ' HD12 ' A' ' 6' ' ' ILE . 3.4 mp -115.42 100.96 11.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.815 0.341 . . . . 0.0 111.114 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.658 HD12 HG12 ' A' ' 128' ' ' VAL . 3.5 mm? -96.18 140.2 31.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.77 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -76.93 145.35 38.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.127 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.495 HD11 ' OH ' ' A' ' 31' ' ' TYR . 0.2 OUTLIER -158.06 122.23 4.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.69 179.891 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.453 ' HB2' ' CE3' ' A' ' 17' ' ' TRP . 0.7 OUTLIER -74.18 120.9 20.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.11 -179.8 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.47 138.47 59.21 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.028 179.34 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -67.98 -12.0 33.84 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.192 1.928 . . . . 0.0 112.564 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.4 t -77.76 -36.31 22.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.886 0.374 . . . . 0.0 110.919 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -111.92 -24.39 9.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.044 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 2.4 m170 66.63 34.53 5.8 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.901 0.381 . . . . 0.0 110.654 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.411 ' N ' ' HG3' ' A' ' 10' ' ' GLU . 48.8 mt-10 -138.15 144.54 40.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.859 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.453 ' CE3' ' HB2' ' A' ' 10' ' ' GLU . 49.7 m95 -52.87 146.27 11.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.128 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -150.04 130.65 7.02 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.883 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.94 97.14 1.09 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.436 2.091 . . . . 0.0 112.364 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 15.5 m80 -115.96 149.21 39.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.856 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -65.35 164.44 13.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.946 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.498 ' CD2' ' CD1' ' A' ' 31' ' ' TYR . 0.2 OUTLIER -177.28 119.99 0.11 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.672 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.841 HG13 ' HB3' ' A' ' 4' ' ' ASN . 16.4 t -104.76 142.16 18.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.101 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.649 HD12 HG12 ' A' ' 29' ' ' ILE . 23.1 tp -118.83 103.08 9.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.902 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -101.8 152.2 21.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.865 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.513 ' CB ' HD11 ' A' ' 2' ' ' ILE . 0.4 OUTLIER -59.18 -16.69 21.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.643 -179.768 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.0 p -99.54 -23.34 15.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.575 0.226 . . . . 0.0 111.513 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.602 ' HA ' HG23 ' A' ' 95' ' ' VAL . 0.1 OUTLIER 178.41 -174.72 0.17 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.897 0.379 . . . . 0.0 110.953 -179.722 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.649 HG12 HD12 ' A' ' 24' ' ' LEU . 6.0 mt -119.62 123.9 71.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.812 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.625 ' HD1' HG22 ' A' ' 92' ' ' VAL . 40.7 m-85 -95.42 160.41 14.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.942 0.401 . . . . 0.0 111.01 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.498 ' CD1' ' CD2' ' A' ' 22' ' ' PHE . 45.8 t80 -151.88 123.35 7.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.765 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.1 t -158.34 147.99 19.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.863 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.37 159.64 17.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.995 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.479 ' O ' HG22 ' A' ' 35' ' ' THR . 3.3 pt-20 -156.06 -177.66 6.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.929 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.479 HG22 ' O ' ' A' ' 34' ' ' GLU . 15.1 t 45.12 -166.41 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.323 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.8 t 61.92 80.18 0.23 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.015 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 50.5 p -133.99 157.61 45.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.874 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.89 -35.8 37.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.891 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 58.9 31.5 21.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.922 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -134.39 34.65 2.33 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.495 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -159.02 42.84 0.24 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.85 0.357 . . . . 0.0 110.842 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -134.75 44.41 2.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.961 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -144.49 -169.74 3.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.83 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -140.77 126.1 18.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.983 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -151.79 32.05 0.56 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.873 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -68.16 152.4 96.51 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.839 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.89 88.19 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.639 2.226 . . . . 0.0 112.31 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.8 tttt -95.13 90.44 5.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.877 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -71.6 122.57 20.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.812 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -165.96 34.33 0.05 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.115 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.1 m 62.26 150.62 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.954 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 163.3 -111.59 0.48 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.516 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.1 m -156.29 26.92 0.35 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.753 0.311 . . . . 0.0 111.089 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.4 -176.67 3.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.958 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -152.63 159.79 43.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.797 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.424 HD22 ' HA ' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -159.03 109.83 2.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.968 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 4.3 m170 -89.77 119.11 29.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.801 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.402 ' CA ' HG21 ' A' ' 62' ' ' VAL . 96.0 p -74.56 120.46 20.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.938 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.6 -172.42 2.39 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.352 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.2 tp -58.82 -41.41 86.77 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.129 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -53.14 -25.35 13.08 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.972 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.402 HG21 ' CA ' ' A' ' 58' ' ' SER . 21.8 t -68.44 -44.68 83.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.157 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.3 mp -69.62 -11.23 60.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.304 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -93.48 26.29 3.07 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-O 121.122 0.487 . . . . 0.0 110.727 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -169.39 30.76 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.149 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -113.01 -64.42 0.46 Allowed Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.394 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -50.9 146.51 21.23 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.604 2.203 . . . . 0.0 112.213 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.5 m120 60.9 91.66 0.07 OUTLIER Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.941 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -84.89 18.89 1.48 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.764 2.309 . . . . 0.0 113.005 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.35 28.74 3.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.967 0.413 . . . . 0.0 111.186 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.574 ' O ' HG22 ' A' ' 71' ' ' ILE . 13.3 mt -111.65 -5.24 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.881 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.7 mp -92.26 19.85 6.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.122 0.487 . . . . 0.0 111.831 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.452 ' N ' ' HD3' ' A' ' 74' ' ' PRO . 17.5 mt-10 -140.86 63.5 19.51 Favored Pre-proline 0 C--N 1.316 -0.861 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.983 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.452 ' HD3' ' N ' ' A' ' 73' ' ' GLU . 7.8 Cg_exo -72.53 61.13 3.51 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.768 2.312 . . . . 0.0 112.052 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -92.41 -34.31 14.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.079 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 11.0 mmt-85 -79.28 172.23 14.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.886 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 62.89 35.34 13.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.956 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -178.86 44.58 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.911 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.428 ' H ' HD12 ' A' ' 79' ' ' LEU . 2.1 mp -85.68 133.4 34.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.973 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 58.65 32.35 22.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.981 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -140.97 67.23 1.35 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.904 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -96.25 20.81 9.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.194 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.456 ' CB ' ' HD3' ' A' ' 84' ' ' PRO . 0.1 OUTLIER -85.04 -54.73 0.44 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 120.936 0.398 . . . . 0.0 110.868 179.883 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.456 ' HD3' ' CB ' ' A' ' 83' ' ' SER . 76.6 Cg_endo -88.2 41.39 0.63 Allowed 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 123.322 2.681 . . . . 0.0 112.601 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -166.39 -42.03 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.925 0.393 . . . . 0.0 111.109 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -94.38 33.56 5.22 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.576 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 43.57 31.45 0.44 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.785 0.326 . . . . 0.0 111.464 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -111.66 61.39 0.62 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.911 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.59 38.24 1.55 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.888 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.06 82.46 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.813 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.9 138.26 21.19 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.565 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.625 HG22 ' HD1' ' A' ' 30' ' ' TYR . 21.5 t -127.72 136.0 61.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.755 0.312 . . . . 0.0 111.107 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.637 HD21 ' CE ' ' A' ' 118' ' ' MET . 0.7 OUTLIER -130.86 120.88 24.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.02 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -57.98 148.58 25.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.928 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.826 HG11 ' HB ' ' A' ' 146' ' ' VAL . 17.3 t -78.68 -47.94 1.79 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.823 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' A' ' 95' ' ' VAL . 71.6 Cg_endo -77.49 58.28 6.27 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.225 1.95 . . . . 0.0 112.505 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -179.63 38.68 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.901 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' CYS . . . . . 0.436 ' SG ' HD22 ' A' ' 93' ' ' LEU . 67.4 m -139.13 178.13 7.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.011 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.4 tm0? -158.71 102.49 1.69 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.72 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.966 HD13 HG23 ' A' ' 116' ' ' ILE . 8.3 mm -76.57 160.75 4.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.326 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.435 ' N ' HG22 ' A' ' 100' ' ' ILE . . . -153.0 89.47 1.38 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.803 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 73.9 mt -62.47 145.73 13.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.101 0.477 . . . . 0.0 111.553 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.402 ' HB2' ' CG1' ' A' ' 113' ' ' VAL . 0.2 OUTLIER -134.81 125.85 17.57 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.879 179.305 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -82.55 25.55 0.67 Allowed 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.431 2.087 . . . . 0.0 113.22 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -178.23 74.34 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.722 0.296 . . . . 0.0 111.013 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -59.13 -96.67 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.578 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.67 173.74 1.59 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.795 0.331 . . . . 0.0 110.938 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 68.36 -68.39 0.17 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.12 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -175.46 36.67 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.903 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -129.98 88.44 2.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.796 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 86.2 mt -59.31 -37.58 78.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.825 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -99.12 119.34 37.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.844 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 1.014 HG23 ' HB2' ' A' ' 129' ' ' ALA . 9.4 p -155.05 162.18 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.134 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.432 ' CZ ' ' HB ' ' A' ' 128' ' ' VAL . 10.2 p90 -148.66 114.29 5.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.922 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 12.4 m -92.64 140.01 29.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.939 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.966 HG23 HD13 ' A' ' 100' ' ' ILE . 13.0 mt -104.95 157.48 5.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.977 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.412 ' N ' HG22 ' A' ' 116' ' ' ILE . 5.5 t -162.01 138.31 7.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.781 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' MET . . . . . 0.637 ' CE ' HD21 ' A' ' 93' ' ' LEU . 29.0 mtp -102.39 96.92 7.85 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.062 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.26 59.06 4.51 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.491 2.127 . . . . 0.0 112.368 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 92.2 p -177.85 37.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.809 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.671 HG13 ' H ' ' A' ' 122' ' ' ALA . 0.4 OUTLIER -161.15 -82.33 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.727 -179.854 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.671 ' H ' HG13 ' A' ' 121' ' ' VAL . . . -140.59 -168.89 2.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.921 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -93.55 47.45 1.24 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.77 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' TRP . . . . . 0.458 ' CD1' ' HB3' ' A' ' 122' ' ' ALA . 29.5 m95 -85.28 148.56 26.0 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.853 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 92.1 p -144.34 103.67 4.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.79 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.503 HD23 ' CG2' ' A' ' 128' ' ' VAL . 0.3 OUTLIER -89.59 100.55 13.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.059 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -77.37 124.03 27.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.856 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.658 HG12 HD12 ' A' ' 7' ' ' LEU . 15.7 t -137.1 152.74 28.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.1 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 1.014 ' HB2' HG23 ' A' ' 113' ' ' VAL . . . -157.31 127.11 6.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.234 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.579 ' HB2' HD11 ' A' ' 7' ' ' LEU . . . -93.12 137.35 32.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.924 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -52.5 -35.78 53.76 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.964 0.412 . . . . 0.0 111.106 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.8 t -96.95 115.41 27.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.742 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.22 -27.46 2.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.566 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.42 -45.44 38.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.44 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -63.92 -32.29 73.77 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.197 179.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.454 ' C ' HD23 ' A' ' 136' ' ' LEU . 7.6 tt -67.45 -51.85 46.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.557 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -67.6 -35.52 79.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.375 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -70.8 -30.66 67.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.419 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' TRP . . . . . 0.445 ' CD1' ' HE3' ' A' ' 3' ' ' LYS . 0.8 OUTLIER -68.72 -45.58 71.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.67 179.749 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.547 HG22 HG21 ' A' ' 100' ' ' ILE . 44.6 t -63.49 -42.19 95.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.886 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 11.6 mttm -63.87 -35.62 81.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.809 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.577 ' HE2' HG22 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -67.04 -50.41 62.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.603 179.669 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 68.6 mt -54.44 -35.57 31.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.328 0.585 . . . . 0.0 109.5 178.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 47.3 mtp180 -78.01 -28.68 49.21 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.447 179.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.418 ' O ' HG22 ' A' ' 149' ' ' THR . 12.2 tt0 -76.03 -32.67 59.46 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.864 0.364 . . . . 0.0 110.53 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.826 ' HB ' HG11 ' A' ' 95' ' ' VAL . 90.2 t -80.0 -31.47 13.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.294 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.1 -35.21 66.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.828 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -75.32 -11.08 59.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.144 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.462 HG22 ' HA ' ' A' ' 146' ' ' VAL . 8.9 t -114.27 -34.69 5.23 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.774 0.321 . . . . 0.0 111.097 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.225 -0.893 . . . . 0.0 111.155 -179.928 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.859 0.361 . . . . 0.0 111.12 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.745 HD11 ' HA ' ' A' ' 26' ' ' SER . 29.6 mt -76.48 -34.2 24.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.047 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.56 169.31 24.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.911 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.44 ' HB3' HG13 ' A' ' 23' ' ' VAL . 5.6 p-10 -166.58 125.4 1.46 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.81 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -159.65 -170.59 24.41 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.583 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 28.4 mm -94.81 92.44 3.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.791 0.329 . . . . 0.0 111.142 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.58 HD12 HG12 ' A' ' 128' ' ' VAL . 4.3 mm? -96.58 129.58 43.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.847 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -79.9 146.32 32.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.917 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -147.59 133.69 19.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.766 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.466 ' CG ' ' CD2' ' A' ' 17' ' ' TRP . 3.2 mt-10 -80.36 118.05 21.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.134 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.72 134.32 50.76 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.352 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -68.8 -10.52 29.34 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.306 2.004 . . . . 0.0 112.654 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.2 t -66.56 -39.22 83.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.924 0.392 . . . . 0.0 110.937 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -138.02 9.34 2.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.463 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 49.79 49.46 20.11 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.92 0.391 . . . . 0.0 111.136 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.55 149.62 49.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.876 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.466 ' CD2' ' CG ' ' A' ' 10' ' ' GLU . 43.2 m95 -72.97 143.57 47.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.911 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -129.92 119.04 18.79 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.79 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -68.82 82.65 0.56 Allowed 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.398 2.065 . . . . 0.0 112.353 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 4.4 m80 -114.23 168.36 9.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.882 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -73.85 172.05 12.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.901 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -167.03 141.42 3.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.877 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.44 HG13 ' HB3' ' A' ' 4' ' ' ASN . 38.8 t -134.68 153.39 34.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.868 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.686 HD12 HG12 ' A' ' 29' ' ' ILE . 5.8 tp -133.41 109.49 9.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.117 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 16.9 p -95.46 157.8 15.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.581 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.745 ' HA ' HD11 ' A' ' 2' ' ' ILE . 3.4 m -63.73 -13.86 47.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.915 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.0 m -111.43 -7.14 14.38 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 173.55 -174.84 0.06 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.925 0.393 . . . . 0.0 111.29 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.686 HG12 HD12 ' A' ' 24' ' ' LEU . 5.8 mt -113.59 136.78 48.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.399 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.748 ' HB3' HD12 ' A' ' 89' ' ' LEU . 39.4 m-85 -113.92 138.36 50.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.861 0.362 . . . . 0.0 111.066 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 54.1 p90 -157.55 158.47 35.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.879 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.0 -70.13 0.82 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.893 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 62.01 32.09 17.78 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.826 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -71.52 113.68 8.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.874 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -71.19 -68.12 0.46 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.894 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.4 m 61.01 82.17 0.17 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.893 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.5 m -124.27 100.25 6.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.85 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -141.79 87.34 2.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.888 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 60.23 32.05 20.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.893 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -138.18 43.68 1.17 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.546 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -98.22 31.62 2.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.801 0.334 . . . . 0.0 110.907 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -107.76 36.76 2.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.952 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -122.99 48.52 1.79 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.914 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -133.91 -175.31 3.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.862 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 64.05 133.12 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.882 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -133.59 129.06 20.32 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.922 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.33 162.39 4.45 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.443 2.095 . . . . 0.0 112.319 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -96.98 165.62 12.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.899 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 59.97 109.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.899 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.66 -32.53 73.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.141 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.7 m -123.71 95.61 4.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.909 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -169.13 88.02 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.549 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.5 p 58.41 32.95 22.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.891 0.377 . . . . 0.0 110.958 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -98.34 158.83 15.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.963 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -64.36 -171.82 0.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.998 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 13.1 tp -151.15 140.73 21.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.883 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -105.52 38.29 2.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.063 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.8 t -81.44 64.18 6.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.92 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 7.4 m -162.95 109.9 1.21 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.918 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.4 tt -99.53 -35.43 9.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.892 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -67.45 -28.94 68.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.914 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 32.8 t -71.24 -33.04 49.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.052 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -87.71 -4.44 58.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.364 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -91.27 25.24 2.6 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-O 121.224 0.535 . . . . 0.0 110.551 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -176.1 31.32 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.977 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.456 ' N ' ' CD ' ' A' ' 67' ' ' PRO . . . -149.59 48.17 0.6 Allowed Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.437 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' ' 66' ' ' GLY . 89.6 Cg_endo -77.3 97.8 1.17 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.595 2.197 . . . . 0.0 112.293 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 61.07 98.54 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.698 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -82.55 12.94 2.72 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.653 2.235 . . . . 0.0 113.059 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -96.79 30.27 2.72 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.818 0.342 . . . . 0.0 111.164 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.449 ' O ' HG22 ' A' ' 71' ' ' ILE . 15.7 mt -105.3 -12.95 9.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.703 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 11.6 mt -89.4 18.21 5.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.326 0.584 . . . . 0.0 111.545 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -145.78 75.15 13.31 Favored Pre-proline 0 C--N 1.316 -0.883 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.315 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -68.46 59.45 1.07 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.844 2.363 . . . . 0.0 112.41 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -88.95 -34.59 16.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.836 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.871 ' HD3' HD13 ' A' ' 79' ' ' LEU . 0.3 OUTLIER -129.06 143.98 51.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.948 179.88 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -139.87 31.2 2.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.899 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 5.2 m170 -161.86 31.41 0.12 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.527 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.871 HD13 ' HD3' ' A' ' 76' ' ' ARG . 4.0 tp -90.0 175.93 6.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.931 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.07 85.88 1.33 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.971 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.91 160.7 15.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.869 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -98.11 34.62 1.9 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.967 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.462 ' CB ' ' HD2' ' A' ' 84' ' ' PRO . 0.3 OUTLIER -52.85 173.3 0.18 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.222 179.434 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.462 ' HD2' ' CB ' ' A' ' 83' ' ' SER . 41.8 Cg_endo -67.71 62.18 0.87 Allowed 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.086 1.857 . . . . 0.0 112.341 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.7 mp -87.18 -31.37 20.4 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.934 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -72.06 68.79 1.08 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.523 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -175.25 89.5 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.794 0.33 . . . . 0.0 110.832 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 6.5 mt -144.59 -55.86 0.34 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.985 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.748 HD12 ' HB3' ' A' ' 30' ' ' TYR . 3.8 mm? 61.06 92.64 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.857 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -113.99 -33.25 5.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.036 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -64.67 123.16 26.38 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.506 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 11.8 p -132.85 137.76 53.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.757 0.313 . . . . 0.0 111.085 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -139.63 129.16 24.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.14 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -60.38 119.7 8.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.82 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.698 HG12 ' HD3' ' A' ' 96' ' ' PRO . 8.7 p -83.13 -34.18 0.6 Allowed Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.698 ' HD3' HG12 ' A' ' 95' ' ' VAL . 3.1 Cg_exo -75.24 54.48 3.77 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.262 1.975 . . . . 0.0 112.597 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.558 ' HB2' ' O ' ' A' ' 96' ' ' PRO . . . 168.78 42.56 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.018 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 1.7 m -125.3 162.94 23.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.943 0.401 . . . . 0.0 111.215 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.04 101.18 3.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.542 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.867 HD13 HG23 ' A' ' 116' ' ' ILE . 14.2 mm -71.03 160.12 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.403 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.468 ' N ' HG22 ' A' ' 100' ' ' ILE . . . -156.08 90.25 1.19 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.898 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.3 mt -56.43 149.28 3.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.33 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 15.6 mtp180 -142.97 113.75 5.83 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.554 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -67.5 0.33 4.22 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.549 2.166 . . . . 0.0 113.034 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -141.27 59.15 1.52 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.988 0.423 . . . . 0.0 110.536 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -43.06 -85.49 0.01 OUTLIER Glycine 0 C--N 1.331 0.251 0 CA-C-N 115.769 -0.65 . . . . 0.0 113.249 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 23.9 ttmt -176.69 160.47 1.95 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.947 0.403 . . . . 0.0 111.358 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 60.53 -84.3 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.128 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -146.41 31.2 1.0 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.951 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.428 ' HG3' ' CE2' ' A' ' 17' ' ' TRP . 13.9 mmt180 -114.57 100.36 8.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.777 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.2 mt -85.08 5.41 29.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.469 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -139.98 78.6 1.67 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.822 0.344 . . . . 0.0 110.972 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.49 HG13 ' HB2' ' A' ' 129' ' ' ALA . 36.2 t -129.13 135.61 61.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.933 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.428 ' CZ ' ' HB ' ' A' ' 128' ' ' VAL . 42.0 p90 -114.48 122.57 47.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.017 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 10.9 t -97.7 136.06 38.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.885 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.867 HG23 HD13 ' A' ' 100' ' ' ILE . 10.9 mt -96.31 157.94 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.974 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.416 ' N ' HG22 ' A' ' 116' ' ' ILE . 1.5 m -150.04 166.85 28.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.951 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 13.7 mtp -139.53 100.43 7.56 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.903 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -79.94 54.69 5.32 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.568 2.179 . . . . 0.0 112.627 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 178.94 49.49 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.98 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.647 HG22 ' N ' ' A' ' 122' ' ' ALA . 0.3 OUTLIER -161.85 -82.11 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.92 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.647 ' N ' HG22 ' A' ' 121' ' ' VAL . . . -157.08 -165.47 1.84 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.184 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -84.64 56.93 4.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.945 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 39.9 m95 -104.21 148.87 25.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.926 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 14.1 m -153.3 123.66 7.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.808 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.657 HD23 HD12 ' A' ' 116' ' ' ILE . 14.4 tp -102.83 155.85 18.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.99 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -131.95 134.41 45.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.836 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.58 HG12 HD12 ' A' ' 7' ' ' LEU . 23.7 t -152.38 159.15 3.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.092 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.49 ' HB2' HG13 ' A' ' 113' ' ' VAL . . . -158.57 117.65 3.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.161 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.581 ' HB3' ' HB2' ' A' ' 136' ' ' LEU . . . -81.37 134.98 35.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.842 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -54.47 -34.39 61.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.885 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.94 113.4 24.94 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.744 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -48.04 -27.94 2.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.475 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 -76.65 -44.29 34.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.292 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -65.66 -31.88 73.14 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.011 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.581 ' HB2' ' HB3' ' A' ' 130' ' ' ALA . 7.2 tt -67.77 -50.78 55.25 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.314 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -66.39 -37.17 84.64 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.262 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -70.43 -31.5 68.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.403 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' TRP . . . . . 0.444 ' CE2' HD21 ' A' ' 7' ' ' LEU . 0.7 OUTLIER -67.65 -43.03 81.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.58 179.821 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.686 HG13 ' CB ' ' A' ' 100' ' ' ILE . 26.7 t -65.22 -44.2 95.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.848 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 7.3 ttmm -63.84 -33.77 76.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.884 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.671 ' HD2' HG22 ' A' ' 2' ' ' ILE . 17.0 mmtt -67.93 -49.46 61.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.525 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.753 HD13 HD11 ' A' ' 100' ' ' ILE . 30.7 mt -54.35 -38.15 39.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.352 0.596 . . . . 0.0 109.517 178.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 66.2 mtt180 -77.95 -27.69 49.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.479 179.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.651 ' O ' HG22 ' A' ' 149' ' ' THR . 2.1 tp10 -75.16 -33.23 61.47 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.861 0.362 . . . . 0.0 110.705 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.645 HG11 HG21 ' A' ' 95' ' ' VAL . 9.9 p -79.63 -34.3 15.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.065 0.459 . . . . 0.0 110.19 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -71.48 -34.43 70.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.563 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -75.1 -10.7 59.71 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.931 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.651 HG22 ' O ' ' A' ' 145' ' ' GLU . 10.9 t -126.26 21.34 7.34 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.103 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.166 -0.921 . . . . 0.0 111.19 179.985 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 8.0 t . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 120.885 0.374 . . . . 0.0 111.159 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.424 HD11 ' HA ' ' A' ' 26' ' ' SER . 39.4 mt -79.79 -34.48 15.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.121 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.7 tttp -140.1 153.82 46.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.01 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -160.97 124.39 3.34 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.924 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -160.4 -178.0 34.01 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.542 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.637 ' N ' HD12 ' A' ' 6' ' ' ILE . 3.2 mp -89.52 92.01 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.909 0.385 . . . . 0.0 110.985 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 1.078 HD12 HG12 ' A' ' 128' ' ' VAL . 3.2 mm? -95.6 135.38 37.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.732 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -76.76 158.36 30.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.95 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.437 HD12 ' O ' ' A' ' 127' ' ' ASP . 1.4 tp -161.78 128.19 3.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.808 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.436 ' HG3' ' CE3' ' A' ' 17' ' ' TRP . 3.4 mt-10 -71.11 111.57 6.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.99 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.92 127.54 66.77 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.53 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -56.69 -16.81 20.56 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.504 2.136 . . . . 0.0 112.899 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 37.8 t -69.36 -41.67 80.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.858 0.361 . . . . 0.0 111.352 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -117.75 -10.18 10.57 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.649 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 62.86 30.84 16.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.789 0.328 . . . . 0.0 110.815 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.64 160.4 39.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.801 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.463 ' NE1' ' HG3' ' A' ' 110' ' ' ARG . 45.0 m95 -56.7 138.04 53.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.051 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -126.07 125.31 24.73 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.686 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.64 112.06 2.95 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.439 2.092 . . . . 0.0 112.228 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 22.0 m80 -148.64 141.79 24.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.871 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -59.38 154.6 16.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.719 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.427 ' CE2' ' CD1' ' A' ' 31' ' ' TYR . 0.1 OUTLIER -147.35 138.86 23.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.976 -179.827 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.8 t -131.41 150.8 34.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.113 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 25.7 tp -134.37 118.99 18.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.952 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.431 ' HG1' ' C ' ' A' ' 28' ' ' LYS . 62.6 p -97.95 157.58 16.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.983 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.424 ' HA ' HD11 ' A' ' 2' ' ' ILE . 29.4 t -48.97 -38.08 22.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.85 -0.613 . . . . 0.0 112.057 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.3 m -129.59 39.06 3.78 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.555 ' N ' HG23 ' A' ' 95' ' ' VAL . 2.6 tttt 175.01 170.03 0.28 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.007 0.432 . . . . 0.0 111.378 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.667 HD12 ' HB3' ' A' ' 93' ' ' LEU . 3.5 mt -128.87 153.23 38.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.716 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.404 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 0.6 OUTLIER -129.93 146.28 51.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.904 0.383 . . . . 0.0 111.112 -179.889 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.427 ' CD1' ' CE2' ' A' ' 22' ' ' PHE . 39.7 t80 -146.35 143.48 29.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.84 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.4 m -124.23 174.13 7.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.963 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -146.97 178.98 7.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.864 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.93 155.48 21.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.939 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.58 132.11 47.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.896 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.4 m -162.74 33.45 0.1 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.928 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.0 m 60.69 62.25 1.53 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.886 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.11 115.94 18.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.869 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -148.46 60.92 1.09 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.731 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 179.58 -32.48 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.748 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -94.58 31.69 1.73 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.79 0.329 . . . . 0.0 111.099 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -101.95 33.14 3.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.845 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.5 t70 61.7 82.59 0.17 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.95 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -86.35 177.48 7.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.934 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -121.21 135.81 55.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.902 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 58.33 78.68 0.35 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.009 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.4 87.89 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.559 2.172 . . . . 0.0 112.298 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.78 -169.33 2.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.008 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 47.2 mm-40 -100.57 119.75 39.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.807 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -112.15 102.43 10.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.064 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.3 p -89.14 88.96 7.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.979 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 66.93 141.84 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.45 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.68 125.33 35.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.803 0.335 . . . . 0.0 110.857 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.3 t -99.81 37.1 1.67 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.897 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -80.29 150.29 30.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.881 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 60.2 84.09 0.13 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.812 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -132.58 165.05 25.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.926 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 66.6 m -104.31 162.61 13.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.93 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.754 ' O ' HD13 ' A' ' 63' ' ' LEU . 3.3 m -58.93 132.36 53.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.955 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.63 -61.92 1.38 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.09 0.471 . . . . 0.0 110.973 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -59.89 -34.05 72.65 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.885 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.8 t -71.84 -27.67 28.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.085 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.754 HD13 ' O ' ' A' ' 59' ' ' SER . 6.5 mp -79.21 -12.87 59.97 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.27 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -85.96 23.79 1.41 Allowed 'General case' 0 CA--C 1.528 0.123 0 CA-C-O 121.259 0.552 . . . . 0.0 110.311 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 172.56 35.34 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.438 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 163.67 66.5 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.222 -179.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -66.62 138.86 51.05 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.576 2.184 . . . . 0.0 112.301 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.448 ' N ' ' HD3' ' A' ' 69' ' ' PRO . 2.4 m120 61.9 51.77 2.02 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.92 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.448 ' HD3' ' N ' ' A' ' 68' ' ' ASN . 86.3 Cg_endo -80.81 1.77 9.05 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.645 2.23 . . . . 0.0 112.781 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -96.24 30.09 2.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.797 0.332 . . . . 0.0 111.347 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.527 ' O ' HG22 ' A' ' 71' ' ' ILE . 14.9 mt -106.04 -7.88 10.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.764 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 72' ' ' LEU . 15.8 mt -89.5 19.69 4.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.107 0.479 . . . . 0.0 111.45 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -144.07 90.41 6.82 Favored Pre-proline 0 C--N 1.319 -0.748 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.358 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -67.27 59.34 0.67 Allowed 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.936 2.424 . . . . 0.0 112.471 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -122.36 -40.75 2.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.843 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.405 ' HD3' HD11 ' A' ' 79' ' ' LEU . 0.6 OUTLIER -68.39 -171.98 0.3 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.874 179.934 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 63.57 31.55 14.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.917 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.56 ' H ' HD12 ' A' ' 79' ' ' LEU . 10.5 t-160 -177.05 75.5 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.854 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.56 HD12 ' H ' ' A' ' 78' ' ' HIS . 5.6 mp -131.36 153.38 49.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.919 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.0 t70 59.84 31.07 20.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.094 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -70.71 -174.04 0.85 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.705 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 -94.4 38.48 1.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.34 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.434 ' CB ' ' HD2' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -61.15 171.79 1.09 Allowed Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.07 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.434 ' HD2' ' CB ' ' A' ' 83' ' ' SER . 39.2 Cg_endo -67.1 61.8 0.64 Allowed 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.087 1.858 . . . . 0.0 112.059 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.402 ' N ' ' O ' ' A' ' 83' ' ' SER . 0.3 OUTLIER -116.31 -38.1 3.63 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.098 -179.835 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 57.97 97.21 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.523 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -117.6 -77.53 0.57 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.868 0.365 . . . . 0.0 110.876 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.1 mp 60.48 35.11 20.35 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.849 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 8.7 tt -96.65 111.91 23.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.899 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.81 -48.71 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.847 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -139.52 142.62 12.93 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.51 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 29' ' ' ILE . 11.3 p -151.43 136.33 10.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.877 0.37 . . . . 0.0 111.033 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.667 ' HB3' HD12 ' A' ' 29' ' ' ILE . 0.3 OUTLIER -123.92 -176.44 3.48 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.891 -179.966 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -119.59 141.36 49.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.91 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.724 ' CG1' HG23 ' A' ' 146' ' ' VAL . 21.8 t -80.87 -46.87 1.19 Allowed Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.778 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 95' ' ' VAL . 84.6 Cg_endo -81.83 50.31 3.44 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.367 2.045 . . . . 0.0 112.497 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -179.55 37.85 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.959 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 14.4 p -134.34 -177.45 4.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.963 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.4 100.79 0.83 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.697 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 1.089 HD13 HG23 ' A' ' 116' ' ' ILE . 16.9 mm -76.82 160.58 4.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.02 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.468 ' N ' HG22 ' A' ' 100' ' ' ILE . . . -159.02 91.75 1.05 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.901 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.63 HG12 HG21 ' A' ' 140' ' ' VAL . 27.7 mt -58.07 157.47 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.242 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.498 ' N ' HG22 ' A' ' 102' ' ' ILE . 95.3 mtt180 -151.41 112.32 3.01 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.366 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.09 49.25 2.75 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.429 2.086 . . . . 0.0 112.523 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 167.35 61.98 0.0 OUTLIER 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.001 0.429 . . . . 0.0 110.223 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -55.04 -94.97 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.676 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.406 ' HD2' ' CZ2' ' A' ' 17' ' ' TRP . 0.0 OUTLIER 174.1 163.18 0.19 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.823 0.344 . . . . 0.0 111.014 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 57.07 54.6 6.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.975 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 9.0 m120 62.76 51.98 2.89 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.215 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.463 ' HG3' ' NE1' ' A' ' 17' ' ' TRP . 23.9 mmt180 -147.53 97.38 2.83 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.718 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.01 -32.47 57.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.978 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.614 ' HB3' HD13 ' A' ' 136' ' ' LEU . 6.5 m-85 -102.87 104.21 14.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.939 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.533 HG13 ' HB2' ' A' ' 129' ' ' ALA . 20.4 t -152.0 134.04 5.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.16 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -118.96 131.3 56.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.744 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 15.0 t -100.18 132.86 45.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.965 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 1.089 HG23 HD13 ' A' ' 100' ' ' ILE . 2.4 mp -104.29 159.82 5.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.942 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.477 ' N ' HG22 ' A' ' 116' ' ' ILE . 70.5 p -155.74 179.99 8.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.905 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' MET . . . . . 0.696 ' HE3' HG11 ' A' ' 121' ' ' VAL . 7.3 mtm -143.33 93.26 6.47 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.782 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.93 -2.29 12.51 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.584 2.189 . . . . 0.0 112.794 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 48.6 m -108.9 33.88 4.0 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.718 0.294 . . . . 0.0 111.142 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.696 HG11 ' HE3' ' A' ' 118' ' ' MET . 0.4 OUTLIER -160.31 -82.45 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.94 179.907 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.653 ' H ' HG13 ' A' ' 121' ' ' VAL . . . -143.98 -166.06 2.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.838 0.351 . . . . 0.0 111.049 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -86.21 55.32 3.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.971 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' TRP . . . . . 0.499 ' CD1' ' HB3' ' A' ' 122' ' ' ALA . 89.4 m95 -85.93 142.24 28.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.786 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.16 119.94 5.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.006 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.608 HD23 ' N ' ' A' ' 126' ' ' LEU . 1.2 pt? -129.28 124.7 35.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.88 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.437 ' O ' HD12 ' A' ' 9' ' ' LEU . 1.1 m-20 -86.9 142.89 27.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.949 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 1.078 HG12 HD12 ' A' ' 7' ' ' LEU . 14.0 t -151.32 141.9 15.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.081 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.533 ' HB2' HG13 ' A' ' 113' ' ' VAL . . . -140.93 131.49 25.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.129 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.602 ' HB3' ' HB2' ' A' ' 136' ' ' LEU . . . -93.22 138.58 31.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.92 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -55.5 -39.62 70.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.0 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.73 113.13 25.31 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.905 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -48.05 -28.41 2.81 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.547 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -76.8 -44.29 33.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.328 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -65.65 -32.29 73.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.996 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.614 HD13 ' HB3' ' A' ' 112' ' ' PHE . 6.2 tt -67.38 -51.22 54.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.394 179.408 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 73.4 mm-40 -67.68 -35.25 78.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.192 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -71.5 -30.18 65.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.205 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' TRP . . . . . 0.406 ' CH2' ' HB3' ' A' ' 22' ' ' PHE . 0.5 OUTLIER -67.41 -47.07 71.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.348 179.54 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.729 HG13 HG21 ' A' ' 100' ' ' ILE . 23.3 t -61.76 -45.52 98.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.797 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 1.1 ttpt -62.97 -36.94 85.18 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.742 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.601 ' O ' HG22 ' A' ' 146' ' ' VAL . 17.9 tppt? -65.66 -56.26 13.08 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.294 179.543 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.653 HG21 HD11 ' A' ' 100' ' ' ILE . 71.0 mt -50.97 -31.76 10.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.107 0.48 . . . . 0.0 109.706 178.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.439 ' HD2' HG12 ' A' ' 140' ' ' VAL . 30.5 mtt180 -78.69 -30.15 45.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.493 179.316 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.827 ' O ' HG23 ' A' ' 149' ' ' THR . 5.2 tt0 -77.23 -35.94 55.04 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-O 120.761 0.315 . . . . 0.0 110.777 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.724 HG23 ' CG1' ' A' ' 95' ' ' VAL . 5.6 m -79.44 -28.45 13.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.306 179.227 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.479 ' HA ' HG12 ' A' ' 95' ' ' VAL . . . -74.37 -36.97 63.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.684 179.369 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -72.34 -13.07 61.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.042 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.827 HG23 ' O ' ' A' ' 145' ' ' GLU . 11.5 p -106.53 -38.96 6.01 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.107 0.479 . . . . 0.0 110.48 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.271 -0.871 . . . . 0.0 111.291 -179.924 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 24.1 m . . . . . 0 N--CA 1.487 1.409 0 CA-C-O 120.776 0.322 . . . . 0.0 111.179 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.512 HD11 ' CB ' ' A' ' 26' ' ' SER . 19.9 mt -88.5 -34.09 6.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.933 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.42 ' HG2' ' NE1' ' A' ' 139' ' ' TRP . 0.0 OUTLIER -136.56 142.1 43.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.768 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -154.58 121.27 5.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.968 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -170.04 -176.32 39.59 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.421 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.539 ' N ' HD12 ' A' ' 6' ' ' ILE . 4.2 mp -103.26 89.17 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.866 0.365 . . . . 0.0 111.026 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.534 HD11 ' HB2' ' A' ' 130' ' ' ALA . 3.4 mm? -82.06 142.46 32.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.651 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -77.74 144.67 37.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.29 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.465 HD21 HG22 ' A' ' 128' ' ' VAL . 2.6 mp -152.89 115.55 4.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.611 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.411 ' HB3' ' CE3' ' A' ' 17' ' ' TRP . 2.0 pp20? -72.6 140.73 48.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.257 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.42 148.33 36.98 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.531 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.39 -5.46 17.17 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.434 2.089 . . . . 0.0 112.705 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 25.2 t -65.75 -40.83 88.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.984 0.421 . . . . 0.0 110.724 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -139.12 9.34 2.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.407 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 49.03 59.07 4.71 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.878 0.371 . . . . 0.0 111.266 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -149.1 139.33 22.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.808 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.411 ' CE3' ' HB3' ' A' ' 10' ' ' GLU . 75.5 m95 -57.72 143.03 43.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.895 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -135.73 137.17 24.97 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.84 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.75 90.51 1.22 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.491 2.127 . . . . 0.0 112.399 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 12.7 m170 -112.3 138.72 48.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.008 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -60.19 159.5 9.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.782 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.483 ' CD2' ' CD1' ' A' ' 31' ' ' TYR . 0.1 OUTLIER -170.95 128.69 0.75 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.789 179.901 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 19.1 t -122.22 153.66 26.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.09 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.9 tp -128.58 118.99 23.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.986 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.8 p -99.54 154.43 18.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.846 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.512 ' CB ' HD11 ' A' ' 2' ' ' ILE . 1.4 m -54.43 -25.53 25.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.832 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.8 p -136.24 35.56 2.77 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.4 mttt 170.9 177.13 0.06 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.973 0.415 . . . . 0.0 111.12 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.8 mt -140.16 131.71 31.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.707 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.496 ' CD1' HD22 ' A' ' 89' ' ' LEU . 42.8 m-85 -110.35 144.32 39.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.938 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.483 ' CD1' ' CD2' ' A' ' 22' ' ' PHE . 35.1 t80 -139.5 130.21 25.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.871 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -135.8 178.89 6.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.777 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -140.32 -45.95 0.42 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.002 0.43 . . . . 0.0 111.031 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -144.56 108.19 4.66 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.939 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.466 HG22 ' H ' ' A' ' 36' ' ' SER . 0.2 OUTLIER -86.73 176.08 7.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.826 -179.887 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.466 ' H ' HG22 ' A' ' 35' ' ' THR . 0.8 OUTLIER -148.42 144.64 27.58 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.899 -179.922 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.24 108.13 3.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.962 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -147.27 76.23 1.4 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.909 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -141.15 33.01 1.72 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.993 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -94.66 99.66 2.47 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.443 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -170.47 71.36 0.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.847 0.356 . . . . 0.0 110.886 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -140.12 44.81 1.89 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.953 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.3 t0 61.34 154.6 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.919 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -88.42 114.01 24.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.921 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.74 177.05 5.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.854 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -88.09 114.21 58.32 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.888 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -51.71 160.34 2.82 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.417 2.078 . . . . 0.0 112.342 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -87.07 65.88 9.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.883 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -92.69 169.55 10.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.843 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -154.79 139.81 17.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.146 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -164.91 34.05 0.06 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.895 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -165.48 -169.26 28.86 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.442 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.4 m -125.28 31.91 5.48 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.832 0.349 . . . . 0.0 110.822 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.448 ' O ' HG23 ' A' ' 54' ' ' THR . 4.2 t -131.52 84.06 2.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.793 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -173.1 155.94 3.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.902 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 62.71 147.82 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.841 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 64.7 m80 -156.3 102.98 2.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.872 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 60.55 160.81 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.892 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.5 m -93.41 123.35 36.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.919 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -163.91 -44.07 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.842 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -68.18 -35.7 78.45 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.847 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.5 t -70.3 -30.52 43.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.101 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -76.96 -13.6 59.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.237 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -91.1 24.83 2.69 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 121.223 0.535 . . . . 0.0 110.73 179.343 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -163.4 29.76 0.09 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.668 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -123.36 -73.69 0.27 Allowed Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.178 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -56.52 83.89 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.832 2.355 . . . . 0.0 112.289 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 55.35 93.26 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.927 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.77 -0.05 10.11 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.646 2.231 . . . . 0.0 112.979 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -96.77 29.87 2.86 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.815 0.341 . . . . 0.0 111.352 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.534 ' O ' HG22 ' A' ' 71' ' ' ILE . 6.8 mt -117.5 -8.53 11.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.817 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.419 ' HA ' HD23 ' A' ' 72' ' ' LEU . 7.0 mt -88.34 20.63 3.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.032 0.444 . . . . 0.0 111.6 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.457 ' N ' ' HD3' ' A' ' 74' ' ' PRO . 8.7 pt-20 -145.18 63.69 10.19 Favored Pre-proline 0 C--N 1.317 -0.812 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.753 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.457 ' HD3' ' N ' ' A' ' 73' ' ' GLU . 1.9 Cg_endo -85.32 39.32 0.7 Allowed 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 123.235 2.623 . . . . 0.0 112.498 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -97.21 -34.28 11.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.834 0.35 . . . . 0.0 110.903 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.84 167.03 22.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.946 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -174.68 127.54 0.31 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.764 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 5.1 t60 64.43 31.79 12.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.691 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.3 tp -85.76 -168.56 2.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.983 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -78.87 74.51 5.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.893 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -76.96 142.18 40.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.896 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -98.28 32.16 2.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.025 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.43 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 0.4 OUTLIER -71.12 -58.93 3.68 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.113 179.907 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 83' ' ' SER . 67.4 Cg_endo -75.37 -23.89 12.77 Favored 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 122.916 2.411 . . . . 0.0 112.426 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.38 33.38 2.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.97 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -78.88 148.61 31.98 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.516 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -62.32 -22.52 66.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.723 0.296 . . . . 0.0 111.104 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 12.5 mt -96.42 37.96 1.23 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.029 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.496 HD22 ' CD1' ' A' ' 30' ' ' TYR . 11.0 mt -154.47 109.8 3.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.739 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 7.5 tpt180 -113.89 -33.67 5.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.227 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.413 ' HA3' ' HB3' ' A' ' 31' ' ' TYR . . . -83.28 125.45 7.02 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.741 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 10.6 p -158.13 130.84 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.775 0.322 . . . . 0.0 110.903 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.692 HD23 ' H ' ' A' ' 94' ' ' ASP . 0.6 OUTLIER -148.48 150.53 33.59 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.103 -179.788 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.692 ' H ' HD23 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -81.96 128.05 33.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.711 179.802 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.655 HG12 ' HD3' ' A' ' 96' ' ' PRO . 8.3 p -71.44 -32.87 2.4 Favored Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.655 ' HD3' HG12 ' A' ' 95' ' ' VAL . 6.3 Cg_exo -73.9 56.36 3.57 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.202 1.934 . . . . 0.0 112.418 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.534 ' HB2' ' O ' ' A' ' 96' ' ' PRO . . . 170.09 63.48 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.963 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 64.9 m -146.46 168.11 21.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.125 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -154.0 99.47 2.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.606 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.916 HD13 HG23 ' A' ' 116' ' ' ILE . 11.2 mm -76.34 159.18 5.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.235 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.431 ' N ' HG22 ' A' ' 100' ' ' ILE . . . -154.45 88.21 1.21 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.904 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.559 ' CG1' HG21 ' A' ' 140' ' ' VAL . 7.6 mt -58.27 156.32 2.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.158 0.504 . . . . 0.0 111.365 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.483 ' N ' HG22 ' A' ' 102' ' ' ILE . 33.2 mtt180 -145.81 125.56 6.91 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.082 179.529 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -82.98 30.06 0.54 Allowed 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.41 2.073 . . . . 0.0 112.914 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -177.75 69.73 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.88 0.371 . . . . 0.0 110.642 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -55.11 -94.21 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.732 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -174.88 169.68 3.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.861 0.362 . . . . 0.0 110.913 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 61.66 -82.69 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.031 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -153.92 31.71 0.45 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.943 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.4 ' HB3' ' CG2' ' A' ' 113' ' ' VAL . 6.1 mmt85 -117.51 90.2 3.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.834 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.571 ' H ' HD12 ' A' ' 111' ' ' LEU . 2.9 mp -62.91 -30.86 71.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.826 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.768 ' HB3' HD13 ' A' ' 136' ' ' LEU . 75.2 m-85 -109.82 105.24 14.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.035 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.425 HG13 ' HB2' ' A' ' 129' ' ' ALA . 39.4 t -144.76 138.87 22.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.967 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.425 ' CE2' ' HB ' ' A' ' 128' ' ' VAL . 39.9 p90 -122.88 133.47 54.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.928 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.59 129.49 50.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.933 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.916 HG23 HD13 ' A' ' 100' ' ' ILE . 1.7 mt -97.84 159.56 3.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.014 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.471 ' N ' HG22 ' A' ' 116' ' ' ILE . 52.3 p -156.72 175.22 14.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.964 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' MET . . . . . 0.565 ' CE ' HG11 ' A' ' 121' ' ' VAL . 2.2 mtm -137.95 91.56 13.23 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.815 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.45 -2.04 12.19 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.624 2.216 . . . . 0.0 112.816 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.4 m -108.94 31.44 5.68 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.692 0.282 . . . . 0.0 111.261 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.655 HG13 ' H ' ' A' ' 122' ' ' ALA . 0.4 OUTLIER -158.41 -82.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.885 179.864 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.655 ' H ' HG13 ' A' ' 121' ' ' VAL . . . -146.07 -164.93 2.08 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.079 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -85.05 57.18 4.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.827 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' TRP . . . . . 0.639 ' NE1' ' HB3' ' A' ' 122' ' ' ALA . 36.9 m95 -102.47 117.27 34.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.793 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -142.39 138.85 31.43 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.882 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.45 HD11 HD13 ' A' ' 116' ' ' ILE . 0.5 OUTLIER -127.6 170.08 13.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.901 -179.937 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -123.87 129.54 51.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.955 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.48 HG12 ' N ' ' A' ' 129' ' ' ALA . 18.7 t -140.94 159.54 23.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.928 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.48 ' N ' HG12 ' A' ' 128' ' ' VAL . . . -159.94 148.89 17.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.909 0.385 . . . . 0.0 111.221 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.534 ' HB2' HD11 ' A' ' 7' ' ' LEU . . . -112.59 135.5 53.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.938 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.47 -35.35 52.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.954 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.04 112.77 24.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.826 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.435 ' HG2' ' CD1' ' A' ' 112' ' ' PHE . 15.8 mt-30 -48.56 -27.8 3.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.725 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -77.12 -43.87 32.51 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.34 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -65.82 -31.25 72.1 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.137 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.768 HD13 ' HB3' ' A' ' 112' ' ' PHE . 7.7 tt -69.84 -50.44 42.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.474 179.529 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -67.87 -36.61 80.57 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.237 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -71.0 -28.51 64.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.407 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' TRP . . . . . 0.42 ' NE1' ' HG2' ' A' ' 3' ' ' LYS . 0.8 OUTLIER -69.75 -46.32 66.14 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.52 179.667 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.701 HG13 HG21 ' A' ' 100' ' ' ILE . 30.5 t -63.45 -42.29 95.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.741 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.45 -36.79 84.9 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.819 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.45 ' O ' HG22 ' A' ' 146' ' ' VAL . 0.0 OUTLIER -65.77 -56.0 14.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.312 179.521 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.786 HG21 HD11 ' A' ' 100' ' ' ILE . 65.9 mt -51.6 -31.8 13.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.167 0.508 . . . . 0.0 109.844 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 58.2 mtt180 -80.88 -28.63 35.89 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.535 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.626 ' O ' HG22 ' A' ' 149' ' ' THR . 0.6 OUTLIER -72.59 -39.52 67.27 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.839 0.352 . . . . 0.0 110.675 179.671 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.597 ' CG2' HG21 ' A' ' 95' ' ' VAL . 9.0 m -78.48 -32.72 16.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.072 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.42 -34.26 65.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.416 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -73.05 -13.28 61.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.791 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.626 HG22 ' O ' ' A' ' 145' ' ' GLU . 8.9 t -122.96 19.24 10.09 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.152 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.257 -0.878 . . . . 0.0 111.112 179.92 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 61.7 m . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.765 0.317 . . . . 0.0 111.262 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.833 HD11 ' HA ' ' A' ' 26' ' ' SER . 12.3 mt -77.2 -35.55 22.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.887 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -157.92 150.44 22.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.873 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.435 ' HB3' HG13 ' A' ' 23' ' ' VAL . 36.1 p-10 -157.91 137.8 12.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.887 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -170.06 179.06 42.56 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.493 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.57 ' N ' HD12 ' A' ' 6' ' ' ILE . 3.7 mp -93.31 79.24 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.933 0.397 . . . . 0.0 111.105 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.59 HD23 ' CZ2' ' A' ' 139' ' ' TRP . 2.0 mm? -77.26 163.62 26.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.808 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -100.51 142.51 31.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.04 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -148.64 105.62 3.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.768 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.59 120.74 11.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.126 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.07 129.14 68.46 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.49 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -68.74 -9.82 27.29 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.395 2.063 . . . . 0.0 112.687 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.9 t -64.22 -40.19 88.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.069 0.462 . . . . 0.0 110.602 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 54.6 p30 -142.22 12.81 1.99 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.355 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 50.27 79.35 0.09 Allowed 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 120.666 0.27 . . . . 0.0 111.071 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -162.96 133.34 4.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.922 0.391 . . . . 0.0 111.028 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 29.5 m95 -67.9 137.3 55.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.863 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -137.32 132.27 17.82 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.879 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.22 127.18 24.77 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.414 2.076 . . . . 0.0 112.241 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -135.51 122.17 20.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.869 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -80.24 85.27 5.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.924 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.441 ' CE2' ' HB3' ' A' ' 31' ' ' TYR . 4.0 m-85 -79.42 157.45 27.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.873 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.435 HG13 ' HB3' ' A' ' 4' ' ' ASN . 21.6 t -143.03 104.38 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.399 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.425 HD21 HG11 ' A' ' 146' ' ' VAL . 20.0 tp -86.51 117.36 25.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.717 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -99.7 157.97 16.1 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.301 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.833 ' HA ' HD11 ' A' ' 2' ' ' ILE . 7.0 t -44.55 -33.43 1.75 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.835 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.456 ' HA ' HG11 ' A' ' 95' ' ' VAL . 3.6 m -144.07 46.33 1.44 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.798 0.332 . . . . 0.0 111.403 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.3 mttt 179.27 167.91 1.03 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.939 0.399 . . . . 0.0 111.174 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.1 mt -139.51 106.15 2.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.825 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -97.03 139.61 32.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.989 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.441 ' HB3' ' CE2' ' A' ' 22' ' ' PHE . 13.2 p90 -140.33 112.95 8.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.827 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.5 m -124.07 151.28 44.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.837 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -96.26 130.28 43.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.88 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -67.79 167.3 13.68 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.84 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.7 t -127.26 -171.19 2.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.94 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -168.54 117.07 0.7 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.894 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 8.6 m -118.26 90.27 3.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.913 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.2 t0 59.6 61.5 1.96 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.903 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -144.47 55.67 1.28 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.905 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 106.2 31.76 3.97 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.505 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -164.17 49.93 0.13 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.925 0.393 . . . . 0.0 110.903 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -98.04 31.67 2.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.982 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -95.19 151.57 19.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.928 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.72 89.69 8.09 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.872 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 60.5 -170.42 0.15 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.91 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -116.14 84.25 13.62 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.967 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.58 157.04 10.3 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.543 2.162 . . . . 0.0 112.337 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.83 149.3 22.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.897 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -128.72 170.6 13.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.89 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -160.58 -173.89 4.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.07 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.85 31.64 4.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.934 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 137.91 -86.5 0.22 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.525 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 91.5 p -152.82 157.93 41.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.726 0.298 . . . . 0.0 110.868 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -106.88 -175.68 2.86 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.931 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.11 -174.62 4.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.872 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.44 -31.02 14.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.02 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -102.09 31.54 3.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.921 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 54.2 p -127.08 24.57 6.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.111 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 62.86 125.75 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.963 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -151.52 -46.27 0.11 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.017 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -68.06 -30.74 70.02 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.897 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.5 t -73.66 -30.58 29.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.092 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -78.22 -13.62 59.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.289 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -93.01 26.18 2.92 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.115 0.483 . . . . 0.0 110.75 179.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -167.8 30.02 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.147 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -109.5 -60.29 0.52 Allowed Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.411 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_exo -53.01 91.92 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.635 2.223 . . . . 0.0 112.391 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 58.51 81.06 0.26 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.957 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -88.94 17.83 1.57 Allowed 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.871 2.381 . . . . 0.0 112.853 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.52 29.66 3.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.837 0.351 . . . . 0.0 111.186 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.493 ' O ' HG22 ' A' ' 71' ' ' ILE . 7.8 mt -116.65 -11.3 11.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.926 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 7.9 mt -88.86 21.24 3.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.022 0.439 . . . . 0.0 111.768 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.487 ' N ' ' HD3' ' A' ' 74' ' ' PRO . 19.8 mt-10 -144.55 61.9 9.12 Favored Pre-proline 0 C--N 1.318 -0.799 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.809 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.487 ' HD3' ' N ' ' A' ' 73' ' ' GLU . 5.8 Cg_exo -74.49 59.35 4.76 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.718 2.279 . . . . 0.0 112.049 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -93.13 -49.79 5.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.106 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -91.07 179.64 5.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.07 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 62.11 111.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.878 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 12.0 t60 61.69 83.11 0.16 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.874 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.2 mp -104.67 -170.45 1.76 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.843 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.3 94.04 5.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.974 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -143.19 156.61 44.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.907 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -97.22 25.49 5.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.026 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.417 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 0.9 OUTLIER -73.86 -59.96 1.69 Allowed Pre-proline 0 C--N 1.331 -0.211 0 CA-C-O 120.915 0.388 . . . . 0.0 111.014 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.417 ' HD2' ' N ' ' A' ' 83' ' ' SER . 64.7 Cg_endo -74.54 -22.37 15.97 Favored 'Trans proline' 0 N--CA 1.465 -0.179 0 C-N-CA 122.902 2.401 . . . . 0.0 112.501 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.6 mp 63.48 -80.6 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.965 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -171.59 91.91 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.598 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -136.01 75.85 1.57 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.954 0.407 . . . . 0.0 110.947 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.25 -49.08 59.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.865 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -129.61 165.63 21.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.858 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 59.77 50.27 7.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.846 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.428 ' HA3' ' CZ ' ' A' ' 31' ' ' TYR . . . -70.85 113.86 4.99 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.61 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.5 p -95.77 133.52 36.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.765 0.317 . . . . 0.0 111.033 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.7 tp -132.56 152.41 51.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.056 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.475 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 2.3 p30 -89.56 126.88 35.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.752 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.772 HG21 HG13 ' A' ' 146' ' ' VAL . 7.6 p -72.42 -33.33 2.23 Favored Pre-proline 0 CA--C 1.534 0.365 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.649 ' HD3' HG12 ' A' ' 95' ' ' VAL . 6.4 Cg_exo -74.28 55.23 3.5 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.334 2.022 . . . . 0.0 112.546 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.531 ' HB2' ' O ' ' A' ' 96' ' ' PRO . . . 170.02 66.44 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.999 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 31.1 p -142.87 161.39 38.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.121 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.408 ' HB2' ' HD3' ' A' ' 119' ' ' PRO . 0.0 OUTLIER -148.59 105.97 3.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.636 179.878 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 1.031 HG21 HG23 ' A' ' 140' ' ' VAL . 4.7 mm -78.02 163.33 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.322 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.433 ' H ' HG22 ' A' ' 100' ' ' ILE . . . -159.89 87.63 0.81 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.822 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.464 HG22 ' N ' ' A' ' 103' ' ' ARG . 84.1 mt -56.72 155.16 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.127 0.489 . . . . 0.0 111.292 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.464 ' N ' HG22 ' A' ' 102' ' ' ILE . 7.2 mtt85 -148.61 118.19 4.09 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.174 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -81.53 33.85 0.54 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.43 2.086 . . . . 0.0 112.784 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 178.87 69.35 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.894 0.378 . . . . 0.0 110.42 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -61.51 -98.79 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.735 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.54 170.27 21.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.866 0.365 . . . . 0.0 110.976 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 60.85 -83.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.114 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -161.35 31.22 0.14 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.824 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.552 ' O ' HG23 ' A' ' 113' ' ' VAL . 2.6 mmp_? -118.25 94.26 4.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.771 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.514 ' H ' HD12 ' A' ' 111' ' ' LEU . 0.9 OUTLIER -69.9 -34.69 73.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.934 -179.93 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.494 ' HB3' HD13 ' A' ' 136' ' ' LEU . 12.1 m-85 -86.56 81.76 8.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.893 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 110' ' ' ARG . 23.6 t -134.06 120.45 35.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.153 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.427 ' CD1' ' HG ' ' A' ' 136' ' ' LEU . 38.7 p90 -106.79 120.45 42.05 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.687 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 31.4 t -92.64 131.39 37.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.227 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.813 HD12 HD12 ' A' ' 100' ' ' ILE . 6.3 mm -92.99 162.84 2.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.684 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.435 ' N ' HG22 ' A' ' 116' ' ' ILE . 2.3 m -150.0 -179.55 7.25 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.027 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 31.1 mtp -155.67 96.59 2.38 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.87 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.408 ' HD3' ' HB2' ' A' ' 99' ' ' GLN . 40.1 Cg_endo -67.3 -27.01 41.14 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.443 2.095 . . . . 0.0 112.297 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.2 p -94.65 43.57 1.1 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.793 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 44.2 t -154.61 -68.51 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.984 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.465 ' HB3' ' CD1' ' A' ' 124' ' ' TRP . . . 179.57 -155.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.225 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 -83.88 49.96 1.73 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.803 0.335 . . . . 0.0 110.977 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' TRP . . . . . 0.465 ' CD1' ' HB3' ' A' ' 122' ' ' ALA . 12.4 m0 -83.73 122.88 29.24 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.876 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -142.29 96.11 2.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.671 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.484 ' H ' HD23 ' A' ' 126' ' ' LEU . 0.6 OUTLIER -98.58 161.6 13.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.03 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -117.04 142.32 47.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.03 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.542 HG12 HD12 ' A' ' 7' ' ' LEU . 15.6 t -148.38 141.58 18.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.939 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -146.43 134.33 21.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.307 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.409 ' HB2' HD11 ' A' ' 7' ' ' LEU . . . -99.81 138.52 36.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.912 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -52.88 -34.67 55.78 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.036 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 9.2 t -102.1 115.94 31.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.844 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.433 ' HG3' ' CE2' ' A' ' 112' ' ' PHE . 0.0 OUTLIER -48.47 -28.0 3.03 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.386 179.424 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -73.31 -39.89 64.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.206 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.32 -32.79 72.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.027 179.299 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.494 HD13 ' HB3' ' A' ' 112' ' ' PHE . 6.2 tt -66.35 -46.4 76.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.48 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.45 ' O ' HG12 ' A' ' 140' ' ' VAL . 14.8 mm100 -70.11 -39.2 75.65 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.293 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -68.68 -31.2 70.14 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.325 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' TRP . . . . . 0.59 ' CZ2' HD23 ' A' ' 7' ' ' LEU . 1.1 m95 -68.77 -46.72 68.01 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.656 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 1.031 HG23 HG21 ' A' ' 100' ' ' ILE . 0.3 OUTLIER -60.88 -40.43 85.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.753 179.888 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 15.7 mtmt -68.18 -37.38 80.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.742 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 10.5 mttt -67.61 -51.82 45.67 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.295 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.551 HG21 HD11 ' A' ' 100' ' ' ILE . 85.8 mt -54.22 -35.13 28.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.308 0.575 . . . . 0.0 109.579 178.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 34.1 mtt180 -79.17 -27.45 42.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.595 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.522 ' O ' HG22 ' A' ' 149' ' ' THR . 1.2 tm-20 -77.35 -34.04 55.23 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.867 0.365 . . . . 0.0 110.767 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.772 HG13 HG21 ' A' ' 95' ' ' VAL . 9.6 p -81.97 -29.46 9.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.372 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -81.0 -34.77 32.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.493 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -79.27 -11.15 59.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.965 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.532 HG22 ' HA ' ' A' ' 146' ' ' VAL . 15.2 t -107.38 -21.5 12.91 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.078 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.215 -0.897 . . . . 0.0 111.14 179.945 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 78.0 p . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 120.845 0.355 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.766 HD11 ' HA ' ' A' ' 26' ' ' SER . 19.6 mt -78.27 -34.94 19.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.145 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.31 140.57 4.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.049 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 33.1 p-10 -146.47 141.91 27.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.819 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -163.4 -171.14 29.26 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.467 -0.873 . . . . 0.0 112.611 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.446 HG21 ' CB ' ' A' ' 36' ' ' SER . 20.8 mm -98.24 80.1 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.777 0.322 . . . . 0.0 111.031 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.754 HD23 ' CZ2' ' A' ' 139' ' ' TRP . 1.7 mm? -88.59 134.72 33.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.663 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.455 ' O ' HG12 ' A' ' 128' ' ' VAL . 28.1 m-85 -73.11 165.56 24.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.242 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -160.01 114.44 2.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.669 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.43 ' HG2' ' CZ3' ' A' ' 17' ' ' TRP . 3.6 pt-20 -73.43 90.49 1.7 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.17 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -60.73 113.33 7.38 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.62 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.66 -18.68 16.27 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.66 2.24 . . . . 0.0 112.916 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.4 t -68.44 -41.11 83.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.897 0.38 . . . . 0.0 111.269 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 -113.92 -13.34 12.56 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.231 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 68.4 m80 61.99 50.91 3.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.862 0.363 . . . . 0.0 110.854 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -152.94 151.7 30.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.792 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.43 ' CZ3' ' HG2' ' A' ' 10' ' ' GLU . 67.1 m95 -80.42 125.1 29.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.931 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -119.85 142.33 32.96 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.813 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -68.6 101.03 0.72 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.46 2.106 . . . . 0.0 112.176 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 35.2 m170 -119.16 138.05 53.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.847 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -82.67 140.0 33.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.865 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.487 ' CZ ' ' CD2' ' A' ' 31' ' ' TYR . 0.2 OUTLIER -133.55 124.78 27.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.914 179.854 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.5 t -111.89 103.31 15.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.829 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.9 tp -82.69 109.37 16.8 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.018 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.512 ' HG1' ' C ' ' A' ' 28' ' ' LYS . 43.2 p -99.1 155.94 17.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.794 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.766 ' HA ' HD11 ' A' ' 2' ' ' ILE . 1.5 m -65.0 -12.13 46.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.898 -179.571 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.8 m -121.22 2.78 10.37 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.559 ' HA ' HG23 ' A' ' 95' ' ' VAL . 0.5 OUTLIER 173.28 -170.91 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.97 0.414 . . . . 0.0 111.316 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.4 mt -136.74 119.91 21.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.838 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -103.03 153.08 20.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.029 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.487 ' CD2' ' CZ ' ' A' ' 22' ' ' PHE . 25.3 p90 -167.17 148.25 5.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.953 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.45 -175.85 3.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.931 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -68.47 129.05 38.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.928 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -167.14 170.4 11.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.776 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.7 t -98.74 174.89 6.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.865 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.446 ' CB ' HG21 ' A' ' 6' ' ' ILE . 40.1 p -91.25 109.08 20.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.958 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.2 p -106.46 128.83 54.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.823 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -110.86 -30.63 7.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.029 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 9.5 mm-40 -135.02 53.81 1.97 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.852 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -94.78 38.53 3.1 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.565 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 59.88 31.66 20.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.839 0.352 . . . . 0.0 110.868 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -114.5 41.53 2.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.06 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -111.55 -179.64 3.77 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.018 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -82.49 100.39 10.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.932 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -72.28 160.24 32.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.863 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -78.66 137.42 58.71 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.832 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.99 166.46 1.51 Allowed 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.35 2.033 . . . . 0.0 112.328 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.71 137.0 33.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.924 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -106.16 31.84 4.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.977 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -101.66 147.41 26.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.042 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.6 m -138.2 -48.87 0.55 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.919 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 138.98 -34.88 2.04 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.517 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.6 m 60.59 99.4 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.837 0.351 . . . . 0.0 110.928 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.555 ' O ' HG23 ' A' ' 54' ' ' THR . 10.1 t -165.68 73.58 0.19 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.925 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -174.51 -174.5 0.85 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.943 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.2 mt -145.33 -48.26 0.23 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.877 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -104.81 157.44 17.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.939 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.7 m -143.85 129.36 19.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.008 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.441 ' HB3' HG23 ' A' ' 62' ' ' VAL . 69.7 m -105.92 121.32 43.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.82 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.96 -44.29 15.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.915 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.8 -38.33 79.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.708 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.441 HG23 ' HB3' ' A' ' 59' ' ' SER . 40.9 t -68.44 -29.61 44.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.607 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 11.0 mt -81.78 -3.75 54.64 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.074 179.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -87.29 25.9 1.31 Allowed 'General case' 0 C--O 1.231 0.108 0 CA-C-O 121.198 0.523 . . . . 0.0 110.476 179.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -178.36 32.04 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.927 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.414 ' N ' ' CD ' ' A' ' 67' ' ' PRO . . . -163.32 50.32 0.31 Allowed Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.458 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 66' ' ' GLY . 73.1 Cg_endo -75.77 -173.46 1.66 Allowed 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.646 2.231 . . . . 0.0 112.501 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -66.25 112.74 9.93 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.832 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -77.34 0.38 9.81 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.426 2.084 . . . . 0.0 112.988 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.22 29.72 3.07 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.796 0.331 . . . . 0.0 111.242 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.471 ' O ' HG22 ' A' ' 71' ' ' ILE . 7.3 mt -117.39 -12.31 11.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.843 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.9 mt -88.03 17.62 4.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.194 0.521 . . . . 0.0 111.813 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.456 ' N ' ' HD3' ' A' ' 74' ' ' PRO . 4.4 mm-40 -142.3 63.18 14.66 Favored Pre-proline 0 C--N 1.315 -0.931 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.623 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.456 ' HD3' ' N ' ' A' ' 73' ' ' GLU . 5.7 Cg_exo -78.17 53.73 4.62 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.997 2.465 . . . . 0.0 112.293 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -108.96 -34.23 6.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.906 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.701 ' HA ' HD11 ' A' ' 79' ' ' LEU . 1.9 mmt85 -138.64 -172.27 3.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.802 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 63.36 110.77 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.822 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 61.9 91.73 0.06 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.924 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.701 HD11 ' HA ' ' A' ' 76' ' ' ARG . 2.9 mp -129.91 -178.83 4.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.857 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.83 59.56 4.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.711 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.28 175.45 7.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.025 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 58.67 20.54 7.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.266 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.493 ' CB ' ' HD2' ' A' ' 84' ' ' PRO . 0.3 OUTLIER -62.09 175.44 0.57 Allowed Pre-proline 0 C--N 1.329 -0.295 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.116 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.493 ' HD2' ' CB ' ' A' ' 83' ' ' SER . 41.0 Cg_endo -67.74 61.71 0.87 Allowed 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 121.974 1.782 . . . . 0.0 112.249 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.47 30.55 4.9 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.952 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -75.63 -74.59 0.9 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.488 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -138.46 75.04 1.5 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.902 0.382 . . . . 0.0 110.86 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.2 mp -145.07 38.63 1.18 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.846 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.17 121.68 34.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.824 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -177.31 -39.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.875 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.43 ' HA3' ' CE1' ' A' ' 31' ' ' TYR . . . -119.62 100.24 0.79 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.498 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.6 m -97.87 156.8 3.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.87 0.367 . . . . 0.0 111.062 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.414 ' HA ' HD12 ' A' ' 93' ' ' LEU . 9.9 tp -151.05 129.77 12.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.027 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.39 138.93 49.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.816 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.819 ' CG1' HG13 ' A' ' 146' ' ' VAL . 18.7 t -79.66 -47.87 1.46 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.752 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.469 ' HD3' ' HB ' ' A' ' 95' ' ' VAL . 94.3 Cg_endo -79.07 55.33 5.56 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.232 1.955 . . . . 0.0 112.499 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.449 ' HB2' ' O ' ' A' ' 96' ' ' PRO . . . 175.53 39.53 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.034 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -156.82 104.15 2.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.943 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -89.76 131.32 35.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.765 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.939 HD11 HG21 ' A' ' 143' ' ' ILE . 11.5 mm -82.28 160.93 3.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.147 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.451 ' N ' HG22 ' A' ' 100' ' ' ILE . . . -154.93 93.95 1.6 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.959 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 46.3 mt -58.48 151.25 4.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.089 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.43 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 10.3 mtt180 -140.72 114.26 7.21 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.617 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 103' ' ' ARG . 5.9 Cg_exo -74.11 11.54 1.18 Allowed 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.681 2.254 . . . . 0.0 112.942 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.74 65.39 0.6 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.925 0.393 . . . . 0.0 110.423 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -48.87 -90.24 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.935 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -171.74 171.61 5.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.89 0.376 . . . . 0.0 111.127 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 60.69 -83.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.233 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -155.07 32.13 0.39 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.069 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 15.1 mtt-85 -122.05 109.97 15.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.806 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.501 ' H ' HD23 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -96.51 23.48 6.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.124 -179.88 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -143.99 68.65 1.27 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.921 0.391 . . . . 0.0 110.764 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.937 HG22 ' HB2' ' A' ' 129' ' ' ALA . 39.5 t -130.02 140.96 47.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.047 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.592 ' CZ ' HG23 ' A' ' 128' ' ' VAL . 25.1 p90 -117.64 132.71 56.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.589 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.4 m -110.58 137.23 48.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.093 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.829 HG23 HD13 ' A' ' 100' ' ' ILE . 2.9 mp -99.89 159.08 3.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.85 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.449 ' N ' HG22 ' A' ' 116' ' ' ILE . 20.1 m -147.87 159.65 43.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.901 0.382 . . . . 0.0 110.953 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 12.9 mtp -113.05 155.33 44.43 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.889 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.96 74.35 0.33 Allowed 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.541 2.161 . . . . 0.0 112.228 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 13.3 p 58.87 107.65 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.985 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.5 t -140.4 -66.66 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.101 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.602 ' HB3' ' NE1' ' A' ' 124' ' ' TRP . . . -169.39 44.77 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.162 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 61.27 37.5 17.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.983 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' TRP . . . . . 0.602 ' NE1' ' HB3' ' A' ' 122' ' ' ALA . 24.1 m95 -90.2 115.01 27.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.871 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -129.29 118.12 21.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.887 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -84.65 151.15 24.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.917 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -138.33 117.95 13.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.81 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.661 ' HB ' HD12 ' A' ' 7' ' ' LEU . 2.3 m -144.94 154.42 14.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.201 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.937 ' HB2' HG22 ' A' ' 113' ' ' VAL . . . -148.74 122.33 9.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.146 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -90.13 130.96 36.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.991 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.07 -35.94 65.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.922 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.1 m -90.9 111.21 22.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.828 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.84 -28.45 3.74 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.525 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.93 -40.36 60.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.383 179.491 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -68.06 -33.1 73.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.223 179.285 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.459 ' O ' HG23 ' A' ' 140' ' ' VAL . 5.2 tt -67.53 -47.91 68.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.449 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -68.21 -40.9 82.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.297 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -66.62 -30.35 70.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.216 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' TRP . . . . . 0.754 ' CZ2' HD23 ' A' ' 7' ' ' LEU . 1.0 OUTLIER -66.31 -50.21 64.43 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.535 179.64 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.601 HG12 ' HD2' ' A' ' 144' ' ' ARG . 38.4 t -61.63 -38.17 79.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.051 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -68.29 -38.83 82.06 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.047 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 3.3 mttt -67.11 -52.76 37.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.302 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.939 HG21 HD11 ' A' ' 100' ' ' ILE . 74.1 mt -54.71 -33.79 28.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.601 ' HD2' HG12 ' A' ' 140' ' ' VAL . 0.1 OUTLIER -78.43 -28.44 46.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.547 179.093 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.619 ' O ' HG22 ' A' ' 149' ' ' THR . 47.4 tt0 -75.26 -39.51 59.72 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.857 0.36 . . . . 0.0 110.579 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.819 HG13 ' CG1' ' A' ' 95' ' ' VAL . 7.8 p -77.54 -27.81 15.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.147 179.181 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -74.5 -39.04 62.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.621 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -72.53 -16.84 61.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.918 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.619 HG22 ' O ' ' A' ' 145' ' ' GLU . 11.8 t -112.79 18.53 18.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.794 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.225 -0.893 . . . . 0.0 111.113 179.945 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 120.862 0.363 . . . . 0.0 111.273 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.758 HD11 ' HA ' ' A' ' 26' ' ' SER . 39.2 mt -74.19 -37.61 46.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.032 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.519 ' HB3' ' HZ2' ' A' ' 3' ' ' LYS . 0.1 OUTLIER -156.12 145.09 20.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.965 -179.828 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.578 ' HB3' HG13 ' A' ' 23' ' ' VAL . 2.6 p-10 -161.92 135.02 6.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.834 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -161.59 -163.86 15.35 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.501 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.691 HD13 ' HD1' ' A' ' 21' ' ' TYR . 25.2 mm -99.66 73.49 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.938 0.399 . . . . 0.0 111.083 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.832 HD12 HG12 ' A' ' 128' ' ' VAL . 0.9 OUTLIER -79.75 150.11 30.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.734 179.957 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.659 ' C ' HD22 ' A' ' 9' ' ' LEU . 23.1 m-85 -87.49 138.4 31.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.977 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.659 HD22 ' C ' ' A' ' 8' ' ' TYR . 4.4 mm? -126.74 175.03 8.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.845 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.447 ' HG3' ' CZ3' ' A' ' 17' ' ' TRP . 18.0 mt-10 -118.33 107.85 14.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.095 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.27 146.63 62.73 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.492 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.23 -17.33 19.14 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.486 2.124 . . . . 0.0 112.735 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.3 t -69.12 -43.76 81.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.0 0.428 . . . . 0.0 111.187 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -112.42 -18.47 12.45 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.192 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 24.8 m-70 62.16 29.25 17.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.809 0.338 . . . . 0.0 110.862 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -130.76 176.17 8.43 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.699 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.579 ' HH2' HG11 ' A' ' 113' ' ' VAL . 21.7 m95 -61.79 137.92 58.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.693 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -139.45 141.69 29.56 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.858 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.72 126.41 10.13 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.542 2.161 . . . . 0.0 112.252 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -152.45 167.81 27.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.93 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.691 ' HD1' HD13 ' A' ' 6' ' ' ILE . 7.2 t80 -108.29 115.23 29.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.974 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.446 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 2.2 m-85 -108.54 141.46 40.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.922 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.578 HG13 ' HB3' ' A' ' 4' ' ' ASN . 25.8 t -126.63 148.8 31.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.174 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.646 HD22 HG23 ' A' ' 29' ' ' ILE . 1.5 tm? -128.04 110.84 12.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.873 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.1 p -98.76 155.37 17.39 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.006 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.758 ' HA ' HD11 ' A' ' 2' ' ' ILE . 56.4 p -60.58 -16.41 37.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.079 -179.416 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -133.94 24.27 3.92 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.422 ' CD ' HG21 ' A' ' 92' ' ' VAL . 0.3 OUTLIER 171.67 -176.36 0.05 OUTLIER 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 121.077 0.465 . . . . 0.0 111.684 179.604 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.646 HG23 HD22 ' A' ' 24' ' ' LEU . 1.5 mt -144.79 127.03 9.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.639 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -104.07 142.02 35.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.859 0.361 . . . . 0.0 111.037 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.446 ' HB2' ' CZ ' ' A' ' 22' ' ' PHE . 3.6 p90 -156.66 100.97 1.96 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.942 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.7 t -169.68 158.61 7.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.986 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -76.58 157.81 31.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -167.42 154.8 8.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.88 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.0 t -126.16 -171.67 2.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.883 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.3 m -146.3 95.36 2.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.867 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.8 p -145.57 115.94 7.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.889 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -128.54 86.44 2.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.885 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 60.3 mm-40 -143.48 37.36 1.35 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.925 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -141.15 61.23 0.55 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.536 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 16.1 m-20 -102.02 36.01 2.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.861 0.362 . . . . 0.0 110.878 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -133.19 33.63 3.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.012 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 59.68 92.92 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.903 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -125.97 155.92 40.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.946 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -128.47 -175.52 3.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.883 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -114.17 87.62 13.57 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.955 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -52.11 174.63 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.6 2.2 . . . . 0.0 112.285 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.56 102.18 14.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.89 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -113.74 143.07 45.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.867 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 59.7 36.97 22.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.158 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.3 p -62.51 166.68 4.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.918 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -72.42 115.64 5.45 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.471 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 44.7 m -73.94 169.82 16.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.83 0.348 . . . . 0.0 110.891 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.75 31.77 4.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.914 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -153.15 141.26 20.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.917 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 18.3 mt -81.64 128.63 34.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.886 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 57.2 m-70 -141.65 175.18 9.9 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.963 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 60.98 169.13 0.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.831 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -127.18 170.26 12.59 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.905 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 77.31 -2.75 2.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.48 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -96.1 -28.11 14.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.012 0.434 . . . . 0.0 110.106 179.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.8 t -74.26 -29.8 25.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.819 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -80.08 -9.24 59.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.165 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -93.44 25.97 3.2 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.049 0.452 . . . . 0.0 110.605 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -165.54 29.84 0.05 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.187 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -108.16 -62.19 0.55 Allowed Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.672 -0.694 . . . . 0.0 112.143 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.95 140.66 58.42 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.572 2.181 . . . . 0.0 112.112 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.5 m120 60.09 100.19 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.716 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.94 -4.19 14.97 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.56 2.174 . . . . 0.0 112.988 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.64 28.98 2.43 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.853 0.359 . . . . 0.0 111.385 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.446 ' O ' HG22 ' A' ' 71' ' ' ILE . 6.7 mt -117.36 -13.24 10.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.764 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.8 mp -88.21 18.74 4.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.126 0.489 . . . . 0.0 111.704 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 -143.44 75.12 16.87 Favored Pre-proline 0 C--N 1.316 -0.867 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.414 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -68.04 59.33 0.92 Allowed 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.971 2.447 . . . . 0.0 112.352 -179.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -95.37 -36.0 11.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.812 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 26.6 mmt-85 -105.02 176.06 5.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.893 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 59.61 103.7 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.869 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 61.02 86.36 0.1 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.813 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.1 mp -103.6 150.48 23.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.917 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 60.89 41.44 14.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.933 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -128.95 32.16 4.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.923 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -103.98 -27.19 12.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.005 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.444 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 0.3 OUTLIER -56.23 -59.42 11.96 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.15 -179.915 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 83' ' ' SER . 60.3 Cg_endo -74.01 -26.11 13.35 Favored 'Trans proline' 0 N--CA 1.465 -0.152 0 C-N-CA 122.846 2.364 . . . . 0.0 112.413 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 14.8 tp 73.65 6.37 4.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.518 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 57.57 108.35 0.01 OUTLIER Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.753 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.54 -34.99 72.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.901 0.382 . . . . 0.0 110.727 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 63.97 98.94 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.255 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.636 HD11 ' CD1' ' A' ' 126' ' ' LEU . 16.2 tp 51.65 38.31 22.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.313 179.631 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.6 mmt85 -140.89 95.86 2.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.94 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 173.87 -146.25 8.66 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.528 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.422 HG21 ' CD ' ' A' ' 28' ' ' LYS . 12.2 p -107.45 152.83 8.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.803 0.335 . . . . 0.0 111.158 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.499 HD23 ' N ' ' A' ' 94' ' ' ASP . 1.4 tt -139.96 129.58 24.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.943 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.499 ' N ' HD23 ' A' ' 93' ' ' LEU . 0.6 OUTLIER -68.93 141.65 54.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.829 179.94 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.723 ' CG2' HG13 ' A' ' 146' ' ' VAL . 11.7 p -81.98 -29.08 0.48 Allowed Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.646 ' CD ' ' N ' ' A' ' 95' ' ' VAL . 98.6 Cg_endo -86.18 47.15 1.74 Allowed 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.149 1.899 . . . . 0.0 112.642 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -177.95 37.85 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.006 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 1.3 m -131.67 120.13 22.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.966 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.15 109.09 20.92 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.736 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.987 HD11 HG21 ' A' ' 143' ' ' ILE . 14.2 mm -75.35 157.66 5.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.079 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.414 ' N ' HG22 ' A' ' 100' ' ' ILE . . . -153.87 87.6 1.22 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.987 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 52.9 mt -58.58 146.22 8.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.193 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.83 104.82 5.77 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.618 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -73.65 52.95 2.61 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.36 2.04 . . . . 0.0 112.424 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.425 ' HG3' HD22 ' A' ' 111' ' ' LEU . 2.6 mt-10 168.0 56.65 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.408 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.418 ' O ' ' HG3' ' A' ' 107' ' ' LYS . . . -65.85 -102.6 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.768 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.418 ' HG3' ' O ' ' A' ' 106' ' ' GLY . 0.0 OUTLIER -154.35 -177.0 6.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.993 0.425 . . . . 0.0 111.191 -179.795 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.447 ' HB2' ' NE1' ' A' ' 17' ' ' TRP . 0.8 OUTLIER 47.9 41.65 14.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.611 179.524 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 61.84 31.3 18.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.337 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 -118.31 106.3 12.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.517 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.425 HD22 ' HG3' ' A' ' 105' ' ' GLU . 3.3 mt -96.54 30.28 2.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.108 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.511 ' O ' HD13 ' A' ' 136' ' ' LEU . 39.4 m-85 -145.82 61.72 1.26 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.528 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.7 HG22 ' HB2' ' A' ' 129' ' ' ALA . 38.7 t -125.32 126.37 70.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.009 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.444 ' CZ ' ' HB ' ' A' ' 128' ' ' VAL . 35.8 p90 -103.63 131.53 50.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.578 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 13.0 t -105.45 127.08 52.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.105 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.956 HG23 HD13 ' A' ' 100' ' ' ILE . 12.8 mt -94.97 158.16 2.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.499 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 2.5 m -154.62 132.17 11.31 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.803 0.335 . . . . 0.0 111.146 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' MET . . . . . 0.44 ' SD ' HD21 ' A' ' 93' ' ' LEU . 77.1 mtp -92.17 115.56 64.9 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.85 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -79.68 53.67 4.84 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.485 2.124 . . . . 0.0 112.519 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 30.5 t 177.59 39.95 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.634 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 45.6 t -145.66 -69.96 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.088 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -179.26 -155.13 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.416 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -83.78 49.27 1.58 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.738 0.304 . . . . 0.0 111.07 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 12.4 m95 -74.47 169.87 16.85 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.73 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -169.17 98.61 0.36 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.955 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.649 HD23 HD12 ' A' ' 116' ' ' ILE . 1.6 tp -83.97 95.73 8.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.075 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.5 130.56 35.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.96 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.832 HG12 HD12 ' A' ' 7' ' ' LEU . 21.7 t -152.25 159.03 4.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.147 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.7 ' HB2' HG22 ' A' ' 113' ' ' VAL . . . -164.81 131.05 2.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.241 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -97.55 141.52 30.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.981 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -55.66 -34.36 64.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.952 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.0 m -94.23 114.49 26.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.816 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.436 ' HG2' ' CZ ' ' A' ' 112' ' ' PHE . 1.1 mp0 -49.67 -27.16 4.37 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.431 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -74.77 -45.45 43.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.424 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -64.6 -31.38 72.58 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.202 179.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.525 ' O ' HG23 ' A' ' 140' ' ' VAL . 1.4 tp -68.05 -50.07 57.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.445 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.506 ' OE1' HD23 ' A' ' 136' ' ' LEU . 4.1 mp0 -68.17 -36.94 80.42 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.332 179.588 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -69.19 -34.4 74.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.163 179.189 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' TRP . . . . . 0.697 ' CZ2' HD23 ' A' ' 7' ' ' LEU . 1.3 m95 -63.8 -47.67 79.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.564 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.85 HG13 HG21 ' A' ' 100' ' ' ILE . 33.4 t -62.83 -44.5 99.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.801 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.1 -33.03 72.71 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.701 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.502 ' O ' HG12 ' A' ' 146' ' ' VAL . 0.2 OUTLIER -70.06 -50.89 36.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.378 179.72 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.987 HG21 HD11 ' A' ' 100' ' ' ILE . 66.8 mt -53.83 -31.27 20.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.178 0.513 . . . . 0.0 109.617 178.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 50.4 mtp85 -80.23 -32.37 38.44 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.159 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.427 ' O ' HG22 ' A' ' 149' ' ' THR . 4.9 pt-20 -77.97 -31.34 50.75 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.755 0.312 . . . . 0.0 110.895 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.723 HG13 ' CG2' ' A' ' 95' ' ' VAL . 9.8 p -83.63 -29.24 7.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.01 0.433 . . . . 0.0 110.296 179.217 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -75.3 -34.62 61.3 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.587 179.178 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -74.55 -11.5 60.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.952 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.443 HG22 ' HA ' ' A' ' 146' ' ' VAL . 10.5 t -117.23 13.05 14.57 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.285 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.2 -0.905 . . . . 0.0 111.204 -179.968 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.488 1.438 0 CA-C-O 120.822 0.344 . . . . 0.0 111.146 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.449 HD11 ' CB ' ' A' ' 26' ' ' SER . 15.6 mt -88.87 -32.88 5.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.051 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.599 ' O ' HG13 ' A' ' 23' ' ' VAL . 3.2 tptp -125.94 135.08 51.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.775 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 17.9 p-10 -154.52 121.8 5.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.006 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.503 ' C ' HD12 ' A' ' 6' ' ' ILE . . . -170.02 -145.68 4.8 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.485 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.653 ' N ' HD12 ' A' ' 6' ' ' ILE . 3.2 mp -127.97 88.44 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.824 0.345 . . . . 0.0 110.953 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.589 HD11 ' HB2' ' A' ' 130' ' ' ALA . 4.4 mm? -87.78 144.24 26.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.84 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -76.33 165.84 24.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.019 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -171.12 101.33 0.21 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.822 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.431 ' HG2' ' CZ3' ' A' ' 17' ' ' TRP . 0.3 OUTLIER -78.55 164.22 24.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.064 -179.875 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.4 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 2.2 t0 -126.42 132.1 24.19 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.714 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 11' ' ' ASP . 31.5 Cg_exo -58.98 -15.59 28.23 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.536 2.157 . . . . 0.0 112.917 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.1 t -68.78 -42.85 83.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.98 0.419 . . . . 0.0 111.438 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -115.41 -15.84 11.48 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.412 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 2.2 m80 62.79 42.7 7.73 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.931 0.396 . . . . 0.0 110.802 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.73 134.81 37.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.818 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.441 ' CD1' ' HG3' ' A' ' 110' ' ' ARG . 85.5 m95 -65.59 135.05 54.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.915 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.433 ' HB3' ' CD2' ' A' ' 20' ' ' HIS . 11.5 m-85 -120.31 104.59 43.04 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.939 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 18' ' ' TYR . 38.5 Cg_endo -67.05 107.84 1.41 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.48 2.12 . . . . 0.0 112.317 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.433 ' CD2' ' HB3' ' A' ' 18' ' ' TYR . 95.1 m-70 -132.25 158.08 42.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.869 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -59.85 151.38 25.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.925 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.477 ' CZ ' ' CD1' ' A' ' 31' ' ' TYR . 0.3 OUTLIER -154.9 142.9 20.13 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.806 -179.939 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.599 HG13 ' O ' ' A' ' 3' ' ' LYS . 14.3 t -139.29 145.82 26.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.158 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.495 HD12 HG12 ' A' ' 29' ' ' ILE . 27.2 tp -125.94 115.88 20.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.792 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 35.0 p -90.58 158.29 17.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.932 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.449 ' CB ' HD11 ' A' ' 2' ' ' ILE . 4.5 t -52.75 -24.0 7.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.693 -179.571 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.0 m -143.33 35.5 1.33 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.552 0.215 . . . . 0.0 111.435 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.528 ' CA ' HG23 ' A' ' 95' ' ' VAL . 1.2 tttt 177.73 179.21 0.3 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.891 0.377 . . . . 0.0 111.305 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.562 HD12 HD23 ' A' ' 93' ' ' LEU . 1.6 mt -141.25 130.27 24.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.715 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -124.52 133.59 53.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.078 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.477 ' CD1' ' CZ ' ' A' ' 22' ' ' PHE . 33.5 p90 -156.43 153.58 29.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.911 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 84.0 p -156.13 -171.04 3.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.848 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -142.22 33.49 1.51 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.811 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.48 94.66 4.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.824 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.54 -173.76 4.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.953 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.7 t 60.3 38.44 19.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.956 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -111.44 37.81 2.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.934 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -125.2 97.6 5.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.934 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 60.04 32.57 21.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.902 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -77.15 82.41 1.13 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.542 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.9 t30 59.56 50.3 7.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.85 0.357 . . . . 0.0 111.01 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -98.61 34.27 2.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.89 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.8 t0 61.69 88.08 0.09 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.838 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -87.74 122.97 32.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.947 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -173.68 178.76 2.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.848 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -156.8 84.1 3.1 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.893 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.54 145.57 52.98 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.628 2.218 . . . . 0.0 112.315 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.86 163.87 11.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.984 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -61.27 175.62 0.54 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.97 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -151.64 112.22 4.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.151 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 28.5 t 62.97 -79.9 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.939 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 148.04 129.47 1.88 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.469 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -147.23 152.11 37.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.847 0.356 . . . . 0.0 110.937 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.3 t -144.82 175.1 10.44 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.924 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -122.61 141.31 51.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.813 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.14 -58.47 3.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.958 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 8.2 t-160 -153.5 -47.43 0.09 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.854 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 60.1 m -128.04 153.5 46.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.922 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.544 ' O ' HD12 ' A' ' 60' ' ' LEU . 19.9 m -65.5 118.15 9.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.925 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.544 HD12 ' O ' ' A' ' 59' ' ' SER . 0.3 OUTLIER -149.85 -46.36 0.13 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.898 -179.987 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.23 -31.61 69.22 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.902 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.4 t -73.71 -31.1 30.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.165 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 15.8 mt -84.85 -4.38 59.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.3 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -90.02 24.96 2.27 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 121.233 0.54 . . . . 0.0 110.424 179.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.29 33.01 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.746 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.418 ' N ' ' CD ' ' A' ' 67' ' ' PRO . . . -165.9 50.43 0.27 Allowed Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.31 -179.596 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.418 ' CD ' ' N ' ' A' ' 66' ' ' GLY . 39.5 Cg_endo -66.54 128.32 18.94 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.528 2.152 . . . . 0.0 112.102 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.5 t30 63.2 117.44 0.02 OUTLIER Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.573 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.44 ' HB2' ' H ' ' A' ' 70' ' ' ALA . 47.1 Cg_endo -90.83 -136.74 0.02 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.876 2.384 . . . . 0.0 111.699 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.44 ' H ' ' HB2' ' A' ' 69' ' ' PRO . . . 58.59 27.63 15.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.901 0.381 . . . . 0.0 110.999 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 69' ' ' PRO . 7.0 mt -115.8 -16.58 8.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.647 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 72.8 mt -86.23 18.92 2.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.095 0.474 . . . . 0.0 111.592 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -149.09 82.39 7.09 Favored Pre-proline 0 C--N 1.316 -0.873 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.159 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_exo -66.57 59.3 0.52 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.94 2.427 . . . . 0.0 112.556 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -96.79 47.32 1.05 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.7 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.641 ' CD ' HD22 ' A' ' 79' ' ' LEU . 11.1 mtm-85 63.28 128.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.761 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -123.26 118.23 27.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.936 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 58.66 83.95 0.11 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.892 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.641 HD22 ' CD ' ' A' ' 76' ' ' ARG . 0.2 OUTLIER -132.07 -163.47 1.34 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.768 179.985 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -86.18 52.53 2.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.846 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -101.92 122.0 43.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.778 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -95.43 19.31 11.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.369 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.416 ' CB ' ' HD3' ' A' ' 84' ' ' PRO . 0.3 OUTLIER -80.9 -55.1 0.7 Allowed Pre-proline 0 C--N 1.331 -0.219 0 CA-C-O 120.895 0.378 . . . . 0.0 110.839 179.906 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.416 ' HD3' ' CB ' ' A' ' 83' ' ' SER . 95.8 Cg_endo -84.53 48.91 2.55 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 123.141 2.561 . . . . 0.0 112.483 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -128.67 30.4 5.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.958 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 156.02 -146.28 13.78 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.587 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.7 t0 61.38 18.8 9.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.716 0.294 . . . . 0.0 111.132 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 48.33 84.11 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.883 0.373 . . . . 0.0 111.301 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.0 117.57 15.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.806 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.97 82.43 0.17 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.692 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -67.67 131.18 28.83 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.499 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 11.5 p -129.06 142.65 43.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.863 0.364 . . . . 0.0 111.07 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.562 HD23 HD12 ' A' ' 29' ' ' ILE . 3.3 tp -147.31 145.05 29.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.931 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.0 133.11 34.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.827 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.777 HG11 HG23 ' A' ' 146' ' ' VAL . 19.8 t -82.46 -45.34 0.95 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.605 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.553 ' O ' ' HB2' ' A' ' 97' ' ' ALA . 11.6 Cg_exo -71.29 55.14 1.9 Allowed 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.632 2.221 . . . . 0.0 112.457 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.553 ' HB2' ' O ' ' A' ' 96' ' ' PRO . . . 168.83 40.47 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.878 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -157.37 98.25 1.69 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.989 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -80.27 129.79 34.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.693 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.713 HD13 HG23 ' A' ' 116' ' ' ILE . 10.7 mm -84.34 157.63 3.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.151 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.424 ' N ' HG22 ' A' ' 100' ' ' ILE . . . -145.84 88.41 1.82 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.869 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.462 HD13 ' OE1' ' A' ' 137' ' ' GLN . 86.3 mt -57.79 143.4 12.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.091 0.472 . . . . 0.0 111.349 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 9.0 mtt-85 -132.45 125.64 19.79 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.069 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -82.42 24.36 0.73 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.386 2.058 . . . . 0.0 112.956 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -176.77 74.83 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.948 0.404 . . . . 0.0 110.538 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -54.45 -93.77 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.68 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.79 172.01 1.02 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.877 0.37 . . . . 0.0 111.07 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 61.8 m-80 61.8 -82.04 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.149 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -152.96 42.9 0.62 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.95 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.441 ' HG3' ' CD1' ' A' ' 17' ' ' TRP . 0.6 OUTLIER -135.48 108.64 7.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.92 179.911 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.5 mt -78.28 -33.75 49.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.823 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.756 ' HB3' HD13 ' A' ' 136' ' ' LEU . 41.1 m-85 -108.7 115.24 29.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.975 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.552 HG13 ' HB2' ' A' ' 129' ' ' ALA . 21.1 t -153.22 140.23 12.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.029 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.436 ' CE2' ' HB ' ' A' ' 128' ' ' VAL . 25.3 p90 -119.93 115.31 23.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.828 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.4 p -93.44 125.94 38.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.992 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.713 HG23 HD13 ' A' ' 100' ' ' ILE . 3.1 mp -92.01 159.99 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.918 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.49 ' N ' HG22 ' A' ' 116' ' ' ILE . 22.1 p -158.43 158.96 35.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.955 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' MET . . . . . 0.453 ' SD ' HG11 ' A' ' 121' ' ' VAL . 32.3 mtp -110.14 155.65 41.43 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.724 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -65.54 -30.9 51.68 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.528 2.152 . . . . 0.0 112.385 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 78.9 p -178.78 129.69 0.11 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.101 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.656 HG22 ' N ' ' A' ' 122' ' ' ALA . 0.2 OUTLIER -167.18 -80.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.817 179.799 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.656 ' N ' HG22 ' A' ' 121' ' ' VAL . . . -155.53 37.33 0.37 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.172 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 61.1 44.22 10.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.857 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' TRP . . . . . 0.541 ' CD1' ' HB3' ' A' ' 122' ' ' ALA . 27.2 m95 -90.45 132.62 35.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.061 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 59.9 m -128.33 139.23 52.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.837 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.639 HD13 ' H ' ' A' ' 127' ' ' ASP . 0.2 OUTLIER -118.72 143.32 46.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.944 0.402 . . . . 0.0 111.111 -179.92 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.639 ' H ' HD13 ' A' ' 126' ' ' LEU . 62.2 m-20 -130.56 119.13 22.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.52 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.611 HG23 HD12 ' A' ' 126' ' ' LEU . 21.9 t -141.32 159.61 22.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.172 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.552 ' HB2' HG13 ' A' ' 113' ' ' VAL . . . -159.66 141.16 12.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.222 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.589 ' HB2' HD11 ' A' ' 7' ' ' LEU . . . -105.97 145.75 30.92 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.834 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -58.13 -60.94 2.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.045 0.45 . . . . 0.0 110.875 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.8 t -70.7 115.7 10.16 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.72 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.443 ' HG3' ' CE2' ' A' ' 112' ' ' PHE . 0.1 OUTLIER -48.71 -26.45 2.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.664 179.59 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -76.03 -43.37 44.31 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.474 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.79 -32.49 74.06 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.292 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.756 HD13 ' HB3' ' A' ' 112' ' ' PHE . 8.1 tt -68.57 -50.07 54.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.465 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.462 ' OE1' HD13 ' A' ' 102' ' ' ILE . 8.5 mm100 -68.17 -36.53 79.77 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.355 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -70.44 -29.77 66.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.446 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' TRP . . . . . 0.418 ' CE2' HD21 ' A' ' 7' ' ' LEU . 0.6 OUTLIER -69.28 -46.18 67.86 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.034 0.445 . . . . 0.0 110.621 179.629 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.547 HG13 HG21 ' A' ' 100' ' ' ILE . 21.9 t -63.31 -40.99 91.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.878 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 2.3 mtpp -64.18 -37.42 87.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.781 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.576 ' O ' HG22 ' A' ' 146' ' ' VAL . 0.0 OUTLIER -65.8 -54.3 28.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.374 179.706 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.621 HG21 HD11 ' A' ' 100' ' ' ILE . 70.9 mt -52.72 -32.99 17.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.194 0.521 . . . . 0.0 109.691 178.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 25.0 mtp85 -80.01 -29.3 39.39 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.388 179.25 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.45 ' O ' HG22 ' A' ' 149' ' ' THR . 1.2 tt0 -74.49 -37.4 63.17 Favored 'General case' 0 N--CA 1.457 -0.106 0 CA-C-O 120.922 0.391 . . . . 0.0 110.64 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.777 HG23 HG11 ' A' ' 95' ' ' VAL . 11.7 m -80.73 -28.32 11.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.228 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -78.98 -34.35 44.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.754 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -78.47 -10.01 59.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.958 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.517 HG22 ' HA ' ' A' ' 146' ' ' VAL . 12.4 t -110.84 -29.83 7.8 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.882 0.373 . . . . 0.0 111.066 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.198 -0.906 . . . . 0.0 111.111 179.948 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.816 0.341 . . . . 0.0 111.138 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.486 HD11 ' CB ' ' A' ' 26' ' ' SER . 30.5 mt -77.95 -36.13 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.138 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.436 ' HG2' ' CD1' ' A' ' 139' ' ' TRP . 0.2 OUTLIER -138.09 102.57 4.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.005 -179.906 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.845 ' HB3' HG13 ' A' ' 23' ' ' VAL . 6.9 p30 -131.22 124.62 30.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.77 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -166.35 -147.22 5.13 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.55 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 25.2 mm -107.98 86.07 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.735 0.302 . . . . 0.0 111.168 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.75 HD12 HG12 ' A' ' 128' ' ' VAL . 0.4 OUTLIER -88.0 163.96 16.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.833 179.891 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.707 ' C ' HD23 ' A' ' 9' ' ' LEU . 23.0 m-85 -110.61 150.41 29.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.104 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.797 HD21 ' HB2' ' A' ' 20' ' ' HIS . 0.2 OUTLIER -161.29 129.52 4.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.772 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.435 ' HB3' ' CD2' ' A' ' 17' ' ' TRP . 0.2 OUTLIER -86.69 121.51 29.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.127 -179.772 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.529 ' HB3' HG22 ' A' ' 13' ' ' VAL . 0.3 OUTLIER -88.91 146.77 37.39 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.601 179.622 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.0 -4.52 15.53 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.487 2.125 . . . . 0.0 113.388 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.529 HG22 ' HB3' ' A' ' 11' ' ' ASP . 0.2 OUTLIER -67.97 -45.52 83.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.032 0.444 . . . . 0.0 110.818 179.972 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -128.6 -2.06 5.46 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.175 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 57.62 74.83 0.4 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.964 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.95 135.47 1.77 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.976 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.435 ' CD2' ' HB3' ' A' ' 10' ' ' GLU . 27.9 m95 -63.92 134.37 54.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.895 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -135.98 148.62 65.65 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.922 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.77 124.58 10.31 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.594 2.196 . . . . 0.0 112.356 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.797 ' HB2' HD21 ' A' ' 9' ' ' LEU . 0.1 OUTLIER -141.09 111.45 6.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.897 179.877 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -54.28 111.38 0.77 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.124 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.51 ' CZ ' ' CD2' ' A' ' 31' ' ' TYR . 2.8 m-30 -109.27 155.77 20.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.829 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.845 HG13 ' HB3' ' A' ' 4' ' ' ASN . 24.5 t -142.0 92.52 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.122 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.7 tp -76.03 117.91 18.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.926 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 17.1 p -97.88 154.71 17.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.984 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.486 ' CB ' HD11 ' A' ' 2' ' ' ILE . 51.7 p -52.53 -24.66 8.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.997 -179.567 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -140.79 37.49 1.8 Allowed 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.99 -0.284 . . . . 0.0 111.726 -179.523 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 172.45 171.94 0.11 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.926 0.393 . . . . 0.0 111.383 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.6 mt -134.56 116.64 22.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.55 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -96.13 141.41 29.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.316 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.51 ' CD2' ' CZ ' ' A' ' 22' ' ' PHE . 4.4 m-85 -119.33 124.29 46.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.726 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 12.3 m -131.8 -176.79 4.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.824 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 67.91 115.59 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.121 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -100.81 159.39 15.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.684 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.47 175.15 10.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.974 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.6 t 61.57 114.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.977 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.9 m 60.88 -169.54 0.16 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.887 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -179.12 -37.82 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.786 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 63.45 62.8 0.93 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.837 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -98.79 89.64 0.94 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.35 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.66 38.77 15.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.883 0.373 . . . . 0.0 110.803 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -135.41 36.17 2.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.844 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -59.63 151.03 25.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.983 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -87.37 123.31 32.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.974 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -62.61 141.33 58.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.695 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -110.68 99.14 40.48 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.085 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -68.49 62.64 1.16 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.667 2.245 . . . . 0.0 112.132 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.37 -171.28 0.92 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.87 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -142.27 119.82 11.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.832 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.51 -69.86 0.71 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.116 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 61.49 90.38 0.07 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.033 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -77.21 155.84 44.56 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.453 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.0 t -99.77 114.56 27.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.791 0.329 . . . . 0.0 110.916 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 8.6 t -115.36 146.46 41.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.914 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -73.25 156.91 38.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.903 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 54.9 mt -64.8 -56.93 10.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.959 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -89.52 116.7 27.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.85 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.6 m -84.63 150.23 25.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.956 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -155.88 123.07 5.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.884 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.6 mt -171.09 -41.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.921 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.66 -31.16 72.25 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.828 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 26.2 t -70.26 -37.7 72.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.073 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.6 tp -72.84 -12.64 61.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.272 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -91.23 25.2 2.6 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.195 0.521 . . . . 0.0 110.687 179.323 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -164.36 29.91 0.07 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.831 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -120.45 -74.19 0.38 Allowed Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.061 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -49.83 140.36 30.64 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.825 2.35 . . . . 0.0 111.989 179.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 21.5 m120 60.83 110.99 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.688 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -84.32 27.64 0.6 Allowed 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.641 2.228 . . . . 0.0 113.101 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.07 29.34 3.91 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.932 0.396 . . . . 0.0 110.978 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.581 ' O ' HG22 ' A' ' 71' ' ' ILE . 44.1 mt -93.49 -4.26 10.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.62 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 98.4 mt -93.41 20.02 7.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.165 0.507 . . . . 0.0 111.558 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -139.57 68.33 37.91 Favored Pre-proline 0 C--N 1.315 -0.911 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.621 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -68.53 59.97 1.11 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.984 2.456 . . . . 0.0 112.278 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -85.95 -30.35 22.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.015 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.544 ' HD3' HD22 ' A' ' 79' ' ' LEU . 34.8 mtt85 -120.21 127.56 52.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.959 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -160.27 133.85 6.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.817 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 60.71 31.66 20.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.757 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.544 HD22 ' HD3' ' A' ' 76' ' ' ARG . 0.7 OUTLIER -63.88 -168.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.959 -179.958 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -72.35 68.67 0.78 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.811 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.24 -175.78 4.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.717 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 77.17 -53.6 0.55 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.286 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.51 ' CB ' ' HD2' ' A' ' 84' ' ' PRO . 0.8 OUTLIER 59.12 -179.97 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 -179.663 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.51 ' HD2' ' CB ' ' A' ' 83' ' ' SER . 59.5 Cg_endo -73.99 55.74 3.47 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 121.802 1.668 . . . . 0.0 112.435 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.2 tp -104.75 28.53 7.0 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 120.858 0.361 . . . . 0.0 111.008 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.26 -162.61 10.96 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.479 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -117.12 -37.18 3.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.749 0.309 . . . . 0.0 110.92 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 5.6 mp -73.19 -77.85 0.1 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.961 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.482 ' H ' HD23 ' A' ' 89' ' ' LEU . 0.3 OUTLIER -67.37 118.69 11.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.854 -179.873 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.97 -34.02 6.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.903 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -156.06 168.28 33.46 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.611 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 11.1 p -158.66 133.83 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.834 0.35 . . . . 0.0 111.026 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.451 HD23 ' O ' ' A' ' 94' ' ' ASP . 0.6 OUTLIER -146.31 153.49 40.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.892 -179.901 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.451 ' O ' HD23 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -83.82 137.31 33.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.903 -179.961 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.676 HG21 ' CG2' ' A' ' 146' ' ' VAL . 13.0 p -83.33 -27.99 0.42 Allowed Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.638 ' CD ' ' N ' ' A' ' 95' ' ' VAL . 89.8 Cg_endo -84.52 49.87 2.82 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.079 1.852 . . . . 0.0 112.593 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.406 ' HB2' ' O ' ' A' ' 96' ' ' PRO . . . 178.33 38.96 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.968 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -156.69 97.44 1.72 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.953 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -78.95 136.36 37.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.84 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.813 HD11 HG21 ' A' ' 143' ' ' ILE . 8.1 mm -87.52 161.21 2.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.168 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.445 ' N ' HG22 ' A' ' 100' ' ' ILE . . . -149.83 96.39 2.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.96 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 70.3 mt -61.03 149.85 7.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.079 0.466 . . . . 0.0 111.255 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.407 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 72.3 mtp180 -138.99 123.14 11.28 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.292 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 103' ' ' ARG . 6.3 Cg_exo -73.84 11.9 1.04 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.569 2.179 . . . . 0.0 113.004 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -160.37 67.82 0.35 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.103 0.478 . . . . 0.0 110.591 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.414 ' HA3' ' CG2' ' A' ' 113' ' ' VAL . . . -46.95 -88.67 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.224 0 CA-C-N 115.925 -0.579 . . . . 0.0 113.134 -179.624 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -174.99 162.59 3.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.849 0.357 . . . . 0.0 111.224 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 59.01 -84.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.157 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 44.7 m-20 -148.28 31.58 0.83 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.977 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.402 ' HB3' ' CG2' ' A' ' 113' ' ' VAL . 33.7 mmt180 -115.33 94.66 4.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.805 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.1 mt -67.65 -28.83 68.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.102 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -109.09 100.26 9.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.944 0.402 . . . . 0.0 111.094 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.423 HG11 ' CH2' ' A' ' 17' ' ' TRP . 42.8 t -146.47 127.27 6.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.69 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.439 ' CE2' ' HB ' ' A' ' 128' ' ' VAL . 29.6 p90 -108.65 124.31 50.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.064 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 28.0 t -94.48 129.46 41.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.672 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.791 HG23 HD13 ' A' ' 100' ' ' ILE . 11.0 mt -93.87 160.01 2.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.092 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.449 ' N ' HG22 ' A' ' 116' ' ' ILE . 0.3 OUTLIER -158.61 158.14 33.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.563 179.874 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 118' ' ' MET . . . . . 0.44 ' HB2' ' CD1' ' A' ' 124' ' ' TRP . 13.4 mtp -98.02 152.72 38.19 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.748 0.309 . . . . 0.0 111.236 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -80.59 77.95 3.86 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.661 2.241 . . . . 0.0 112.6 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.686 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.9 OUTLIER 69.68 107.63 0.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.922 179.95 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.686 HG23 ' O ' ' A' ' 120' ' ' SER . 3.4 t -164.45 -76.61 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.318 0.58 . . . . 0.0 110.815 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.634 ' N ' HG12 ' A' ' 121' ' ' VAL . . . -146.65 -149.67 0.3 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.267 -0.878 . . . . 0.0 110.671 -179.138 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -89.36 29.94 1.05 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.747 0.308 . . . . 0.0 111.607 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' TRP . . . . . 0.449 ' CD1' ' HB ' ' A' ' 121' ' ' VAL . 1.7 p-90 -46.38 168.51 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.299 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.405 ' CB ' ' O ' ' A' ' 124' ' ' TRP . 0.9 OUTLIER 163.89 103.12 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.805 179.512 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.459 ' HA ' HD12 ' A' ' 126' ' ' LEU . 8.0 tp -116.39 157.37 25.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.99 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -142.86 139.27 30.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.896 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.75 HG12 HD12 ' A' ' 7' ' ' LEU . 22.4 t -151.74 153.5 9.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.131 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.5 ' O ' HD13 ' A' ' 7' ' ' LEU . . . -155.99 136.98 13.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.197 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -105.01 139.74 39.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.985 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -53.89 -35.85 62.05 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.903 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.5 m -93.32 111.53 23.21 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.811 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -48.35 -28.49 3.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.54 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.88 -43.34 58.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.216 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -67.12 -31.37 71.79 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.194 179.383 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.517 ' O ' HG23 ' A' ' 140' ' ' VAL . 6.4 tt -67.82 -46.92 70.49 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.503 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -69.0 -40.43 78.73 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.377 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.0 -29.1 68.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.286 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' TRP . . . . . 0.62 ' CZ2' HD23 ' A' ' 7' ' ' LEU . 1.1 m95 -68.52 -48.29 64.73 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.694 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.615 HG12 ' HD2' ' A' ' 144' ' ' ARG . 33.9 t -63.55 -39.86 86.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.678 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 31.2 tttt -63.79 -36.75 84.93 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.744 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.515 ' O ' HG22 ' A' ' 146' ' ' VAL . 1.2 mptp? -67.26 -52.32 42.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.273 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.813 HG21 HD11 ' A' ' 100' ' ' ILE . 69.5 mt -52.77 -33.45 18.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.16 0.505 . . . . 0.0 109.76 178.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.615 ' HD2' HG12 ' A' ' 140' ' ' VAL . 0.4 OUTLIER -79.59 -28.11 41.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.628 179.273 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.47 -38.29 55.59 Favored 'General case' 0 CA--C 1.523 -0.096 0 CA-C-O 120.856 0.36 . . . . 0.0 110.861 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.676 ' CG2' HG21 ' A' ' 95' ' ' VAL . 16.2 m -79.67 -29.28 13.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.299 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -77.83 -34.83 51.75 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.544 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -74.13 -13.78 60.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.987 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.445 HG22 ' HA ' ' A' ' 146' ' ' VAL . 10.8 t -107.51 -22.11 12.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.106 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.446 ' HB3' ' HB3' ' A' ' 96' ' ' PRO . . . . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.158 -0.925 . . . . 0.0 111.091 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.464 ' N ' HG22 ' A' ' 25' ' ' THR . 4.0 m . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.859 0.361 . . . . 0.0 111.164 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.906 HD11 ' HB3' ' A' ' 26' ' ' SER . 28.6 mt -71.77 -32.94 46.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.953 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.429 ' HD2' ' CD1' ' A' ' 139' ' ' TRP . 3.4 mttm -157.86 123.77 4.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.89 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.917 ' HB3' HG13 ' A' ' 23' ' ' VAL . 11.1 p-10 -143.99 135.04 25.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.909 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.553 ' C ' HD12 ' A' ' 6' ' ' ILE . . . -170.02 -135.47 1.91 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.434 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.642 ' N ' HD12 ' A' ' 6' ' ' ILE . 3.2 mp -127.15 83.64 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.963 0.411 . . . . 0.0 110.981 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.926 HD12 HG12 ' A' ' 128' ' ' VAL . 1.8 mm? -80.85 145.12 31.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.911 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -90.92 119.08 30.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.98 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.68 HD11 ' OH ' ' A' ' 31' ' ' TYR . 0.5 OUTLIER -126.86 144.22 51.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.95 179.903 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.434 ' HG2' ' CZ3' ' A' ' 17' ' ' TRP . 0.0 OUTLIER -87.5 122.81 31.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.895 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.406 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 1.2 t0 -93.14 126.68 50.03 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.67 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 11' ' ' ASP . 32.2 Cg_exo -58.37 -15.4 24.16 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.505 2.137 . . . . 0.0 112.869 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.0 t -68.76 -42.82 83.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.887 0.375 . . . . 0.0 111.275 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -115.82 -15.82 11.25 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.484 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 63.21 50.81 2.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.918 0.39 . . . . 0.0 110.907 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -157.31 157.25 33.82 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.89 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.434 ' CZ3' ' HG2' ' A' ' 10' ' ' GLU . 40.5 m95 -72.56 139.06 47.28 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.725 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -138.86 121.77 10.72 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.961 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.38 92.86 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.426 2.084 . . . . 0.0 112.256 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.549 ' HB2' HD21 ' A' ' 9' ' ' LEU . 43.9 m-70 -117.27 150.27 39.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.921 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -77.65 147.65 35.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.927 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.49 ' CE2' ' CD1' ' A' ' 31' ' ' TYR . 0.2 OUTLIER -154.57 133.81 12.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.765 -179.876 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.917 HG13 ' HB3' ' A' ' 4' ' ' ASN . 21.7 t -117.13 138.32 48.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.105 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 34.3 tp -118.69 104.08 10.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.879 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.464 HG22 ' N ' ' A' ' 1' ' ' SER . 0.6 OUTLIER -100.59 149.28 23.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.763 179.97 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.906 ' HB3' HD11 ' A' ' 2' ' ' ILE . 0.4 OUTLIER -63.04 -14.62 50.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.626 -179.94 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.2 t -105.89 -14.17 15.29 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.47 ' HA ' HG23 ' A' ' 95' ' ' VAL . 9.4 mttt -179.81 -173.32 0.24 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.916 0.388 . . . . 0.0 111.138 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.449 HG22 ' HE1' ' A' ' 22' ' ' PHE . 3.2 mt -129.72 130.13 66.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.436 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -106.82 142.85 35.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.016 0.436 . . . . 0.0 111.357 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.68 ' OH ' HD11 ' A' ' 9' ' ' LEU . 25.3 t80 -136.49 122.05 19.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.805 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.4 p -171.63 -177.83 2.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.986 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -110.33 142.68 41.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.899 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -107.12 145.34 32.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.908 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.44 175.6 0.43 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.92 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 59.91 103.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.901 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.2 t 61.5 115.75 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.931 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 176.97 -33.17 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.816 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 63.63 30.09 14.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.782 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -125.71 -33.75 0.68 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.533 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -100.33 34.94 2.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.86 0.362 . . . . 0.0 111.016 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -137.84 37.95 2.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.957 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -89.66 94.38 9.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.848 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -86.8 147.84 25.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.998 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -85.77 171.71 11.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.875 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -99.89 97.52 6.05 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.97 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -68.18 144.39 62.75 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.426 2.084 . . . . 0.0 112.306 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.9 mttt -69.31 132.22 46.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.924 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 57.7 mm-40 -73.36 154.34 40.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.907 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -126.76 143.39 51.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.094 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.3 m -95.07 74.91 3.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.877 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -69.04 161.69 51.88 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.463 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 63.8 m -83.83 63.19 7.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.915 0.388 . . . . 0.0 110.86 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -104.45 165.05 11.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.825 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -150.56 165.03 34.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.937 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.3 mt -60.3 -177.82 0.07 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.824 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 62.39 149.84 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.823 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 32.5 t -127.87 166.08 18.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.874 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.35 165.06 25.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.912 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.5 tt -59.53 -40.72 88.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.819 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -68.02 -31.47 71.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.552 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 26.0 t -69.48 -43.85 80.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.825 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.4 mt -59.68 -33.48 71.62 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.128 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -92.15 21.56 5.01 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.49 0.662 . . . . 0.0 109.821 178.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.433 ' O ' ' HG3' ' A' ' 65' ' ' GLN . 0.5 OUTLIER -155.0 28.62 0.41 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.856 -1.066 . . . . 0.0 109.133 179.718 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -113.62 -74.89 0.66 Allowed Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.156 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -54.1 -178.82 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.766 2.311 . . . . 0.0 112.163 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -56.38 108.86 1.34 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.099 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -88.91 20.94 1.03 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.756 2.304 . . . . 0.0 112.779 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.22 29.98 3.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.836 0.351 . . . . 0.0 111.284 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.484 ' O ' HG22 ' A' ' 71' ' ' ILE . 26.6 mt -100.44 -9.91 8.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.637 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 72' ' ' LEU . 20.6 mt -90.8 20.47 4.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.122 0.487 . . . . 0.0 111.603 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -145.2 70.7 14.47 Favored Pre-proline 0 C--N 1.319 -0.757 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.543 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -67.77 59.69 0.84 Allowed 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.012 2.475 . . . . 0.0 112.417 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -75.31 -78.39 0.11 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.875 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -93.57 137.87 32.41 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.889 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.446 ' H ' HD13 ' A' ' 79' ' ' LEU . 3.6 mm-40 -150.88 100.84 2.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.937 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 24.8 m170 60.92 43.65 11.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.95 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.446 HD13 ' H ' ' A' ' 77' ' ' GLU . 3.0 mp -87.09 -177.4 6.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.823 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -69.79 69.27 0.29 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.902 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -66.13 101.89 0.76 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.939 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 -131.74 24.59 4.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.089 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.415 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 0.4 OUTLIER -76.25 -57.1 1.44 Allowed Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.998 179.939 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.415 ' HD2' ' N ' ' A' ' 83' ' ' SER . 77.6 Cg_endo -79.22 57.46 6.48 Favored 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 122.98 2.453 . . . . 0.0 112.341 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 17.5 mt -142.53 34.58 1.45 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.872 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -111.82 97.56 0.94 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.503 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.635 ' HB3' HD23 ' A' ' 89' ' ' LEU . 1.0 OUTLIER -144.7 -47.3 0.24 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.91 0.386 . . . . 0.0 110.979 179.941 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 58.46 81.81 0.15 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.878 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.635 HD23 ' HB3' ' A' ' 87' ' ' ASP . 0.7 OUTLIER -132.64 54.83 1.92 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.971 -179.939 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -96.21 93.62 7.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.954 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.87 106.89 2.34 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.44 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.419 HG21 ' HD3' ' A' ' 28' ' ' LYS . 11.3 p -93.14 147.18 5.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.776 0.322 . . . . 0.0 111.082 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.2 mp -142.26 133.21 25.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.948 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.435 ' HA ' ' HG3' ' A' ' 28' ' ' LYS . 1.4 t0 -70.55 127.42 32.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.906 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.737 HG11 ' HB ' ' A' ' 146' ' ' VAL . 4.5 t -69.12 -45.96 29.68 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.347 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.492 ' CD ' ' N ' ' A' ' 95' ' ' VAL . 6.4 Cg_exo -73.87 56.37 3.56 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.766 2.311 . . . . 0.0 112.409 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.457 ' HB2' ' O ' ' A' ' 96' ' ' PRO . . . 175.22 38.94 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.021 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 34.2 m -148.6 108.67 4.08 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.902 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -91.45 126.25 36.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.816 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.937 HD13 HG23 ' A' ' 116' ' ' ILE . 6.4 mm -90.04 161.37 2.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.106 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.414 ' N ' HG22 ' A' ' 100' ' ' ILE . . . -152.52 88.66 1.36 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.857 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.402 HG22 ' N ' ' A' ' 103' ' ' ARG . 76.4 mt -57.02 152.54 2.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.283 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.402 ' N ' HG22 ' A' ' 102' ' ' ILE . 18.1 mtt180 -143.7 118.08 6.09 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.241 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -81.02 37.44 0.68 Allowed 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.351 2.034 . . . . 0.0 112.756 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -178.42 63.58 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.939 0.4 . . . . 0.0 110.525 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -56.37 -95.9 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.73 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.59 165.36 0.82 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.83 0.348 . . . . 0.0 111.126 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.2 m120 56.12 47.14 20.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.073 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 24.6 m-20 63.17 58.26 1.46 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.088 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 6.8 mmt85 -152.25 88.73 1.39 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.782 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 69.4 mt -67.78 -33.01 73.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.02 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.682 ' HB3' HD13 ' A' ' 136' ' ' LEU . 19.0 m-85 -91.62 96.83 10.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.966 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 22.0 t -152.74 127.56 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.03 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.423 ' CZ ' ' HB ' ' A' ' 128' ' ' VAL . 43.4 p90 -114.64 138.55 50.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.785 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 20.3 m -107.63 128.38 54.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.074 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.937 HG23 HD13 ' A' ' 100' ' ' ILE . 20.0 mt -99.09 159.59 3.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.928 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.466 ' N ' HG22 ' A' ' 116' ' ' ILE . 81.1 p -152.54 158.81 43.06 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.866 0.365 . . . . 0.0 110.939 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 43.7 mtp -130.63 93.96 30.49 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.828 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.39 61.89 2.1 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.475 2.117 . . . . 0.0 112.306 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.7 m -165.16 -44.88 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.979 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.478 ' CG1' ' N ' ' A' ' 122' ' ' ALA . 2.5 p -75.57 -47.72 32.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.93 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.642 ' HB3' ' CD1' ' A' ' 124' ' ' TRP . . . 174.64 -163.32 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.742 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 24.1 mm-40 -93.6 44.92 1.14 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.886 0.374 . . . . 0.0 110.751 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' TRP . . . . . 0.642 ' CD1' ' HB3' ' A' ' 122' ' ' ALA . 13.7 m95 -98.39 130.17 45.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.901 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 8.6 t -120.47 133.99 55.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.941 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.551 HD23 HD12 ' A' ' 116' ' ' ILE . 12.2 tp -98.58 152.68 19.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.922 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -125.72 128.16 47.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.775 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.926 HG12 HD12 ' A' ' 7' ' ' LEU . 16.9 t -150.15 141.1 16.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.16 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.453 ' HB1' ' O ' ' A' ' 112' ' ' PHE . . . -143.57 121.86 12.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.167 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.441 ' HB2' HD11 ' A' ' 7' ' ' LEU . . . -82.39 142.2 32.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.883 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -54.07 -44.15 70.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.082 0.468 . . . . 0.0 110.95 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.1 p -92.63 120.4 33.02 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.718 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.401 ' HG3' ' CZ ' ' A' ' 112' ' ' PHE . 0.6 OUTLIER -49.86 -24.13 2.29 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.654 179.553 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -73.99 -48.15 32.28 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.626 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -62.76 -33.11 74.48 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.319 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.682 HD13 ' HB3' ' A' ' 112' ' ' PHE . 8.8 tt -66.92 -49.3 65.96 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.634 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.67 -36.44 76.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.416 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -70.98 -29.26 65.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.378 179.456 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' TRP . . . . . 0.541 ' CZ2' HD23 ' A' ' 7' ' ' LEU . 1.5 m95 -70.49 -46.05 64.46 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.742 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.616 HG13 HG21 ' A' ' 100' ' ' ILE . 26.2 t -64.55 -38.66 83.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.864 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.69 -38.04 88.13 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.835 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.419 ' O ' HG23 ' A' ' 146' ' ' VAL . 0.1 OUTLIER -66.0 -49.18 68.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.364 179.71 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.837 HG21 HD11 ' A' ' 100' ' ' ILE . 30.5 mt -54.1 -38.52 38.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.275 0.56 . . . . 0.0 109.573 178.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 14.7 mtt180 -77.95 -27.8 49.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.395 179.033 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.833 ' O ' HG23 ' A' ' 149' ' ' THR . 6.2 tt0 -73.34 -35.65 66.06 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.584 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.737 ' HB ' HG11 ' A' ' 95' ' ' VAL . 46.6 t -78.01 -34.02 18.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.034 179.147 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.71 -38.47 73.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.506 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -64.86 -20.34 66.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.611 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.833 HG23 ' O ' ' A' ' 145' ' ' GLU . 5.1 p -101.12 -33.48 10.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.118 0.485 . . . . 0.0 110.499 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.195 -0.907 . . . . 0.0 111.283 -179.953 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.5 m . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.845 0.355 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.41 ' CD1' ' HA ' ' A' ' 26' ' ' SER . 41.7 mt -84.34 -33.98 9.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.197 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.412 ' HB2' ' HB3' ' A' ' 24' ' ' LEU . 2.9 mmtt -134.38 139.36 45.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.02 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.759 ' OD1' HG22 ' A' ' 23' ' ' VAL . 7.0 m-80 -149.79 125.54 10.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.803 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -169.99 178.62 42.76 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.476 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.601 HD13 ' HD1' ' A' ' 21' ' ' TYR . 23.1 mm -94.02 90.02 2.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.882 0.372 . . . . 0.0 111.034 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.875 HD12 HG12 ' A' ' 128' ' ' VAL . 3.4 mm? -92.04 139.67 30.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.929 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -79.86 164.84 23.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.97 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.3 tt -171.86 134.38 0.78 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.932 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.441 ' HG3' ' CZ3' ' A' ' 17' ' ' TRP . 14.6 mt-10 -65.31 90.54 0.1 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.962 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.72 138.36 96.86 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.679 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.56 -8.66 22.91 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.447 2.098 . . . . 0.0 112.552 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.437 HG12 ' ND2' ' A' ' 14' ' ' ASN . 21.4 t -67.43 -42.4 87.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.992 0.425 . . . . 0.0 110.998 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.437 ' ND2' HG12 ' A' ' 13' ' ' VAL . 5.4 m-80 -132.1 4.54 4.1 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.555 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 8.5 t-160 52.66 59.49 4.45 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.915 0.388 . . . . 0.0 111.147 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -158.68 159.59 35.48 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.884 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.441 ' CZ3' ' HG3' ' A' ' 10' ' ' GLU . 46.4 m95 -57.6 129.86 43.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.923 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -134.67 124.64 17.0 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.836 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.13 88.54 0.82 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.377 2.052 . . . . 0.0 112.318 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -111.75 151.89 28.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.839 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.601 ' HD1' HD13 ' A' ' 6' ' ' ILE . 5.1 t80 -60.05 155.74 16.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.898 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.406 ' HB3' ' CH2' ' A' ' 139' ' ' TRP . 0.1 OUTLIER -154.14 138.29 16.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.775 -179.892 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.759 HG22 ' OD1' ' A' ' 4' ' ' ASN . 6.3 t -127.77 153.86 37.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.37 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.533 HD13 ' N ' ' A' ' 25' ' ' THR . 0.8 OUTLIER -133.5 119.37 19.46 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.923 -179.939 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.533 ' N ' HD13 ' A' ' 24' ' ' LEU . 11.0 p -103.26 157.51 16.96 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.94 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.41 ' HA ' ' CD1' ' A' ' 2' ' ' ILE . 4.1 t -39.94 -32.45 0.16 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.246 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 58.6 m -152.09 48.27 0.77 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.657 0.265 . . . . 0.0 111.467 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.1 mtmm -175.5 156.54 1.97 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.989 0.423 . . . . 0.0 111.252 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.7 mt -124.34 123.7 66.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.707 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -115.5 154.0 30.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.025 0.44 . . . . 0.0 111.255 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 21.6 p90 -158.99 148.9 19.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.713 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 84.2 p . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.033 -179.912 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.38 0 N-CA-C 112.42 -0.272 . . . . 0.0 112.42 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 11.4 p -144.23 151.82 15.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.78 0.324 . . . . 0.0 111.115 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.521 HD23 ' N ' ' A' ' 94' ' ' ASP . 0.6 OUTLIER -156.04 170.89 21.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.891 -179.991 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.521 ' N ' HD23 ' A' ' 93' ' ' LEU . 64.0 m-20 -100.59 118.56 37.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.976 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.694 HG23 HG23 ' A' ' 143' ' ' ILE . 12.6 p -83.31 -27.6 0.42 Allowed Pre-proline 0 CA--C 1.535 0.403 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.659 ' CD ' ' N ' ' A' ' 95' ' ' VAL . 95.2 Cg_endo -85.51 49.77 2.51 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.153 1.902 . . . . 0.0 112.539 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -179.43 38.13 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.977 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 31.1 p -137.31 173.94 11.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.961 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 50.0 tp60 -137.84 113.5 9.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.703 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.914 HD13 HG23 ' A' ' 116' ' ' ILE . 14.6 mm -79.13 159.68 4.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.035 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.476 ' N ' HG22 ' A' ' 100' ' ' ILE . . . -151.68 92.5 1.76 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.969 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 50.1 mt -58.24 138.54 19.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.022 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -127.31 107.95 21.35 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.715 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -77.69 22.85 0.58 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.783 2.322 . . . . 0.0 112.631 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -173.38 64.86 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.961 0.41 . . . . 0.0 110.483 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -56.79 -95.84 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.721 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.85 156.04 0.6 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.855 0.36 . . . . 0.0 111.045 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 66.2 m-80 58.43 57.4 3.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.113 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 59.06 58.49 3.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.088 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -152.59 90.14 1.46 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.723 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.456 HD12 ' CZ ' ' A' ' 112' ' ' PHE . 0.3 OUTLIER -81.41 -27.97 34.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.184 -179.84 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.738 ' HB3' HD13 ' A' ' 136' ' ' LEU . 36.3 m-85 -101.31 95.59 6.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.001 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.492 HG22 ' HB2' ' A' ' 129' ' ' ALA . 21.4 t -153.6 120.9 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.039 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.451 ' CZ ' ' HB ' ' A' ' 128' ' ' VAL . 42.1 p90 -105.3 122.17 45.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.805 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 22.9 t -92.95 131.44 37.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.12 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.914 HG23 HD13 ' A' ' 100' ' ' ILE . 16.6 mt -97.62 160.72 2.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.828 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.463 ' N ' HG22 ' A' ' 116' ' ' ILE . 99.2 p -173.29 128.66 0.45 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.094 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.38 127.56 32.66 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.721 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -84.37 48.15 2.38 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.733 2.289 . . . . 0.0 112.708 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.8 m 177.8 39.25 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.935 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.587 ' O ' ' HB2' ' A' ' 122' ' ' ALA . 2.5 p -131.72 -49.61 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.086 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.587 ' HB2' ' O ' ' A' ' 121' ' ' VAL . . . 165.3 40.16 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.195 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 7.0 mm100 51.19 32.16 7.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.148 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . 0.43 ' CD1' ' HB3' ' A' ' 122' ' ' ALA . 23.0 m95 -69.75 171.59 8.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.895 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 75.3 p -158.23 110.75 2.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.912 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 5.3 tp -100.02 162.01 13.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.881 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -140.26 130.93 25.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.936 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.875 HG12 HD12 ' A' ' 7' ' ' LEU . 39.1 t -144.32 147.02 19.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.922 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.492 ' HB2' HG22 ' A' ' 113' ' ' VAL . . . -139.64 133.88 31.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.244 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.554 ' H ' HD12 ' A' ' 136' ' ' LEU . . . -102.85 135.0 45.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.851 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.76 -47.93 59.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.321 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -87.61 117.4 26.39 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.897 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.452 ' HG2' ' CE2' ' A' ' 112' ' ' PHE . 1.3 mt-30 -47.92 -27.96 2.44 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.342 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.66 -42.54 51.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.523 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -64.54 -34.04 77.31 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.055 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.738 HD13 ' HB3' ' A' ' 112' ' ' PHE . 8.9 tt -66.83 -52.24 46.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.543 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -67.03 -36.9 83.12 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.313 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -69.72 -31.53 69.58 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.483 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' TRP . . . . . 0.409 ' CZ2' HD23 ' A' ' 7' ' ' LEU . 0.4 OUTLIER -67.68 -44.8 76.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.489 179.592 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.649 HG13 HG21 ' A' ' 100' ' ' ILE . 23.8 t -61.48 -45.21 99.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.723 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 8.3 ttmt -60.94 -36.22 78.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.633 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.514 ' O ' HG22 ' A' ' 146' ' ' VAL . 0.0 OUTLIER -65.99 -50.03 65.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.347 179.787 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.728 HG21 HD11 ' A' ' 100' ' ' ILE . 69.0 mt -52.79 -36.88 24.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.246 0.546 . . . . 0.0 109.641 178.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 28.6 mtp85 -78.69 -27.65 45.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.509 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.503 ' O ' HG22 ' A' ' 149' ' ' THR . 1.9 tt0 -73.44 -38.38 65.52 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.645 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.514 HG22 ' O ' ' A' ' 142' ' ' LYS . 13.4 m -79.27 -30.51 14.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.272 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -76.25 -34.16 59.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.396 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -76.12 -11.0 59.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.894 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.503 HG22 ' O ' ' A' ' 145' ' ' GLU . 15.3 t -119.07 15.52 13.26 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.198 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.431 ' HB3' ' HB3' ' A' ' 96' ' ' PRO . . . . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.204 -0.903 . . . . 0.0 111.092 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 8.4 t . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.871 0.367 . . . . 0.0 111.24 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.832 HD11 ' HB3' ' A' ' 26' ' ' SER . 31.0 mt -83.53 -34.6 10.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.082 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.7 tptt -148.75 115.72 6.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.03 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.9 ' HB3' HG13 ' A' ' 23' ' ' VAL . 14.5 p-10 -137.08 137.53 39.42 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.81 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -170.03 -167.92 31.18 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.532 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 23.9 mm -94.27 96.31 5.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.799 0.333 . . . . 0.0 111.056 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.62 HD12 HG12 ' A' ' 128' ' ' VAL . 1.3 mm? -101.6 154.28 19.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.847 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.44 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 3.0 m-85 -109.92 131.22 55.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.918 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.75 HD13 ' CZ ' ' A' ' 22' ' ' PHE . 3.6 mp -125.09 -2.09 7.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.632 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.455 ' HB3' ' CD2' ' A' ' 17' ' ' TRP . 2.9 pt-20 46.5 -169.8 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.951 0.405 . . . . 0.0 111.449 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -150.5 146.27 19.55 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.531 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -75.04 -17.37 19.5 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.434 2.09 . . . . 0.0 112.577 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.4 t -73.85 -41.73 53.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.935 0.397 . . . . 0.0 111.155 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -106.32 -23.18 12.61 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.906 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 64.88 33.24 10.17 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.917 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -126.0 143.86 50.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.852 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.455 ' CD2' ' HB3' ' A' ' 10' ' ' GLU . 40.0 m95 -90.04 124.81 35.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.042 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.434 ' CE1' ' HA ' ' A' ' 10' ' ' GLU . 1.7 p90 -127.81 147.6 63.56 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.63 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -67.99 124.72 12.14 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.491 2.127 . . . . 0.0 112.452 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -125.55 165.29 18.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.664 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -98.99 110.01 22.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.884 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.75 ' CZ ' HD13 ' A' ' 9' ' ' LEU . 7.5 m-85 -123.1 132.01 53.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.842 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.9 HG13 ' HB3' ' A' ' 4' ' ' ASN . 29.8 t -121.13 134.39 64.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.92 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.628 HD12 HG12 ' A' ' 29' ' ' ILE . 24.6 tp -110.4 107.37 17.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.146 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 17.3 p -100.86 144.2 30.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.788 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.832 ' HB3' HD11 ' A' ' 2' ' ' ILE . 12.6 p -51.91 -21.47 3.01 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.827 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.412 ' O ' ' CG ' ' A' ' 28' ' ' LYS . 12.6 p -101.19 -27.58 13.14 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.745 ' HA ' HG23 ' A' ' 95' ' ' VAL . 4.5 mtmp? -162.2 -175.45 4.59 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.912 0.387 . . . . 0.0 111.341 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.628 HG12 HD12 ' A' ' 24' ' ' LEU . 3.1 mt -128.82 117.31 44.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.677 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.415 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 7.4 m-85 -89.28 138.87 31.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.157 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.457 ' HB3' ' CD2' ' A' ' 22' ' ' PHE . 5.4 p90 -162.04 102.7 1.13 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.829 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 34.9 p . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.745 -179.995 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 CA-C-O 120.441 -0.088 . . . . 0.0 112.942 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.716 HG22 ' HD2' ' A' ' 28' ' ' LYS . 15.0 p -163.74 141.58 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.758 0.313 . . . . 0.0 111.298 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -151.95 153.47 34.16 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.917 0.389 . . . . 0.0 111.05 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -71.99 133.87 45.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.956 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.745 HG23 ' HA ' ' A' ' 28' ' ' LYS . 13.6 t -75.04 -47.71 4.6 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.707 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.507 ' HD2' ' N ' ' A' ' 95' ' ' VAL . 73.7 Cg_endo -75.67 58.78 5.42 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.156 1.904 . . . . 0.0 112.495 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -176.21 36.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.974 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 27.3 p -139.12 162.43 34.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.924 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.15 108.74 6.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.859 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 1.037 HD13 HG23 ' A' ' 116' ' ' ILE . 15.1 mm -79.84 160.51 4.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.168 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.469 ' N ' HG22 ' A' ' 100' ' ' ILE . . . -161.21 92.26 0.9 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.99 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 45.5 mt -59.47 141.26 16.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.073 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -134.79 106.64 10.66 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.731 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.402 ' HA ' ' O ' ' A' ' 111' ' ' LEU . 13.0 Cg_exo -69.8 50.91 0.86 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.576 2.184 . . . . 0.0 112.409 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 173.36 53.09 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.991 0.424 . . . . 0.0 110.26 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.401 ' HA3' HG21 ' A' ' 113' ' ' VAL . . . -44.47 -87.43 0.01 OUTLIER Glycine 0 C--N 1.332 0.312 0 CA-C-N 115.986 -0.552 . . . . 0.0 113.127 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.1 mttt 178.96 169.02 0.93 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.997 0.427 . . . . 0.0 111.101 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 60.95 -82.75 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.21 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -150.55 31.85 0.65 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.908 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 1.2 mmt85 -118.0 110.5 17.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.878 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.447 HD23 ' H ' ' A' ' 111' ' ' LEU . 0.3 OUTLIER -85.62 -32.07 22.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.954 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.439 ' CE2' ' HG3' ' A' ' 133' ' ' GLN . 5.2 m-85 -105.89 87.52 2.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.87 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.723 HG13 ' HB2' ' A' ' 129' ' ' ALA . 22.0 t -132.21 143.66 39.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.104 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.435 ' CE2' ' HB ' ' A' ' 128' ' ' VAL . 19.0 p90 -125.57 133.65 52.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.928 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -105.18 141.35 36.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.831 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 1.037 HG23 HD13 ' A' ' 100' ' ' ILE . 12.5 mt -105.26 157.91 5.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.97 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.424 ' N ' HG22 ' A' ' 116' ' ' ILE . 55.8 p -150.13 -166.84 2.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.839 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 28.0 mtp -135.9 155.57 77.76 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.934 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -63.7 73.11 0.16 Allowed 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.692 2.261 . . . . 0.0 112.359 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 59.26 109.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.947 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.0 t -145.56 -66.63 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.058 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.706 ' HB3' ' NE1' ' A' ' 124' ' ' TRP . . . -176.01 73.06 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.032 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.402 ' HG2' ' O ' ' A' ' 122' ' ' ALA . 0.0 OUTLIER 40.63 36.87 0.41 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.781 -179.917 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . 0.706 ' NE1' ' HB3' ' A' ' 122' ' ' ALA . 22.6 m95 -91.89 126.25 36.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.872 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.9 t -165.65 120.37 1.24 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.903 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.493 HD23 ' H ' ' A' ' 126' ' ' LEU . 0.5 OUTLIER -101.88 166.66 10.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.877 179.943 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -115.08 142.26 46.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.936 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.62 HG12 HD12 ' A' ' 7' ' ' LEU . 17.1 t -148.56 154.01 10.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.022 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.723 ' HB2' HG13 ' A' ' 113' ' ' VAL . . . -159.84 135.08 8.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.252 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -104.71 132.25 51.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.962 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -54.49 -36.75 64.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.069 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.77 111.98 23.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.804 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.439 ' HG3' ' CE2' ' A' ' 112' ' ' PHE . 5.2 tt0 -48.31 -28.64 3.25 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.521 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.95 -40.88 53.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.279 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.53 -33.33 73.93 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.054 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.542 ' O ' HG23 ' A' ' 140' ' ' VAL . 5.2 tt -66.68 -48.52 69.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.41 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -69.26 -38.1 78.27 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.291 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -69.88 -28.76 65.9 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.282 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' TRP . . . . . 0.615 ' CZ2' HD23 ' A' ' 7' ' ' LEU . 1.3 m95 -69.64 -46.93 65.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.599 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 136' ' ' LEU . 25.4 t -63.44 -40.11 87.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.033 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 5.5 ttpp -65.59 -36.6 84.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.797 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.428 ' O ' HG23 ' A' ' 146' ' ' VAL . 0.1 OUTLIER -67.42 -50.35 59.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.464 179.849 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.491 HG21 HD11 ' A' ' 100' ' ' ILE . 54.7 mt -54.53 -35.85 33.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.311 0.577 . . . . 0.0 109.498 178.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 14.4 mtp-105 -76.97 -29.4 55.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.385 179.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.697 ' O ' HG22 ' A' ' 149' ' ' THR . 3.9 tt0 -75.87 -32.18 59.61 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-O 120.825 0.345 . . . . 0.0 110.621 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.738 ' HB ' HG11 ' A' ' 95' ' ' VAL . 59.1 t -78.82 -32.18 15.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.142 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.93 -39.68 66.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.845 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -72.47 -16.65 61.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.881 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.697 HG22 ' O ' ' A' ' 145' ' ' GLU . 11.9 t -111.62 16.81 20.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.896 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.14 -179.963 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.613 ' N ' HG22 ' A' ' 25' ' ' THR . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.829 0.347 . . . . 0.0 111.2 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.699 HD11 ' HA ' ' A' ' 26' ' ' SER . 30.1 mt -85.29 -33.18 7.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.246 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.5 tttp -160.0 141.52 12.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.944 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.921 ' ND2' HG13 ' A' ' 23' ' ' VAL . 5.7 m120 -139.53 132.81 29.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.81 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -169.97 175.53 44.01 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.51 -0.853 . . . . 0.0 112.623 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.508 HD13 ' HA ' ' A' ' 21' ' ' TYR . 22.5 mm -93.1 75.83 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.775 0.321 . . . . 0.0 111.099 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.788 HD12 HG12 ' A' ' 128' ' ' VAL . 4.0 mm? -79.05 131.5 36.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.734 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.692 ' O ' HD12 ' A' ' 9' ' ' LEU . 50.6 m-85 -81.58 155.25 25.78 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.164 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.692 HD12 ' O ' ' A' ' 8' ' ' TYR . 2.1 mp -141.46 164.85 29.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.716 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.454 ' HG2' ' CE3' ' A' ' 17' ' ' TRP . 1.4 mm-40 -111.76 111.78 23.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.908 0.385 . . . . 0.0 111.1 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.22 113.04 50.07 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.339 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.58 -17.08 8.94 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.562 2.175 . . . . 0.0 113.137 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.6 t -63.99 -39.66 86.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.018 0.437 . . . . 0.0 110.947 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 16.4 m-80 -128.19 -6.74 5.4 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.597 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 53.84 63.24 2.26 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.88 0.371 . . . . 0.0 111.036 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -148.36 160.86 42.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.892 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.454 ' CE3' ' HG2' ' A' ' 10' ' ' GLU . 70.7 m95 -81.01 136.97 36.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.929 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -137.22 129.29 16.8 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.726 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.1 138.95 31.76 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.487 2.125 . . . . 0.0 112.246 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -155.39 130.04 9.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.911 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.508 ' HA ' HD13 ' A' ' 6' ' ' ILE . 25.4 t80 -74.2 90.63 2.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.907 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.413 ' CD2' ' HB3' ' A' ' 31' ' ' TYR . 5.5 m-85 -76.84 143.73 39.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.927 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.921 HG13 ' ND2' ' A' ' 4' ' ' ASN . 22.6 t -121.54 102.75 12.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.926 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.546 HD23 ' HB ' ' A' ' 2' ' ' ILE . 1.4 tt -91.22 112.12 23.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.989 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.613 HG22 ' N ' ' A' ' 1' ' ' SER . 0.6 OUTLIER -106.64 152.04 24.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.826 179.885 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.699 ' HA ' HD11 ' A' ' 2' ' ' ILE . 7.7 t -70.11 58.57 0.16 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.714 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 178.38 -28.64 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.875 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.609 ' HE3' HG21 ' A' ' 92' ' ' VAL . 9.7 mtpt -172.89 168.82 4.92 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.831 0.348 . . . . 0.0 110.864 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 15.3 mt -107.99 128.51 63.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.012 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -121.69 118.51 29.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.868 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.413 ' HB3' ' CD2' ' A' ' 22' ' ' PHE . 37.7 p90 -123.43 146.86 47.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.944 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.7 m . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.934 179.97 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.412 ' HA3' ' CZ ' ' A' ' 31' ' ' TYR . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.609 HG21 ' HE3' ' A' ' 28' ' ' LYS . 11.4 p -111.44 155.1 12.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.757 0.313 . . . . 0.0 111.127 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.426 ' N ' HG22 ' A' ' 92' ' ' VAL . 0.5 OUTLIER -154.29 112.33 3.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.918 -180.0 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.51 127.14 30.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.091 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.902 HG11 HG13 ' A' ' 146' ' ' VAL . 38.8 t -74.24 -48.4 5.77 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.577 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.659 ' HB3' ' HB3' ' A' ' 150' ' ' ALA . 64.3 Cg_endo -74.16 57.82 4.11 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.19 1.926 . . . . 0.0 112.349 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.494 ' HB2' ' O ' ' A' ' 96' ' ' PRO . . . 171.94 40.55 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.655 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -159.81 99.66 1.41 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.893 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -79.58 136.94 36.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.764 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.723 HD11 HG21 ' A' ' 143' ' ' ILE . 6.2 mm -87.26 162.58 2.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.054 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.562 ' HB3' ' O ' ' A' ' 115' ' ' SER . . . -149.85 83.74 1.4 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.0 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.577 HG12 HG21 ' A' ' 140' ' ' VAL . 69.0 mt -58.68 152.82 3.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.078 0.466 . . . . 0.0 111.215 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.419 ' N ' HG22 ' A' ' 102' ' ' ILE . 0.0 OUTLIER -147.94 114.99 4.01 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.213 179.644 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -78.42 42.47 1.24 Allowed 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.358 2.038 . . . . 0.0 112.688 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 175.16 62.32 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.045 0.45 . . . . 0.0 110.424 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -53.47 -93.54 0.01 OUTLIER Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.757 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.9 pttt -177.8 170.09 1.97 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.845 0.355 . . . . 0.0 110.949 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 64.07 -79.78 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.859 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -159.51 31.98 0.19 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.957 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 25.1 mmm180 -119.82 92.39 3.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.878 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.432 ' H ' HD12 ' A' ' 111' ' ' LEU . 3.8 mp -68.3 -30.75 69.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.854 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.487 ' HB3' HD13 ' A' ' 136' ' ' LEU . 40.2 m-85 -105.66 92.84 4.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.985 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.41 HG13 ' HB2' ' A' ' 129' ' ' ALA . 24.1 t -137.24 143.16 35.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.048 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.428 ' CE2' ' HB ' ' A' ' 128' ' ' VAL . 39.8 p90 -128.9 131.1 47.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.891 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.562 ' O ' ' HB3' ' A' ' 101' ' ' ALA . 1.2 m -102.38 128.33 49.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.833 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.691 HG23 HD13 ' A' ' 100' ' ' ILE . 1.6 mt -100.12 159.99 3.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.987 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.472 ' N ' HG22 ' A' ' 116' ' ' ILE . 60.9 p -153.76 149.95 27.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.945 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 39.7 mtp -96.12 108.48 41.53 Favored Pre-proline 0 CA--C 1.531 0.234 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.106 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -74.97 54.77 3.72 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.72 2.28 . . . . 0.0 112.394 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.9 p 171.39 41.84 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.72 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 45.2 t -150.5 -68.35 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.995 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -177.62 -154.36 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.316 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -85.62 45.62 1.22 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.7 0.286 . . . . 0.0 111.169 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 11.8 m0 -73.95 139.56 44.96 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.784 0.326 . . . . 0.0 110.744 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -140.58 110.25 6.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.097 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.45 112.37 24.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.913 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -84.51 118.75 24.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.98 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.788 HG12 HD12 ' A' ' 7' ' ' LEU . 21.7 t -141.95 151.79 18.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.925 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.542 ' O ' HD13 ' A' ' 7' ' ' LEU . . . -160.32 148.58 16.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.269 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -114.2 150.41 34.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.909 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.12 -58.82 6.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.864 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.76 113.64 11.14 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.751 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -48.74 -27.56 3.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.567 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 25.8 mp0 -73.84 -40.54 63.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.482 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -67.37 -31.77 72.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.173 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.489 ' O ' HG23 ' A' ' 140' ' ' VAL . 7.5 tt -68.12 -49.44 61.14 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.521 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.78 -40.31 84.0 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.307 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -67.32 -29.21 68.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.322 179.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' TRP . . . . . 0.502 ' CZ2' HD23 ' A' ' 7' ' ' LEU . 0.8 OUTLIER -67.82 -49.09 64.16 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.471 179.611 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.68 HG13 ' CB ' ' A' ' 100' ' ' ILE . 33.5 t -60.28 -40.97 85.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.034 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -67.25 -38.37 85.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.907 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.486 ' O ' HG12 ' A' ' 146' ' ' VAL . 6.4 mptt -66.59 -49.86 64.95 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.524 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.723 HG21 HD11 ' A' ' 100' ' ' ILE . 41.6 mt -55.21 -37.14 42.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.369 0.605 . . . . 0.0 109.532 178.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 24.3 mtp180 -79.85 -25.74 40.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.212 -0.903 . . . . 0.0 110.673 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -76.04 -38.71 56.88 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-O 120.909 0.385 . . . . 0.0 110.75 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.902 HG13 HG11 ' A' ' 95' ' ' VAL . 7.2 p -80.85 -28.57 11.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.236 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.47 ' HB2' HG12 ' A' ' 95' ' ' VAL . . . -79.29 -33.89 42.94 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.291 179.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -74.2 -13.78 60.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.883 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.45 HG22 ' HA ' ' A' ' 146' ' ' VAL . 9.2 t -105.4 -20.5 13.47 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.101 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.659 ' HB3' ' HB3' ' A' ' 96' ' ' PRO . . . . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.216 -0.897 . . . . 0.0 111.141 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.49 ' HB3' HG13 ' A' ' 23' ' ' VAL . 6.7 m . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.844 0.354 . . . . 0.0 111.184 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.4 HD12 HG11 ' A' ' 146' ' ' VAL . 38.3 mt -76.53 -34.78 24.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.148 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.8 tptp -142.01 91.94 2.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.871 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.678 ' HB3' HG13 ' A' ' 23' ' ' VAL . 24.5 p-10 -125.06 131.91 53.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.919 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -169.88 -165.18 26.83 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.525 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.657 HD13 ' HD1' ' A' ' 21' ' ' TYR . 25.1 mm -97.21 80.45 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.743 0.306 . . . . 0.0 111.1 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.697 HD23 ' CZ2' ' A' ' 139' ' ' TRP . 0.8 OUTLIER -87.58 158.62 18.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.779 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.476 ' C ' HD23 ' A' ' 9' ' ' LEU . 36.1 m-85 -102.16 163.68 12.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.026 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.75 HD21 ' HB2' ' A' ' 20' ' ' HIS . 0.6 OUTLIER -177.78 129.16 0.14 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.785 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.443 ' HG2' ' CZ3' ' A' ' 17' ' ' TRP . 0.0 OUTLIER -95.16 166.29 11.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.974 0.416 . . . . 0.0 111.024 -179.814 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.42 150.12 53.8 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.709 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -73.63 -17.96 22.84 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.597 2.198 . . . . 0.0 112.506 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.1 t -77.77 -38.62 25.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.985 0.421 . . . . 0.0 110.975 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -101.81 -23.88 14.13 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.835 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 63.87 33.27 12.72 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.822 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -144.76 156.1 43.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.048 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.443 ' CZ3' ' HG2' ' A' ' 10' ' ' GLU . 30.8 m95 -77.24 139.57 39.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.869 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -132.4 138.72 32.81 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.838 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.42 130.26 14.81 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.464 2.11 . . . . 0.0 112.3 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.75 ' HB2' HD21 ' A' ' 9' ' ' LEU . 9.7 m-70 -144.75 -178.34 5.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.864 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.657 ' HD1' HD13 ' A' ' 6' ' ' ILE . 34.1 t80 -119.96 139.39 52.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.934 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.49 ' CZ ' ' CD1' ' A' ' 31' ' ' TYR . 1.5 m-85 -132.44 148.28 52.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.873 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.678 HG13 ' HB3' ' A' ' 4' ' ' ASN . 21.7 t -140.0 92.06 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.03 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.64 HD11 HG21 ' A' ' 146' ' ' VAL . 0.2 OUTLIER -69.84 115.09 8.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.094 -179.857 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -99.44 157.28 16.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.023 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -42.83 -34.37 0.93 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.229 -179.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.432 ' HA ' HG11 ' A' ' 95' ' ' VAL . 5.5 p -144.14 46.66 1.43 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.732 0.301 . . . . 0.0 111.622 -179.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 177.12 167.68 0.57 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.834 0.35 . . . . 0.0 111.358 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.639 HG23 HD22 ' A' ' 24' ' ' LEU . 3.0 mt -132.2 100.32 4.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.539 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -73.43 132.17 42.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.172 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.49 ' CD1' ' CZ ' ' A' ' 22' ' ' PHE . 69.4 t80 -143.31 123.37 13.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.783 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.5 t . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.885 179.971 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.419 0 N-CA-C 112.567 -0.213 . . . . 0.0 112.567 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.41 HG22 ' H ' ' A' ' 92' ' ' VAL . 5.2 m -84.87 139.47 17.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.733 0.301 . . . . 0.0 111.091 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.1 mt -130.98 134.56 46.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.895 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -69.39 126.8 30.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.871 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.946 HG21 HG23 ' A' ' 146' ' ' VAL . 13.3 p -81.95 -27.73 0.44 Allowed Pre-proline 0 CA--C 1.534 0.347 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.649 ' CD ' ' N ' ' A' ' 95' ' ' VAL . 88.8 Cg_endo -85.97 47.64 1.89 Allowed 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.146 1.898 . . . . 0.0 112.665 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 178.69 39.37 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.865 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 1.9 m -119.48 173.51 6.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.958 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.01 102.59 2.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.769 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 1.031 HD13 HG23 ' A' ' 116' ' ' ILE . 14.7 mm -79.2 158.19 4.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.078 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.422 ' N ' HG22 ' A' ' 100' ' ' ILE . . . -155.56 93.17 1.46 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.037 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.732 HD13 HE22 ' A' ' 137' ' ' GLN . 54.3 mt -59.25 143.87 13.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.144 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.413 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 4.6 mtt180 -133.28 114.15 13.53 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.525 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 103' ' ' ARG . 3.0 Cg_exo -74.78 29.87 0.35 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.587 2.191 . . . . 0.0 112.651 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -177.62 74.22 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.734 0.302 . . . . 0.0 110.413 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -42.28 -84.67 0.01 OUTLIER Glycine 0 C--N 1.332 0.344 0 CA-C-N 116.077 -0.51 . . . . 0.0 113.19 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -175.11 -80.5 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.832 0.349 . . . . 0.0 111.236 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -96.8 109.71 22.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.215 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 32.8 m120 48.04 38.78 10.11 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.235 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 7.9 mmp_? -140.11 112.66 7.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.936 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.86 -33.51 12.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.822 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.667 ' HB3' HD13 ' A' ' 136' ' ' LEU . 3.4 m-85 -108.21 107.12 17.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.861 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.445 HG13 ' HB2' ' A' ' 129' ' ' ALA . 22.0 t -151.18 132.3 4.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.128 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.418 ' CE2' ' HB ' ' A' ' 128' ' ' VAL . 31.3 p90 -115.54 122.51 45.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.895 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 58.1 m -89.32 128.38 35.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.983 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 1.031 HG23 HD13 ' A' ' 100' ' ' ILE . 14.1 mt -100.97 158.5 4.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.996 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.422 ' N ' HG22 ' A' ' 116' ' ' ILE . 54.6 p -151.38 -170.52 3.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.968 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . 0.481 ' SD ' HG21 ' A' ' 121' ' ' VAL . 32.7 mtp -146.82 105.02 3.92 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.073 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -78.16 59.17 6.91 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.506 2.137 . . . . 0.0 112.376 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -177.2 -45.6 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.877 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.481 HG21 ' SD ' ' A' ' 118' ' ' MET . 43.1 t -65.63 -66.69 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.999 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.439 ' HB3' ' HD1' ' A' ' 124' ' ' TRP . . . 179.88 -154.76 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.296 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -84.63 47.63 1.4 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.772 0.32 . . . . 0.0 111.04 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . 0.439 ' HD1' ' HB3' ' A' ' 122' ' ' ALA . 23.6 m95 -79.94 128.7 33.78 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.804 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.14 114.95 14.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.944 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.3 tp -112.5 112.62 24.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.022 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -82.2 126.46 32.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.858 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.47 HG12 HD12 ' A' ' 7' ' ' LEU . 21.2 t -136.44 154.43 32.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.077 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.445 ' HB2' HG13 ' A' ' 113' ' ' VAL . . . -161.21 127.37 3.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.144 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.494 ' H ' HD12 ' A' ' 136' ' ' LEU . . . -92.55 142.46 27.37 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.978 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -56.0 -37.66 69.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.896 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -97.55 114.02 25.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.797 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -48.5 -27.42 2.69 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.539 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -73.67 -42.12 61.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.357 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.19 -30.21 68.36 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.117 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.667 HD13 ' HB3' ' A' ' 112' ' ' PHE . 9.8 tt -68.44 -45.89 71.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.418 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.732 HE22 HD13 ' A' ' 102' ' ' ILE . 80.3 mm-40 -68.05 -42.7 80.1 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.309 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -66.87 -30.44 70.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.325 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' TRP . . . . . 0.697 ' CZ2' HD23 ' A' ' 7' ' ' LEU . 1.0 OUTLIER -66.38 -46.74 75.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.512 179.563 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.677 HG13 HG21 ' A' ' 100' ' ' ILE . 40.6 t -61.45 -44.62 98.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.941 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 7.2 ttmm -63.46 -35.9 81.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.936 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.623 ' O ' HG22 ' A' ' 146' ' ' VAL . 0.0 OUTLIER -66.7 -52.0 49.69 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.476 179.792 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.578 HG21 HD11 ' A' ' 100' ' ' ILE . 74.0 mt -53.64 -34.92 25.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.28 0.562 . . . . 0.0 109.646 178.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 3.1 mtt180 -78.4 -28.39 46.91 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.584 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -74.91 -39.56 61.37 Favored 'General case' 0 CA--C 1.523 -0.088 0 CA-C-O 120.898 0.38 . . . . 0.0 110.78 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.946 HG23 HG21 ' A' ' 95' ' ' VAL . 8.9 m -78.74 -26.71 13.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.258 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -77.43 -35.01 54.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.819 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -78.53 -9.58 59.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.136 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.52 HG22 ' HA ' ' A' ' 146' ' ' VAL . 15.2 t -113.5 -30.14 6.95 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.777 0.323 . . . . 0.0 111.144 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.251 -0.88 . . . . 0.0 111.088 -179.989 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.4 p . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.749 0.309 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.891 HD11 ' HB3' ' A' ' 26' ' ' SER . 33.9 mt -74.93 -30.9 24.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.145 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.9 mttp -147.51 116.79 6.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.964 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.731 ' HB3' HG13 ' A' ' 23' ' ' VAL . 4.2 p-10 -135.37 124.81 24.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.896 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -163.31 -156.07 8.46 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.498 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 26.5 mm -105.53 99.61 8.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.814 0.34 . . . . 0.0 111.184 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.941 HD12 HG12 ' A' ' 128' ' ' VAL . 3.2 mm? -102.92 139.88 37.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.834 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -80.68 140.83 35.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.035 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.495 HD12 HG22 ' A' ' 128' ' ' VAL . 5.9 tt -152.49 102.57 2.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.797 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.409 ' HB3' ' CD2' ' A' ' 17' ' ' TRP . 0.6 OUTLIER -70.67 153.26 43.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.878 -179.806 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -113.25 150.71 43.46 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.913 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.07 -17.98 24.34 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.619 2.213 . . . . 0.0 112.549 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -72.4 -48.41 47.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.168 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -100.73 -19.39 16.05 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.936 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 59.9 42.51 16.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.973 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -146.4 146.62 30.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.874 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.429 ' CE2' ' HG3' ' A' ' 110' ' ' ARG . 58.7 m95 -72.72 150.5 42.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.873 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -144.33 139.91 16.22 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.851 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -73.83 87.94 1.1 Allowed 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.583 2.189 . . . . 0.0 112.41 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -104.27 162.64 13.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.874 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -93.3 137.64 32.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.845 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.501 ' CZ ' ' CE1' ' A' ' 31' ' ' TYR . 44.0 m-85 -138.66 156.56 47.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.938 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.731 HG13 ' HB3' ' A' ' 4' ' ' ASN . 25.3 t -141.17 150.28 20.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.874 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.453 HD12 HG12 ' A' ' 29' ' ' ILE . 21.0 tp -133.02 118.37 18.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.237 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 15.0 p -109.76 149.12 30.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.695 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.891 ' HB3' HD11 ' A' ' 2' ' ' ILE . 0.2 OUTLIER -56.79 -18.72 13.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.863 -179.671 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.2 m -99.09 -24.7 14.8 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 111.624 0.231 . . . . 0.0 111.624 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.546 ' HA ' HG23 ' A' ' 95' ' ' VAL . 0.0 OUTLIER -175.01 -173.92 0.73 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.727 0.298 . . . . 0.0 110.799 -179.647 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.699 ' O ' HG23 ' A' ' 92' ' ' VAL . 7.7 mt -110.83 162.28 8.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.705 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.454 ' N ' HG22 ' A' ' 29' ' ' ILE . 0.7 OUTLIER -133.59 138.25 45.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.075 -179.895 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.501 ' CE1' ' CZ ' ' A' ' 22' ' ' PHE . 10.9 t80 -121.25 139.15 53.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.87 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.943 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.226 0 N-CA-C 112.406 -0.278 . . . . 0.0 112.406 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.699 HG23 ' O ' ' A' ' 29' ' ' ILE . 11.8 p -169.49 131.04 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.77 0.319 . . . . 0.0 111.297 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.663 ' HB3' HD12 ' A' ' 29' ' ' ILE . 2.9 tp -113.88 -173.74 2.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.542 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -123.71 140.01 53.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.94 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.844 HG11 ' HB ' ' A' ' 146' ' ' VAL . 22.7 t -86.05 -45.89 0.59 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.982 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' A' ' 95' ' ' VAL . 88.0 Cg_endo -80.36 54.7 5.34 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.258 1.972 . . . . 0.0 112.525 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.433 ' HB2' ' O ' ' A' ' 96' ' ' PRO . . . 176.03 39.57 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.797 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 8.4 m -141.05 -178.88 5.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.979 0.419 . . . . 0.0 111.198 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -160.38 105.5 1.48 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.525 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 1.004 HD13 HG23 ' A' ' 116' ' ' ILE . 14.7 mm -74.47 160.59 5.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.224 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.47 ' N ' HG22 ' A' ' 100' ' ' ILE . . . -160.6 92.78 0.98 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.866 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 15.0 mt -57.07 136.4 20.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.017 0.437 . . . . 0.0 111.31 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.87 123.86 26.74 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.197 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -82.71 19.2 1.34 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.465 2.11 . . . . 0.0 112.926 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -169.0 70.95 0.08 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.797 0.332 . . . . 0.0 110.674 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -56.59 -95.13 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.682 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -168.33 165.85 12.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.851 0.357 . . . . 0.0 110.992 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 63.63 -80.4 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.114 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -158.29 31.23 0.24 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.911 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.429 ' HG3' ' CE2' ' A' ' 17' ' ' TRP . 11.7 mmt180 -119.62 85.67 2.42 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.853 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -69.19 -32.22 71.37 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.084 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -97.73 87.71 4.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.017 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.725 HG13 ' HB2' ' A' ' 129' ' ' ALA . 21.4 t -139.94 144.66 27.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.939 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.43 ' CE2' ' HB ' ' A' ' 128' ' ' VAL . 48.9 p90 -118.22 125.51 50.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.895 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.2 t -98.62 133.03 43.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.985 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 1.004 HG23 HD13 ' A' ' 100' ' ' ILE . 14.6 mt -101.67 159.69 4.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.828 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.452 ' N ' HG22 ' A' ' 116' ' ' ILE . 19.7 t -151.97 -179.67 7.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.81 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 10.2 mtt -135.38 135.44 22.44 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.833 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -59.4 -66.01 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.479 2.119 . . . . 0.0 112.697 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.65 104.65 11.91 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.327 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.541 ' O ' ' HB2' ' A' ' 122' ' ' ALA . 2.0 p -178.81 -47.99 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.787 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.541 ' HB2' ' O ' ' A' ' 121' ' ' VAL . . . 169.26 -167.41 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.769 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 9.7 mm100 -98.16 36.31 1.6 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.807 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . 0.424 ' CD1' ' HB3' ' A' ' 122' ' ' ALA . 22.9 m95 -63.94 -177.7 0.27 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.983 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 89.3 p -178.16 103.02 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.758 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.47 HD22 HD22 ' A' ' 93' ' ' LEU . 10.0 tp -92.53 104.7 16.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.143 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -85.97 131.85 34.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.822 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.941 HG12 HD12 ' A' ' 7' ' ' LEU . 22.0 t -152.5 147.53 14.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.06 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.725 ' HB2' HG13 ' A' ' 113' ' ' VAL . . . -148.27 143.92 27.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.261 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -104.83 135.77 45.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.031 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -54.29 -34.61 61.28 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.995 0.426 . . . . 0.0 110.898 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 5.9 t -95.94 114.89 26.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.669 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -48.96 -26.16 2.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.725 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -75.63 -42.9 50.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.591 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -67.86 -32.0 72.21 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.239 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.577 ' O ' HG23 ' A' ' 140' ' ' VAL . 7.4 tt -68.99 -46.93 66.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.516 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -68.86 -41.08 78.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.39 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.55 -28.93 68.2 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.357 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' TRP . . . . . 0.474 ' CZ2' HD23 ' A' ' 7' ' ' LEU . 1.1 m95 -69.05 -47.51 65.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.608 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.684 HG13 HG21 ' A' ' 100' ' ' ILE . 33.2 t -61.53 -40.39 86.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.904 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.94 -38.26 90.36 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.841 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.92 -52.13 52.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.366 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.992 HG21 HD11 ' A' ' 100' ' ' ILE . 73.9 mt -53.85 -34.37 25.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.23 0.538 . . . . 0.0 109.644 178.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -81.23 -27.91 35.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.482 179.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.607 ' O ' HG22 ' A' ' 149' ' ' THR . 1.5 tm-20 -70.93 -39.95 72.36 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-O 120.906 0.384 . . . . 0.0 110.413 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.844 ' HB ' HG11 ' A' ' 95' ' ' VAL . 61.8 t -78.48 -33.55 17.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.859 179.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.34 -34.33 65.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.479 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.88 -11.72 60.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.858 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.607 HG22 ' O ' ' A' ' 145' ' ' GLU . 10.6 t -120.98 17.07 11.72 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.083 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.282 -0.866 . . . . 0.0 111.082 -179.982 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 25.7 m . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.808 0.337 . . . . 0.0 111.271 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.577 HG22 ' HE2' ' A' ' 142' ' ' LYS . 30.2 mt -85.59 -33.01 7.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.064 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.445 ' HE3' ' CD1' ' A' ' 139' ' ' TRP . 21.2 tttp -158.63 116.41 2.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.007 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.841 ' HB3' HG13 ' A' ' 23' ' ' VAL . 8.2 p30 -131.72 127.73 37.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.966 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -166.29 -155.54 8.91 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.549 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.643 ' N ' HD12 ' A' ' 6' ' ' ILE . 3.4 mp -115.42 100.96 11.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.815 0.341 . . . . 0.0 111.114 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.658 HD12 HG12 ' A' ' 128' ' ' VAL . 3.5 mm? -96.18 140.2 31.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.77 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -76.93 145.35 38.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.127 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.495 HD11 ' OH ' ' A' ' 31' ' ' TYR . 0.2 OUTLIER -158.06 122.23 4.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.69 179.891 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.453 ' HB2' ' CE3' ' A' ' 17' ' ' TRP . 0.7 OUTLIER -74.18 120.9 20.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.11 -179.8 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.47 138.47 59.21 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.028 179.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -67.98 -12.0 33.84 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.192 1.928 . . . . 0.0 112.564 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.4 t -77.76 -36.31 22.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.886 0.374 . . . . 0.0 110.919 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -111.92 -24.39 9.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.044 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 2.4 m170 66.63 34.53 5.8 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.901 0.381 . . . . 0.0 110.654 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.411 ' N ' ' HG3' ' A' ' 10' ' ' GLU . 48.8 mt-10 -138.15 144.54 40.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.859 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.453 ' CE3' ' HB2' ' A' ' 10' ' ' GLU . 49.7 m95 -52.87 146.27 11.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.128 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -150.04 130.65 7.02 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.883 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.94 97.14 1.09 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.436 2.091 . . . . 0.0 112.364 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 15.5 m80 -115.96 149.21 39.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.856 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -65.35 164.44 13.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.946 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.498 ' CD2' ' CD1' ' A' ' 31' ' ' TYR . 0.2 OUTLIER -177.28 119.99 0.11 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.672 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.841 HG13 ' HB3' ' A' ' 4' ' ' ASN . 16.4 t -104.76 142.16 18.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.101 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.649 HD12 HG12 ' A' ' 29' ' ' ILE . 23.1 tp -118.83 103.08 9.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.902 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -101.8 152.2 21.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.865 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.513 ' CB ' HD11 ' A' ' 2' ' ' ILE . 0.4 OUTLIER -59.18 -16.69 21.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.643 -179.768 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.0 p -99.54 -23.34 15.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.575 0.226 . . . . 0.0 111.513 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.602 ' HA ' HG23 ' A' ' 95' ' ' VAL . 0.1 OUTLIER 178.41 -174.72 0.17 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.897 0.379 . . . . 0.0 110.953 -179.722 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.649 HG12 HD12 ' A' ' 24' ' ' LEU . 6.0 mt -119.62 123.9 71.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.812 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.625 ' HD1' HG22 ' A' ' 92' ' ' VAL . 40.7 m-85 -95.42 160.41 14.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.942 0.401 . . . . 0.0 111.01 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.498 ' CD1' ' CD2' ' A' ' 22' ' ' PHE . 45.8 t80 -151.88 123.35 7.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.765 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.1 t . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.863 -179.993 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.565 -0.214 . . . . 0.0 112.565 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.625 HG22 ' HD1' ' A' ' 30' ' ' TYR . 21.5 t -127.72 136.0 61.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.755 0.312 . . . . 0.0 111.107 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.637 HD21 ' CE ' ' A' ' 118' ' ' MET . 0.7 OUTLIER -130.86 120.88 24.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.02 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -57.98 148.58 25.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.928 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.826 HG11 ' HB ' ' A' ' 146' ' ' VAL . 17.3 t -78.68 -47.94 1.79 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.823 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' A' ' 95' ' ' VAL . 71.6 Cg_endo -77.49 58.28 6.27 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.225 1.95 . . . . 0.0 112.505 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -179.63 38.68 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.901 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . 0.436 ' SG ' HD22 ' A' ' 93' ' ' LEU . 67.4 m -139.13 178.13 7.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.011 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.4 tm0? -158.71 102.49 1.69 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.72 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.966 HD13 HG23 ' A' ' 116' ' ' ILE . 8.3 mm -76.57 160.75 4.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.326 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.435 ' N ' HG22 ' A' ' 100' ' ' ILE . . . -153.0 89.47 1.38 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.803 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 73.9 mt -62.47 145.73 13.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.101 0.477 . . . . 0.0 111.553 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.402 ' HB2' ' CG1' ' A' ' 113' ' ' VAL . 0.2 OUTLIER -134.81 125.85 17.57 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.879 179.305 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -82.55 25.55 0.67 Allowed 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.431 2.087 . . . . 0.0 113.22 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -178.23 74.34 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.722 0.296 . . . . 0.0 111.013 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -59.13 -96.67 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.578 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.67 173.74 1.59 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.795 0.331 . . . . 0.0 110.938 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 68.36 -68.39 0.17 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.12 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -175.46 36.67 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.903 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -129.98 88.44 2.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.796 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 86.2 mt -59.31 -37.58 78.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.825 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -99.12 119.34 37.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.844 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 1.014 HG23 ' HB2' ' A' ' 129' ' ' ALA . 9.4 p -155.05 162.18 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.134 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.432 ' CZ ' ' HB ' ' A' ' 128' ' ' VAL . 10.2 p90 -148.66 114.29 5.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.922 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 12.4 m -92.64 140.01 29.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.939 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.966 HG23 HD13 ' A' ' 100' ' ' ILE . 13.0 mt -104.95 157.48 5.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.977 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.412 ' N ' HG22 ' A' ' 116' ' ' ILE . 5.5 t -162.01 138.31 7.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.781 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . 0.637 ' CE ' HD21 ' A' ' 93' ' ' LEU . 29.0 mtp -102.39 96.92 7.85 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.062 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.26 59.06 4.51 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.491 2.127 . . . . 0.0 112.368 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 92.2 p -177.85 37.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.809 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.671 HG13 ' H ' ' A' ' 122' ' ' ALA . 0.4 OUTLIER -161.15 -82.33 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.727 -179.854 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.671 ' H ' HG13 ' A' ' 121' ' ' VAL . . . -140.59 -168.89 2.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.921 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -93.55 47.45 1.24 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.77 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . 0.458 ' CD1' ' HB3' ' A' ' 122' ' ' ALA . 29.5 m95 -85.28 148.56 26.0 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.853 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 92.1 p -144.34 103.67 4.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.79 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.503 HD23 ' CG2' ' A' ' 128' ' ' VAL . 0.3 OUTLIER -89.59 100.55 13.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.059 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -77.37 124.03 27.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.856 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.658 HG12 HD12 ' A' ' 7' ' ' LEU . 15.7 t -137.1 152.74 28.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.1 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 1.014 ' HB2' HG23 ' A' ' 113' ' ' VAL . . . -157.31 127.11 6.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.234 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.579 ' HB2' HD11 ' A' ' 7' ' ' LEU . . . -93.12 137.35 32.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.924 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -52.5 -35.78 53.76 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.964 0.412 . . . . 0.0 111.106 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.8 t -96.95 115.41 27.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.742 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.22 -27.46 2.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.566 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.42 -45.44 38.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.44 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -63.92 -32.29 73.77 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.197 179.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.454 HD23 ' C ' ' A' ' 136' ' ' LEU . 7.6 tt -67.45 -51.85 46.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.557 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -67.6 -35.52 79.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.375 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -70.8 -30.66 67.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.419 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' TRP . . . . . 0.445 ' CD1' ' HE3' ' A' ' 3' ' ' LYS . 0.8 OUTLIER -68.72 -45.58 71.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.67 179.749 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.547 HG22 HG21 ' A' ' 100' ' ' ILE . 44.6 t -63.49 -42.19 95.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.886 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 11.6 mttm -63.87 -35.62 81.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.809 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.577 ' HE2' HG22 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -67.04 -50.41 62.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.603 179.669 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 68.6 mt -54.44 -35.57 31.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.328 0.585 . . . . 0.0 109.5 178.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 47.3 mtp180 -78.01 -28.68 49.21 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.447 179.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.418 ' O ' HG22 ' A' ' 149' ' ' THR . 12.2 tt0 -76.03 -32.67 59.46 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.864 0.364 . . . . 0.0 110.53 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.826 ' HB ' HG11 ' A' ' 95' ' ' VAL . 90.2 t -80.0 -31.47 13.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.294 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.1 -35.21 66.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.828 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -75.32 -11.08 59.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.144 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.462 HG22 ' HA ' ' A' ' 146' ' ' VAL . 8.9 t -114.27 -34.69 5.23 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.774 0.321 . . . . 0.0 111.097 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.225 -0.893 . . . . 0.0 111.155 -179.928 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.859 0.361 . . . . 0.0 111.12 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.745 HD11 ' HA ' ' A' ' 26' ' ' SER . 29.6 mt -76.48 -34.2 24.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.047 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.56 169.31 24.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.911 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.44 ' HB3' HG13 ' A' ' 23' ' ' VAL . 3.0 p30 -166.58 125.4 1.46 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.81 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -159.65 -170.59 24.41 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.583 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 28.4 mm -94.81 92.44 3.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.791 0.329 . . . . 0.0 111.142 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.58 HD12 HG12 ' A' ' 128' ' ' VAL . 4.3 mm? -96.58 129.58 43.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.847 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -79.9 146.32 32.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.917 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -147.59 133.69 19.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.766 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.466 ' CG ' ' CD2' ' A' ' 17' ' ' TRP . 3.2 mt-10 -80.36 118.05 21.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.134 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.72 134.32 50.76 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.352 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -68.8 -10.52 29.34 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.306 2.004 . . . . 0.0 112.654 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.2 t -66.56 -39.22 83.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.924 0.392 . . . . 0.0 110.937 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -138.02 9.34 2.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.463 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 49.79 49.46 20.11 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.92 0.391 . . . . 0.0 111.136 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.55 149.62 49.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.876 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.466 ' CD2' ' CG ' ' A' ' 10' ' ' GLU . 43.2 m95 -72.97 143.57 47.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.911 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -129.92 119.04 18.79 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.79 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -68.82 82.65 0.56 Allowed 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.398 2.065 . . . . 0.0 112.353 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 4.4 m80 -114.23 168.36 9.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.882 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -73.85 172.05 12.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.901 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -167.03 141.42 3.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.877 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.44 HG13 ' HB3' ' A' ' 4' ' ' ASN . 38.8 t -134.68 153.39 34.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.868 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.686 HD12 HG12 ' A' ' 29' ' ' ILE . 5.8 tp -133.41 109.49 9.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.117 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 16.9 p -95.46 157.8 15.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.581 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.745 ' HA ' HD11 ' A' ' 2' ' ' ILE . 3.4 m -63.73 -13.86 47.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.915 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.0 m -111.43 -7.14 14.38 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 173.55 -174.84 0.06 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.925 0.393 . . . . 0.0 111.29 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.686 HG12 HD12 ' A' ' 24' ' ' LEU . 5.8 mt -113.59 136.78 48.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.399 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.411 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 39.4 m-85 -113.92 138.36 50.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.861 0.362 . . . . 0.0 111.066 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 54.1 p90 -157.55 158.47 35.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.879 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.893 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.375 0 N-CA-C 112.506 -0.237 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 11.8 p -132.85 137.76 53.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.757 0.313 . . . . 0.0 111.085 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -139.63 129.16 24.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.14 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -60.38 119.7 8.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.82 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.698 HG12 ' HD3' ' A' ' 96' ' ' PRO . 8.7 p -83.13 -34.18 0.6 Allowed Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.698 ' HD3' HG12 ' A' ' 95' ' ' VAL . 3.1 Cg_exo -75.24 54.48 3.77 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.262 1.975 . . . . 0.0 112.597 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.558 ' HB2' ' O ' ' A' ' 96' ' ' PRO . . . 168.78 42.56 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.018 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 1.7 m -125.3 162.94 23.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.943 0.401 . . . . 0.0 111.215 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.04 101.18 3.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.542 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.867 HD13 HG23 ' A' ' 116' ' ' ILE . 14.2 mm -71.03 160.12 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.403 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.468 ' N ' HG22 ' A' ' 100' ' ' ILE . . . -156.08 90.25 1.19 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.898 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.3 mt -56.43 149.28 3.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.33 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 15.6 mtp180 -142.97 113.75 5.83 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.554 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -67.5 0.33 4.22 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.549 2.166 . . . . 0.0 113.034 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -141.27 59.15 1.52 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.988 0.423 . . . . 0.0 110.536 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -43.06 -85.49 0.01 OUTLIER Glycine 0 C--N 1.331 0.251 0 CA-C-N 115.769 -0.65 . . . . 0.0 113.249 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 23.9 ttmt -176.69 160.47 1.95 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.947 0.403 . . . . 0.0 111.358 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 60.53 -84.3 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.128 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -146.41 31.2 1.0 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.951 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.428 ' HG3' ' CE2' ' A' ' 17' ' ' TRP . 13.9 mmt180 -114.57 100.36 8.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.777 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.2 mt -85.08 5.41 29.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.469 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -139.98 78.6 1.67 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.822 0.344 . . . . 0.0 110.972 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.49 HG13 ' HB2' ' A' ' 129' ' ' ALA . 36.2 t -129.13 135.61 61.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.933 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.428 ' CZ ' ' HB ' ' A' ' 128' ' ' VAL . 42.0 p90 -114.48 122.57 47.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.017 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 10.9 t -97.7 136.06 38.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.885 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.867 HG23 HD13 ' A' ' 100' ' ' ILE . 10.9 mt -96.31 157.94 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.974 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.416 ' N ' HG22 ' A' ' 116' ' ' ILE . 1.5 m -150.04 166.85 28.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.951 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 13.7 mtp -139.53 100.43 7.56 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.903 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -79.94 54.69 5.32 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.568 2.179 . . . . 0.0 112.627 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 178.94 49.49 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.98 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.647 HG22 ' N ' ' A' ' 122' ' ' ALA . 0.3 OUTLIER -161.85 -82.11 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.92 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.647 ' N ' HG22 ' A' ' 121' ' ' VAL . . . -157.08 -165.47 1.84 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.184 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -84.64 56.93 4.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.945 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 39.9 m95 -104.21 148.87 25.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.926 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 14.1 m -153.3 123.66 7.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.808 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.657 HD23 HD12 ' A' ' 116' ' ' ILE . 14.4 tp -102.83 155.85 18.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.99 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -131.95 134.41 45.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.836 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.58 HG12 HD12 ' A' ' 7' ' ' LEU . 23.7 t -152.38 159.15 3.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.092 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.49 ' HB2' HG13 ' A' ' 113' ' ' VAL . . . -158.57 117.65 3.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.161 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.581 ' HB3' ' HB2' ' A' ' 136' ' ' LEU . . . -81.37 134.98 35.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.842 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -54.47 -34.39 61.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.885 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.94 113.4 24.94 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.744 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -48.04 -27.94 2.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.475 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 -76.65 -44.29 34.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.292 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -65.66 -31.88 73.14 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.011 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.581 ' HB2' ' HB3' ' A' ' 130' ' ' ALA . 7.2 tt -67.77 -50.78 55.25 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.314 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -66.39 -37.17 84.64 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.262 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -70.43 -31.5 68.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.403 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' TRP . . . . . 0.444 ' CE2' HD21 ' A' ' 7' ' ' LEU . 0.7 OUTLIER -67.65 -43.03 81.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.58 179.821 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.686 HG13 ' CB ' ' A' ' 100' ' ' ILE . 26.7 t -65.22 -44.2 95.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.848 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 7.3 ttmm -63.84 -33.77 76.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.884 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.671 ' HD2' HG22 ' A' ' 2' ' ' ILE . 17.0 mmtt -67.93 -49.46 61.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.525 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.753 HD13 HD11 ' A' ' 100' ' ' ILE . 30.7 mt -54.35 -38.15 39.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.352 0.596 . . . . 0.0 109.517 178.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 66.2 mtt180 -77.95 -27.69 49.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.479 179.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.651 ' O ' HG22 ' A' ' 149' ' ' THR . 2.1 tp10 -75.16 -33.23 61.47 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.861 0.362 . . . . 0.0 110.705 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.645 HG11 HG21 ' A' ' 95' ' ' VAL . 9.9 p -79.63 -34.3 15.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.065 0.459 . . . . 0.0 110.19 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -71.48 -34.43 70.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.563 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -75.1 -10.7 59.71 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.931 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.651 HG22 ' O ' ' A' ' 145' ' ' GLU . 10.9 t -126.26 21.34 7.34 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.103 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.166 -0.921 . . . . 0.0 111.19 179.985 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 8.0 t . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 120.885 0.374 . . . . 0.0 111.159 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.424 HD11 ' HA ' ' A' ' 26' ' ' SER . 39.4 mt -79.79 -34.48 15.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.121 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.7 tttp -140.1 153.82 46.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.01 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -160.97 124.39 3.34 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.924 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -160.4 -178.0 34.01 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.542 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.637 ' N ' HD12 ' A' ' 6' ' ' ILE . 3.2 mp -89.52 92.01 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.909 0.385 . . . . 0.0 110.985 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 1.078 HD12 HG12 ' A' ' 128' ' ' VAL . 3.2 mm? -95.6 135.38 37.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.732 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -76.76 158.36 30.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.95 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.437 HD12 ' O ' ' A' ' 127' ' ' ASP . 1.4 tp -161.78 128.19 3.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.808 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.436 ' HG3' ' CE3' ' A' ' 17' ' ' TRP . 3.4 mt-10 -71.11 111.57 6.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.99 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.92 127.54 66.77 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.53 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -56.69 -16.81 20.56 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.504 2.136 . . . . 0.0 112.899 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 37.8 t -69.36 -41.67 80.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.858 0.361 . . . . 0.0 111.352 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -117.75 -10.18 10.57 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.649 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 62.86 30.84 16.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.789 0.328 . . . . 0.0 110.815 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.64 160.4 39.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.801 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.463 ' NE1' ' HG3' ' A' ' 110' ' ' ARG . 45.0 m95 -56.7 138.04 53.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.051 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -126.07 125.31 24.73 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.686 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.64 112.06 2.95 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.439 2.092 . . . . 0.0 112.228 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 22.0 m80 -148.64 141.79 24.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.871 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -59.38 154.6 16.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.719 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.427 ' CE2' ' CD1' ' A' ' 31' ' ' TYR . 0.1 OUTLIER -147.35 138.86 23.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.976 -179.827 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.8 t -131.41 150.8 34.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.113 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 25.7 tp -134.37 118.99 18.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.952 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.431 ' HG1' ' C ' ' A' ' 28' ' ' LYS . 62.6 p -97.95 157.58 16.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.983 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.424 ' HA ' HD11 ' A' ' 2' ' ' ILE . 29.4 t -48.97 -38.08 22.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.85 -0.613 . . . . 0.0 112.057 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.3 m -129.59 39.06 3.78 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.555 ' N ' HG23 ' A' ' 95' ' ' VAL . 2.6 tttt 175.01 170.03 0.28 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.007 0.432 . . . . 0.0 111.378 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.667 HD12 ' HB3' ' A' ' 93' ' ' LEU . 3.5 mt -128.87 153.23 38.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.716 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.404 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 0.6 OUTLIER -129.93 146.28 51.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.904 0.383 . . . . 0.0 111.112 -179.889 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.427 ' CD1' ' CE2' ' A' ' 22' ' ' PHE . 39.7 t80 -146.35 143.48 29.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.84 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.963 -179.926 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 29' ' ' ILE . 11.3 p -151.43 136.33 10.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.877 0.37 . . . . 0.0 111.033 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.667 ' HB3' HD12 ' A' ' 29' ' ' ILE . 0.3 OUTLIER -123.92 -176.44 3.48 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.891 -179.966 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -119.59 141.36 49.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.91 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.724 ' CG1' HG23 ' A' ' 146' ' ' VAL . 21.8 t -80.87 -46.87 1.19 Allowed Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.778 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 95' ' ' VAL . 84.6 Cg_endo -81.83 50.31 3.44 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.367 2.045 . . . . 0.0 112.497 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -179.55 37.85 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.959 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 14.4 p -134.34 -177.45 4.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.963 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.4 100.79 0.83 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.697 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 1.089 HD13 HG23 ' A' ' 116' ' ' ILE . 16.9 mm -76.82 160.58 4.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.02 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.468 ' N ' HG22 ' A' ' 100' ' ' ILE . . . -159.02 91.75 1.05 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.901 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.63 HG12 HG21 ' A' ' 140' ' ' VAL . 27.7 mt -58.07 157.47 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.242 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.498 ' N ' HG22 ' A' ' 102' ' ' ILE . 95.3 mtt180 -151.41 112.32 3.01 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.366 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.09 49.25 2.75 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.429 2.086 . . . . 0.0 112.523 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 167.35 61.98 0.0 OUTLIER 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.001 0.429 . . . . 0.0 110.223 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -55.04 -94.97 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.676 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.406 ' HD2' ' CZ2' ' A' ' 17' ' ' TRP . 0.0 OUTLIER 174.1 163.18 0.19 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.823 0.344 . . . . 0.0 111.014 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 57.07 54.6 6.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.975 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 9.0 m120 62.76 51.98 2.89 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.215 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.463 ' HG3' ' NE1' ' A' ' 17' ' ' TRP . 23.9 mmt180 -147.53 97.38 2.83 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.718 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.01 -32.47 57.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.978 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.614 ' HB3' HD13 ' A' ' 136' ' ' LEU . 6.5 m-85 -102.87 104.21 14.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.939 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.533 HG13 ' HB2' ' A' ' 129' ' ' ALA . 20.4 t -152.0 134.04 5.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.16 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -118.96 131.3 56.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.744 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 15.0 t -100.18 132.86 45.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.965 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 1.089 HG23 HD13 ' A' ' 100' ' ' ILE . 2.4 mp -104.29 159.82 5.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.942 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.477 ' N ' HG22 ' A' ' 116' ' ' ILE . 70.5 p -155.74 179.99 8.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.905 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . 0.696 ' HE3' HG11 ' A' ' 121' ' ' VAL . 7.3 mtm -143.33 93.26 6.47 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.782 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.93 -2.29 12.51 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.584 2.189 . . . . 0.0 112.794 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 48.6 m -108.9 33.88 4.0 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.718 0.294 . . . . 0.0 111.142 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.696 HG11 ' HE3' ' A' ' 118' ' ' MET . 0.4 OUTLIER -160.31 -82.45 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.94 179.907 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.653 ' H ' HG13 ' A' ' 121' ' ' VAL . . . -143.98 -166.06 2.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.838 0.351 . . . . 0.0 111.049 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -86.21 55.32 3.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.971 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . 0.499 ' CD1' ' HB3' ' A' ' 122' ' ' ALA . 89.4 m95 -85.93 142.24 28.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.786 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.16 119.94 5.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.006 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.608 HD23 ' N ' ' A' ' 126' ' ' LEU . 1.2 pt? -129.28 124.7 35.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.88 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.437 ' O ' HD12 ' A' ' 9' ' ' LEU . 1.1 m-20 -86.9 142.89 27.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.949 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 1.078 HG12 HD12 ' A' ' 7' ' ' LEU . 14.0 t -151.32 141.9 15.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.081 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.533 ' HB2' HG13 ' A' ' 113' ' ' VAL . . . -140.93 131.49 25.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.129 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.602 ' HB3' ' HB2' ' A' ' 136' ' ' LEU . . . -93.22 138.58 31.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.92 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -55.5 -39.62 70.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.0 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.73 113.13 25.31 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.905 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -48.05 -28.41 2.81 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.547 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -76.8 -44.29 33.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.328 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -65.65 -32.29 73.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.996 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.614 HD13 ' HB3' ' A' ' 112' ' ' PHE . 6.2 tt -67.38 -51.22 54.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.394 179.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 73.4 mm-40 -67.68 -35.25 78.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.192 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -71.5 -30.18 65.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.205 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' TRP . . . . . 0.406 ' CH2' ' HB3' ' A' ' 22' ' ' PHE . 0.5 OUTLIER -67.41 -47.07 71.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.348 179.54 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.729 HG13 HG21 ' A' ' 100' ' ' ILE . 23.3 t -61.76 -45.52 98.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.797 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 1.1 ttpt -62.97 -36.94 85.18 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.742 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.601 ' O ' HG22 ' A' ' 146' ' ' VAL . 17.9 tppt? -65.66 -56.26 13.08 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.294 179.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.653 HG21 HD11 ' A' ' 100' ' ' ILE . 71.0 mt -50.97 -31.76 10.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.107 0.48 . . . . 0.0 109.706 178.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.439 ' HD2' HG12 ' A' ' 140' ' ' VAL . 30.5 mtt180 -78.69 -30.15 45.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.493 179.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.827 ' O ' HG23 ' A' ' 149' ' ' THR . 5.2 tt0 -77.23 -35.94 55.04 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-O 120.761 0.315 . . . . 0.0 110.777 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.724 HG23 ' CG1' ' A' ' 95' ' ' VAL . 5.6 m -79.44 -28.45 13.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.306 179.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.479 ' HA ' HG12 ' A' ' 95' ' ' VAL . . . -74.37 -36.97 63.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.684 179.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -72.34 -13.07 61.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.042 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.827 HG23 ' O ' ' A' ' 145' ' ' GLU . 11.5 p -106.53 -38.96 6.01 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.107 0.479 . . . . 0.0 110.48 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.271 -0.871 . . . . 0.0 111.291 -179.924 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 24.1 m . . . . . 0 N--CA 1.487 1.409 0 CA-C-O 120.776 0.322 . . . . 0.0 111.179 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.512 HD11 ' CB ' ' A' ' 26' ' ' SER . 19.9 mt -88.5 -34.09 6.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.933 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.42 ' HG2' ' NE1' ' A' ' 139' ' ' TRP . 0.0 OUTLIER -136.56 142.1 43.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.768 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -154.58 121.27 5.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.968 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -170.04 -176.32 39.59 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.421 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.539 ' N ' HD12 ' A' ' 6' ' ' ILE . 4.2 mp -103.26 89.17 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.866 0.365 . . . . 0.0 111.026 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.534 HD11 ' HB2' ' A' ' 130' ' ' ALA . 3.4 mm? -82.06 142.46 32.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.651 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -77.74 144.67 37.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.29 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.465 HD21 HG22 ' A' ' 128' ' ' VAL . 2.6 mp -152.89 115.55 4.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.611 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.411 ' HB3' ' CE3' ' A' ' 17' ' ' TRP . 2.0 pp20? -72.6 140.73 48.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.257 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.42 148.33 36.98 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.531 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.39 -5.46 17.17 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.434 2.089 . . . . 0.0 112.705 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 25.2 t -65.75 -40.83 88.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.984 0.421 . . . . 0.0 110.724 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -139.12 9.34 2.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.407 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 49.03 59.07 4.71 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.878 0.371 . . . . 0.0 111.266 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -149.1 139.33 22.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.808 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.411 ' CE3' ' HB3' ' A' ' 10' ' ' GLU . 75.5 m95 -57.72 143.03 43.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.895 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -135.73 137.17 24.97 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.84 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.75 90.51 1.22 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.491 2.127 . . . . 0.0 112.399 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 12.7 m170 -112.3 138.72 48.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.008 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -60.19 159.5 9.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.782 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.483 ' CD2' ' CD1' ' A' ' 31' ' ' TYR . 0.1 OUTLIER -170.95 128.69 0.75 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.789 179.901 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 19.1 t -122.22 153.66 26.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.09 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.9 tp -128.58 118.99 23.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.986 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.8 p -99.54 154.43 18.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.846 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.512 ' CB ' HD11 ' A' ' 2' ' ' ILE . 1.4 m -54.43 -25.53 25.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.832 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.8 p -136.24 35.56 2.77 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.4 mttt 170.9 177.13 0.06 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.973 0.415 . . . . 0.0 111.12 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.8 mt -140.16 131.71 31.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.707 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -110.35 144.32 39.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.938 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.483 ' CD1' ' CD2' ' A' ' 22' ' ' PHE . 35.1 t80 -139.5 130.21 25.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.871 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.777 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.413 ' HA3' ' HB3' ' A' ' 31' ' ' TYR . . . . . . . . 0 N--CA 1.45 -0.397 0 N-CA-C 112.741 -0.144 . . . . 0.0 112.741 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 10.6 p -158.13 130.84 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.775 0.322 . . . . 0.0 110.903 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.692 HD23 ' H ' ' A' ' 94' ' ' ASP . 0.6 OUTLIER -148.48 150.53 33.59 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.103 -179.788 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.692 ' H ' HD23 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -81.96 128.05 33.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.711 179.802 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.655 HG12 ' HD3' ' A' ' 96' ' ' PRO . 8.3 p -71.44 -32.87 2.4 Favored Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.655 ' HD3' HG12 ' A' ' 95' ' ' VAL . 6.3 Cg_exo -73.9 56.36 3.57 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.202 1.934 . . . . 0.0 112.418 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.534 ' HB2' ' O ' ' A' ' 96' ' ' PRO . . . 170.09 63.48 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.963 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 64.9 m -146.46 168.11 21.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.125 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -154.0 99.47 2.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.606 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.916 HD13 HG23 ' A' ' 116' ' ' ILE . 11.2 mm -76.34 159.18 5.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.235 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.431 ' N ' HG22 ' A' ' 100' ' ' ILE . . . -154.45 88.21 1.21 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.904 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.559 ' CG1' HG21 ' A' ' 140' ' ' VAL . 7.6 mt -58.27 156.32 2.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.158 0.504 . . . . 0.0 111.365 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.483 ' N ' HG22 ' A' ' 102' ' ' ILE . 33.2 mtt180 -145.81 125.56 6.91 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.082 179.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -82.98 30.06 0.54 Allowed 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.41 2.073 . . . . 0.0 112.914 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -177.75 69.73 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.88 0.371 . . . . 0.0 110.642 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -55.11 -94.21 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.732 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -174.88 169.68 3.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.861 0.362 . . . . 0.0 110.913 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 61.66 -82.69 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.031 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -153.92 31.71 0.45 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.943 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.4 ' HB3' ' CG2' ' A' ' 113' ' ' VAL . 6.1 mmt85 -117.51 90.2 3.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.834 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.571 ' H ' HD12 ' A' ' 111' ' ' LEU . 2.9 mp -62.91 -30.86 71.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.826 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.768 ' HB3' HD13 ' A' ' 136' ' ' LEU . 75.2 m-85 -109.82 105.24 14.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.035 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.425 HG13 ' HB2' ' A' ' 129' ' ' ALA . 39.4 t -144.76 138.87 22.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.967 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.425 ' CE2' ' HB ' ' A' ' 128' ' ' VAL . 39.9 p90 -122.88 133.47 54.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.928 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.59 129.49 50.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.933 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.916 HG23 HD13 ' A' ' 100' ' ' ILE . 1.7 mt -97.84 159.56 3.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.014 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.471 ' N ' HG22 ' A' ' 116' ' ' ILE . 52.3 p -156.72 175.22 14.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.964 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . 0.565 ' CE ' HG11 ' A' ' 121' ' ' VAL . 2.2 mtm -137.95 91.56 13.23 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.815 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.45 -2.04 12.19 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.624 2.216 . . . . 0.0 112.816 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.4 m -108.94 31.44 5.68 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.692 0.282 . . . . 0.0 111.261 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.655 HG13 ' H ' ' A' ' 122' ' ' ALA . 0.4 OUTLIER -158.41 -82.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.885 179.864 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.655 ' H ' HG13 ' A' ' 121' ' ' VAL . . . -146.07 -164.93 2.08 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.079 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -85.05 57.18 4.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.827 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . 0.639 ' NE1' ' HB3' ' A' ' 122' ' ' ALA . 36.9 m95 -102.47 117.27 34.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.793 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -142.39 138.85 31.43 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.882 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.45 HD11 HD13 ' A' ' 116' ' ' ILE . 0.5 OUTLIER -127.6 170.08 13.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.901 -179.937 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -123.87 129.54 51.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.955 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.48 HG12 ' N ' ' A' ' 129' ' ' ALA . 18.7 t -140.94 159.54 23.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.928 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.48 ' N ' HG12 ' A' ' 128' ' ' VAL . . . -159.94 148.89 17.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.909 0.385 . . . . 0.0 111.221 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.534 ' HB2' HD11 ' A' ' 7' ' ' LEU . . . -112.59 135.5 53.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.938 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.47 -35.35 52.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.954 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.04 112.77 24.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.826 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.435 ' HG2' ' CD1' ' A' ' 112' ' ' PHE . 3.1 mt-30 -48.56 -27.8 3.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.725 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -77.12 -43.87 32.51 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.34 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -65.82 -31.25 72.1 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.137 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.768 HD13 ' HB3' ' A' ' 112' ' ' PHE . 7.7 tt -69.84 -50.44 42.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.474 179.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.492 HE22 HD13 ' A' ' 102' ' ' ILE . 36.2 mm-40 -67.87 -36.61 80.57 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.237 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -71.0 -28.51 64.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.407 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' TRP . . . . . 0.42 ' NE1' ' HG2' ' A' ' 3' ' ' LYS . 0.8 OUTLIER -69.75 -46.32 66.14 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.52 179.667 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.701 HG13 HG21 ' A' ' 100' ' ' ILE . 30.5 t -63.45 -42.29 95.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.741 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.45 -36.79 84.9 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.819 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.45 ' O ' HG22 ' A' ' 146' ' ' VAL . 0.0 OUTLIER -65.77 -56.0 14.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.312 179.521 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.786 HG21 HD11 ' A' ' 100' ' ' ILE . 65.9 mt -51.6 -31.8 13.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.167 0.508 . . . . 0.0 109.844 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 58.2 mtt180 -80.88 -28.63 35.89 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.535 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.626 ' O ' HG22 ' A' ' 149' ' ' THR . 0.6 OUTLIER -72.59 -39.52 67.27 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.839 0.352 . . . . 0.0 110.675 179.671 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.597 ' CG2' HG21 ' A' ' 95' ' ' VAL . 9.0 m -78.48 -32.72 16.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.072 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.42 -34.26 65.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.416 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -73.05 -13.28 61.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.791 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.626 HG22 ' O ' ' A' ' 145' ' ' GLU . 8.9 t -122.96 19.24 10.09 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.152 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.257 -0.878 . . . . 0.0 111.112 179.92 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 61.7 m . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.765 0.317 . . . . 0.0 111.262 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.833 HD11 ' HA ' ' A' ' 26' ' ' SER . 12.3 mt -77.2 -35.55 22.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.887 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -157.92 150.44 22.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.873 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.435 ' HB3' HG13 ' A' ' 23' ' ' VAL . 36.1 p-10 -157.91 137.8 12.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.887 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -170.06 179.06 42.56 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.493 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.57 ' N ' HD12 ' A' ' 6' ' ' ILE . 3.7 mp -93.31 79.24 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.933 0.397 . . . . 0.0 111.105 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.59 HD23 ' CZ2' ' A' ' 139' ' ' TRP . 2.0 mm? -77.26 163.62 26.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.808 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -100.51 142.51 31.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.04 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -148.64 105.62 3.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.768 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.59 120.74 11.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.126 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.07 129.14 68.46 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.49 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -68.74 -9.82 27.29 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.395 2.063 . . . . 0.0 112.687 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.9 t -64.22 -40.19 88.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.069 0.462 . . . . 0.0 110.602 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 54.6 p30 -142.22 12.81 1.99 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.355 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 50.27 79.35 0.09 Allowed 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 120.666 0.27 . . . . 0.0 111.071 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -162.96 133.34 4.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.922 0.391 . . . . 0.0 111.028 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 29.5 m95 -67.9 137.3 55.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.863 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -137.32 132.27 17.82 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.879 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.22 127.18 24.77 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.414 2.076 . . . . 0.0 112.241 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -135.51 122.17 20.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.869 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -80.24 85.27 5.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.924 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.441 ' CE2' ' HB3' ' A' ' 31' ' ' TYR . 4.0 m-85 -79.42 157.45 27.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.873 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.435 HG13 ' HB3' ' A' ' 4' ' ' ASN . 21.6 t -143.03 104.38 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.399 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.425 HD21 HG11 ' A' ' 146' ' ' VAL . 20.0 tp -86.51 117.36 25.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.717 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -99.7 157.97 16.1 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.301 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.833 ' HA ' HD11 ' A' ' 2' ' ' ILE . 7.0 t -44.55 -33.43 1.75 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.835 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.456 ' HA ' HG11 ' A' ' 95' ' ' VAL . 3.6 m -144.07 46.33 1.44 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.798 0.332 . . . . 0.0 111.403 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.3 mttt 179.27 167.91 1.03 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.939 0.399 . . . . 0.0 111.174 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.1 mt -139.51 106.15 2.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.825 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -97.03 139.61 32.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.989 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.441 ' HB3' ' CE2' ' A' ' 22' ' ' PHE . 13.2 p90 -140.33 112.95 8.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.827 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.5 m . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.837 -179.95 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.428 ' HA3' ' CZ ' ' A' ' 31' ' ' TYR . . . . . . . . 0 N--CA 1.45 -0.399 0 N-CA-C 112.61 -0.196 . . . . 0.0 112.61 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.5 p -95.77 133.52 36.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.765 0.317 . . . . 0.0 111.033 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.7 tp -132.56 152.41 51.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.056 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.475 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 2.3 p30 -89.56 126.88 35.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.752 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.772 HG21 HG13 ' A' ' 146' ' ' VAL . 7.6 p -72.42 -33.33 2.23 Favored Pre-proline 0 CA--C 1.534 0.365 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.649 ' HD3' HG12 ' A' ' 95' ' ' VAL . 6.4 Cg_exo -74.28 55.23 3.5 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.334 2.022 . . . . 0.0 112.546 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.531 ' HB2' ' O ' ' A' ' 96' ' ' PRO . . . 170.02 66.44 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.999 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 31.1 p -142.87 161.39 38.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.121 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.408 ' HB2' ' HD3' ' A' ' 119' ' ' PRO . 0.0 OUTLIER -148.59 105.97 3.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.636 179.878 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 1.031 HG21 HG23 ' A' ' 140' ' ' VAL . 4.7 mm -78.02 163.33 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.322 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.433 ' H ' HG22 ' A' ' 100' ' ' ILE . . . -159.89 87.63 0.81 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.822 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.464 HG22 ' N ' ' A' ' 103' ' ' ARG . 84.1 mt -56.72 155.16 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.127 0.489 . . . . 0.0 111.292 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.464 ' N ' HG22 ' A' ' 102' ' ' ILE . 7.2 mtt85 -148.61 118.19 4.09 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.174 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -81.53 33.85 0.54 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.43 2.086 . . . . 0.0 112.784 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 178.87 69.35 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.894 0.378 . . . . 0.0 110.42 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -61.51 -98.79 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.735 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.54 170.27 21.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.866 0.365 . . . . 0.0 110.976 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 60.85 -83.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.114 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -161.35 31.22 0.14 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.824 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.552 ' O ' HG23 ' A' ' 113' ' ' VAL . 2.6 mmp_? -118.25 94.26 4.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.771 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.514 ' H ' HD12 ' A' ' 111' ' ' LEU . 0.9 OUTLIER -69.9 -34.69 73.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.934 -179.93 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.494 ' HB3' HD13 ' A' ' 136' ' ' LEU . 12.1 m-85 -86.56 81.76 8.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.893 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 110' ' ' ARG . 23.6 t -134.06 120.45 35.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.153 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.427 ' CD1' ' HG ' ' A' ' 136' ' ' LEU . 38.7 p90 -106.79 120.45 42.05 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.687 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 31.4 t -92.64 131.39 37.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.227 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.813 HD12 HD12 ' A' ' 100' ' ' ILE . 6.3 mm -92.99 162.84 2.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.684 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.435 ' N ' HG22 ' A' ' 116' ' ' ILE . 2.3 m -150.0 -179.55 7.25 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.027 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 31.1 mtp -155.67 96.59 2.38 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.87 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.408 ' HD3' ' HB2' ' A' ' 99' ' ' GLN . 40.1 Cg_endo -67.3 -27.01 41.14 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.443 2.095 . . . . 0.0 112.297 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.2 p -94.65 43.57 1.1 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.793 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 44.2 t -154.61 -68.51 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.984 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.465 ' HB3' ' CD1' ' A' ' 124' ' ' TRP . . . 179.57 -155.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.225 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 -83.88 49.96 1.73 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.803 0.335 . . . . 0.0 110.977 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . 0.465 ' CD1' ' HB3' ' A' ' 122' ' ' ALA . 12.4 m0 -83.73 122.88 29.24 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.876 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -142.29 96.11 2.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.671 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.484 HD23 ' H ' ' A' ' 126' ' ' LEU . 0.6 OUTLIER -98.58 161.6 13.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.03 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -117.04 142.32 47.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.03 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.542 HG12 HD12 ' A' ' 7' ' ' LEU . 15.6 t -148.38 141.58 18.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.939 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -146.43 134.33 21.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.307 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.409 ' HB2' HD11 ' A' ' 7' ' ' LEU . . . -99.81 138.52 36.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.912 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -52.88 -34.67 55.78 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.036 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 9.2 t -102.1 115.94 31.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.844 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.433 ' HG3' ' CE2' ' A' ' 112' ' ' PHE . 0.3 OUTLIER -48.47 -28.0 3.03 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.386 179.424 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -73.31 -39.89 64.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.206 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.32 -32.79 72.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.027 179.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.494 HD13 ' HB3' ' A' ' 112' ' ' PHE . 6.2 tt -66.35 -46.4 76.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.48 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.45 ' O ' HG12 ' A' ' 140' ' ' VAL . 12.8 mm-40 -70.11 -39.2 75.65 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.293 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -68.68 -31.2 70.14 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.325 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' TRP . . . . . 0.59 ' CZ2' HD23 ' A' ' 7' ' ' LEU . 1.1 m95 -68.77 -46.72 68.01 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.656 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 1.031 HG23 HG21 ' A' ' 100' ' ' ILE . 0.3 OUTLIER -60.88 -40.43 85.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.753 179.888 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 15.7 mtmt -68.18 -37.38 80.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.742 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 10.5 mttt -67.61 -51.82 45.67 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.295 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.551 HG21 HD11 ' A' ' 100' ' ' ILE . 85.8 mt -54.22 -35.13 28.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.308 0.575 . . . . 0.0 109.579 178.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 34.1 mtt180 -79.17 -27.45 42.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.595 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.522 ' O ' HG22 ' A' ' 149' ' ' THR . 1.2 tm-20 -77.35 -34.04 55.23 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.867 0.365 . . . . 0.0 110.767 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.772 HG13 HG21 ' A' ' 95' ' ' VAL . 9.6 p -81.97 -29.46 9.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.372 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -81.0 -34.77 32.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.493 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -79.27 -11.15 59.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.965 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.532 HG22 ' HA ' ' A' ' 146' ' ' VAL . 15.2 t -107.38 -21.5 12.91 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.078 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.215 -0.897 . . . . 0.0 111.14 179.945 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 78.0 p . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 120.845 0.355 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.766 HD11 ' HA ' ' A' ' 26' ' ' SER . 19.6 mt -78.27 -34.94 19.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.145 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.31 140.57 4.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.049 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 33.1 p-10 -146.47 141.91 27.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.819 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -163.4 -171.14 29.26 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.467 -0.873 . . . . 0.0 112.611 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.8 mm -98.24 80.1 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.777 0.322 . . . . 0.0 111.031 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.754 HD23 ' CZ2' ' A' ' 139' ' ' TRP . 1.7 mm? -88.59 134.72 33.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.663 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.455 ' O ' HG12 ' A' ' 128' ' ' VAL . 28.1 m-85 -73.11 165.56 24.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.242 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -160.01 114.44 2.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.669 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.43 ' HG2' ' CZ3' ' A' ' 17' ' ' TRP . 3.6 pt-20 -73.43 90.49 1.7 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.17 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -60.73 113.33 7.38 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.62 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.66 -18.68 16.27 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.66 2.24 . . . . 0.0 112.916 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.4 t -68.44 -41.11 83.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.897 0.38 . . . . 0.0 111.269 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 -113.92 -13.34 12.56 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.231 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 68.4 m80 61.99 50.91 3.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.862 0.363 . . . . 0.0 110.854 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -152.94 151.7 30.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.792 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.43 ' CZ3' ' HG2' ' A' ' 10' ' ' GLU . 67.1 m95 -80.42 125.1 29.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.931 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -119.85 142.33 32.96 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.813 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -68.6 101.03 0.72 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.46 2.106 . . . . 0.0 112.176 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 35.2 m170 -119.16 138.05 53.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.847 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -82.67 140.0 33.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.865 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.487 ' CZ ' ' CD2' ' A' ' 31' ' ' TYR . 0.2 OUTLIER -133.55 124.78 27.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.914 179.854 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.5 t -111.89 103.31 15.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.829 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.9 tp -82.69 109.37 16.8 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.018 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.512 ' HG1' ' C ' ' A' ' 28' ' ' LYS . 43.2 p -99.1 155.94 17.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.794 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.766 ' HA ' HD11 ' A' ' 2' ' ' ILE . 1.5 m -65.0 -12.13 46.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.898 -179.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.8 m -121.22 2.78 10.37 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.559 ' HA ' HG23 ' A' ' 95' ' ' VAL . 0.5 OUTLIER 173.28 -170.91 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.97 0.414 . . . . 0.0 111.316 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.4 mt -136.74 119.91 21.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.838 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -103.03 153.08 20.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.029 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.487 ' CD2' ' CZ ' ' A' ' 22' ' ' PHE . 25.3 p90 -167.17 148.25 5.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.953 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.931 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.43 ' HA3' ' CE1' ' A' ' 31' ' ' TYR . . . . . . . . 0 N--CA 1.45 -0.414 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.6 m -97.87 156.8 3.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.87 0.367 . . . . 0.0 111.062 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.414 ' HA ' HD12 ' A' ' 93' ' ' LEU . 9.9 tp -151.05 129.77 12.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.027 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.39 138.93 49.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.816 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.819 ' CG1' HG13 ' A' ' 146' ' ' VAL . 18.7 t -79.66 -47.87 1.46 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.752 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.469 ' HD3' ' HB ' ' A' ' 95' ' ' VAL . 94.3 Cg_endo -79.07 55.33 5.56 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.232 1.955 . . . . 0.0 112.499 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.449 ' HB2' ' O ' ' A' ' 96' ' ' PRO . . . 175.53 39.53 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.034 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -156.82 104.15 2.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.943 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -89.76 131.32 35.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.765 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.939 HD11 HG21 ' A' ' 143' ' ' ILE . 11.5 mm -82.28 160.93 3.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.147 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.451 ' N ' HG22 ' A' ' 100' ' ' ILE . . . -154.93 93.95 1.6 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.959 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 46.3 mt -58.48 151.25 4.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.089 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.43 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 10.3 mtt180 -140.72 114.26 7.21 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.617 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 103' ' ' ARG . 5.9 Cg_exo -74.11 11.54 1.18 Allowed 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.681 2.254 . . . . 0.0 112.942 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.74 65.39 0.6 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.925 0.393 . . . . 0.0 110.423 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -48.87 -90.24 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.935 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -171.74 171.61 5.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.89 0.376 . . . . 0.0 111.127 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 60.69 -83.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.233 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -155.07 32.13 0.39 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.069 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 15.1 mtt-85 -122.05 109.97 15.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.806 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.501 HD23 ' H ' ' A' ' 111' ' ' LEU . 0.6 OUTLIER -96.51 23.48 6.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.124 -179.88 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -143.99 68.65 1.27 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.921 0.391 . . . . 0.0 110.764 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.937 HG22 ' HB2' ' A' ' 129' ' ' ALA . 39.5 t -130.02 140.96 47.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.047 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.592 ' CZ ' HG23 ' A' ' 128' ' ' VAL . 25.1 p90 -117.64 132.71 56.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.589 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.4 m -110.58 137.23 48.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.093 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.829 HG23 HD13 ' A' ' 100' ' ' ILE . 2.9 mp -99.89 159.08 3.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.85 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.449 ' N ' HG22 ' A' ' 116' ' ' ILE . 20.1 m -147.87 159.65 43.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.901 0.382 . . . . 0.0 110.953 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 12.9 mtp -113.05 155.33 44.43 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.889 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.96 74.35 0.33 Allowed 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.541 2.161 . . . . 0.0 112.228 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 13.3 p 58.87 107.65 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.985 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.5 t -140.4 -66.66 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.101 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.602 ' HB3' ' NE1' ' A' ' 124' ' ' TRP . . . -169.39 44.77 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.162 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 61.27 37.5 17.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.983 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . 0.602 ' NE1' ' HB3' ' A' ' 122' ' ' ALA . 24.1 m95 -90.2 115.01 27.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.871 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -129.29 118.12 21.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.887 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -84.65 151.15 24.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.917 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -138.33 117.95 13.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.81 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.661 ' HB ' HD12 ' A' ' 7' ' ' LEU . 2.3 m -144.94 154.42 14.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.201 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.937 ' HB2' HG22 ' A' ' 113' ' ' VAL . . . -148.74 122.33 9.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.146 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -90.13 130.96 36.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.991 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.07 -35.94 65.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.922 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.1 m -90.9 111.21 22.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.828 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.84 -28.45 3.74 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.525 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.93 -40.36 60.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.383 179.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -68.06 -33.1 73.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.223 179.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.459 ' O ' HG23 ' A' ' 140' ' ' VAL . 5.2 tt -67.53 -47.91 68.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.449 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -68.21 -40.9 82.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.297 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -66.62 -30.35 70.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.216 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' TRP . . . . . 0.754 ' CZ2' HD23 ' A' ' 7' ' ' LEU . 1.0 OUTLIER -66.31 -50.21 64.43 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.535 179.64 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.601 HG12 ' HD2' ' A' ' 144' ' ' ARG . 38.4 t -61.63 -38.17 79.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.051 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -68.29 -38.83 82.06 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.047 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 3.3 mttt -67.11 -52.76 37.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.302 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.939 HG21 HD11 ' A' ' 100' ' ' ILE . 74.1 mt -54.71 -33.79 28.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.601 ' HD2' HG12 ' A' ' 140' ' ' VAL . 0.1 OUTLIER -78.43 -28.44 46.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.547 179.093 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.619 ' O ' HG22 ' A' ' 149' ' ' THR . 47.4 tt0 -75.26 -39.51 59.72 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.857 0.36 . . . . 0.0 110.579 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.819 HG13 ' CG1' ' A' ' 95' ' ' VAL . 7.8 p -77.54 -27.81 15.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.147 179.181 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -74.5 -39.04 62.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.621 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -72.53 -16.84 61.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.918 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.619 HG22 ' O ' ' A' ' 145' ' ' GLU . 11.8 t -112.79 18.53 18.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.794 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.225 -0.893 . . . . 0.0 111.113 179.945 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 120.862 0.363 . . . . 0.0 111.273 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.758 HD11 ' HA ' ' A' ' 26' ' ' SER . 39.2 mt -74.19 -37.61 46.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.032 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.519 ' HZ2' ' HB3' ' A' ' 3' ' ' LYS . 0.1 OUTLIER -156.12 145.09 20.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.965 -179.828 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.578 ' HB3' HG13 ' A' ' 23' ' ' VAL . 2.6 p-10 -161.92 135.02 6.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.834 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -161.59 -163.86 15.35 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.501 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.691 HD13 ' HD1' ' A' ' 21' ' ' TYR . 25.2 mm -99.66 73.49 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.938 0.399 . . . . 0.0 111.083 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.832 HD12 HG12 ' A' ' 128' ' ' VAL . 0.9 OUTLIER -79.75 150.11 30.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.734 179.957 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.659 ' C ' HD22 ' A' ' 9' ' ' LEU . 23.1 m-85 -87.49 138.4 31.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.977 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.659 HD22 ' C ' ' A' ' 8' ' ' TYR . 4.4 mm? -126.74 175.03 8.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.845 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.447 ' HG3' ' CZ3' ' A' ' 17' ' ' TRP . 18.0 mt-10 -118.33 107.85 14.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.095 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.27 146.63 62.73 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.492 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.23 -17.33 19.14 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.486 2.124 . . . . 0.0 112.735 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.3 t -69.12 -43.76 81.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.0 0.428 . . . . 0.0 111.187 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -112.42 -18.47 12.45 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.192 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 20.6 m170 62.16 29.25 17.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.809 0.338 . . . . 0.0 110.862 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -130.76 176.17 8.43 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.699 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.579 ' HH2' HG11 ' A' ' 113' ' ' VAL . 21.7 m95 -61.79 137.92 58.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.693 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -139.45 141.69 29.56 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.858 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.72 126.41 10.13 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.542 2.161 . . . . 0.0 112.252 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -152.45 167.81 27.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.93 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.691 ' HD1' HD13 ' A' ' 6' ' ' ILE . 7.2 t80 -108.29 115.23 29.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.974 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.446 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 2.2 m-85 -108.54 141.46 40.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.922 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.578 HG13 ' HB3' ' A' ' 4' ' ' ASN . 25.8 t -126.63 148.8 31.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.174 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.646 HD22 HG23 ' A' ' 29' ' ' ILE . 1.5 tm? -128.04 110.84 12.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.873 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.1 p -98.76 155.37 17.39 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.006 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.758 ' HA ' HD11 ' A' ' 2' ' ' ILE . 56.4 p -60.58 -16.41 37.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.079 -179.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -133.94 24.27 3.92 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.422 ' CD ' HG21 ' A' ' 92' ' ' VAL . 0.3 OUTLIER 171.67 -176.36 0.05 OUTLIER 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 121.077 0.465 . . . . 0.0 111.684 179.604 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.646 HG23 HD22 ' A' ' 24' ' ' LEU . 1.5 mt -144.79 127.03 9.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.639 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -104.07 142.02 35.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.859 0.361 . . . . 0.0 111.037 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.446 ' HB2' ' CZ ' ' A' ' 22' ' ' PHE . 3.6 p90 -156.66 100.97 1.96 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.942 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.7 t . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.986 179.889 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.273 0 N-CA-C 112.528 -0.229 . . . . 0.0 112.528 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.422 HG21 ' CD ' ' A' ' 28' ' ' LYS . 12.2 p -107.45 152.83 8.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.803 0.335 . . . . 0.0 111.158 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.499 HD23 ' N ' ' A' ' 94' ' ' ASP . 1.4 tt -139.96 129.58 24.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.943 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.499 ' N ' HD23 ' A' ' 93' ' ' LEU . 0.6 OUTLIER -68.93 141.65 54.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.829 179.94 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.723 ' CG2' HG13 ' A' ' 146' ' ' VAL . 11.7 p -81.98 -29.08 0.48 Allowed Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.646 ' CD ' ' N ' ' A' ' 95' ' ' VAL . 98.6 Cg_endo -86.18 47.15 1.74 Allowed 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.149 1.899 . . . . 0.0 112.642 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -177.95 37.85 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.006 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 1.3 m -131.67 120.13 22.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.966 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.15 109.09 20.92 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.736 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.987 HD11 HG21 ' A' ' 143' ' ' ILE . 14.2 mm -75.35 157.66 5.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.079 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.414 ' N ' HG22 ' A' ' 100' ' ' ILE . . . -153.87 87.6 1.22 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.987 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 52.9 mt -58.58 146.22 8.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.193 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.83 104.82 5.77 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.618 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -73.65 52.95 2.61 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.36 2.04 . . . . 0.0 112.424 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.425 ' HG3' HD22 ' A' ' 111' ' ' LEU . 2.6 mt-10 168.0 56.65 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.408 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.418 ' O ' ' HG3' ' A' ' 107' ' ' LYS . . . -65.85 -102.6 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.768 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.418 ' HG3' ' O ' ' A' ' 106' ' ' GLY . 0.0 OUTLIER -154.35 -177.0 6.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.993 0.425 . . . . 0.0 111.191 -179.795 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.447 ' HB2' ' NE1' ' A' ' 17' ' ' TRP . 1.3 m-80 47.9 41.65 14.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.611 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 61.84 31.3 18.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.337 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 -118.31 106.3 12.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.517 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.425 HD22 ' HG3' ' A' ' 105' ' ' GLU . 3.3 mt -96.54 30.28 2.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.108 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.511 ' O ' HD13 ' A' ' 136' ' ' LEU . 39.4 m-85 -145.82 61.72 1.26 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.528 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.7 HG22 ' HB2' ' A' ' 129' ' ' ALA . 38.7 t -125.32 126.37 70.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.009 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.444 ' CZ ' ' HB ' ' A' ' 128' ' ' VAL . 35.8 p90 -103.63 131.53 50.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.578 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 13.0 t -105.45 127.08 52.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.105 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.956 HG23 HD13 ' A' ' 100' ' ' ILE . 12.8 mt -94.97 158.16 2.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.499 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 2.5 m -154.62 132.17 11.31 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.803 0.335 . . . . 0.0 111.146 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . 0.44 ' SD ' HD21 ' A' ' 93' ' ' LEU . 77.1 mtp -92.17 115.56 64.9 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.85 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -79.68 53.67 4.84 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.485 2.124 . . . . 0.0 112.519 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 30.5 t 177.59 39.95 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.634 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 45.6 t -145.66 -69.96 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.088 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -179.26 -155.13 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.416 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -83.78 49.27 1.58 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.738 0.304 . . . . 0.0 111.07 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 12.4 m95 -74.47 169.87 16.85 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.73 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -169.17 98.61 0.36 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.955 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.649 HD23 HD12 ' A' ' 116' ' ' ILE . 1.6 tp -83.97 95.73 8.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.075 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.5 130.56 35.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.96 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.832 HG12 HD12 ' A' ' 7' ' ' LEU . 21.7 t -152.25 159.03 4.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.147 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.7 ' HB2' HG22 ' A' ' 113' ' ' VAL . . . -164.81 131.05 2.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.241 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -97.55 141.52 30.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.981 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -55.66 -34.36 64.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.952 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.0 m -94.23 114.49 26.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.816 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.436 ' HG2' ' CZ ' ' A' ' 112' ' ' PHE . 1.1 mp0 -49.67 -27.16 4.37 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.431 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -74.77 -45.45 43.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.424 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -64.6 -31.38 72.58 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.202 179.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.525 ' O ' HG23 ' A' ' 140' ' ' VAL . 1.4 tp -68.05 -50.07 57.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.445 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.506 ' OE1' HD23 ' A' ' 136' ' ' LEU . 4.1 mp0 -68.17 -36.94 80.42 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.332 179.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -69.19 -34.4 74.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.163 179.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' TRP . . . . . 0.697 ' CZ2' HD23 ' A' ' 7' ' ' LEU . 1.3 m95 -63.8 -47.67 79.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.564 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.85 HG13 HG21 ' A' ' 100' ' ' ILE . 33.4 t -62.83 -44.5 99.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.801 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.1 -33.03 72.71 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.701 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.502 ' O ' HG12 ' A' ' 146' ' ' VAL . 0.2 OUTLIER -70.06 -50.89 36.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.378 179.72 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.987 HG21 HD11 ' A' ' 100' ' ' ILE . 66.8 mt -53.83 -31.27 20.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.178 0.513 . . . . 0.0 109.617 178.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 50.4 mtp85 -80.23 -32.37 38.44 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.159 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.427 ' O ' HG22 ' A' ' 149' ' ' THR . 4.9 pt-20 -77.97 -31.34 50.75 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.755 0.312 . . . . 0.0 110.895 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.723 HG13 ' CG2' ' A' ' 95' ' ' VAL . 9.8 p -83.63 -29.24 7.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.01 0.433 . . . . 0.0 110.296 179.217 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -75.3 -34.62 61.3 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.587 179.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -74.55 -11.5 60.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.952 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.443 HG22 ' HA ' ' A' ' 146' ' ' VAL . 10.5 t -117.23 13.05 14.57 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.285 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.2 -0.905 . . . . 0.0 111.204 -179.968 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.488 1.438 0 CA-C-O 120.822 0.344 . . . . 0.0 111.146 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.449 HD11 ' CB ' ' A' ' 26' ' ' SER . 15.6 mt -88.87 -32.88 5.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.051 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.599 ' O ' HG13 ' A' ' 23' ' ' VAL . 3.2 tptp -125.94 135.08 51.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.775 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 17.9 p-10 -154.52 121.8 5.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.006 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.503 ' C ' HD12 ' A' ' 6' ' ' ILE . . . -170.02 -145.68 4.8 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.485 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.653 ' N ' HD12 ' A' ' 6' ' ' ILE . 3.2 mp -127.97 88.44 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.824 0.345 . . . . 0.0 110.953 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.589 HD11 ' HB2' ' A' ' 130' ' ' ALA . 4.4 mm? -87.78 144.24 26.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.84 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -76.33 165.84 24.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.019 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -171.12 101.33 0.21 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.822 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.431 ' HG2' ' CZ3' ' A' ' 17' ' ' TRP . 0.3 OUTLIER -78.55 164.22 24.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.064 -179.875 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.4 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 2.2 t0 -126.42 132.1 24.19 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.714 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 11' ' ' ASP . 31.5 Cg_exo -58.98 -15.59 28.23 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.536 2.157 . . . . 0.0 112.917 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.1 t -68.78 -42.85 83.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.98 0.419 . . . . 0.0 111.438 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -115.41 -15.84 11.48 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.412 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 2.2 m80 62.79 42.7 7.73 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.931 0.396 . . . . 0.0 110.802 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.73 134.81 37.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.818 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.441 ' CD1' ' HG3' ' A' ' 110' ' ' ARG . 85.5 m95 -65.59 135.05 54.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.915 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.433 ' HB3' ' CD2' ' A' ' 20' ' ' HIS . 11.5 m-85 -120.31 104.59 43.04 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.939 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 18' ' ' TYR . 38.5 Cg_endo -67.05 107.84 1.41 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.48 2.12 . . . . 0.0 112.317 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.433 ' CD2' ' HB3' ' A' ' 18' ' ' TYR . 95.1 m-70 -132.25 158.08 42.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.869 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -59.85 151.38 25.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.925 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.477 ' CZ ' ' CD1' ' A' ' 31' ' ' TYR . 0.3 OUTLIER -154.9 142.9 20.13 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.806 -179.939 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.599 HG13 ' O ' ' A' ' 3' ' ' LYS . 14.3 t -139.29 145.82 26.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.158 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.495 HD12 HG12 ' A' ' 29' ' ' ILE . 27.2 tp -125.94 115.88 20.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.792 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 35.0 p -90.58 158.29 17.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.932 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.449 ' CB ' HD11 ' A' ' 2' ' ' ILE . 4.5 t -52.75 -24.0 7.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.693 -179.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.0 m -143.33 35.5 1.33 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.552 0.215 . . . . 0.0 111.435 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.528 ' CA ' HG23 ' A' ' 95' ' ' VAL . 1.2 tttt 177.73 179.21 0.3 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.891 0.377 . . . . 0.0 111.305 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.562 HD12 HD23 ' A' ' 93' ' ' LEU . 1.6 mt -141.25 130.27 24.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.715 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -124.52 133.59 53.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.078 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.477 ' CD1' ' CZ ' ' A' ' 22' ' ' PHE . 33.5 p90 -156.43 153.58 29.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.911 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 84.0 p . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.848 -179.958 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.4 0 N-CA-C 112.499 -0.241 . . . . 0.0 112.499 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 11.5 p -129.06 142.65 43.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.863 0.364 . . . . 0.0 111.07 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.562 HD23 HD12 ' A' ' 29' ' ' ILE . 3.3 tp -147.31 145.05 29.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.931 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.0 133.11 34.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.827 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.777 HG11 HG23 ' A' ' 146' ' ' VAL . 19.8 t -82.46 -45.34 0.95 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.605 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.553 ' O ' ' HB2' ' A' ' 97' ' ' ALA . 11.6 Cg_exo -71.29 55.14 1.9 Allowed 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.632 2.221 . . . . 0.0 112.457 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.553 ' HB2' ' O ' ' A' ' 96' ' ' PRO . . . 168.83 40.47 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.878 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -157.37 98.25 1.69 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.989 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -80.27 129.79 34.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.693 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.713 HD13 HG23 ' A' ' 116' ' ' ILE . 10.7 mm -84.34 157.63 3.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.151 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.424 ' N ' HG22 ' A' ' 100' ' ' ILE . . . -145.84 88.41 1.82 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.869 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.612 HD13 ' NE2' ' A' ' 137' ' ' GLN . 86.3 mt -57.79 143.4 12.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.091 0.472 . . . . 0.0 111.349 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 9.0 mtt-85 -132.45 125.64 19.79 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.069 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -82.42 24.36 0.73 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.386 2.058 . . . . 0.0 112.956 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -176.77 74.83 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.948 0.404 . . . . 0.0 110.538 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -54.45 -93.77 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.68 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.79 172.01 1.02 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.877 0.37 . . . . 0.0 111.07 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 61.8 m-80 61.8 -82.04 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.149 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -152.96 42.9 0.62 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.95 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.441 ' HG3' ' CD1' ' A' ' 17' ' ' TRP . 0.6 OUTLIER -135.48 108.64 7.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.92 179.911 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.5 mt -78.28 -33.75 49.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.823 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.756 ' HB3' HD13 ' A' ' 136' ' ' LEU . 41.1 m-85 -108.7 115.24 29.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.975 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.552 HG13 ' HB2' ' A' ' 129' ' ' ALA . 21.1 t -153.22 140.23 12.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.029 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.436 ' CE2' ' HB ' ' A' ' 128' ' ' VAL . 25.3 p90 -119.93 115.31 23.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.828 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.4 p -93.44 125.94 38.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.992 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.713 HG23 HD13 ' A' ' 100' ' ' ILE . 3.1 mp -92.01 159.99 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.918 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.49 ' N ' HG22 ' A' ' 116' ' ' ILE . 22.1 p -158.43 158.96 35.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.955 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . 0.453 ' SD ' HG11 ' A' ' 121' ' ' VAL . 32.3 mtp -110.14 155.65 41.43 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.724 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -65.54 -30.9 51.68 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.528 2.152 . . . . 0.0 112.385 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 78.9 p -178.78 129.69 0.11 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.101 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.656 HG22 ' N ' ' A' ' 122' ' ' ALA . 0.2 OUTLIER -167.18 -80.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.817 179.799 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.656 ' N ' HG22 ' A' ' 121' ' ' VAL . . . -155.53 37.33 0.37 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.172 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 61.1 44.22 10.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.857 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . 0.541 ' CD1' ' HB3' ' A' ' 122' ' ' ALA . 27.2 m95 -90.45 132.62 35.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.061 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 59.9 m -128.33 139.23 52.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.837 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.639 HD13 ' H ' ' A' ' 127' ' ' ASP . 0.2 OUTLIER -118.72 143.32 46.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.944 0.402 . . . . 0.0 111.111 -179.92 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.639 ' H ' HD13 ' A' ' 126' ' ' LEU . 62.2 m-20 -130.56 119.13 22.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.52 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.611 HG23 HD12 ' A' ' 126' ' ' LEU . 21.9 t -141.32 159.61 22.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.172 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.552 ' HB2' HG13 ' A' ' 113' ' ' VAL . . . -159.66 141.16 12.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.222 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.589 ' HB2' HD11 ' A' ' 7' ' ' LEU . . . -105.97 145.75 30.92 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.834 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -58.13 -60.94 2.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.045 0.45 . . . . 0.0 110.875 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.8 t -70.7 115.7 10.16 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.72 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.443 ' HG3' ' CE2' ' A' ' 112' ' ' PHE . 0.1 OUTLIER -48.71 -26.45 2.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.664 179.59 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -76.03 -43.37 44.31 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.474 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.79 -32.49 74.06 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.292 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.756 HD13 ' HB3' ' A' ' 112' ' ' PHE . 8.1 tt -68.57 -50.07 54.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.465 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.612 ' NE2' HD13 ' A' ' 102' ' ' ILE . 57.9 mm-40 -68.17 -36.53 79.77 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.355 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -70.44 -29.77 66.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.446 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' TRP . . . . . 0.418 ' CE2' HD21 ' A' ' 7' ' ' LEU . 0.6 OUTLIER -69.28 -46.18 67.86 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.034 0.445 . . . . 0.0 110.621 179.629 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.547 HG13 HG21 ' A' ' 100' ' ' ILE . 21.9 t -63.31 -40.99 91.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.878 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 2.3 mtpp -64.18 -37.42 87.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.781 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.576 ' O ' HG22 ' A' ' 146' ' ' VAL . 0.0 OUTLIER -65.8 -54.3 28.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.374 179.706 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.621 HG21 HD11 ' A' ' 100' ' ' ILE . 70.9 mt -52.72 -32.99 17.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.194 0.521 . . . . 0.0 109.691 178.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 25.0 mtp85 -80.01 -29.3 39.39 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.388 179.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.45 ' O ' HG22 ' A' ' 149' ' ' THR . 1.2 tt0 -74.49 -37.4 63.17 Favored 'General case' 0 N--CA 1.457 -0.106 0 CA-C-O 120.922 0.391 . . . . 0.0 110.64 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.777 HG23 HG11 ' A' ' 95' ' ' VAL . 11.7 m -80.73 -28.32 11.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.228 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -78.98 -34.35 44.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.754 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -78.47 -10.01 59.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.958 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.517 HG22 ' HA ' ' A' ' 146' ' ' VAL . 12.4 t -110.84 -29.83 7.8 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.882 0.373 . . . . 0.0 111.066 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.198 -0.906 . . . . 0.0 111.111 179.948 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.816 0.341 . . . . 0.0 111.138 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.486 HD11 ' CB ' ' A' ' 26' ' ' SER . 30.5 mt -77.95 -36.13 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.138 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.436 ' HG2' ' CD1' ' A' ' 139' ' ' TRP . 0.2 OUTLIER -138.09 102.57 4.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.005 -179.906 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.845 ' HB3' HG13 ' A' ' 23' ' ' VAL . 2.6 p-10 -131.22 124.62 30.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.77 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -166.35 -147.22 5.13 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.55 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 25.2 mm -107.98 86.07 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.735 0.302 . . . . 0.0 111.168 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.75 HD12 HG12 ' A' ' 128' ' ' VAL . 0.4 OUTLIER -88.0 163.96 16.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.833 179.891 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.707 ' C ' HD23 ' A' ' 9' ' ' LEU . 23.0 m-85 -110.61 150.41 29.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.104 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.797 HD21 ' HB2' ' A' ' 20' ' ' HIS . 0.2 OUTLIER -161.29 129.52 4.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.772 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.435 ' HB3' ' CD2' ' A' ' 17' ' ' TRP . 0.2 OUTLIER -86.69 121.51 29.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.127 -179.772 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.529 ' HB3' HG22 ' A' ' 13' ' ' VAL . 0.3 OUTLIER -88.91 146.77 37.39 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.601 179.622 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.401 ' HA ' ' CD2' ' A' ' 15' ' ' HIS . 72.9 Cg_endo -75.0 -4.52 15.53 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.487 2.125 . . . . 0.0 113.388 -179.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.529 HG22 ' HB3' ' A' ' 11' ' ' ASP . 0.2 OUTLIER -67.97 -45.52 83.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.032 0.444 . . . . 0.0 110.818 179.972 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -128.6 -2.06 5.46 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.175 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.401 ' CD2' ' HA ' ' A' ' 12' ' ' PRO . 14.6 m170 57.62 74.83 0.4 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.964 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.95 135.47 1.77 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.976 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.435 ' CD2' ' HB3' ' A' ' 10' ' ' GLU . 27.9 m95 -63.92 134.37 54.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.895 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -135.98 148.62 65.65 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.922 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.77 124.58 10.31 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.594 2.196 . . . . 0.0 112.356 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.797 ' HB2' HD21 ' A' ' 9' ' ' LEU . 0.1 OUTLIER -141.09 111.45 6.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.897 179.877 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -54.28 111.38 0.77 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.124 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.51 ' CZ ' ' CD2' ' A' ' 31' ' ' TYR . 2.8 m-30 -109.27 155.77 20.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.829 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.845 HG13 ' HB3' ' A' ' 4' ' ' ASN . 24.5 t -142.0 92.52 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.122 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.7 tp -76.03 117.91 18.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.926 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 17.1 p -97.88 154.71 17.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.984 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.486 ' CB ' HD11 ' A' ' 2' ' ' ILE . 51.7 p -52.53 -24.66 8.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.997 -179.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -140.79 37.49 1.8 Allowed 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.99 -0.284 . . . . 0.0 111.726 -179.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 172.45 171.94 0.11 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.926 0.393 . . . . 0.0 111.383 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.6 mt -134.56 116.64 22.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.55 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -96.13 141.41 29.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.316 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.51 ' CD2' ' CZ ' ' A' ' 22' ' ' PHE . 4.4 m-85 -119.33 124.29 46.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.726 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 12.3 m . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.824 179.983 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 N-CA-C 112.611 -0.196 . . . . 0.0 112.611 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 11.1 p -158.66 133.83 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.834 0.35 . . . . 0.0 111.026 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.451 HD23 ' O ' ' A' ' 94' ' ' ASP . 0.6 OUTLIER -146.31 153.49 40.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.892 -179.901 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.451 ' O ' HD23 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -83.82 137.31 33.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.903 -179.961 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.676 HG21 ' CG2' ' A' ' 146' ' ' VAL . 13.0 p -83.33 -27.99 0.42 Allowed Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.638 ' CD ' ' N ' ' A' ' 95' ' ' VAL . 89.8 Cg_endo -84.52 49.87 2.82 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.079 1.852 . . . . 0.0 112.593 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.406 ' HB2' ' O ' ' A' ' 96' ' ' PRO . . . 178.33 38.96 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.968 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -156.69 97.44 1.72 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.953 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -78.95 136.36 37.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.84 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.813 HD11 HG21 ' A' ' 143' ' ' ILE . 8.1 mm -87.52 161.21 2.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.168 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.445 ' N ' HG22 ' A' ' 100' ' ' ILE . . . -149.83 96.39 2.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.96 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 70.3 mt -61.03 149.85 7.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.079 0.466 . . . . 0.0 111.255 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.407 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 72.3 mtp180 -138.99 123.14 11.28 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.292 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 103' ' ' ARG . 6.3 Cg_exo -73.84 11.9 1.04 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.569 2.179 . . . . 0.0 113.004 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -160.37 67.82 0.35 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.103 0.478 . . . . 0.0 110.591 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.414 ' HA3' ' CG2' ' A' ' 113' ' ' VAL . . . -46.95 -88.67 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.224 0 CA-C-N 115.925 -0.579 . . . . 0.0 113.134 -179.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -174.99 162.59 3.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.849 0.357 . . . . 0.0 111.224 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 59.01 -84.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.157 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 44.7 m-20 -148.28 31.58 0.83 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.977 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.402 ' HB3' ' CG2' ' A' ' 113' ' ' VAL . 33.7 mmt180 -115.33 94.66 4.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.805 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.1 mt -67.65 -28.83 68.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.102 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -109.09 100.26 9.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.944 0.402 . . . . 0.0 111.094 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.423 HG11 ' CH2' ' A' ' 17' ' ' TRP . 42.8 t -146.47 127.27 6.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.69 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.439 ' CE2' ' HB ' ' A' ' 128' ' ' VAL . 29.6 p90 -108.65 124.31 50.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.064 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 28.0 t -94.48 129.46 41.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.672 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.791 HG23 HD13 ' A' ' 100' ' ' ILE . 11.0 mt -93.87 160.01 2.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.092 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.449 ' N ' HG22 ' A' ' 116' ' ' ILE . 0.3 OUTLIER -158.61 158.14 33.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.563 179.874 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . 0.44 ' HB2' ' CD1' ' A' ' 124' ' ' TRP . 13.4 mtp -98.02 152.72 38.19 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.748 0.309 . . . . 0.0 111.236 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -80.59 77.95 3.86 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.661 2.241 . . . . 0.0 112.6 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.686 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.9 OUTLIER 69.68 107.63 0.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.922 179.95 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.686 HG23 ' O ' ' A' ' 120' ' ' SER . 3.4 t -164.45 -76.61 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.318 0.58 . . . . 0.0 110.815 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.634 ' N ' HG12 ' A' ' 121' ' ' VAL . . . -146.65 -149.67 0.3 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.267 -0.878 . . . . 0.0 110.671 -179.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -89.36 29.94 1.05 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.747 0.308 . . . . 0.0 111.607 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . 0.449 ' CD1' ' HB ' ' A' ' 121' ' ' VAL . 1.7 p-90 -46.38 168.51 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.299 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.405 ' CB ' ' O ' ' A' ' 124' ' ' TRP . 0.9 OUTLIER 163.89 103.12 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.805 179.512 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.459 HD12 ' HA ' ' A' ' 126' ' ' LEU . 8.0 tp -116.39 157.37 25.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.99 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -142.86 139.27 30.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.896 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.75 HG12 HD12 ' A' ' 7' ' ' LEU . 22.4 t -151.74 153.5 9.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.131 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.5 ' O ' HD13 ' A' ' 7' ' ' LEU . . . -155.99 136.98 13.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.197 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -105.01 139.74 39.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.985 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -53.89 -35.85 62.05 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.903 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.5 m -93.32 111.53 23.21 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.811 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -48.35 -28.49 3.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.54 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.88 -43.34 58.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.216 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -67.12 -31.37 71.79 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.194 179.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.517 ' O ' HG23 ' A' ' 140' ' ' VAL . 6.4 tt -67.82 -46.92 70.49 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.503 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -69.0 -40.43 78.73 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.377 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.0 -29.1 68.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.286 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' TRP . . . . . 0.62 ' CZ2' HD23 ' A' ' 7' ' ' LEU . 1.1 m95 -68.52 -48.29 64.73 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.694 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.615 HG12 ' HD2' ' A' ' 144' ' ' ARG . 33.9 t -63.55 -39.86 86.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.678 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 31.2 tttt -63.79 -36.75 84.93 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.744 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.515 ' O ' HG22 ' A' ' 146' ' ' VAL . 1.2 mptp? -67.26 -52.32 42.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.273 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.813 HG21 HD11 ' A' ' 100' ' ' ILE . 69.5 mt -52.77 -33.45 18.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.16 0.505 . . . . 0.0 109.76 178.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.615 ' HD2' HG12 ' A' ' 140' ' ' VAL . 0.4 OUTLIER -79.59 -28.11 41.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.628 179.273 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.47 -38.29 55.59 Favored 'General case' 0 CA--C 1.523 -0.096 0 CA-C-O 120.856 0.36 . . . . 0.0 110.861 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.676 ' CG2' HG21 ' A' ' 95' ' ' VAL . 16.2 m -79.67 -29.28 13.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.299 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -77.83 -34.83 51.75 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.544 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -74.13 -13.78 60.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.987 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.445 HG22 ' HA ' ' A' ' 146' ' ' VAL . 10.8 t -107.51 -22.11 12.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.106 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.446 ' HB3' ' HB3' ' A' ' 96' ' ' PRO . . . . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.158 -0.925 . . . . 0.0 111.091 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.464 ' N ' HG22 ' A' ' 25' ' ' THR . 4.0 m . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.859 0.361 . . . . 0.0 111.164 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.906 HD11 ' HB3' ' A' ' 26' ' ' SER . 28.6 mt -71.77 -32.94 46.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.953 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.429 ' HD2' ' CD1' ' A' ' 139' ' ' TRP . 3.4 mttm -157.86 123.77 4.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.89 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.917 ' HB3' HG13 ' A' ' 23' ' ' VAL . 11.1 p-10 -143.99 135.04 25.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.909 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.553 ' C ' HD12 ' A' ' 6' ' ' ILE . . . -170.02 -135.47 1.91 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.434 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.642 ' N ' HD12 ' A' ' 6' ' ' ILE . 3.2 mp -127.15 83.64 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.963 0.411 . . . . 0.0 110.981 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.926 HD12 HG12 ' A' ' 128' ' ' VAL . 1.8 mm? -80.85 145.12 31.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.911 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -90.92 119.08 30.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.98 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.68 HD11 ' OH ' ' A' ' 31' ' ' TYR . 0.5 OUTLIER -126.86 144.22 51.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.95 179.903 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.434 ' HG2' ' CZ3' ' A' ' 17' ' ' TRP . 0.0 OUTLIER -87.5 122.81 31.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.895 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.406 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 1.2 t0 -93.14 126.68 50.03 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.67 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 11' ' ' ASP . 32.2 Cg_exo -58.37 -15.4 24.16 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.505 2.137 . . . . 0.0 112.869 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.0 t -68.76 -42.82 83.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.887 0.375 . . . . 0.0 111.275 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -115.82 -15.82 11.25 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.484 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 63.21 50.81 2.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.918 0.39 . . . . 0.0 110.907 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -157.31 157.25 33.82 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.89 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.434 ' CZ3' ' HG2' ' A' ' 10' ' ' GLU . 40.5 m95 -72.56 139.06 47.28 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.725 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -138.86 121.77 10.72 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.961 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.38 92.86 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.426 2.084 . . . . 0.0 112.256 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.549 ' HB2' HD21 ' A' ' 9' ' ' LEU . 43.9 m-70 -117.27 150.27 39.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.921 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -77.65 147.65 35.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.927 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.49 ' CE2' ' CD1' ' A' ' 31' ' ' TYR . 0.2 OUTLIER -154.57 133.81 12.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.765 -179.876 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.917 HG13 ' HB3' ' A' ' 4' ' ' ASN . 21.7 t -117.13 138.32 48.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.105 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 34.3 tp -118.69 104.08 10.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.879 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.464 HG22 ' N ' ' A' ' 1' ' ' SER . 0.6 OUTLIER -100.59 149.28 23.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.763 179.97 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.906 ' HB3' HD11 ' A' ' 2' ' ' ILE . 0.4 OUTLIER -63.04 -14.62 50.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.626 -179.94 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.2 t -105.89 -14.17 15.29 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.47 ' HA ' HG23 ' A' ' 95' ' ' VAL . 9.4 mttt -179.81 -173.32 0.24 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.916 0.388 . . . . 0.0 111.138 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.449 HG22 ' HE1' ' A' ' 22' ' ' PHE . 3.2 mt -129.72 130.13 66.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.436 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -106.82 142.85 35.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.016 0.436 . . . . 0.0 111.357 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.68 ' OH ' HD11 ' A' ' 9' ' ' LEU . 25.3 t80 -136.49 122.05 19.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.805 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.4 p . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.986 -179.941 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.279 0 N-CA-C 112.44 -0.264 . . . . 0.0 112.44 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.419 HG21 ' HD3' ' A' ' 28' ' ' LYS . 11.3 p -93.14 147.18 5.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.776 0.322 . . . . 0.0 111.082 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.2 mp -142.26 133.21 25.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.948 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.435 ' HA ' ' HG3' ' A' ' 28' ' ' LYS . 1.4 t0 -70.55 127.42 32.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.906 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.737 HG11 ' HB ' ' A' ' 146' ' ' VAL . 4.5 t -69.12 -45.96 29.68 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.347 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.492 ' CD ' ' N ' ' A' ' 95' ' ' VAL . 6.4 Cg_exo -73.87 56.37 3.56 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.766 2.311 . . . . 0.0 112.409 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.457 ' HB2' ' O ' ' A' ' 96' ' ' PRO . . . 175.22 38.94 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.021 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 34.2 m -148.6 108.67 4.08 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.902 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -91.45 126.25 36.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.816 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.937 HD13 HG23 ' A' ' 116' ' ' ILE . 6.4 mm -90.04 161.37 2.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.106 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.414 ' N ' HG22 ' A' ' 100' ' ' ILE . . . -152.52 88.66 1.36 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.857 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.402 HG22 ' N ' ' A' ' 103' ' ' ARG . 76.4 mt -57.02 152.54 2.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.283 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.402 ' N ' HG22 ' A' ' 102' ' ' ILE . 18.1 mtt180 -143.7 118.08 6.09 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.241 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -81.02 37.44 0.68 Allowed 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.351 2.034 . . . . 0.0 112.756 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -178.42 63.58 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.939 0.4 . . . . 0.0 110.525 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -56.37 -95.9 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.73 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.59 165.36 0.82 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.83 0.348 . . . . 0.0 111.126 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 31.6 m-20 56.12 47.14 20.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.073 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 24.6 m-20 63.17 58.26 1.46 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.088 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 6.8 mmt85 -152.25 88.73 1.39 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.782 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 69.4 mt -67.78 -33.01 73.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.02 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.682 ' HB3' HD13 ' A' ' 136' ' ' LEU . 19.0 m-85 -91.62 96.83 10.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.966 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 22.0 t -152.74 127.56 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.03 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.423 ' CZ ' ' HB ' ' A' ' 128' ' ' VAL . 43.4 p90 -114.64 138.55 50.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.785 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 20.3 m -107.63 128.38 54.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.074 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.937 HG23 HD13 ' A' ' 100' ' ' ILE . 20.0 mt -99.09 159.59 3.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.928 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.466 ' N ' HG22 ' A' ' 116' ' ' ILE . 81.1 p -152.54 158.81 43.06 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.866 0.365 . . . . 0.0 110.939 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 43.7 mtp -130.63 93.96 30.49 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.828 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.39 61.89 2.1 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.475 2.117 . . . . 0.0 112.306 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.7 m -165.16 -44.88 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.979 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.478 ' CG1' ' N ' ' A' ' 122' ' ' ALA . 2.5 p -75.57 -47.72 32.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.93 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.642 ' HB3' ' CD1' ' A' ' 124' ' ' TRP . . . 174.64 -163.32 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.742 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 24.1 mm-40 -93.6 44.92 1.14 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.886 0.374 . . . . 0.0 110.751 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . 0.642 ' CD1' ' HB3' ' A' ' 122' ' ' ALA . 13.7 m95 -98.39 130.17 45.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.901 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 8.6 t -120.47 133.99 55.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.941 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.551 HD23 HD12 ' A' ' 116' ' ' ILE . 12.2 tp -98.58 152.68 19.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.922 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -125.72 128.16 47.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.775 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.926 HG12 HD12 ' A' ' 7' ' ' LEU . 16.9 t -150.15 141.1 16.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.16 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.453 ' HB1' ' O ' ' A' ' 112' ' ' PHE . . . -143.57 121.86 12.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.167 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.441 ' HB2' HD11 ' A' ' 7' ' ' LEU . . . -82.39 142.2 32.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.883 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -54.07 -44.15 70.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.082 0.468 . . . . 0.0 110.95 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.1 p -92.63 120.4 33.02 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.718 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.401 ' HG3' ' CZ ' ' A' ' 112' ' ' PHE . 0.6 OUTLIER -49.86 -24.13 2.29 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.654 179.553 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -73.99 -48.15 32.28 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.626 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -62.76 -33.11 74.48 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.319 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.682 HD13 ' HB3' ' A' ' 112' ' ' PHE . 8.8 tt -66.92 -49.3 65.96 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.634 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -69.67 -36.44 76.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.416 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -70.98 -29.26 65.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.378 179.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' TRP . . . . . 0.541 ' CZ2' HD23 ' A' ' 7' ' ' LEU . 1.5 m95 -70.49 -46.05 64.46 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.742 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.616 HG13 HG21 ' A' ' 100' ' ' ILE . 26.2 t -64.55 -38.66 83.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.864 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.69 -38.04 88.13 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.835 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.419 ' O ' HG23 ' A' ' 146' ' ' VAL . 0.1 OUTLIER -66.0 -49.18 68.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.364 179.71 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.837 HG21 HD11 ' A' ' 100' ' ' ILE . 30.5 mt -54.1 -38.52 38.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.275 0.56 . . . . 0.0 109.573 178.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 14.7 mtt180 -77.95 -27.8 49.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.395 179.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.833 ' O ' HG23 ' A' ' 149' ' ' THR . 6.2 tt0 -73.34 -35.65 66.06 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.584 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.737 ' HB ' HG11 ' A' ' 95' ' ' VAL . 46.6 t -78.01 -34.02 18.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.034 179.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.71 -38.47 73.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.506 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -64.86 -20.34 66.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.611 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.833 HG23 ' O ' ' A' ' 145' ' ' GLU . 5.1 p -101.12 -33.48 10.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.118 0.485 . . . . 0.0 110.499 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.195 -0.907 . . . . 0.0 111.283 -179.953 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.5 m . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.845 0.355 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.41 ' CD1' ' HA ' ' A' ' 26' ' ' SER . 41.7 mt -84.34 -33.98 9.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.197 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.412 ' HB2' ' HB3' ' A' ' 24' ' ' LEU . 2.9 mmtt -134.38 139.36 45.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.02 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.759 ' OD1' HG22 ' A' ' 23' ' ' VAL . 7.0 m-80 -149.79 125.54 10.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.803 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -169.99 178.62 42.76 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.476 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.601 HD13 ' HD1' ' A' ' 21' ' ' TYR . 23.1 mm -94.02 90.02 2.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.882 0.372 . . . . 0.0 111.034 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.875 HD12 HG12 ' A' ' 128' ' ' VAL . 3.4 mm? -92.04 139.67 30.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.929 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -79.86 164.84 23.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.97 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.3 tt -171.86 134.38 0.78 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.932 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.441 ' HG3' ' CZ3' ' A' ' 17' ' ' TRP . 14.6 mt-10 -65.31 90.54 0.1 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.962 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.72 138.36 96.86 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.679 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.56 -8.66 22.91 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.447 2.098 . . . . 0.0 112.552 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.437 HG12 ' ND2' ' A' ' 14' ' ' ASN . 21.4 t -67.43 -42.4 87.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.992 0.425 . . . . 0.0 110.998 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.437 ' ND2' HG12 ' A' ' 13' ' ' VAL . 5.4 m-80 -132.1 4.54 4.1 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.555 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 8.5 t-160 52.66 59.49 4.45 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.915 0.388 . . . . 0.0 111.147 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -158.68 159.59 35.48 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.884 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.441 ' CZ3' ' HG3' ' A' ' 10' ' ' GLU . 46.4 m95 -57.6 129.86 43.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.923 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -134.67 124.64 17.0 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.836 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.13 88.54 0.82 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.377 2.052 . . . . 0.0 112.318 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -111.75 151.89 28.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.839 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.601 ' HD1' HD13 ' A' ' 6' ' ' ILE . 5.1 t80 -60.05 155.74 16.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.898 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.406 ' HB3' ' CH2' ' A' ' 139' ' ' TRP . 0.1 OUTLIER -154.14 138.29 16.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.775 -179.892 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.759 HG22 ' OD1' ' A' ' 4' ' ' ASN . 6.3 t -127.77 153.86 37.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.37 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.533 HD13 ' N ' ' A' ' 25' ' ' THR . 0.8 OUTLIER -133.5 119.37 19.46 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.923 -179.939 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.533 ' N ' HD13 ' A' ' 24' ' ' LEU . 11.0 p -103.26 157.51 16.96 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.94 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.41 ' HA ' ' CD1' ' A' ' 2' ' ' ILE . 4.1 t -39.94 -32.45 0.16 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.246 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 58.6 m -152.09 48.27 0.77 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.657 0.265 . . . . 0.0 111.467 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.1 mtmm -175.5 156.54 1.97 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.989 0.423 . . . . 0.0 111.252 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.7 mt -124.34 123.7 66.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.707 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.546 ' HE2' HD13 ' A' ' 89' ' ' LEU . 41.6 m-85 -115.5 154.0 30.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.025 0.44 . . . . 0.0 111.255 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 21.6 p90 -158.99 148.9 19.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.713 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 84.2 p -150.69 176.45 11.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.033 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.41 -16.45 25.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.172 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 68.49 96.77 0.06 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.866 0.365 . . . . 0.0 110.882 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.47 HG22 ' H ' ' A' ' 36' ' ' SER . 0.2 OUTLIER -71.08 -174.76 1.02 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.938 -179.962 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.47 ' H ' HG22 ' A' ' 35' ' ' THR . 2.9 p -98.2 39.92 1.21 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.888 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.0 t -102.9 118.11 36.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.937 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -161.28 80.51 0.6 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.914 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 59.27 31.97 21.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.825 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -86.76 59.07 4.6 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.487 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -133.29 42.62 3.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.889 0.376 . . . . 0.0 110.886 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -139.03 40.58 2.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.969 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -154.12 85.8 1.16 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.907 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -103.25 135.32 45.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.921 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.19 101.91 9.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.838 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -144.54 159.12 52.41 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.939 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.96 63.16 1.91 Allowed 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.512 2.142 . . . . 0.0 112.325 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 63.54 137.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.994 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -84.05 163.39 19.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.834 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -144.0 125.16 14.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.142 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.8 m -101.48 146.09 28.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.991 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.81 -168.37 33.62 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.53 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.8 m -98.68 32.67 2.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.735 0.302 . . . . 0.0 110.889 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.3 t -151.08 121.84 7.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.906 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.462 ' O ' HD12 ' A' ' 56' ' ' LEU . 0.7 OUTLIER -161.88 179.52 7.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.851 179.968 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.462 HD12 ' O ' ' A' ' 55' ' ' GLU . 10.1 mp -124.6 166.03 16.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.945 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -176.07 90.24 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.824 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.3 m -99.77 -178.3 3.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.93 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.411 ' O ' ' CB ' ' A' ' 60' ' ' LEU . 2.5 p -150.09 166.98 28.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.758 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.411 ' CB ' ' O ' ' A' ' 59' ' ' SER . 0.2 OUTLIER 80.67 -10.58 1.23 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.573 -179.889 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.67 -28.32 21.89 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.935 0.397 . . . . 0.0 110.419 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.2 t -70.17 -36.51 68.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.733 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.53 -15.6 63.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.934 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -89.73 21.58 3.46 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.261 0.553 . . . . 0.0 110.561 179.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -151.43 26.47 0.68 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.493 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -114.74 -75.01 0.62 Allowed Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.377 -0.828 . . . . 0.0 112.181 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -62.61 84.22 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.656 2.237 . . . . 0.0 112.26 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 59.56 80.49 0.27 Allowed Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.962 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -80.26 7.7 4.56 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 123.163 2.575 . . . . 0.0 112.794 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -96.5 30.18 2.66 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.794 0.33 . . . . 0.0 111.279 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.472 HG22 ' O ' ' A' ' 71' ' ' ILE . 17.4 mt -104.75 -12.33 9.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.697 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.441 HD23 ' HA ' ' A' ' 72' ' ' LEU . 14.2 mt -90.15 20.69 4.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.138 0.494 . . . . 0.0 111.471 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -150.31 66.86 7.99 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.449 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -68.69 59.56 1.15 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.858 2.372 . . . . 0.0 112.356 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -107.31 -41.79 5.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.013 0.435 . . . . 0.0 110.884 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.818 ' HD3' HD22 ' A' ' 79' ' ' LEU . 13.0 mtt85 -156.78 139.4 15.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.764 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.666 ' O ' HD12 ' A' ' 79' ' ' LEU . 13.6 pt-20 -124.16 131.76 53.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.921 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 62.52 38.29 12.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.891 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.818 HD22 ' HD3' ' A' ' 76' ' ' ARG . 0.5 OUTLIER -126.94 -178.25 4.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.858 179.996 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.91 72.33 0.24 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.873 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -93.43 116.34 28.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.998 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 59.46 40.02 21.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.864 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.407 ' N ' ' CD ' ' A' ' 84' ' ' PRO . 0.3 OUTLIER -76.43 -55.28 1.7 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.926 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.407 ' CD ' ' N ' ' A' ' 83' ' ' SER . 85.9 Cg_endo -83.02 50.94 3.51 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 123.148 2.565 . . . . 0.0 112.402 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 85' ' ' LEU . 5.6 mt -164.57 -44.04 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.895 0.378 . . . . 0.0 110.908 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -111.92 40.45 2.53 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.594 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -165.77 -44.81 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.937 0.398 . . . . 0.0 110.873 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 8.8 mp 56.12 89.17 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.925 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.584 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.6 OUTLIER -67.79 132.65 47.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.044 -179.959 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -95.52 -36.4 11.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.771 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -138.7 147.75 19.45 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.42 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 11.4 p -144.23 151.82 15.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.78 0.324 . . . . 0.0 111.115 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.521 HD23 ' N ' ' A' ' 94' ' ' ASP . 0.6 OUTLIER -156.04 170.89 21.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.891 -179.991 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.521 ' N ' HD23 ' A' ' 93' ' ' LEU . 64.0 m-20 -100.59 118.56 37.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.976 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.694 HG23 HG23 ' A' ' 143' ' ' ILE . 12.6 p -83.31 -27.6 0.42 Allowed Pre-proline 0 CA--C 1.535 0.403 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.659 ' CD ' ' N ' ' A' ' 95' ' ' VAL . 95.2 Cg_endo -85.51 49.77 2.51 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.153 1.902 . . . . 0.0 112.539 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -179.43 38.13 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.977 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 31.1 p -137.31 173.94 11.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.961 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 50.0 tp60 -137.84 113.5 9.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.703 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.914 HD13 HG23 ' A' ' 116' ' ' ILE . 14.6 mm -79.13 159.68 4.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.035 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.476 ' N ' HG22 ' A' ' 100' ' ' ILE . . . -151.68 92.5 1.76 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.969 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 50.1 mt -58.24 138.54 19.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.022 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -127.31 107.95 21.35 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.715 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -77.69 22.85 0.58 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.783 2.322 . . . . 0.0 112.631 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -173.38 64.86 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.961 0.41 . . . . 0.0 110.483 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -56.79 -95.84 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.721 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.85 156.04 0.6 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.855 0.36 . . . . 0.0 111.045 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 66.2 m-80 58.43 57.4 3.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.113 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 59.06 58.49 3.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.088 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -152.59 90.14 1.46 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.723 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.456 HD12 ' CZ ' ' A' ' 112' ' ' PHE . 0.3 OUTLIER -81.41 -27.97 34.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.184 -179.84 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.738 ' HB3' HD13 ' A' ' 136' ' ' LEU . 36.3 m-85 -101.31 95.59 6.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.001 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.492 HG22 ' HB2' ' A' ' 129' ' ' ALA . 21.4 t -153.6 120.9 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.039 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.451 ' CZ ' ' HB ' ' A' ' 128' ' ' VAL . 42.1 p90 -105.3 122.17 45.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.805 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 22.9 t -92.95 131.44 37.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.12 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.914 HG23 HD13 ' A' ' 100' ' ' ILE . 16.6 mt -97.62 160.72 2.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.828 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.463 ' N ' HG22 ' A' ' 116' ' ' ILE . 99.2 p -173.29 128.66 0.45 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.094 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.38 127.56 32.66 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.721 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -84.37 48.15 2.38 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.733 2.289 . . . . 0.0 112.708 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.8 m 177.8 39.25 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.935 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.587 ' O ' ' HB2' ' A' ' 122' ' ' ALA . 2.5 p -131.72 -49.61 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.086 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.587 ' HB2' ' O ' ' A' ' 121' ' ' VAL . . . 165.3 40.16 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.195 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 7.0 mm100 51.19 32.16 7.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.148 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . 0.43 ' CD1' ' HB3' ' A' ' 122' ' ' ALA . 23.0 m95 -69.75 171.59 8.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.895 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 75.3 p -158.23 110.75 2.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.912 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 5.3 tp -100.02 162.01 13.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.881 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -140.26 130.93 25.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.936 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.875 HG12 HD12 ' A' ' 7' ' ' LEU . 39.1 t -144.32 147.02 19.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.922 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.492 ' HB2' HG22 ' A' ' 113' ' ' VAL . . . -139.64 133.88 31.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.244 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.554 ' H ' HD12 ' A' ' 136' ' ' LEU . . . -102.85 135.0 45.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.851 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.76 -47.93 59.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.321 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -87.61 117.4 26.39 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.897 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.452 ' HG2' ' CE2' ' A' ' 112' ' ' PHE . 1.3 mt-30 -47.92 -27.96 2.44 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.342 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.66 -42.54 51.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.523 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -64.54 -34.04 77.31 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.055 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.738 HD13 ' HB3' ' A' ' 112' ' ' PHE . 8.9 tt -66.83 -52.24 46.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.543 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -67.03 -36.9 83.12 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.313 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -69.72 -31.53 69.58 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.483 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' TRP . . . . . 0.409 ' CZ2' HD23 ' A' ' 7' ' ' LEU . 0.4 OUTLIER -67.68 -44.8 76.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.489 179.592 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.649 HG13 HG21 ' A' ' 100' ' ' ILE . 23.8 t -61.48 -45.21 99.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.723 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 8.3 ttmt -60.94 -36.22 78.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.633 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.514 ' O ' HG22 ' A' ' 146' ' ' VAL . 0.0 OUTLIER -65.99 -50.03 65.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.347 179.787 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.728 HG21 HD11 ' A' ' 100' ' ' ILE . 69.0 mt -52.79 -36.88 24.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.246 0.546 . . . . 0.0 109.641 178.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 28.6 mtp85 -78.69 -27.65 45.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.509 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.503 ' O ' HG22 ' A' ' 149' ' ' THR . 1.9 tt0 -73.44 -38.38 65.52 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.645 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.514 HG22 ' O ' ' A' ' 142' ' ' LYS . 13.4 m -79.27 -30.51 14.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.272 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -76.25 -34.16 59.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.396 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -76.12 -11.0 59.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.894 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.503 HG22 ' O ' ' A' ' 145' ' ' GLU . 15.3 t -119.07 15.52 13.26 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.198 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.431 ' HB3' ' HB3' ' A' ' 96' ' ' PRO . . . . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.204 -0.903 . . . . 0.0 111.092 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 8.4 t . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.871 0.367 . . . . 0.0 111.24 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.832 HD11 ' HB3' ' A' ' 26' ' ' SER . 31.0 mt -83.53 -34.6 10.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.082 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.7 tptt -148.75 115.72 6.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.03 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.9 ' HB3' HG13 ' A' ' 23' ' ' VAL . 14.5 p-10 -137.08 137.53 39.42 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.81 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -170.03 -167.92 31.18 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.532 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 23.9 mm -94.27 96.31 5.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.799 0.333 . . . . 0.0 111.056 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.62 HD12 HG12 ' A' ' 128' ' ' VAL . 1.3 mm? -101.6 154.28 19.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.847 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.44 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 3.0 m-85 -109.92 131.22 55.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.918 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.75 HD13 ' CZ ' ' A' ' 22' ' ' PHE . 3.6 mp -125.09 -2.09 7.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.632 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.455 ' HB3' ' CD2' ' A' ' 17' ' ' TRP . 2.9 pt-20 46.5 -169.8 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.951 0.405 . . . . 0.0 111.449 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -150.5 146.27 19.55 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.531 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -75.04 -17.37 19.5 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.434 2.09 . . . . 0.0 112.577 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.4 t -73.85 -41.73 53.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.935 0.397 . . . . 0.0 111.155 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -106.32 -23.18 12.61 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.906 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 64.88 33.24 10.17 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.917 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -126.0 143.86 50.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.852 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.455 ' CD2' ' HB3' ' A' ' 10' ' ' GLU . 40.0 m95 -90.04 124.81 35.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.042 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.434 ' CE1' ' HA ' ' A' ' 10' ' ' GLU . 1.7 p90 -127.81 147.6 63.56 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.63 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -67.99 124.72 12.14 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.491 2.127 . . . . 0.0 112.452 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -125.55 165.29 18.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.664 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -98.99 110.01 22.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.884 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.75 ' CZ ' HD13 ' A' ' 9' ' ' LEU . 7.5 m-85 -123.1 132.01 53.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.842 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.9 HG13 ' HB3' ' A' ' 4' ' ' ASN . 29.8 t -121.13 134.39 64.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.92 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.628 HD12 HG12 ' A' ' 29' ' ' ILE . 24.6 tp -110.4 107.37 17.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.146 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 17.3 p -100.86 144.2 30.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.788 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.832 ' HB3' HD11 ' A' ' 2' ' ' ILE . 12.6 p -51.91 -21.47 3.01 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.827 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.412 ' O ' ' CG ' ' A' ' 28' ' ' LYS . 12.6 p -101.19 -27.58 13.14 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.745 ' HA ' HG23 ' A' ' 95' ' ' VAL . 4.5 mtmp? -162.2 -175.45 4.59 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.912 0.387 . . . . 0.0 111.341 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.628 HG12 HD12 ' A' ' 24' ' ' LEU . 3.1 mt -128.82 117.31 44.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.677 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.415 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 7.4 m-85 -89.28 138.87 31.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.157 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.457 ' HB3' ' CD2' ' A' ' 22' ' ' PHE . 5.4 p90 -162.04 102.7 1.13 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.829 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 34.9 p 178.29 85.4 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.745 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 62.71 177.93 0.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.891 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -77.11 167.03 22.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.895 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.459 HG22 ' NE2' ' A' ' 39' ' ' GLN . 0.8 OUTLIER -73.91 146.45 44.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.994 179.971 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.3 m -163.69 37.45 0.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.914 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.9 m 60.65 171.43 0.09 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.903 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.7 t70 60.44 40.55 17.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.874 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.459 ' NE2' HG22 ' A' ' 35' ' ' THR . 7.1 pt20 -128.88 31.82 4.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.914 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 68.55 29.51 72.92 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.585 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -107.67 31.43 5.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.842 0.353 . . . . 0.0 110.825 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -104.21 37.09 2.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.902 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -146.35 83.79 1.62 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.919 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -86.55 149.63 24.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.937 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.82 84.46 1.29 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.821 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -141.37 100.45 6.28 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.903 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -68.33 111.54 2.54 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.403 2.069 . . . . 0.0 112.297 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.65 51.4 0.79 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.0 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 61.34 177.45 0.11 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.967 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -128.72 -175.9 3.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.104 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.4 m -148.76 -72.48 0.19 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.875 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -91.57 161.72 27.49 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.491 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.1 p -109.79 139.65 44.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.861 0.362 . . . . 0.0 110.94 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.6 t -158.23 159.55 36.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.964 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.22 128.6 37.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.936 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.7 tp -97.78 145.15 26.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.91 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 7.3 m170 -105.49 107.61 18.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.84 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.7 t -64.27 118.39 8.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.835 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.71 109.5 21.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.879 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.6 mp -147.45 -45.85 0.17 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.944 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -57.3 -30.6 64.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.997 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.7 t -63.59 -29.72 48.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.158 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.803 ' O ' HD23 ' A' ' 63' ' ' LEU . 3.8 tt -87.48 -13.49 42.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.29 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -88.41 24.47 1.91 Allowed 'General case' 0 C--O 1.231 0.118 0 CA-C-O 121.27 0.557 . . . . 0.0 110.465 179.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 177.04 33.5 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.669 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.42 ' N ' ' CD ' ' A' ' 67' ' ' PRO . . . -166.84 50.22 0.25 Allowed Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.692 -0.686 . . . . 0.0 112.361 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.42 ' CD ' ' N ' ' A' ' 66' ' ' GLY . 43.6 Cg_endo -67.66 135.94 37.5 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.537 2.158 . . . . 0.0 112.018 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 62.91 105.69 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.595 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.2 11.04 1.89 Allowed 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.848 2.366 . . . . 0.0 113.07 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -95.21 29.92 2.34 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.802 0.334 . . . . 0.0 111.422 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.485 HG22 ' O ' ' A' ' 71' ' ' ILE . 21.1 mt -101.97 -11.78 8.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.631 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 15.6 mt -88.77 20.2 3.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.2 0.524 . . . . 0.0 111.414 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 76.8 mt-10 -156.24 83.73 3.34 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.231 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -68.87 57.24 1.08 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.85 2.367 . . . . 0.0 112.654 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.21 -76.89 0.45 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.865 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.6 mtt85 -115.15 137.61 51.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.934 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -160.63 80.32 0.65 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.854 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 60.08 79.03 0.25 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.843 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.2 mp -101.43 -170.14 1.79 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.926 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 33.5 p30 -82.65 61.15 5.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.917 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -67.74 122.53 18.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.824 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 23.9 p30 -97.22 38.43 1.25 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.126 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.468 ' CB ' ' HD2' ' A' ' 84' ' ' PRO . 0.3 OUTLIER -54.67 173.97 0.21 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.168 179.455 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.468 ' HD2' ' CB ' ' A' ' 83' ' ' SER . 52.2 Cg_endo -69.88 55.85 1.37 Allowed 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.154 1.903 . . . . 0.0 112.457 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.1 mt 51.12 23.49 1.59 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.535 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 43.38 42.93 5.86 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 121.012 -0.614 . . . . 0.0 113.049 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -99.49 -38.07 8.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.751 0.31 . . . . 0.0 111.231 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.68 -73.03 0.7 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.996 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.22 115.62 20.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.999 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.415 ' HB3' ' CZ ' ' A' ' 31' ' ' TYR . 1.7 tpt180 -120.76 -37.46 2.99 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.238 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 103.4 -23.19 33.81 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.942 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.716 HG22 ' HD2' ' A' ' 28' ' ' LYS . 15.0 p -163.74 141.58 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.758 0.313 . . . . 0.0 111.298 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -151.95 153.47 34.16 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.917 0.389 . . . . 0.0 111.05 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -71.99 133.87 45.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.956 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.745 HG23 ' HA ' ' A' ' 28' ' ' LYS . 13.6 t -75.04 -47.71 4.6 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.707 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.507 ' HD2' ' N ' ' A' ' 95' ' ' VAL . 73.7 Cg_endo -75.67 58.78 5.42 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.156 1.904 . . . . 0.0 112.495 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -176.21 36.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.974 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 27.3 p -139.12 162.43 34.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.924 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.15 108.74 6.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.859 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 1.037 HD13 HG23 ' A' ' 116' ' ' ILE . 15.1 mm -79.84 160.51 4.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.168 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.469 ' N ' HG22 ' A' ' 100' ' ' ILE . . . -161.21 92.26 0.9 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.99 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 45.5 mt -59.47 141.26 16.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.073 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -134.79 106.64 10.66 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.731 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.402 ' HA ' ' O ' ' A' ' 111' ' ' LEU . 13.0 Cg_exo -69.8 50.91 0.86 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.576 2.184 . . . . 0.0 112.409 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 173.36 53.09 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.991 0.424 . . . . 0.0 110.26 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.401 ' HA3' HG21 ' A' ' 113' ' ' VAL . . . -44.47 -87.43 0.01 OUTLIER Glycine 0 C--N 1.332 0.312 0 CA-C-N 115.986 -0.552 . . . . 0.0 113.127 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.1 mttt 178.96 169.02 0.93 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.997 0.427 . . . . 0.0 111.101 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 60.95 -82.75 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.21 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -150.55 31.85 0.65 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.908 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 1.2 mmt85 -118.0 110.5 17.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.878 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.447 HD23 ' H ' ' A' ' 111' ' ' LEU . 0.3 OUTLIER -85.62 -32.07 22.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.954 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.439 ' CE2' ' HG3' ' A' ' 133' ' ' GLN . 5.2 m-85 -105.89 87.52 2.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.87 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.723 HG13 ' HB2' ' A' ' 129' ' ' ALA . 22.0 t -132.21 143.66 39.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.104 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.435 ' CE2' ' HB ' ' A' ' 128' ' ' VAL . 19.0 p90 -125.57 133.65 52.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.928 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -105.18 141.35 36.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.831 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 1.037 HG23 HD13 ' A' ' 100' ' ' ILE . 12.5 mt -105.26 157.91 5.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.97 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.424 ' N ' HG22 ' A' ' 116' ' ' ILE . 55.8 p -150.13 -166.84 2.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.839 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 28.0 mtp -135.9 155.57 77.76 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.934 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -63.7 73.11 0.16 Allowed 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.692 2.261 . . . . 0.0 112.359 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 59.26 109.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.947 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.0 t -145.56 -66.63 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.058 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.706 ' HB3' ' NE1' ' A' ' 124' ' ' TRP . . . -176.01 73.06 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.032 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.402 ' HG2' ' O ' ' A' ' 122' ' ' ALA . 0.0 OUTLIER 40.63 36.87 0.41 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.781 -179.917 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . 0.706 ' NE1' ' HB3' ' A' ' 122' ' ' ALA . 22.6 m95 -91.89 126.25 36.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.872 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.9 t -165.65 120.37 1.24 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.903 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.493 HD23 ' H ' ' A' ' 126' ' ' LEU . 0.5 OUTLIER -101.88 166.66 10.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.877 179.943 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -115.08 142.26 46.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.936 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.62 HG12 HD12 ' A' ' 7' ' ' LEU . 17.1 t -148.56 154.01 10.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.022 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.723 ' HB2' HG13 ' A' ' 113' ' ' VAL . . . -159.84 135.08 8.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.252 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -104.71 132.25 51.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.962 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -54.49 -36.75 64.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.069 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.77 111.98 23.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.804 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.439 ' HG3' ' CE2' ' A' ' 112' ' ' PHE . 5.2 tt0 -48.31 -28.64 3.25 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.521 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.95 -40.88 53.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.279 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.53 -33.33 73.93 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.054 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.542 ' O ' HG23 ' A' ' 140' ' ' VAL . 5.2 tt -66.68 -48.52 69.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.41 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -69.26 -38.1 78.27 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.291 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -69.88 -28.76 65.9 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.282 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' TRP . . . . . 0.615 ' CZ2' HD23 ' A' ' 7' ' ' LEU . 1.3 m95 -69.64 -46.93 65.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.599 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 136' ' ' LEU . 25.4 t -63.44 -40.11 87.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.033 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 5.5 ttpp -65.59 -36.6 84.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.797 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.428 ' O ' HG23 ' A' ' 146' ' ' VAL . 0.1 OUTLIER -67.42 -50.35 59.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.464 179.849 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.491 HG21 HD11 ' A' ' 100' ' ' ILE . 54.7 mt -54.53 -35.85 33.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.311 0.577 . . . . 0.0 109.498 178.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 14.4 mtp-105 -76.97 -29.4 55.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.385 179.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.697 ' O ' HG22 ' A' ' 149' ' ' THR . 3.9 tt0 -75.87 -32.18 59.61 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-O 120.825 0.345 . . . . 0.0 110.621 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.738 ' HB ' HG11 ' A' ' 95' ' ' VAL . 59.1 t -78.82 -32.18 15.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.142 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.93 -39.68 66.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.845 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -72.47 -16.65 61.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.881 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.697 HG22 ' O ' ' A' ' 145' ' ' GLU . 11.9 t -111.62 16.81 20.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.896 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.14 -179.963 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.613 ' N ' HG22 ' A' ' 25' ' ' THR . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.829 0.347 . . . . 0.0 111.2 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.699 HD11 ' HA ' ' A' ' 26' ' ' SER . 30.1 mt -85.29 -33.18 7.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.246 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.5 tttp -160.0 141.52 12.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.944 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.921 ' ND2' HG13 ' A' ' 23' ' ' VAL . 5.7 m120 -139.53 132.81 29.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.81 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -169.97 175.53 44.01 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.51 -0.853 . . . . 0.0 112.623 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.508 HD13 ' HA ' ' A' ' 21' ' ' TYR . 22.5 mm -93.1 75.83 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.775 0.321 . . . . 0.0 111.099 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.788 HD12 HG12 ' A' ' 128' ' ' VAL . 4.0 mm? -79.05 131.5 36.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.734 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.692 ' O ' HD12 ' A' ' 9' ' ' LEU . 50.6 m-85 -81.58 155.25 25.78 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.164 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.692 HD12 ' O ' ' A' ' 8' ' ' TYR . 2.1 mp -141.46 164.85 29.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.716 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.454 ' HG2' ' CE3' ' A' ' 17' ' ' TRP . 1.4 mm-40 -111.76 111.78 23.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.908 0.385 . . . . 0.0 111.1 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.22 113.04 50.07 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.339 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.58 -17.08 8.94 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.562 2.175 . . . . 0.0 113.137 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.6 t -63.99 -39.66 86.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.018 0.437 . . . . 0.0 110.947 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 16.4 m-80 -128.19 -6.74 5.4 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.597 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 53.84 63.24 2.26 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.88 0.371 . . . . 0.0 111.036 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -148.36 160.86 42.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.892 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.454 ' CE3' ' HG2' ' A' ' 10' ' ' GLU . 70.7 m95 -81.01 136.97 36.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.929 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -137.22 129.29 16.8 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.726 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.1 138.95 31.76 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.487 2.125 . . . . 0.0 112.246 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -155.39 130.04 9.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.911 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.508 ' HA ' HD13 ' A' ' 6' ' ' ILE . 25.4 t80 -74.2 90.63 2.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.907 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.413 ' CD2' ' HB3' ' A' ' 31' ' ' TYR . 5.5 m-85 -76.84 143.73 39.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.927 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.921 HG13 ' ND2' ' A' ' 4' ' ' ASN . 22.6 t -121.54 102.75 12.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.926 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.546 HD23 ' HB ' ' A' ' 2' ' ' ILE . 1.4 tt -91.22 112.12 23.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.989 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.613 HG22 ' N ' ' A' ' 1' ' ' SER . 0.6 OUTLIER -106.64 152.04 24.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.826 179.885 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.699 ' HA ' HD11 ' A' ' 2' ' ' ILE . 7.7 t -70.11 58.57 0.16 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.714 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 178.38 -28.64 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.875 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.609 ' HE3' HG21 ' A' ' 92' ' ' VAL . 9.7 mtpt -172.89 168.82 4.92 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.831 0.348 . . . . 0.0 110.864 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 15.3 mt -107.99 128.51 63.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.012 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -121.69 118.51 29.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.868 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.413 ' HB3' ' CD2' ' A' ' 22' ' ' PHE . 37.7 p90 -123.43 146.86 47.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.944 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.7 m -163.34 151.84 13.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.934 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -59.2 114.2 2.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.81 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -150.49 130.75 13.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.987 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.496 HG22 ' H ' ' A' ' 36' ' ' SER . 0.2 OUTLIER -59.14 179.13 0.1 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.919 179.974 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.496 ' H ' HG22 ' A' ' 35' ' ' THR . 74.9 m -91.69 51.37 1.85 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.849 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 7.2 m -87.46 -169.48 2.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.959 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 60.93 86.1 0.11 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.901 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -143.89 37.79 1.31 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.954 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 116.21 -25.8 9.09 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.51 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 62.1 31.68 17.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.869 0.366 . . . . 0.0 110.898 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -101.26 35.49 2.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.952 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -146.25 123.51 11.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.906 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -138.67 172.4 12.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.879 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -164.01 130.18 3.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.809 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -59.86 141.65 89.24 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.954 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -74.12 157.14 46.74 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.56 2.173 . . . . 0.0 112.382 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.57 67.87 3.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.751 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -107.32 79.38 1.3 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.925 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -127.06 143.78 51.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.174 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.3 m -135.99 168.58 19.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.951 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 150.13 107.81 0.41 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.409 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -92.98 -31.51 14.87 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.779 0.323 . . . . 0.0 110.876 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.3 t -133.63 111.54 10.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.881 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.76 172.48 12.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.881 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.65 -74.7 0.3 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.895 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 54.0 m80 -134.57 -52.31 0.81 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.868 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 53.3 p -86.95 -169.83 2.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.922 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.9 p -157.82 135.72 10.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.913 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.1 tp -144.18 -47.62 0.27 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.95 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -65.58 -30.58 71.33 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.772 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 27.6 t -70.69 -38.43 73.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.001 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.7 mp -68.28 -18.04 64.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.062 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -91.94 22.53 4.21 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.137 0.494 . . . . 0.0 110.805 179.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -155.64 27.74 0.38 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.865 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -97.91 -56.16 1.09 Allowed Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.423 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -51.68 139.56 48.08 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.634 2.223 . . . . 0.0 112.286 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 59.72 69.23 1.3 Allowed Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.865 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -85.98 15.54 2.18 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.738 2.292 . . . . 0.0 112.846 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.49 29.87 3.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.859 0.361 . . . . 0.0 111.264 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.571 HG22 ' O ' ' A' ' 71' ' ' ILE . 24.9 mt -101.7 -5.2 9.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.651 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 14.4 mt -91.69 22.06 4.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.059 0.457 . . . . 0.0 111.578 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -136.06 69.07 63.81 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.793 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -68.6 60.44 1.15 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.917 2.411 . . . . 0.0 112.191 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -55.2 -28.83 55.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.213 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.7 mtt85 -138.16 135.06 35.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.945 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -172.82 87.84 0.07 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.87 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 61.62 78.97 0.27 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.927 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 69.9 mt -134.51 115.38 13.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.906 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 59.73 31.74 21.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.804 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -69.5 142.38 53.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.968 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -73.07 -49.16 30.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.982 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.49 ' CB ' ' HD2' ' A' ' 84' ' ' PRO . 0.3 OUTLIER 55.49 178.4 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.208 -179.798 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.49 ' HD2' ' CB ' ' A' ' 83' ' ' SER . 68.0 Cg_endo -75.54 44.48 1.25 Allowed 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 122.022 1.815 . . . . 0.0 112.883 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.1 mp 43.57 54.22 5.5 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 113.3 -41.02 2.32 Favored Glycine 0 C--N 1.33 0.223 0 C-N-CA 120.559 -0.829 . . . . 0.0 113.054 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.45 ' CA ' ' HG2' ' A' ' 84' ' ' PRO . 16.3 t70 75.52 96.29 0.07 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.945 0.402 . . . . 0.0 110.992 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.2 mt -122.73 57.13 1.12 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.743 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.575 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.5 OUTLIER -65.49 77.56 0.07 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.058 -179.838 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -167.73 80.84 0.19 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.894 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.412 ' HA3' ' CZ ' ' A' ' 31' ' ' TYR . . . -104.38 140.43 14.96 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.52 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.609 HG21 ' HE3' ' A' ' 28' ' ' LYS . 11.4 p -111.44 155.1 12.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.757 0.313 . . . . 0.0 111.127 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.426 ' N ' HG22 ' A' ' 92' ' ' VAL . 0.5 OUTLIER -154.29 112.33 3.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.918 -180.0 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.51 127.14 30.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.091 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.902 HG11 HG13 ' A' ' 146' ' ' VAL . 38.8 t -74.24 -48.4 5.77 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.577 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.659 ' HB3' ' HB3' ' A' ' 150' ' ' ALA . 64.3 Cg_endo -74.16 57.82 4.11 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.19 1.926 . . . . 0.0 112.349 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.494 ' HB2' ' O ' ' A' ' 96' ' ' PRO . . . 171.94 40.55 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.655 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -159.81 99.66 1.41 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.893 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -79.58 136.94 36.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.764 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.723 HD11 HG21 ' A' ' 143' ' ' ILE . 6.2 mm -87.26 162.58 2.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.054 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.562 ' HB3' ' O ' ' A' ' 115' ' ' SER . . . -149.85 83.74 1.4 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.0 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.577 HG12 HG21 ' A' ' 140' ' ' VAL . 69.0 mt -58.68 152.82 3.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.078 0.466 . . . . 0.0 111.215 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.419 ' N ' HG22 ' A' ' 102' ' ' ILE . 0.0 OUTLIER -147.94 114.99 4.01 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.213 179.644 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -78.42 42.47 1.24 Allowed 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.358 2.038 . . . . 0.0 112.688 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 175.16 62.32 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.045 0.45 . . . . 0.0 110.424 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -53.47 -93.54 0.01 OUTLIER Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.757 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.9 pttt -177.8 170.09 1.97 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.845 0.355 . . . . 0.0 110.949 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 64.07 -79.78 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.859 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -159.51 31.98 0.19 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.957 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 25.1 mmm180 -119.82 92.39 3.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.878 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.432 ' H ' HD12 ' A' ' 111' ' ' LEU . 3.8 mp -68.3 -30.75 69.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.854 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.487 ' HB3' HD13 ' A' ' 136' ' ' LEU . 40.2 m-85 -105.66 92.84 4.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.985 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.41 HG13 ' HB2' ' A' ' 129' ' ' ALA . 24.1 t -137.24 143.16 35.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.048 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.428 ' CE2' ' HB ' ' A' ' 128' ' ' VAL . 39.8 p90 -128.9 131.1 47.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.891 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.562 ' O ' ' HB3' ' A' ' 101' ' ' ALA . 1.2 m -102.38 128.33 49.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.833 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.691 HG23 HD13 ' A' ' 100' ' ' ILE . 1.6 mt -100.12 159.99 3.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.987 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.472 ' N ' HG22 ' A' ' 116' ' ' ILE . 60.9 p -153.76 149.95 27.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.945 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 39.7 mtp -96.12 108.48 41.53 Favored Pre-proline 0 CA--C 1.531 0.234 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.106 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -74.97 54.77 3.72 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.72 2.28 . . . . 0.0 112.394 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.9 p 171.39 41.84 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.72 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 45.2 t -150.5 -68.35 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.995 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -177.62 -154.36 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.316 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -85.62 45.62 1.22 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.7 0.286 . . . . 0.0 111.169 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 11.8 m0 -73.95 139.56 44.96 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.784 0.326 . . . . 0.0 110.744 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -140.58 110.25 6.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.097 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.45 112.37 24.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.913 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -84.51 118.75 24.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.98 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.788 HG12 HD12 ' A' ' 7' ' ' LEU . 21.7 t -141.95 151.79 18.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.925 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.542 ' O ' HD13 ' A' ' 7' ' ' LEU . . . -160.32 148.58 16.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.269 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -114.2 150.41 34.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.909 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.12 -58.82 6.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.864 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.76 113.64 11.14 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.751 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -48.74 -27.56 3.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.567 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 25.8 mp0 -73.84 -40.54 63.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.482 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -67.37 -31.77 72.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.173 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.489 ' O ' HG23 ' A' ' 140' ' ' VAL . 7.5 tt -68.12 -49.44 61.14 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.521 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.78 -40.31 84.0 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.307 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -67.32 -29.21 68.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.322 179.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' TRP . . . . . 0.502 ' CZ2' HD23 ' A' ' 7' ' ' LEU . 0.8 OUTLIER -67.82 -49.09 64.16 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.471 179.611 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.68 HG13 ' CB ' ' A' ' 100' ' ' ILE . 33.5 t -60.28 -40.97 85.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.034 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -67.25 -38.37 85.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.907 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.486 ' O ' HG12 ' A' ' 146' ' ' VAL . 6.4 mptt -66.59 -49.86 64.95 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.524 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.723 HG21 HD11 ' A' ' 100' ' ' ILE . 41.6 mt -55.21 -37.14 42.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.369 0.605 . . . . 0.0 109.532 178.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 24.3 mtp180 -79.85 -25.74 40.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.212 -0.903 . . . . 0.0 110.673 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -76.04 -38.71 56.88 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-O 120.909 0.385 . . . . 0.0 110.75 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.902 HG13 HG11 ' A' ' 95' ' ' VAL . 7.2 p -80.85 -28.57 11.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.236 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.47 ' HB2' HG12 ' A' ' 95' ' ' VAL . . . -79.29 -33.89 42.94 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.291 179.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -74.2 -13.78 60.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.883 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.45 HG22 ' HA ' ' A' ' 146' ' ' VAL . 9.2 t -105.4 -20.5 13.47 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.101 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.659 ' HB3' ' HB3' ' A' ' 96' ' ' PRO . . . . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.216 -0.897 . . . . 0.0 111.141 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.49 ' HB3' HG13 ' A' ' 23' ' ' VAL . 6.7 m . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.844 0.354 . . . . 0.0 111.184 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.4 HD12 HG11 ' A' ' 146' ' ' VAL . 38.3 mt -76.53 -34.78 24.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.148 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.8 tptp -142.01 91.94 2.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.871 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.678 ' HB3' HG13 ' A' ' 23' ' ' VAL . 24.5 p-10 -125.06 131.91 53.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.919 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -169.88 -165.18 26.83 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.525 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.657 HD13 ' HD1' ' A' ' 21' ' ' TYR . 25.1 mm -97.21 80.45 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.743 0.306 . . . . 0.0 111.1 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.697 HD23 ' CZ2' ' A' ' 139' ' ' TRP . 0.8 OUTLIER -87.58 158.62 18.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.779 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.476 ' C ' HD23 ' A' ' 9' ' ' LEU . 36.1 m-85 -102.16 163.68 12.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.026 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.75 HD21 ' HB2' ' A' ' 20' ' ' HIS . 0.6 OUTLIER -177.78 129.16 0.14 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.785 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.443 ' HG2' ' CZ3' ' A' ' 17' ' ' TRP . 0.0 OUTLIER -95.16 166.29 11.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.974 0.416 . . . . 0.0 111.024 -179.814 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.42 150.12 53.8 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.709 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -73.63 -17.96 22.84 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.597 2.198 . . . . 0.0 112.506 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.1 t -77.77 -38.62 25.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.985 0.421 . . . . 0.0 110.975 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -101.81 -23.88 14.13 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.835 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 63.87 33.27 12.72 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.822 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -144.76 156.1 43.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.048 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.443 ' CZ3' ' HG2' ' A' ' 10' ' ' GLU . 30.8 m95 -77.24 139.57 39.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.869 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -132.4 138.72 32.81 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.838 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.42 130.26 14.81 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.464 2.11 . . . . 0.0 112.3 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.75 ' HB2' HD21 ' A' ' 9' ' ' LEU . 9.7 m-70 -144.75 -178.34 5.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.864 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.657 ' HD1' HD13 ' A' ' 6' ' ' ILE . 34.1 t80 -119.96 139.39 52.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.934 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.49 ' CZ ' ' CD1' ' A' ' 31' ' ' TYR . 1.5 m-85 -132.44 148.28 52.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.873 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.678 HG13 ' HB3' ' A' ' 4' ' ' ASN . 21.7 t -140.0 92.06 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.03 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.64 HD11 HG21 ' A' ' 146' ' ' VAL . 0.2 OUTLIER -69.84 115.09 8.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.094 -179.857 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -99.44 157.28 16.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.023 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -42.83 -34.37 0.93 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.229 -179.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.432 ' HA ' HG11 ' A' ' 95' ' ' VAL . 5.5 p -144.14 46.66 1.43 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.732 0.301 . . . . 0.0 111.622 -179.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 177.12 167.68 0.57 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.834 0.35 . . . . 0.0 111.358 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.639 HG23 HD22 ' A' ' 24' ' ' LEU . 3.0 mt -132.2 100.32 4.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.539 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -73.43 132.17 42.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.172 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.49 ' CD1' ' CZ ' ' A' ' 22' ' ' PHE . 69.4 t80 -143.31 123.37 13.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.783 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.5 t -166.88 -79.02 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.885 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -162.06 179.4 8.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.918 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.431 ' HG2' ' CD1' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -80.83 146.56 30.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.918 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.05 143.99 28.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.817 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 95.2 p -148.99 38.11 0.81 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.944 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.1 m -128.2 173.76 9.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.879 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -122.26 97.17 5.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.977 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -144.73 48.93 1.31 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.877 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.37 44.75 2.43 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.485 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 31.6 p-10 -134.37 35.87 3.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.797 0.332 . . . . 0.0 110.826 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 45.14 35.22 1.59 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.433 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.6 t70 60.1 171.27 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.952 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -86.42 112.78 21.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.885 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -143.18 125.49 15.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.868 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -70.72 111.55 10.06 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.889 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.93 168.38 23.25 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.398 2.065 . . . . 0.0 112.261 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.06 152.25 22.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.853 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -118.99 168.02 11.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.886 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -111.96 90.99 3.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.137 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.6 p -86.78 160.59 18.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.92 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -101.37 -132.37 7.72 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.474 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.2 t -100.02 160.41 14.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.747 0.308 . . . . 0.0 110.858 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.3 t 43.1 72.21 0.19 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.487 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -160.12 170.38 21.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.853 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.98 138.33 52.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.845 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 20.7 p-80 -164.84 160.03 19.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.87 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.6 t -163.54 128.66 2.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.895 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 72.2 m -152.28 122.62 7.23 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.874 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -147.55 -46.92 0.17 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.906 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -59.53 -31.31 69.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.738 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.3 t -62.14 -34.41 63.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.859 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.0 mp -63.92 -18.89 64.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.958 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -90.27 21.97 3.56 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 121.188 0.518 . . . . 0.0 110.735 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.1 mm-40 -152.03 26.3 0.63 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.736 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.401 ' H ' ' HD2' ' A' ' 67' ' ' PRO . . . -101.87 -71.66 0.92 Allowed Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.483 -0.78 . . . . 0.0 112.206 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.401 ' HD2' ' H ' ' A' ' 66' ' ' GLY . 3.2 Cg_endo -46.06 113.21 0.55 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 123.03 2.487 . . . . 0.0 112.109 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.0 t30 63.35 90.91 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.778 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -82.23 9.53 3.94 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.769 2.313 . . . . 0.0 113.019 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -96.85 29.96 2.85 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.863 0.363 . . . . 0.0 111.223 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.549 HG22 ' O ' ' A' ' 71' ' ' ILE . 27.7 mt -99.59 -6.63 9.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.692 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 17.4 mt -92.0 21.31 5.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.114 0.483 . . . . 0.0 111.595 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -139.14 67.93 40.5 Favored Pre-proline 0 C--N 1.317 -0.821 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.575 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -68.18 60.22 1.0 Allowed 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 123.017 2.478 . . . . 0.0 112.279 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -93.45 20.17 7.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.209 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.1 mmt85 -147.16 170.76 16.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.891 0.376 . . . . 0.0 110.742 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 61.48 112.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.869 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 60.56 91.83 0.05 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.905 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.4 mp -124.05 -177.71 3.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.898 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.9 t70 60.33 38.21 19.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.8 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -87.55 55.11 3.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.903 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 -98.19 28.85 3.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.975 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.415 ' CB ' ' HD3' ' A' ' 84' ' ' PRO . 0.3 OUTLIER -74.04 -58.94 1.89 Allowed Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.96 -179.921 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.415 ' HD3' ' CB ' ' A' ' 83' ' ' SER . 74.0 Cg_endo -76.62 -44.4 0.23 Allowed 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.919 2.413 . . . . 0.0 112.47 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.4 tp 68.89 -66.79 0.23 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.042 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -100.77 155.69 19.3 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.591 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.45 -70.87 0.76 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.925 0.393 . . . . 0.0 110.963 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -145.93 -56.32 0.29 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.836 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -133.14 31.93 3.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.971 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.537 ' CD ' HG13 ' A' ' 92' ' ' VAL . 6.0 tmm_? -133.65 77.82 1.74 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.924 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -89.24 75.48 1.89 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.567 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.537 HG13 ' CD ' ' A' ' 90' ' ' ARG . 5.2 m -84.87 139.47 17.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.733 0.301 . . . . 0.0 111.091 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.1 mt -130.98 134.56 46.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.895 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -69.39 126.8 30.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.871 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.946 HG21 HG23 ' A' ' 146' ' ' VAL . 13.3 p -81.95 -27.73 0.44 Allowed Pre-proline 0 CA--C 1.534 0.347 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.649 ' CD ' ' N ' ' A' ' 95' ' ' VAL . 88.8 Cg_endo -85.97 47.64 1.89 Allowed 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.146 1.898 . . . . 0.0 112.665 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 178.69 39.37 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.865 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 1.9 m -119.48 173.51 6.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.958 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.01 102.59 2.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.769 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 1.031 HD13 HG23 ' A' ' 116' ' ' ILE . 14.7 mm -79.2 158.19 4.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.078 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.422 ' N ' HG22 ' A' ' 100' ' ' ILE . . . -155.56 93.17 1.46 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.037 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.732 HD13 HE22 ' A' ' 137' ' ' GLN . 54.3 mt -59.25 143.87 13.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.144 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.413 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 4.6 mtt180 -133.28 114.15 13.53 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.525 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 103' ' ' ARG . 3.0 Cg_exo -74.78 29.87 0.35 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.587 2.191 . . . . 0.0 112.651 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -177.62 74.22 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.734 0.302 . . . . 0.0 110.413 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -42.28 -84.67 0.01 OUTLIER Glycine 0 C--N 1.332 0.344 0 CA-C-N 116.077 -0.51 . . . . 0.0 113.19 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -175.11 -80.5 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.832 0.349 . . . . 0.0 111.236 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -96.8 109.71 22.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.215 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 32.8 m120 48.04 38.78 10.11 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.235 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 7.9 mmp_? -140.11 112.66 7.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.936 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.86 -33.51 12.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.822 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.667 ' HB3' HD13 ' A' ' 136' ' ' LEU . 3.4 m-85 -108.21 107.12 17.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.861 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.445 HG13 ' HB2' ' A' ' 129' ' ' ALA . 22.0 t -151.18 132.3 4.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.128 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.418 ' CE2' ' HB ' ' A' ' 128' ' ' VAL . 31.3 p90 -115.54 122.51 45.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.895 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 58.1 m -89.32 128.38 35.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.983 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 1.031 HG23 HD13 ' A' ' 100' ' ' ILE . 14.1 mt -100.97 158.5 4.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.996 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.422 ' N ' HG22 ' A' ' 116' ' ' ILE . 54.6 p -151.38 -170.52 3.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.968 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . 0.481 ' SD ' HG21 ' A' ' 121' ' ' VAL . 32.7 mtp -146.82 105.02 3.92 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.073 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -78.16 59.17 6.91 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.506 2.137 . . . . 0.0 112.376 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -177.2 -45.6 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.877 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.481 HG21 ' SD ' ' A' ' 118' ' ' MET . 43.1 t -65.63 -66.69 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.999 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.439 ' HB3' ' HD1' ' A' ' 124' ' ' TRP . . . 179.88 -154.76 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.296 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -84.63 47.63 1.4 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.772 0.32 . . . . 0.0 111.04 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . 0.439 ' HD1' ' HB3' ' A' ' 122' ' ' ALA . 23.6 m95 -79.94 128.7 33.78 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.804 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.14 114.95 14.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.944 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.3 tp -112.5 112.62 24.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.022 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -82.2 126.46 32.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.858 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.47 HG12 HD12 ' A' ' 7' ' ' LEU . 21.2 t -136.44 154.43 32.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.077 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.445 ' HB2' HG13 ' A' ' 113' ' ' VAL . . . -161.21 127.37 3.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.144 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.494 ' H ' HD12 ' A' ' 136' ' ' LEU . . . -92.55 142.46 27.37 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.978 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -56.0 -37.66 69.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.896 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -97.55 114.02 25.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.797 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -48.5 -27.42 2.69 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.539 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -73.67 -42.12 61.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.357 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.19 -30.21 68.36 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.117 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.667 HD13 ' HB3' ' A' ' 112' ' ' PHE . 9.8 tt -68.44 -45.89 71.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.418 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.732 HE22 HD13 ' A' ' 102' ' ' ILE . 80.3 mm-40 -68.05 -42.7 80.1 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.309 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -66.87 -30.44 70.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.325 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' TRP . . . . . 0.697 ' CZ2' HD23 ' A' ' 7' ' ' LEU . 1.0 OUTLIER -66.38 -46.74 75.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.512 179.563 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.677 HG13 HG21 ' A' ' 100' ' ' ILE . 40.6 t -61.45 -44.62 98.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.941 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 7.2 ttmm -63.46 -35.9 81.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.936 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.623 ' O ' HG22 ' A' ' 146' ' ' VAL . 0.0 OUTLIER -66.7 -52.0 49.69 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.476 179.792 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.578 HG21 HD11 ' A' ' 100' ' ' ILE . 74.0 mt -53.64 -34.92 25.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.28 0.562 . . . . 0.0 109.646 178.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 3.1 mtt180 -78.4 -28.39 46.91 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.584 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -74.91 -39.56 61.37 Favored 'General case' 0 CA--C 1.523 -0.088 0 CA-C-O 120.898 0.38 . . . . 0.0 110.78 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.946 HG23 HG21 ' A' ' 95' ' ' VAL . 8.9 m -78.74 -26.71 13.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.258 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -77.43 -35.01 54.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.819 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -78.53 -9.58 59.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.136 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.52 HG22 ' HA ' ' A' ' 146' ' ' VAL . 15.2 t -113.5 -30.14 6.95 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.777 0.323 . . . . 0.0 111.144 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.251 -0.88 . . . . 0.0 111.088 -179.989 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.4 p . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.749 0.309 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.891 HD11 ' HB3' ' A' ' 26' ' ' SER . 33.9 mt -74.93 -30.9 24.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.145 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.9 mttp -147.51 116.79 6.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.964 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.731 ' HB3' HG13 ' A' ' 23' ' ' VAL . 4.2 p-10 -135.37 124.81 24.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.896 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -163.31 -156.07 8.46 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.498 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 26.5 mm -105.53 99.61 8.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.814 0.34 . . . . 0.0 111.184 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.941 HD12 HG12 ' A' ' 128' ' ' VAL . 3.2 mm? -102.92 139.88 37.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.834 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -80.68 140.83 35.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.035 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.495 HD12 HG22 ' A' ' 128' ' ' VAL . 5.9 tt -152.49 102.57 2.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.797 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.409 ' HB3' ' CD2' ' A' ' 17' ' ' TRP . 0.6 OUTLIER -70.67 153.26 43.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.878 -179.806 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -113.25 150.71 43.46 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.913 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.07 -17.98 24.34 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.619 2.213 . . . . 0.0 112.549 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -72.4 -48.41 47.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.168 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -100.73 -19.39 16.05 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.936 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 59.9 42.51 16.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.973 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -146.4 146.62 30.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.874 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.429 ' CE2' ' HG3' ' A' ' 110' ' ' ARG . 58.7 m95 -72.72 150.5 42.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.873 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -144.33 139.91 16.22 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.851 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -73.83 87.94 1.1 Allowed 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.583 2.189 . . . . 0.0 112.41 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -104.27 162.64 13.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.874 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -93.3 137.64 32.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.845 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.501 ' CZ ' ' CE1' ' A' ' 31' ' ' TYR . 44.0 m-85 -138.66 156.56 47.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.938 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.731 HG13 ' HB3' ' A' ' 4' ' ' ASN . 25.3 t -141.17 150.28 20.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.874 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.453 HD12 HG12 ' A' ' 29' ' ' ILE . 21.0 tp -133.02 118.37 18.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.237 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 15.0 p -109.76 149.12 30.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.695 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.891 ' HB3' HD11 ' A' ' 2' ' ' ILE . 0.2 OUTLIER -56.79 -18.72 13.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.863 -179.671 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.2 m -99.09 -24.7 14.8 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 111.624 0.231 . . . . 0.0 111.624 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.546 ' HA ' HG23 ' A' ' 95' ' ' VAL . 0.0 OUTLIER -175.01 -173.92 0.73 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.727 0.298 . . . . 0.0 110.799 -179.647 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.699 ' O ' HG23 ' A' ' 92' ' ' VAL . 7.7 mt -110.83 162.28 8.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.705 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.454 ' N ' HG22 ' A' ' 29' ' ' ILE . 0.7 OUTLIER -133.59 138.25 45.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.075 -179.895 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.501 ' CE1' ' CZ ' ' A' ' 22' ' ' PHE . 10.9 t80 -121.25 139.15 53.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.87 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.39 161.33 41.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.943 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -126.46 152.98 45.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.882 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -92.04 179.63 5.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.887 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.3 t -129.12 -170.07 2.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.822 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 56.5 p -83.55 144.11 29.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.888 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -153.3 156.35 38.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.847 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -90.19 -38.42 13.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.895 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 57.94 31.72 20.97 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.878 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -132.02 34.12 2.59 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.499 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -163.82 31.69 0.08 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.814 0.34 . . . . 0.0 110.875 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -107.04 34.67 3.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.012 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.1 t70 61.04 -175.3 0.12 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.922 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -88.17 -174.7 4.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.928 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -71.0 105.54 3.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.897 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 58.92 84.41 0.2 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.946 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.33 161.26 46.23 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.606 2.204 . . . . 0.0 112.363 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -88.05 167.33 13.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.874 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.95 136.31 39.11 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.825 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -109.35 -176.09 2.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.025 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.7 m -160.35 -45.4 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.951 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 166.3 137.31 2.19 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.485 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -105.21 31.71 4.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.823 0.344 . . . . 0.0 110.829 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.492 HG21 ' HA ' ' A' ' 58' ' ' SER . 10.4 t -79.79 -177.79 6.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.916 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -141.14 158.41 43.95 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.848 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.7 tp 69.26 -66.28 0.26 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.991 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 30.4 t60 -127.59 158.77 36.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.83 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.492 ' HA ' HG21 ' A' ' 54' ' ' THR . 63.8 m -129.64 158.85 38.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.814 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 7.9 t -152.8 178.5 9.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.943 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.6 mp 65.21 9.69 5.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.48 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -109.26 -30.81 7.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.071 0.462 . . . . 0.0 109.894 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.9 t -80.12 -26.03 11.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.524 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -84.1 -12.48 54.98 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.245 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -91.41 26.17 2.35 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 121.063 0.459 . . . . 0.0 110.709 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -168.97 31.23 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.963 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -120.89 -72.95 0.32 Allowed Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.199 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -43.73 133.69 7.68 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.024 2.483 . . . . 0.0 112.295 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 64.12 103.37 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.718 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -77.16 8.89 3.01 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.809 2.339 . . . . 0.0 113.044 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -95.34 29.59 2.48 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.833 0.349 . . . . 0.0 111.437 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.591 HG22 ' O ' ' A' ' 71' ' ' ILE . 22.2 mt -103.13 -3.31 9.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.689 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 72' ' ' LEU . 12.7 mt -91.85 22.41 4.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.092 0.472 . . . . 0.0 111.607 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -134.01 69.87 74.61 Favored Pre-proline 0 C--N 1.318 -0.78 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.829 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -69.14 59.47 1.32 Allowed 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.939 2.426 . . . . 0.0 112.366 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -68.82 -43.5 75.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.969 0.414 . . . . 0.0 110.576 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 5.2 mtt180 -143.24 122.44 12.96 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.94 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -111.47 30.44 6.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.858 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -139.74 31.34 2.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.399 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.617 HD23 ' HB2' ' A' ' 80' ' ' ASP . 6.1 tt -112.95 144.13 43.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.933 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.617 ' HB2' HD23 ' A' ' 79' ' ' LEU . 14.2 t0 57.17 40.35 28.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.98 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -141.27 116.74 10.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.991 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 57.49 83.31 0.11 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.067 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.458 ' N ' ' CD ' ' A' ' 84' ' ' PRO . 0.1 OUTLIER -84.18 -52.18 0.56 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.042 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.458 ' CD ' ' N ' ' A' ' 83' ' ' SER . 50.2 Cg_exo -52.31 -31.4 46.74 Favored 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.857 2.372 . . . . 0.0 112.271 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.64 ' O ' HD23 ' A' ' 85' ' ' LEU . 7.4 tt -116.29 78.67 1.22 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.886 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -138.68 -81.75 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.547 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -83.7 -36.54 23.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.785 0.326 . . . . 0.0 110.892 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 72.5 mt 60.22 97.99 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.853 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -95.14 148.66 22.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.809 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.4 tpm_? -173.43 -66.65 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.999 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -127.78 173.11 18.85 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.406 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.699 HG23 ' O ' ' A' ' 29' ' ' ILE . 11.8 p -169.49 131.04 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.77 0.319 . . . . 0.0 111.297 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.663 ' HB3' HD12 ' A' ' 29' ' ' ILE . 2.9 tp -113.88 -173.74 2.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.542 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -123.71 140.01 53.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.94 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.844 HG11 ' HB ' ' A' ' 146' ' ' VAL . 22.7 t -86.05 -45.89 0.59 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.982 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' A' ' 95' ' ' VAL . 88.0 Cg_endo -80.36 54.7 5.34 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.258 1.972 . . . . 0.0 112.525 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.433 ' HB2' ' O ' ' A' ' 96' ' ' PRO . . . 176.03 39.57 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.797 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 8.4 m -141.05 -178.88 5.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.979 0.419 . . . . 0.0 111.198 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -160.38 105.5 1.48 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.525 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 1.004 HD13 HG23 ' A' ' 116' ' ' ILE . 14.7 mm -74.47 160.59 5.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.224 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.47 ' N ' HG22 ' A' ' 100' ' ' ILE . . . -160.6 92.78 0.98 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.866 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 15.0 mt -57.07 136.4 20.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.017 0.437 . . . . 0.0 111.31 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.87 123.86 26.74 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.197 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -82.71 19.2 1.34 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.465 2.11 . . . . 0.0 112.926 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -169.0 70.95 0.08 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.797 0.332 . . . . 0.0 110.674 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -56.59 -95.13 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.682 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -168.33 165.85 12.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.851 0.357 . . . . 0.0 110.992 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 63.63 -80.4 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.114 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -158.29 31.23 0.24 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.911 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.429 ' HG3' ' CE2' ' A' ' 17' ' ' TRP . 11.7 mmt180 -119.62 85.67 2.42 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.853 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -69.19 -32.22 71.37 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.084 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -97.73 87.71 4.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.017 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.725 HG13 ' HB2' ' A' ' 129' ' ' ALA . 21.4 t -139.94 144.66 27.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.939 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.43 ' CE2' ' HB ' ' A' ' 128' ' ' VAL . 48.9 p90 -118.22 125.51 50.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.895 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.2 t -98.62 133.03 43.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.985 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 1.004 HG23 HD13 ' A' ' 100' ' ' ILE . 14.6 mt -101.67 159.69 4.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.828 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.452 ' N ' HG22 ' A' ' 116' ' ' ILE . 19.7 t -151.97 -179.67 7.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.81 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 10.2 mtt -135.38 135.44 22.44 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.833 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -59.4 -66.01 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.479 2.119 . . . . 0.0 112.697 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.65 104.65 11.91 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.327 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.541 ' O ' ' HB2' ' A' ' 122' ' ' ALA . 2.0 p -178.81 -47.99 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.787 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.541 ' HB2' ' O ' ' A' ' 121' ' ' VAL . . . 169.26 -167.41 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.769 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 9.7 mm100 -98.16 36.31 1.6 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.807 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . 0.424 ' CD1' ' HB3' ' A' ' 122' ' ' ALA . 22.9 m95 -63.94 -177.7 0.27 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.983 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 89.3 p -178.16 103.02 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.758 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.47 HD22 HD22 ' A' ' 93' ' ' LEU . 10.0 tp -92.53 104.7 16.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.143 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -85.97 131.85 34.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.822 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.941 HG12 HD12 ' A' ' 7' ' ' LEU . 22.0 t -152.5 147.53 14.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.06 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.725 ' HB2' HG13 ' A' ' 113' ' ' VAL . . . -148.27 143.92 27.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.261 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -104.83 135.77 45.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.031 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -54.29 -34.61 61.28 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.995 0.426 . . . . 0.0 110.898 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 5.9 t -95.94 114.89 26.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.669 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -48.96 -26.16 2.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.725 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -75.63 -42.9 50.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.591 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -67.86 -32.0 72.21 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.239 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.577 ' O ' HG23 ' A' ' 140' ' ' VAL . 7.4 tt -68.99 -46.93 66.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.516 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -68.86 -41.08 78.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.39 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.55 -28.93 68.2 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.357 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' TRP . . . . . 0.474 ' CZ2' HD23 ' A' ' 7' ' ' LEU . 1.1 m95 -69.05 -47.51 65.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.608 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.684 HG13 HG21 ' A' ' 100' ' ' ILE . 33.2 t -61.53 -40.39 86.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.904 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.94 -38.26 90.36 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.841 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.92 -52.13 52.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.366 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.992 HG21 HD11 ' A' ' 100' ' ' ILE . 73.9 mt -53.85 -34.37 25.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.23 0.538 . . . . 0.0 109.644 178.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -81.23 -27.91 35.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.482 179.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.607 ' O ' HG22 ' A' ' 149' ' ' THR . 1.5 tm-20 -70.93 -39.95 72.36 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-O 120.906 0.384 . . . . 0.0 110.413 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.844 ' HB ' HG11 ' A' ' 95' ' ' VAL . 61.8 t -78.48 -33.55 17.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.859 179.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.34 -34.33 65.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.479 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.88 -11.72 60.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.858 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.607 HG22 ' O ' ' A' ' 145' ' ' GLU . 10.6 t -120.98 17.07 11.72 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.083 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.282 -0.866 . . . . 0.0 111.082 -179.982 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 25.7 m . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.808 0.337 . . . . 0.0 111.271 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.577 HG22 ' HE2' ' A' ' 142' ' ' LYS . 30.2 mt -85.59 -33.01 7.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.064 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.445 ' HE3' ' CD1' ' A' ' 139' ' ' TRP . 21.2 tttp -158.63 116.41 2.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.007 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.841 ' HB3' HG13 ' A' ' 23' ' ' VAL . 8.2 p30 -131.72 127.73 37.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.966 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -166.29 -155.54 8.91 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.549 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.643 ' N ' HD12 ' A' ' 6' ' ' ILE . 3.4 mp -115.42 100.96 11.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.815 0.341 . . . . 0.0 111.114 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.658 HD12 HG12 ' A' ' 128' ' ' VAL . 3.5 mm? -96.18 140.2 31.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.77 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -76.93 145.35 38.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.127 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.495 HD11 ' OH ' ' A' ' 31' ' ' TYR . 0.2 OUTLIER -158.06 122.23 4.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.69 179.891 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.453 ' HB2' ' CE3' ' A' ' 17' ' ' TRP . 0.7 OUTLIER -74.18 120.9 20.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.11 -179.8 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.47 138.47 59.21 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.028 179.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -67.98 -12.0 33.84 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.192 1.928 . . . . 0.0 112.564 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.4 t -77.76 -36.31 22.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.886 0.374 . . . . 0.0 110.919 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -111.92 -24.39 9.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.044 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 2.4 m170 66.63 34.53 5.8 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.901 0.381 . . . . 0.0 110.654 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.411 ' N ' ' HG3' ' A' ' 10' ' ' GLU . 48.8 mt-10 -138.15 144.54 40.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.859 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.453 ' CE3' ' HB2' ' A' ' 10' ' ' GLU . 49.7 m95 -52.87 146.27 11.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.128 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -150.04 130.65 7.02 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.883 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.94 97.14 1.09 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.436 2.091 . . . . 0.0 112.364 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 15.5 m80 -115.96 149.21 39.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.856 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -65.35 164.44 13.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.946 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.498 ' CD2' ' CD1' ' A' ' 31' ' ' TYR . 0.2 OUTLIER -177.28 119.99 0.11 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.672 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.841 HG13 ' HB3' ' A' ' 4' ' ' ASN . 16.4 t -104.76 142.16 18.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.101 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.649 HD12 HG12 ' A' ' 29' ' ' ILE . 23.1 tp -118.83 103.08 9.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.902 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -101.8 152.2 21.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.865 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.513 ' CB ' HD11 ' A' ' 2' ' ' ILE . 0.4 OUTLIER -59.18 -16.69 21.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.643 -179.768 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.0 p -99.54 -23.34 15.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.575 0.226 . . . . 0.0 111.513 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.602 ' HA ' HG23 ' A' ' 95' ' ' VAL . 0.1 OUTLIER 178.41 -174.72 0.17 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.897 0.379 . . . . 0.0 110.953 -179.722 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.649 HG12 HD12 ' A' ' 24' ' ' LEU . 6.0 mt -119.62 123.9 71.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.812 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.625 ' HD1' HG22 ' A' ' 92' ' ' VAL . 40.7 m-85 -95.42 160.41 14.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.942 0.401 . . . . 0.0 111.01 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.498 ' CD1' ' CD2' ' A' ' 22' ' ' PHE . 45.8 t80 -151.88 123.35 7.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.765 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.1 t -158.34 147.99 19.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.863 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.37 159.64 17.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.995 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.479 ' O ' HG22 ' A' ' 35' ' ' THR . 3.3 pt-20 -156.06 -177.66 6.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.929 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.479 HG22 ' O ' ' A' ' 34' ' ' GLU . 15.1 t 45.12 -166.41 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.323 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.8 t 61.92 80.18 0.23 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.015 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 50.5 p -133.99 157.61 45.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.874 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.89 -35.8 37.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.891 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 58.9 31.5 21.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.922 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -134.39 34.65 2.33 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.495 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -159.02 42.84 0.24 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.85 0.357 . . . . 0.0 110.842 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -134.75 44.41 2.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.961 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -144.49 -169.74 3.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.83 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -140.77 126.1 18.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.983 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -151.79 32.05 0.56 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.873 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -68.16 152.4 96.51 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.839 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.89 88.19 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.639 2.226 . . . . 0.0 112.31 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.8 tttt -95.13 90.44 5.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.877 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -71.6 122.57 20.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.812 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -165.96 34.33 0.05 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.115 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.1 m 62.26 150.62 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.954 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 163.3 -111.59 0.48 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.516 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.1 m -156.29 26.92 0.35 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.753 0.311 . . . . 0.0 111.089 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.4 -176.67 3.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.958 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -152.63 159.79 43.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.797 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.424 HD22 ' HA ' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -159.03 109.83 2.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.968 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 4.3 m170 -89.77 119.11 29.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.801 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.402 ' CA ' HG21 ' A' ' 62' ' ' VAL . 96.0 p -74.56 120.46 20.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.938 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.6 -172.42 2.39 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.352 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.2 tp -58.82 -41.41 86.77 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.129 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -53.14 -25.35 13.08 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.972 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.402 HG21 ' CA ' ' A' ' 58' ' ' SER . 21.8 t -68.44 -44.68 83.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.157 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.3 mp -69.62 -11.23 60.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.304 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -93.48 26.29 3.07 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-O 121.122 0.487 . . . . 0.0 110.727 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -169.39 30.76 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.149 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -113.01 -64.42 0.46 Allowed Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.394 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -50.9 146.51 21.23 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.604 2.203 . . . . 0.0 112.213 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.5 m120 60.9 91.66 0.07 OUTLIER Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.941 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -84.89 18.89 1.48 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.764 2.309 . . . . 0.0 113.005 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.35 28.74 3.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.967 0.413 . . . . 0.0 111.186 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.574 HG22 ' O ' ' A' ' 71' ' ' ILE . 13.3 mt -111.65 -5.24 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.881 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.7 mp -92.26 19.85 6.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.122 0.487 . . . . 0.0 111.831 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.452 ' N ' ' HD3' ' A' ' 74' ' ' PRO . 17.5 mt-10 -140.86 63.5 19.51 Favored Pre-proline 0 C--N 1.316 -0.861 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.983 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.452 ' HD3' ' N ' ' A' ' 73' ' ' GLU . 7.8 Cg_exo -72.53 61.13 3.51 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.768 2.312 . . . . 0.0 112.052 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -92.41 -34.31 14.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.079 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 11.0 mmt-85 -79.28 172.23 14.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.886 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 62.89 35.34 13.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.956 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -178.86 44.58 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.911 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.428 HD12 ' H ' ' A' ' 79' ' ' LEU . 2.1 mp -85.68 133.4 34.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.973 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 58.65 32.35 22.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.981 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -140.97 67.23 1.35 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.904 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -96.25 20.81 9.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.194 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.456 ' CB ' ' HD3' ' A' ' 84' ' ' PRO . 0.1 OUTLIER -85.04 -54.73 0.44 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 120.936 0.398 . . . . 0.0 110.868 179.883 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.456 ' HD3' ' CB ' ' A' ' 83' ' ' SER . 76.6 Cg_endo -88.2 41.39 0.63 Allowed 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 123.322 2.681 . . . . 0.0 112.601 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -166.39 -42.03 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.925 0.393 . . . . 0.0 111.109 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -94.38 33.56 5.22 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.576 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 43.57 31.45 0.44 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.785 0.326 . . . . 0.0 111.464 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -111.66 61.39 0.62 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.911 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.59 38.24 1.55 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.888 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.06 82.46 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.813 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.9 138.26 21.19 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.565 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.625 HG22 ' HD1' ' A' ' 30' ' ' TYR . 21.5 t -127.72 136.0 61.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.755 0.312 . . . . 0.0 111.107 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.637 HD21 ' CE ' ' A' ' 118' ' ' MET . 0.7 OUTLIER -130.86 120.88 24.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.02 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -57.98 148.58 25.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.928 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.826 HG11 ' HB ' ' A' ' 146' ' ' VAL . 17.3 t -78.68 -47.94 1.79 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.823 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' A' ' 95' ' ' VAL . 71.6 Cg_endo -77.49 58.28 6.27 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.225 1.95 . . . . 0.0 112.505 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -179.63 38.68 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.901 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . 0.436 ' SG ' HD22 ' A' ' 93' ' ' LEU . 67.4 m -139.13 178.13 7.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.011 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.4 tm0? -158.71 102.49 1.69 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.72 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.966 HD13 HG23 ' A' ' 116' ' ' ILE . 8.3 mm -76.57 160.75 4.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.326 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.435 ' N ' HG22 ' A' ' 100' ' ' ILE . . . -153.0 89.47 1.38 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.803 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 73.9 mt -62.47 145.73 13.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.101 0.477 . . . . 0.0 111.553 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.402 ' HB2' ' CG1' ' A' ' 113' ' ' VAL . 0.2 OUTLIER -134.81 125.85 17.57 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.879 179.305 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -82.55 25.55 0.67 Allowed 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.431 2.087 . . . . 0.0 113.22 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -178.23 74.34 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.722 0.296 . . . . 0.0 111.013 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -59.13 -96.67 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.578 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.67 173.74 1.59 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.795 0.331 . . . . 0.0 110.938 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 68.36 -68.39 0.17 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.12 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -175.46 36.67 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.903 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -129.98 88.44 2.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.796 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 86.2 mt -59.31 -37.58 78.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.825 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -99.12 119.34 37.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.844 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 1.014 HG23 ' HB2' ' A' ' 129' ' ' ALA . 9.4 p -155.05 162.18 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.134 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.432 ' CZ ' ' HB ' ' A' ' 128' ' ' VAL . 10.2 p90 -148.66 114.29 5.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.922 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 12.4 m -92.64 140.01 29.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.939 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.966 HG23 HD13 ' A' ' 100' ' ' ILE . 13.0 mt -104.95 157.48 5.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.977 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.412 ' N ' HG22 ' A' ' 116' ' ' ILE . 5.5 t -162.01 138.31 7.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.781 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . 0.637 ' CE ' HD21 ' A' ' 93' ' ' LEU . 29.0 mtp -102.39 96.92 7.85 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.062 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.26 59.06 4.51 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.491 2.127 . . . . 0.0 112.368 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 92.2 p -177.85 37.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.809 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.671 HG13 ' H ' ' A' ' 122' ' ' ALA . 0.4 OUTLIER -161.15 -82.33 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.727 -179.854 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.671 ' H ' HG13 ' A' ' 121' ' ' VAL . . . -140.59 -168.89 2.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.921 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -93.55 47.45 1.24 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.77 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . 0.458 ' CD1' ' HB3' ' A' ' 122' ' ' ALA . 29.5 m95 -85.28 148.56 26.0 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.853 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 92.1 p -144.34 103.67 4.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.79 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.503 HD23 ' CG2' ' A' ' 128' ' ' VAL . 0.3 OUTLIER -89.59 100.55 13.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.059 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -77.37 124.03 27.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.856 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.658 HG12 HD12 ' A' ' 7' ' ' LEU . 15.7 t -137.1 152.74 28.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.1 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 1.014 ' HB2' HG23 ' A' ' 113' ' ' VAL . . . -157.31 127.11 6.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.234 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.579 ' HB2' HD11 ' A' ' 7' ' ' LEU . . . -93.12 137.35 32.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.924 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -52.5 -35.78 53.76 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.964 0.412 . . . . 0.0 111.106 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.8 t -96.95 115.41 27.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.742 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.22 -27.46 2.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.566 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.42 -45.44 38.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.44 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -63.92 -32.29 73.77 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.197 179.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.454 HD23 ' C ' ' A' ' 136' ' ' LEU . 7.6 tt -67.45 -51.85 46.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.557 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -67.6 -35.52 79.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.375 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -70.8 -30.66 67.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.419 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' TRP . . . . . 0.445 ' CD1' ' HE3' ' A' ' 3' ' ' LYS . 0.8 OUTLIER -68.72 -45.58 71.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.67 179.749 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.547 HG22 HG21 ' A' ' 100' ' ' ILE . 44.6 t -63.49 -42.19 95.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.886 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 11.6 mttm -63.87 -35.62 81.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.809 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.577 ' HE2' HG22 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -67.04 -50.41 62.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.603 179.669 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 68.6 mt -54.44 -35.57 31.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.328 0.585 . . . . 0.0 109.5 178.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 47.3 mtp180 -78.01 -28.68 49.21 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.447 179.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.418 ' O ' HG22 ' A' ' 149' ' ' THR . 12.2 tt0 -76.03 -32.67 59.46 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.864 0.364 . . . . 0.0 110.53 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.826 ' HB ' HG11 ' A' ' 95' ' ' VAL . 90.2 t -80.0 -31.47 13.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.294 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.1 -35.21 66.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.828 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -75.32 -11.08 59.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.144 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.462 HG22 ' HA ' ' A' ' 146' ' ' VAL . 8.9 t -114.27 -34.69 5.23 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.774 0.321 . . . . 0.0 111.097 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.225 -0.893 . . . . 0.0 111.155 -179.928 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.859 0.361 . . . . 0.0 111.12 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.745 HD11 ' HA ' ' A' ' 26' ' ' SER . 29.6 mt -76.48 -34.2 24.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.047 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.56 169.31 24.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.911 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.44 ' HB3' HG13 ' A' ' 23' ' ' VAL . 3.0 p30 -166.58 125.4 1.46 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.81 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -159.65 -170.59 24.41 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.583 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 28.4 mm -94.81 92.44 3.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.791 0.329 . . . . 0.0 111.142 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.58 HD12 HG12 ' A' ' 128' ' ' VAL . 4.3 mm? -96.58 129.58 43.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.847 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -79.9 146.32 32.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.917 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -147.59 133.69 19.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.766 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.466 ' CG ' ' CD2' ' A' ' 17' ' ' TRP . 3.2 mt-10 -80.36 118.05 21.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.134 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.72 134.32 50.76 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.352 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -68.8 -10.52 29.34 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.306 2.004 . . . . 0.0 112.654 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.2 t -66.56 -39.22 83.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.924 0.392 . . . . 0.0 110.937 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -138.02 9.34 2.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.463 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 49.79 49.46 20.11 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.92 0.391 . . . . 0.0 111.136 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.55 149.62 49.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.876 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.466 ' CD2' ' CG ' ' A' ' 10' ' ' GLU . 43.2 m95 -72.97 143.57 47.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.911 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -129.92 119.04 18.79 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.79 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -68.82 82.65 0.56 Allowed 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.398 2.065 . . . . 0.0 112.353 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 4.4 m80 -114.23 168.36 9.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.882 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -73.85 172.05 12.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.901 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -167.03 141.42 3.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.877 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.44 HG13 ' HB3' ' A' ' 4' ' ' ASN . 38.8 t -134.68 153.39 34.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.868 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.686 HD12 HG12 ' A' ' 29' ' ' ILE . 5.8 tp -133.41 109.49 9.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.117 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 16.9 p -95.46 157.8 15.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.581 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.745 ' HA ' HD11 ' A' ' 2' ' ' ILE . 3.4 m -63.73 -13.86 47.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.915 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.0 m -111.43 -7.14 14.38 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 173.55 -174.84 0.06 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.925 0.393 . . . . 0.0 111.29 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.686 HG12 HD12 ' A' ' 24' ' ' LEU . 5.8 mt -113.59 136.78 48.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.399 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.748 ' HB3' HD12 ' A' ' 89' ' ' LEU . 39.4 m-85 -113.92 138.36 50.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.861 0.362 . . . . 0.0 111.066 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 54.1 p90 -157.55 158.47 35.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.879 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.0 -70.13 0.82 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.893 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 62.01 32.09 17.78 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.826 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -71.52 113.68 8.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.874 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -71.19 -68.12 0.46 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.894 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.4 m 61.01 82.17 0.17 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.893 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.5 m -124.27 100.25 6.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.85 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -141.79 87.34 2.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.888 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 60.23 32.05 20.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.893 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -138.18 43.68 1.17 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.546 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -98.22 31.62 2.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.801 0.334 . . . . 0.0 110.907 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -107.76 36.76 2.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.952 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -122.99 48.52 1.79 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.914 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -133.91 -175.31 3.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.862 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 64.05 133.12 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.882 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -133.59 129.06 20.32 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.922 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.33 162.39 4.45 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.443 2.095 . . . . 0.0 112.319 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -96.98 165.62 12.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.899 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 59.97 109.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.899 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.66 -32.53 73.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.141 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.7 m -123.71 95.61 4.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.909 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -169.13 88.02 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.549 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.5 p 58.41 32.95 22.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.891 0.377 . . . . 0.0 110.958 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -98.34 158.83 15.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.963 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -64.36 -171.82 0.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.998 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 13.1 tp -151.15 140.73 21.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.883 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -105.52 38.29 2.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.063 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.8 t -81.44 64.18 6.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.92 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 7.4 m -162.95 109.9 1.21 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.918 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.4 tt -99.53 -35.43 9.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.892 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -67.45 -28.94 68.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.914 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 32.8 t -71.24 -33.04 49.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.052 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -87.71 -4.44 58.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.364 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -91.27 25.24 2.6 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-O 121.224 0.535 . . . . 0.0 110.551 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -176.1 31.32 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.977 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.456 ' N ' ' CD ' ' A' ' 67' ' ' PRO . . . -149.59 48.17 0.6 Allowed Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.437 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' ' 66' ' ' GLY . 89.6 Cg_endo -77.3 97.8 1.17 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.595 2.197 . . . . 0.0 112.293 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 61.07 98.54 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.698 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -82.55 12.94 2.72 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.653 2.235 . . . . 0.0 113.059 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -96.79 30.27 2.72 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.818 0.342 . . . . 0.0 111.164 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.449 HG22 ' O ' ' A' ' 71' ' ' ILE . 15.7 mt -105.3 -12.95 9.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.703 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 11.6 mt -89.4 18.21 5.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.326 0.584 . . . . 0.0 111.545 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -145.78 75.15 13.31 Favored Pre-proline 0 C--N 1.316 -0.883 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.315 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -68.46 59.45 1.07 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.844 2.363 . . . . 0.0 112.41 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -88.95 -34.59 16.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.836 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.871 ' HD3' HD13 ' A' ' 79' ' ' LEU . 0.3 OUTLIER -129.06 143.98 51.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.948 179.88 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -139.87 31.2 2.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.899 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 5.2 m170 -161.86 31.41 0.12 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.527 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.871 HD13 ' HD3' ' A' ' 76' ' ' ARG . 4.0 tp -90.0 175.93 6.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.931 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.07 85.88 1.33 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.971 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.91 160.7 15.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.869 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -98.11 34.62 1.9 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.967 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.462 ' CB ' ' HD2' ' A' ' 84' ' ' PRO . 0.3 OUTLIER -52.85 173.3 0.18 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.222 179.434 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.462 ' HD2' ' CB ' ' A' ' 83' ' ' SER . 41.8 Cg_endo -67.71 62.18 0.87 Allowed 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.086 1.857 . . . . 0.0 112.341 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.7 mp -87.18 -31.37 20.4 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.934 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -72.06 68.79 1.08 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.523 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -175.25 89.5 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.794 0.33 . . . . 0.0 110.832 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 6.5 mt -144.59 -55.86 0.34 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.985 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.748 HD12 ' HB3' ' A' ' 30' ' ' TYR . 3.8 mm? 61.06 92.64 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.857 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -113.99 -33.25 5.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.036 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -64.67 123.16 26.38 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.506 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 11.8 p -132.85 137.76 53.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.757 0.313 . . . . 0.0 111.085 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -139.63 129.16 24.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.14 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -60.38 119.7 8.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.82 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.698 HG12 ' HD3' ' A' ' 96' ' ' PRO . 8.7 p -83.13 -34.18 0.6 Allowed Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.698 ' HD3' HG12 ' A' ' 95' ' ' VAL . 3.1 Cg_exo -75.24 54.48 3.77 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.262 1.975 . . . . 0.0 112.597 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.558 ' HB2' ' O ' ' A' ' 96' ' ' PRO . . . 168.78 42.56 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.018 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 1.7 m -125.3 162.94 23.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.943 0.401 . . . . 0.0 111.215 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.04 101.18 3.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.542 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.867 HD13 HG23 ' A' ' 116' ' ' ILE . 14.2 mm -71.03 160.12 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.403 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.468 ' N ' HG22 ' A' ' 100' ' ' ILE . . . -156.08 90.25 1.19 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.898 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.3 mt -56.43 149.28 3.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.33 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 15.6 mtp180 -142.97 113.75 5.83 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.554 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -67.5 0.33 4.22 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.549 2.166 . . . . 0.0 113.034 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -141.27 59.15 1.52 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.988 0.423 . . . . 0.0 110.536 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -43.06 -85.49 0.01 OUTLIER Glycine 0 C--N 1.331 0.251 0 CA-C-N 115.769 -0.65 . . . . 0.0 113.249 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 23.9 ttmt -176.69 160.47 1.95 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.947 0.403 . . . . 0.0 111.358 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 60.53 -84.3 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.128 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -146.41 31.2 1.0 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.951 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.428 ' HG3' ' CE2' ' A' ' 17' ' ' TRP . 13.9 mmt180 -114.57 100.36 8.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.777 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.2 mt -85.08 5.41 29.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.469 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -139.98 78.6 1.67 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.822 0.344 . . . . 0.0 110.972 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.49 HG13 ' HB2' ' A' ' 129' ' ' ALA . 36.2 t -129.13 135.61 61.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.933 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.428 ' CZ ' ' HB ' ' A' ' 128' ' ' VAL . 42.0 p90 -114.48 122.57 47.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.017 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 10.9 t -97.7 136.06 38.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.885 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.867 HG23 HD13 ' A' ' 100' ' ' ILE . 10.9 mt -96.31 157.94 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.974 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.416 ' N ' HG22 ' A' ' 116' ' ' ILE . 1.5 m -150.04 166.85 28.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.951 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 13.7 mtp -139.53 100.43 7.56 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.903 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -79.94 54.69 5.32 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.568 2.179 . . . . 0.0 112.627 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 178.94 49.49 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.98 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.647 HG22 ' N ' ' A' ' 122' ' ' ALA . 0.3 OUTLIER -161.85 -82.11 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.92 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.647 ' N ' HG22 ' A' ' 121' ' ' VAL . . . -157.08 -165.47 1.84 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.184 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -84.64 56.93 4.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.945 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 39.9 m95 -104.21 148.87 25.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.926 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 14.1 m -153.3 123.66 7.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.808 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.657 HD23 HD12 ' A' ' 116' ' ' ILE . 14.4 tp -102.83 155.85 18.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.99 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -131.95 134.41 45.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.836 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.58 HG12 HD12 ' A' ' 7' ' ' LEU . 23.7 t -152.38 159.15 3.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.092 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.49 ' HB2' HG13 ' A' ' 113' ' ' VAL . . . -158.57 117.65 3.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.161 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.581 ' HB3' ' HB2' ' A' ' 136' ' ' LEU . . . -81.37 134.98 35.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.842 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -54.47 -34.39 61.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.885 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.94 113.4 24.94 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.744 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -48.04 -27.94 2.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.475 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 -76.65 -44.29 34.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.292 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -65.66 -31.88 73.14 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.011 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.581 ' HB2' ' HB3' ' A' ' 130' ' ' ALA . 7.2 tt -67.77 -50.78 55.25 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.314 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -66.39 -37.17 84.64 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.262 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -70.43 -31.5 68.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.403 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' TRP . . . . . 0.444 ' CE2' HD21 ' A' ' 7' ' ' LEU . 0.7 OUTLIER -67.65 -43.03 81.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.58 179.821 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.686 HG13 ' CB ' ' A' ' 100' ' ' ILE . 26.7 t -65.22 -44.2 95.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.848 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 7.3 ttmm -63.84 -33.77 76.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.884 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.671 ' HD2' HG22 ' A' ' 2' ' ' ILE . 17.0 mmtt -67.93 -49.46 61.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.525 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.753 HD13 HD11 ' A' ' 100' ' ' ILE . 30.7 mt -54.35 -38.15 39.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.352 0.596 . . . . 0.0 109.517 178.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 66.2 mtt180 -77.95 -27.69 49.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.479 179.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.651 ' O ' HG22 ' A' ' 149' ' ' THR . 2.1 tp10 -75.16 -33.23 61.47 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.861 0.362 . . . . 0.0 110.705 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.645 HG11 HG21 ' A' ' 95' ' ' VAL . 9.9 p -79.63 -34.3 15.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.065 0.459 . . . . 0.0 110.19 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -71.48 -34.43 70.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.563 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -75.1 -10.7 59.71 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.931 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.651 HG22 ' O ' ' A' ' 145' ' ' GLU . 10.9 t -126.26 21.34 7.34 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.103 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.166 -0.921 . . . . 0.0 111.19 179.985 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 8.0 t . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 120.885 0.374 . . . . 0.0 111.159 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.424 HD11 ' HA ' ' A' ' 26' ' ' SER . 39.4 mt -79.79 -34.48 15.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.121 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.7 tttp -140.1 153.82 46.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.01 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -160.97 124.39 3.34 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.924 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -160.4 -178.0 34.01 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.542 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.637 ' N ' HD12 ' A' ' 6' ' ' ILE . 3.2 mp -89.52 92.01 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.909 0.385 . . . . 0.0 110.985 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 1.078 HD12 HG12 ' A' ' 128' ' ' VAL . 3.2 mm? -95.6 135.38 37.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.732 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -76.76 158.36 30.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.95 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.437 HD12 ' O ' ' A' ' 127' ' ' ASP . 1.4 tp -161.78 128.19 3.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.808 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.436 ' HG3' ' CE3' ' A' ' 17' ' ' TRP . 3.4 mt-10 -71.11 111.57 6.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.99 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.92 127.54 66.77 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.53 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -56.69 -16.81 20.56 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.504 2.136 . . . . 0.0 112.899 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 37.8 t -69.36 -41.67 80.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.858 0.361 . . . . 0.0 111.352 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -117.75 -10.18 10.57 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.649 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 62.86 30.84 16.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.789 0.328 . . . . 0.0 110.815 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.64 160.4 39.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.801 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.463 ' NE1' ' HG3' ' A' ' 110' ' ' ARG . 45.0 m95 -56.7 138.04 53.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.051 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -126.07 125.31 24.73 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.686 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.64 112.06 2.95 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.439 2.092 . . . . 0.0 112.228 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 22.0 m80 -148.64 141.79 24.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.871 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -59.38 154.6 16.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.719 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.427 ' CE2' ' CD1' ' A' ' 31' ' ' TYR . 0.1 OUTLIER -147.35 138.86 23.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.976 -179.827 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.8 t -131.41 150.8 34.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.113 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 25.7 tp -134.37 118.99 18.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.952 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.431 ' HG1' ' C ' ' A' ' 28' ' ' LYS . 62.6 p -97.95 157.58 16.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.983 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.424 ' HA ' HD11 ' A' ' 2' ' ' ILE . 29.4 t -48.97 -38.08 22.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.85 -0.613 . . . . 0.0 112.057 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.3 m -129.59 39.06 3.78 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.555 ' N ' HG23 ' A' ' 95' ' ' VAL . 2.6 tttt 175.01 170.03 0.28 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.007 0.432 . . . . 0.0 111.378 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.667 HD12 ' HB3' ' A' ' 93' ' ' LEU . 3.5 mt -128.87 153.23 38.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.716 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.404 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 0.6 OUTLIER -129.93 146.28 51.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.904 0.383 . . . . 0.0 111.112 -179.889 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.427 ' CD1' ' CE2' ' A' ' 22' ' ' PHE . 39.7 t80 -146.35 143.48 29.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.84 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.4 m -124.23 174.13 7.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.963 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -146.97 178.98 7.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.864 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.93 155.48 21.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.939 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.58 132.11 47.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.896 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.4 m -162.74 33.45 0.1 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.928 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.0 m 60.69 62.25 1.53 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.886 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.11 115.94 18.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.869 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -148.46 60.92 1.09 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.731 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 179.58 -32.48 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.748 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -94.58 31.69 1.73 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.79 0.329 . . . . 0.0 111.099 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -101.95 33.14 3.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.845 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.5 t70 61.7 82.59 0.17 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.95 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -86.35 177.48 7.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.934 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -121.21 135.81 55.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.902 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 58.33 78.68 0.35 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.009 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.4 87.89 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.559 2.172 . . . . 0.0 112.298 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.78 -169.33 2.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.008 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 47.2 mm-40 -100.57 119.75 39.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.807 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -112.15 102.43 10.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.064 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.3 p -89.14 88.96 7.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.979 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 66.93 141.84 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.45 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.68 125.33 35.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.803 0.335 . . . . 0.0 110.857 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.3 t -99.81 37.1 1.67 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.897 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -80.29 150.29 30.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.881 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 60.2 84.09 0.13 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.812 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -132.58 165.05 25.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.926 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 66.6 m -104.31 162.61 13.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.93 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.754 ' O ' HD13 ' A' ' 63' ' ' LEU . 3.3 m -58.93 132.36 53.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.955 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.63 -61.92 1.38 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.09 0.471 . . . . 0.0 110.973 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -59.89 -34.05 72.65 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.885 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.8 t -71.84 -27.67 28.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.085 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.754 HD13 ' O ' ' A' ' 59' ' ' SER . 6.5 mp -79.21 -12.87 59.97 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.27 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -85.96 23.79 1.41 Allowed 'General case' 0 CA--C 1.528 0.123 0 CA-C-O 121.259 0.552 . . . . 0.0 110.311 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 172.56 35.34 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.438 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 163.67 66.5 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.222 -179.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -66.62 138.86 51.05 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.576 2.184 . . . . 0.0 112.301 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.448 ' N ' ' HD3' ' A' ' 69' ' ' PRO . 2.4 m120 61.9 51.77 2.02 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.92 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.448 ' HD3' ' N ' ' A' ' 68' ' ' ASN . 86.3 Cg_endo -80.81 1.77 9.05 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.645 2.23 . . . . 0.0 112.781 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -96.24 30.09 2.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.797 0.332 . . . . 0.0 111.347 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.527 HG22 ' O ' ' A' ' 71' ' ' ILE . 14.9 mt -106.04 -7.88 10.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.764 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 72' ' ' LEU . 15.8 mt -89.5 19.69 4.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.107 0.479 . . . . 0.0 111.45 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -144.07 90.41 6.82 Favored Pre-proline 0 C--N 1.319 -0.748 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.358 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -67.27 59.34 0.67 Allowed 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.936 2.424 . . . . 0.0 112.471 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -122.36 -40.75 2.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.843 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.405 ' HD3' HD11 ' A' ' 79' ' ' LEU . 0.6 OUTLIER -68.39 -171.98 0.3 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.874 179.934 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 63.57 31.55 14.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.917 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.56 ' H ' HD12 ' A' ' 79' ' ' LEU . 0.8 OUTLIER -177.05 75.5 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.854 179.94 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.56 HD12 ' H ' ' A' ' 78' ' ' HIS . 5.6 mp -131.36 153.38 49.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.919 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.0 t70 59.84 31.07 20.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.094 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -70.71 -174.04 0.85 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.705 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 -94.4 38.48 1.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.34 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.434 ' CB ' ' HD2' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -61.15 171.79 1.09 Allowed Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.07 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.434 ' HD2' ' CB ' ' A' ' 83' ' ' SER . 39.2 Cg_endo -67.1 61.8 0.64 Allowed 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.087 1.858 . . . . 0.0 112.059 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.402 ' N ' ' O ' ' A' ' 83' ' ' SER . 0.3 OUTLIER -116.31 -38.1 3.63 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.098 -179.835 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 57.97 97.21 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.523 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -117.6 -77.53 0.57 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.868 0.365 . . . . 0.0 110.876 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.1 mp 60.48 35.11 20.35 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.849 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 8.7 tt -96.65 111.91 23.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.899 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.81 -48.71 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.847 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -139.52 142.62 12.93 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.51 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 29' ' ' ILE . 11.3 p -151.43 136.33 10.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.877 0.37 . . . . 0.0 111.033 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.667 ' HB3' HD12 ' A' ' 29' ' ' ILE . 0.3 OUTLIER -123.92 -176.44 3.48 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.891 -179.966 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -119.59 141.36 49.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.91 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.724 ' CG1' HG23 ' A' ' 146' ' ' VAL . 21.8 t -80.87 -46.87 1.19 Allowed Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.778 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 95' ' ' VAL . 84.6 Cg_endo -81.83 50.31 3.44 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.367 2.045 . . . . 0.0 112.497 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -179.55 37.85 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.959 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 14.4 p -134.34 -177.45 4.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.963 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.4 100.79 0.83 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.697 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 1.089 HD13 HG23 ' A' ' 116' ' ' ILE . 16.9 mm -76.82 160.58 4.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.02 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.468 ' N ' HG22 ' A' ' 100' ' ' ILE . . . -159.02 91.75 1.05 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.901 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.63 HG12 HG21 ' A' ' 140' ' ' VAL . 27.7 mt -58.07 157.47 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.242 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.498 ' N ' HG22 ' A' ' 102' ' ' ILE . 95.3 mtt180 -151.41 112.32 3.01 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.366 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.09 49.25 2.75 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.429 2.086 . . . . 0.0 112.523 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 167.35 61.98 0.0 OUTLIER 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.001 0.429 . . . . 0.0 110.223 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -55.04 -94.97 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.676 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.406 ' HD2' ' CZ2' ' A' ' 17' ' ' TRP . 0.0 OUTLIER 174.1 163.18 0.19 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.823 0.344 . . . . 0.0 111.014 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 57.07 54.6 6.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.975 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 9.0 m120 62.76 51.98 2.89 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.215 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.463 ' HG3' ' NE1' ' A' ' 17' ' ' TRP . 23.9 mmt180 -147.53 97.38 2.83 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.718 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.01 -32.47 57.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.978 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.614 ' HB3' HD13 ' A' ' 136' ' ' LEU . 6.5 m-85 -102.87 104.21 14.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.939 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.533 HG13 ' HB2' ' A' ' 129' ' ' ALA . 20.4 t -152.0 134.04 5.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.16 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -118.96 131.3 56.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.744 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 15.0 t -100.18 132.86 45.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.965 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 1.089 HG23 HD13 ' A' ' 100' ' ' ILE . 2.4 mp -104.29 159.82 5.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.942 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.477 ' N ' HG22 ' A' ' 116' ' ' ILE . 70.5 p -155.74 179.99 8.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.905 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . 0.696 ' HE3' HG11 ' A' ' 121' ' ' VAL . 7.3 mtm -143.33 93.26 6.47 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.782 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.93 -2.29 12.51 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.584 2.189 . . . . 0.0 112.794 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 48.6 m -108.9 33.88 4.0 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.718 0.294 . . . . 0.0 111.142 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.696 HG11 ' HE3' ' A' ' 118' ' ' MET . 0.4 OUTLIER -160.31 -82.45 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.94 179.907 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.653 ' H ' HG13 ' A' ' 121' ' ' VAL . . . -143.98 -166.06 2.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.838 0.351 . . . . 0.0 111.049 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -86.21 55.32 3.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.971 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . 0.499 ' CD1' ' HB3' ' A' ' 122' ' ' ALA . 89.4 m95 -85.93 142.24 28.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.786 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.16 119.94 5.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.006 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.608 HD23 ' N ' ' A' ' 126' ' ' LEU . 1.2 pt? -129.28 124.7 35.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.88 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.437 ' O ' HD12 ' A' ' 9' ' ' LEU . 1.1 m-20 -86.9 142.89 27.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.949 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 1.078 HG12 HD12 ' A' ' 7' ' ' LEU . 14.0 t -151.32 141.9 15.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.081 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.533 ' HB2' HG13 ' A' ' 113' ' ' VAL . . . -140.93 131.49 25.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.129 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.602 ' HB3' ' HB2' ' A' ' 136' ' ' LEU . . . -93.22 138.58 31.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.92 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -55.5 -39.62 70.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.0 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.73 113.13 25.31 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.905 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -48.05 -28.41 2.81 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.547 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -76.8 -44.29 33.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.328 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -65.65 -32.29 73.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.996 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.614 HD13 ' HB3' ' A' ' 112' ' ' PHE . 6.2 tt -67.38 -51.22 54.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.394 179.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 73.4 mm-40 -67.68 -35.25 78.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.192 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -71.5 -30.18 65.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.205 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' TRP . . . . . 0.406 ' CH2' ' HB3' ' A' ' 22' ' ' PHE . 0.5 OUTLIER -67.41 -47.07 71.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.348 179.54 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.729 HG13 HG21 ' A' ' 100' ' ' ILE . 23.3 t -61.76 -45.52 98.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.797 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 1.1 ttpt -62.97 -36.94 85.18 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.742 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.601 ' O ' HG22 ' A' ' 146' ' ' VAL . 17.9 tppt? -65.66 -56.26 13.08 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.294 179.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.653 HG21 HD11 ' A' ' 100' ' ' ILE . 71.0 mt -50.97 -31.76 10.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.107 0.48 . . . . 0.0 109.706 178.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.439 ' HD2' HG12 ' A' ' 140' ' ' VAL . 30.5 mtt180 -78.69 -30.15 45.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.493 179.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.827 ' O ' HG23 ' A' ' 149' ' ' THR . 5.2 tt0 -77.23 -35.94 55.04 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-O 120.761 0.315 . . . . 0.0 110.777 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.724 HG23 ' CG1' ' A' ' 95' ' ' VAL . 5.6 m -79.44 -28.45 13.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.306 179.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.479 ' HA ' HG12 ' A' ' 95' ' ' VAL . . . -74.37 -36.97 63.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.684 179.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -72.34 -13.07 61.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.042 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.827 HG23 ' O ' ' A' ' 145' ' ' GLU . 11.5 p -106.53 -38.96 6.01 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.107 0.479 . . . . 0.0 110.48 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.271 -0.871 . . . . 0.0 111.291 -179.924 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 24.1 m . . . . . 0 N--CA 1.487 1.409 0 CA-C-O 120.776 0.322 . . . . 0.0 111.179 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.512 HD11 ' CB ' ' A' ' 26' ' ' SER . 19.9 mt -88.5 -34.09 6.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.933 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.42 ' HG2' ' NE1' ' A' ' 139' ' ' TRP . 0.0 OUTLIER -136.56 142.1 43.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.768 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -154.58 121.27 5.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.968 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -170.04 -176.32 39.59 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.421 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.539 ' N ' HD12 ' A' ' 6' ' ' ILE . 4.2 mp -103.26 89.17 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.866 0.365 . . . . 0.0 111.026 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.534 HD11 ' HB2' ' A' ' 130' ' ' ALA . 3.4 mm? -82.06 142.46 32.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.651 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -77.74 144.67 37.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.29 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.465 HD21 HG22 ' A' ' 128' ' ' VAL . 2.6 mp -152.89 115.55 4.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.611 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.411 ' HB3' ' CE3' ' A' ' 17' ' ' TRP . 2.0 pp20? -72.6 140.73 48.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.257 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.42 148.33 36.98 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.531 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.39 -5.46 17.17 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.434 2.089 . . . . 0.0 112.705 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 25.2 t -65.75 -40.83 88.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.984 0.421 . . . . 0.0 110.724 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -139.12 9.34 2.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.407 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 49.03 59.07 4.71 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.878 0.371 . . . . 0.0 111.266 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -149.1 139.33 22.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.808 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.411 ' CE3' ' HB3' ' A' ' 10' ' ' GLU . 75.5 m95 -57.72 143.03 43.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.895 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -135.73 137.17 24.97 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.84 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.75 90.51 1.22 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.491 2.127 . . . . 0.0 112.399 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 12.7 m170 -112.3 138.72 48.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.008 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -60.19 159.5 9.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.782 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.483 ' CD2' ' CD1' ' A' ' 31' ' ' TYR . 0.1 OUTLIER -170.95 128.69 0.75 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.789 179.901 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 19.1 t -122.22 153.66 26.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.09 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.9 tp -128.58 118.99 23.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.986 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.8 p -99.54 154.43 18.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.846 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.512 ' CB ' HD11 ' A' ' 2' ' ' ILE . 1.4 m -54.43 -25.53 25.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.832 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.8 p -136.24 35.56 2.77 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.4 mttt 170.9 177.13 0.06 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.973 0.415 . . . . 0.0 111.12 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.8 mt -140.16 131.71 31.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.707 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.496 ' CD1' HD22 ' A' ' 89' ' ' LEU . 42.8 m-85 -110.35 144.32 39.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.938 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.483 ' CD1' ' CD2' ' A' ' 22' ' ' PHE . 35.1 t80 -139.5 130.21 25.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.871 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -135.8 178.89 6.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.777 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -140.32 -45.95 0.42 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.002 0.43 . . . . 0.0 111.031 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -144.56 108.19 4.66 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.939 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.466 HG22 ' H ' ' A' ' 36' ' ' SER . 0.2 OUTLIER -86.73 176.08 7.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.826 -179.887 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.466 ' H ' HG22 ' A' ' 35' ' ' THR . 0.8 OUTLIER -148.42 144.64 27.58 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.899 -179.922 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.24 108.13 3.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.962 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -147.27 76.23 1.4 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.909 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -141.15 33.01 1.72 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.993 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -94.66 99.66 2.47 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.443 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -170.47 71.36 0.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.847 0.356 . . . . 0.0 110.886 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -140.12 44.81 1.89 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.953 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.3 t0 61.34 154.6 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.919 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -88.42 114.01 24.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.921 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.74 177.05 5.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.854 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -88.09 114.21 58.32 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.888 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -51.71 160.34 2.82 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.417 2.078 . . . . 0.0 112.342 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -87.07 65.88 9.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.883 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -92.69 169.55 10.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.843 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -154.79 139.81 17.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.146 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -164.91 34.05 0.06 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.895 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -165.48 -169.26 28.86 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.442 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.4 m -125.28 31.91 5.48 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.832 0.349 . . . . 0.0 110.822 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.448 HG23 ' O ' ' A' ' 54' ' ' THR . 4.2 t -131.52 84.06 2.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.793 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -173.1 155.94 3.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.902 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 62.71 147.82 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.841 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 64.7 m80 -156.3 102.98 2.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.872 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 60.55 160.81 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.892 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.5 m -93.41 123.35 36.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.919 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -163.91 -44.07 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.842 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -68.18 -35.7 78.45 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.847 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.5 t -70.3 -30.52 43.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.101 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -76.96 -13.6 59.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.237 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -91.1 24.83 2.69 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 121.223 0.535 . . . . 0.0 110.73 179.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -163.4 29.76 0.09 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.668 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -123.36 -73.69 0.27 Allowed Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.178 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -56.52 83.89 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.832 2.355 . . . . 0.0 112.289 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 55.35 93.26 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.927 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.77 -0.05 10.11 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.646 2.231 . . . . 0.0 112.979 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -96.77 29.87 2.86 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.815 0.341 . . . . 0.0 111.352 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.534 HG22 ' O ' ' A' ' 71' ' ' ILE . 6.8 mt -117.5 -8.53 11.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.817 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.419 ' HA ' HD23 ' A' ' 72' ' ' LEU . 7.0 mt -88.34 20.63 3.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.032 0.444 . . . . 0.0 111.6 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.457 ' N ' ' HD3' ' A' ' 74' ' ' PRO . 8.7 pt-20 -145.18 63.69 10.19 Favored Pre-proline 0 C--N 1.317 -0.812 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.753 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.457 ' HD3' ' N ' ' A' ' 73' ' ' GLU . 1.9 Cg_endo -85.32 39.32 0.7 Allowed 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 123.235 2.623 . . . . 0.0 112.498 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -97.21 -34.28 11.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.834 0.35 . . . . 0.0 110.903 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.84 167.03 22.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.946 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -174.68 127.54 0.31 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.764 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 5.1 t60 64.43 31.79 12.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.691 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.3 tp -85.76 -168.56 2.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.983 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -78.87 74.51 5.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.893 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -76.96 142.18 40.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.896 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -98.28 32.16 2.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.025 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.43 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 0.4 OUTLIER -71.12 -58.93 3.68 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.113 179.907 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 83' ' ' SER . 67.4 Cg_endo -75.37 -23.89 12.77 Favored 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 122.916 2.411 . . . . 0.0 112.426 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.38 33.38 2.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.97 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -78.88 148.61 31.98 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.516 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -62.32 -22.52 66.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.723 0.296 . . . . 0.0 111.104 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 12.5 mt -96.42 37.96 1.23 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.029 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.496 HD22 ' CD1' ' A' ' 30' ' ' TYR . 11.0 mt -154.47 109.8 3.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.739 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 7.5 tpt180 -113.89 -33.67 5.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.227 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.413 ' HA3' ' HB3' ' A' ' 31' ' ' TYR . . . -83.28 125.45 7.02 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.741 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 10.6 p -158.13 130.84 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.775 0.322 . . . . 0.0 110.903 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.692 HD23 ' H ' ' A' ' 94' ' ' ASP . 0.6 OUTLIER -148.48 150.53 33.59 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.103 -179.788 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.692 ' H ' HD23 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -81.96 128.05 33.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.711 179.802 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.655 HG12 ' HD3' ' A' ' 96' ' ' PRO . 8.3 p -71.44 -32.87 2.4 Favored Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.655 ' HD3' HG12 ' A' ' 95' ' ' VAL . 6.3 Cg_exo -73.9 56.36 3.57 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.202 1.934 . . . . 0.0 112.418 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.534 ' HB2' ' O ' ' A' ' 96' ' ' PRO . . . 170.09 63.48 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.963 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 64.9 m -146.46 168.11 21.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.125 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -154.0 99.47 2.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.606 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.916 HD13 HG23 ' A' ' 116' ' ' ILE . 11.2 mm -76.34 159.18 5.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.235 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.431 ' N ' HG22 ' A' ' 100' ' ' ILE . . . -154.45 88.21 1.21 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.904 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.559 ' CG1' HG21 ' A' ' 140' ' ' VAL . 7.6 mt -58.27 156.32 2.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.158 0.504 . . . . 0.0 111.365 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.483 ' N ' HG22 ' A' ' 102' ' ' ILE . 33.2 mtt180 -145.81 125.56 6.91 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.082 179.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -82.98 30.06 0.54 Allowed 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.41 2.073 . . . . 0.0 112.914 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -177.75 69.73 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.88 0.371 . . . . 0.0 110.642 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -55.11 -94.21 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.732 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -174.88 169.68 3.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.861 0.362 . . . . 0.0 110.913 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 61.66 -82.69 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.031 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -153.92 31.71 0.45 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.943 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.4 ' HB3' ' CG2' ' A' ' 113' ' ' VAL . 6.1 mmt85 -117.51 90.2 3.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.834 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.571 ' H ' HD12 ' A' ' 111' ' ' LEU . 2.9 mp -62.91 -30.86 71.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.826 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.768 ' HB3' HD13 ' A' ' 136' ' ' LEU . 75.2 m-85 -109.82 105.24 14.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.035 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.425 HG13 ' HB2' ' A' ' 129' ' ' ALA . 39.4 t -144.76 138.87 22.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.967 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.425 ' CE2' ' HB ' ' A' ' 128' ' ' VAL . 39.9 p90 -122.88 133.47 54.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.928 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.59 129.49 50.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.933 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.916 HG23 HD13 ' A' ' 100' ' ' ILE . 1.7 mt -97.84 159.56 3.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.014 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.471 ' N ' HG22 ' A' ' 116' ' ' ILE . 52.3 p -156.72 175.22 14.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.964 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . 0.565 ' CE ' HG11 ' A' ' 121' ' ' VAL . 2.2 mtm -137.95 91.56 13.23 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.815 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.45 -2.04 12.19 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.624 2.216 . . . . 0.0 112.816 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.4 m -108.94 31.44 5.68 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.692 0.282 . . . . 0.0 111.261 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.655 HG13 ' H ' ' A' ' 122' ' ' ALA . 0.4 OUTLIER -158.41 -82.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.885 179.864 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.655 ' H ' HG13 ' A' ' 121' ' ' VAL . . . -146.07 -164.93 2.08 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.079 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -85.05 57.18 4.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.827 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . 0.639 ' NE1' ' HB3' ' A' ' 122' ' ' ALA . 36.9 m95 -102.47 117.27 34.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.793 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -142.39 138.85 31.43 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.882 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.45 HD11 HD13 ' A' ' 116' ' ' ILE . 0.5 OUTLIER -127.6 170.08 13.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.901 -179.937 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -123.87 129.54 51.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.955 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.48 HG12 ' N ' ' A' ' 129' ' ' ALA . 18.7 t -140.94 159.54 23.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.928 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.48 ' N ' HG12 ' A' ' 128' ' ' VAL . . . -159.94 148.89 17.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.909 0.385 . . . . 0.0 111.221 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.534 ' HB2' HD11 ' A' ' 7' ' ' LEU . . . -112.59 135.5 53.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.938 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.47 -35.35 52.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.954 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.04 112.77 24.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.826 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.435 ' HG2' ' CD1' ' A' ' 112' ' ' PHE . 3.1 mt-30 -48.56 -27.8 3.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.725 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -77.12 -43.87 32.51 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.34 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -65.82 -31.25 72.1 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.137 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.768 HD13 ' HB3' ' A' ' 112' ' ' PHE . 7.7 tt -69.84 -50.44 42.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.474 179.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.492 HE22 HD13 ' A' ' 102' ' ' ILE . 36.2 mm-40 -67.87 -36.61 80.57 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.237 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -71.0 -28.51 64.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.407 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' TRP . . . . . 0.42 ' NE1' ' HG2' ' A' ' 3' ' ' LYS . 0.8 OUTLIER -69.75 -46.32 66.14 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.52 179.667 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.701 HG13 HG21 ' A' ' 100' ' ' ILE . 30.5 t -63.45 -42.29 95.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.741 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.45 -36.79 84.9 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.819 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.45 ' O ' HG22 ' A' ' 146' ' ' VAL . 0.0 OUTLIER -65.77 -56.0 14.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.312 179.521 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.786 HG21 HD11 ' A' ' 100' ' ' ILE . 65.9 mt -51.6 -31.8 13.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.167 0.508 . . . . 0.0 109.844 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 58.2 mtt180 -80.88 -28.63 35.89 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.535 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.626 ' O ' HG22 ' A' ' 149' ' ' THR . 0.6 OUTLIER -72.59 -39.52 67.27 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.839 0.352 . . . . 0.0 110.675 179.671 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.597 ' CG2' HG21 ' A' ' 95' ' ' VAL . 9.0 m -78.48 -32.72 16.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.072 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.42 -34.26 65.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.416 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -73.05 -13.28 61.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.791 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.626 HG22 ' O ' ' A' ' 145' ' ' GLU . 8.9 t -122.96 19.24 10.09 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.152 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.257 -0.878 . . . . 0.0 111.112 179.92 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 61.7 m . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.765 0.317 . . . . 0.0 111.262 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.833 HD11 ' HA ' ' A' ' 26' ' ' SER . 12.3 mt -77.2 -35.55 22.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.887 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -157.92 150.44 22.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.873 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.435 ' HB3' HG13 ' A' ' 23' ' ' VAL . 36.1 p-10 -157.91 137.8 12.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.887 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -170.06 179.06 42.56 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.493 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.57 ' N ' HD12 ' A' ' 6' ' ' ILE . 3.7 mp -93.31 79.24 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.933 0.397 . . . . 0.0 111.105 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.59 HD23 ' CZ2' ' A' ' 139' ' ' TRP . 2.0 mm? -77.26 163.62 26.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.808 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -100.51 142.51 31.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.04 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -148.64 105.62 3.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.768 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.59 120.74 11.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.126 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.07 129.14 68.46 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.49 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -68.74 -9.82 27.29 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.395 2.063 . . . . 0.0 112.687 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.9 t -64.22 -40.19 88.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.069 0.462 . . . . 0.0 110.602 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 54.6 p30 -142.22 12.81 1.99 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.355 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 50.27 79.35 0.09 Allowed 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 120.666 0.27 . . . . 0.0 111.071 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -162.96 133.34 4.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.922 0.391 . . . . 0.0 111.028 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 29.5 m95 -67.9 137.3 55.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.863 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -137.32 132.27 17.82 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.879 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.22 127.18 24.77 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.414 2.076 . . . . 0.0 112.241 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -135.51 122.17 20.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.869 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -80.24 85.27 5.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.924 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.441 ' CE2' ' HB3' ' A' ' 31' ' ' TYR . 4.0 m-85 -79.42 157.45 27.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.873 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.435 HG13 ' HB3' ' A' ' 4' ' ' ASN . 21.6 t -143.03 104.38 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.399 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.425 HD21 HG11 ' A' ' 146' ' ' VAL . 20.0 tp -86.51 117.36 25.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.717 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -99.7 157.97 16.1 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.301 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.833 ' HA ' HD11 ' A' ' 2' ' ' ILE . 7.0 t -44.55 -33.43 1.75 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.835 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.456 ' HA ' HG11 ' A' ' 95' ' ' VAL . 3.6 m -144.07 46.33 1.44 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.798 0.332 . . . . 0.0 111.403 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.3 mttt 179.27 167.91 1.03 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.939 0.399 . . . . 0.0 111.174 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.1 mt -139.51 106.15 2.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.825 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -97.03 139.61 32.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.989 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.441 ' HB3' ' CE2' ' A' ' 22' ' ' PHE . 13.2 p90 -140.33 112.95 8.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.827 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.5 m -124.07 151.28 44.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.837 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -96.26 130.28 43.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.88 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -67.79 167.3 13.68 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.84 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.7 t -127.26 -171.19 2.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.94 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -168.54 117.07 0.7 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.894 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 8.6 m -118.26 90.27 3.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.913 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.2 t0 59.6 61.5 1.96 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.903 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -144.47 55.67 1.28 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.905 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 106.2 31.76 3.97 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.505 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -164.17 49.93 0.13 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.925 0.393 . . . . 0.0 110.903 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -98.04 31.67 2.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.982 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -95.19 151.57 19.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.928 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.72 89.69 8.09 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.872 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 60.5 -170.42 0.15 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.91 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -116.14 84.25 13.62 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.967 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.58 157.04 10.3 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.543 2.162 . . . . 0.0 112.337 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.83 149.3 22.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.897 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -128.72 170.6 13.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.89 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -160.58 -173.89 4.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.07 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.85 31.64 4.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.934 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 137.91 -86.5 0.22 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.525 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 91.5 p -152.82 157.93 41.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.726 0.298 . . . . 0.0 110.868 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -106.88 -175.68 2.86 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.931 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.11 -174.62 4.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.872 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.44 -31.02 14.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.02 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -102.09 31.54 3.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.921 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 54.2 p -127.08 24.57 6.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.111 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 62.86 125.75 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.963 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -151.52 -46.27 0.11 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.017 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -68.06 -30.74 70.02 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.897 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.5 t -73.66 -30.58 29.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.092 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -78.22 -13.62 59.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.289 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -93.01 26.18 2.92 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.115 0.483 . . . . 0.0 110.75 179.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -167.8 30.02 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.147 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -109.5 -60.29 0.52 Allowed Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.411 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_exo -53.01 91.92 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.635 2.223 . . . . 0.0 112.391 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 58.51 81.06 0.26 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.957 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -88.94 17.83 1.57 Allowed 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.871 2.381 . . . . 0.0 112.853 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.52 29.66 3.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.837 0.351 . . . . 0.0 111.186 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.493 HG22 ' O ' ' A' ' 71' ' ' ILE . 7.8 mt -116.65 -11.3 11.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.926 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 7.9 mt -88.86 21.24 3.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.022 0.439 . . . . 0.0 111.768 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.487 ' N ' ' HD3' ' A' ' 74' ' ' PRO . 19.8 mt-10 -144.55 61.9 9.12 Favored Pre-proline 0 C--N 1.318 -0.799 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.809 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.487 ' HD3' ' N ' ' A' ' 73' ' ' GLU . 5.8 Cg_exo -74.49 59.35 4.76 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.718 2.279 . . . . 0.0 112.049 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -93.13 -49.79 5.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.106 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -91.07 179.64 5.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.07 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 62.11 111.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.878 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 12.0 t60 61.69 83.11 0.16 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.874 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.2 mp -104.67 -170.45 1.76 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.843 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.3 94.04 5.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.974 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -143.19 156.61 44.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.907 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -97.22 25.49 5.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.026 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.417 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 0.9 OUTLIER -73.86 -59.96 1.69 Allowed Pre-proline 0 C--N 1.331 -0.211 0 CA-C-O 120.915 0.388 . . . . 0.0 111.014 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.417 ' HD2' ' N ' ' A' ' 83' ' ' SER . 64.7 Cg_endo -74.54 -22.37 15.97 Favored 'Trans proline' 0 N--CA 1.465 -0.179 0 C-N-CA 122.902 2.401 . . . . 0.0 112.501 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.6 mp 63.48 -80.6 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.965 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -171.59 91.91 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.598 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -136.01 75.85 1.57 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.954 0.407 . . . . 0.0 110.947 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.25 -49.08 59.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.865 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -129.61 165.63 21.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.858 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 59.77 50.27 7.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.846 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.428 ' HA3' ' CZ ' ' A' ' 31' ' ' TYR . . . -70.85 113.86 4.99 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.61 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.5 p -95.77 133.52 36.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.765 0.317 . . . . 0.0 111.033 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.7 tp -132.56 152.41 51.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.056 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.475 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 2.3 p30 -89.56 126.88 35.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.752 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.772 HG21 HG13 ' A' ' 146' ' ' VAL . 7.6 p -72.42 -33.33 2.23 Favored Pre-proline 0 CA--C 1.534 0.365 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.649 ' HD3' HG12 ' A' ' 95' ' ' VAL . 6.4 Cg_exo -74.28 55.23 3.5 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.334 2.022 . . . . 0.0 112.546 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.531 ' HB2' ' O ' ' A' ' 96' ' ' PRO . . . 170.02 66.44 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.999 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 31.1 p -142.87 161.39 38.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.121 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.408 ' HB2' ' HD3' ' A' ' 119' ' ' PRO . 0.0 OUTLIER -148.59 105.97 3.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.636 179.878 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 1.031 HG21 HG23 ' A' ' 140' ' ' VAL . 4.7 mm -78.02 163.33 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.322 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.433 ' H ' HG22 ' A' ' 100' ' ' ILE . . . -159.89 87.63 0.81 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.822 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.464 HG22 ' N ' ' A' ' 103' ' ' ARG . 84.1 mt -56.72 155.16 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.127 0.489 . . . . 0.0 111.292 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.464 ' N ' HG22 ' A' ' 102' ' ' ILE . 7.2 mtt85 -148.61 118.19 4.09 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.174 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -81.53 33.85 0.54 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.43 2.086 . . . . 0.0 112.784 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 178.87 69.35 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.894 0.378 . . . . 0.0 110.42 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -61.51 -98.79 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.735 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.54 170.27 21.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.866 0.365 . . . . 0.0 110.976 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 60.85 -83.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.114 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -161.35 31.22 0.14 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.824 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.552 ' O ' HG23 ' A' ' 113' ' ' VAL . 2.6 mmp_? -118.25 94.26 4.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.771 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.514 ' H ' HD12 ' A' ' 111' ' ' LEU . 0.9 OUTLIER -69.9 -34.69 73.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.934 -179.93 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.494 ' HB3' HD13 ' A' ' 136' ' ' LEU . 12.1 m-85 -86.56 81.76 8.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.893 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 110' ' ' ARG . 23.6 t -134.06 120.45 35.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.153 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.427 ' CD1' ' HG ' ' A' ' 136' ' ' LEU . 38.7 p90 -106.79 120.45 42.05 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.687 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 31.4 t -92.64 131.39 37.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.227 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.813 HD12 HD12 ' A' ' 100' ' ' ILE . 6.3 mm -92.99 162.84 2.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.684 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.435 ' N ' HG22 ' A' ' 116' ' ' ILE . 2.3 m -150.0 -179.55 7.25 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.027 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 31.1 mtp -155.67 96.59 2.38 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.87 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.408 ' HD3' ' HB2' ' A' ' 99' ' ' GLN . 40.1 Cg_endo -67.3 -27.01 41.14 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.443 2.095 . . . . 0.0 112.297 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.2 p -94.65 43.57 1.1 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.793 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 44.2 t -154.61 -68.51 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.984 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.465 ' HB3' ' CD1' ' A' ' 124' ' ' TRP . . . 179.57 -155.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.225 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 -83.88 49.96 1.73 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.803 0.335 . . . . 0.0 110.977 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . 0.465 ' CD1' ' HB3' ' A' ' 122' ' ' ALA . 12.4 m0 -83.73 122.88 29.24 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.876 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -142.29 96.11 2.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.671 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.484 HD23 ' H ' ' A' ' 126' ' ' LEU . 0.6 OUTLIER -98.58 161.6 13.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.03 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -117.04 142.32 47.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.03 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.542 HG12 HD12 ' A' ' 7' ' ' LEU . 15.6 t -148.38 141.58 18.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.939 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -146.43 134.33 21.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.307 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.409 ' HB2' HD11 ' A' ' 7' ' ' LEU . . . -99.81 138.52 36.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.912 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -52.88 -34.67 55.78 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.036 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 9.2 t -102.1 115.94 31.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.844 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.433 ' HG3' ' CE2' ' A' ' 112' ' ' PHE . 0.3 OUTLIER -48.47 -28.0 3.03 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.386 179.424 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -73.31 -39.89 64.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.206 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.32 -32.79 72.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.027 179.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.494 HD13 ' HB3' ' A' ' 112' ' ' PHE . 6.2 tt -66.35 -46.4 76.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.48 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.45 ' O ' HG12 ' A' ' 140' ' ' VAL . 12.8 mm-40 -70.11 -39.2 75.65 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.293 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -68.68 -31.2 70.14 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.325 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' TRP . . . . . 0.59 ' CZ2' HD23 ' A' ' 7' ' ' LEU . 1.1 m95 -68.77 -46.72 68.01 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.656 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 1.031 HG23 HG21 ' A' ' 100' ' ' ILE . 0.3 OUTLIER -60.88 -40.43 85.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.753 179.888 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 15.7 mtmt -68.18 -37.38 80.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.742 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 10.5 mttt -67.61 -51.82 45.67 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.295 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.551 HG21 HD11 ' A' ' 100' ' ' ILE . 85.8 mt -54.22 -35.13 28.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.308 0.575 . . . . 0.0 109.579 178.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 34.1 mtt180 -79.17 -27.45 42.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.595 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.522 ' O ' HG22 ' A' ' 149' ' ' THR . 1.2 tm-20 -77.35 -34.04 55.23 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.867 0.365 . . . . 0.0 110.767 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.772 HG13 HG21 ' A' ' 95' ' ' VAL . 9.6 p -81.97 -29.46 9.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.372 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -81.0 -34.77 32.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.493 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -79.27 -11.15 59.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.965 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.532 HG22 ' HA ' ' A' ' 146' ' ' VAL . 15.2 t -107.38 -21.5 12.91 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.078 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.215 -0.897 . . . . 0.0 111.14 179.945 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 78.0 p . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 120.845 0.355 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.766 HD11 ' HA ' ' A' ' 26' ' ' SER . 19.6 mt -78.27 -34.94 19.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.145 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.31 140.57 4.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.049 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 33.1 p-10 -146.47 141.91 27.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.819 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -163.4 -171.14 29.26 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.467 -0.873 . . . . 0.0 112.611 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.446 HG21 ' CB ' ' A' ' 36' ' ' SER . 20.8 mm -98.24 80.1 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.777 0.322 . . . . 0.0 111.031 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.754 HD23 ' CZ2' ' A' ' 139' ' ' TRP . 1.7 mm? -88.59 134.72 33.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.663 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.455 ' O ' HG12 ' A' ' 128' ' ' VAL . 28.1 m-85 -73.11 165.56 24.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.242 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -160.01 114.44 2.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.669 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.43 ' HG2' ' CZ3' ' A' ' 17' ' ' TRP . 3.6 pt-20 -73.43 90.49 1.7 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.17 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -60.73 113.33 7.38 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.62 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.66 -18.68 16.27 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.66 2.24 . . . . 0.0 112.916 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.4 t -68.44 -41.11 83.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.897 0.38 . . . . 0.0 111.269 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 -113.92 -13.34 12.56 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.231 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 68.4 m80 61.99 50.91 3.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.862 0.363 . . . . 0.0 110.854 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -152.94 151.7 30.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.792 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.43 ' CZ3' ' HG2' ' A' ' 10' ' ' GLU . 67.1 m95 -80.42 125.1 29.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.931 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -119.85 142.33 32.96 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.813 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -68.6 101.03 0.72 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.46 2.106 . . . . 0.0 112.176 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 35.2 m170 -119.16 138.05 53.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.847 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -82.67 140.0 33.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.865 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.487 ' CZ ' ' CD2' ' A' ' 31' ' ' TYR . 0.2 OUTLIER -133.55 124.78 27.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.914 179.854 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.5 t -111.89 103.31 15.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.829 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.9 tp -82.69 109.37 16.8 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.018 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.512 ' HG1' ' C ' ' A' ' 28' ' ' LYS . 43.2 p -99.1 155.94 17.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.794 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.766 ' HA ' HD11 ' A' ' 2' ' ' ILE . 1.5 m -65.0 -12.13 46.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.898 -179.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.8 m -121.22 2.78 10.37 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.559 ' HA ' HG23 ' A' ' 95' ' ' VAL . 0.5 OUTLIER 173.28 -170.91 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.97 0.414 . . . . 0.0 111.316 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.4 mt -136.74 119.91 21.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.838 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -103.03 153.08 20.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.029 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.487 ' CD2' ' CZ ' ' A' ' 22' ' ' PHE . 25.3 p90 -167.17 148.25 5.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.953 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.45 -175.85 3.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.931 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -68.47 129.05 38.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.928 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -167.14 170.4 11.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.776 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.7 t -98.74 174.89 6.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.865 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.446 ' CB ' HG21 ' A' ' 6' ' ' ILE . 40.1 p -91.25 109.08 20.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.958 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.2 p -106.46 128.83 54.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.823 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -110.86 -30.63 7.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.029 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 7.2 mm100 -135.02 53.81 1.97 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.852 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -94.78 38.53 3.1 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.565 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 59.88 31.66 20.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.839 0.352 . . . . 0.0 110.868 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -114.5 41.53 2.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.06 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -111.55 -179.64 3.77 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.018 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -82.49 100.39 10.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.932 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -72.28 160.24 32.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.863 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -78.66 137.42 58.71 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.832 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.99 166.46 1.51 Allowed 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.35 2.033 . . . . 0.0 112.328 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.71 137.0 33.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.924 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -106.16 31.84 4.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.977 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -101.66 147.41 26.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.042 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.6 m -138.2 -48.87 0.55 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.919 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 138.98 -34.88 2.04 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.517 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.6 m 60.59 99.4 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.837 0.351 . . . . 0.0 110.928 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.555 HG23 ' O ' ' A' ' 54' ' ' THR . 10.1 t -165.68 73.58 0.19 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.925 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -174.51 -174.5 0.85 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.943 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.2 mt -145.33 -48.26 0.23 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.877 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -104.81 157.44 17.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.939 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.7 m -143.85 129.36 19.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.008 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.441 ' HB3' HG23 ' A' ' 62' ' ' VAL . 69.7 m -105.92 121.32 43.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.82 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.96 -44.29 15.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.915 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.8 -38.33 79.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.708 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.441 HG23 ' HB3' ' A' ' 59' ' ' SER . 40.9 t -68.44 -29.61 44.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.607 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 11.0 mt -81.78 -3.75 54.64 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.074 179.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -87.29 25.9 1.31 Allowed 'General case' 0 C--O 1.231 0.108 0 CA-C-O 121.198 0.523 . . . . 0.0 110.476 179.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -178.36 32.04 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.927 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.414 ' N ' ' CD ' ' A' ' 67' ' ' PRO . . . -163.32 50.32 0.31 Allowed Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.458 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 66' ' ' GLY . 73.1 Cg_endo -75.77 -173.46 1.66 Allowed 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.646 2.231 . . . . 0.0 112.501 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -66.25 112.74 9.93 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.832 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -77.34 0.38 9.81 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.426 2.084 . . . . 0.0 112.988 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.22 29.72 3.07 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.796 0.331 . . . . 0.0 111.242 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.471 HG22 ' O ' ' A' ' 71' ' ' ILE . 7.3 mt -117.39 -12.31 11.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.843 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.9 mt -88.03 17.62 4.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.194 0.521 . . . . 0.0 111.813 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.456 ' N ' ' HD3' ' A' ' 74' ' ' PRO . 4.4 mm-40 -142.3 63.18 14.66 Favored Pre-proline 0 C--N 1.315 -0.931 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.623 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.456 ' HD3' ' N ' ' A' ' 73' ' ' GLU . 5.7 Cg_exo -78.17 53.73 4.62 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.997 2.465 . . . . 0.0 112.293 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -108.96 -34.23 6.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.906 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.701 ' HA ' HD11 ' A' ' 79' ' ' LEU . 1.9 mmt85 -138.64 -172.27 3.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.802 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 63.36 110.77 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.822 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 61.9 91.73 0.06 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.924 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.701 HD11 ' HA ' ' A' ' 76' ' ' ARG . 2.9 mp -129.91 -178.83 4.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.857 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.83 59.56 4.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.711 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.28 175.45 7.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.025 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 58.67 20.54 7.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.266 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.493 ' CB ' ' HD2' ' A' ' 84' ' ' PRO . 0.3 OUTLIER -62.09 175.44 0.57 Allowed Pre-proline 0 C--N 1.329 -0.295 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.116 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.493 ' HD2' ' CB ' ' A' ' 83' ' ' SER . 41.0 Cg_endo -67.74 61.71 0.87 Allowed 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 121.974 1.782 . . . . 0.0 112.249 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.47 30.55 4.9 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.952 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -75.63 -74.59 0.9 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.488 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -138.46 75.04 1.5 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.902 0.382 . . . . 0.0 110.86 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.2 mp -145.07 38.63 1.18 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.846 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.17 121.68 34.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.824 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -177.31 -39.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.875 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.43 ' HA3' ' CE1' ' A' ' 31' ' ' TYR . . . -119.62 100.24 0.79 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.498 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.6 m -97.87 156.8 3.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.87 0.367 . . . . 0.0 111.062 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.414 ' HA ' HD12 ' A' ' 93' ' ' LEU . 9.9 tp -151.05 129.77 12.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.027 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.39 138.93 49.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.816 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.819 ' CG1' HG13 ' A' ' 146' ' ' VAL . 18.7 t -79.66 -47.87 1.46 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.752 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.469 ' HD3' ' HB ' ' A' ' 95' ' ' VAL . 94.3 Cg_endo -79.07 55.33 5.56 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.232 1.955 . . . . 0.0 112.499 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.449 ' HB2' ' O ' ' A' ' 96' ' ' PRO . . . 175.53 39.53 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.034 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -156.82 104.15 2.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.943 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -89.76 131.32 35.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.765 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.939 HD11 HG21 ' A' ' 143' ' ' ILE . 11.5 mm -82.28 160.93 3.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.147 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.451 ' N ' HG22 ' A' ' 100' ' ' ILE . . . -154.93 93.95 1.6 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.959 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 46.3 mt -58.48 151.25 4.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.089 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.43 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 10.3 mtt180 -140.72 114.26 7.21 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.617 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 103' ' ' ARG . 5.9 Cg_exo -74.11 11.54 1.18 Allowed 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.681 2.254 . . . . 0.0 112.942 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.74 65.39 0.6 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.925 0.393 . . . . 0.0 110.423 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -48.87 -90.24 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.935 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -171.74 171.61 5.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.89 0.376 . . . . 0.0 111.127 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 60.69 -83.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.233 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -155.07 32.13 0.39 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.069 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 15.1 mtt-85 -122.05 109.97 15.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.806 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.501 HD23 ' H ' ' A' ' 111' ' ' LEU . 0.6 OUTLIER -96.51 23.48 6.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.124 -179.88 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -143.99 68.65 1.27 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.921 0.391 . . . . 0.0 110.764 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.937 HG22 ' HB2' ' A' ' 129' ' ' ALA . 39.5 t -130.02 140.96 47.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.047 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.592 ' CZ ' HG23 ' A' ' 128' ' ' VAL . 25.1 p90 -117.64 132.71 56.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.589 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.4 m -110.58 137.23 48.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.093 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.829 HG23 HD13 ' A' ' 100' ' ' ILE . 2.9 mp -99.89 159.08 3.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.85 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.449 ' N ' HG22 ' A' ' 116' ' ' ILE . 20.1 m -147.87 159.65 43.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.901 0.382 . . . . 0.0 110.953 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 12.9 mtp -113.05 155.33 44.43 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.889 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.96 74.35 0.33 Allowed 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.541 2.161 . . . . 0.0 112.228 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 13.3 p 58.87 107.65 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.985 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.5 t -140.4 -66.66 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.101 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.602 ' HB3' ' NE1' ' A' ' 124' ' ' TRP . . . -169.39 44.77 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.162 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 61.27 37.5 17.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.983 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . 0.602 ' NE1' ' HB3' ' A' ' 122' ' ' ALA . 24.1 m95 -90.2 115.01 27.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.871 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -129.29 118.12 21.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.887 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -84.65 151.15 24.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.917 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -138.33 117.95 13.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.81 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.661 ' HB ' HD12 ' A' ' 7' ' ' LEU . 2.3 m -144.94 154.42 14.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.201 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.937 ' HB2' HG22 ' A' ' 113' ' ' VAL . . . -148.74 122.33 9.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.146 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -90.13 130.96 36.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.991 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.07 -35.94 65.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.922 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.1 m -90.9 111.21 22.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.828 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.84 -28.45 3.74 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.525 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.93 -40.36 60.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.383 179.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -68.06 -33.1 73.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.223 179.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.459 ' O ' HG23 ' A' ' 140' ' ' VAL . 5.2 tt -67.53 -47.91 68.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.449 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -68.21 -40.9 82.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.297 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -66.62 -30.35 70.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.216 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' TRP . . . . . 0.754 ' CZ2' HD23 ' A' ' 7' ' ' LEU . 1.0 OUTLIER -66.31 -50.21 64.43 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.535 179.64 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.601 HG12 ' HD2' ' A' ' 144' ' ' ARG . 38.4 t -61.63 -38.17 79.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.051 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -68.29 -38.83 82.06 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.047 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 3.3 mttt -67.11 -52.76 37.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.302 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.939 HG21 HD11 ' A' ' 100' ' ' ILE . 74.1 mt -54.71 -33.79 28.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.601 ' HD2' HG12 ' A' ' 140' ' ' VAL . 0.1 OUTLIER -78.43 -28.44 46.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.547 179.093 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.619 ' O ' HG22 ' A' ' 149' ' ' THR . 47.4 tt0 -75.26 -39.51 59.72 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.857 0.36 . . . . 0.0 110.579 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.819 HG13 ' CG1' ' A' ' 95' ' ' VAL . 7.8 p -77.54 -27.81 15.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.147 179.181 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -74.5 -39.04 62.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.621 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -72.53 -16.84 61.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.918 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.619 HG22 ' O ' ' A' ' 145' ' ' GLU . 11.8 t -112.79 18.53 18.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.794 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.225 -0.893 . . . . 0.0 111.113 179.945 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 120.862 0.363 . . . . 0.0 111.273 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.758 HD11 ' HA ' ' A' ' 26' ' ' SER . 39.2 mt -74.19 -37.61 46.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.032 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.519 ' HZ2' ' HB3' ' A' ' 3' ' ' LYS . 0.1 OUTLIER -156.12 145.09 20.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.965 -179.828 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.578 ' HB3' HG13 ' A' ' 23' ' ' VAL . 2.6 p-10 -161.92 135.02 6.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.834 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -161.59 -163.86 15.35 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.501 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.691 HD13 ' HD1' ' A' ' 21' ' ' TYR . 25.2 mm -99.66 73.49 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.938 0.399 . . . . 0.0 111.083 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.832 HD12 HG12 ' A' ' 128' ' ' VAL . 0.9 OUTLIER -79.75 150.11 30.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.734 179.957 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.659 ' C ' HD22 ' A' ' 9' ' ' LEU . 23.1 m-85 -87.49 138.4 31.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.977 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.659 HD22 ' C ' ' A' ' 8' ' ' TYR . 4.4 mm? -126.74 175.03 8.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.845 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.447 ' HG3' ' CZ3' ' A' ' 17' ' ' TRP . 18.0 mt-10 -118.33 107.85 14.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.095 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.27 146.63 62.73 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.492 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.23 -17.33 19.14 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.486 2.124 . . . . 0.0 112.735 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.3 t -69.12 -43.76 81.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.0 0.428 . . . . 0.0 111.187 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -112.42 -18.47 12.45 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.192 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 20.6 m170 62.16 29.25 17.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.809 0.338 . . . . 0.0 110.862 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -130.76 176.17 8.43 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.699 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.579 ' HH2' HG11 ' A' ' 113' ' ' VAL . 21.7 m95 -61.79 137.92 58.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.693 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -139.45 141.69 29.56 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.858 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.72 126.41 10.13 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.542 2.161 . . . . 0.0 112.252 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -152.45 167.81 27.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.93 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.691 ' HD1' HD13 ' A' ' 6' ' ' ILE . 7.2 t80 -108.29 115.23 29.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.974 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.446 ' CZ ' ' HB2' ' A' ' 31' ' ' TYR . 2.2 m-85 -108.54 141.46 40.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.922 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.578 HG13 ' HB3' ' A' ' 4' ' ' ASN . 25.8 t -126.63 148.8 31.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.174 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.646 HD22 HG23 ' A' ' 29' ' ' ILE . 1.5 tm? -128.04 110.84 12.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.873 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.1 p -98.76 155.37 17.39 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.006 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.758 ' HA ' HD11 ' A' ' 2' ' ' ILE . 56.4 p -60.58 -16.41 37.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.079 -179.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -133.94 24.27 3.92 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.422 ' CD ' HG21 ' A' ' 92' ' ' VAL . 0.3 OUTLIER 171.67 -176.36 0.05 OUTLIER 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 121.077 0.465 . . . . 0.0 111.684 179.604 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.646 HG23 HD22 ' A' ' 24' ' ' LEU . 1.5 mt -144.79 127.03 9.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.639 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -104.07 142.02 35.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.859 0.361 . . . . 0.0 111.037 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.446 ' HB2' ' CZ ' ' A' ' 22' ' ' PHE . 3.6 p90 -156.66 100.97 1.96 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.942 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.7 t -169.68 158.61 7.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.986 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -76.58 157.81 31.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -167.42 154.8 8.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.88 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.0 t -126.16 -171.67 2.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.883 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.3 m -146.3 95.36 2.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.867 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.8 p -145.57 115.94 7.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.889 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -128.54 86.44 2.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.885 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 60.3 mm-40 -143.48 37.36 1.35 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.925 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -141.15 61.23 0.55 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.536 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 16.1 m-20 -102.02 36.01 2.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.861 0.362 . . . . 0.0 110.878 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -133.19 33.63 3.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.012 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 59.68 92.92 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.903 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -125.97 155.92 40.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.946 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -128.47 -175.52 3.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.883 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -114.17 87.62 13.57 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.955 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -52.11 174.63 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.6 2.2 . . . . 0.0 112.285 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.56 102.18 14.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.89 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -113.74 143.07 45.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.867 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 59.7 36.97 22.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.158 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.3 p -62.51 166.68 4.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.918 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -72.42 115.64 5.45 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.471 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 44.7 m -73.94 169.82 16.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.83 0.348 . . . . 0.0 110.891 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.75 31.77 4.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.914 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -153.15 141.26 20.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.917 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 18.3 mt -81.64 128.63 34.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.886 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 57.2 m-70 -141.65 175.18 9.9 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.963 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 60.98 169.13 0.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.831 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -127.18 170.26 12.59 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.905 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 77.31 -2.75 2.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.48 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -96.1 -28.11 14.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.012 0.434 . . . . 0.0 110.106 179.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.8 t -74.26 -29.8 25.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.819 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -80.08 -9.24 59.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.165 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -93.44 25.97 3.2 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.049 0.452 . . . . 0.0 110.605 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -165.54 29.84 0.05 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.187 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -108.16 -62.19 0.55 Allowed Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.672 -0.694 . . . . 0.0 112.143 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.95 140.66 58.42 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.572 2.181 . . . . 0.0 112.112 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.5 m120 60.09 100.19 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.716 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.94 -4.19 14.97 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.56 2.174 . . . . 0.0 112.988 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.64 28.98 2.43 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.853 0.359 . . . . 0.0 111.385 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.446 HG22 ' O ' ' A' ' 71' ' ' ILE . 6.7 mt -117.36 -13.24 10.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.764 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.8 mp -88.21 18.74 4.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.126 0.489 . . . . 0.0 111.704 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 -143.44 75.12 16.87 Favored Pre-proline 0 C--N 1.316 -0.867 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.414 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -68.04 59.33 0.92 Allowed 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.971 2.447 . . . . 0.0 112.352 -179.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -95.37 -36.0 11.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.812 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 26.6 mmt-85 -105.02 176.06 5.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.893 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 59.61 103.7 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.869 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 61.02 86.36 0.1 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.813 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.1 mp -103.6 150.48 23.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.917 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 60.89 41.44 14.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.933 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -128.95 32.16 4.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.923 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -103.98 -27.19 12.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.005 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.444 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 0.3 OUTLIER -56.23 -59.42 11.96 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.15 -179.915 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 83' ' ' SER . 60.3 Cg_endo -74.01 -26.11 13.35 Favored 'Trans proline' 0 N--CA 1.465 -0.152 0 C-N-CA 122.846 2.364 . . . . 0.0 112.413 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 14.8 tp 73.65 6.37 4.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.518 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 57.57 108.35 0.01 OUTLIER Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.753 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.54 -34.99 72.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.901 0.382 . . . . 0.0 110.727 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 63.97 98.94 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.255 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.636 HD11 ' CD1' ' A' ' 126' ' ' LEU . 16.2 tp 51.65 38.31 22.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.313 179.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.6 mmt85 -140.89 95.86 2.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.94 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 173.87 -146.25 8.66 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.528 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.422 HG21 ' CD ' ' A' ' 28' ' ' LYS . 12.2 p -107.45 152.83 8.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.803 0.335 . . . . 0.0 111.158 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.499 HD23 ' N ' ' A' ' 94' ' ' ASP . 1.4 tt -139.96 129.58 24.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.943 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.499 ' N ' HD23 ' A' ' 93' ' ' LEU . 0.6 OUTLIER -68.93 141.65 54.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.829 179.94 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.723 ' CG2' HG13 ' A' ' 146' ' ' VAL . 11.7 p -81.98 -29.08 0.48 Allowed Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.646 ' CD ' ' N ' ' A' ' 95' ' ' VAL . 98.6 Cg_endo -86.18 47.15 1.74 Allowed 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.149 1.899 . . . . 0.0 112.642 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -177.95 37.85 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.006 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 1.3 m -131.67 120.13 22.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.966 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.15 109.09 20.92 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.736 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.987 HD11 HG21 ' A' ' 143' ' ' ILE . 14.2 mm -75.35 157.66 5.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.079 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.414 ' N ' HG22 ' A' ' 100' ' ' ILE . . . -153.87 87.6 1.22 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.987 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 52.9 mt -58.58 146.22 8.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.193 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.83 104.82 5.77 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.618 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -73.65 52.95 2.61 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.36 2.04 . . . . 0.0 112.424 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.425 ' HG3' HD22 ' A' ' 111' ' ' LEU . 2.6 mt-10 168.0 56.65 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.408 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.418 ' O ' ' HG3' ' A' ' 107' ' ' LYS . . . -65.85 -102.6 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.768 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.418 ' HG3' ' O ' ' A' ' 106' ' ' GLY . 0.0 OUTLIER -154.35 -177.0 6.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.993 0.425 . . . . 0.0 111.191 -179.795 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.447 ' HB2' ' NE1' ' A' ' 17' ' ' TRP . 1.3 m-80 47.9 41.65 14.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.611 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 61.84 31.3 18.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.337 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 -118.31 106.3 12.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.517 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.425 HD22 ' HG3' ' A' ' 105' ' ' GLU . 3.3 mt -96.54 30.28 2.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.108 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.511 ' O ' HD13 ' A' ' 136' ' ' LEU . 39.4 m-85 -145.82 61.72 1.26 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.528 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.7 HG22 ' HB2' ' A' ' 129' ' ' ALA . 38.7 t -125.32 126.37 70.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.009 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.444 ' CZ ' ' HB ' ' A' ' 128' ' ' VAL . 35.8 p90 -103.63 131.53 50.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.578 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 13.0 t -105.45 127.08 52.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.105 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.956 HG23 HD13 ' A' ' 100' ' ' ILE . 12.8 mt -94.97 158.16 2.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.499 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 2.5 m -154.62 132.17 11.31 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.803 0.335 . . . . 0.0 111.146 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . 0.44 ' SD ' HD21 ' A' ' 93' ' ' LEU . 77.1 mtp -92.17 115.56 64.9 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.85 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -79.68 53.67 4.84 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.485 2.124 . . . . 0.0 112.519 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 30.5 t 177.59 39.95 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.634 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 45.6 t -145.66 -69.96 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.088 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -179.26 -155.13 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.416 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -83.78 49.27 1.58 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.738 0.304 . . . . 0.0 111.07 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 12.4 m95 -74.47 169.87 16.85 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.73 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -169.17 98.61 0.36 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.955 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.649 HD23 HD12 ' A' ' 116' ' ' ILE . 1.6 tp -83.97 95.73 8.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.075 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.5 130.56 35.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.96 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.832 HG12 HD12 ' A' ' 7' ' ' LEU . 21.7 t -152.25 159.03 4.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.147 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.7 ' HB2' HG22 ' A' ' 113' ' ' VAL . . . -164.81 131.05 2.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.241 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -97.55 141.52 30.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.981 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -55.66 -34.36 64.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.952 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.0 m -94.23 114.49 26.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.816 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.436 ' HG2' ' CZ ' ' A' ' 112' ' ' PHE . 1.1 mp0 -49.67 -27.16 4.37 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.431 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -74.77 -45.45 43.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.424 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -64.6 -31.38 72.58 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.202 179.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.525 ' O ' HG23 ' A' ' 140' ' ' VAL . 1.4 tp -68.05 -50.07 57.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.445 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.506 ' OE1' HD23 ' A' ' 136' ' ' LEU . 4.1 mp0 -68.17 -36.94 80.42 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.332 179.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -69.19 -34.4 74.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.163 179.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' TRP . . . . . 0.697 ' CZ2' HD23 ' A' ' 7' ' ' LEU . 1.3 m95 -63.8 -47.67 79.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.564 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.85 HG13 HG21 ' A' ' 100' ' ' ILE . 33.4 t -62.83 -44.5 99.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.801 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.1 -33.03 72.71 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.701 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.502 ' O ' HG12 ' A' ' 146' ' ' VAL . 0.2 OUTLIER -70.06 -50.89 36.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.378 179.72 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.987 HG21 HD11 ' A' ' 100' ' ' ILE . 66.8 mt -53.83 -31.27 20.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.178 0.513 . . . . 0.0 109.617 178.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 50.4 mtp85 -80.23 -32.37 38.44 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.159 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.427 ' O ' HG22 ' A' ' 149' ' ' THR . 4.9 pt-20 -77.97 -31.34 50.75 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.755 0.312 . . . . 0.0 110.895 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.723 HG13 ' CG2' ' A' ' 95' ' ' VAL . 9.8 p -83.63 -29.24 7.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.01 0.433 . . . . 0.0 110.296 179.217 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -75.3 -34.62 61.3 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.587 179.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -74.55 -11.5 60.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.952 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.443 HG22 ' HA ' ' A' ' 146' ' ' VAL . 10.5 t -117.23 13.05 14.57 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.285 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.2 -0.905 . . . . 0.0 111.204 -179.968 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.488 1.438 0 CA-C-O 120.822 0.344 . . . . 0.0 111.146 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.449 HD11 ' CB ' ' A' ' 26' ' ' SER . 15.6 mt -88.87 -32.88 5.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.051 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.599 ' O ' HG13 ' A' ' 23' ' ' VAL . 3.2 tptp -125.94 135.08 51.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.775 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 17.9 p-10 -154.52 121.8 5.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.006 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.503 ' C ' HD12 ' A' ' 6' ' ' ILE . . . -170.02 -145.68 4.8 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.485 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.653 ' N ' HD12 ' A' ' 6' ' ' ILE . 3.2 mp -127.97 88.44 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.824 0.345 . . . . 0.0 110.953 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.589 HD11 ' HB2' ' A' ' 130' ' ' ALA . 4.4 mm? -87.78 144.24 26.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.84 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -76.33 165.84 24.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.019 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -171.12 101.33 0.21 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.822 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.431 ' HG2' ' CZ3' ' A' ' 17' ' ' TRP . 0.3 OUTLIER -78.55 164.22 24.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.064 -179.875 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.4 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 2.2 t0 -126.42 132.1 24.19 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.714 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 11' ' ' ASP . 31.5 Cg_exo -58.98 -15.59 28.23 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.536 2.157 . . . . 0.0 112.917 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.1 t -68.78 -42.85 83.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.98 0.419 . . . . 0.0 111.438 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -115.41 -15.84 11.48 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.412 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 2.2 m80 62.79 42.7 7.73 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.931 0.396 . . . . 0.0 110.802 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.73 134.81 37.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.818 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.441 ' CD1' ' HG3' ' A' ' 110' ' ' ARG . 85.5 m95 -65.59 135.05 54.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.915 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.433 ' HB3' ' CD2' ' A' ' 20' ' ' HIS . 11.5 m-85 -120.31 104.59 43.04 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.939 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 18' ' ' TYR . 38.5 Cg_endo -67.05 107.84 1.41 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.48 2.12 . . . . 0.0 112.317 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.433 ' CD2' ' HB3' ' A' ' 18' ' ' TYR . 95.1 m-70 -132.25 158.08 42.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.869 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -59.85 151.38 25.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.925 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.477 ' CZ ' ' CD1' ' A' ' 31' ' ' TYR . 0.3 OUTLIER -154.9 142.9 20.13 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.806 -179.939 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.599 HG13 ' O ' ' A' ' 3' ' ' LYS . 14.3 t -139.29 145.82 26.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.158 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.495 HD12 HG12 ' A' ' 29' ' ' ILE . 27.2 tp -125.94 115.88 20.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.792 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 35.0 p -90.58 158.29 17.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.932 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.449 ' CB ' HD11 ' A' ' 2' ' ' ILE . 4.5 t -52.75 -24.0 7.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.693 -179.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.0 m -143.33 35.5 1.33 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.552 0.215 . . . . 0.0 111.435 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.528 ' CA ' HG23 ' A' ' 95' ' ' VAL . 1.2 tttt 177.73 179.21 0.3 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.891 0.377 . . . . 0.0 111.305 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.562 HD12 HD23 ' A' ' 93' ' ' LEU . 1.6 mt -141.25 130.27 24.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.715 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -124.52 133.59 53.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.078 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.477 ' CD1' ' CZ ' ' A' ' 22' ' ' PHE . 33.5 p90 -156.43 153.58 29.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.911 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 84.0 p -156.13 -171.04 3.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.848 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -142.22 33.49 1.51 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.811 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.48 94.66 4.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.824 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.54 -173.76 4.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.953 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.7 t 60.3 38.44 19.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.956 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -111.44 37.81 2.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.934 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -125.2 97.6 5.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.934 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 60.04 32.57 21.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.902 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -77.15 82.41 1.13 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.542 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.9 t30 59.56 50.3 7.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.85 0.357 . . . . 0.0 111.01 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -98.61 34.27 2.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.89 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.8 t0 61.69 88.08 0.09 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.838 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -87.74 122.97 32.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.947 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -173.68 178.76 2.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.848 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -156.8 84.1 3.1 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.893 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.54 145.57 52.98 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.628 2.218 . . . . 0.0 112.315 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.86 163.87 11.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.984 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -61.27 175.62 0.54 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.97 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -151.64 112.22 4.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.151 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 28.5 t 62.97 -79.9 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.939 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 148.04 129.47 1.88 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.469 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -147.23 152.11 37.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.847 0.356 . . . . 0.0 110.937 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.3 t -144.82 175.1 10.44 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.924 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -122.61 141.31 51.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.813 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.14 -58.47 3.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.958 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 8.2 t-160 -153.5 -47.43 0.09 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.854 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 60.1 m -128.04 153.5 46.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.922 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.544 ' O ' HD12 ' A' ' 60' ' ' LEU . 19.9 m -65.5 118.15 9.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.925 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.544 HD12 ' O ' ' A' ' 59' ' ' SER . 0.3 OUTLIER -149.85 -46.36 0.13 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.898 -179.987 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.23 -31.61 69.22 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.902 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.4 t -73.71 -31.1 30.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.165 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 15.8 mt -84.85 -4.38 59.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.3 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -90.02 24.96 2.27 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 121.233 0.54 . . . . 0.0 110.424 179.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.29 33.01 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.746 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.418 ' N ' ' CD ' ' A' ' 67' ' ' PRO . . . -165.9 50.43 0.27 Allowed Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.31 -179.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.418 ' CD ' ' N ' ' A' ' 66' ' ' GLY . 39.5 Cg_endo -66.54 128.32 18.94 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.528 2.152 . . . . 0.0 112.102 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.5 t30 63.2 117.44 0.02 OUTLIER Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.573 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.44 ' HB2' ' H ' ' A' ' 70' ' ' ALA . 47.1 Cg_endo -90.83 -136.74 0.02 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.876 2.384 . . . . 0.0 111.699 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.44 ' H ' ' HB2' ' A' ' 69' ' ' PRO . . . 58.59 27.63 15.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.901 0.381 . . . . 0.0 110.999 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 69' ' ' PRO . 7.0 mt -115.8 -16.58 8.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.647 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 72.8 mt -86.23 18.92 2.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.095 0.474 . . . . 0.0 111.592 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -149.09 82.39 7.09 Favored Pre-proline 0 C--N 1.316 -0.873 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.159 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_exo -66.57 59.3 0.52 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.94 2.427 . . . . 0.0 112.556 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -96.79 47.32 1.05 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.7 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.641 ' CD ' HD22 ' A' ' 79' ' ' LEU . 11.1 mtm-85 63.28 128.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.761 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -123.26 118.23 27.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.936 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 58.66 83.95 0.11 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.892 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.641 HD22 ' CD ' ' A' ' 76' ' ' ARG . 0.2 OUTLIER -132.07 -163.47 1.34 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.768 179.985 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -86.18 52.53 2.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.846 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -101.92 122.0 43.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.778 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -95.43 19.31 11.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.369 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.416 ' CB ' ' HD3' ' A' ' 84' ' ' PRO . 0.3 OUTLIER -80.9 -55.1 0.7 Allowed Pre-proline 0 C--N 1.331 -0.219 0 CA-C-O 120.895 0.378 . . . . 0.0 110.839 179.906 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.416 ' HD3' ' CB ' ' A' ' 83' ' ' SER . 95.8 Cg_endo -84.53 48.91 2.55 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 123.141 2.561 . . . . 0.0 112.483 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -128.67 30.4 5.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.958 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 156.02 -146.28 13.78 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.587 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.7 t0 61.38 18.8 9.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.716 0.294 . . . . 0.0 111.132 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 48.33 84.11 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.883 0.373 . . . . 0.0 111.301 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.0 117.57 15.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.806 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.97 82.43 0.17 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.692 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -67.67 131.18 28.83 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.499 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 11.5 p -129.06 142.65 43.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.863 0.364 . . . . 0.0 111.07 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.562 HD23 HD12 ' A' ' 29' ' ' ILE . 3.3 tp -147.31 145.05 29.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.931 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.0 133.11 34.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.827 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.777 HG11 HG23 ' A' ' 146' ' ' VAL . 19.8 t -82.46 -45.34 0.95 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.605 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.553 ' O ' ' HB2' ' A' ' 97' ' ' ALA . 11.6 Cg_exo -71.29 55.14 1.9 Allowed 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.632 2.221 . . . . 0.0 112.457 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.553 ' HB2' ' O ' ' A' ' 96' ' ' PRO . . . 168.83 40.47 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.878 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -157.37 98.25 1.69 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.989 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -80.27 129.79 34.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.693 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.713 HD13 HG23 ' A' ' 116' ' ' ILE . 10.7 mm -84.34 157.63 3.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.151 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.424 ' N ' HG22 ' A' ' 100' ' ' ILE . . . -145.84 88.41 1.82 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.869 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.612 HD13 ' NE2' ' A' ' 137' ' ' GLN . 86.3 mt -57.79 143.4 12.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.091 0.472 . . . . 0.0 111.349 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 9.0 mtt-85 -132.45 125.64 19.79 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.069 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -82.42 24.36 0.73 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.386 2.058 . . . . 0.0 112.956 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -176.77 74.83 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.948 0.404 . . . . 0.0 110.538 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -54.45 -93.77 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.68 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.79 172.01 1.02 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.877 0.37 . . . . 0.0 111.07 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 61.8 m-80 61.8 -82.04 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.149 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -152.96 42.9 0.62 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.95 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.441 ' HG3' ' CD1' ' A' ' 17' ' ' TRP . 0.6 OUTLIER -135.48 108.64 7.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.92 179.911 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.5 mt -78.28 -33.75 49.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.823 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.756 ' HB3' HD13 ' A' ' 136' ' ' LEU . 41.1 m-85 -108.7 115.24 29.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.975 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.552 HG13 ' HB2' ' A' ' 129' ' ' ALA . 21.1 t -153.22 140.23 12.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.029 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.436 ' CE2' ' HB ' ' A' ' 128' ' ' VAL . 25.3 p90 -119.93 115.31 23.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.828 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.4 p -93.44 125.94 38.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.992 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.713 HG23 HD13 ' A' ' 100' ' ' ILE . 3.1 mp -92.01 159.99 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.918 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.49 ' N ' HG22 ' A' ' 116' ' ' ILE . 22.1 p -158.43 158.96 35.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.955 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . 0.453 ' SD ' HG11 ' A' ' 121' ' ' VAL . 32.3 mtp -110.14 155.65 41.43 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.724 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -65.54 -30.9 51.68 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.528 2.152 . . . . 0.0 112.385 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 78.9 p -178.78 129.69 0.11 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.101 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.656 HG22 ' N ' ' A' ' 122' ' ' ALA . 0.2 OUTLIER -167.18 -80.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.817 179.799 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.656 ' N ' HG22 ' A' ' 121' ' ' VAL . . . -155.53 37.33 0.37 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.172 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 61.1 44.22 10.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.857 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . 0.541 ' CD1' ' HB3' ' A' ' 122' ' ' ALA . 27.2 m95 -90.45 132.62 35.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.061 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 59.9 m -128.33 139.23 52.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.837 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.639 HD13 ' H ' ' A' ' 127' ' ' ASP . 0.2 OUTLIER -118.72 143.32 46.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.944 0.402 . . . . 0.0 111.111 -179.92 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.639 ' H ' HD13 ' A' ' 126' ' ' LEU . 62.2 m-20 -130.56 119.13 22.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.52 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.611 HG23 HD12 ' A' ' 126' ' ' LEU . 21.9 t -141.32 159.61 22.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.172 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.552 ' HB2' HG13 ' A' ' 113' ' ' VAL . . . -159.66 141.16 12.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.222 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.589 ' HB2' HD11 ' A' ' 7' ' ' LEU . . . -105.97 145.75 30.92 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.834 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -58.13 -60.94 2.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.045 0.45 . . . . 0.0 110.875 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.8 t -70.7 115.7 10.16 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.72 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.443 ' HG3' ' CE2' ' A' ' 112' ' ' PHE . 0.1 OUTLIER -48.71 -26.45 2.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.664 179.59 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -76.03 -43.37 44.31 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.474 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.79 -32.49 74.06 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.292 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.756 HD13 ' HB3' ' A' ' 112' ' ' PHE . 8.1 tt -68.57 -50.07 54.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.465 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.612 ' NE2' HD13 ' A' ' 102' ' ' ILE . 57.9 mm-40 -68.17 -36.53 79.77 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.355 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -70.44 -29.77 66.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.446 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' TRP . . . . . 0.418 ' CE2' HD21 ' A' ' 7' ' ' LEU . 0.6 OUTLIER -69.28 -46.18 67.86 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.034 0.445 . . . . 0.0 110.621 179.629 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.547 HG13 HG21 ' A' ' 100' ' ' ILE . 21.9 t -63.31 -40.99 91.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.878 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 2.3 mtpp -64.18 -37.42 87.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.781 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.576 ' O ' HG22 ' A' ' 146' ' ' VAL . 0.0 OUTLIER -65.8 -54.3 28.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.374 179.706 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.621 HG21 HD11 ' A' ' 100' ' ' ILE . 70.9 mt -52.72 -32.99 17.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.194 0.521 . . . . 0.0 109.691 178.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 25.0 mtp85 -80.01 -29.3 39.39 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.388 179.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.45 ' O ' HG22 ' A' ' 149' ' ' THR . 1.2 tt0 -74.49 -37.4 63.17 Favored 'General case' 0 N--CA 1.457 -0.106 0 CA-C-O 120.922 0.391 . . . . 0.0 110.64 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.777 HG23 HG11 ' A' ' 95' ' ' VAL . 11.7 m -80.73 -28.32 11.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.228 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -78.98 -34.35 44.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.754 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -78.47 -10.01 59.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.958 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.517 HG22 ' HA ' ' A' ' 146' ' ' VAL . 12.4 t -110.84 -29.83 7.8 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.882 0.373 . . . . 0.0 111.066 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.198 -0.906 . . . . 0.0 111.111 179.948 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.816 0.341 . . . . 0.0 111.138 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.486 HD11 ' CB ' ' A' ' 26' ' ' SER . 30.5 mt -77.95 -36.13 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.138 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.436 ' HG2' ' CD1' ' A' ' 139' ' ' TRP . 0.2 OUTLIER -138.09 102.57 4.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.005 -179.906 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.845 ' HB3' HG13 ' A' ' 23' ' ' VAL . 2.6 p-10 -131.22 124.62 30.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.77 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -166.35 -147.22 5.13 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.55 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 25.2 mm -107.98 86.07 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.735 0.302 . . . . 0.0 111.168 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.75 HD12 HG12 ' A' ' 128' ' ' VAL . 0.4 OUTLIER -88.0 163.96 16.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.833 179.891 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.707 ' C ' HD23 ' A' ' 9' ' ' LEU . 23.0 m-85 -110.61 150.41 29.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.104 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.797 HD21 ' HB2' ' A' ' 20' ' ' HIS . 0.2 OUTLIER -161.29 129.52 4.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.772 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.435 ' HB3' ' CD2' ' A' ' 17' ' ' TRP . 0.2 OUTLIER -86.69 121.51 29.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.127 -179.772 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.529 ' HB3' HG22 ' A' ' 13' ' ' VAL . 0.3 OUTLIER -88.91 146.77 37.39 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.601 179.622 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.401 ' HA ' ' CD2' ' A' ' 15' ' ' HIS . 72.9 Cg_endo -75.0 -4.52 15.53 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.487 2.125 . . . . 0.0 113.388 -179.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.529 HG22 ' HB3' ' A' ' 11' ' ' ASP . 0.2 OUTLIER -67.97 -45.52 83.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.032 0.444 . . . . 0.0 110.818 179.972 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -128.6 -2.06 5.46 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.175 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.401 ' CD2' ' HA ' ' A' ' 12' ' ' PRO . 14.6 m170 57.62 74.83 0.4 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.964 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.95 135.47 1.77 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.976 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.435 ' CD2' ' HB3' ' A' ' 10' ' ' GLU . 27.9 m95 -63.92 134.37 54.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.895 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -135.98 148.62 65.65 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.922 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.77 124.58 10.31 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.594 2.196 . . . . 0.0 112.356 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.797 ' HB2' HD21 ' A' ' 9' ' ' LEU . 0.1 OUTLIER -141.09 111.45 6.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.897 179.877 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -54.28 111.38 0.77 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.124 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.51 ' CZ ' ' CD2' ' A' ' 31' ' ' TYR . 2.8 m-30 -109.27 155.77 20.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.829 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.845 HG13 ' HB3' ' A' ' 4' ' ' ASN . 24.5 t -142.0 92.52 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.122 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.7 tp -76.03 117.91 18.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.926 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 17.1 p -97.88 154.71 17.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.984 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.486 ' CB ' HD11 ' A' ' 2' ' ' ILE . 51.7 p -52.53 -24.66 8.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.997 -179.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -140.79 37.49 1.8 Allowed 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.99 -0.284 . . . . 0.0 111.726 -179.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 172.45 171.94 0.11 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.926 0.393 . . . . 0.0 111.383 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.6 mt -134.56 116.64 22.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.55 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -96.13 141.41 29.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.316 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.51 ' CD2' ' CZ ' ' A' ' 22' ' ' PHE . 4.4 m-85 -119.33 124.29 46.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.726 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 12.3 m -131.8 -176.79 4.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.824 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 67.91 115.59 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.121 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -100.81 159.39 15.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.684 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.47 175.15 10.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.974 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.6 t 61.57 114.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.977 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.9 m 60.88 -169.54 0.16 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.887 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -179.12 -37.82 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.786 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 63.45 62.8 0.93 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.837 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -98.79 89.64 0.94 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.35 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.66 38.77 15.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.883 0.373 . . . . 0.0 110.803 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -135.41 36.17 2.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.844 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -59.63 151.03 25.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.983 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -87.37 123.31 32.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.974 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -62.61 141.33 58.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.695 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -110.68 99.14 40.48 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.085 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -68.49 62.64 1.16 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.667 2.245 . . . . 0.0 112.132 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.37 -171.28 0.92 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.87 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -142.27 119.82 11.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.832 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.51 -69.86 0.71 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.116 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 61.49 90.38 0.07 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.033 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -77.21 155.84 44.56 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.453 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.0 t -99.77 114.56 27.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.791 0.329 . . . . 0.0 110.916 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 8.6 t -115.36 146.46 41.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.914 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -73.25 156.91 38.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.903 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 54.9 mt -64.8 -56.93 10.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.959 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -89.52 116.7 27.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.85 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.6 m -84.63 150.23 25.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.956 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -155.88 123.07 5.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.884 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.6 mt -171.09 -41.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.921 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.66 -31.16 72.25 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.828 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 26.2 t -70.26 -37.7 72.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.073 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.6 tp -72.84 -12.64 61.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.272 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -91.23 25.2 2.6 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.195 0.521 . . . . 0.0 110.687 179.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -164.36 29.91 0.07 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.831 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -120.45 -74.19 0.38 Allowed Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.061 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -49.83 140.36 30.64 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.825 2.35 . . . . 0.0 111.989 179.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 21.5 m120 60.83 110.99 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.688 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -84.32 27.64 0.6 Allowed 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.641 2.228 . . . . 0.0 113.101 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.07 29.34 3.91 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.932 0.396 . . . . 0.0 110.978 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.581 HG22 ' O ' ' A' ' 71' ' ' ILE . 44.1 mt -93.49 -4.26 10.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.62 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 98.4 mt -93.41 20.02 7.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.165 0.507 . . . . 0.0 111.558 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -139.57 68.33 37.91 Favored Pre-proline 0 C--N 1.315 -0.911 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.621 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -68.53 59.97 1.11 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.984 2.456 . . . . 0.0 112.278 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -85.95 -30.35 22.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.015 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.544 ' HD3' HD22 ' A' ' 79' ' ' LEU . 34.8 mtt85 -120.21 127.56 52.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.959 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -160.27 133.85 6.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.817 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 60.71 31.66 20.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.757 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.544 HD22 ' HD3' ' A' ' 76' ' ' ARG . 0.7 OUTLIER -63.88 -168.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.959 -179.958 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -72.35 68.67 0.78 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.811 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.24 -175.78 4.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.717 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 77.17 -53.6 0.55 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.286 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.51 ' CB ' ' HD2' ' A' ' 84' ' ' PRO . 0.8 OUTLIER 59.12 -179.97 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 -179.663 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.51 ' HD2' ' CB ' ' A' ' 83' ' ' SER . 59.5 Cg_endo -73.99 55.74 3.47 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 121.802 1.668 . . . . 0.0 112.435 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.2 tp -104.75 28.53 7.0 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 120.858 0.361 . . . . 0.0 111.008 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.26 -162.61 10.96 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.479 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -117.12 -37.18 3.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.749 0.309 . . . . 0.0 110.92 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 5.6 mp -73.19 -77.85 0.1 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.961 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.482 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -67.37 118.69 11.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.854 -179.873 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.97 -34.02 6.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.903 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -156.06 168.28 33.46 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.611 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 11.1 p -158.66 133.83 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.834 0.35 . . . . 0.0 111.026 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.451 HD23 ' O ' ' A' ' 94' ' ' ASP . 0.6 OUTLIER -146.31 153.49 40.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.892 -179.901 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.451 ' O ' HD23 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -83.82 137.31 33.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.903 -179.961 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.676 HG21 ' CG2' ' A' ' 146' ' ' VAL . 13.0 p -83.33 -27.99 0.42 Allowed Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.638 ' CD ' ' N ' ' A' ' 95' ' ' VAL . 89.8 Cg_endo -84.52 49.87 2.82 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.079 1.852 . . . . 0.0 112.593 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.406 ' HB2' ' O ' ' A' ' 96' ' ' PRO . . . 178.33 38.96 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.968 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -156.69 97.44 1.72 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.953 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -78.95 136.36 37.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.84 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.813 HD11 HG21 ' A' ' 143' ' ' ILE . 8.1 mm -87.52 161.21 2.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.168 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.445 ' N ' HG22 ' A' ' 100' ' ' ILE . . . -149.83 96.39 2.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.96 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 70.3 mt -61.03 149.85 7.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.079 0.466 . . . . 0.0 111.255 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.407 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 72.3 mtp180 -138.99 123.14 11.28 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.292 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 103' ' ' ARG . 6.3 Cg_exo -73.84 11.9 1.04 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.569 2.179 . . . . 0.0 113.004 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -160.37 67.82 0.35 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.103 0.478 . . . . 0.0 110.591 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.414 ' HA3' ' CG2' ' A' ' 113' ' ' VAL . . . -46.95 -88.67 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.224 0 CA-C-N 115.925 -0.579 . . . . 0.0 113.134 -179.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -174.99 162.59 3.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.849 0.357 . . . . 0.0 111.224 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 59.01 -84.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.157 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 44.7 m-20 -148.28 31.58 0.83 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.977 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.402 ' HB3' ' CG2' ' A' ' 113' ' ' VAL . 33.7 mmt180 -115.33 94.66 4.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.805 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.1 mt -67.65 -28.83 68.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.102 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -109.09 100.26 9.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.944 0.402 . . . . 0.0 111.094 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.423 HG11 ' CH2' ' A' ' 17' ' ' TRP . 42.8 t -146.47 127.27 6.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.69 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.439 ' CE2' ' HB ' ' A' ' 128' ' ' VAL . 29.6 p90 -108.65 124.31 50.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.064 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 28.0 t -94.48 129.46 41.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.672 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.791 HG23 HD13 ' A' ' 100' ' ' ILE . 11.0 mt -93.87 160.01 2.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.092 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.449 ' N ' HG22 ' A' ' 116' ' ' ILE . 0.3 OUTLIER -158.61 158.14 33.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.563 179.874 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . 0.44 ' HB2' ' CD1' ' A' ' 124' ' ' TRP . 13.4 mtp -98.02 152.72 38.19 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.748 0.309 . . . . 0.0 111.236 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -80.59 77.95 3.86 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.661 2.241 . . . . 0.0 112.6 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.686 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.9 OUTLIER 69.68 107.63 0.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.922 179.95 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.686 HG23 ' O ' ' A' ' 120' ' ' SER . 3.4 t -164.45 -76.61 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.318 0.58 . . . . 0.0 110.815 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.634 ' N ' HG12 ' A' ' 121' ' ' VAL . . . -146.65 -149.67 0.3 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.267 -0.878 . . . . 0.0 110.671 -179.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -89.36 29.94 1.05 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.747 0.308 . . . . 0.0 111.607 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . 0.449 ' CD1' ' HB ' ' A' ' 121' ' ' VAL . 1.7 p-90 -46.38 168.51 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.299 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.405 ' CB ' ' O ' ' A' ' 124' ' ' TRP . 0.9 OUTLIER 163.89 103.12 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.805 179.512 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.459 HD12 ' HA ' ' A' ' 126' ' ' LEU . 8.0 tp -116.39 157.37 25.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.99 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -142.86 139.27 30.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.896 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.75 HG12 HD12 ' A' ' 7' ' ' LEU . 22.4 t -151.74 153.5 9.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.131 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.5 ' O ' HD13 ' A' ' 7' ' ' LEU . . . -155.99 136.98 13.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.197 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -105.01 139.74 39.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.985 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -53.89 -35.85 62.05 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.903 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.5 m -93.32 111.53 23.21 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.811 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -48.35 -28.49 3.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.54 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.88 -43.34 58.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.216 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -67.12 -31.37 71.79 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.194 179.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.517 ' O ' HG23 ' A' ' 140' ' ' VAL . 6.4 tt -67.82 -46.92 70.49 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.503 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -69.0 -40.43 78.73 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.377 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.0 -29.1 68.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.286 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' TRP . . . . . 0.62 ' CZ2' HD23 ' A' ' 7' ' ' LEU . 1.1 m95 -68.52 -48.29 64.73 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.694 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.615 HG12 ' HD2' ' A' ' 144' ' ' ARG . 33.9 t -63.55 -39.86 86.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.678 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 31.2 tttt -63.79 -36.75 84.93 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.744 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.515 ' O ' HG22 ' A' ' 146' ' ' VAL . 1.2 mptp? -67.26 -52.32 42.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.273 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.813 HG21 HD11 ' A' ' 100' ' ' ILE . 69.5 mt -52.77 -33.45 18.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.16 0.505 . . . . 0.0 109.76 178.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.615 ' HD2' HG12 ' A' ' 140' ' ' VAL . 0.4 OUTLIER -79.59 -28.11 41.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.628 179.273 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.47 -38.29 55.59 Favored 'General case' 0 CA--C 1.523 -0.096 0 CA-C-O 120.856 0.36 . . . . 0.0 110.861 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.676 ' CG2' HG21 ' A' ' 95' ' ' VAL . 16.2 m -79.67 -29.28 13.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.299 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -77.83 -34.83 51.75 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.544 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -74.13 -13.78 60.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.987 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.445 HG22 ' HA ' ' A' ' 146' ' ' VAL . 10.8 t -107.51 -22.11 12.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.106 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.446 ' HB3' ' HB3' ' A' ' 96' ' ' PRO . . . . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.158 -0.925 . . . . 0.0 111.091 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.464 ' N ' HG22 ' A' ' 25' ' ' THR . 4.0 m . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.859 0.361 . . . . 0.0 111.164 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.906 HD11 ' HB3' ' A' ' 26' ' ' SER . 28.6 mt -71.77 -32.94 46.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.953 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.429 ' HD2' ' CD1' ' A' ' 139' ' ' TRP . 3.4 mttm -157.86 123.77 4.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.89 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.917 ' HB3' HG13 ' A' ' 23' ' ' VAL . 11.1 p-10 -143.99 135.04 25.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.909 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.553 ' C ' HD12 ' A' ' 6' ' ' ILE . . . -170.02 -135.47 1.91 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.434 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.642 ' N ' HD12 ' A' ' 6' ' ' ILE . 3.2 mp -127.15 83.64 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.963 0.411 . . . . 0.0 110.981 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.926 HD12 HG12 ' A' ' 128' ' ' VAL . 1.8 mm? -80.85 145.12 31.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.911 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -90.92 119.08 30.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.98 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.68 HD11 ' OH ' ' A' ' 31' ' ' TYR . 0.5 OUTLIER -126.86 144.22 51.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.95 179.903 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.434 ' HG2' ' CZ3' ' A' ' 17' ' ' TRP . 0.0 OUTLIER -87.5 122.81 31.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.895 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.406 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 1.2 t0 -93.14 126.68 50.03 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.67 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 11' ' ' ASP . 32.2 Cg_exo -58.37 -15.4 24.16 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.505 2.137 . . . . 0.0 112.869 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.0 t -68.76 -42.82 83.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.887 0.375 . . . . 0.0 111.275 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -115.82 -15.82 11.25 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.484 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 63.21 50.81 2.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.918 0.39 . . . . 0.0 110.907 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -157.31 157.25 33.82 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.89 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.434 ' CZ3' ' HG2' ' A' ' 10' ' ' GLU . 40.5 m95 -72.56 139.06 47.28 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.725 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -138.86 121.77 10.72 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.961 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.38 92.86 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.426 2.084 . . . . 0.0 112.256 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.549 ' HB2' HD21 ' A' ' 9' ' ' LEU . 43.9 m-70 -117.27 150.27 39.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.921 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -77.65 147.65 35.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.927 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.49 ' CE2' ' CD1' ' A' ' 31' ' ' TYR . 0.2 OUTLIER -154.57 133.81 12.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.765 -179.876 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.917 HG13 ' HB3' ' A' ' 4' ' ' ASN . 21.7 t -117.13 138.32 48.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.105 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 34.3 tp -118.69 104.08 10.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.879 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.464 HG22 ' N ' ' A' ' 1' ' ' SER . 0.6 OUTLIER -100.59 149.28 23.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.763 179.97 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.906 ' HB3' HD11 ' A' ' 2' ' ' ILE . 0.4 OUTLIER -63.04 -14.62 50.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.626 -179.94 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.2 t -105.89 -14.17 15.29 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.47 ' HA ' HG23 ' A' ' 95' ' ' VAL . 9.4 mttt -179.81 -173.32 0.24 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.916 0.388 . . . . 0.0 111.138 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.449 HG22 ' HE1' ' A' ' 22' ' ' PHE . 3.2 mt -129.72 130.13 66.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.436 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -106.82 142.85 35.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.016 0.436 . . . . 0.0 111.357 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.68 ' OH ' HD11 ' A' ' 9' ' ' LEU . 25.3 t80 -136.49 122.05 19.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.805 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.4 p -171.63 -177.83 2.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.986 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -110.33 142.68 41.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.899 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -107.12 145.34 32.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.908 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.44 175.6 0.43 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.92 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 59.91 103.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.901 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.2 t 61.5 115.75 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.931 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 176.97 -33.17 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.816 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 63.63 30.09 14.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.782 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -125.71 -33.75 0.68 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.533 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -100.33 34.94 2.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.86 0.362 . . . . 0.0 111.016 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -137.84 37.95 2.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.957 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -89.66 94.38 9.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.848 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -86.8 147.84 25.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.998 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -85.77 171.71 11.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.875 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -99.89 97.52 6.05 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.97 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -68.18 144.39 62.75 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.426 2.084 . . . . 0.0 112.306 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.9 mttt -69.31 132.22 46.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.924 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 57.7 mm-40 -73.36 154.34 40.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.907 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -126.76 143.39 51.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.094 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.3 m -95.07 74.91 3.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.877 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -69.04 161.69 51.88 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.463 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 63.8 m -83.83 63.19 7.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.915 0.388 . . . . 0.0 110.86 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -104.45 165.05 11.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.825 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -150.56 165.03 34.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.937 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.3 mt -60.3 -177.82 0.07 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.824 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 62.39 149.84 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.823 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 32.5 t -127.87 166.08 18.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.874 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.35 165.06 25.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.912 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.5 tt -59.53 -40.72 88.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.819 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -68.02 -31.47 71.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.552 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 26.0 t -69.48 -43.85 80.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.825 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.4 mt -59.68 -33.48 71.62 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.128 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -92.15 21.56 5.01 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.49 0.662 . . . . 0.0 109.821 178.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.433 ' O ' ' HG3' ' A' ' 65' ' ' GLN . 0.5 OUTLIER -155.0 28.62 0.41 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.856 -1.066 . . . . 0.0 109.133 179.718 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -113.62 -74.89 0.66 Allowed Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.156 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -54.1 -178.82 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.766 2.311 . . . . 0.0 112.163 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -56.38 108.86 1.34 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.099 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -88.91 20.94 1.03 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.756 2.304 . . . . 0.0 112.779 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.22 29.98 3.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.836 0.351 . . . . 0.0 111.284 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.484 HG22 ' O ' ' A' ' 71' ' ' ILE . 26.6 mt -100.44 -9.91 8.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.637 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 72' ' ' LEU . 20.6 mt -90.8 20.47 4.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.122 0.487 . . . . 0.0 111.603 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -145.2 70.7 14.47 Favored Pre-proline 0 C--N 1.319 -0.757 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.543 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -67.77 59.69 0.84 Allowed 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.012 2.475 . . . . 0.0 112.417 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -75.31 -78.39 0.11 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.875 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -93.57 137.87 32.41 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.889 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.446 ' H ' HD13 ' A' ' 79' ' ' LEU . 3.6 mm-40 -150.88 100.84 2.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.937 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 24.8 m170 60.92 43.65 11.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.95 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.446 HD13 ' H ' ' A' ' 77' ' ' GLU . 3.0 mp -87.09 -177.4 6.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.823 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -69.79 69.27 0.29 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.902 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -66.13 101.89 0.76 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.939 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 -131.74 24.59 4.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.089 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.415 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 0.4 OUTLIER -76.25 -57.1 1.44 Allowed Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.998 179.939 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.415 ' HD2' ' N ' ' A' ' 83' ' ' SER . 77.6 Cg_endo -79.22 57.46 6.48 Favored 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 122.98 2.453 . . . . 0.0 112.341 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 17.5 mt -142.53 34.58 1.45 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.872 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -111.82 97.56 0.94 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.503 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.635 ' HB3' HD23 ' A' ' 89' ' ' LEU . 1.0 OUTLIER -144.7 -47.3 0.24 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.91 0.386 . . . . 0.0 110.979 179.941 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 58.46 81.81 0.15 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.878 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.635 HD23 ' HB3' ' A' ' 87' ' ' ASP . 0.7 OUTLIER -132.64 54.83 1.92 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.971 -179.939 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -96.21 93.62 7.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.954 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.87 106.89 2.34 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.44 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.419 HG21 ' HD3' ' A' ' 28' ' ' LYS . 11.3 p -93.14 147.18 5.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.776 0.322 . . . . 0.0 111.082 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.2 mp -142.26 133.21 25.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.948 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.435 ' HA ' ' HG3' ' A' ' 28' ' ' LYS . 1.4 t0 -70.55 127.42 32.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.906 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.737 HG11 ' HB ' ' A' ' 146' ' ' VAL . 4.5 t -69.12 -45.96 29.68 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.347 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.492 ' CD ' ' N ' ' A' ' 95' ' ' VAL . 6.4 Cg_exo -73.87 56.37 3.56 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.766 2.311 . . . . 0.0 112.409 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.457 ' HB2' ' O ' ' A' ' 96' ' ' PRO . . . 175.22 38.94 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.021 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 34.2 m -148.6 108.67 4.08 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.902 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -91.45 126.25 36.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.816 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.937 HD13 HG23 ' A' ' 116' ' ' ILE . 6.4 mm -90.04 161.37 2.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.106 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.414 ' N ' HG22 ' A' ' 100' ' ' ILE . . . -152.52 88.66 1.36 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.857 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.402 HG22 ' N ' ' A' ' 103' ' ' ARG . 76.4 mt -57.02 152.54 2.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.283 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.402 ' N ' HG22 ' A' ' 102' ' ' ILE . 18.1 mtt180 -143.7 118.08 6.09 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.241 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -81.02 37.44 0.68 Allowed 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.351 2.034 . . . . 0.0 112.756 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -178.42 63.58 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.939 0.4 . . . . 0.0 110.525 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -56.37 -95.9 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.73 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.59 165.36 0.82 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.83 0.348 . . . . 0.0 111.126 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 31.6 m-20 56.12 47.14 20.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.073 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 24.6 m-20 63.17 58.26 1.46 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.088 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 6.8 mmt85 -152.25 88.73 1.39 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.782 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 69.4 mt -67.78 -33.01 73.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.02 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.682 ' HB3' HD13 ' A' ' 136' ' ' LEU . 19.0 m-85 -91.62 96.83 10.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.966 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 22.0 t -152.74 127.56 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.03 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.423 ' CZ ' ' HB ' ' A' ' 128' ' ' VAL . 43.4 p90 -114.64 138.55 50.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.785 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 20.3 m -107.63 128.38 54.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.074 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.937 HG23 HD13 ' A' ' 100' ' ' ILE . 20.0 mt -99.09 159.59 3.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.928 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.466 ' N ' HG22 ' A' ' 116' ' ' ILE . 81.1 p -152.54 158.81 43.06 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.866 0.365 . . . . 0.0 110.939 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 43.7 mtp -130.63 93.96 30.49 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.828 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.39 61.89 2.1 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.475 2.117 . . . . 0.0 112.306 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.7 m -165.16 -44.88 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.979 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.478 ' CG1' ' N ' ' A' ' 122' ' ' ALA . 2.5 p -75.57 -47.72 32.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.93 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.642 ' HB3' ' CD1' ' A' ' 124' ' ' TRP . . . 174.64 -163.32 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.742 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 24.1 mm-40 -93.6 44.92 1.14 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.886 0.374 . . . . 0.0 110.751 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . 0.642 ' CD1' ' HB3' ' A' ' 122' ' ' ALA . 13.7 m95 -98.39 130.17 45.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.901 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 8.6 t -120.47 133.99 55.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.941 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.551 HD23 HD12 ' A' ' 116' ' ' ILE . 12.2 tp -98.58 152.68 19.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.922 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -125.72 128.16 47.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.775 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.926 HG12 HD12 ' A' ' 7' ' ' LEU . 16.9 t -150.15 141.1 16.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.16 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.453 ' HB1' ' O ' ' A' ' 112' ' ' PHE . . . -143.57 121.86 12.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.167 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.441 ' HB2' HD11 ' A' ' 7' ' ' LEU . . . -82.39 142.2 32.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.883 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -54.07 -44.15 70.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.082 0.468 . . . . 0.0 110.95 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.1 p -92.63 120.4 33.02 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.718 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.401 ' HG3' ' CZ ' ' A' ' 112' ' ' PHE . 0.6 OUTLIER -49.86 -24.13 2.29 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.654 179.553 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -73.99 -48.15 32.28 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.626 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -62.76 -33.11 74.48 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.319 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.682 HD13 ' HB3' ' A' ' 112' ' ' PHE . 8.8 tt -66.92 -49.3 65.96 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.634 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -69.67 -36.44 76.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.416 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -70.98 -29.26 65.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.378 179.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' TRP . . . . . 0.541 ' CZ2' HD23 ' A' ' 7' ' ' LEU . 1.5 m95 -70.49 -46.05 64.46 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.742 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.616 HG13 HG21 ' A' ' 100' ' ' ILE . 26.2 t -64.55 -38.66 83.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.864 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.69 -38.04 88.13 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.835 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.419 ' O ' HG23 ' A' ' 146' ' ' VAL . 0.1 OUTLIER -66.0 -49.18 68.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.364 179.71 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.837 HG21 HD11 ' A' ' 100' ' ' ILE . 30.5 mt -54.1 -38.52 38.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.275 0.56 . . . . 0.0 109.573 178.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 14.7 mtt180 -77.95 -27.8 49.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.395 179.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.833 ' O ' HG23 ' A' ' 149' ' ' THR . 6.2 tt0 -73.34 -35.65 66.06 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.584 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.737 ' HB ' HG11 ' A' ' 95' ' ' VAL . 46.6 t -78.01 -34.02 18.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.034 179.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.71 -38.47 73.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.506 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -64.86 -20.34 66.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.611 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.833 HG23 ' O ' ' A' ' 145' ' ' GLU . 5.1 p -101.12 -33.48 10.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.118 0.485 . . . . 0.0 110.499 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.195 -0.907 . . . . 0.0 111.283 -179.953 . . . . . . . . 0 0 . 1 stop_ save_